PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sato, T; Nakamura, T				Sato, Toshihiko; Nakamura, Tatsuo			Tissue-engineered airway replacement	LANCET			English	Editorial Material							TRACHEA; RECONSTRUCTION; RESECTION		[Sato, Toshihiko; Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan	Kyoto University	Sato, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.	tsato@frontier.kyoto-u.ac.jp						Elliott MJ, 1996, EUR J CARDIO-THORAC, V10, P707, DOI 10.1016/S1010-7940(96)80328-9; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; GRILLO HC, 1964, J THORAC CARDIOV SUR, V48, P741, DOI 10.1016/S0022-5223(19)33357-4; Kojima K, 2002, J THORAC CARDIOV SUR, V123, P1177, DOI 10.1067/mtc.2002.121161; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Nakamura T, 2000, INT J ARTIF ORGANS, V23, P718, DOI 10.1177/039139880002301010; Omori K, 2005, ANN OTO RHINOL LARYN, V114, P429, DOI 10.1177/000348940511400603; ROSE KG, 1979, LANCET, V1, P433; Suzuki T, 2008, ANN OTO RHINOL LARYN, V117, P453, DOI 10.1177/000348940811700609; Wright CD, 2004, J THORAC CARDIOV SUR, V128, P731, DOI 10.1016/j.jtcvs.2004.07.005	11	14	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2003	2004		10.1016/S0140-6736(08)61599-8	http://dx.doi.org/10.1016/S0140-6736(08)61599-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19022497				2022-12-28	WOS:000261746900004
J	Morey, M; Yee, SK; Herman, T; Nern, A; Blanco, E; Zipursky, SL				Morey, Marta; Yee, Susan K.; Herman, Tory; Nern, Aljoscha; Blanco, Enrique; Zipursky, S. Lawrence			Coordinate control of synaptic-layer specificity and rhodopsins in photoreceptor neurons	NATURE			English	Article							DROSOPHILA VISUAL-SYSTEM; AXON-TARGET INTERACTIONS; TRANSCRIPTION FACTOR; CELL FATES; NF-Y; R7; SENSELESS; DIFFERENTIATION; SELECTION; PROSPERO	How neurons make specific synaptic connections is a central question in neurobiology. The targeting of the Drosophila R7 and R8 photoreceptor axons to different synaptic layers in the brain provides a model with which to explore the genetic programs regulating target specificity. In principle this can be accomplished by cell- type- specific molecules mediating the recognition between synaptic partners(1). Alternatively, specificity could also be achieved through cell- type- specific repression of particular targeting molecules. Here we show that a key step in the targeting of the R7 neuron is the active repression of the R8 targeting program. Repression is dependent on NF-YC, a subunit of the NF-Y ( nuclear factor Y) transcription factor(2). In the absence of NF-YC, R7 axons terminate in the same layer as R8 axons. Genetic experiments indicate that this is due solely to the derepression of the R8specific transcription factor Senseless(3) ( Sens) late in R7 differentiation. Sens is sufficient to control R8 targeting specificity and we demonstrate that Sens directly binds to an evolutionarily conserved DNA sequence upstream of the start of transcription of an R8- specific cell- surface protein, Capricious ( Caps) that regulates R8 target specificity. We show that R7 targeting requires the R7- specific transcription factor Prospero(4,5) ( Pros) in parallel to repression of the R8 targeting pathway by NF-YC. Previous studies demonstrated that Sens(6,7) and Pros(8) directly regulate the expression of specific rhodopsins in R8 and R7. We propose that the use of the same transcription factors to promote the cell- type- specific expression of sensory receptors and cell- surface proteins regulating synaptic target specificity provides a simple and general mechanism for ensuring that transmission of sensory information is processed by the appropriate specialized neural circuits.	[Morey, Marta; Yee, Susan K.; Herman, Tory; Nern, Aljoscha; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Blanco, Enrique] Univ Barcelona, Dept Genet, E-08028 Barcelona, Catalunya, Spain; [Blanco, Enrique] Univ Barcelona, IBUB, E-08028 Barcelona, Catalunya, Spain	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Barcelona; University of Barcelona	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Blanco, Enrique/I-5902-2015; Ramonell, Marta Morey/F-8864-2015; Ramonell, Marta Morey/AAS-1160-2020	Blanco, Enrique/0000-0001-6261-7370; Ramonell, Marta Morey/0000-0001-9732-1983; Ramonell, Marta Morey/0000-0001-9732-1983; Zipursky, Stephen/0000-0001-5630-7181	Ruth L. Kirschstein National Research Service Award [GM7185]; Burroughs Wellcome Fund for Biomedical Research; European Molecular Biology Organization; Human Frontiers Science Program; Juan de la Cierva postdoctoral contract; Ministerio de Educacion y Ciencia [BMC2006- 07334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund for Biomedical Research(Burroughs Wellcome Fund); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Juan de la Cierva postdoctoral contract; Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. N. Jan, H. J. Bellen, A. Nose, S. Britt, C. Desplan, T. Cook, U. Banerjee, the Developmental Studies Hybridoma Bank and Bloomington Stock Center for reagents; H. Schjerven, S. T. Smale and M. Carey for advice and assistance with gel-shift assays; and members of the Zipursky laboratory for comments on the manuscript. S.L.Z. is an investigator of the Howard Hughes Medical Institute. M.M. was supported by the Howard Hughes Medical Institute. S.K.Y. was supported by the Ruth L. Kirschstein National Research Service Award GM7185. T.H. was supported by the Burroughs Wellcome Fund for Biomedical Research. A.N. was supported by the European Molecular Biology Organization and the Human Frontiers Science Program. E. B. was supported by Juan de la Cierva postdoctoral contract and the grant BMC2006- 07334 from the Ministerio de Educacion y Ciencia (MEC), Spain.	Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Domingos PM, 2004, DEV BIOL, V273, P121, DOI 10.1016/j.ydbio.2004.05.026; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Miller AC, 2008, DEVELOPMENT, V135, P707, DOI 10.1242/dev.016386; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yoshioka Y, 2007, GENESIS, V45, P21, DOI 10.1002/dvg.20260	29	64	64	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					795	U82		10.1038/nature07419	http://dx.doi.org/10.1038/nature07419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18978774	Green Accepted			2022-12-28	WOS:000261559900050
J	Hansen, CJ; Esposito, LW; Stewart, AIF; Meinke, B; Wallis, B; Colwell, JE; Hendrix, AR; Larsen, K; Pryor, W; Tian, F				Hansen, C. J.; Esposito, L. W.; Stewart, A. I. F.; Meinke, B.; Wallis, B.; Colwell, J. E.; Hendrix, A. R.; Larsen, K.; Pryor, W.; Tian, F.			Water vapour jets inside the plume of gas leaving Enceladus	NATURE			English	Article							CASSINI; SPECTROSCOPY; DUST	A plume of water vapour escapes from fissures crossing the south polar region of the Saturnian moon Enceladus(1-6). Tidal deformation of a thin surface crust above an internal ocean could result in tensile and compressive stresses that would affect the width of the fissures(7); therefore, the quantity of water vapour released at different locations in Enceladus' eccentric orbit is a crucial measurement of tidal control of venting. Here we report observations of an occultation of a star by the plume on 24 October 2007 that revealed four high- density gas jets superimposed on the background plume. The gas jet positions coincide with those of dust jets reported elsewhere(8) inside the plume. The maximum water column density in the plume is about twice the density reported earlier(2). The density ratio does not agree with predictions(7)-we should have seen less water than was observed in 2005. The ratio of the jets' bulk vertical velocities to their thermal velocities is 1.5 +/- 0.2, which supports the hypothesis that the source of the plume is liquid water, with gas accelerated to supersonic velocity in nozzle- like channels(9).	[Hansen, C. J.; Wallis, B.; Hendrix, A. R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Esposito, L. W.; Stewart, A. I. F.; Meinke, B.; Larsen, K.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Colwell, J. E.] Univ Cent Florida, Planetary Sci Grp, Orlando, FL 32816 USA; [Pryor, W.] Cent Arizona Coll, Dept Sci, Coolidge, AZ 85228 USA; [Tian, F.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Central Florida; Massachusetts Institute of Technology (MIT)	Hansen, CJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	candice.j.hansen@jpl.nasa.gov	Colwell, Joshua/AAP-2692-2020; ESPOSITO, LARRY W/AAB-3673-2021; Tian, Feng/C-1344-2015	Colwell, Joshua/0000-0001-8269-6408; ESPOSITO, LARRY W/0000-0003-3381-2016; Tian, Feng/0000-0002-9607-560X; Meinke, Bonnie/0000-0001-5931-9305	Cassini Project at the Jet Propulsion Laboratory; California Institute of Technology; National Aeronautics and Space Administration	Cassini Project at the Jet Propulsion Laboratory; California Institute of Technology; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	We acknowledge the Cassini Navigation Team, particularly B. Buffington and Y. Hahn, whowere central to the success of this observation. This work was supported by the Cassini Project at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.	COLWELL JE, 1990, ICARUS, V83, P102, DOI 10.1016/0019-1035(90)90009-X; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Esposito LW, 2008, ICARUS, V194, P278, DOI 10.1016/j.icarus.2007.10.001; Esposito LW, 2004, SPACE SCI REV, V115, P299, DOI 10.1007/s11214-004-1455-8; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hurford TA, 2007, NATURE, V447, P292, DOI 10.1038/nature05821; HURFORD TA, 2008, LUNAR PLANET SCI C, V39; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Matson DL, 2007, ICARUS, V187, P569, DOI 10.1016/j.icarus.2006.10.016; Mota R, 2005, CHEM PHYS LETT, V416, P152, DOI 10.1016/j.cplett.2005.09.073; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217; Tian F, 2007, ICARUS, V188, P154, DOI 10.1016/j.icarus.2006.11.010; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	18	97	97	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					477	479		10.1038/nature07542	http://dx.doi.org/10.1038/nature07542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037310				2022-12-28	WOS:000261170500032
J	Trost, BM; Dong, GB				Trost, Barry M.; Dong, Guangbin			Total synthesis of bryostatin 16 using atom-economical and chemoselective approaches	NATURE			English	Article							ANALOGS; ALCOHOLS; ESTERS	Of the concepts used to improve the efficiency of organic syntheses, two have been especially effective: atom economy(1) ( the use of routes in which most of the atoms present in the reactants also end up in the product) and chemoselectivity(2) ( the use of reactions that take place only at desired positions in a molecule). Synthesis of complex natural products is the most demanding arena in which to explore such principles. The bryostatin family of compounds are especially interesting targets, because they combine structural complexity with promising biological activity(3-7). Furthermore, synthetic routes to some bryostatins have already been reported(9-12), providing a benchmark against which new syntheses can be measured. Here we report a concise total synthesis of bryostatin 16 ( 1), a parent structure from which almost all other bryostatins could in principle be accessed. Application of atom-economical and chemoselective reactions currently under development provides ready access to polyhydropyran motifs in the molecule, which are common structural features of many other natural products. The most notable transformations are two transition-metal- catalysed reactions. The first is a palladium- catalysed reaction of two different alkynes to form a large ring. The product of this step is then converted into a dihydropyran ( the 'C ring' of bryostatins) in the second key reaction, which is catalysed by a gold compound. Analogues of bryostatin that do not exist in nature could be readily made by following this route, which might allow the biological activity of bryostatins to be fine- tuned.	[Trost, Barry M.; Dong, Guangbin] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Trost, BM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bmtrost@stanford.edu			National Institutes of Health [GM 13598]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013598, R37GM013598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the National Institutes of Health (GM 13598) for their support of our programs. G. D. is a Stanford Graduate Fellow. We thank H. Yang for discussions and for help characterizing compound 21, and we additionally thank him and C. S. Brindle for providing synthetic intermediates. Palladium and ruthenium salts were supplied by Johnson Matthey. We acknowledge S. R. Lynch for his help with two-dimensional nuclear magnetic resonance analysis. We also thank the Wender group's assistance with reverse-phase high-performance liquid chromatography.	Ball M, 2006, TETRAHEDRON LETT, V47, P2223, DOI 10.1016/j.tetlet.2006.01.097; BROWN HC, 1983, J AM CHEM SOC, V105, P2092, DOI 10.1021/ja00345a085; Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1987, DOI 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO;2-Z; DELLAQUILA ML, 1988, CANCER RES, V48, P3702; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Dowlati A, 2003, CLIN CANCER RES, V9, P5929; Evans DA, 1999, J AM CHEM SOC, V121, P7540, DOI 10.1021/ja990860j; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; INANAGA J, 1979, B CHEM SOC JPN, V52, P1989, DOI 10.1246/bcsj.52.1989; KAGEYAMA M, 1990, J AM CHEM SOC, V112, P7407, DOI 10.1021/ja00176a058; Keck GE, 2008, J AM CHEM SOC, V130, P6660, DOI 10.1021/ja8022169; Lin MJ, 2003, J AM CHEM SOC, V125, P13042, DOI 10.1021/ja037410i; Liu YH, 2005, ORG LETT, V7, P5409, DOI 10.1021/ol052160r; Manaviazar S, 2006, ORG LETT, V8, P4477, DOI 10.1021/ol061626i; Newman DJ, 2004, J NAT PROD, V67, P1216, DOI 10.1021/np040031y; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1378, DOI 10.1002/anie.200462207; Ohmori K, 2000, ANGEW CHEM INT EDIT, V39, P2290; Pettit GR, 1996, J NAT PROD, V59, P286, DOI 10.1021/np960100b; PETTIT GR, 1991, CAN J CHEM, V69, P856, DOI 10.1139/v91-126; Roth GJ, 2004, SYNTHESIS-STUTTGART, P59, DOI 10.1055/s-2003-44346; SCHAUFELBERGER DE, 1991, J NAT PROD, V54, P1265, DOI 10.1021/np50077a004; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Trost BM, 2007, J AM CHEM SOC, V129, P2206, DOI 10.1021/ja067305j; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Trost BM, 2005, ORG LETT, V7, P4761, DOI 10.1021/ol0520065; TROST BM, 1989, J AM CHEM SOC, V111, P8745, DOI 10.1021/ja00205a041; TROST BM, 1983, SCIENCE, V219, P245, DOI 10.1126/science.219.4582.245; Wender PA, 2008, ORG LETT, V10, P3331, DOI 10.1021/ol801235h; Wender PA, 2008, J AM CHEM SOC, V130, P6658, DOI 10.1021/ja8015632	30	198	200	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					485	488		10.1038/nature07543	http://dx.doi.org/10.1038/nature07543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	376FW	19037312	Green Accepted			2022-12-28	WOS:000261170500034
J	Doumy, G; DiMauro, LF				Doumy, Gilles; DiMauro, Louis F.			CHEMISTRY Interrogating Molecules	SCIENCE			English	Editorial Material							HARMONIC-GENERATION; RARE-GASES; IONIZATION		[Doumy, Gilles; DiMauro, Louis F.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Doumy, G (corresponding author), Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA.	gdoumy@mps.ohio-state.edu; dimauro@mps.ohio-state.edu						CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Kitzler M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025029; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; LI XF, 1989, PHYS REV A, V39, P5751, DOI 10.1103/PhysRevA.39.5751; Mairesse Y, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025015; McFarland BK, 2008, SCIENCE, V322, P1232, DOI 10.1126/science.1162780; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h	13	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1194	1195		10.1126/science.1166078	http://dx.doi.org/10.1126/science.1166078			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023069				2022-12-28	WOS:000261033400024
J	Matos, J; Lipp, JJ; Bogdanova, A; Guillot, S; Okaz, E; Junqueira, M; Shevchenko, A; Zachariae, WG				Matos, Joao; Lipp, Jesse J.; Bogdanova, Aliona; Guillot, Sylvine; Okaz, Elwy; Junqueira, Magno; Shevchenko, Andrej; Zachariae, Wolfgang			Dbf4-Dependent Cdc7 Kinase Links DNA Replication to the Segregation of Homologous Chromosomes in Meiosis I	CELL			English	Article							MEIOTIC RECOMBINATION; YEAST MEIOSIS; S-PHASE; CENTROMERIC COHESION; SYNAPTONEMAL COMPLEX; MONOPOLAR ATTACHMENT; MOLECULAR-BIOLOGY; FISSION YEAST; PROTEIN; INITIATION	Meiosis differs from mitosis in that DNA replication is followed by the segregation of homologous chromosomes but not sister chromatids. This depends on the formation of interhomolog connections through crossover recombination and on the attachment of sister kinetochores to microtubules emanating from the same spindle pole. We show that in yeast, the Dbf4-dependent Cdc7 kinase (DDK) provides a link between premeiotic S phase, recombination, and monopolar attachment. Independently from its established role in initiating DNA replication, DDK promotes double-strand break formation, the first step of recombination, and the recruitment of the monopolin complex to kinetochores, which is essential for monopolar attachment. DDK regulates monopolin localization together with the polo-kinase Cdc5 bound to Spo13, probably through phosphorylation of the monopolin subunit Lrs4. Thus, activation of DDK both initiates DNA replication and commits meiotic cells to reductional chromosome segregation in the first division of meiosis.	[Matos, Joao; Lipp, Jesse J.; Bogdanova, Aliona; Guillot, Sylvine; Okaz, Elwy; Junqueira, Magno; Shevchenko, Andrej; Zachariae, Wolfgang] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Zachariae, WG (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zachariae@mpi-cbg.de	Matos, Joao/C-1488-2014; Junqueira, Magno/A-7495-2012	Matos, Joao/0000-0002-3754-3709; Junqueira, Magno/0000-0002-7036-0728				Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lo HC, 2008, MOL BIOL CELL, V19, P4956, DOI 10.1091/mbc.E08-07-0755; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Ogino K, 2006, P NATL ACAD SCI USA, V103, P8131, DOI 10.1073/pnas.0602498103; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Sclafani RA, 2000, J CELL SCI, V113, P2111; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Valentin G, 2006, J BIOL CHEM, V281, P2828, DOI 10.1074/jbc.M510626200; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	42	115	116	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					662	678		10.1016/j.cell.2008.10.026	http://dx.doi.org/10.1016/j.cell.2008.10.026			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013276	Bronze			2022-12-28	WOS:000260886900017
J	Johnson, S; Abonyi, S; Jeffery, B; Hackett, P; Hampton, M; McIntosh, T; Martz, D; Muhajarine, N; Petrucka, P; Sari, N				Johnson, Shanthi; Abonyi, Sylvia; Jeffery, Bonnie; Hackett, Paul; Hampton, Mary; McIntosh, Tom; Martz, Diane; Muhajarine, Nazeem; Petrucka, Pammla; Sari, Nazmi			Recommendations for action on the social determinants of health: a Canadian perspective	LANCET			English	Editorial Material							NATIONS; POLICY		[Johnson, Shanthi; Jeffery, Bonnie; Hampton, Mary; McIntosh, Tom] Univ Regina, Fac Social Work, Saskatchewan Populat Hlth & Evaluat Res Unit, Prince Albert, SK S6V 7M3, Canada; [Abonyi, Sylvia; Hackett, Paul; Martz, Diane; Muhajarine, Nazeem; Petrucka, Pammla; Sari, Nazmi] Univ Saskatchewan, Saskatchewan Populat Hlth & Evaluat Res Unit, Saskatoon, SK, Canada	University of Regina; University of Saskatchewan	Jeffery, B (corresponding author), Univ Regina, Fac Social Work, Saskatchewan Populat Hlth & Evaluat Res Unit, POB 2830, Prince Albert, SK S6V 7M3, Canada.	Bonnie.Jeffery@uregina.ca	Muhajarine, Nazeem/D-7360-2012	Petrucka, Pammla/0000-0003-3174-3328; Abonyi, Sylvia/0000-0003-2657-4144; Johnson, Shanthi/0000-0001-6586-1619				*ACCC INT, 2005, WIND OPP CAP DEV ROL; AGREN G, 2003, SWEDENS NEW PUBLIC H; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; *ATH HLTH AUTH, 2003 2004 ANN REP; BENNET J, 2003, INVESTMENT POP HLTH; Beveridge William, 1942, SOCIAL INSURANCE ALL; BLACK C, 2005, DATA DATA EVERYWHERE; Braveman P, 2002, SOC SCI MED, V54, P1621, DOI 10.1016/S0277-9536(01)00331-8; *CAN, 1964, REP ROY COMM HLTH SE, V1; *CAN I HLTH RES, 2006, POP HLTH INT RES CAN; *CAN I HLTH RES, STRAT TRAIN IN HLTH; Canadian Institute for Health Information, 2008, HLTH IND; *DEP HLTH, 2003, TACKL HLTH IN PROGR; Etches V, 2006, ANNU REV PUBL HEALTH, V27, P29, DOI 10.1146/annurev.publhealth.27.021405.102141; Foreign Affairs and International Trade Canada, 2005, CAN INT POL STAT ROL; HUNTER G, 2008, QUESTION PROSPERITY; JEFFERY B, 2006, COMMUNITY HLTH IND T; JEFFERY B, 2008, EVALUATION FRAMEWORK; LALONDE CE, 2005, CREATING INDEX HLTH; Lalonde M, 1974, NEW PERSPECTIVE HLTH; Low J, 2008, HEALTH PROMOT INT, V23, P200, DOI 10.1093/heapro/dan002; Marmot MG., 2006, SOCIAL DETERMINANTS; Martens P, 2008, WHAT WORKS 1 LOOK EV; Mignone J, 2005, INT J INDIG HEALTH, V2, P26; Muhajarine N., 2007, KIDSFIRST PROGRAM EV; *PUBL HLTH AG CAN, CAN RESP WHO COMM SO; Raphael D., 2007, POVERTY POLICY CANAD; *SEN, POP HLTH POL ISS OPT; *STAT CAN, 2006, HLTH REP, V16, P1; Statistics Canada, CAN COMM HLTH SURV; Ten Fingers K, 2005, CAN J PUBLIC HEALTH, V96, pS60, DOI 10.1007/BF03405319; *WHO REG OFF EUR, 1999, VER BENCHM SYST CHAR; Williamson DL, 2003, HEALTH POLICY, V64, P173, DOI 10.1016/S0168-8510(02)00163-X; World Health Organization, WORLD HLTH SURV	34	9	10	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1690	1693		10.1016/S0140-6736(08)61694-3	http://dx.doi.org/10.1016/S0140-6736(08)61694-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994668	Green Submitted			2022-12-28	WOS:000260899900032
J	Steinberger, B				Steinberger, Bernhard			GEOPHYSICS Reconstructing Earth History in Three Dimensions	SCIENCE			English	Editorial Material							OCEAN		[Steinberger, Bernhard] Geol Survey Norway, Ctr Geodynam, N-7491 Trondheim, Norway	Geological Survey of Norway	Steinberger, B (corresponding author), Geol Survey Norway, Ctr Geodynam, N-7491 Trondheim, Norway.	bernhard.steinberger@ngu.no	Steinberger, Bernhard/ABB-9204-2021; Steinberger, Bernhard/AAG-7148-2019	Steinberger, Bernhard/0000-0002-3643-3049				Bijwaard H, 1998, J GEOPHYS RES-SOL EA, V103, P30055, DOI 10.1029/98JB02467; Bunge HP, 2000, NATURE, V405, P337, DOI 10.1038/35012586; Bunge HP, 2003, GEOPHYS J INT, V152, P280, DOI 10.1046/j.1365-246X.2003.01823.x; GURNIS M, 1990, NATURE, V344, P754, DOI 10.1038/344754a0; Hafkenscheid E, 2001, TECTONOPHYSICS, V333, P35, DOI 10.1016/S0040-1951(00)00265-1; Ismail-Zadeh A, 2004, PHYS EARTH PLANET IN, V145, P99, DOI 10.1016/j.pepi.2004.03.006; Liu LJ, 2008, SCIENCE, V322, P934, DOI 10.1126/science.1162921; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	10	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					866	868		10.1126/science.1166395	http://dx.doi.org/10.1126/science.1166395			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988830				2022-12-28	WOS:000260674100025
J	Wang, J; Wang, W; Li, RQ; Li, YR; Tian, G; Goodman, L; Fan, W; Zhang, JQ; Li, J; Zhang, JB; Guo, YR; Feng, BX; Li, H; Lu, Y; Fang, XD; Liang, HQ; Du, ZL; Li, D; Zhao, YQ; Hu, YJ; Yang, ZZ; Zheng, HC; Hellmann, I; Inouye, M; Pool, J; Yi, X; Zhao, J; Duan, JJ; Zhou, Y; Qin, JJ; Ma, LJ; Li, GQ; Yang, ZT; Zhang, GJ; Yang, B; Yu, C; Liang, F; Li, WJ; Li, SC; Li, DW; Ni, PX; Ruan, J; Li, QB; Zhu, HM; Liu, DY; Lu, ZK; Li, N; Guo, GW; Zhang, JG; Ye, J; Fang, L; Hao, Q; Chen, Q; Liang, Y; Su, YY; San, A; Ping, C; Yang, S; Chen, F; Li, L; Zhou, K; Zheng, HK; Ren, YY; Yang, L; Gao, Y; Yang, GH; Li, Z; Feng, XL; Kristiansen, K; Wong, GKS; Nielsen, R; Durbin, R; Bolund, L; Zhang, XQ; Li, SG; Yang, HM; Wang, J				Wang, Jun; Wang, Wei; Li, Ruiqiang; Li, Yingrui; Tian, Geng; Goodman, Laurie; Fan, Wei; Zhang, Junqing; Li, Jun; Zhang, Juanbin; Guo, Yiran; Feng, Binxiao; Li, Heng; Lu, Yao; Fang, Xiaodong; Liang, Huiqing; Du, Zhenglin; Li, Dong; Zhao, Yiqing; Hu, Yujie; Yang, Zhenzhen; Zheng, Hancheng; Hellmann, Ines; Inouye, Michael; Pool, John; Yi, Xin; Zhao, Jing; Duan, Jinjie; Zhou, Yan; Qin, Junjie; Ma, Lijia; Li, Guoqing; Yang, Zhentao; Zhang, Guojie; Yang, Bin; Yu, Chang; Liang, Fang; Li, Wenjie; Li, Shaochuan; Li, Dawei; Ni, Peixiang; Ruan, Jue; Li, Qibin; Zhu, Hongmei; Liu, Dongyuan; Lu, Zhike; Li, Ning; Guo, Guangwu; Zhang, Jianguo; Ye, Jia; Fang, Lin; Hao, Qin; Chen, Quan; Liang, Yu; Su, Yeyang; San, A.; Ping, Cuo; Yang, Shuang; Chen, Fang; Li, Li; Zhou, Ke; Zheng, Hongkun; Ren, Yuanyuan; Yang, Ling; Gao, Yang; Yang, Guohua; Li, Zhuo; Feng, Xiaoli; Kristiansen, Karsten; Wong, Gane Ka-Shu; Nielsen, Rasmus; Durbin, Richard; Bolund, Lars; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian			The diploid genome sequence of an Asian individual	NATURE			English	Article							STRUCTURAL VARIATION; REVEALS; DISEASE; DNA	Here we present the first diploid genome sequence of an Asian individual. The genome was sequenced to 36- fold average coverage using massively parallel sequencing technology. We aligned the short reads onto the NCBI human reference genome to 99.97% coverage, and guided by the reference genome, we used uniquely mapped reads to assemble a high- quality consensus sequence for 92% of the Asian individual's genome. We identified approximately 3 million single- nucleotide polymorphisms ( SNPs) inside this region, of which 13.6% were not in the dbSNP database. Genotyping analysis showed that SNP identification had high accuracy and consistency, indicating the high sequence quality of this assembly. We also carried out heterozygote phasing and haplotype prediction against HapMap CHB and JPT haplotypes ( Chinese and Japanese, respectively), sequence comparison with the two available individual genomes ( J. D. Watson and J. C. Venter), and structural variation identification. These variations were considered for their potential biological impact. Our sequence data and analyses demonstrate the potential usefulness of next- generation sequencing technologies for personal genomics.	[Wang, Jun; Wang, Wei; Li, Ruiqiang; Li, Yingrui; Tian, Geng; Goodman, Laurie; Fan, Wei; Zhang, Junqing; Li, Jun; Zhang, Juanbin; Guo, Yiran; Feng, Binxiao; Li, Heng; Lu, Yao; Fang, Xiaodong; Liang, Huiqing; Du, Zhenglin; Li, Dong; Zhao, Yiqing; Hu, Yujie; Yang, Zhenzhen; Zheng, Hancheng; Yi, Xin; Zhao, Jing; Duan, Jinjie; Zhou, Yan; Qin, Junjie; Ma, Lijia; Li, Guoqing; Yang, Zhentao; Zhang, Guojie; Yang, Bin; Yu, Chang; Liang, Fang; Li, Wenjie; Li, Shaochuan; Li, Dawei; Ni, Peixiang; Ruan, Jue; Li, Qibin; Zhu, Hongmei; Liu, Dongyuan; Lu, Zhike; Li, Ning; Guo, Guangwu; Zhang, Jianguo; Ye, Jia; Fang, Lin; Hao, Qin; Chen, Quan; Liang, Yu; Su, Yeyang; San, A.; Ping, Cuo; Yang, Shuang; Chen, Fang; Li, Li; Zhou, Ke; Zheng, Hongkun; Ren, Yuanyuan; Yang, Ling; Gao, Yang; Yang, Guohua; Li, Zhuo; Feng, Xiaoli; Wong, Gane Ka-Shu; Bolund, Lars; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian] Beijing Genom Inst Shenzhen, Shenzhen 518000, Peoples R China; [Wang, Jun; Yang, Guohua; Li, Songgang; Yang, Huanming; Wang, Jian] Shenzhen Univ Med Sch, Genome Res Inst, Shenzhen 518000, Peoples R China; [Wang, Jun; Wang, Wei; Li, Ruiqiang; Yang, Huanming; Wang, Jian] Natl Engn Ctr Genom & Bioinformat, Beijing 101300, Peoples R China; [Wang, Jun; Li, Ruiqiang; Zheng, Hongkun; Kristiansen, Karsten] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Li, Yingrui; Chen, Quan; Li, Songgang] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Li, Yingrui; Gao, Yang; Zhang, Xiuqing] Chinese Acad Sci, Beijing Inst Genom, Beijing Genom Inst, Beijing 101300, Peoples R China; [Tian, Geng; Guo, Yiran; Zhao, Yiqing; Hu, Yujie; Yi, Xin; Qin, Junjie; Ma, Lijia; Zhang, Guojie; Liang, Fang; Ruan, Jue; Li, Qibin; Li, Ning; Guo, Guangwu; Hao, Qin; Liang, Yu; Su, Yeyang; San, A.; Ping, Cuo; Chen, Fang] Grad Univ Chinese Acad Sci, Beijing 100062, Peoples R China; [Li, Heng; Inouye, Michael; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hellmann, Ines; Pool, John; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Hellmann, Ines; Pool, John; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB T6G 2E9, Canada; [Bolund, Lars] Aarhus Univ, Inst Human Genet, DK-8000 Aarhus, Denmark	Beijing Genomics Institute (BGI); Shenzhen University; University of Southern Denmark; Peking University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wellcome Trust Sanger Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Alberta; University of Alberta; Aarhus University	Wang, J (corresponding author), Beijing Genom Inst Shenzhen, Shenzhen 518000, Peoples R China.	wangj@genomics.org.cn; wangjian@genomics.org.cn	Zhang, Guojie/J-7273-2019; Li, Yingrui/K-1064-2015; Durbin, Richard/AAE-7178-2019; Guo, Yiran/H-4120-2011; Kristiansen, Karsten/J-5148-2014; Wang, Jun/A-7261-2013; Yang, Zhenzhen/X-3839-2019; Fang, Xiaodong/K-6743-2018; Nielsen, Rasmus/D-4405-2009; Li, Heng/D-9344-2011; WONG, Gane Ka-Shu/G-5784-2013; Zhang, Guojie/B-6188-2014; Yu, Chang/AAE-8538-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Zhang, Guojie/0000-0001-6860-1521; Durbin, Richard/0000-0002-9130-1006; Kristiansen, Karsten/0000-0002-6024-0917; Fang, Xiaodong/0000-0001-7061-3337; Nielsen, Rasmus/0000-0003-0513-6591; Li, Heng/0000-0003-4874-2874; WONG, Gane Ka-Shu/0000-0001-6108-5560; Zhang, Guojie/0000-0001-6860-1521; Wang, Jun/0000-0002-2113-5874; Pool, John/0000-0003-2968-9545; Wang, Jun/0000-0002-8540-8931; Fan, Wei/0000-0001-5036-8733; Duan, Jinjie/0000-0002-3402-302X; Li, Jun/0000-0001-7218-429X; Goodman, Laurie/0000-0001-9724-5976; Ruan, Jue/0000-0003-3713-3192; Inouye, Michael/0000-0001-9413-6520; Hao, Qin/0000-0002-6775-2181; FENG, Binxiao(BENM)/0000-0002-9975-9126; Zhang, Jianguo/0000-0003-0723-1701	Shenzhen Municipal Government; Yantian District local government of Shenzhen; Shenzhen University; National Natural Science Foundation of China [30890032, 30725008, 90403130, 90608010, 30221004, 90612019, 30392130]; Ministry of Science and Technology of China [973 program, 2007CB815701, 2007CB815703, 2007CB815705, 863 program, 2006AA02Z334, 2006AA10A121, 2006AA02Z177]; Chinese Academy of Sciences [GJHZ0701-6, KSCX2-YWN-023]; Beijing Municipal Science and Technology Commission [D07030200740000]; Danish Platform for Integrative Biology; Ole Romer grant; Danish Natural Science Research Council; Danish Research Council; Solexa project [272-07-0196]; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Shenzhen Municipal Government; Yantian District local government of Shenzhen; Shenzhen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Danish Platform for Integrative Biology; Ole Romer grant; Danish Natural Science Research Council(Danish Natural Science Research Council); Danish Research Council(Det Frie Forskningsrad (DFF)); Solexa project; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are indebted to the faculty and staff of Beijing Genomics Institute at Shenzhen, whose names were not included in the author list, but who contributed to this work. This project is funded by the Shenzhen Municipal Government and the Yantian District local government of Shenzhen, and Shenzhen University assisted in this work. This study is also supported by the National Natural Science Foundation of China (30890032, 30725008, 90403130, 90608010, 30221004, 90612019, 30392130), the Ministry of Science and Technology of China ( 973 program: 2007CB815701, 2007CB815703, 2007CB815705; 863 program: 2006AA02Z334, 2006AA10A121, 2006AA02Z177), the Chinese Academy of Sciences (GJHZ0701-6, KSCX2-YWN-023), the Beijing Municipal Science and Technology Commission (D07030200740000), the Danish Platform for Integrative Biology, the Ole Romer grant from the Danish Natural Science Research Council, a pig bioinformatics grant from Danish Research Council and the Solexa project (272-07-0196), and the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP). We thank Illumina Inc. for their assistance in setting up the Illumina Genome Analyzer platform and providing technology support. We appreciate the help of R. Gibbs and D. Wheeler with the SNP data set of the genome of J.D. Watson, and S. Levy's help for providing HuRef novel sequences. LUDAOPEI Hospital provided karyotyping of the DNA sample.	Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wright S, 1931, GENETICS, V16, P0097; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	20	683	718	0	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					60	U1		10.1038/nature07484	http://dx.doi.org/10.1038/nature07484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987735	Green Accepted, hybrid			2022-12-28	WOS:000260674000040
J	Mercier, R; Petit, MA; Schbath, S; Robin, S; El Karoui, M; Boccard, F; Espeli, O				Mercier, Romain; Petit, Marie-Agnes; Schbath, Sophie; Robin, Stephane; El Karoui, Meriem; Boccard, Frederic; Espeli, Olivier			The MatP/matS Site-Specific System Organizes the Terminus Region of the E-coli Chromosome into a Macrodomain	CELL			English	Article							SEPARATE CELL HALVES; BACILLUS-SUBTILIS; DNA-REPLICATION; BINDING-SITES; SEGREGATION; PROTEIN; IDENTIFICATION; MOVEMENT; ARMS; MAINTENANCE	The organization of the Escherichia coli chromosome into insulated macrodomains influences the segregation of sister chromatids and the mobility of chromosomal DNA. Here, we report that organization of the Terminus region (Ter) into a macrodomain relies on the presence of a 13 bp motif called matS repeated 23 times in the 800-kb-long domain. matS sites are the main targets in the E. coli chromosome of a newly identified protein designated MatP. MatP accumulates in the cell as a discrete focus that colocalizes with the Ter macrodomain. The effects of MatP inactivation reveal its role as main organizer of the Ter macrodomain: in the absence of MatP, DNA is less compacted, the mobility of markers is increased, and segregation of Ter macrodomain occurs early in the cell cycle. Our results indicate that a specific organizational system is required in the Terminus region for bacterial chromosome management during the cell cycle.	[Mercier, Romain; Boccard, Frederic; Espeli, Olivier] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Petit, Marie-Agnes; El Karoui, Meriem] INRA, Unite Bacteries Lact & Pathogenes Opportuniste, UR888, F-78350 Jouy En Josas, France; [Schbath, Sophie] INRA, UR Math Informat & Genome 1077, F-78350 Jouy En Josas, France; [Robin, Stephane] AgroParisTech INRA, Unite Math & Informat Appl, UMR518, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Boccard, F (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	boccard@cgm.cnrs-gif.fr; espeli@cgm.cnrs-gif.fr	Mercier, Romain/E-3642-2012; espeli, olivier/A-6337-2009	Petit, Marie-Agnes/0000-0003-2242-2768; SCHBATH, Sophie/0000-0003-3574-8222; Boccard, Frederic/0000-0002-1866-2489; espeli, olivier/0000-0003-2804-2192; El Karoui, Meriem/0000-0003-2522-613X	Agence Nationale de la Recherche; Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire; ACI Biologie Cellulaire, Moleculaire, Structurale; Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire; ACI Biologie Cellulaire, Moleculaire, Structurale; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank Kenneth Marians, Benedicte Michel, and Linda Sperling for critical reading of the manuscript, Stuart Austin, Flemming Hansen, Takashi Horiuchi, Christophe Possoz, and David Sherratt for the kind gift of FROS systems and the Ssb-YFP strain, and Francois-Xavier Barre, Philippe Bouloc, Nelly Dubarry, Alexandra Gruss, Christelle Hennequet-Antier, Sandrine Imbault, Christian Lesterlin, and Michele Valens for helpful discussions. The Migale bioinformatics platform (Institut National de la Recherche Agronomique) provided computational resources. Macroarrays were obtained in the framework of Program "Puces a ADN'' from Centre National de la Recherche Scientifique and the program "Microbiologie, Maladies Infectieuses et parasitaires'' of the French Ministere de l'Education Nationale, de la Recherche et de la Technologie. This study was supported by the Agence Nationale de la Recherche (F.B.), the Action Concertee Incitative (ACI) Informatique, Mathematiques, Physique en Biologie moleculaire (S. S., F. B., and M. E.), the ACI Biologie Cellulaire, Moleculaire, Structurale (F. B.), and the Association pour la Recherche sur le Cancer (F. B.).	Adachi S, 2008, GENES CELLS, V13, P181, DOI 10.1111/j.1365-2443.2007.01157.x; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; BLAKELY G, 1991, NEW BIOL, V3, P789; Brezellec P, 2006, BIOINFORMATICS, V22, P1935, DOI 10.1093/bioinformatics/btl336; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Guarne A, 2005, EMBO J, V24, P1502, DOI 10.1038/sj.emboj.7600634; Halpern D, 2007, PLOS GENET, V3, P1614, DOI 10.1371/journal.pgen.0030153; HILDEBRANDT ER, 1995, CELL, V81, P331, DOI 10.1016/0092-8674(95)90386-0; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mearini G, 2006, CELL CYCLE, V5, P1989, DOI 10.4161/cc.5.17.3186; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Murtin C, 1998, J MOL BIOL, V284, P949, DOI 10.1006/jmbi.1998.2256; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Niki H, 2000, GENE DEV, V14, P212; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Robin S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-84; Sunako Y, 2001, MOL MICROBIOL, V42, P1233, DOI 10.1046/j.1365-2958.2001.02680.x; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	33	187	189	3	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					475	485		10.1016/j.cell.2008.08.031	http://dx.doi.org/10.1016/j.cell.2008.08.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984159	Green Submitted, Bronze			2022-12-28	WOS:000260536300018
J	Alenghat, T; Meyers, K; Mullican, SE; Leitner, K; Adeniji-Adele, A; Avila, J; Bucan, M; Ahima, RS; Kaestner, KH; Lazar, MA				Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Adeniji-Adele, Adetoun; Avila, Jacqueline; Bucan, Maja; Ahima, Rexford S.; Kaestner, Klaus H.; Lazar, Mitchell A.			Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology	NATURE			English	Article							REV-ERB-ALPHA; THYROID-HORMONE RECEPTOR; GENE-EXPRESSION; GLUCOSE-HOMEOSTASIS; CLOCK; TRANSCRIPTION; REPRESSION; PROMOTER; DELETION; ELEMENTS	Rhythmic changes in histone acetylation at circadian clock genes suggest that temporal modulation of gene expression is regulated by chromatin modifications(1-3). Furthermore, recent studies demonstrate a critical relationship between circadian and metabolic physiology(4-7). The nuclear receptor corepressor 1 (Ncor1) functions as an activating subunit for the chromatin modifying enzyme histone deacetylase 3 (Hdac3)(8). Lack of Ncor1 is incompatible with life, and hence it is unknown whether Ncor1, and particularly its regulation of Hdac3, is critical for adult mammalian physiology(9). Here we show that specific, genetic disruption of the Ncor1-Hdac3 interaction in mice causes aberrant regulation of clock genes and results in abnormal circadian behaviour. These mice are also leaner and more insulin- sensitive owing to increased energy expenditure. Unexpectedly, loss of a functional Ncor1-Hdac3 complex in vivo does not lead to sustained increases in known catabolic genes, but instead significantly alters the oscillatory patterns of several metabolic genes, demonstrating that circadian regulation of metabolism is critical for normal energy balance. These findings indicate that activation of Hdac3 by Ncor1 is a nodal point in the epigenetic regulation of circadian and metabolic physiology.	[Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Avila, Jacqueline; Ahima, Rexford S.; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Alenghat, Theresa; Meyers, Katherine; Mullican, Shannon E.; Leitner, Kirstin; Avila, Jacqueline; Ahima, Rexford S.; Kaestner, Klaus H.; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Adeniji-Adele, Adetoun; Bucan, Maja; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019; Ahima, Rexford/W-1394-2019		National Institutes of Health [DK43806]; National Research Training Grant in Developmental Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK050306, R37DK043806, P30DK019525, R01DK043806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Training Grant in Developmental Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Pear for providing EIIa-CreC57BL/6 mice, G. Barnes and J. Rusche for providing MS-275, P. White and J. Tobias for bioinformatics assistance, and L. Yin, S.-H. You, M. Qatanani and other members of the Lazar laboratory for helpful discussions. We also thank J. Richa and The Transgenic Mouse Core, H. Collins and the Radioimmunoassay/Biomarkers Core, R. Dhir and the Metabolic Phenotyping Core of the Penn Diabetes and Endocrinology Research Center (DK19525), H. Fu and the Mouse Embryonic Stem Cell Core (DK49210) and the Morphology Core of the Center for Molecular Studies in Digestive and Liver Disease (DK50306 and DK49210) for consultation and services. This work was supported by National Institutes of Health grant DK43806 (to M.A.L.), and T.A. was supported by a National Research Training Grant in Developmental Biology.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; LEONE TC, 1995, J BIOL CHEM, V270, P16308, DOI 10.1074/jbc.270.27.16308; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qi Y, 2006, DIABETES, V55, P3083, DOI 10.2337/db05-0615; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schultz TF, 2003, SCIENCE, V301, P326, DOI 10.1126/science.1085935; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200	34	200	213	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					997	U88		10.1038/nature07541	http://dx.doi.org/10.1038/nature07541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19037247	Green Accepted			2022-12-28	WOS:000261768300056
J	Barna, M; Pusic, A; Zollo, O; Costa, M; Kondrashov, N; Rego, E; Rao, PH; Ruggero, D				Barna, Maria; Pusic, Aya; Zollo, Ornella; Costa, Maria; Kondrashov, Nadya; Rego, Eduardo; Rao, Pulivarthi H.; Ruggero, Davide			Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency	NATURE			English	Article							KINASE GENE-COMPLEX; C-MYC; CELL-CYCLE; MEDIATED TRANSLATION; ENTRY SITE; CANCER; 1P36; TUMORIGENESIS; CYTOKINESIS; CONTRIBUTES	The Myc oncogene regulates the expression of several components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, RNA polymerase III and ribosomal DNA(1,2). Whether and how increasing the cellular protein synthesis capacity affects the multistep process leading to cancer remains to be addressed. Here we use ribosomal protein heterozygote mice as a genetic tool to restore increased protein synthesis in E mu-Myc/+ transgenic mice to normal levels, and show that the oncogenic potential of Myc in this context is suppressed. Our findings demonstrate that the ability of Myc to increase protein synthesis directly augments cell size and is sufficient to accelerate cell cycle progression independently of known cell cycle targets transcriptionally regulated by Myc. In addition, when protein synthesis is restored to normal levels, Myc- overexpressing precancerous cells are more efficiently eliminated by programmed cell death. Our findings reveal a new mechanism that links increases in general protein synthesis rates downstream of an oncogenic signal to a specific molecular impairment in the modality of translation initiation used to regulate the expression of selective messenger RNAs. We show that an aberrant increase in cap- dependent translation downstream of Myc hyperactivation specifically impairs the translational switch to internal ribosomal entry site ( IRES)- dependent translation that is required for accurate mitotic progression. Failure of this translational switch results in reduced mitotic- specific expression of the endogenous IRES- dependent form of Cdk11 ( also known as Cdc21 and PITSLRE)(3-5), which leads to cytokinesis defects and is associated with increased centrosome numbers and genome instability in E mu-Myc/+ mice. When accurate translational control is re- established in E mu-Myc/+ mice, genome instability is suppressed. Our findings demonstrate how perturbations in translational control provide a highly specific outcome for gene expression, genome stability and cancer initiation that have important implications for understanding the molecular mechanism of cancer formation at the post- genomic level.	[Barna, Maria; Kondrashov, Nadya] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Pusic, Aya; Zollo, Ornella; Costa, Maria; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Pusic, Aya; Zollo, Ornella; Costa, Maria; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Rego, Eduardo] Univ Sao Paulo, Ctr Cell Based Therapy, Fdn Hemoctr Ribeirao Preto, BR-14048900 Sao Paulo, Brazil; [Rao, Pulivarthi H.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universidade de Sao Paulo; Baylor College of Medicine	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Rock Hall Room 384C,1550 4th St, San Francisco, CA 94158 USA.	maria.barna@ucsf.edu; Davide.Ruggero@ucsf.edu	Rego, Eduardo M/A-1058-2012; Rego, Eduardo M./Y-5572-2019; Rego, Eduardo/AFS-7973-2022; Costa, Maria Jose/I-7754-2013	Rego, Eduardo M/0000-0003-1567-4086; Rego, Eduardo M./0000-0003-1567-4086; Rego, Eduardo/0000-0003-1567-4086; Costa, Maria Jose/0000-0001-6111-7614	NIH; Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. McCormick, G. Evan and P. O'Farrell for critically reading the manuscript; J. Testa for support and critical discussion during early stages of this work; W. Xu and R. Adamo for technical assistance; J. Copley for editing the manuscript, S. Cornelis for the Cdk11 IRES bicistronic vector. This work was supported by the NIH (D.R.) and the Sandler Foundation (M.B.).	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chandramouli A, 2007, CARCINOGENESIS, V28, P2028, DOI 10.1093/carcin/bgm066; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Dave BJ, 1999, CANCER GENET CYTOGEN, V108, P120, DOI 10.1016/S0165-4608(98)00138-1; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; LAHTI JM, 1994, NAT GENET, V7, P370, DOI 10.1038/ng0794-370; Lenahan MK, 1996, ONCOGENE, V12, P1847; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Nelson MA, 1999, CANCER GENET CYTOGEN, V108, P91, DOI 10.1016/S0165-4608(98)00122-8; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Wade M, 2006, CURR TOP MICROBIOL, V302, P169; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	35	298	307	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					971	U79		10.1038/nature07449	http://dx.doi.org/10.1038/nature07449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011615	Green Accepted, Green Submitted			2022-12-28	WOS:000261768300050
J	Edvinsson, L				Edvinsson, Lars			CGRP-receptor antagonism in migraine treatment	LANCET			English	Editorial Material							GENE-RELATED PEPTIDE; CALCITONIN-GENE; NEUROPEPTIDE CHANGES; HEADACHE; RELEASE; HUMANS		[Edvinsson, Lars] Univ Lund Hosp, Dept Internal Med, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Edvinsson, L (corresponding author), Univ Lund Hosp, Dept Internal Med, S-22185 Lund, Sweden.	lars.edvinsson@med.lu.se		Edvinsson, Lars/0000-0002-1805-1346				Edvinsson L, 2008, BRIT J PHARMACOL, V155, P967, DOI 10.1038/bjp.2008.346; EDVINSSON L, 1990, BRIT J PHARMACOL, V100, P312, DOI 10.1111/j.1476-5381.1990.tb15801.x; EDVINSSON L, 1985, NEUROSCI LETT, V58, P213, DOI 10.1016/0304-3940(85)90166-1; EDVINSSON L, 1986, FUNCTIONAL ROLE TRIG; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; GOADSBY PJ, 1994, BRAIN, V117, P427, DOI 10.1093/brain/117.3.427; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; HO TW, 2008, LANCET          1125; MCCULLOCH J, 1986, P NATL ACAD SCI USA, V83, P5731, DOI 10.1073/pnas.83.15.5731; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Tepper SJ, 2008, HEADACHE, V48, P1259, DOI 10.1111/j.1526-4610.2008.01214.x; UDDMAN R, 1985, NEUROSCI LETT, V62, P131, DOI 10.1016/0304-3940(85)90296-4	14	20	30	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2089	2090		10.1016/S0140-6736(08)61710-9	http://dx.doi.org/10.1016/S0140-6736(08)61710-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19036426				2022-12-28	WOS:000261894000004
J	Jagger, C; Gillies, C; Moscone, F; Cambois, E; Van Oyen, H; Nusselder, W; Robine, JM				Jagger, Carol; Gillies, Clare; Moscone, Francesco; Cambois, Emmanuelle; Van Oyen, Herman; Nusselder, Wilma; Robine, Jean-Marie		EHLEIS Team	Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis	LANCET			English	Article							INDIVIDUAL PATIENT DATA; OLD-AGE; EXPECTANCY; MORTALITY; DISABILITY; LEVEL; GENDER; TRENDS	Background Although life expectancy in the European Union (EU) is increasing, whether most of these extra years are spent in good health is unclear. This information would be crucial to both contain health-care costs and increase labour-force participation for older people. We investigated inequalities in life expectancies and healthy life years (HLYs) at 50 years of age for the 25 countries in the EU in 2005 and the potential for increasing the proportion of older people in the labour force. Methods We calculated life expectancies and HLYs at 50 years of age by sex and country by the Sullivan method, which was applied to Eurostat life tables and age-specific prevalence of activity limitation from the 2005 statistics of living and income conditions survey. We investigated differences between countries through meta-regression techniques, with structural and sustainable indicators for every country. Findings In 2005, an average 50-year-old man in the 25 EU countries could expect to live until 67.3 years free of activity limitation, and a woman to 68.1 years. HLYs at 50 years for both men and women varied more between countries than did life expectancy (HLY range for men: from 9.1 years in Estonia to 23.6 years in Denmark; for women: from 10 . 4 years in Estonia to 24. 1 years in Denmark). Gross domestic product and expenditure on elderly care were both positively associated with HLYs at 50 years in men and women (p<0 . 039 for both indicators and sexes); however, in men alone, long-term unemployment was negatively associated (p=0 . 023) and life-long learning positively associated (p=0 . 021) with HLYs at 50 years of age. Interpretation Substantial inequalities in HLYs at 50 years exist within EU countries. Our findings suggest that, without major improvements in population health, the target of increasing participation of older people into the labour force will be difficult to meet in all 25 EU countries. Funding EU Public Health Programme.	[Jagger, Carol; Gillies, Clare] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Moscone, Francesco] Univ Leicester, Dept Econ, Leicester LE1 6TP, Leics, England; [Cambois, Emmanuelle] INED, Inst Demog Studies, Paris, France; [Van Oyen, Herman] Sci Inst Publ Hlth, Brussels, Belgium; [Nusselder, Wilma] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Rotterdam, Netherlands; [Robine, Jean-Marie] INSERM, French Inst Hlth & Med Res, Montpellier, France	University of Leicester; University of Leicester; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Jagger, C (corresponding author), Univ Leicester, Dept Hlth Sci, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.	cxj@le.ac.uk	Robine, Jean-Marie/F-5439-2011	Robine, Jean-Marie/0000-0002-4111-6195; Jagger, Carol/0000-0002-6377-9926; Van Oyen, Herman/0000-0003-2119-4433; Gillies, Clare/0000-0002-8417-9700; Moscone, Francesco/0000-0001-5378-680X	Eurostat	Eurostat	We thank Eurostat for their support.	Acemoglu D, 2003, J EUR ECON ASSOC, V1, P397, DOI 10.1162/154247603322391035; Bajekal Madhavi, 2005, Health Stat Q, P18; BALTAGI B, 2008, HLTH EXPENDITU UNPUB; Beland F, 2002, SOC SCI MED, V55, P2033, DOI 10.1016/S0277-9536(01)00344-6; BREAKWELL C, 2005, HLTH STAT Q, V26, P17; Cambois E, 2001, DEMOGRAPHY, V38, P513, DOI 10.1353/dem.2001.0033; CAMBOIS E, IN PRESS EUR J AGEIN; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Grabauskas V, 2002, SCAND J PUBLIC HEALT, V30, P12, DOI 10.1177/14034948020300032001; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Guralnik JM, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00174-0; Hunt-McCool J, 1998, ECON EDUC REV, V17, P237, DOI 10.1016/S0272-7757(97)00045-9; JAGGER C, 1999, NIHON U POPULATION R, V68; Jagger C, 2007, INT J EPIDEMIOL, V36, P358, DOI 10.1093/ije/dyl307; Janssen F, 2004, J CLIN EPIDEMIOL, V57, P203, DOI [10.1016/j.jclinepi.2003.07.005, 10.1016/j.clinepi.2003.07.005]; Lafortune G., 2007, 26 ORG EC COOP DEV; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Matthews RJ, 2006, SOC SCI MED, V62, P2489, DOI 10.1016/j.socscimed.2005.11.019; Melzer D, 2000, J EPIDEMIOL COMMUN H, V54, P286, DOI 10.1136/jech.54.4.286; Murthy NRV, 2006, ATLANTIC ECON J, V34, P237, DOI 10.1007/s11293-006-9011-4; NEWHOUSE JP, 1977, J HUM RESOUR, V12, P115, DOI 10.2307/145602; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Robine J-M., 2003, DETERMINING HLTH EXP, P75, DOI 10.1002/0470858885.ch4; Robine JM, 2003, EUR J PUBLIC HEALTH, V13, P6, DOI 10.1093/eurpub/13.suppl_1.6; ROMANS F, TRANSITION WOMEN MEN; SANDERS BS, 1964, AM J PUBLIC HEALTH N, V54, P1063, DOI 10.2105/AJPH.54.7.1063; Siegrist J, 2007, EUR J PUBLIC HEALTH, V17, P62, DOI 10.1093/eurpub/ckl084; *SPRING EUR COUNC, 2005, WORK TOG GROWTH JOBS; Subramanian SV, 2002, ANNU REV PUBL HEALTH, V23, P287, DOI 10.1146/annurev.publhealth.23.100901.140540; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Oyen H, 2006, SOZ PRAVENTIV MED, V51, P153, DOI 10.1007/s00038-006-0035-y; Velkova A, 1997, INT J EPIDEMIOL, V26, P75, DOI 10.1093/ije/26.1.75; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; Williamson JB, 1997, SOC SCI MED, V45, P305, DOI 10.1016/S0277-9536(96)00346-2	39	215	218	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2124	2131		10.1016/S0140-6736(08)61594-9	http://dx.doi.org/10.1016/S0140-6736(08)61594-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19010526				2022-12-28	WOS:000261894000035
J	Seeger, M; Bewig, B				Seeger, Marcus; Bewig, Burkhard			Ultrasound Imaging of the Thoracic Duct	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Seeger, Marcus; Bewig, Burkhard] Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Seeger, M (corresponding author), Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany.								0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					E28	E28		10.1056/NEJMicm074093	http://dx.doi.org/10.1056/NEJMicm074093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	19038875				2022-12-28	WOS:000261270300009
J	Limb, M				Limb, Matthew			On commission	BRITISH MEDICAL JOURNAL			English	Editorial Material												mlimb@blueyonder.co.uk						Audit Commission, 2008, IS TREATM WORK PROGR; Kmietowicz Z, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2623; LEWIS R, 2008, PRACTICE BASED COMMI	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 25	2008	337								a2673	10.1136/bmj.a2673	http://dx.doi.org/10.1136/bmj.a2673			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QA	19033336				2022-12-28	WOS:000261827500015
J	Fitzgerald, R				Fitzgerald, Richard			Medical regulation in the telemedicine era	LANCET			English	Editorial Material									[Fitzgerald, Richard] Royal Wolverhampton Hosp NHS Trust, Wolverhampton WV10 0QP, W Midlands, England		Fitzgerald, R (corresponding author), Royal Wolverhampton Hosp NHS Trust, Wolverhampton WV10 0QP, W Midlands, England.	shifnalrad@yahoo.co.uk						Cwiek MA, 2007, TELEMED J E-HEALTH, V13, P141, DOI 10.1089/tmj.2006.0029; Department of Health, 2008, MED REV PRINC NEXT S; *EUR COMM EU MEMB, 2008, EHEALTH EUR FRONT BU; *EUR COMM INF SOC, 2008, LEG EHEALTH PUTT EHE; *EUR INF SOC, 2007, TELEHEALTH 2007; *EUR SOC RAD, 2007, SUBM RESP EUR SOC RA; Health and Consumer Protection Directorate-General European Commission, 2006, SUMM REP RESP CONS R; *INT RAD QUAL NETW, 2007, TOP 10 PRINC INT CLI; Kidd MR, 2008, BRIT MED J, V336, P1029, DOI 10.1136/bmj.39567.550301.80; Singh SN, 2008, NEW ENGL J MED, V358, P1622, DOI 10.1056/NEJMhle0707298; Thrall JH, 2008, RADIOLOGY, V247, P3, DOI 10.1148/radiol.2471072134	11	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1795	1796		10.1016/S0140-6736(08)61743-2	http://dx.doi.org/10.1016/S0140-6736(08)61743-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027474				2022-12-28	WOS:000261112000010
J	Kim, ES; Hirsh, V; Mok, T; Socinski, MA; Gervais, R; Wu, YL; Li, LY; Watkins, CL; Sellers, MV; Lowe, ES; Sun, Y; Liao, ML; Osterlind, K; Reck, M; Armour, AA; Shepherd, FA; Lippman, SM; Douillard, JY				Kim, Edward S.; Hirsh, Vera; Mok, Tony; Socinski, Mark A.; Gervais, Radj; Wu, Yi-Long; Li, Long-Yun; Watkins, Claire L.; Sellers, Mark V.; Lowe, Elizabeth S.; Sun, Yan; Liao, Mei-Lin; Osterlind, Kell; Reck, Martin; Armour, Alison A.; Shepherd, Frances A.; Lippman, Scott M.; Douillard, Jean-Yves			Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial	LANCET			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; FUNCTIONAL ASSESSMENT; SUPPORTIVE CARE; THERAPY; PREDICTORS; ERLOTINIB; IRESSA	Background Two phase II trials in patients with previously-treated advanced non-small-cell lung cancer suggested that gefitinib was efficacious and less toxic than was chemotherapy. We compared gefitinib with docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who had been pretreated with platinum-based chemotherapy. Methods We undertook an open-label phase III study with recruitment between March 1, 2004, and Feb 17, 2006, at 149 centres in 24 countries. 1466 patients with pretreated ( :one platinum-based regimen) advanced non-small-cell lung cancer were randomly assigned with dynamic balancing to receive gefitinib (250 mg per day orally; n=733) or docetaxel (75 mg/m(2) intravenously in 1-h infusion every 3 weeks; n=733). The primary objective was to compare overall survival between the groups with co-primary analyses to assess non-inferiority in the overall per-protocol population and superiority in patients with high epidermal growth factor receptor (EGFR)-gene-copy number in the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT00076388. Findings 1433 patients were analysed per protocol (723 in gefitinib group and 710 in docetaxel group). Non-inferiority of gefitinib compared with docetaxel was confirmed for overall survival (593 vs 576 events; hazard ratio [HR] 1 . 020, 96% CI 0.905-1.150, meeting the predefined non-inferiority criterion; median survival 7.6 vs 8.0 months) Superiority of gefitinib in patients with high EGFR-gene-copy number (85 vs 89 patients) was not proven (72 vs 71 events; HR 1. 09, 95% Cl 0 . 78-1.51; p=0 . 62; median survival 8 . 4 vs 7.5 months). In the gefitinib group, the most common adverse events were rash or acne (360 [49%] vs 73 [10%]) and diarrhoea (255 [35%] vs 177 [25%]); whereas in the docetaxel group, neutropenia (35 [5%] vs 514 [74%]), asthenic disorders (182 [25%] vs 334 (47%]), and alopecia (23 [3%] vs 254 [36%]) were most common. Interpretation INTEREST established non-inferior survival of gefitinib compared with docetaxel, suggesting that gefitinib is a valid treatment for pretreated patients with advanced non-small-cell lung cancer. Funding AstraZeneca.	[Kim, Edward S.; Lippman, Scott M.] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77401 USA; [Hirsh, Vera] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Mok, Tony] Chinese Univ Hong Kong, State Key Lab Oncol S China, Sir YK Pao Ctr Canc, Dept Clin Oncol, Hong Kong, Peoples R China; [Socinski, Mark A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gervais, Radj] Ctr Reg Lutte Canc Baclesse, Caen, France; [Wu, Yi-Long] Guangdong Prov Peoples Hosp, Lung Canc Res Inst & Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Long-Yun] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Watkins, Claire L.; Sellers, Mark V.; Armour, Alison A.] AstraZeneca, Macclesfield, Cheshire, England; [Lowe, Elizabeth S.] AstraZeneca, Wilmington, DE USA; [Sun, Yan] Canc Hosp, Beijing, Peoples R China; [Liao, Mei-Lin] Shanghai Chest Hosp, Shanghai, Peoples R China; [Osterlind, Kell] Herlev Hosp, DK-2730 Herlev, Denmark; [Reck, Martin] Hosp Grosshansdorf, Grosshansdorf, Germany; [Shepherd, Frances A.] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; [Douillard, Jean-Yves] Ctr Rene Gauducheau, F-44035 Nantes, France	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; McGill University; Chinese University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; AstraZeneca; AstraZeneca; Shanghai Jiao Tong University; University of Copenhagen; Herlev & Gentofte Hospital; Grosshansdorf Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Kim, ES (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol Box 432,1515 Holcomb, Houston, TX 77401 USA.	edkim@mdanderson.org	Mok, Tony Shu Kam/B-2310-2019; Wu, Yi-Long/AAB-9137-2022; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/GRJ-9238-2022; Wu, Yi-Long/C-3396-2008; Reck, Martin/ABF-5721-2020	Mok, Tony Shu Kam/0000-0002-8251-0551; Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; Reck, Martin/0000-0002-5348-4462	AstraZeneca	AstraZeneca(AstraZeneca)	This study was supported by AstraZeneca. We thank the patients and their families for their support and participation in INTEREST, and Muhammed Karolia from Complete Medical Group who provided editorial assistance funded by AstraZeneca.	Cancer Therapy Evaluation Program, 1999, COMM TOX CRIT; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; Cella D, 2002, J CLIN EPIDEMIOL, V55, P285, DOI 10.1016/S0895-4356(01)00477-2; CELLA DF, 1995, LUNG CANCER-J IASLC, V12, P199, DOI 10.1016/0169-5002(95)00450-F; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Cufer T, 2006, ANTI-CANCER DRUG, V17, P401, DOI 10.1097/01.cad.0000203381.99490.ab; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; *ICH GUID, 1998, STAT PRINC CLIN TRIA; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rothmann M, 2003, STAT MED, V22, P239, DOI 10.1002/sim.1400; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736	28	1062	1138	2	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1809	1818		10.1016/S0140-6736(08)61758-4	http://dx.doi.org/10.1016/S0140-6736(08)61758-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027483				2022-12-28	WOS:000261112000023
J	van Leeuwen, JFN; Froyd, CA; van der Knaap, WO; Coffey, EE; Tye, A; Willis, KJ				van Leeuwen, Jacqueline F. N.; Froyd, Cynthia A.; van der Knaap, W. O.; Coffey, Emily E.; Tye, Alan; Willis, Katherine J.			Fossil Pollen as a Guide to Conservation in the Galapagos	SCIENCE			English	Article									[Froyd, Cynthia A.; Coffey, Emily E.; Willis, Katherine J.] Univ Oxford, Ctr Environm, Long Term Ecol Lab, Oxford OX1 3QY, England; [van Leeuwen, Jacqueline F. N.; van der Knaap, W. O.] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [van Leeuwen, Jacqueline F. N.; van der Knaap, W. O.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3013 Bern, Switzerland; [Tye, Alan] Charles Darwin Res Stn, Galapagos, Ecuador; [Willis, Katherine J.] Univ Bergen, Dept Biol, N-5007 Bergen, Norway	University of Oxford; University of Bern; University of Bern; University of Bergen	Froyd, CA (corresponding author), Univ Oxford, Ctr Environm, Long Term Ecol Lab, S Parks Rd, Oxford OX1 3QY, England.	cynthia.froyd@ouce.ox.ac.uk	Froyd, Cynthia/A-8488-2012	Froyd, Cynthia/0000-0001-5291-9156; Willis, Katherine/0000-0002-6763-2489	UK Natural Environment Research Council [NE/C510667/1]; National Geographic Society; Swiss Association of Friends of the Galapagos Islands; European Commission [017008-2]; Natural Environment Research Council [NE/C510667/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Geographic Society(National Geographic Society); Swiss Association of Friends of the Galapagos Islands; European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank I. Robertson for helpful comments on the manuscript, the Galapagos National Park Service, and I. Flett and P.Q. Dresser for radiocarbon dates. This research was supported by the UK Natural Environment Research Council (grant NE/C510667/1 awarded to K.J.W. and C.A.F.), the National Geographic Society and the Swiss Association of Friends of the Galapagos Islands (W.O.v.d.K.), and European Commission grant 017008-2.	LAWESSON JE, 1987, REPORTS BOT I U AARH, V16, P1; Magee J, 2001, SCIENCE, V294, P1279; Porter D. M., 1983, PATTERNS EVOLUTION G, P33; SUGGS RC, 1967, Z ETHNOL, V92, P239	4	74	77	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1206	1206		10.1126/science.1163454	http://dx.doi.org/10.1126/science.1163454			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023075				2022-12-28	WOS:000261033400030
J	Coffin, JM				Coffin, John M.			Attenuation by a Thousand Cuts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		[Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University	Coffin, JM (corresponding author), Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.				NCI NIH HHS [R37 CA089441] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA089441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; GRAHAM BS, 2007, FIELDS VIROLOGY, P487; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06	4	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2283	2285		10.1056/NEJMcibr0805820	http://dx.doi.org/10.1056/NEJMcibr0805820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020330				2022-12-28	WOS:000260994000014
J	Blank, DA				Blank, David A.			CHEMISTRY A Sideways Glance at Chemical Reactivity	SCIENCE			English	Editorial Material							FEMTOSECOND-STIMULATED RAMAN; ISOMERIZATION		[Blank, David A.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Blank, DA (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	blank@umn.edu						DERHORST MV, 2004, ACCOUNTS CHEM RES, V37, P13; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Eyring H, 1931, Z PHYS CHEM B-CHEM E, V12, P279; Heitler W., 1927, Z PHYS, V44, P455, DOI [DOI 10.1007/BF01397394, 10.1007/BF01397394]; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Takeuchi S, 2008, SCIENCE, V322, P1073, DOI 10.1126/science.1160902	8	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1056	1057		10.1126/science.1166563	http://dx.doi.org/10.1126/science.1166563			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008432				2022-12-28	WOS:000260867700022
J	Sandhu, AS; Gagnon, E; Santra, R; Sharma, V; Li, W; Ho, P; Ranitovic, P; Cocke, CL; Murnane, MM; Kapteyn, HC				Sandhu, Arvinder S.; Gagnon, Etienne; Santra, Robin; Sharma, Vandana; Li, Wen; Ho, Phay; Ranitovic, Predrag; Cocke, C. Lewis; Murnane, Margaret M.; Kapteyn, Henry C.			Observing the Creation of Electronic Feshbach Resonances in Soft X-ray-Induced O-2 Dissociation	SCIENCE			English	Article							PROGRAM SYSTEM; EXCITED-STATES; SPECTROSCOPY; MOLECULES; ENERGY; DYNAMICS; COLUMBUS; O-2(2+); ATOMS; DECAY	When an atom or molecule is ionized by an x- ray, highly excited states can be created that then decay, or autoionize, by ejecting a second electron from the ion. We found that autoionization after soft x- ray photoionization of molecular oxygen follows a complex multistep process. By interrupting the autoionization process with a short laser pulse, we showed that autoionization cannot occur until the internuclear separation of the fragments is greater than approximately 30 angstroms. As the ion and excited neutral atom separated, we directly observed the transformation of electronically bound states of the molecular ion into Feshbach resonances of the neutral oxygen atom that are characterized by both positive and negative binding energies. States with negative binding energies have not previously been predicted or observed in neutral atoms.	[Sandhu, Arvinder S.; Gagnon, Etienne; Sharma, Vandana; Li, Wen; Murnane, Margaret M.; Kapteyn, Henry C.] Univ Colorado, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Santra, Robin; Ho, Phay] Argonne Natl Lab, Argonne, IL 60439 USA; [Santra, Robin] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Ranitovic, Predrag; Cocke, C. Lewis] Kansas State Univ, JR Macdonald Lab, Dept Phys, Manhattan, KS 66506 USA	University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Kansas State University	Murnane, MM (corresponding author), Univ Colorado, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	margaret.murnane@colorado.edu	Kapteyn, Henry C/H-6559-2011; Ranitovic, Predrag/AAG-5692-2020; Santra, Robin/E-8332-2014; ranitovic, predrag/A-2282-2014	Kapteyn, Henry C/0000-0001-8386-6317; Santra, Robin/0000-0002-1442-9815; Li, Wen/0000-0002-3721-4008; Sharma, Vandana/0000-0001-9830-2485; Sandhu, Arvinder/0000-0002-7876-855X	NSF; Physics Frontiers Centers Program; Office of Basic Energy Sciences; Office of Science; U.S. Department of Energy [DOE DE-FG02-99ER14982];  [DE-AC02-06CH11357]	NSF(National Science Foundation (NSF)); Physics Frontiers Centers Program; Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); 	We thank J.H.D. Eland and B. Krassig for helpful discussions. We acknowledge support for this work from NSF through the Physics Frontiers Centers Program and from the Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DOE) (H.C.K. and M.M.M. under grant DOE DE-FG02-99ER14982; R.S. and P.H. under contract DE-AC02-06CH11357).	Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; CEDERBAUM LS, 1977, J PHYS B-AT MOL OPT, V10, pL549, DOI 10.1088/0022-3700/10/15/001; DEHMER PM, 1977, J CHEM PHYS, V67, P195, DOI 10.1063/1.434518; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Dreuw A., 2000, PHYS REV A, V63; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Feifel R, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1872836; FESHBACH H, 1958, ANN PHYS-NEW YORK, V5, P357, DOI 10.1016/0003-4916(58)90007-1; Gagnon E, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2930869; Gagnon E, 2007, SCIENCE, V317, P1374, DOI 10.1126/science.1144920; HALL RI, 1992, PHYS REV LETT, V68, P2751, DOI 10.1103/PhysRevLett.68.2751; Hikosaka Y, 2003, J CHEM PHYS, V119, P7693, DOI 10.1063/1.1608854; Hsieh S, 1996, J PHYS B-AT MOL OPT, V29, P5795, DOI 10.1088/0953-4075/29/23/021; Jahnke T, 2004, J ELECTRON SPECTROSC, V141, P229, DOI 10.1016/j.elspec.2004.06.010; Jahnke T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163401; Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280; Kuleff AI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083201; Lischka H, 2001, PHYS CHEM CHEM PHYS, V3, P664, DOI 10.1039/b008063m; LISCHKA H, 1981, INT J QUANTUM CHEM, P91; Lundqvist M, 1996, J PHYS B-AT MOL OPT, V29, P499, DOI 10.1088/0953-4075/29/3/016; Miaja-Avila L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.046101; PRICE SD, 1991, J PHYS B-AT MOL OPT, V24, P4379, DOI 10.1088/0953-4075/24/20/009; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Santra R, 2000, PHYS REV LETT, V85, P4490, DOI 10.1103/PhysRevLett.85.4490; SHEPARD R, 1988, INT J QUANTUM CHEM, P149; Wang XB, 1999, NATURE, V400, P245, DOI 10.1038/22286; Yang J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2889001	28	86	86	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1081	1085		10.1126/science.1164498	http://dx.doi.org/10.1126/science.1164498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008441				2022-12-28	WOS:000260867700032
J	Blas, E; Gilson, L; Kelly, MP; Labonte, R; Lapitan, J; Muntaner, C; Ostlin, P; Popay, J; Ritu, S; Sen, G; Schrecker, T; Vaghri, Z				Blas, Erik; Gilson, Lucy; Kelly, Michael P.; Labonte, Ronald; Lapitan, Jostacio; Muntaner, Carles; Ostlin, Piroska; Popay, Jennie; Ritu, Sadana; Sen, Gita; Schrecker, Ted; Vaghri, Ziba			Addressing social determinants of health inequities: what can the state and civil society do?	LANCET			English	Article							POLITICS	In this Health Policy article, we selected and reviewed evidence synthesised by nine knowledge networks established by WHO to support the Commission on the Social Determinants of Health. We have indicated the part that national governments and civil society can play in reducing health inequity. Government action can take three forms: (1) as provider or guarantor of human rights and essential services; (2) as facilitator of policy frameworks that provide the basis for equitable health improvement; and (3) as gatherer and monitor of data about their populations in ways that generate health information about mortality and morbidity and data about health equity. We use examples from the knowledge networks to illustrate some of the options governments have in fulfilling this role. Civil society takes many forms: here, we have used examples of community groups and social movements. Governments and civil society can have important positive roles in addressing health inequity if political will exists.	[Kelly, Michael P.] Natl Inst Hlth &, Clin Excellence NICE, London WC1V 6NA, England; [Blas, Erik; Ritu, Sadana] WHO, CH-1211 Geneva, Switzerland; [Lapitan, Jostacio] WHO, Ctr Hlth Dev, Kobe, Hyogo, Japan; [Gilson, Lucy] Univ Cape Town, Sch Publ Hlth & Family Med, Fac Hlth Sci, Observatory, South Africa; [Labonte, Ronald; Schrecker, Ted] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada; [Muntaner, Carles] Univ Toronto, Toronto, ON, Canada; [Ostlin, Piroska] Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth, Stockholm, Sweden; [Popay, Jennie] Univ Lancaster, Div Hlth Res, Lancaster, England; [Sen, Gita] Indian Inst Management, Ctr Publ Hlth Policy, Bangalore, Karnataka, India; [Vaghri, Ziba] Univ British Columbia, Int Res Initiat Program, Human Early Learning Partnership, Vancouver, BC V5Z 1M9, Canada	National Institute for Health & Care Excellence; World Health Organization; World Health Organization; University of Cape Town; University of Ottawa; University of Toronto; Karolinska Institutet; Lancaster University; Indian Institute of Management (IIM System); Indian Institute of Management Bangalore; University of British Columbia	Kelly, MP (corresponding author), Natl Inst Hlth &, Clin Excellence NICE, Mid City Pl,71 High Holborn, London WC1V 6NA, England.	mike.kelly@nice.org.uk	Muntaner, C/A-5043-2010; Labonte, Ronald/G-4229-2011; Vaghri, Ziba/AAX-9150-2021; Martínez, José Miguel/AAU-3228-2021; Gilson, Lucy/R-8846-2019; Lönnroth, Knut/L-2339-2014	Martínez, José Miguel/0000-0002-9633-1204; Gilson, Lucy/0000-0002-2775-7703; Lönnroth, Knut/0000-0001-5054-8240; Popay, Jennie/0000-0001-9234-908X; Vaghri, Dr. Ziba/0000-0001-9708-8704; Schrecker, Ted/0000-0002-4447-5281				AGNES F, 2005, COMBAT LAW, V4; ALBIZU JL, 2005, EFECTO GUATEMALA VIA; ALBRECHT D, 2008, 10 M COMM SOC DET HL; Benach J, 2007, EMPLOYMENT CONDITION; BLAS E, IN PRESS PRIORITY PU; CSDH, 2008, CLOS GAP GEN HLTH EQ; Feachem RGA, 2001, BRIT MED J, V323, P504, DOI 10.1136/bmj.323.7311.504; GANDARA Miguel Alvarez, 2004, MOVIMIENTOS SOCIALES, P103; Gilson L, 2007, WHO COMM SOC DET HLT; Hacker JS, 2004, AM POLIT SCI REV, V98, P243, DOI 10.1017/S0003055404001121; HEREDIA J, SALUD AUTONOMIA CASO; Irwin L, 2007, EARLY CHILD DEV POWE; KELLY PM, 2007, SOCIAL DETERMINANTS; Kjellstrom T., 2007, OUR CITIES OUR HLTH; Labonte R., 2008, HLTH EQUITABLE GLOBA; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-5; Lundberg O., 2008, NORDIC EXPERIENCE WE; Navarro V, 2006, LANCET, V368, P1033, DOI 10.1016/S0140-6736(06)69341-0; NYGRENKRUG H, 2002, 25 QUESTIONS ANSWERS; Pan American Health Organizationpaho, 2006, MISS BARR AD RIGHT H; Popay J., 2008, UNDERSTANDING TACKLI; SARAG H, 2007, 7 SEKN; Sen G., 2007, UNEQUAL UNFAIR INEFF; Solar O, 2007, CONCEPTUAL FRAMEWORK; Szreter Simon, 1988, SOCIAL SCI MED, V1, P1, DOI DOI 10.1145/1073943.1073950; Townsend P, 2007, 18 INT LAB OFF; VEGAROMERO R, 2007, ROLE CIVIL SOC BUILD; VILLARREAL G, 2006, NARCO NEWS B; Wallerstein N., 2006, WHAT IS EVIDENCE EFF; Watts Susan, 2007, IMPACT WOMEN CHANGES	30	100	103	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1684	1689		10.1016/S0140-6736(08)61693-1	http://dx.doi.org/10.1016/S0140-6736(08)61693-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18994667				2022-12-28	WOS:000260899900031
J	Kim, WY; Snider, WD				Kim, Woo-Yang; Snider, William D.			NEUROSCIENCE Overcoming Inhibitions	SCIENCE			English	Editorial Material							RETINAL GANGLION-CELLS; RECEPTOR FAMILY-MEMBER; NOGO RECEPTOR; AXON REGENERATION; VISUAL-CORTEX; MYELIN; PLASTICITY; CORECEPTOR; COMPLEX		[Kim, Woo-Yang; Snider, William D.] Univ N Carolina, Ctr Neurosci, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kim, WY (corresponding author), Univ N Carolina, Ctr Neurosci, Sch Med, Chapel Hill, NC 27599 USA.	william_snider@med.unc.edu						Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng BH, 2006, TRENDS NEUROSCI, V29, P640, DOI 10.1016/j.tins.2006.09.005	19	12	12	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					869	872		10.1126/science.1166152	http://dx.doi.org/10.1126/science.1166152			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988832				2022-12-28	WOS:000260674100027
J	O'Brien, CP				O'Brien, Charles P.			The CAGE Questionnaire for Detection of Alcoholism A Remarkably Useful but Simple Tool (Reprinted from JAMA, vol 252, pg 1905-1907, 1984)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							USE DISORDERS; CARE		[O'Brien, Charles P.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania	O'Brien, CP (corresponding author), Univ Penn, Dept Psychiat, 3900 Chestnut St, Philadelphia, PA 19104 USA.	obrien@mail.trc.upenn.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017164] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA R01-17164-01] Funding Source: Medline; NIDA NIH HHS [DA P60-001586-22] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; *COL U NAT CTR ADD, 2000, MISS OPP NAT SURV PR; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; EWING JA, 1970, 29 INT C ALC DRUG DE; FORD DE, 1994, ALCOHOL ALCOHOLISM, V29, P329; Isaacson JH, 2000, J STUD ALCOHOL, V61, P912, DOI 10.15288/jsa.2000.61.912; MAGRUDERHABIB K, 1993, J CLIN EPIDEMIOL, V46, P435, DOI 10.1016/0895-4356(93)90020-2; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Institute on Alcohol Abuse and Alcoholism, 1995, PUBL NIH; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681	12	120	122	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2054	2056		10.1001/jama.2008.570	http://dx.doi.org/10.1001/jama.2008.570			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984895				2022-12-28	WOS:000260605400029
J	Zylke, JW; DeAngelis, CD				Zylke, Jody W.; DeAngelis, Catherine D.			Child and Adolescent Health - A Call for Papers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jody.zylke@jama-archives.org						*AG HEALTHC RES QU, 2008, GUID CLIN PREV SERV; Centers for Medicare & Medicaid Services, NAT HLTH EXP DAT HIS; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P2437, DOI 10.1001/jama.299.20.2437; 2007, US SLIPPING LIFE EXP	5	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2062	2062		10.1001/jama.2008.606	http://dx.doi.org/10.1001/jama.2008.606			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984898				2022-12-28	WOS:000260605400032
J	Buchbinder, SP; Mehrotra, DV; Duerr, A; Fitzgerald, DW; Mogg, R; Li, D; Gilbert, PB; Lama, JR; Marmor, M; del Rio, C; McElrath, MJ; Casimiro, DR; Gottesdiener, KM; Chodakewitz, JA; Corey, L; Robertson, MN				Buchbinder, Susan P.; Mehrotra, Devon V.; Duerr, Ann; Fitzgerald, Daniel W.; Mogg, Robin; Li, David; Gilbert, Peter B.; Lama, Javier R.; Marmor, Michael; del Rio, Carlos; McElrath, M. Juliana; Casimiro, Danilo R.; Gottesdiener, Keith M.; Chodakewitz, Jeffrey A.; Corey, Lawrence; Robertson, Michael N.		Step Study Protocol Team	Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial	LANCET			English	Article; Proceedings Paper	15th Conference on Retroviruses and Opportunistic Infections	FEB 03-06, 2008	Boston, MA				IMMUNODEFICIENCY-VIRUS-INFECTION; T-CELL; ADENOVIRUS TYPE-5; RESPONSES; DNA; SAFETY; AIDS; IMMUNOGENICITY; REPLICATION; CIRCUMCISION	Background Observational data and non-human primate challenge studies suggest that cell-mediated immune responses might provide control of HIV replication. The Step Study directly assessed the efficacy of a cell-mediated immunity, vaccine to protect against HIV-1 infection or change in early plasma HIV-1 levels. Methods We undertook a double-blind, phase 11, test-of-concept study at 34 sites in North America, the Caribbean, South America, and Australia. We randomly assigned 3000 HIV-1-seronegative participants by computer-generated assignments to receive three injections of MRKAd5 HIV-1 gag/pol/nef vaccine (n=1494) or placebo (n=1.506). Randomisation was prestratified by sex, adenovirus type 5 (AdS) antibody titre at baseline, and study site. Primary objective was a reduction in HIV-1 acquisition rates (tested every 6 months) or a decrease in HIV-1 viral-load setpoint (early plasma HIV-1 RNA measured 3 months after HIV-1 diagnosis). Analyses were per protocol and modified intention to treat. The study was stopped early because it unexpectedly met the prespecified futility boundaries at the first interim analysis. This study is registered with ClinicalTrials.gov, number NCT00095576. Findings In a prespecified interim analysis in participants with baseline AC15 antibody titre 200 or less, 24 (3%) of 741 vaccine recipients became HIV-1 infected versus 21 (3%) of 762 placebo recipients (hazard ratio [HR] 1.2 [95% Cl 0.6-2.2]). All but one infection occurred in men. The corresponding geometric mean plasma HIVA RNA was comparable in infected male vaccine and placebo recipients (4.61 vs 4.41 log(10) copies per mL, one tailed p value for potential benefit 0. 66). The vaccine elicited interferon-gamma ELISPOT responses in 75% (267) of the 25% random sample of all vaccine recipients (including both low and high Ad5 antibody titres) on whose specimens this testing was done (n=354). In exploratory analyses of all study volunteers, irrespective of baseline Ad5 antibody titre, the HR of HIV-1 infection between vaccine and placebo recipients was higher in Ad5 seropositive men (HR 2.3 [95% C1 1. 2-4.3]) and uncircumcised men (3.8 [1.5-9.3]), but was not increased in Ad5 seronegative (1 .0 [0 . 5-1.9]) or circumcised (1. 0 [0.6-1.7]) men. Interpretation This cell-mediated immunity vaccine did not prevent HIV-1 infection or reduce early viral level. Mechanisms for insufficient efficacy of the vaccine and the increased HIV-1 infection rates in subgroups of vaccine recipients are being explored. Funding Merck Research Laboratories; the Division of AIDS, National Institute of Allergy and Infectious Diseases, in the US National institutes of Health (NIH); and the NIH-sponsored HIV Vaccine Trials Network (HVTN).	[Buchbinder, Susan P.] San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA 94102 USA; [Mehrotra, Devon V.; Mogg, Robin; Li, David; Casimiro, Danilo R.; Gottesdiener, Keith M.; Chodakewitz, Jeffrey A.; Robertson, Michael N.] Merck Res Labs, N Wales, PA USA; [Duerr, Ann; Gilbert, Peter B.; McElrath, M. Juliana; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Fitzgerald, Daniel W.] GHESKIO, Port Au Prince, Haiti; [Fitzgerald, Daniel W.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Lama, Javier R.] Asoc Civil IMPACTA Salud & Educ, Lima, Peru; [Marmor, Michael] NYU, Langone Med Ctr, New York, NY USA; [del Rio, Carlos] Emory Univ, Hope Clin, Atlanta, GA 30322 USA	San Francisco Department of Public Health; Merck & Company; Fred Hutchinson Cancer Center; Cornell University; New York University; NYU Langone Medical Center; Emory University	Buchbinder, SP (corresponding author), San Francisco Dept Publ Hlth, HIV Res Sect, 25 Van Ness Ave,Suite 710, San Francisco, CA 94102 USA.	susan.buchbinder@sfdph.org	Emery, Sean/O-9122-2019; del Rio, Carlos/B-3763-2012; Emery, Sean/J-3825-2017; Corey, Lawrence/AAE-1796-2020; Frew, Paula M./B-4774-2012; Marmor, Michael/L-9014-2015	Emery, Sean/0000-0001-6072-8309; del Rio, Carlos/0000-0002-0153-3517; Emery, Sean/0000-0001-6072-8309; Corey, Lawrence/0000-0002-2179-2436; Frew, Paula M./0000-0002-3078-9124; Marmor, Michael/0000-0001-6605-2661	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NCRR NIH HHS [M01 RR000079-420634, M01 RR000079] Funding Source: Medline; NIAID NIH HHS [UM1 AI069496, P30 AI050409] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Boyer JD, 2000, J INFECT DIS, V181, P476, DOI 10.1086/315229; Breslow N E, 1987, IARC Sci Publ, P1; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Ellenberger D, 2006, VIROLOGY, V352, P216, DOI 10.1016/j.virol.2006.04.005; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Gorse GJ, 2008, VACCINE, V26, P215, DOI 10.1016/j.vaccine.2007.10.061; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; HARRO C, 2005, 12 C RETR OPP INF BO; Haynes Barton F, 2006, Expert Rev Vaccines, V5, P579, DOI 10.1586/14760584.5.4.579; Iankov ID, 2006, J VIROL, V80, P8530, DOI 10.1128/JVI.00593-06; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kelleher AD, 2006, AIDS, V20, P294, DOI 10.1097/01.aids.0000199819.40079.e9; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; KRIESS JK, 1993, J INFECT DIS, V168, P1404, DOI 10.1093/infdis/168.6.1404; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Liang XP, 2005, J VIROL, V79, P12321, DOI 10.1128/JVI.79.19.12321-12331.2005; MAST TC, 2005, AIDS VACC C SEPT 6 9; MCELRATH MJ, 2008, LANCET          1113, DOI DOI 10.1016/S0140-6736(08)61592-5; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Mehrotra DV, 2006, BIOMETRICS, V62, P893, DOI 10.1111/j.1541-0420.2005.00516.x; Millett GA, 2007, JAIDS-J ACQ IMM DEF, V46, P643, DOI 10.1097/QAI.0b013e31815b834d; Mogg R, 2007, STAT MED, V26, P484, DOI 10.1002/sim.2555; Mulligan MJ, 2006, AIDS RES HUM RETROV, V22, P678, DOI 10.1089/aid.2006.22.678; Osmanov S, 2007, AIDS, V21, P539, DOI 10.1097/QAD.0b013e328011a0c9; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Staprans Silvija I, 2004, Expert Rev Vaccines, V3, pS5, DOI 10.1586/14760584.3.4.S5; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	52	1293	1353	2	152	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1881	1893		10.1016/S0140-6736(08)61591-3	http://dx.doi.org/10.1016/S0140-6736(08)61591-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	379IA	19012954	Green Accepted			2022-12-28	WOS:000261388700023
J	Marchetti, A; Parker, MS; Moccia, LP; Lin, EO; Arrieta, AL; Ribalet, F; Murphy, MEP; Maldonado, MT; Armbrust, EV				Marchetti, Adrian; Parker, Micaela S.; Moccia, Lauren P.; Lin, Ellen O.; Arrieta, Angele L.; Ribalet, Francois; Murphy, Michael E. P.; Maldonado, Maria T.; Armbrust, E. Virginia			Ferritin is used for iron storage in bloom-forming marine pennate diatoms	NATURE			English	Article							SOUTHERN-OCEAN; PHYTOPLANKTON; GROWTH; REQUIREMENTS; HYDROLYSIS; LIMITATION; CHEMISTRY; EVOLUTION; OXIDATION; PACIFIC	Primary productivity in 30 - 40% of the world's oceans is limited by availability of the micronutrient iron(1,2). Regions with chronically low iron concentrations are sporadically pulsed with new iron inputs by way of dust(3) or lateral advection from continental margins(4). Addition of iron to surface waters in these areas induces massive phytoplankton blooms dominated primarily by pennate diatoms(5,6). Here we provide evidence that the bloom- forming pennate diatoms Pseudo- nitzschia and Fragilariopsis use the iron- concentrating protein, ferritin, to safely store iron. Ferritin has not been reported previously in any member of the Stramenopiles, a diverse eukaryotic lineage that includes unicellular algae, macroalgae and plant parasites. Phylogenetic analyses suggest that ferritin may have arisen in this small subset of diatoms through a lateral gene transfer. The crystal structure and functional assays of recombinant ferritin derived from Pseudo- nitzschia multiseries reveal a maxi- ferritin that exhibits ferroxidase activity and binds iron. The protein is predicted to be targeted to the chloroplast to control the distribution and storage of iron for proper functioning of the photosynthetic machinery. Abundance of Pseudo- nitzschia ferritin transcripts is regulated by iron nutritional status, and is closely tied to the loss and recovery of photosynthetic competence. Enhanced iron storage with ferritin allows the oceanic diatom Pseudo- nitzschia granii to undergo several more cell divisions in the absence of iron than the comparably sized, oceanic centric diatom Thalassiosira oceanica. Ferritin in pennate diatoms probably contributes to their success in chronically low- iron regions that receive intermittent iron inputs, and provides an explanation for the importance of these organisms in regulating oceanic CO2 over geological timescales(7,8).	[Marchetti, Adrian; Parker, Micaela S.; Lin, Ellen O.; Ribalet, Francois; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Moccia, Lauren P.; Maldonado, Maria T.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Arrieta, Angele L.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of Washington; University of Washington Seattle; University of British Columbia; University of British Columbia	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Box 357940, Seattle, WA 98195 USA.	armbrust@ocean.washington.edu	ribalet, francois/C-2626-2011; Murphy, Michael/R-6805-2017; Maldonado, Maria T/N-2877-2017	ribalet, francois/0000-0002-7431-0234; Murphy, Michael/0000-0003-2589-0014; Maldonado, Maria T/0000-0001-8134-9375; Marchetti, Adrian/0000-0003-4608-4775; Parker, Micaela/0000-0003-1007-4612	Gordon and Betty Moore Foundation Marine Microbiology Investigator Award; National Science Foundation; National Institute of Environmental Health Sciences; National Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health; National Center for Research Resources; Biomedical Technology Program; National Institute of General Medical Sciences	Gordon and Betty Moore Foundation Marine Microbiology Investigator Award; National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. S. Bates for providing P. multiseries CLN-47 and CLN-17 isolates used in this study, and T. Rynearson for sea water from OSP in which P. granii (UWOSP36) was isolated. We are grateful to K.R. Boissonneault for providing P. multiseries actin sequences, R. Marohl and I. Oleinkov for assistance with culture maintenance and sample analyses, and W.C. Lee for assistance with X-ray diffraction data collection. This study was supported by a Gordon and Betty Moore Foundation Marine Microbiology Investigator Award, National Science Foundation grants and a National Institute of Environmental Health Sciences grant to E.V.A.; a National Sciences and Engineering Research Council of Canada grant to M.T.M.; and a Canadian Institutes of Health Research grant to M.E.P.M. Portions of this research were carried out at the Canadian Light Source (CLS) and the Stanford Synchrotron Radiation Laboratory (SSRL). SSRL is a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BI X, 1991, J BIOL CHEM, V266, P19965; Bou-Abdallah F, 2002, J BIOL CHEM, V277, P37064, DOI 10.1074/jbc.M205712200; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Cortese G, 2007, EARTH PLANET SC LETT, V257, P526, DOI 10.1016/j.epsl.2007.03.021; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Katsuki K, 2005, DEEP-SEA RES PT II, V52, P2110, DOI 10.1016/j.dsr2.2005.07.001; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Lam PJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033294; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2095, DOI 10.1016/j.dsr2.2006.05.038; Marchetti A, 2006, LIMNOL OCEANOGR, V51, P2092, DOI 10.4319/lo.2006.51.5.2092; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XK, 2000, BIOCHEM J, V349, P783, DOI 10.1042/bj3490783; 2006, PHAEODACTYLUM TRICOR	26	234	242	6	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					467	470		10.1038/nature07539	http://dx.doi.org/10.1038/nature07539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19037243				2022-12-28	WOS:000262519200044
J	Varambally, S; Cao, Q; Mani, RS; Shankar, S; Wang, XS; Ateeq, B; Laxman, B; Cao, XH; Jing, XJ; Ramnarayanan, K; Brenner, JC; Yu, JD; Kim, JH; Han, B; Tan, P; Kumar-Sinha, C; Lonigro, RJ; Palanisamy, N; Maher, CA; Chinnaiyan, AM				Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Cao, Xuhong; Jing, Xiaojun; Ramnarayanan, Kalpana; Brenner, J. Chad; Yu, Jindan; Kim, Jung H.; Han, Bo; Tan, Patrick; Kumar-Sinha, Chandan; Lonigro, Robert J.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.			Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; H3 LYSINE-27 METHYLATION; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; ZESTE HOMOLOG-2; IN-VIVO; POLYCOMB; ENHANCER; EXPRESSION; TARGETS	Enhancer of zeste homolog 2 ( EZH2) is a mammalian histone methyltransferase that contributes to the epigenetic silencing of target genes and regulates the survival and metastasis of cancer cells. EZH2 is overexpressed in aggressive solid tumors by mechanisms that remain unclear. Here we show that the expression and function of EZH2 in cancer cell lines are inhibited by microRNA- 101 ( miR- 101). Analysis of human prostate tumors revealed that miR- 101 expression decreases during cancer progression, paralleling an increase in EZH2 expression. One or both of the two genomic loci encoding miR- 101 were somatically lost in 37.5% of clinically localized prostate cancer cells ( 6 of 16) and 66.7% of metastatic disease cells ( 22 of 33). We propose that the genomic loss of miR- 101 in cancer leads to overexpression of EZH2 and concomitant dysregulation of epigenetic pathways, resulting in cancer progression.	[Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Cao, Xuhong; Jing, Xiaojun; Brenner, J. Chad; Yu, Jindan; Kim, Jung H.; Han, Bo; Kumar-Sinha, Chandan; Lonigro, Robert J.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Cao, Qi; Mani, Ram-Shankar; Shankar, Sunita; Wang, Xiaosong; Ateeq, Bushra; Laxman, Bharathi; Jing, Xiaojun; Brenner, J. Chad; Yu, Jindan; Han, Bo; Kumar-Sinha, Chandan; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Kim, Jung H.; Lonigro, Robert J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ramnarayanan, Kalpana; Tan, Patrick; Palanisamy, Nallasivam] Genome Inst Singapore, Singapore 138672, Singapore; [Brenner, J. Chad; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Tan, Patrick] Natl Canc Ctr, Singapore 169610, Singapore; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Michigan System; University of Michigan; National Cancer Centre Singapore (NCCS); University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010; Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020	Cao, Qi/0000-0002-5140-3681; Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Mani, Ram/0000-0003-3552-7905; Varambally, Sooryanarayana/0000-0002-2277-1127; Kumar, Chandan/0000-0002-8696-3400	NIH (Prostate Specialized Program of Reasearch Excellence [P50CA69568]; Early Detection Research Network [UO1 111275]; U.S. Department of Defense Era of Hope Scholar [BC075023, PC051081, BC083217]; NIH postdoctoral training; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research; Canary Foundation; American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [K99CA129565, U01CA111275, P50CA069568] Funding Source: NIH RePORTER	NIH (Prostate Specialized Program of Reasearch Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; U.S. Department of Defense Era of Hope Scholar(United States Department of Defense); NIH postdoctoral training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research(Amgen); Canary Foundation; American Cancer Society Early Detection Postdoctoral Fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. M. Dhanasekaran, S. Tomlins, and J. Yu for helpful discussions; J. Siddiqui and M. Pandhi for technical assistance; and J. Granger and K. Giles for critically reading the manuscript. A. M. C. is supported by a Burroughs Welcome Foundation Award in Clinical Translational Research. This work was supported in part by NIH (Prostate Specialized Program of Reasearch Excellence grant P50CA69568 to A.M.C. and Early Detection Research Network grant UO1 111275 to A.M.C.) and the U.S. Department of Defense (Era of Hope Scholar grant BC075023 to A.M.C., PC051081 to A.M.C. and S.V., and BC083217 to J.C.B.). C.A.M. was supported by an NIH postdoctoral training grant and currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research and the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship. The microarray data used in this study have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus with the accession number GSE13286.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Weikert S, 2005, INT J MOL MED, V16, P349; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	27	817	904	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1695	1699		10.1126/science.1165395	http://dx.doi.org/10.1126/science.1165395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19008416	Green Accepted			2022-12-28	WOS:000261608300046
J	Price, TAR; Hodgson, DJ; Lewis, Z; Hurst, GDD; Wedell, N				Price, T. A. R.; Hodgson, D. J.; Lewis, Z.; Hurst, G. D. D.; Wedell, N.			Selfish Genetic Elements Promote Polyandry in a Fly	SCIENCE			English	Article							SPERM COMPETITIVE ABILITY; SEX-RATIO; MEIOTIC DRIVE; DROSOPHILA-PSEUDOOBSCURA; FEMALES; SELECTION; CHROMOSOME; STERILITY; INSECT; COMMON	It is unknown why females mate with multiple males when mating is frequently costly and a single copulation often provides enough sperm to fertilize all a female's eggs. One possibility is that remating increases the fitness of offspring, because fertilization success is biased toward the sperm of high- fitness males. We show that female Drosophila pseudoobscura evolved increased remating rates when exposed to the risk of mating with males carrying a deleterious sex ratio- distorting gene that also reduces sperm competitive ability. Because selfish genetic elements that reduce sperm competitive ability are generally associated with low genetic fitness, they may represent a common driver of the evolution of polyandry.	[Price, T. A. R.; Hodgson, D. J.; Wedell, N.] Univ Exeter, Sch Biosci, Penryn TR10 9EZ, England; [Lewis, Z.] Okayama Univ, Grad Sch Environm Sci, Okayama 7008530, Japan; [Hurst, G. D. D.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Exeter; Okayama University; University of Liverpool	Wedell, N (corresponding author), Univ Exeter, Sch Biosci, Cornwall Campus, Penryn TR10 9EZ, England.	n.wedell@exeter.ac.uk	Hurst, Gregory D D/C-2723-2008; Lewis, Zenobia/T-2928-2019	Hurst, Gregory D D/0000-0002-7163-7784; Price, Thomas/0000-0002-4394-6301; Lewis, Zenobia/0000-0001-9464-7638	Funded by a Natural Environment Research Council; Natural Environment Research Council [NER/A/S/2003/00536/2] Funding Source: researchfish	Funded by a Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Isofemale lines were collected with assistance from T. Markow. We thank J. Blount, F. E. Champion de Crespigny, D. J. Hosken, and T. Tregenza for discussion. Funded by a Natural Environment Research Council grant (N.W. and G.H.).	Arnqvist Goran, 2005, pUnpaginated; BEUKEBOOM LW, 1994, EVOL ECOL, V8, P1, DOI 10.1007/BF01237662; Birkhead TR, 1998, SPERM COMPETITION SE; BRYANT SH, 1982, EVOLUTION, V36, P27, DOI 10.1111/j.1558-5646.1982.tb05006.x; Burt A, 2006, GENES CONFLICT BIOL; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; de Crespigny FEC, 2006, P ROY SOC B-BIOL SCI, V273, P1455, DOI 10.1098/rspb.2006.3478; HAIG D, 1995, J EVOLUTION BIOL, V8, P265, DOI 10.1046/j.1420-9101.1995.8030265.x; Hosken DJ, 2003, P ROY SOC B-BIOL SCI, V270, P1933, DOI 10.1098/rspb.2003.2443; HURST LD, 1991, GENETICS, V128, P841; Jaenike J, 1996, AM NAT, V148, P237, DOI 10.1086/285923; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jiggins FM, 1999, AM NAT, V154, P481, DOI 10.1086/303251; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; POLICANSKY D, 1978, EVOLUTION, V32, P922, DOI 10.1111/j.1558-5646.1978.tb04647.x; Powell J. R., 1997, PROGR PROSPECTS EVOL; Price TAR, 2008, EVOLUTION, V62, P1644, DOI 10.1111/j.1558-5646.2008.00386.x; Price TAR, 2008, GENETICA, V132, P295, DOI 10.1007/s10709-007-9173-2; Rajendra TK, 2001, J GENET, V80, P97, DOI 10.1007/BF02728335; Rice WR, 2005, EVOLUTION, V59, P682; Simmons L. W., 2001, MG BEH ECOL; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	26	83	84	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1241	1243		10.1126/science.1163766	http://dx.doi.org/10.1126/science.1163766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023079				2022-12-28	WOS:000261033400040
J	Violari, A; Cotton, MF; Gibb, DM; Babiker, AG; Steyn, J; Madhi, SA; Jean-Philippe, P; McIntyre, JA				Violari, Avy; Cotton, Mark F.; Gibb, Diana M.; Babiker, Abdel G.; Steyn, Jan; Madhi, Shabir A.; Jean-Philippe, Patrick; McIntyre, James A.		CHER Study Team	Early Antiretroviral Therapy and Mortality among HIV-Infected Infants.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE PROGRESSION; HIV-1-INFECTED CHILDREN; METAANALYSIS; ZIDOVUDINE; SURVIVAL; REGIMENS; COHORT; TRIAL	Background: In countries with a high seroprevalence of human immunodeficiency virus type 1 (HIV-1), HIV infection contributes significantly to infant mortality. We investigated antiretroviral-treatment strategies in the Children with HIV Early Antiretroviral Therapy (CHER) trial. Methods: HIV-infected infants 6 to 12 weeks of age with a CD4 lymphocyte percentage (the CD4 percentage) of 25% or more were randomly assigned to receive antiretroviral therapy (lopinavir-ritonavir, zidovudine, and lamivudine) when the CD4 percentage decreased to less than 20% (or 25% if the child was younger than 1 year) or clinical criteria were met (the deferred antiretroviral-therapy group) or to immediate initiation of limited antiretroviral therapy until 1 year of age or 2 years of age (the early antiretroviral-therapy groups). We report the early outcomes for infants who received deferred antiretroviral therapy as compared with early antiretroviral therapy. Results: At a median age of 7.4 weeks (interquartile range, 6.6 to 8.9) and a CD4 percentage of 35.2% (interquartile range, 29.1 to 41.2), 125 infants were randomly assigned to receive deferred therapy, and 252 infants were randomly assigned to receive early therapy. After a median follow-up of 40 weeks (interquartile range, 24 to 58), antiretroviral therapy was initiated in 66% of infants in the deferred-therapy group. Twenty infants in the deferred-therapy group (16%) died versus 10 infants in the early-therapy groups (4%) (hazard ratio for death, 0.24; 95% confidence interval [CI], 0.11 to 0.51; P<0.001). In 32 infants in the deferred-therapy group (26%) versus 16 infants in the early-therapy groups (6%), disease progressed to Centers for Disease Control and Prevention stage C or severe stage B (hazard ratio for disease progression, 0.25; 95% CI, 0.15 to 0.41; P<0.001). Stavudine was substituted for zidovudine in four infants in the early-therapy groups because of neutropenia in three infants and anemia in one infant; no drugs were permanently discontinued. After a review by the data and safety monitoring board, the deferred-therapy group was modified, and infants in this group were all reassessed for initiation of antiretroviral therapy. Conclusions: Early HIV diagnosis and early antiretroviral therapy reduced early infant mortality by 76% and HIV progression by 75%. (ClinicalTrials.gov number, NCT00102960.).	[Violari, Avy; Steyn, Jan; McIntyre, James A.] Univ Witwatersrand, Perinatal HIV Res Unit, ZA-1864 Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, ZA-1864 Johannesburg, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Fac Hlth Sci, Childrens Infect Dis Clin Res Unit, ZA-7505 Tygerberg, South Africa; [Gibb, Diana M.; Babiker, Abdel G.] MRC, Clin Trials Unit, London, England; [Jean-Philippe, Patrick] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA	University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Stellenbosch University; Medical Research Council Clinical Trials Unit; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Violari, A (corresponding author), Univ Witwatersrand, Perinatal HIV Res Unit, POB 114, ZA-1864 Johannesburg, South Africa.	violari@mweb.co.za	Cotton, Mark/AAQ-9936-2020; McIntyre, James/V-7115-2019	Cotton, Mark/0000-0003-2559-6034; Gibb, Diana/0000-0002-9738-5490; Glencross, Deborah/0000-0001-7106-769X	National Institute of Allergy and Infectious Diseases; National Institutes for Health; Comprehensive International Program of Research on AIDS network [U19 AI53217]; Departments of Health of the Western Cape and Gauteng, South Africa; GlaxoSmithKline; Abbott Laboratories; Meningitis Research Foundation; Gilead; MRC [MC_U122886353] Funding Source: UKRI; Medical Research Council [MC_U122886353] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217, UM1AI069521] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive International Program of Research on AIDS network; Departments of Health of the Western Cape and Gauteng, South Africa; GlaxoSmithKline(GlaxoSmithKline); Abbott Laboratories(Abbott Laboratories); Meningitis Research Foundation(Meningitis Research Foundation (MRF)); Gilead(Gilead Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a grant from the National Institute of Allergy and Infectious Diseases of the National Institutes for Health through the Comprehensive International Program of Research on AIDS network (U19 AI53217); the Departments of Health of the Western Cape and Gauteng, South Africa; and GlaxoSmithKline. Drs. Violari and Cotton report receiving lecture fees from Abbott Laboratories; Dr. Babiker, research support from Abbott Laboratories; and Dr. Gibb, research support from the Meningitis Research Foundation, GlaxoSmithKline, and Gilead. No other potential conflict of interest relevant to this article was reported. The views expressed in this report do not necessarily reflect the views or policies of the National Institute of Allergy and Infectious Diseases, nor does mention of trade names, commercial projects, or organizations imply endorsement by the U. S. government. We thank the families and children who participated in the trial.	Aboulker JP, 2002, LANCET, V359, P733; Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; Barthel FMS, 2006, STAT MED, V25, P2521, DOI 10.1002/sim.2517; Berk DR, 2005, JAMA-J AM MED ASSOC, V293, P2221, DOI 10.1001/jama.293.18.2221; Chadwick EG, 2008, AIDS, V22, P249, DOI 10.1097/QAD.0b013e3282f2be1d; Chiappini E, 2006, AIDS, V20, P207, DOI 10.1097/01.aids.0000200529.64113.3e; Chiappini E, 2006, AIDS, V20, P1789, DOI 10.1097/01.aids.0000242833.12743.78; Diaz C, 1998, J ACQ IMMUN DEF SYND, V18, P221, DOI 10.1097/00042560-199807010-00004; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; Faye A, 2004, CLIN INFECT DIS, V39, P1692, DOI 10.1086/425739; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; GOETGHEBUER T, 2007, 4 DOM DORMONT INT C; Kuhn L, 2000, J INFECT DIS, V182, P104, DOI 10.1086/315678; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Mayaux MJ, 1996, JAMA-J AM MED ASSOC, V275, P606, DOI 10.1001/jama.275.8.606; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; *NAT I ALL INF DIS, 2004, TABL GRAD SEV AD PED; National Department of Health, 2004, NAT ANT TREATM GUID; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Royston P, 2002, STATA J, V2, P151, DOI 10.1177/1536867X0200200204; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; TOVO PA, 1992, LANCET, V339, P1249, DOI 10.1016/0140-6736(92)91592-V; WHO & UNDP, 2007, WHO UNDP REPORT EC H, P20; *WORK GROUP ANT TH, 2006, GUID US ANT AG PED H; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2002, SCAL ANT THER RES LT	28	990	1024	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2233	2244		10.1056/NEJMoa0800971	http://dx.doi.org/10.1056/NEJMoa0800971			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020325	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000260994000006
J	Allegranzi, B; Pittet, D				Allegranzi, Benedetta; Pittet, Didier			Preventing infections acquired during health-care delivery	LANCET			English	Editorial Material									[Allegranzi, Benedetta] WHO, Global Patient Safety Challenge 1, World Alliance Patient Safety, CH-1211 Geneva 27, Switzerland; [Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Pittet, Didier] Univ Geneva, Fac Med, Geneva, Switzerland	World Health Organization; University of Geneva; University of Geneva; World Health Organization; University of Geneva	Allegranzi, B (corresponding author), WHO, Global Patient Safety Challenge 1, World Alliance Patient Safety, CH-1211 Geneva 27, Switzerland.	allegranzib@who.int						Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; ALLEGRANZI B, 2008, GENFOR GLOB ACC HLTH; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; *DEP HLTH, SAV LIV DEL PROGR; *HEALTHC COMM, 2008, ANN HLTH CHECK 2007; *HLTH PROT AG, 2008, LAT FIG SHOW MRSA BL; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; *LANC C, 2008, HEALTHC ASS INF MOV; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Pittet D, 2005, LANCET INFECT DIS, V5, P242, DOI 10.1016/S1473-3099(05)70055-4; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X; Pittet Didier, 2008, J Infect Public Health, V1, P4, DOI 10.1016/j.jiph.2008.08.006; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; *WHO, 2008, COUNTR COMM ADDR HAI; World Health Organisation (WHO), 2008, GLOB BURD DIS UPD 20	16	42	44	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1719	1720		10.1016/S0140-6736(08)61715-8	http://dx.doi.org/10.1016/S0140-6736(08)61715-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19013310				2022-12-28	WOS:000261077900010
J	Gross, CP				Gross, Cary P.			Racial disparities in clinical trial enrolment	LANCET			English	Editorial Material									[Gross, Cary P.] Yale Univ, Sch Med, Primary Care Ctr, New Haven, CT 06520 USA	Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, 333 Cedar St, New Haven, CT 06520 USA.	cary.gross@yale.edu						APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; *EDICT, 2008, INTR POL REC; EDICT, 2008, MAJ DEF DES FUND CLI; Gross CP, 2006, PLOS MED, V3, P800, DOI 10.1371/journal.pmed.0030188; Hightower D., 2006, MINORITY PARTICIPATI; *INT CANC COUNC, CANC CLIN TRIALS PAR; KALUZNY A, 1993, J NATL CANCER I, V85, P1945, DOI 10.1093/jnci/85.23.1945; Mason S, 2003, BRIT MED J, V326, P1244, DOI 10.1136/bmj.326.7401.1244; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Newman LA, 2008, ANN SURG ONCOL, V15, P1818, DOI 10.1245/s10434-008-9869-2; Paskett ED, 2008, CONTEMP CLIN TRIALS, V29, P847, DOI 10.1016/j.cct.2008.07.006; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; 2004, NATURE GENET, V36, P1	14	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1713	1714		10.1016/S0140-6736(08)61714-6	http://dx.doi.org/10.1016/S0140-6736(08)61714-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	19013309				2022-12-28	WOS:000261077900007
J	Takeuchi, S; Ruhman, S; Tsuneda, T; Chiba, M; Taketsugu, T; Tahara, T				Takeuchi, Satoshi; Ruhman, Sanford; Tsuneda, Takao; Chiba, Mahito; Taketsugu, Tetsuya; Tahara, Tahei			Spectroscopic Tracking of Structural Evolution in Ultrafast Stilbene Photoisomerization	SCIENCE			English	Article							FEMTOSECOND-STIMULATED RAMAN; S-1 CIS-STILBENE; EXCITED-STATE; WAVEPACKET MOTION; ISOMERIZATION; DYNAMICS; DEPENDENCE; TRANS; SCATTERING; MOLECULES	Understanding a chemical reaction ultimately requires the knowledge of how each atom in the reactants moves during product formation. Such knowledge is seldom complete and is often limited to an oversimplified reaction coordinate that neglects global motions across the molecular framework. To overcome this limit, we recorded transient impulsive Raman spectra during ultrafast photoisomerization of cis- stilbene in solution. The results demonstrate a gradual frequency shift of a low- frequency spectator vibration, reflecting changes in the restoring force along this coordinate throughout the isomerization. A high- level quantum- chemical calculation reproduces this feature and associates it with a continuous structural change leading to the twisted configuration. This combined spectroscopic and computational approach should be amenable to detailed reaction visualization in other photoisomerizing systems as well.	[Takeuchi, Satoshi; Tahara, Tahei] RIKEN, Mol Spect Lab, Wako, Saitama 3510198, Japan; [Ruhman, Sanford] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Tsuneda, Takao] Univ Tokyo, Sch Engn, Tokyo 1138656, Japan; [Chiba, Mahito] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3056568, Japan; [Taketsugu, Tetsuya] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan	RIKEN; Hebrew University of Jerusalem; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University	Tahara, T (corresponding author), RIKEN, Mol Spect Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tahei@riken.jp	Tahara, Tahei/I-5714-2014; Tsuneda, Takao/H-2363-2014; Taketsugu, Tetsuya/A-4304-2012; Tsuneda, Takao/AAC-8557-2019	Tahara, Tahei/0000-0002-6340-8535; Tsuneda, Takao/0000-0002-0249-5276; Taketsugu, Tetsuya/0000-0002-1337-6694	Grant-in-Aid for Science Research on Priority Area [19056009]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant-in-Aid for Scientific Research (B) [19350017]; Japan Society for the Promotion of Science	Grant-in-Aid for Science Research on Priority Area(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant-in-Aid for Scientific Research (B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Science Research on Priority Area (no. 19056009) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. S. T. acknowledges financial support by a Grant-in-Aid for Scientific Research (B) ( no. 19350017) from the Japan Society for the Promotion of Science (JSPS). T. Tahara and S. R. acknowledge the JSPS invitation fellowship program.	ABRASH S, 1990, J CHEM PHYS, V93, P1041, DOI 10.1063/1.459168; BANIN U, 1993, J CHEM PHYS, V99, P9318, DOI 10.1063/1.465501; Cerullo G, 2003, J PHYS CHEM A, V107, P8339, DOI 10.1021/jp022696j; FAYER MD, 2001, ULTRAFAST INFRARED R; Fujiyoshi S, 2003, J PHYS CHEM A, V107, P494, DOI 10.1021/jp0270856; Herbst J, 2002, SCIENCE, V297, P822, DOI 10.1126/science.1072144; Hornung T, 2005, CHEM PHYS LETT, V402, P283, DOI 10.1016/j.cplett.2004.11.135; Iikura H, 2001, J CHEM PHYS, V115, P3540, DOI 10.1063/1.1383587; Improta R, 2005, J PHYS CHEM A, V109, P10058, DOI 10.1021/jp054250j; Ishii K, 2004, CHEM PHYS LETT, V398, P400, DOI 10.1016/j.cplett.2004.09.075; Iwata K, 1997, J PHYS CHEM A, V101, P632, DOI 10.1021/jp962010l; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Kwok WM, 2003, J RAMAN SPECTROSC, V34, P886, DOI 10.1002/jrs.1070; MYERS AB, 1984, J CHEM PHYS, V81, P1552, DOI 10.1063/1.447884; PEDERSEN S, 1992, J CHEM PHYS, V97, P8801, DOI 10.1063/1.463350; PETEK H, 1990, J PHYS CHEM-US, V94, P7539, DOI 10.1021/j100382a043; Quenneville J, 2003, J PHYS CHEM A, V107, P829, DOI 10.1021/jp021210w; REPINEC ST, 1991, J PHYS CHEM-US, V95, P10380, DOI 10.1021/j100178a026; RODIER JM, 1993, J AM CHEM SOC, V115, P10791, DOI 10.1021/ja00076a041; SALTIEL J, 1968, J AM CHEM SOC, V90, P6394, DOI 10.1021/ja01025a026; SENSION RJ, 1992, J CHEM PHYS, V97, P5239, DOI 10.1063/1.463822; SUMITANI M, 1979, CHEM PHYS LETT, V68, P255, DOI 10.1016/0009-2614(79)87195-X; TODD DC, 1990, J CHEM PHYS, V93, P8658, DOI 10.1063/1.459252; TODD DC, 1993, J CHEM PHYS, V98, P269, DOI 10.1063/1.464672	25	170	170	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1073	1077		10.1126/science.1160902	http://dx.doi.org/10.1126/science.1160902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008439				2022-12-28	WOS:000260867700030
J	de Smit, E; Swart, I; Creemer, JF; Hoveling, GH; Gilles, MK; Tyliszczak, T; Kooyman, PJ; Zandbergen, HW; Morin, C; Weckhuysen, BM; de Groot, FMF				de Smit, Emiel; Swart, Ingmar; Creemer, J. Fredrik; Hoveling, Gerard H.; Gilles, Mary K.; Tyliszczak, Tolek; Kooyman, Patricia J.; Zandbergen, Henny W.; Morin, Cynthia; Weckhuysen, Bert M.; de Groot, Frank M. F.			Nanoscale chemical imaging of a working catalyst by scanning transmission X-ray microscopy	NATURE			English	Article							FISCHER-TROPSCH SYNTHESIS; ADVANCED LIGHT-SOURCE; ELECTRON-MICROSCOPY; REDUCTION BEHAVIOR; ZEOLITE CRYSTALS; TEM-EELS; ABSORPTION; SILICA; OXYGEN; MICROSPECTROSCOPY	The modern chemical industryuses heterogeneous catalysts in almost every production process(1). They commonly consist of nanometre- size active components ( typically metals or metal oxides) dispersed on a high- surface- area solid support, with performance depending on the catalysts' nanometre- size features and on interactions involving the active components, the support and the reactant and product molecules. To gain insight into the mechanisms of heterogeneous catalysts, which could guide the design of improved or novel catalysts, it is thus necessary to have a detailed characterization of the physicochemical composition of heterogeneous catalysts in their working state at the nanometre scale(1,2). Scanning probe microscopy methods have been used to study inorganic catalyst phases at subnanometre resolution(3-6), but detailed chemical information of the materials in their working state is often difficult to obtain(5-7). By contrast, optical microspectroscopic approaches offer much flexibility for in situ chemical characterization; however, this comes at the expense of limited spatial resolution(8-11). A recent development promising high spatial resolution and chemical characterization capabilities is scanning transmission X- ray microscopy(4,12,13), which has been used in a proof- of- principle study to characterize a solid catalyst(14). Here we show that when adapting a nanoreactor specially designed for high-resolution electron microscopy(7), scanning transmission X- ray microscopy can be used at atmospheric pressure and up to 350 degrees C to monitor in situ phase changes in a complex iron- based Fisher-Tropsch catalyst and the nature and location of carbon species produced. We expect that our system, which is capable of operating up to 500 degrees C, will open new opportunities for nanometre- resolution imaging of a range of important chemical processes taking place on solids in gaseous or liquid environments.	[de Smit, Emiel; Swart, Ingmar; Morin, Cynthia; Weckhuysen, Bert M.; de Groot, Frank M. F.] Univ Utrecht, Debye Inst, NL-3584 CA Utrecht, Netherlands; [Creemer, J. Fredrik] Delft Univ Technol, DIMES ECTM, NL-2600 GB Delft, Netherlands; [Hoveling, Gerard H.] Delft Univ Technol, NL-2600 GA Delft, Netherlands; [Gilles, Mary K.; Tyliszczak, Tolek] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Kooyman, Patricia J.] Delft Univ Technol, DelftChemTech, NL-2628 BL Delft, Netherlands; [Kooyman, Patricia J.] Delft Univ Technol, Natl Ctr High Resolut Elect Microscopy, NL-2628 BL Delft, Netherlands; [Zandbergen, Henny W.] Delft Univ Technol, Kavli Inst Nanosci, Natl Ctr High Resolut Elect Microscopy, NL-2600 GA Delft, Netherlands	Utrecht University; Delft University of Technology; Delft University of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Delft University of Technology; Delft University of Technology; Delft University of Technology	de Groot, FMF (corresponding author), Univ Utrecht, Debye Inst, Sorbonnelaan 16, NL-3584 CA Utrecht, Netherlands.	b.m.weckhuysen@uu.nl; f.m.f.degroot@uu.nl	de Smit, Emiel/C-4936-2009; Kooyman, Patricia J./AAJ-5384-2020; Weckhuysen, Bert/AAT-8145-2021; de Groot, Frank M F/A-1918-2009; Kooyman, Patricia J/G-9416-2012; Weckhuysen, Bert/D-3742-2009; Swart, Ingmar/E-6977-2012	Kooyman, Patricia J./0000-0003-1252-5296; Weckhuysen, Bert/0000-0001-5245-1426; de Groot, Frank M F/0000-0002-1340-2186; Weckhuysen, Bert/0000-0001-5245-1426; Swart, Ingmar/0000-0003-3201-7301	Dutch National Science Foundation; VICI; Netherlands Research School Combination on Catalysis; Shell Global Solutions; Office of Science; Office of Basic Energy Sciences; US Department of Energy	Dutch National Science Foundation(Netherlands Organization for Scientific Research (NWO)); VICI(Netherlands Organization for Scientific Research (NWO)); Netherlands Research School Combination on Catalysis; Shell Global Solutions; Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	We acknowledge financial support for this research work from the Dutch National Science Foundation in the form of two VICI grants (to F.M.F.d.G. and B.M.W.), a grant from the Netherlands Research School Combination on Catalysis (to B.M.W. and F.M.F.d.G.) and a grant from Shell Global Solutions (to B.M.W.). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, US Department of Energy. The nanoreactors were fabricated with the assistance of the DIMES ICP-group and the Nanofacility of TU Delft.	Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; Braun A, 2005, CARBON, V43, P117, DOI 10.1016/j.carbon.2004.08.029; Creemer JF, 2008, ULTRAMICROSCOPY, V108, P993, DOI 10.1016/j.ultramic.2008.04.014; DAVOLI I, 1992, PHYS CHEM MINER, V19, P171, DOI 10.1007/BF00202105; de Smit E, 2008, CHEM SOC REV, V37, P2758, DOI 10.1039/b805427d; DEGROOT, 2008, CORE LEVEL SPECTROSC; DEGROOT FMF, 1989, PHYS REV B, V40, P5715, DOI 10.1103/PhysRevB.40.5715; Drake IJ, 2004, REV SCI INSTRUM, V75, P3242, DOI 10.1063/1.1791320; DRY ME, 1981, CATALYSIS SCI TECHNO, V1, P160; Frenken J, 2007, MRS BULL, V32, P1015, DOI 10.1557/mrs2007.210; Hansen TW, 2001, SCIENCE, V294, P1508, DOI 10.1126/science.1064399; Heijboer WM, 2003, J PHYS CHEM B, V107, P13069, DOI 10.1021/jp034125c; Hitchcock AP, 2008, MICRON, V39, P311, DOI 10.1016/j.micron.2007.09.008; Jozwiak WK, 2007, APPL CATAL A-GEN, V326, P17, DOI 10.1016/j.apcata.2007.03.021; Kilcoyne ALD, 2003, J SYNCHROTRON RADIAT, V10, P125, DOI 10.1107/S0909049502017739; Kox MHF, 2007, ANGEW CHEM INT EDIT, V46, P3652, DOI 10.1002/anie.200700246; Le Gros MA, 2005, CURR OPIN STRUC BIOL, V15, P593, DOI 10.1016/j.sbi.2005.08.008; Roeffaers MBJ, 2006, NATURE, V439, P572, DOI 10.1038/nature04502; Sharp T, 1996, PHYS CHEM MINER, V23, P17, DOI 10.1007/BF00202989; Stavitski E, 2008, ANGEW CHEM INT EDIT, V47, P3543, DOI 10.1002/anie.200705562; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Urbonaite S, 2007, CARBON, V45, P2047, DOI 10.1016/j.carbon.2007.05.022; Van der Laan GP, 1999, CATAL REV, V41, P255, DOI 10.1081/CR-100101170; Wang F, 2007, MICRON, V38, P371, DOI 10.1016/j.micron.2006.06.006; Warwick T, 1998, REV SCI INSTRUM, V69, P2964, DOI 10.1063/1.1149041; Weckhuysen BM, 2006, NATURE, V439, P548, DOI 10.1038/439548a; WIELERS AFH, 1989, J CATAL, V117, P1, DOI 10.1016/0021-9517(89)90216-9; Zambelli T, 1997, NATURE, V390, P495, DOI 10.1038/37329; Zhang CH, 2006, CATAL COMMUN, V7, P733, DOI 10.1016/j.catcom.2006.03.018; Zurner A, 2007, NATURE, V450, P705, DOI 10.1038/nature06398	30	298	299	12	424	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					222	U39		10.1038/nature07516	http://dx.doi.org/10.1038/nature07516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005551	Green Published			2022-12-28	WOS:000261039300036
J	Starfield, B				Starfield, Barbara			The Future of Primary Care: Refocusing the System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Starfield, Barbara] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Starfield, B (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.							Macinko J, 2007, RENEWING PRIMARY HLT; Rosser WW, 1996, J FAM PRACTICE, V42, P139; Starfield B, 2005, HEALTH AFFAIR, V24, pW97, DOI 10.1377/hlthaff.W5.97; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; WHO, 2008, PHARMAFORUM 0121	5	40	42	3	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2087	+		10.1056/NEJMp0805763	http://dx.doi.org/10.1056/NEJMp0805763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005193				2022-12-28	WOS:000260823900005
J	Ramaraj, R				Ramaraj, Radhakrishnan			Sudden onset of headache and recent breathlessness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE AORTIC DISSECTION; STENT-GRAFT PLACEMENT; INTERNATIONAL REGISTRY; SPIRAL CT; DIAGNOSIS; MANAGEMENT; MANIFESTATION; ANEURYSM; INSIGHTS		[Ramaraj, Radhakrishnan] Univ Arizona, Coll Med, Dept Internal Med, Tucson, AZ 85724 USA	University of Arizona	Ramaraj, R (corresponding author), Univ Arizona, Coll Med, Dept Internal Med, Tucson, AZ 85724 USA.	drkutty2@gmail.com						Baydin A, 2005, EMERG MED J, V22, P756, DOI 10.1136/emj.2004.014829; Chen Karen, 1997, Journal of Emergency Medicine, V15, P859, DOI 10.1016/S0736-4679(97)00196-0; Clark CE, 2001, BRIT MED J, V323, P399, DOI 10.1136/bmj.323.7309.399; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; Eggebrecht H, 2006, EUR HEART J, V27, P489, DOI 10.1093/eurheartj/ehi493; Erbel R, 2001, EUR HEART J, V22, P1642, DOI 10.1053/euhj.2001.2782; GLOWER DD, 1990, CIRCULATION, V82, P39; Gotway MB, 2003, RADIOL CLIN N AM, V41, P521, DOI 10.1016/S0033-8389(03)00035-6; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Halstead JC, 2007, J THORAC CARDIOV SUR, V133, P127, DOI 10.1016/j.jtcvs.2006.07.043; HASHIMOTO S, 1989, J AM COLL CARDIOL, V14, P1253, DOI 10.1016/0735-1097(89)90424-5; Immer FF, 2005, CIRCULATION, V112, pI249, DOI 10.1161/CIRCULATIONAHA.104.525733; Ince H, 2007, HEART, V93, P266, DOI 10.1136/hrt.2005.078550; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; KAMP TJ, 1994, AM HEART J, V128, P1234, DOI 10.1016/0002-8703(94)90756-0; Khan IA, 2002, CHEST, V122, P311, DOI 10.1378/chest.122.1.311; Ledbetter S, 1999, RADIOL CLIN N AM, V37, P575, DOI 10.1016/S0033-8389(05)70112-3; Levine GN, 2007, CIRCULATION, V116, P2878, DOI 10.1161/CIRCULATIONAHA.107.187256; Mathys J, 2004, HEADACHE, V44, P706, DOI 10.1111/j.1526-4610.2004.04130.x; Nienaber CA, 2003, CIRCULATION, V108, P772, DOI 10.1161/01.CIR.0000087400.48663.19; Nienaber CA, 2005, AM HEART J, V149, P592, DOI 10.1016/j.ahj.2004.05.060; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; Nohe B, 2005, ANESTH ANALG, V101, P233, DOI 10.1213/01.ANE.0000154190.06408.38; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Singh S, 2007, EUR J EMERG MED, V14, P47, DOI 10.1097/01.mej.0000224435.89740.bc; Sommer T, 1996, RADIOLOGY, V199, P347, DOI 10.1148/radiology.199.2.8668776; Stollberger C, 1998, CEPHALALGIA, V18, P583, DOI 10.1046/j.1468-2982.1998.1808583.x; Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340; von Kodolitsch Y, 2004, AM J MED, V116, P73, DOI 10.1016/j.amjmed.2003.08.030; Winnerkvist A, 2006, EUR J VASC ENDOVASC, V32, P349, DOI 10.1016/j.ejvs.2006.04.004	30	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2008	337								a1844	10.1136/bmj.a1844	http://dx.doi.org/10.1136/bmj.a1844			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AD	19004878				2022-12-28	WOS:000261784400018
J	Fowler, JH; Schreiber, D				Fowler, James H.; Schreiber, Darren			Biology, Politics, and the Emerging Science of Human Nature	SCIENCE			English	Editorial Material							VOTER TURNOUT; HERITABILITY; BEHAVIOR; FMRI; PARTICIPATION; DEACTIVATE; ATTITUDES; COGNITION; ALTRUISM; AUTISM	In the past 50 years, biologists have learned a tremendous amount about human brain function and its genetic basis. At the same time, political scientists have been intensively studying the effect of the social and institutional environment on mass political attitudes and behaviors. However, these separate fields of inquiry are subject to inherent limitations that may only be resolved through collaboration across disciplines. We describe recent advances and argue that biologists and political scientists must work together to advance a new science of human nature.	[Fowler, James H.; Schreiber, Darren] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Fowler, JH (corresponding author), Univ Calif San Diego, Dept Polit Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhfowler@ucsd.edu	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638				Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Aristotle, 1996, CAMBRIDGE TEXTS HIST; Baker LA, 2006, TWIN RES HUM GENET, V9, P933, DOI 10.1375/twin.9.6.933; BOHEM C, 1999, HIERARCHY FOREST EVO; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Byrne R., 1988, MACHIAVELLIAN INTELL; Campbell Angus., 1960, AM VOTER; CESARINI D, IN PRESS Q J EC; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; DAWES CT, IN PRESS J POLIT; DEWAAL F, 1982, CHIMPANZEE POLITICS; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Fowler JH, 2008, J POLIT, V70, P579, DOI 10.1017/S0022381608080638; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; Fowler JH, 2007, J POLIT, V69, P813, DOI 10.1111/j.1468-2508.2007.00577.x; Fowler JH, 2006, J POLIT, V68, P674, DOI 10.1111/j.1468-2508.2006.00453.x; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hatemi PK, 2007, BEHAV GENET, V37, P435, DOI 10.1007/s10519-006-9138-8; HATEMI PK, IN PRESS POLIT RES Q; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lieberman MD, 2003, POLIT PSYCHOL, V24, P681, DOI 10.1046/j.1467-9221.2003.00347.x; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; Matsusaka JG, 1999, PUBLIC CHOICE, V98, P431, DOI 10.1023/A:1018328621580; MAY RM, 2006, NATURE, V440, P744; Olson JM, 2001, J PERS SOC PSYCHOL, V80, P845, DOI 10.1037/0022-3514.80.6.845; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Plutzer E, 2002, AM POLIT SCI REV, V96, P41, DOI 10.1017/S0003055402004227; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schreiber D, 2007, AFFECT EFFECT DYNAMI, P48; SETTLE JE, IN PRESS POLIT RES Q; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Westen D, 2006, J COGNITIVE NEUROSCI, V18, P1947, DOI 10.1162/jocn.2006.18.11.1947	37	126	127	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					912	914		10.1126/science.1158188	http://dx.doi.org/10.1126/science.1158188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	369DI	18988845				2022-12-28	WOS:000260674100038
J	de Jong, D; Vasmel, WLE; de Boer, JP; Verhave, G; Barbe, E; Casparie, MK; van Leeuwen, FE				de Jong, Daphne; Vasmel, Wies L. E.; de Boer, Jan Paul; Verhave, Gideon; Barbe, Ellis; Casparie, Mariel K.; van Leeuwen, Flora E.			Anaplastic Large-Cell Lymphoma in Women With Breast Implants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONCERTED ACTION BHM4-CT98-3936; SILICONE; CANCER; NATIONWIDE; PATHOLOGY; ADJACENT; RISK	Context Recently, we identified 2 patients with anaplastic large T- cell lymphoma ( ALCL) negative for tyrosine kinase anaplastic lymphoma kinase ( ALK- negative) in the fibrous capsule of silicone breast prostheses, placed for cosmetic reasons. Similar cases have been reported in the literature. Although an increased risk of ALCL in patients with breast prostheses has been speculated, no studies have been conducted so far. Objective To determine whether ALCL risk is associated with breast prostheses. Design A search for all patients with lymphoma in the breast diagnosed in the Netherlands between 1990 and 2006 was performed through the population- based nationwide pathology database. Subsequently, we performed an individually matched case- control study. Conditional logistic regression analysis was performed to estimate the relative risk of ALCL associated with breast prostheses. Setting and Patients Eleven patients with breast ALCL were identified in the registry. For each case patient with ALCL in the breast, we selected 1 to 5 controls with other lymphomas in the breast, matched on age and year of diagnosis. For all cases and controls ( n= 35), pathological and clinical information was obtained with special emphasis on the presence of a breast prosthesis. Main Outcome Measure Association between breast implants and ALCL of the breast. Results The 11 patients with ALCL of the breast were diagnosed between 1994 and 2006 at a median age of 40 years ( range, 24- 68 years). In 5 of these patients, bilateral silicone breast prostheses had been placed 1 to 23 years before diagnosis. All received prostheses for cosmetic reasons. Lymphoma classes of 35 eligible control patients were 12 diffuse large B- cell lymphomas, including 1 T- cell rich B- cell lymphoma; 5 Burkitt lymphomas; 10 mucosa- associated lymphoid tissue - type lymphoma; 3 follicular lymphomas; 3 peripheral T- cell lymphomas; and 2 indolent B- cell lymphomas, unclassified. One of 35 control patients had a breast implant placed before diagnosis of lymphoma. The odds ratio for ALCL associated with breast prostheses was 18.2 ( 95% confidence interval, 2.1- 156.8). Conclusions These preliminary findings suggest an association between silicone breast prostheses and ALCL, although the absolute risk is exceedingly low due to the rare occurrence of ALCL of the breast ( 11 cases in the Netherlands in 17 years). These findings require confirmation in other studies.	[de Jong, Daphne] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; [de Boer, Jan Paul] Netherlands Canc Inst, Dept Hematol, NL-1066 CX Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, NL-1066 CX Amsterdam, Netherlands; [Vasmel, Wies L. E.; Verhave, Gideon] St Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Barbe, Ellis] St Lucas Andreas Hosp, Dept Pathol, Amsterdam, Netherlands; [Casparie, Mariel K.] PALGA, Nationwide Network, Utrecht, Netherlands; [Casparie, Mariel K.] PALGA, Registry Histopathol & Cytopathol Netherlands, Utrecht, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Sint Lucas Andreas Hospital; Sint Lucas Andreas Hospital	de Jong, D (corresponding author), Netherlands Canc Inst, Dept Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.d.jong@nki.nl			Netherlands Cancer Institute	Netherlands Cancer Institute	This study was supported by the Netherlands Cancer Institute without external funding.	Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; BRESLOW NE, 1980, IARC SCI PUBL, V1, P176; Brinton LA, 1997, J NATL CANCER I, V89, P1341, DOI 10.1093/jnci/89.18.1341; Brisson J, 2006, INT J CANCER, V118, P2854, DOI 10.1002/ijc.21711; BRONZHEIM I, 2004, BLOOD, V104, P3358; Casparie M, 2007, CELL ONCOL, V29, P19; COOK PD, 1995, AM J SURG PATHOL, V19, P712, DOI 10.1097/00000478-199506000-00012; DUVIC M, 1995, J AM ACAD DERMATOL, V32, P939, DOI 10.1016/0190-9622(95)91328-9; Evans PAS, 2007, LEUKEMIA, V21, P207, DOI 10.1038/sj.leu.2404479; Fritzsche FR, 2006, VIRCHOWS ARCH, V449, P561, DOI 10.1007/s00428-006-0287-1; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Gaudet G, 2002, LEUKEMIA LYMPHOMA, V43, P115, DOI 10.1080/10428190210189; Jaffe ES, 2001, TUMOURS HAEMATOPOIET; Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105; Keech JA, 1997, PLAST RECONSTR SURG, V100, P554, DOI 10.1097/00006534-199708000-00065; Kleinrock L., 2003, AD HOC NETW, V1, P3; Kraemer DM, 2004, HAEMATOLOGICA, V89, pELT01; McLaughlin JK, 2006, J NATL CANCER I, V98, P557, DOI 10.1093/jnci/djj134; Newman MK, 2008, J PLAST RECONSTR AES, V61, P822, DOI 10.1016/j.bjps.2007.03.027; Roden AC, 2008, MODERN PATHOL, V21, P455, DOI 10.1038/modpathol.3801024; Sahoo Sunati, 2003, Arch Pathol Lab Med, V127, pe115; Said JW, 1996, BLOOD, V88, P3124, DOI 10.1182/blood.V88.8.3124.bloodjournal8883124; Shanklin DR, 1998, IMMUNOL RES, V18, P125, DOI 10.1007/BF02788777; van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467	25	252	257	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2030	2035		10.1001/jama.2008.585	http://dx.doi.org/10.1001/jama.2008.585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984890	Bronze			2022-12-28	WOS:000260605400023
J	Kohyama, M; Ise, W; Edelson, BT; Wilker, PR; Hildner, K; Mejia, C; Frazier, WA; Murphy, TL; Murphy, KM				Kohyama, Masako; Ise, Wataru; Edelson, Brian T.; Wilker, Peter R.; Hildner, Kai; Mejia, Carlo; Frazier, William A.; Murphy, Theresa L.; Murphy, Kenneth M.			Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis	NATURE			English	Article							ETS PROTEIN; IN-VIVO; B-CELLS; EXPRESSION; GENE; HEMOCHROMATOSIS; MICE; HETEROGENEITY; RECOGNITION; RECEPTORS	Tissue macrophages comprise a heterogeneous group of cell types differing in location, surface markers and function(1). Red pulp macrophages are a distinct splenic subset involved in removing senescent red blood cells(2). Transcription factors such as PU.1 ( also known as Sfpi1) and C/EBPa (Cebpa) have general roles in myelomonocytic development(3,4), but the transcriptional basis for producing tissue macrophage subsets remains unknown. Here we show that Spi-C ( encoded by Spic), a PU.1- related transcription factor, selectively controls the development of red pulp macrophages. Spi-C is highly expressed in red pulp macrophages, but not monocytes, dendritic cells or other tissue macrophages. Spic(-/-) mice have a cell- autonomous defect in the development of red pulp macrophages that is corrected by retroviral Spi- C expression in bone marrow cells, but have normal monocyte and other macrophage subsets. Red pulp macrophages highly express genes involved in capturing circulating haemoglobin and in iron regulation. Spic(-/-) mice show ormal trapping of red blood cells in the spleen, but fail to phagocytose these red blood cells efficiently, and develop an iron overload localized selectively to splenic red pulp. Thus, Spi- C controls development of red pulp macrophages required for red blood cell recycling and iron homeostasis.	[Kohyama, Masako; Ise, Wataru; Edelson, Brian T.; Wilker, Peter R.; Hildner, Kai; Mejia, Carlo; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kohyama, Masako; Ise, Wataru; Hildner, Kai; Mejia, Carlo; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Frazier, William A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	murphy@wustl.edu		Edelson, Brian/0000-0003-2856-7650	Howard Hughes Medical Institute; Burroughs Wellcome Fund Career Award for Medical Scientists	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund)	This work was supported by the Howard Hughes Medical Institute (K.M.M.), and the Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.).	Bemark M, 1999, J BIOL CHEM, V274, P10259, DOI 10.1074/jbc.274.15.10259; Biggs TE, 2001, EUR J IMMUNOL, V31, P2060, DOI 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Carlsson R, 2002, GENE, V299, P271, DOI 10.1016/S0378-1119(02)01078-8; Carlsson R, 2006, BIOCHEM BIOPH RES CO, V344, P1155, DOI 10.1016/j.bbrc.2006.04.026; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hashimoto S, 1999, INT IMMUNOL, V11, P1423, DOI 10.1093/intimm/11.9.1423; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Lloberas J, 1999, IMMUNOL TODAY, V20, P184, DOI 10.1016/S0167-5699(99)01442-5; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schweitzer BL, 2006, J IMMUNOL, V177, P2195, DOI 10.4049/jimmunol.177.4.2195; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Ulyanova T, 2005, BLOOD, V106, P86, DOI 10.1182/blood-2004-09-3417; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Zhou XY, 1998, GASTROENTEROLOGY, V114, pA1372, DOI 10.1016/S0016-5085(98)85570-4	30	290	299	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					318	321		10.1038/nature07472	http://dx.doi.org/10.1038/nature07472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19037245	Green Accepted			2022-12-28	WOS:000262440900040
J	Ni, ZF; Kim, ED; Ha, MS; Lackey, E; Liu, JX; Zhang, YR; Sun, QX; Chen, ZJ				Ni, Zhongfu; Kim, Eun-Deok; Ha, Misook; Lackey, Erika; Liu, Jianxin; Zhang, Yirong; Sun, Qixin; Chen, Z. Jeffrey			Altered circadian rhythms regulate growth vigour in hybrids and allopolyploids	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS ALLOTETRAPLOIDS; STARCH DEGRADATION; FLOWERING-TIME; CLOCK; THALIANA; MUTANT; PLANTS; CCA1; TRANSCRIPTION	Segregating hybrids and stable allopolyploids display morphological vigour(1-3), and Arabidopsis allotetraploids are larger than the parents Arabidopsis thaliana and Arabidopsis arenosa(1,4)- the mechanisms for this are unknown. Circadian clocks mediate metabolic pathways and increase fitness in animals and plants(5-8). Here we report that epigenetic modifications of the circadian clock genes CIRCADIAN CLOCK ASSOCIATED 1 (CCA1) and LATE ELONGATED HYPOCOTYL (LHY)(9-11) and their reciprocal regulators TIMING OF CAB EXPRESSION 1 ( TOC1) and GIGANTEA (GI)(10,12,13) mediate expression changes in downstream genes and pathways. During the day, epigenetic repression of CCA1 and LHY induced the expression of TOC1, GI and downstream genes containing evening elements(14) in chlorophyll and starch metabolic pathways in allotetraploids and F-1 hybrids, which produced more chlorophyll and starch than the parents in the same environment. Mutations in cca1 and cca1 lhy and the daily repression of cca1 by RNA interference (RNAi) in TOC1:: cca1(RNAi) transgenic plants increased the expression of downstream genes and increased chlorophyll and starch content, whereas constitutively expressing CCA1 or ectopically expressing TOC1:: CCA1 had the opposite effect. The causal effects of CCA1 on output traits suggest that hybrids and allopolyploids gain advantages from the control of circadian- mediated physiological and metabolic pathways, leading to growth vigour and increased biomass.	[Ni, Zhongfu; Kim, Eun-Deok; Ha, Misook; Lackey, Erika; Liu, Jianxin; Zhang, Yirong; Chen, Z. Jeffrey] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Ha, Misook; Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ha, Misook; Chen, Z. Jeffrey] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Chen, Z. Jeffrey] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Sun, Qixin] China Agr Univ, Dept Genet & Plant Breeding, Beijing 100094, Peoples R China	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; China Agricultural University	Chen, ZJ (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, 1 University Stn,A-4800, Austin, TX 78712 USA.	zjchen@mail.utexas.edu		KIM, EUN-DEOK/0000-0002-0593-4553	National Science Foundation Plant Genome Research Program [DBI0733857, DBI0624077]; National Institutes of Health [GM067015]; National Basic Research Program of China [2007CB109000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067015] Funding Source: NIH RePORTER	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to E. Tobin for her gifts of the CCA1-overexpression (CCA1-OX) line and antibodies against CCA1. We thank H.Y. Chen for advice on recombinant CCA1 production, D. W. Ng for western blot analysis, T. Juenger for insightful discussions on life history traits in Arabidopsis, and D.Y. Chen and E. Huq for careful readings of the manuscript. The work was supported by the grants from the National Science Foundation Plant Genome Research Program (DBI0733857 and DBI0624077) and the National Institutes of Health (GM067015; Z.J.C.) and National Basic Research Program of China (2007CB109000; Q.S.).	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lloyd JR, 2005, TRENDS PLANT SCI, V10, P130, DOI 10.1016/j.tplants.2005.01.001; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Sperling U, 1997, PLANT J, V12, P649, DOI 10.1046/j.1365-313X.1997.00649.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; Wang JL, 2006, GENETICS, V173, P965, DOI 10.1534/genetics.106.056580; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907	42	469	520	9	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					327	U7		10.1038/nature07523	http://dx.doi.org/10.1038/nature07523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19029881	Green Accepted			2022-12-28	WOS:000262440900042
J	Gertz, J; Siggia, ED; Cohen, BA				Gertz, Jason; Siggia, Eric D.; Cohen, Barak A.			Analysis of combinatorial cis-regulation in synthetic and genomic promoters	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PATTERNS; ASSOCIATIONS; SEQUENCE; NETWORK; MODELS	Transcription factor binding sites are being discovered at a rapid pace(1,2). It is now necessary to turn attention towards understanding how these sites work in combination to influence gene expression. Quantitative models that accurately predict gene expression from promoter sequence(3-5) will be a crucial part of solving this problem. Here we present such a model, based on the analysis of synthetic promoter libraries in yeast ( Saccharomyces cerevisiae). Thermodynamic models based only on the equilibrium binding of transcription factors to DNA and to each other captured a large fraction of the variation in expression in every library. Thermodynamic analysis of these libraries uncovered several phenomena in our system, including cooperativity and the effects of weak binding sites. When applied to the S. cerevisiae genome, a model of repression by Mig1 ( which was trained on synthetic promoters) predicts a number of Mig1- regulated genes that lack significant Mig1- binding sites in their promoters. The success of the thermodynamic approach suggests that the information encoded by combinations of cis- regulatory sites is interpreted primarily through simple protein - DNA and protein - protein interactions, with complicated biochemical reactions - such as nucleosome modifications - being downstream events. Quantitative analyses of synthetic promoter libraries will be an important tool in unravelling the rules underlying combinatorial cis- regulation.	[Gertz, Jason; Cohen, Barak A.] Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, St Louis, MO 63108 USA; [Siggia, Eric D.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Washington University (WUSTL); Rockefeller University	Cohen, BA (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, 4444 Forest Park Ave, St Louis, MO 63108 USA.	cohen@genetics.wustl.edu		Gertz, Jason/0000-0001-7568-6789	NIH [R01 GM078222]; NSF [DMR0129848, DGE-0202737]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Mitra, G. Stormo, M. Johnston, K. Varley, S. Doniger and members of the Cohen laboratory for discussions and suggestions, and J. Sabina for technical help with LacZ experiments. B.A.C. and J.G. were supported by the NIH (R01 GM078222) and E.D.S. was supported by the NSF (DMR0129848). J.G. was also supported by an NSF Graduate Research Fellowship (DGE-0202737).	Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brachmann CB, 1998, YEAST, V14, P115; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; GISH W, 1995, WU BLAST; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Ligr M, 2006, GENETICS, V172, P2113, DOI 10.1534/genetics.105.052688; Lutfiyya LL, 1998, GENETICS, V150, P1377; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; PTASHNE M, 2002, GENES SIGNALS; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	26	215	219	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					215	U113		10.1038/nature07521	http://dx.doi.org/10.1038/nature07521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19029883	Green Accepted			2022-12-28	WOS:000262360200037
J	Nagano, T; Mitchell, JA; Sanz, LA; Pauler, FM; Ferguson-Smith, AC; Feil, R; Fraser, P				Nagano, Takashi; Mitchell, Jennifer A.; Sanz, Lionel A.; Pauler, Florian M.; Ferguson-Smith, Anne C.; Feil, Robert; Fraser, Peter			The Air Noncoding RNA Epigenetically Silences Transcription by Targeting G9a to Chromatin	SCIENCE			English	Article							IMPRINTED IGF2R; XIST RNA; GENES; PLACENTA; GROWTH; LOCUS; STATE	A number of large noncoding RNAs ( ncRNAs) epigenetically silence genes through unknown mechanisms. The Air ncRNA is imprinted-monoallelically expressed from the paternal allele. Air is required for allele- specific silencing of the cis- linked Slc22a3, Slc22a2, and Igf2r genes in mouse placenta. We show that Air interacts with the Slc22a3 promoter chromatin and the H3K9 histone methyltransferase G9a in placenta. Air accumulates at the Slc22a3 promoter in correlation with localized H3K9 methylation and transcriptional repression. Genetic ablation of G9a results in nonimprinted, biallelic transcription of Slc22a3. Truncated Air fails to accumulate at the Slc22a3 promoter, which results in reduced G9a recruitment and biallelic transcription. Our results suggest that Air, and potentially other large ncRNAs, target repressive histone- modifying activities through molecular interaction with specific chromatin domains to epigenetically silence transcription.	[Nagano, Takashi; Mitchell, Jennifer A.; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England; [Nagano, Takashi] Univ Fukui, Fac Med Sci, Dept Morphol & Physiol Sci, Div Cell Biol & Neurosci, Fukui 9101193, Japan; [Sanz, Lionel A.; Feil, Robert] CNRS, Inst Mol Genet, UMR 5535, F-34293 Montpellier, France; [Sanz, Lionel A.; Feil, Robert] Univ Montpellier 2, F-34293 Montpellier, France; [Pauler, Florian M.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna Bioctr, A-1030 Vienna, Austria; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Fukui; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); University of Cambridge	Nagano, T (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB22 3AT, England.	takashi.nagano@bbsrc.ac.uk; peter.fraser@bbsrc.ac.uk	Ferguson-Smith, Anne C/G-7534-2011; Fraser, Peter/B-7549-2009; Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Mitchell, Jennifer/0000-0002-7147-4604; Ferguson-Smith, Anne/0000-0002-7608-5894; Fraser, Peter/0000-0002-0041-1227	Biotechnology and Biological Sciences Research Council, UK; Agence National de la Recherche and Institut National de Cancer, France; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C151, BB/D014050/1, BBS/E/B/0000M232] Funding Source: researchfish; Medical Research Council [G0400156] Funding Source: researchfish; BBSRC [BBS/E/B/0000C151, BB/D014050/1, BBS/E/B/0000M232] Funding Source: UKRI; MRC [G0400156] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agence National de la Recherche and Institut National de Cancer, France(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Segonds-Pichon for statistics, G. Kelsey and W. Reik for critical reading, D. Barlow and members of the Fraser lab for discussions. P. F. is a Senior Fellow of the Medical Research Council, UK. This work was supported by the Biotechnology and Biological Sciences Research Council, UK, and by the Agence National de la Recherche and Institut National de Cancer, France. The authors declare that they have no competing financial interests.	BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Pauler FM, 2005, GENOME RES, V15, P1379, DOI 10.1101/gr.3783805; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; Wagschal A, 2008, MOL CELL BIOL, V28, P1104, DOI 10.1128/MCB.01111-07; Wutz A, 2001, DEVELOPMENT, V128, P1881; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	19	715	783	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1717	1720		10.1126/science.1163802	http://dx.doi.org/10.1126/science.1163802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	18988810				2022-12-28	WOS:000261608300052
J	Daffner, KR; Sherman, JC; Gonzalez, RG; Hasserjian, RP; Alcalay, RN; Cole, AJ; Hedley-Whyte, ET				Daffner, Kirk R.; Sherman, Janet C.; Gonzalez, R. Gilberto; Hasserjian, Robert P.; Alcalay, Roy N.; Cole, Andrew J.; Hedley-Whyte, E. Tessa			A Man with Confusion and Memory Loss Atypical carcinoid tumor (well-differentiated neuroendocrine carcinoma) of the thymus, associated with paraneoplastic limbic encephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; POTASSIUM CHANNEL ANTIBODIES; LUNG-CANCER; NERVOUS-SYSTEM; MRI; DIAGNOSIS; PATIENT; MARKER		[Daffner, Kirk R.] Brigham & Womens Hosp, Div Cognit & Behav Neurol, Boston, MA 02115 USA; [Sherman, Janet C.] Massachusetts Gen Hosp, Psychol Assessment Ctr, Boston, MA 02114 USA; [Sherman, Janet C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Daffner, Kirk R.; Sherman, Janet C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Daffner, KR (corresponding author), Brigham & Womens Hosp, Div Cognit & Behav Neurol, 75 Francis St, Boston, MA 02115 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905	Bayer; General Electric; NATIONAL INSTITUTE ON AGING [R01AG017935] Funding Source: NIH RePORTER	Bayer(Bayer AG); General Electric(General Electric); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Gonzalez reports receiving lecture fees from Bayer and General Electric. No other potential conflict of interest relevant to this article was reported.	Alamowitch S, 1997, BRAIN, V120, P923, DOI 10.1093/brain/120.6.923; Ances BM, 2005, BRAIN, V128, P1764, DOI 10.1093/brain/awh526; Bash S, 2001, AM J NEURORADIOL, V22, P314; Benyahia B, 1999, ANN NEUROL, V45, P162, DOI 10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R; Boivin Guy, 2004, Herpes, V11 Suppl 2, p48A; Budson AE, 2005, NEW ENGL J MED, V352, P692, DOI 10.1056/NEJMra041071; Chan KH, 2001, ANN NEUROL, V50, P301, DOI 10.1002/ana.1127; Chan S, 1996, AM J NEURORADIOL, V17, P1725; CORSELLIS JA, 1968, BRAIN, V91, P481, DOI 10.1093/brain/91.3.481; Dalmau J, 2004, BRAIN, V127, P1831, DOI 10.1093/brain/awh203; DAVIS RD, 1987, ANN THORAC SURG, V44, P229, DOI 10.1016/S0003-4975(10)62059-0; DEMAEREL P, 1992, NEURORADIOLOGY, V34, P490, DOI 10.1007/BF00598957; Domingues RB, 1998, J NEUROL SCI, V157, P148, DOI 10.1016/S0022-510X(98)00069-0; Dropcho EJ, 1996, ANN NEUROL, V39, P659, DOI 10.1002/ana.410390516; Ferracci F, 2006, J NEUROL, V253, P975, DOI 10.1007/s00415-006-0170-7; Flacke S, 2000, NEURORADIOLOGY, V42, P92, DOI 10.1007/s002340050021; Gorniak RJT, 2006, AM J NEURORADIOL, V27, P887; Graus F, 2001, BRAIN, V124, P1138, DOI 10.1093/brain/124.6.1138; Gultekin SH, 2000, BRAIN, V123, P1481, DOI 10.1093/brain/123.7.1481; Harloff A, 2005, J NEUROL, V252, P1404, DOI 10.1007/s00415-005-0841-9; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P1334, DOI 10.1136/jnnp.57.11.1334; Lawn ND, 2003, MAYO CLIN PROC, V78, P1363, DOI 10.4065/78.11.1363; Levitz RE, 1998, HEART LUNG, V27, P209, DOI 10.1016/S0147-9563(98)90009-7; Lucchinetti CF, 1998, NEUROLOGY, V50, P652, DOI 10.1212/WNL.50.3.652; MARX A, 2004, PATHOLOGY GENETICS T, P188; McCabe, 2000, NEUROLOGY, V54, P1876; McCabe DJH, 2000, NEUROLOGY, V54, P737, DOI 10.1212/WNL.54.3.737; Mesulam M. M., 2000, PRINCIPLES BEHAV COG; Muller-Hermelink H.K., 2004, TUMOURS THYMUS INTRO, P148; Ohshita T, 2006, J NEUROL SCI, V250, P167, DOI 10.1016/j.jns.2006.08.003; Pozo-Rosich P, 2003, ANN NEUROL, V54, P530, DOI 10.1002/ana.10713; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Strollo Diane C, 2002, Chest Surg Clin N Am, V12, P645, DOI 10.1016/S1052-3359(02)00026-1; Stubgen JP, 1998, LUPUS, V7, P557, DOI 10.1191/096120398678920523; Szilak I, 2001, CLIN INFECT DIS, V32, P1108, DOI 10.1086/319598; Tattevin P, 2001, SCAND J INFECT DIS, V33, P786, DOI 10.1080/003655401317074680; Urbach H, 2006, NEURORADIOLOGY, V48, P380, DOI 10.1007/s00234-006-0069-0; Vernino S, 2000, ANN NEUROL, V47, P297, DOI 10.1002/1531-8249(200003)47:3<297::AID-ANA4>3.3.CO;2-W; WHITLEY RJ, 1995, CLIN INFECT DIS, V20, P414, DOI 10.1093/clinids/20.2.414; WICK MR, 2002, CURR DIAGN PATHOL, V8, P102, DOI DOI 10.1054/CDIP.2001.0102; 2007, N ENGL J MED, V356, P2185	42	5	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2155	2164		10.1056/NEJMcpc0804643	http://dx.doi.org/10.1056/NEJMcpc0804643			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005200				2022-12-28	WOS:000260823900015
J	Lundberg, O; Yngwe, MA; Stjarne, MK; Elstad, JI; Ferrarini, T; Kangas, O; Norstrom, T; Palme, J; Fritzell, J				Lundberg, Olle; Yngwe, Monica Aberg; Stjarne, Maria Kolegard; Elstad, Jon Ivar; Ferrarini, Tommy; Kangas, Olli; Norstrom, Thor; Palme, Joakim; Fritzell, Johan		NEWS Nordic Expert Grp	The role of welfare state principles and generosity in social policy programmes for public health: an international comparative study	LANCET			English	Article							CHILD HEALTH; INEQUALITY; LEAVE	Background Many important social determinants of health are also the focus for social policies. Welfare states contribute to the resources available for their citizens through cash transfer programmes and subsidised services. Although all rich nations have welfare programmes, there are clear cross-national differences with respect to their design and generosity These differences are evident in national variations in poverty rates, especially among children and elderly people. We investigated to what extent variations in family and pension policies are linked to infant mortality and old-age excess mortality. Methods Infant mortality rates and old-age excess mortality rates were analysed in relation to social policy characteristics and generosity. We did pooled cross-sectional time-series analyses of 18 OECD (Organisation for Economic Co-operation and Development) countries during the period 1970-2000 for family policies and 1950-2000 for pension policies. Findings Increased generosity in family policies that support dual-earner families is linked with lower infant mortality rates, whereas the generosity in family policies that support more traditional families with gainfully employed men and homemaking women is not. An increase by one percentage point in dual-earner support lowers infant mortality by 0.04 deaths per 1000 births. Generosity in basic security type of pensions is linked to lower old-age excess mortality, whereas the generosity of earnings-related income security pensions is not. An increase by one percentage point in basic security pensions is associated with a decrease in the old age excess mortality by 0.02 for men as well as for women. Interpretation The ways in which social policies are designed, as well as their generosity, are important for health because of the increase in resources that social policies entail. Hence, social policies are of major importance for how we can tackle the social determinants of health.	[Lundberg, Olle; Yngwe, Monica Aberg; Stjarne, Maria Kolegard; Fritzell, Johan] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, SE-10691 Stockholm, Sweden; [Elstad, Jon Ivar] NOVA, Oslo, Norway; [Ferrarini, Tommy; Norstrom, Thor; Palme, Joakim] Stockholm Univ, Swedish Inst Social Res, S-10691 Stockholm, Sweden; [Kangas, Olli] Social Insurance Inst, Helsinki, Finland; [Palme, Joakim; Fritzell, Johan] Inst Futures Studies, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Stockholm University	Lundberg, O (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, SE-10691 Stockholm, Sweden.	olle.lundberg@chess.su.se	Diderichsen, Finn/P-4654-2019	Diderichsen, Finn/0000-0002-9998-4972; Fritzell, Johan/0000-0003-0496-3085; Lahelma, Eero/0000-0002-1064-1333	Swedish Ministry for Health and Social Affairs; Norwegian Directorate for Health; Finnish National Research and Development centre for Welfare and Health (STAKES); Institute for Futures Studies, Stockholm	Swedish Ministry for Health and Social Affairs; Norwegian Directorate for Health; Finnish National Research and Development centre for Welfare and Health (STAKES); Institute for Futures Studies, Stockholm	The study reports some key findings from the NEWS project (The Nordic Experience: Welfare States and public health), initiated in collaboration with the Commission on Social Determinants of Health. The NEWS project was partly funded by the Swedish Ministry for Health and Social Affairs, and supported by the Norwegian Directorate for Health, the Finnish National Research and Development centre for Welfare and Health (STAKES), and the Institute for Futures Studies, Stockholm.	BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Berger LM, 2005, ECON J, V115, pF29, DOI 10.1111/j.0013-0133.2005.00971.x; Chen AM, 2004, PEDIATRICS, V113, pE435, DOI 10.1542/peds.113.5.e435; Chung H, 2006, SOC SCI MED, V63, P829, DOI 10.1016/j.socscimed.2006.01.030; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Ferrarini T, 2006, FAMILIES, STATES AND LABOUR MARKETS: INSTITUTIONS, CAUSES AND CONSEQUENCES OF FAMILY POLICY IN POST-WAR WELFARE STATES, P1; FRITZELL J, 2007, HLTH INEQUALITIES WE, P1; Fritzell J., 2001, NORDIC WELFARE STATE, P18; Korpi W, 1998, AM SOCIOL REV, V63, P661, DOI 10.2307/2657333; Korpi W, 2000, SOC POLIT, V7, P127, DOI 10.1093/sp/7.2.127; KORPI W, 2008, SOCIAL CITIZIENSHIP; Lewis J., 1992, J EUR SOC POLICY, V2, P159, DOI [DOI 10.1177/095892879200200301, 10.1177/095892879200200301]; Lundberg O., 2008, NORDIC EXPERIENCE WE; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Palme J., 1990, PENSION RIGHTS WELFA; Palme J., 2006, RES SOC STRAT MOBIL, V24, P387, DOI [/10.1016/j.rssm.2006.10.004, DOI 10.1016/J.RSSM.2006.10.004, DOI 10.1016/j.rssm.2006.10.004]; PAXTON C, 2007, 4226 WORLD BANK; Pierson P, 2000, AM POLIT SCI REV, V94, P251, DOI 10.2307/2586011; Podesta F, 2006, QUAL QUANT, V40, P539, DOI 10.1007/s11135-005-2076-3; Roe B, 1999, DEMOGRAPHY, V36, P157, DOI 10.2307/2648105; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Ruhm CJ, 1998, Q J ECON, V113, P285, DOI 10.1162/003355398555586; WENNEMO I, 1925, THESIS SWEDISH I SOC	24	183	185	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1633	1640		10.1016/S0140-6736(08)61686-4	http://dx.doi.org/10.1016/S0140-6736(08)61686-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994660				2022-12-28	WOS:000260899900024
J	Yen, HCS; Xu, QK; Chou, DM; Zhao, ZM; Elledge, SJ				Yen, Hsueh-Chi Sherry; Xu, Qikai; Chou, Danny M.; Zhao, Zhenming; Elledge, Stephen J.			Global Protein Stability Profiling in Mammalian Cells	SCIENCE			English	Article							PROTEASOME-MEDIATED DEGRADATION; SCFFBW7 UBIQUITIN LIGASE; CYCLIN-E; SACCHAROMYCES-CEREVISIAE; HUMAN-DISEASES; PHOSPHORYLATION; PROTEOMICS; SYSTEM; PATHOGENESIS; DESTRUCTION	The abundance of cellular proteins is determined largely by the rate of transcription and translation coupled with the stability of individual proteins. Although we know a great deal about global transcript abundance, little is known about global protein stability. We present a highly parallel multiplexing strategy to monitor protein turnover on a global scale by coupling flow cytometry with microarray technology to track the stability of individual proteins within a complex mixture. We demonstrated the feasibility of this approach by measuring the stability of similar to 8000 human proteins and identifying proteasome substrates. The technology provides a general platform for proteome- scale analysis of protein turnover under various physiological and disease conditions.	[Yen, Hsueh-Chi Sherry; Xu, Qikai; Chou, Danny M.; Zhao, Zhenming; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	Jane Coffin Childs Memorial Fund fellow; National Science Foundation; NIH [AG11085]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund fellow; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Vidal, J. W. Harper, G. Hu, and J. Jin for the hORFome v1.1 library; J. Daly and S. Lazo-Kallanian for FACS assistance; and J. Love, S. Gupta, and K. Hurov for helpful discussions. H.-C.S.Y. is a Jane Coffin Childs Memorial Fund fellow. D.M.C. is supported by the National Science Foundation. This work is supported by an NIH grant AG11085 to J.W.H. and S.J.E. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Sun Y, 2003, CANCER BIOL THER, V2, P623; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462	33	320	334	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					918	923		10.1126/science.1160489	http://dx.doi.org/10.1126/science.1160489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988847				2022-12-28	WOS:000260674100040
J	Kesselheim, AS				Kesselheim, Aaron S.			Drug Development for Neglected Diseases - The Trouble with FDA Review Vouchers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEVELOPING-COUNTRIES; MARKET		Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Love J, 2007, CHI KENT L REV, V82, P1519; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7	4	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1981	1983		10.1056/NEJMp0806684	http://dx.doi.org/10.1056/NEJMp0806684			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368OW	18987367				2022-12-28	WOS:000260632700002
J	Lim, E; Brown, A; Helmy, A; Mussa, S; Altman, DG				Lim, Eric; Brown, Adam; Helmy, Adel; Mussa, Shafi; Altman, Douglas G.			Composite Outcomes in Cardiovascular Research: A Survey of Randomized Trials	ANNALS OF INTERNAL MEDICINE			English	Article							END-POINTS; CLINICAL-TRIALS; LESSONS	Background: Composite end points are common in clinical trials. Objective: To describe how composite outcomes are used, constructed, and reported in cardiovascular trials and to evaluate the contribution of individual end points to the composite estimate of effect in those trials. Design: Review of 2-group, parallel-design, randomized cardiovascular trials that used composite end points and were published in 14 clinical journals from 1 January 2000 to 1 January 2007. Setting: Published randomized trials in cardiovascular medicine and surgery. Participants: Two-group, parallel-design trials published in 14 leading general medical, cardiology, and cardiothoracic surgery journals from 1 January 2000 to 1 January 2007. Measurements: The types and numbers of individual events included in the composite outcome and P values and risk estimates for the composite outcome. Results: Of 304 trials published that used composite outcomes, 221 (73%) reported a composite primary outcome and 83 (27%) reported a composite secondary outcome. Composite outcomes comprised a median of 3 (interquartile range, 3 to 4) individual outcomes; death was the most common individual outcome. The total number of individual events and the total number of events represented by the composite outcome differed in 79% of trials. P values for composite outcomes were less than 0.050 more frequently than they were 0.050 or greater. Death as an individual end point made a relatively minimal contribution to estimates of effect summarized by the trials' composite end points, whereas revascularization made a greater contribution. Limitation: All-cause and cardiovascular mortality were not distinguished, and the findings might not apply to trials in other fields. Conclusion: Composite outcomes in cardiovascular trials are frequent and commonly comprise 3 to 4 individual end points that vary in clinical significance. Discrepancies between the total number of individual events in a trial and those reported for composite outcomes are common. Individual outcomes do not contribute equally to composite measures, so the overall estimate of effect for a composite measure cannot be assumed to apply equally to each of its individual outcomes.	Papworth Hosp, Cambridge CB3 8RE, England; Addenbrookes Hosp, Cambridge, England; Ctr Stat Med, Oxford, England	Papworth Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford	Lim, E (corresponding author), Royal Brompton Hosp, Acad Div Thorac Surg, Sydney St, London SW3 6NP, England.	e.lim@rbht.nhs.uk	Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Brown, Adam/0000-0003-4531-6052; Lim, Eric/0000-0002-9078-3226				BRAUNWALD E, 1993, AM J CARDIOL, V72, pG3, DOI 10.1016/0002-9149(93)90101-H; Cannon CP, 1997, CONTROL CLIN TRIALS, V18, P517, DOI 10.1016/S0197-2456(97)00005-6; DeMets DL, 2002, CIRCULATION, V106, P746, DOI 10.1161/01.CIR.0000023219.51483.66; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Lauer MS, 2003, JAMA-J AM MED ASSOC, V289, P2575, DOI 10.1001/jama.289.19.2575; Lubsen J, 2002, STAT MED, V21, P2959, DOI 10.1002/sim.1300; Massel D, 2004, J AM COLL CARDIOL, V43, P1926, DOI 10.1016/j.jacc.2004.02.021; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594	9	72	75	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					612	+		10.7326/0003-4819-149-9-200811040-00004	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18981486				2022-12-28	WOS:000260585700002
J	Regard, JB; Sato, IT; Coughlin, SR				Regard, Jean B.; Sato, Isaac T.; Coughlin, Shaun R.			Anatomical Profiling of G Protein-Coupled Receptor Expression	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; NICOTINIC-ACID; FUNCTIONAL EXPRESSION; CHEMOKINE RECEPTOR; MICE LACKING; MOLECULAR-IDENTIFICATION; SACCHAROMYCES-CEREVISIAE; PARATHYROID-HORMONE; GABA(B) RECEPTOR; LYMPHOID ORGANS	G protein-coupled receptors (GPCRs) comprise the largest family of transmembrane signaling molecules and regulate a host of physiological and disease processes. To better understand the functions of GPCRs in vivo, we quantified transcript levels of 353 nonodorant GPCRs in 41 adult mouse tissues. Cluster analysis placed many GPCRs into anticipated anatomical and functional groups and predicted previously unidentified roles for less-studied receptors. From one such prediction, we showed that the Gpr91 ligand succinate can regulate lipolysis in white adipose tissue, suggesting that signaling by this citric acid cycle intermediate may regulate energy homeostasis. We also showed that pairwise analysis of GPCR expression across tissues may help predict drug side effects. This resource will aid studies to understand GPCR function in vivo and may assist in the identification of therapeutic targets.	[Regard, Jean B.; Sato, Isaac T.; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Regard, JB (corresponding author), NHGRI, NIH, Bldg 49,Room 4C60,49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	regardj@mail.nih.gov; shaun.coughlin@ucsf.edu			National Institutes of Health; Sandler Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044907, R01HL065590, R01HL065185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Coughlin lab for valuable discussions, Ivo Cornelissen, Gerard Honig, and Grant Li, for technical assistance in isolating mouse tissues, and Stuart Peirson for sharing qPCR efficiency transformations. We also thank Dale Webster and Joseph Derisi for help with informatics, Silvio Gutkind for providing the Adrb2 construct, and Bryan Roth for critical reading of the manuscript. This work was supported by the National Institutes of Health (S.R.C.) and Sandler Family Foundation (J.B.R.).	Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Bates B, 2006, BRAIN RES, V1087, P1, DOI 10.1016/j.brainres.2006.02.123; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; BUTCHER RW, 1970, ACTA PHYSIOL SCAND, V79, P559, DOI 10.1111/j.1748-1716.1970.tb04758.x; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Cheng ZQ, 2007, ENDOCRINOLOGY, V148, P4984, DOI 10.1210/en.2007-0653; CHIU MI, 1994, GENOMICS, V21, P440, DOI 10.1006/geno.1994.1292; COHEN AI, 1992, P NATL ACAD SCI USA, V89, P12093, DOI 10.1073/pnas.89.24.12093; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Date Y, 2000, MOL BRAIN RES, V76, P1, DOI 10.1016/S0169-328X(99)00317-4; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Forni LG, 2005, CRIT CARE, V9, pR591, DOI 10.1186/cc3806; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; HOCHACHKA PW, 1976, EUR J APPL PHYSIOL O, V35, P235, DOI 10.1007/BF00423282; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Joost P, 2002, GENOME BIOL, V3; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; KREBS HA, 1950, ANNU REV BIOCHEM, V19, P409, DOI 10.1146/annurev.bi.19.070150.002205; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kumar U, 1997, ENDOCRINOLOGY, V138, P4473, DOI 10.1210/en.138.10.4473; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kushnir MM, 2001, CLIN CHEM, V47, P1993; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lorsignol A, 1999, J NEUROENDOCRINOL, V11, P171; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Mazella J, 1996, J NEUROSCI, V16, P5613; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; MORENO FJ, 1983, J BIOL CHEM, V258, P938; MOSKOWITZ J, 1969, J CLIN INVEST, V48, P1802, DOI 10.1172/JCI106146; Muller G, 2000, CURR MED CHEM, V7, P861, DOI 10.2174/0929867003374534; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NORDMANN J, 1961, ADV CLIN CHEM, V4, P53, DOI 10.1016/S0065-2423(08)60035-9; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Popova N K, 2007, Neurosci Behav Physiol, V37, P631, DOI 10.1007/s11055-007-0062-z; Rao S, 1999, J BIOL CHEM, V274, P34245, DOI 10.1074/jbc.274.48.34245; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SHUSTER DE, 1995, SCIENCE, V269, P1590, DOI 10.1126/science.7667641; SIMONIN F, 1995, P NATL ACAD SCI USA, V92, P7006, DOI 10.1073/pnas.92.15.7006; SINHA TK, 1976, METABOLISM, V25, P251, DOI 10.1016/0026-0495(76)90083-4; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Soto H, 1998, P NATL ACAD SCI USA, V95, P8205, DOI 10.1073/pnas.95.14.8205; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; TSUTSUMI M, 1992, MOL ENDOCRINOL, V6, P1163, DOI 10.1210/me.6.7.1163; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626	94	445	470	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					561	571		10.1016/j.cell.2008.08.040	http://dx.doi.org/10.1016/j.cell.2008.08.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984166	Green Accepted, Bronze			2022-12-28	WOS:000260536300025
J	Stephenson, AE; DeYoreo, JJ; Wu, L; Wu, KJ; Hoyer, J; Dove, PM				Stephenson, A. E.; DeYoreo, J. J.; Wu, L.; Wu, K. J.; Hoyer, J.; Dove, P. M.			Peptides Enhance Magnesium Signature in Calcite: Insights into Origins of Vital Effects	SCIENCE			English	Article							GROWTH; SURFACE; SUPERSATURATION; TEMPERATURE; PRECIPITATION; DESOLVATION; INHIBITION; CARBONATE; PROTEINS; KINETICS	Studies relating the magnesium (Mg) content of calcified skeletons to temperature often report unexplained deviations from the signature expected for inorganically grown calcite. These "vital effects" are believed to have biological origins, but mechanistic bases for measured offsets remain unclear. We show that a simple hydrophilic peptide, with the same carboxyl- rich character as that of macromolecules isolated from sites of calcification, increases calcite Mg content by up to 3 mole percent. Comparisons to previous studies correlating Mg content of carbonate minerals with temperature show that the Mg enhancement due to peptides results in offsets equivalent to 7 degrees to 14 degrees C. The insights also provide a physical basis for anecdotal evidence that organic chemistry modulates the mineralization of inorganic carbonates and suggest an approach to tuning impurity levels in controlled materials synthesis.	[Stephenson, A. E.; Dove, P. M.] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA; [DeYoreo, J. J.; Wu, L.; Wu, K. J.] Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94551 USA; [Wu, L.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Hoyer, J.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; University of Delaware	Stephenson, AE (corresponding author), Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA.	aestephe@vt.edu; dove@vt.edu	Wu, Ligang/C-7770-2009; Dove, Patricia M/A-7911-2010; yu, yu/C-7781-2009		NSF [OCE-052667]; U.S. Department of Energy [FG02-00ER15112]	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE))	We thank J.F. Read and D. Rimstidt for thoughtful discussions. This research was supported by awards to P.M.D. from the NSF (grant OCE-052667) and U. S. Department of Energy (grant FG02-00ER15112). This work was also performed under the auspices of the U.S. DOE by an award to J.D.Y. at the University of California, Lawrence Livermore National Laboratory, under Contract No. W-7405-Eng-48. Opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF or DOE.	ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; ADDADI L, 1990, CROAT CHEM ACTA, V63, P539; Astilleros JM, 2003, GEOCHIM COSMOCHIM AC, V67, P1601, DOI 10.1016/S0016-7037(02)01166-3; Bentov S, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001015; BERNER RA, 1978, AM J SCI, V278, P816, DOI 10.2475/ajs.278.6.816; CARTER PW, 1978, GEOCHIM COSMOCHIM AC, V42, P1231, DOI 10.1016/0016-7037(78)90116-3; Chernov AA, 1998, MATER SCI FORUM, V276-2, P57, DOI 10.4028/www.scientific.net/MSF.276-277.57; CHILINGAR GEORGE V., 1962, BULL SOUTHERN CALIFORNIA ACAD SCI, V61, P45; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; DEYOREO JJ, 2007, 233 ANN M AM CHEM SO; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; EPSTEIN S, 1951, GEOL SOC AM BULL, V62, P417, DOI 10.1130/0016-7606(1951)62[417:CITS]2.0.CO;2; Falini G, 1996, CHEM COMMUN, P1037, DOI 10.1039/cc9960001037; FOLK RL, 1974, J SEDIMENT PETROL, V44, P40; Fu G, 2005, ADV MATER, V17, P2678, DOI 10.1002/adma.200500633; FUCHTBAUER H, 1976, GEOL SOC AM ABSTR, V8, P87719; Gledhill DK, 2006, GEOCHIM COSMOCHIM AC, V70, P5802, DOI 10.1016/j.gca.2006.03.024; Huheey J., 1983, INORGANIC CHEM PRINC; KATZ A, 1973, GEOCHIM COSMOCHIM AC, V37, P1563, DOI 10.1016/0016-7037(73)90091-4; Kowacz M, 2007, GEOCHIM COSMOCHIM AC, V71, P5168, DOI 10.1016/j.gca.2007.09.008; Lea D. W., 2003, OCEANS MARINE GEOCHE, DOI DOI 10.1016/B0-08-043751-6/06114-4; LORENS RB, 1981, GEOCHIM COSMOCHIM AC, V45, P553, DOI 10.1016/0016-7037(81)90188-5; MUCCI A, 1987, GEOCHIM COSMOCHIM AC, V51, P1977, DOI 10.1016/0016-7037(87)90186-4; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Piana S, 2006, J AM CHEM SOC, V128, P13568, DOI 10.1021/ja064706q; Prieto M, 2007, AM J SCI, V307, P1034, DOI 10.2475/07.2007.04; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Reeder RJ, 1996, GEOCHIM COSMOCHIM AC, V60, P1543, DOI 10.1016/0016-7037(96)00034-8; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Vinogradov AP., 1953, ELEMENTARY CHEM COMP; Wasylenki LE, 2005, GEOCHIM COSMOCHIM AC, V69, P4227, DOI 10.1016/j.gca.2005.04.006; Weaver ML, 2007, J CRYST GROWTH, V306, P135, DOI 10.1016/j.jcrysgro.2007.04.053	36	120	127	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					724	727		10.1126/science.1159417	http://dx.doi.org/10.1126/science.1159417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974348				2022-12-28	WOS:000260605200043
J	Rebouissou, S; Amessou, M; Couchy, G; Poussin, K; Imbeaud, S; Pilati, C; Izard, T; Balabaud, C; Bioulac-Sage, P; Zucman-Rossi, J				Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Imbeaud, Sandrine; Pilati, Camilla; Izard, Tina; Balabaud, Charles; Bioulac-Sage, Paulette; Zucman-Rossi, Jessica			Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours	NATURE			English	Article							SIGNAL TRANSDUCER; MOLECULAR-CLONING; CYTOKINE RECEPTOR; IL-6; INTERLEUKIN-6; BINDING; ADENOMA; GENE; CLASSIFICATION; TRANSCRIPTION	Inflammatory hepatocellular adenomas are benign liver tumours defined by the presence of inflammatory infiltrates and by the increased expression of inflammatory proteins in tumour hepatocytes(1,2). Here we show a marked activation of the interleukin ( IL)- 6 signalling pathway in this tumour type; sequencing candidate genes pinpointed this response to somatic gain- of- function mutations in the IL6ST gene, which encodes the signalling co- receptor gp130. Indeed, 60% of inflammatory hepatocellular adenomas harbour small in- frame deletions that target the binding site of gp130 for IL- 6, and expression of four different gp130 mutants in hepatocellular cells activates signal transducer and activator of transcription 3 ( STAT3) in the absence of ligand. Furthermore, analysis of hepatocellular carcinomas revealed that rare gp130 alterations are always accompanied by beta-catenin-activating mutations, suggesting a cooperative effect of these signalling pathways in the malignant conversion of hepatocytes. The recurrent gain- of function gp130 mutations in these human hepatocellular adenomas fully explains activation of the acute inflammatory phase observed in tumourous hepatocytes, and suggests that similar alterations may occur in other inflammatory epithelial tumours with STAT3 activation.	[Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Pilati, Camilla; Zucman-Rossi, Jessica] INSERM, Genom Fonct Tumeurs Solides U674, F-75010 Paris, France; [Rebouissou, Sandra; Amessou, Mohamed; Couchy, Gabrielle; Poussin, Karine; Pilati, Camilla; Zucman-Rossi, Jessica] Univ Paris 07, Inst Univ Hematol, F-75010 Paris, France; [Imbeaud, Sandrine] CNRS, Arrays IMAGE Genexpress Funct Genom & Syst Biol H, UMR 7091, F-94801 Villejuif, France; [Imbeaud, Sandrine] Univ Paris 06, F-94801 Villejuif, France; [Imbeaud, Sandrine] CNRS, Ctr Genet Mol, Gif Orsay DNA Microarray Platform GODMAP, UPR 2167, F-91198 Gif Sur Yvette, France; [Imbeaud, Sandrine] Univ Paris 11, F-91198 Gif Sur Yvette, France; [Izard, Tina] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Balabaud, Charles; Bioulac-Sage, Paulette] INSERM, U889, F-33076 Bordeaux, France; [Balabaud, Charles; Bioulac-Sage, Paulette] Univ Bordeaux 2, IFR66, F-33076 Bordeaux, France; [Balabaud, Charles] Hop St Andre, Serv Hepatol, CHU Bordeaux, F-33076 Bordeaux, France; [Bioulac-Sage, Paulette] Hop Pellegrin, Serv Anat Pathol, CHU Bordeaux, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux	Zucman-Rossi, J (corresponding author), INSERM, Genom Fonct Tumeurs Solides U674, F-75010 Paris, France.	zucman@cephb.fr	zucman-rossi, Jessica/B-5098-2009; j, zucman-rossi/AAV-3594-2021; Rebouissou, Sandra/O-5938-2017; Imbeaud, Sandrine/P-8780-2017	zucman-rossi, Jessica/0000-0002-5687-0334; j, zucman-rossi/0000-0002-5687-0334; Rebouissou, Sandra/0000-0003-0188-2271; Pilati, Camilla/0000-0002-1781-5180; Imbeaud, Sandrine/0000-0001-8439-6732	Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations); Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program); ARC [5158]; Fondation de France; la Ligue Nationale Contre le Cancer; Inca; Inserm; Bordeaux Hospital; National Institutes of Health [GM071596, AI055894, AI067949]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055894, R01AI067949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071596] Funding Source: NIH RePORTER	Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program); ARC(Australian Research Council); Fondation de France(Fondation de France); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Inca(Institut National du Cancer (INCA) France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Bordeaux Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to P. Bois and O. Bernard for scientific discussion and critical reading of this manuscript. We thank C. Thomas and G. Cubel for their participation to this work. We also thank J. Saric, C. Laurent, A. Sa Cunha, B. Le Bail and A. Rullier for contributing to the tissue collection (CHU Bordeaux). This work was supported by Inserm (Reseaux de Recherche Clinique et Reseaux de Recherche en Sante des Populations), the Ligue Nationale Contre le Cancer ("Cartes d'Identite des Tumeurs'' program), ARC (grant 5158), and the Fondation de France. S.R. and M.A. are supported by a fellowship from la Ligue Nationale Contre le Cancer and the Inca, respectively. J.Z.-R. is supported by an interface contract between Inserm and Bordeaux Hospital. T. I. is supported by the National Institutes of Health grants GM071596, AI055894 and AI067949.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bioulac-Sage P, 2005, GASTROENTEROLOGY, V128, P1211, DOI 10.1053/j.gastro.2005.02.004; Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Chen YW, 2002, HEPATOLOGY, V36, P927, DOI 10.1053/jhep.2002.36126; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Coulouarn C, 2005, HEPATOLOGY, V42, P946, DOI 10.1002/hep.20848; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Li H, 2002, J VIROL, V76, P5627, DOI 10.1128/JVI.76.11.5627-5636.2002; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Maione D, 1998, EMBO J, V17, P5588, DOI 10.1093/emboj/17.19.5588; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Rebouissou S, 2007, J BIOL CHEM, V282, P14437, DOI 10.1074/jbc.M610725200; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; WARD LD, 1994, J BIOL CHEM, V269, P23286; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	34	341	349	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					200	U96		10.1038/nature07475	http://dx.doi.org/10.1038/nature07475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19020503	Green Submitted, Green Accepted			2022-12-28	WOS:000262360200034
J	Granich, RM; Gilks, CF; Dye, C; De Cock, KM; Williams, BG				Granich, Reuben M.; Gilks, Charles F.; Dye, Christopher; De Cock, Kevin M.; Williams, Brian G.			Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model	LANCET			English	Article							PREVENTION INTERVENTIONS; MALE CIRCUMCISION; PUBLIC-HEALTH; INFECTION; IMPACT; RISK; MORTALITY; COUNTRIES; EPIDEMIC; BEHAVIOR	Background Roughly 3 million people worldwide were receiving antiretroviral therapy (ART) at the end of 2007, but an estimated 6.7 million were still in need of treatment and a further 2.7 million became infected with HIV in 2007. Prevention efforts might reduce HIV incidence but are unlikely to eliminate this disease. We investigated a theoretical strategy of universal voluntary HIV testing and immediate treatment with ART, and examined the conditions under which the HIV epidemic could be driven towards elimination. Methods We used mathematical models to explore the effect on the case reproduction number (stochastic model) and long-term dynamics of the HIV epidemic (deterministic transmission model) of testing all people in our test-case community (aged 15 years and older) for HIV every year and starting people on ART immediately after they are diagnosed HIV positive. We used data from South Africa as the test case for a generalised epidemic, and assumed that all HIV transmission was heterosexual. Findings The studied strategy could greatly accelerate the transition from the present endemic phase, in which most adults living with HIV are not receiving ART, to an elimination phase, in which most are on ART, within 5 years. it could reduce HIV incidence and mortality to less than one case per 1000 people per year by 2016, or within 10 years of full implementation of the strategy, and reduce the prevalence of HIV to less than 1% within 50 years. We estimate that in 2032, the yearly cost of the present strategy and the theoretical strategy would both be US$1.7 billion; however, after this time, the cost of the present strategy would continue to increase whereas that of the theoretical strategy would decrease. Interpretation Universal voluntary HIV testing and immediate ART, combined with present prevention approaches, could have a major effect on severe genralised HIV/AIDS epidemics. This approach merits further mathematical modelling, research, and broad consultation. Funding None.	[Granich, Reuben M.; Gilks, Charles F.; De Cock, Kevin M.] WHO, Antiretroviral Treatment & HIV Care Unit, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland; [Dye, Christopher; Williams, Brian G.] WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland	World Health Organization; World Health Organization	Granich, RM (corresponding author), WHO, Antiretroviral Treatment & HIV Care Unit, Dept HIV AIDS, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	granichr@who.int	Dye, Christopher/AIC-4659-2022; Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; Dye, Christopher/0000-0002-2957-1793; Williams, Brian/0000-0002-3174-4876				Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bennett DE, 2008, ANTIVIR THER, V13, P25; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592; *CLINT FDN, 2008, ANT ARV PRIC LIST; Cohen J, 2008, SCIENCE, V321, P512, DOI 10.1126/science.321.5888.512; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; DESROSIERS R, 2008, 15 C RETR OPP INF CR; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI55, DOI 10.1136/sti.2006.023663; Hirsch MS, 2008, J INFECT DIS, V197, pS252, DOI 10.1086/533416; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Horton R, 2008, LANCET, V372, P421, DOI 10.1016/S0140-6736(08)60882-X; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Kilby JM, 2008, AIDS, V22, P957, DOI 10.1097/QAD.0b013e3282fbd1da; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; *MED SANS FRONT, 2007, UNT WEB ARV PRIC RED; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; NASH D, 2008, 15 C RETR OPP INF CR; *PEPFAR, 2007, POW PARTN PRES EM PL; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; SHISANA O, 2005, S AFRICAN NATL HIV P; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2008, EX SUMM 2008 REP GLO; UNAIDS, 2007, FIN RES REQ ACH UN A; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; WHO / UNAIDS, 2008, UN ACC SCAL UP PRIOR; Williams BG, 2000, S AFR J SCI, V96, P305; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2007, ESSENTIAL PREVENTION; Wright RJ, 2004, AM J PREV MED, V27, P42, DOI 10.1016/j.amepre.2004.03.004; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; 2008, NATL HIV SYPHILIS AN; 2008, S AFR J HIV MED, V29, P18	55	1418	1447	2	161	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					48	57		10.1016/S0140-6736(08)61697-9	http://dx.doi.org/10.1016/S0140-6736(08)61697-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19038438				2022-12-28	WOS:000262183800031
J	Samson, RY; Obita, T; Freund, SM; Williams, RL; Bell, SD				Samson, Rachel Y.; Obita, Takayuki; Freund, Stefan M.; Williams, Roger L.; Bell, Stephen D.			A Role for the ESCRT System in Cell Division in Archaea	SCIENCE			English	Article							III RECOGNITION; SULFOLOBUS; ALIX	Archaea are prokaryotic organisms that lack endomembrane structures. However, a number of hyperthermophilic members of the Kingdom Crenarchaea, including members of the Sulfolobus genus, encode homologs of the eukaryotic endosomal sorting system components Vps4 and ESCRT- III ( endosomal sorting complex required for transport- III). We found that Sulfolobus ESCRT- III and Vps4 homologs underwent regulation of their expression during the cell cycle. The proteins interacted and we established the structural basis of this interaction. Furthermore, these proteins specifically localized to the mid- cell during cell division. Overexpression of a catalytically inactive mutant Vps4 in Sulfolobus resulted in the accumulation of enlarged cells, indicative of failed cell division. Thus, the archaeal ESCRT system plays a key role in cell division.	[Samson, Rachel Y.; Bell, Stephen D.] MRC, Canc Cell Unit, Cambridge CB2 0XZ, England; [Obita, Takayuki; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Freund, Stefan M.] MRC, Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Bell, SD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	stephen.bell@path.ox.ac.uk		Bell, Stephen/0000-0002-8474-6592; Williams, Roger/0000-0001-7754-4207	Wellcome Trust [083639/Z/07/Z]; Edward Penley Abraham Trust; MRC; MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Edward Penley Abraham Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank O. Perisic and I. Duggin for advice and helpful discussions, C. Mueller-Dieckmann for help with European Synchrotron Radiation Facility beamline ID29, and S. McCallum for flow cytometry. The work was supported by Wellcome Trust (grant 083639/Z/07/Z to R. L. W.), the Edward Penley Abraham Trust (S.D.B.). and the MRC (R.L.W. and S.D.B.). The coordinates for the structure reported in this work have been deposited in the Protein Data Bank (accession number 2w2u).	Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Dye NA, 2007, TRENDS CELL BIOL, V17, P239, DOI 10.1016/j.tcb.2007.03.005; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Hobel CFV, 2008, BIOCHEM SOC T, V36, P94, DOI 10.1042/BST0360094; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Lubelska JM, 2006, EXTREMOPHILES, V10, P383, DOI 10.1007/s00792-006-0510-7; Maaty WSA, 2006, J VIROL, V80, P7625, DOI 10.1128/JVI.00522-06; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Pogliano J, 2008, CURR OPIN CELL BIOL, V20, P19, DOI 10.1016/j.ceb.2007.12.006; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	21	243	254	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1710	1713		10.1126/science.1165322	http://dx.doi.org/10.1126/science.1165322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	19008417	Green Accepted			2022-12-28	WOS:000261608300050
J	Marley, MS				Marley, Mark S.			ASTRONOMY Exoplanets-Seeing Is Believing	SCIENCE			English	Editorial Material							BROWN DWARF; GIANT PLANETS		[Marley, Mark S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Marley, MS (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	mark.s.marley@nasa.gov	Marley, Mark S/I-4704-2013					BURROWS A, 1993, ASTROPHYS J, V406, P158, DOI 10.1086/172427; Chauvin G, 2004, ASTRON ASTROPHYS, V425, pL29, DOI 10.1051/0004-6361:200400056; Johnson JA, 2008, ASTROPHYS J, V675, P784, DOI 10.1086/526453; Kalas P, 2008, SCIENCE, V322, P1345, DOI 10.1126/science.1166609; LAFRENIERE D, ASTROPHYS J IN PRESS; Liou JC, 1999, ASTRON J, V118, P580, DOI 10.1086/300938; Lunine Jonathan, 2008, REPORT EXOPLANET TAS; Marley MS, 2007, ASTROPHYS J, V655, P541, DOI 10.1086/509759; NAKAJIMA T, 1995, NATURE, V378, P463, DOI 10.1038/378463a0; Saumon D, 1996, ASTROPHYS J, V460, P993, DOI 10.1086/177027	11	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1335	1337		10.1126/science.1167569	http://dx.doi.org/10.1126/science.1167569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19008413				2022-12-28	WOS:000261170600024
J	Li, M; Pernice, WHP; Xiong, C; Baehr-Jones, T; Hochberg, M; Tang, HX				Li, Mo; Pernice, W. H. P.; Xiong, C.; Baehr-Jones, T.; Hochberg, M.; Tang, H. X.			Harnessing optical forces in integrated photonic circuits	NATURE			English	Article							BISTABILITY; SYSTEMS; MOTION	The force exerted by photons is of fundamental importance in light matter interactions. For example, in free space, optical tweezers have been widely used to manipulate atoms and microscale dielectric particles(1,2). This optical force is expected to be greatly enhanced in integrated photonic circuits in which light is highly concentrated at the nanoscale(3,4). Harnessing the optical force on a semiconductor chip will allow solid state devices, such as electromechanical systems, to operate under new physical principles. Indeed, recent experiments have elucidated the radiation forces of light in highfinesse optical microcavities(5-7), but the large footprint of these devices ultimately prevents scaling down to nanoscale dimensions. Recent theoreticalwork has predicted that a transverse optical force can be generated and used directly for electromechanical actuation without the need for a high- finesse cavity(3). However, on- chip exploitation of this force has been a significant challenge, primarily owing to the lack of efficient nanoscale mechanical transducers in the photonics domain. Here we report the direct detection and exploitation of transverse optical forces in an integrated silicon photonic circuit through an embedded nanomechanical resonator. The nanomechanical device, a free-standing waveguide, is driven by the optical force and read out through evanescent coupling of the guided light to the dielectric substrate. This new optical force enables all- optical operation of nanomechanical systems on a CMOS ( complementary metal- oxide- semiconductor)- compatible platform, with substantial bandwidth and design flexibility compared to conventional electrical- based schemes.	[Li, Mo; Pernice, W. H. P.; Xiong, C.; Tang, H. X.] Yale Univ, Dept Elect Engn, New Haven, CT 06511 USA; [Li, Mo; Pernice, W. H. P.; Xiong, C.; Tang, H. X.] Yale Univ, Dept Mech Engn, New Haven, CT 06511 USA; [Baehr-Jones, T.; Hochberg, M.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	Yale University; Yale University; University of Washington; University of Washington Seattle	Tang, HX (corresponding author), Yale Univ, Dept Elect Engn, New Haven, CT 06511 USA.	hong.tang@yale.edu	Xiong, Chi/E-4080-2010; Pernice, Wolfram/E-8412-2010; Li, Mo/B-4673-2008; Tang, Hong/D-1587-2009; Pernice, Wolfram/F-6406-2014	Xiong, Chi/0000-0001-9851-9780; Li, Mo/0000-0002-5500-0900; Pernice, Wolfram/0000-0003-4569-4213	Alexander von Humboldt postdoctoral fellowship programme; Air Force Office of Scientific Research Young Investigator Program; NSF STC MDITR Center	Alexander von Humboldt postdoctoral fellowship programme(Alexander von Humboldt Foundation); Air Force Office of Scientific Research Young Investigator Program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF STC MDITR Center(National Science Foundation (NSF))	We thank J. Chen and B. Penkov for contributions at the early stage of this project. W. H. P. P. acknowledges support from the Alexander von Humboldt postdoctoral fellowship programme. The devices were fabricated at Yale University Microelectronics Center and the NSF-sponsored Cornell Nanoscale Facility. M. H. acknowledges support from the Air Force Office of Scientific Research Young Investigator Program and the NSF STC MDITR Center. H. X. T. thanks M. Roukes, A. Scherer, J. Harris and S. Girvin for discussions.	Almeida VR, 2004, NATURE, V431, P1081, DOI 10.1038/nature02921; Almeida VR, 2003, OPT LETT, V28, P1302, DOI 10.1364/OL.28.001302; Almeida VR, 2004, OPT LETT, V29, P2387, DOI 10.1364/OL.29.002387; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; CAHILL DG, 1990, REV SCI INSTRUM, V61, P802, DOI 10.1063/1.1141498; Carmon T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.123901; CHU S, 1991, SCIENCE, V253, P861, DOI 10.1126/science.253.5022.861; Eichenfield M, 2007, NAT PHOTONICS, V1, P416, DOI 10.1038/nphoton.2007.96; GARMIRE E, 1989, IEEE J QUANTUM ELECT, V25, P289, DOI 10.1109/3.18542; Huang MCY, 2008, NAT PHOTONICS, V2, P180, DOI 10.1038/nphoton.2008.3; Huang XMH, 2003, NATURE, V421, P496, DOI 10.1038/421496a; Ilic B, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1919395; Kippenberg TJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033901; Kippenberg TJ, 2007, OPT EXPRESS, V15, P17172, DOI 10.1364/OE.15.017172; Kleckner D, 2006, NATURE, V444, P75, DOI 10.1038/nature05231; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Masmanidis SC, 2007, SCIENCE, V317, P780, DOI 10.1126/science.1144793; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; Nayfeh A.H., 1995, NONLINEAR OSCIL; Povinelli ML, 2005, OPT LETT, V30, P3042, DOI 10.1364/OL.30.003042; Rakich PT, 2007, NAT PHOTONICS, V1, P658, DOI 10.1038/nphoton.2007.203; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439; Schliesser A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243905; SOREF RA, 1987, IEEE J QUANTUM ELECT, V23, P123, DOI 10.1109/JQE.1987.1073206; Taillaert D, 2004, OPT LETT, V29, P2749, DOI 10.1364/OL.29.002749	28	408	418	6	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					480	U28		10.1038/nature07545	http://dx.doi.org/10.1038/nature07545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037311				2022-12-28	WOS:000261170500033
J	Watts, G				Watts, Geoff			Profile John Bell: a Canadian at the top of UK academic medicine	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1801	1801		10.1016/S0140-6736(08)61748-1	http://dx.doi.org/10.1016/S0140-6736(08)61748-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027476				2022-12-28	WOS:000261112000013
J	Johnson, JB; Lees, JM; Gerst, A; Sahagian, D; Varley, N				Johnson, Jeffrey B.; Lees, Jonathan M.; Gerst, Alexander; Sahagian, Dork; Varley, Nick			Long-period earthquakes and co-eruptive dome inflation seen with particle image velocimetry	NATURE			English	Article							MOUNT ST-HELENS; WAVE-FIELDS; VOLCANO; SEISMICITY; EXTRUSION	Dome growth and explosive degassing are fundamental processes in the cycle of continental arc volcanism(1,2). Because both processes generate seismic energy, geophysical field studies of volcanic processes are often grounded in the interpretation of volcanic earthquakes(3). Although previous seismic studies have provided important constraints on volcano dynamics(4-6), such inversion results do not uniquely constrain magma source dimension and material properties. Here we report combined optical geodetic and seismic observations that robustly constrain the sources of long-period volcanic earthquakes coincident with frequent explosive eruptions at the volcano Santiaguito, in Guatemala. The acceleration of dome deformation, extracted from high- resolution optical image processing, is shown to be associated with recorded long-period seismic sources and the frequency content of seismic signals measured across a broadband network. These earthquake sources are observed as abrupt subvertical surface displacements of the dome, in which 20 - 50- cm uplift originates at the central vent and propagates at similar to 50 m s(-1) towards the 200- m- diameter periphery. Episodic shifts of the 20 - 80- m thick dome induce peak forces greater than 10(9) N and reflect surface manifestations of the volcanic long- period earthquakes, a broad class of volcano seismic activity that is poorly understood and observed at many volcanic centres worldwide(7). On the basis of these observations, the abrupt mass shift of solidified domes, conduit magma or magma pads may play a part in generating long- period earthquakes at silicic volcanic systems.	[Johnson, Jeffrey B.] New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA; [Lees, Jonathan M.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Gerst, Alexander] Univ Hamburg, Inst Geophys, D-20146 Hamburg, Germany; [Sahagian, Dork] Lehigh Univ, Bethlehem, PA 18015 USA; [Varley, Nick] Univ Colima, Fac Ciencias, Colima 28045, Mexico	New Mexico Institute of Mining Technology; University of North Carolina; University of North Carolina Chapel Hill; University of Hamburg; Lehigh University; Universidad de Colima	Johnson, JB (corresponding author), New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA.	jeff.johnson@ees.nmt.edu	Varley, Nick/AAW-8540-2020; Varley, Nick R/A-5591-2013	Varley, Nick/0000-0001-9626-4024; Varley, Nick R/0000-0001-9626-4024; Lees, Jonathan/0000-0002-0218-7038	US National Science Foundation EAR [0440225, 0440054]; Directorate For Geosciences [0738802, 0838395] Funding Source: National Science Foundation	US National Science Foundation EAR(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the many personnel involved with instrumentation preparation and field work, including R. Sanderson, O. Marcillo, M. Hort, E. Sanchez, W. Rose, M. Ruiz, R. Salguero and staff at IRIS PASSCAL and INSIVUMEH (Guatemala). This project was made possible by the US National Science Foundation EAR grants 0440225 and 0440054.	Anderson SW, 1995, J VOLCANOL GEOTH RES, V69, P105, DOI 10.1016/0377-0273(95)00022-4; Bluth GJS, 2004, J VOLCANOL GEOTH RES, V136, P297, DOI 10.1016/j.jvolgeores.2004.06.001; BOUCHON M, 1979, J GEOPHYS RES, V84, P3609, DOI 10.1029/JB084iB07p03609; Brodsky EE, 1999, J GEOPHYS RES-SOL EA, V104, P29387, DOI 10.1029/1999JB900308; Chouet B, 1997, J GEOPHYS RES-SOL EA, V102, P15129, DOI 10.1029/97JB00953; Chouet B, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003524; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Cruz FG, 1997, J VOLCANOL GEOTH RES, V77, P121, DOI 10.1016/S0377-0273(96)00091-1; Harris AJL, 2003, B VOLCANOL, V65, P77, DOI 10.1007/s00445-002-0243-0; Iverson RM, 2006, NATURE, V444, P439, DOI 10.1038/nature05322; Johnson JB, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020020; Jousset P, 2004, GEOPHYS J INT, V159, P776, DOI 10.1111/j.1365-246X.2004.02411.x; KANAMORI H, 1984, J GEOPHYS RES, V89, P1856, DOI 10.1029/JB089iB03p01856; KANAMORI H, 1982, J GEOPHYS RES, V87, P5422, DOI 10.1029/JB087iB07p05422; Leprince S., 2008, EOS T AM GEOPHYS UN, V89, P1, DOI [10.1029/2008EO010001, DOI 10.1029/2008EO010001]; Manga M, 2006, ANNU REV EARTH PL SC, V34, P263, DOI 10.1146/annurev.earth.34.031405.125125; McNutt S. R., 1996, MONITORING MITIGATIO, P100; MORI J, 1989, J VOLCANOL GEOTH RES, V38, P243, DOI 10.1016/0377-0273(89)90040-1; NISHIMURA T, 1995, J GEOPHYS RES-SOL EA, V100, P12465, DOI 10.1029/95JB00867; Ohminato T, 1998, J GEOPHYS RES-SOL EA, V103, P23839, DOI 10.1029/98JB01122; Rose W.I., 1987, GEOL SOC AM SPEC PAP, V212, P17, DOI DOI 10.1130/SPE212-P17; Sahagian D, 2005, J VOLCANOL GEOTH RES, V143, P1, DOI 10.1016/j.jvolgeores.2004.12.006; SAHETAPYENGEL S, 2008, B VOLCANOL, DOI DOI 10.1007/S00445-00008-00204-00443; Starostin AB, 2005, J VOLCANOL GEOTH RES, V143, P133, DOI 10.1016/j.jvolgeores.2004.09.014; Waite GP, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005259; Watts R.B., 2002, GEOLOGICAL SOC LONDO, V21, P115, DOI DOI 10.1144/GSL.MEM.2002.021.01.06; Young SR, 1997, SCIENCE, V276, P371	27	69	70	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					377	381		10.1038/nature07429	http://dx.doi.org/10.1038/nature07429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020619				2022-12-28	WOS:000261039600041
J	Myerburg, RJ				Myerburg, Robert J.			Implantable Cardioverter-Defibrillators after Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LEFT-VENTRICULAR DYSFUNCTION; SUDDEN CARDIAC DEATH; CORONARY-ARTERY-DISEASE; FRACTION LESS-THAN; EJECTION FRACTION; RANDOMIZED-TRIAL; RISK STRATIFICATION; 30-PERCENT RECEIVE; IMPROVED SURVIVAL; PROPHYLACTIC USE		[Myerburg, Robert J.] Univ Miami, Miller Sch Med, Div Cardiol D 39, Miami, FL 33101 USA	University of Miami	Myerburg, RJ (corresponding author), Univ Miami, Miller Sch Med, Div Cardiol D 39, POB 016960, Miami, FL 33101 USA.	rmyerbur@med.miami.edu			Leducq Foundation (Network on Sudden Cardiac Death); American Heart Association Chair in Cardiovascular Research at the University of Miami Miller School of Medicine; Boston Scientific; Procter Gamble; GlaxoSmithKline; SanofiAventis; General Electric; Medtronic; St. Jude Medical	Leducq Foundation (Network on Sudden Cardiac Death)(Leducq Foundation); American Heart Association Chair in Cardiovascular Research at the University of Miami Miller School of Medicine(American Heart Association); Boston Scientific(Boston Scientific); Procter Gamble(Procter & Gamble); GlaxoSmithKline(GlaxoSmithKline); SanofiAventis(Sanofi-Aventis); General Electric(General Electric); Medtronic(Medtronic); St. Jude Medical(St. Jude Medical)	Supported in part by a grant from the Leducq Foundation (Network on Sudden Cardiac Death) and by the American Heart Association Chair in Cardiovascular Research at the University of Miami Miller School of Medicine.; Dr. Myerburg reports receiving consulting fees from Boston Scientific, Procter & Gamble, GlaxoSmithKline, and SanofiAventis and lecture fees from Boston Scientific, General Electric, Medtronic, and St. Jude Medical. Dr. Myerburg is president of the Cardiac Arrhythmias Research and Education ( CARE) Foundation, a nonprofit organization that has received educational grants from Boston Scientific, Medtronic, and Procter & Gamble; he receives no personal income from CARE Foundation - related activities. No other potential conflict of interest relevant to this article was reported.	AMIN MS, 2008, J CARDIOVASC EL 0725; [Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 1988, AM J CARDIOL, V61, P501; ARIAS E, 2007, NATL VITAL STAT REPO, V9; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Barthel P, 2003, CIRCULATION, V108, P1221, DOI 10.1161/01.CIR.0000088783.34082.89; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; Bloomfield DM, 2004, CIRCULATION, V110, P1885, DOI 10.1161/01.CIR.0000143160.14610.53; BOURKE JP, 1991, J AM COLL CARDIOL, V18, P780, DOI 10.1016/0735-1097(91)90802-G; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Buxton AE, 2000, NEW ENGL J MED, V343, P1813; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Buxton AE, 2005, J AM COLL CARDIOL, V46, P310, DOI 10.1016/j.jacc.2005.03.060; Buxton AE, 2005, CIRCULATION, V111, P2537, DOI 10.1161/01.CIR.0000165057.88551.2C; BUXTON AE, 1987, CIRCULATION, V75, P1178, DOI 10.1161/01.CIR.75.6.1178; Buxton AE, 2007, J AM COLL CARDIOL, V50, P1150, DOI 10.1016/j.jacc.2007.04.095; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Cairns JA, 1997, LANCET, V349, P1776; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Cuculich PS, 2007, PACE, V30, P207, DOI 10.1111/j.1540-8159.2007.00651.x; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Greenberg H, 2004, J AM COLL CARDIOL, V43, P1459, DOI 10.1016/j.jacc.2003.11.038; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; Halkin A, 2005, AM J CARDIOL, V96, P325, DOI 10.1016/j.amjcard.2005.03.069; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huang DT, 2007, J CARDIOVASC ELECTR, V18, P833, DOI 10.1111/j.1540-8167.2007.00857.x; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Julian DG, 1997, LANCET, V349, P667, DOI 10.1016/S0140-6736(96)09145-3; Julian DG, 1997, LANCET, V349, P1776; JULIAN DG, 1997, LANCET, V349, P1180; Kaikkonen KS, 2006, CIRCULATION, V114, P1462, DOI 10.1161/CIRCULATIONAHA.106.624593; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Linzer M, 2006, AM J MED, V119, P528, DOI 10.1016/j.amjmed.2006.03.007; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P955, DOI 10.1001/jama.294.8.955; Makikallio TH, 2005, EUR HEART J, V26, P762, DOI 10.1093/eurheartj/ehi188; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; McClellan MB, 2005, NEW ENGL J MED, V352, P222, DOI 10.1056/NEJMp048354; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 2005, CIRCULATION, V111, P2542; Moss AJ, 2001, AM J CARDIOL, V88, P516, DOI 10.1016/S0002-9149(01)01729-5; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; Myerburg RJ, 2006, HEART RHYTHM, V3, P235, DOI 10.1016/j.hrthm.2005.09.023; Myerburg RJ, 2002, J CARDIOVASC ELECTR, V13, P709, DOI 10.1046/j.1540-8167.2002.00709.x; MYERBURG RJ, 2008, BRAUNWALDS HEART DIS, P933; Myerburg RJ, 2006, NEW ENGL J MED, V354, P2309, DOI 10.1056/NEJMp068112; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Ross AM, 1998, CIRCULATION, V97, P1549, DOI 10.1161/01.CIR.97.16.1549; Schmidt A, 2007, CIRCULATION, V115, P2006, DOI 10.1161/CIRCULATIONAHA.106.653568; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; WILBER DJ, 1990, CIRCULATION, V82, P350, DOI 10.1161/01.CIR.82.2.350; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; ZIPES DP, 1995, CIRCULATION, V92, P59, DOI 10.1161/01.CIR.92.1.59	66	113	120	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2245	2253		10.1056/NEJMra0803409	http://dx.doi.org/10.1056/NEJMra0803409			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020326				2022-12-28	WOS:000260994000007
J	Beskow, LM; Dame, L; Costello, EJ				Beskow, Laura M.; Dame, Lauren; Costello, E. Jane			RESEARCH ETHICS Certificates of Confidentiality and Compelled Disclosure of Data	SCIENCE			English	Editorial Material									[Beskow, Laura M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27710 USA; [Beskow, Laura M.; Dame, Lauren] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA; [Dame, Lauren] Duke Univ, Sch Law, Durham, NC 27708 USA; [Costello, E. Jane] Duke Univ, Med Ctr, Dev Epidemiol Program, Dept Psychiat & Behav Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Beskow, LM (corresponding author), Duke Univ, Duke Translat Med Inst, Durham, NC 27710 USA.	laura.beskow@duke.edu			NCRR NIH HHS [1UL1RR024128-01, UL1 RR024128-01, UL1 RR024128] Funding Source: Medline; NHGRI NIH HHS [P50 HG003391-05, P50 HG003391] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Currie Peter M, 2005, IRB, V27, P7, DOI 10.2307/3564529; *DHHS ADV COMM OFF, REC CONF RES DAT PRO; hhs, 1979, BELM REP ETH PRINC G; *NCI NIH, 2007, NAT CANC I BEST PRAC	4	35	35	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1054	1055		10.1126/science.1164100	http://dx.doi.org/10.1126/science.1164100			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008431	Green Accepted			2022-12-28	WOS:000260867700021
J	Lopez, A				Lopez, Alan			Health and health-research priorities: has WHO got it right?	LANCET			English	Editorial Material							POPULATION; DISEASE		[Lopez, Alan] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia	University of Queensland	Lopez, A (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia.	a.lopez@sph.uq.edu.au	Swaibu, Ramadhani A/H-3164-2011; Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; 				Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; James W.P.T., 2004, COMP QUANTIFICATION, P497; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Norton R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P737; Peto R., 2001, CRITICAL ISSUES GLOB, P154, DOI DOI 10.4314/NMP.V55I6.45441; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2007, WORLD POP PROSP 2006; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; WHO (World Health Organization), 2008, FIN REP AUD FIN STAT; World Health Organization, 2002, WORLD REPORT VIOLENC	12	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1525	1527		10.1016/S0140-6736(08)61632-3	http://dx.doi.org/10.1016/S0140-6736(08)61632-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984173				2022-12-28	WOS:000260590500006
J	Massie, BM; Carson, PE; McMurray, JJ; Komajda, M; McKelvie, R; Zile, MR; Anderson, S; Donovan, M; Iverson, E; Staiger, C; Ptaszynska, A				Massie, Barry M.; Carson, Peter E.; McMurray, John J.; Komajda, Michel; McKelvie, Robert; Zile, Michael R.; Anderson, Susan; Donovan, Mark; Iverson, Erik; Staiger, Christoph; Ptaszynska, Agata		I-PRESERVE Investigators	Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; BRAIN NATRIURETIC PEPTIDE; DIASTOLIC DYSFUNCTION; CLINICAL CHARACTERISTICS; CARDIOVASCULAR OUTCOMES; RANDOMIZED TRIAL; MECHANISMS; MORBIDITY; MORTALITY; DIAGNOSIS	Background: Approximately 50% of patients with heart failure have a left ventricular ejection fraction of at least 45%, but no therapies have been shown to improve the outcome of these patients. Therefore, we studied the effects of irbesartan in patients with this syndrome. Methods: We enrolled 4128 patients who were at least 60 years of age and had New York Heart Association class II, III, or IV heart failure and an ejection fraction of at least 45% and randomly assigned them to receive 300 mg of irbesartan or placebo per day. The primary composite outcome was death from any cause or hospitalization for a cardiovascular cause (heart failure, myocardial infarction, unstable angina, arrhythmia, or stroke). Secondary outcomes included death from heart failure or hospitalization for heart failure, death from any cause and from cardiovascular causes, and quality of life. Results: During a mean follow-up of 49.5 months, the primary outcome occurred in 742 patients in the irbesartan group and 763 in the placebo group. Primary event rates in the irbesartan and placebo groups were 100.4 and 105.4 per 1000 patient-years, respectively (hazard ratio, 0.95; 95% confidence interval [CI], 0.86 to 1.05; P=0.35). Overall rates of death were 52.6 and 52.3 per 1000 patient-years, respectively (hazard ratio, 1.00; 95% CI, 0.88 to 1.14; P=0.98). Rates of hospitalization for cardiovascular causes that contributed to the primary outcome were 70.6 and 74.3 per 1000 patient-years, respectively (hazard ratio, 0.95; 95% CI, 0.85 to 1.08; P=0.44). There were no significant differences in the other prespecified outcomes. Conclusions: Irbesartan did not improve the outcomes of patients with heart failure and a preserved left ventricular ejection fraction. (ClinicalTrials.gov number, NCT00095238.).	[Massie, Barry M.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Carson, Peter E.] Georgetown Univ, Washington, DC USA; [Carson, Peter E.] Vet Affairs Med Ctr, Washington, DC 20422 USA; [McMurray, John J.] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Komajda, Michel] Univ Paris 06, Paris, France; [Komajda, Michel] Grp Hosp Pitie Salpetriere, F-75634 Paris, France; [McKelvie, Robert] McMaster Univ, Hamilton, ON, Canada; [Zile, Michael R.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Zile, Michael R.] Med Univ S Carolina, Charleston, SC 29425 USA; [Anderson, Susan; Iverson, Erik] Univ Wisconsin, Madison, WI USA; [Donovan, Mark; Ptaszynska, Agata] Bristol Myers Squibb Co, Princeton, NJ USA; [Staiger, Christoph] Sanofi Aventis, Bridgewater, NJ USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Glasgow; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; McMaster University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; Bristol-Myers Squibb; Sanofi-Aventis	Massie, BM (corresponding author), Vet Affairs Med Ctr, 111C,4150 Clement St, San Francisco, CA 94121 USA.	barry.massie@va.gov	mcmurray, John/B-2467-2013; Ponikowski, Piotr/O-6454-2015; Mareev, Vyacheslav Yurievich/Q-1375-2017; Hradec, Jaromir/S-2388-2016; Brito, Dulce/G-9650-2016	mcmurray, John/0000-0002-6317-3975; Ponikowski, Piotr/0000-0002-3391-7064; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; Liang, Chang-seng/0000-0002-0328-0277; Volpe, Massimo/0000-0002-9642-8380; Maher, Vincent/0000-0002-3592-4508; Hradec, Jaromir/0000-0001-7597-8239; Brito, Dulce/0000-0003-1278-1847; Gillebert, Thierry/0000-0002-3832-919X; Boman, Kurt/0000-0002-0350-2132; Kober, Lars/0000-0002-6635-1466; Zile, Michael/0000-0001-7076-221X	Bristol-Myers Squibb; Sanofi-Aventis; Merck; Duke Clinical Research Institute; Momentum Research; Novartis; GlaxoSmithKline; Scios-Johnson Johnson; Corthera; Niles Therapeutics; AstraZeneca; Servier; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Merck(Merck & Company); Duke Clinical Research Institute; Momentum Research; Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Scios-Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Corthera; Niles Therapeutics; AstraZeneca(AstraZeneca); Servier(Servier); Pfizer(Pfizer)	Supported by Bristol-Myers Squibb and Sanofi-Aventis.; Dr. Massie reports receiving grant support from Bristol-Myers Squibb, Sanofi-Aventis, and Merck, consulting fees from Bristol-Myers Squibb, Sanofi-Aventis, Merck, Duke Clinical Research Institute, Momentum Research, Novartis, GlaxoSmithKline, Scios-Johnson & Johnson, Corthera, and Niles Therapeutics, and lecture fees from Merck; Dr. Carson, receiving consulting fees from Bristol-Myers Squibb, Sanofi-Aventis, and Merck and lecture fees from AstraZeneca and Novartis; Dr. McMurray, receiving support from Bristol-Myers Squibb (to Glasgow University) for his work on this trial; Dr. Komajda, receiving consulting fees from Bristol-Myers Squibb and Servier and lecture fees from Servier, Sanofi-Aventis, and AstraZeneca; Dr. McKelvie, receiving consulting fees from Bristol-Myers Squibb and Sanofi-Aventis and lecture fees from Bristol-Myers Squibb, Sanofi-Aventis, Pfizer, Merck, and AstraZeneca; Dr. Zile, receiving consulting fees from Bristol-Myers Squibb and Sanofi-Aventis; Ms. Anderson, being employed by the Statistical Data Analysis Center at the University of Wisconsin - Madison, which conducted statistical analysis for this trial, supported by Bristol- Myers Squibb and Sanofi-Aventis; Drs. Donovan and Ptaszynska, being employees of and having an equity interest in Bristol- Myers Squibb; and Dr. Staiger, being an employee of and having an equity interest in Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.; We thank clinical scientists Jean-Michel Bocquet and Magalie Thuault for their care in handling the logistics of the trial.	Abhayaratna WP, 2006, AM HEART J, V152, P941, DOI 10.1016/j.ahj.2006.05.007; Arnold JMO, 2003, CIRCULATION, V107, P1284, DOI 10.1161/01.CIR.0000054165.93055.42; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Berl T, 2003, ANN INTERN MED, V138, P542, DOI 10.7326/0003-4819-138-7-200304010-00010; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Borlaug BA, 2006, TRENDS CARDIOVAS MED, V16, P273, DOI 10.1016/j.tcm.2006.05.003; Carson P, 2005, J CARD FAIL, V11, P576, DOI 10.1016/j.cardfail.2005.06.432; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Desai A, 2007, CURR OPIN CARDIOL, V22, P578; Einhorn PT, 2007, AM HEART J, V153, P42, DOI 10.1016/j.ahj.2006.10.012; Galasko GIW, 2005, EUR HEART J, V26, P2269, DOI 10.1093/eurheartj/ehi410; Grewal J, 2008, AM J CARDIOL, V102, P733, DOI 10.1016/j.amjcard.2008.04.048; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hogg K, 2005, PROG CARDIOVASC DIS, V47, P357, DOI 10.1016/j.pcad.2005.02.001; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Little WC, 2005, PROG CARDIOVASC DIS, V47, P380, DOI 10.1016/j.pcad.2005.02.004; McMurray JJV, 2008, EUR J HEART FAIL, V10, P149, DOI 10.1016/j.ejheart.2007.12.010; Mottram PM, 2004, CIRCULATION, V110, P558, DOI 10.1161/01.CIR.0000138680.89536.A9; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; RECTOR TS, 1993, AM J CARDIOL, V71, P1106, DOI 10.1016/0002-9149(93)90582-W; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Wright JW, 2008, HEART FAIL REV, V13, P367, DOI 10.1007/s10741-007-9060-z; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	36	1293	1363	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2008	359	23					2456	2467		10.1056/NEJMoa0805450	http://dx.doi.org/10.1056/NEJMoa0805450			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378MT	19001508				2022-12-28	WOS:000261325900006
J	Merksamer, PI; Trusina, A; Papa, FR				Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.			Real-Time Redox Measurements during Endoplasmic Reticulum Stress Reveal Interlinked Protein Folding Functions	CELL			English	Article							ER-ASSOCIATED DEGRADATION; UNFOLDED-PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; DISULFIDE-ISOMERASE; MISFOLDED PROTEINS; LUMINAL DOMAIN; MEMBRANE; PATHWAY; KINASE	Disruption of protein folding in the endoplasmic reticulum (ER) causes unfolded proteins to accumulate, triggering the unfolded protein response (UPR). UPR outputs in turn decrease ER unfolded proteins to close a negative feedback loop. However, because it is infeasible to directly measure the concentration of unfolded proteins in vivo, cells are generically described as experiencing "ER stress'' whenever the UPR is active. Because ER redox potential is optimized for oxidative protein folding, we reasoned that measureable redox changes should accompany unfolded protein accumulation. To test this concept, we employed fluorescent protein reporters to dynamically measure ER redox status and UPR activity in single cells. Using these tools, we show that diverse stressors, both experimental and physiological, compromise ER protein oxidation when UPR-imposed homeostatic control is lost. Using genetic analysis we uncovered redox heterogeneities in isogenic cell populations, and revealed functional interlinks between ER protein folding, modification, and quality control systems.	[Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Merksamer, Philip I.; Trusina, Ala; Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu	trusina, ala/H-7312-2012; Trusina, Ala/L-6069-2013; Trusina, Ala/N-5030-2019	Trusina, Ala/0000-0003-1945-454X; Trusina, Ala/0000-0003-1945-454X; Papa, Feroz/0000-0002-3684-9108	NIH Director's New Innovator [DP2OD001925]; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Culpeper Scholarship from the Partnership for Cures; Sandler Foundation; Hillblom Foundation; National Science Foundation Predoctoral; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	NIH Director's New Innovator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Culpeper Scholarship from the Partnership for Cures; Sandler Foundation; Hillblom Foundation; National Science Foundation Predoctoral(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. James Remington for providing the roGFP2 construct; Victor Chubukov for assistance with automated flow cytometry and for data analysis software; Maya Schuldiner, Martin Jonikas, Erin Quan, Davis Ng, Chao Zhang, and Antony Cooper for reagents; and Kurt Thorn for imaging assistance. We thank Mark Hochstrasser, Scott Oakes, Chris Patil, Jonathan Weissman, and members of the Papa lab for comments on the manuscript. Microscopy images were collected at the Nikon Imaging Center at UCSF/QB3. F. R. P. is funded through an NIH Director's New Innovator Award (DP2OD001925), a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Culpeper Scholarship from the Partnership for Cures, and startup awards from the Sandler Foundation and the Hillblom Foundation. P. I. M. is supported through a National Science Foundation Predoctoral Fellowship.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	41	224	228	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					933	947		10.1016/j.cell.2008.10.011	http://dx.doi.org/10.1016/j.cell.2008.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19026441	Green Accepted, Bronze			2022-12-28	WOS:000261183900023
J	Mazumder, AA; Pope, GA				Mazumder, Asif Atik; Pope, George Anthony			A case of right sided weakness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; ATRIAL-FIBRILLATION; MINOR STROKE; EARLY RISK; VALIDATION; ENDARTERECTOMY; DIAGNOSIS; ACCURACY; SCALE		[Mazumder, Asif Atik; Pope, George Anthony] Kings Coll Hosp London, Dept Stroke Med, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Mazumder, AA (corresponding author), Kings Coll Hosp London, Dept Stroke Med, Denmark Hill, London SE5 9RS, England.	asifmaz@gmail.com						Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Dennis M, 2005, LANCET, V365, P755, DOI 10.1016/S0140-6736(05)17982-3; Friberg L, 2006, EUR HEART J, V27, P1954, DOI 10.1093/eurheartj/ehl146; Fuster V, 2001, EUR HEART J, V22, P1852, DOI 10.1053/euhj.2001.2983; Hacke W, 2004, LANCET, V363, P768; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Langdon PC, 2007, J CLIN NEUROSCI, V14, P630, DOI 10.1016/j.jocn.2006.04.009; Lemesle M, 1998, NEUROEPIDEMIOLOGY, V17, P74, DOI 10.1159/000026156; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; *NAT I HLTH CLIN E, 2007, ISCH STROK AC ALT AL; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Norton B, 1996, BRIT MED J, V312, P13, DOI 10.1136/bmj.312.7022.13; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Rothwell PM, 2004, STROKE, V35, P2855, DOI 10.1161/01.STR.0000147040.20446.f6; *ROYAL COLL PHYS, 2004, NAT CLIN GUID STROK; Sandercock P, 1997, LANCET, V349, P1569; SANDERCOCK P, 2003, COCHRANE DB SYST REV; Sandercock P, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000029; SANDERCOCK PAG, 1985, BRIT MED J, V291, P1675, DOI 10.1136/bmj.291.6510.1675; VONARBIN M, 1981, STROKE, V12, P288, DOI 10.1161/01.STR.12.3.288	28	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2008	337								a2427	10.1136/bmj.a2427	http://dx.doi.org/10.1136/bmj.a2427			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QB	19036768				2022-12-28	WOS:000261827600006
J	O'Brien, J				O'Brien, Jeanne			Bodies and Spirit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jeanne.obrien@urmc.rochester.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2348	2349		10.1001/jama.2008.735	http://dx.doi.org/10.1001/jama.2008.735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033576				2022-12-28	WOS:000261150800001
J	Schneider, DS; Chambers, MC				Schneider, David S.; Chambers, Moria C.			MICROBIOLOGY Rogue Insect Immunity	SCIENCE			English	Editorial Material							PROTECTION; WOLBACHIA		[Schneider, David S.; Chambers, Moria C.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Schneider, DS (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	dschneider@stanford.edu		Chambers, Moria/0000-0002-2577-549X	NIAID NIH HHS [R01 AI069164, T32 AI007328] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI069164] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Evans JD, 2003, J INVERTEBR PATHOL, V83, P46, DOI 10.1016/S0022-2011(03)00039-9; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Shirasu-Hiza MM, 2007, CELL MICROBIOL, V9, P2775, DOI 10.1111/j.1462-5822.2007.01042.x	10	13	14	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1199	1200		10.1126/science.1167450	http://dx.doi.org/10.1126/science.1167450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023073				2022-12-28	WOS:000261033400028
J	Blunt, MO; Russell, JC; Gimenez-Lopez, MD; Garrahan, JP; Lin, X; Schroder, M; Champness, NR; Beton, PH				Blunt, Matthew O.; Russell, James C.; Gimenez-Lopez, Maria del Carmen; Garrahan, Juan P.; Lin, Xiang; Schroder, Martin; Champness, Neil R.; Beton, Peter H.			Random Tiling and Topological Defects in a Two-Dimensional Molecular Network	SCIENCE			English	Article							LIQUID-SOLID INTERFACE; CRYSTALLIZATION; QUASICRYSTALS; TRANSITIONS; TEMPLATE; SURFACES; PHASE; MODEL	A molecular network that exhibits critical correlations in the spatial order that is characteristic of a random, entropically stabilized, rhombus tiling is described. Specifically, we report a random tiling formed in a two- dimensional molecular network of p-terphenyl-3,5,3 ',5 '-tetracarboxylic acid adsorbed on graphite. The network is stabilized by hexagonal junctions of three, four, five, or six molecules and may be mapped onto a rhombus tiling in which an ordered array of vertices is embedded within a nonperiodic framework with spatial fluctuations in a local order characteristic of an entropically stabilized phase. We identified a topological defect that can propagate through the network, giving rise to a local reordering of molecular tiles and thus to transitions between quasi- degenerate local minima of a complex energy landscape. We draw parallels between the molecular tiling and dynamically arrested systems, such as glasses.	[Gimenez-Lopez, Maria del Carmen; Lin, Xiang; Schroder, Martin; Champness, Neil R.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; [Blunt, Matthew O.; Russell, James C.; Garrahan, Juan P.; Beton, Peter H.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Champness, NR (corresponding author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.	neil.champness@nottingham.ac.uk; peter.beton@nottingham.ac.uk	del Carmen Gimenez-Lopez, Maria/A-8481-2012; Blunt, Matthew O/A-4133-2015; Schroder, Martin/I-5432-2013; Champness, Neil/A-1342-2010; del Carmen Gimenez Lopez, Maria/ABX-8778-2022; Beton, Peter/M-5303-2014	del Carmen Gimenez-Lopez, Maria/0000-0003-4644-2528; Blunt, Matthew O/0000-0001-9877-4183; Schroder, Martin/0000-0001-6992-0700; Champness, Neil/0000-0003-2970-1487; Beton, Peter/0000-0002-2120-8033; Garrahan, Juan/0000-0002-0185-3924	EPSRC [EP/D048761/01, GR/S54074/01]; Royal Society Wolfson Merit Award; EPSRC [EP/E04882X/1, EP/D048761/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D048761/1, GR/S54074/01, EP/E04882X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Merit Award(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the UK Engineering and Physical Sciences Research Council (EPSRC) for financial support under grant EP/D048761/01. J. P. G. was supported by EPSRC grant GR/S54074/01. M. S. acknowledges receipt of a Royal Society Wolfson Merit Award.	Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; BLOTE HWJ, 1982, J PHYS A-MATH GEN, V15, pL631, DOI 10.1088/0305-4470/15/11/011; Blunt M, 2008, CHEM COMMUN, P2304, DOI 10.1039/b801267a; Cohn H, 2001, J AM MATH SOC, V14, P297, DOI 10.1090/S0894-0347-00-00355-6; De Feyter S, 2005, J PHYS CHEM B, V109, P4290, DOI 10.1021/jp045298k; Destainville N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevB.88.030601; FISHER ME, 1961, PHYS REV, V124, P1664, DOI 10.1103/PhysRev.124.1664; FREDRICKSON GH, 1984, PHYS REV LETT, V53, P1244, DOI 10.1103/PhysRevLett.53.1244; Garrahan JP, 2003, P NATL ACAD SCI USA, V100, P9710, DOI 10.1073/pnas.1233719100; Griessl SJH, 2004, LANGMUIR, V20, P9403, DOI 10.1021/la049441c; Henley C.L., 1999, QUASICRYSTALS STATE, P459; KASTELEYN PW, 1963, J MATH PHYS, V4, P287, DOI 10.1063/1.1703953; Keys AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235503; Krauth W, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.064503; Lackinger M, 2005, LANGMUIR, V21, P4984, DOI 10.1021/la0467640; Ledieu J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.135507; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; Li M, 2008, ANGEW CHEM INT EDIT, V47, P6717, DOI 10.1002/anie.200802518; Linde J., 2001, DISCRETE MATH THE AA, P23; Moessner R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.024504; ONODA GY, 1988, PHYS REV LETT, V60, P2653, DOI 10.1103/PhysRevLett.60.2653; Otero R, 2008, SCIENCE, V319, P312, DOI 10.1126/science.1150532; Pivetta M, 2008, ANGEW CHEM INT EDIT, V47, P1076, DOI 10.1002/anie.200704479; Rosei F, 2003, PROG SURF SCI, V71, P95, DOI 10.1016/S0079-6816(03)00004-2; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; WIDOM M, 1989, PHYS REV LETT, V63, P310, DOI 10.1103/PhysRevLett.63.310; Wilson DB, 2004, ANN APPL PROBAB, V14, P274, DOI 10.1214/aoap/1075828054; Yuhara J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024203; Zhou H, 2007, J AM CHEM SOC, V129, P13774, DOI 10.1021/ja0742535	30	190	190	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1077	1081		10.1126/science.1163338	http://dx.doi.org/10.1126/science.1163338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008440				2022-12-28	WOS:000260867700031
J	Lin, CH; MacGum, JA; Chu, T; Stefan, CJ; Emr, SD				Lin, Charles H.; MacGum, Jason A.; Chu, Tony; Stefan, Christopher J.; Emr, Scott D.			Arrestin-Related Ubiquitin-Ligase Adaptors Regulate Endocytosis and Protein Turnover at the Cell Surface	CELL			English	Article							PLASMA-MEMBRANE ATPASE; QUALITY-CONTROL; NEUROMUSCULAR SYNAPTOGENESIS; SACCHAROMYCES-CEREVISIAE; BETA-ARRESTINS; PY MOTIFS; YEAST; RETROMER; RECEPTOR; BINDING	The diversity of plasma membrane (PM) proteins presents a challenge for the achievement of cargo-specific regulation of endocytosis. Here, we describe a family of proteins in yeast (ARTs, for arrestin-related trafficking adaptors) that function by targeting specific PM proteins to the endocytic system. Two members (Art1 and Art2) of the family were discovered in chemical-genetic screens, and they direct downregulation of distinct amino acid transporters triggered by specific stimuli. Sequence analysis revealed a total of nine ART family members in yeast. In addition to similarity to arrestins, the ARTs each contain multiple PY motifs. These motifs are required for recruitment of the Rsp5/Nedd4-like ubiquitin ligase, which modifies the cargoes as well as the ARTs. As a result, ubiquitinated cargoes are internalized and targeted to the vacuole (lysosome) for degradation. We propose that ARTs provide a cargo-specific quality-control pathway that mediates endocytic downregulation by coupling Rsp5/Nedd4 to diverse plasma membrane proteins.	[Lin, Charles H.; Chu, Tony; Stefan, Christopher J.; Emr, Scott D.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Emr, SD (corresponding author), Cornell Univ, Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	sde26@cornell.edu		Stefan, Christopher/0000-0002-4118-5721	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andoh T, 2002, FEBS LETT, V525, P131, DOI 10.1016/S0014-5793(02)03104-6; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li Y, 1999, MOL CELL BIOL, V19, P3588; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Wolf B, 1998, DEVELOPMENT, V125, P3853	36	362	377	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					714	725		10.1016/j.cell.2008.09.025	http://dx.doi.org/10.1016/j.cell.2008.09.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	18976803	Bronze			2022-12-28	WOS:000260886900021
J	Menon, U; Gentry-Maharaj, A; Ryan, A; Sharma, A; Burnell, M; Hallett, R; Lewis, S; Lopez, A; Godfrey, K; Oram, D; Herod, J; Williamson, K; Seif, M; Scott, I; Mould, T; Woolas, R; Murdoch, J; Dobbs, S; Amso, N; Leeson, S; Cruickshank, D; McGuire, A; Campbell, S; Fallowfield, L; Skates, S; Parmar, M; Jacobs, I				Menon, Usha; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sharma, Aarti; Burnell, Matthew; Hallett, Rachel; Lewis, Sara; Lopez, Alberto; Godfrey, Keith; Oram, David; Herod, Jonathan; Williamson, Karin; Seif, Mourad; Scott, Ian; Mould, Tim; Woolas, Robert; Murdoch, John; Dobbs, Stephen; Amso, Nazar; Leeson, Simon; Cruickshank, Derek; McGuire, Ali; Campbell, Stuart; Fallowfield, Lesley; Skates, Steve; Parmar, Mahesh; Jacobs, Ian			Recruitment to multicentre trials-lessons from UKCTOCS: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; OVARIAN-CANCER; FLEXIBLE SIGMOIDOSCOPY; POSTMENOPAUSAL WOMEN; COLORECTAL-CANCER; CLINICAL-TRIAL; FOLLOW-UP; PROGRAM; DESIGN; COHORT	Objective To describe the factors that contributed to successful recruitment of more than 200 000 women to the UK Collaborative Trial of Ovarian Cancer Screening, one of the largest ever randomised controlled trials. Design Descriptive study. Setting 13 NHS trusts in England, Wales, and Northern Ireland. Participants Postmenopausal women aged 50- 74; exclusion criteria included ovarian malignancy, bilateral oophorectomy, increased risk of familial ovarian cancer, active non- ovarian malignancy, and participation in other ovarian cancer screening trials. Main outcome measures Achievement of target recruitment, acceptance rates of invitation, and recruitment rates. Results The trial was set up in 13 centres with 27 adjoining local health authorities. The coordinating centre team was led by one of the senior investigators, who was closely involved in planning and day to day trial management. Of 1 243 282 women invited, 23.2% ( 288 955) replied that they were eligible and would like to participate. Of those sent appointments, 73.6% ( 205 090) attended for recruitment. The acceptance rate varied from 19% to 33% between trial centres. Measures to ensure target recruitment included named coordinating centre staff supporting and monitoring each centre, prompt identification and resolution of logistic problems, varying the volume of invitations by centre, using local nonattendance rates to determine the size of recruitment clinics, and organising large ad hoc clinics supported by coordinating centre staff. The trial randomised 202 638 women in 4.3 years. Conclusions Planning and trial management are as important as trial design and require equal attention from senior investigators. Successful recruitment needs constant monitoring by a committed proactive management team that is willing to explore individual solutions for different centres and use central resources to improve local recruitment. Automation of trial processes with web based trial management systems is crucial in large multicentre randomised controlled trials. Recruitment can be further enhanced by using information videos and group discussions. Trial registration Current Controlled Trials ISRCTN22488978.	[Menon, Usha; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sharma, Aarti; Burnell, Matthew; Hallett, Rachel; Lewis, Sara; Jacobs, Ian] UCL, EGA Inst Womens Hlth, London W1T 7DN, England; [Oram, David] St Bartholomews Hosp, London EC1A 7BE, England; [Herod, Jonathan] Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England; [Williamson, Karin] City Hosp Nottingham, Nottingham NG5 1PB, England; [Seif, Mourad] St Marys Hosp, Manchester M13 9WL, Lancs, England; [Scott, Ian] Derby City Hosp, Derby DE22 3NE, England; [Mould, Tim] Royal Free Hosp, London NW3 2QG, England; [Woolas, Robert] St Marys Hosp, Portsmouth PO3 6AD, Hants, England; [Murdoch, John] St Michaels Hosp, Bristol BS2 8EG, Avon, England; [Dobbs, Stephen] Belfast City Hosp, Belfast BT9 7AB, Antrim, North Ireland; [Amso, Nazar] Cardiff Univ, Cardiff CF14 4XN, Wales; [Cruickshank, Derek] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [McGuire, Ali] London Sch Econ, London WC2A 2AE, England; [Campbell, Stuart] Create Hlth Clin, London W1G 6AJ, England; [Fallowfield, Lesley] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England; [Skates, Steve] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Parmar, Mahesh] MRC, Clin Trials Unit, London NW1 2DA, England	University of London; University College London; University of London; Queen Mary University London; University of Liverpool; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Manchester; University of Nottingham; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Belfast City Hospital; Cardiff University; James Cook University Hospital; University of London; London School Economics & Political Science; University of Brighton; University of Sussex; Harvard University; Harvard Medical School; Medical Research Council Clinical Trials Unit	Menon, U (corresponding author), UCL, EGA Inst Womens Hlth, London W1T 7DN, England.	u.menon@ucl.ac.uk	Jacobs, Ian J/F-1743-2013; Menon, Usha/C-4716-2008	Jacobs, Ian J/0000-0002-8112-4624; Menon, Usha/0000-0003-3708-1732; Fallowfield, Lesley/0000-0003-0577-4518; Amso, Nazar/0000-0002-8646-6623; Jacobs, Ian/0000-0002-5005-2672	Medical Research Council; Cancer Research UK; Department of Health; Eve Appeal; Special Trustees of Bart's; London, and Special Trustees of UCLH; MRC [G9901012, G0000735] Funding Source: UKRI; Medical Research Council [G9901012, G0000735] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA086381, P50CA083639] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Department of Health; Eve Appeal; Special Trustees of Bart's; London, and Special Trustees of UCLH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The trial is core funded by the Medical Research Council, Cancer Research UK, and the Department of Health with additional support from the Eve Appeal, Special Trustees of Bart's and the London, and Special Trustees of UCLH. This work was done at UCLH/UCL within the " women's health theme" of the NIHR UCLH/UCL Comprehensive Biomedical Research Centre supported by the Department of Health. The researchers are independent from the funders.	Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2001, J MED SCREEN, V8, P137, DOI 10.1136/jms.8.3.137; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Cambron JA, 2001, J MANIP PHYSIOL THER, V24, P79, DOI 10.1067/mmt.2001.112567; Cosgrove N, 1999, CONTROL CLIN TRIALS, V20, P133, DOI 10.1016/S0197-2456(98)00055-5; Denhaerynck K, 2003, AM J PREV MED, V25, P195, DOI 10.1016/S0749-3797(03)00201-0; Eisinger F, 2001, Fam Cancer, V1, P175, DOI 10.1023/A:1021177417531; Farrell B, 1998, BRIT MED J, V317, P1236, DOI 10.1136/bmj.317.7167.1236; Fegan W, 2008, PLOS MED, V5, P347, DOI 10.1371/journal.pmed.0050006; Froom P, 1999, J CLIN EPIDEMIOL, V52, P731, DOI 10.1016/S0895-4356(99)00070-0; Gordon JS, 2006, NICOTINE TOB RES, V8, pS35, DOI 10.1080/14622200601039014; Gray M, 2000, Health Bull (Edinb), V58, P137; Hasson MA, 2000, CONTROL CLIN TRIALS, V21, p329S, DOI 10.1016/S0197-2456(00)00100-8; JACOBS I, 1988, LANCET, V1, P268; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jacobs IJ, 1996, BMJ-BRIT MED J, V313, P1355, DOI 10.1136/bmj.313.7069.1355; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Lindsted KD, 1996, J CLIN EPIDEMIOL, V49, P783, DOI 10.1016/0895-4356(96)00009-1; MacDonald N, 1999, BRIT J CANCER, V80, P1826, DOI 10.1038/sj.bjc.6690605; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2007, MENOPAUSE, V14, P462, DOI 10.1097/01.gme.0000243569.70946.9d; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; *OFF NAT, 2001, H CENS 2001 POP DAT; *OFF NAT STAT, 2004, CANC STAT REG REG CA, P24; Ott CD, 2006, CANCER NURS, V29, P21, DOI 10.1097/00002820-200601000-00004; OTT CD, 2006, CANC NURS, V29, P32; Paine BJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-5; Parkes C A, 1994, J Med Screen, V1, P209; PRESCOTT RJ, 1999, HEALTH TECHNOL ASSES, V3, P65; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomson CA, 2005, J CLIN EPIDEMIOL, V58, P378, DOI 10.1016/j.jclinepi.2004.10.013	33	70	70	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2008	337								a2079	10.1136/bmj.a2079	http://dx.doi.org/10.1136/bmj.a2079			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008269	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000261784500002
J	Bynum, B				Bynum, Bill			The art of medicine Road maps to health	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk						Glacken Clarence J., 1976, TRACES RHODIAN SHORE; Hamlin C., 1998, PUBLIC HLTH SOCIAL J; Lloyd G.E.R., 1978, HIPPOCRATIC WRITINGS; Ramazzini B., 1940, DIS WORKERS; Virchow R., 1848, COLLECTED ESSAYS PUB	5	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1626	1627		10.1016/S0140-6736(08)61676-1	http://dx.doi.org/10.1016/S0140-6736(08)61676-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	19006814	Bronze			2022-12-28	WOS:000260899900014
J	McDonald, GR; Hudson, AL; Dunn, SMJ; You, HT; Baker, GB; Whittal, RM; Martin, JW; Jha, A; Edmondson, DE; Holt, A				McDonald, G. Reid; Hudson, Alan L.; Dunn, Susan M. J.; You, Haitao; Baker, Glen B.; Whittal, Randy M.; Martin, Jonathan W.; Jha, Amitabh; Edmondson, Dale E.; Holt, Andrew			Bioactive Contaminants Leach from Disposable Laboratory Plasticware	SCIENCE			English	Article									[McDonald, G. Reid; Hudson, Alan L.; Dunn, Susan M. J.; You, Haitao; Holt, Andrew] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2B7, Canada; [Baker, Glen B.] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2R7, Canada; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Martin, Jonathan W.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2G3, Canada; [Jha, Amitabh] Acadia Univ, Dept Chem, Wolfville, NS B4P 2R6, Canada; [Edmondson, Dale E.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Acadia University; Emory University	Holt, A (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2B7, Canada.	aholt@pmcol.ualberta.ca	Jha, Amitabh/B-5452-2010; Jha, Amitabh/AAU-2075-2021; Martin, Jonathan W/J-3824-2013	Jha, Amitabh/0000-0002-6305-0721; Martin, Jonathan W/0000-0001-6265-4294; Hudson, Alan/0000-0003-1105-7646				COOPER I, 1995, FOOD ADDIT CONTAM, V12, P235, DOI 10.1080/02652039509374298; Hiley CR, 2007, CARDIOVASC DRUG REV, V25, P46, DOI 10.1111/j.1527-3466.2007.00004.x; Maher B, 2008, NATURE, V453, P964, DOI 10.1038/453964a; Shotyk W, 2007, ENVIRON SCI TECHNOL, V41, P1560, DOI 10.1021/es061511+; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010	5	166	167	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					917	917		10.1126/science.1162395	http://dx.doi.org/10.1126/science.1162395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988846				2022-12-28	WOS:000260674100039
J	Lisiecki, LE; Raymo, ME; Curry, WB				Lisiecki, Lorraine E.; Raymo, Maureen E.; Curry, William B.			Atlantic overturning responses to Late Pleistocene climate forcings	NATURE			English	Article							THERMOHALINE CIRCULATION; DEEP-WATER; OCEAN; CYCLES; TERMINATION; GLACIATION; EVOLUTION	The factors driving glacial changes in ocean overturning circulation are not well understood. On the basis of a comparison of 20 climate variables over the past four glacial cycles, the SPECMAP project(1) proposed that summer insolation at high northern latitudes ( that is, Milankovitch forcing) drives the same sequence of ocean circulation and other climate responses over 100- kyr eccentricity cycles, 41- kyr obliquity cycles and 23- kyr precession cycles. SPECMAP analysed the circulation response at only a few sites in the Atlantic Ocean, however, and the phase of circulation response has been shown to vary by site and orbital band(2). Here we test the SPECMAP hypothesis by measuring the phase of orbital responses in benthic delta C-13 ( a proxy indicator of ocean nutrient content) at 24 sites throughout the Atlantic over the past 425 kyr. On the basis of delta C-13 responses at 3,000 - 4,010 mwater depth, we find that maxima in Milankovitch forcing are associated with greater mid- depth overturning in the obliquity band but less overturning in the precession band. This suggests that Atlantic overturning is strongly sensitive to factors beyond ice volume and summer insolation at high northern latitudes. A better understanding of these processes could lead to improvements in model estimates of overturning rates, which range from a 40 per cent increase to a 40 per cent decrease at the Last Glacial Maximum(3) and a 10 - 50 per cent decrease over the next 140 yr in response to projected increases in atmospheric CO2 ( ref. 4).	[Lisiecki, Lorraine E.; Raymo, Maureen E.] Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; [Curry, William B.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Boston University; Woods Hole Oceanographic Institution	Lisiecki, LE (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	lisiecki@alumni.brown.edu	Raymo, Maureen E/A-1270-2012; Lisiecki, Lorraine/C-4066-2008		NOAA Postdoctoral Program in Climate and Global Change; NSF	NOAA Postdoctoral Program in Climate and Global Change(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF))	We thank T. Herbert, D. Oppo, Z. Liu, P. Huybers, A. Carlson and L. Robinson for discussions. L.E.L. was supported by the NOAA Postdoctoral Program in Climate and Global Change, administered by the University Corporation for Atmospheric Research. M.E.R. and W.B.C. acknowledge the support of NSF grants.	BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; Crucifix M, 2002, CLIM DYNAM, V19, P417, DOI 10.1007/s00382-002-0234-z; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Curry WB, 1996, SOUTH ATLANTIC, P577; Dahl K, 2005, CLIM DYNAM, V24, P325, DOI 10.1007/s00382-004-0499-5; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Harris RN, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015120; Huybers P, 2007, J PHYS OCEANOGR, V37, P394, DOI 10.1175/JPO3018.1; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Imbrie J., 1989, CLIMATE GEO SCI, P121, DOI DOI 10.1007/978-94-009-2446-8_7; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Khodri M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003gl017108; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; MACKENSEN A, 1993, PALEOCEANOGRAPHY, V8, P587, DOI 10.1029/93PA01291; Marchitto TM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001323; MCCAVE IN, 1995, NATURE, V374, P149, DOI 10.1038/374149a0; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; McManus JF, 2002, QUATERNARY RES, V58, P17, DOI 10.1006/qres.2002.2367; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; RAYMO ME, 1990, EARTH PLANET SC LETT, V97, P353, DOI 10.1016/0012-821X(90)90051-X; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; RUDDIMAN WF, 1981, SCIENCE, V212, P617, DOI 10.1126/science.212.4495.617; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Schmidt MW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC000957; Shin SI, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015513; Skinner LC, 2005, QUATERNARY SCI REV, V24, P571, DOI 10.1016/j.quascirev.2004.11.008; Tuenter E, 2005, CLIM DYNAM, V24, P279, DOI [10.1007/s00382-004-0490-1, 10.1007/s00382-004-0490-l]; Weber SL, 2007, CLIM PAST, V3, P51, DOI 10.5194/cp-3-51-2007; Yoshimori M, 2001, CLIM DYNAM, V17, P571, DOI 10.1007/s003820000134	30	58	61	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					85	88		10.1038/nature07425	http://dx.doi.org/10.1038/nature07425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987740				2022-12-28	WOS:000260674000045
J	McLellan, AT; Skipper, GS; Campbell, M; DuPont, RL				McLellan, A. Thomas; Skipper, Gregory S.; Campbell, Michael; DuPont, Robert L.			Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE PROFESSIONALS	Objective To evaluate the effectiveness of US state physician health programmes in treating physicians with substance use disorders. Design Five year, longitudinal, cohort study. Setting Purposive sample of 16 state physician health programmes in the United States. Participants 904 physicians consecutively admitted to one of the 16 programmes from September 1995 to September 2001. Main outcome measures Completion of the programme, continued alcohol and drug misuse ( regular urine tests), and occupational status at five years. Results 155 of 802 physicians ( 19.3%) with known outcomes failed the programme, usually early during treatment. Of the 647 ( 80.7%) who completed treatment and resumed practice under supervision and monitoring, alcohol or drug misuse was detected by urine testing in 126 ( 19%) over five years; 33 ( 26%) of these had a repeat positive test result. At five year follow- up, 631 ( 78.7%) physicians were licensed and working, 87 ( 10.8%) had their licences revoked, 28 ( 3.5%) had retired, 30 ( 3.7%) had died, and 26 ( 3.2%) had unknown status. Conclusion About three quarters of US physicians with substance use disorders managed in this subset of physician health programmes had favourable outcomes at five years. Such programmes seem to provide an appropriate combination of treatment, support, and sanctions to manage addiction among physicians effectively.	[McLellan, A. Thomas] Treatment Res Inst, Philadelphia, PA 19106 USA; [Skipper, Gregory S.] Alabama Phys Assistance Program, Montgomery, AL USA; [Campbell, Michael; DuPont, Robert L.] Inst Behav & Hlth Inc, Rockville, MD USA		McLellan, AT (corresponding author), Treatment Res Inst, 600 Publ Ledger Bldg,150 S Independence Mall, Philadelphia, PA 19106 USA.	tmclellan@tresearch.org		DuPont, Robert/0000-0002-3345-0759	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was supported by the Robert Wood Johnson Foundation.	Allen JP, 1997, J STUD ALCOHOL, V58, P7; Domino KB, 2005, JAMA-J AM MED ASSOC, V293, P1453, DOI 10.1001/jama.293.12.1453; DUPONT RL, 2009, J SUBST ABU IN PRESS, P36; FLAHERTY JA, 1993, PSYCHIAT CLIN N AM, V16, P189; Galanter M, 2007, AM J ADDICTION, V16, P117, DOI 10.1080/10550490601184456; HASEMYER D, 2007, STATE DROPS AID ADDI; HUBBARD RL, 2001, RELAPSE DRUG TREATME; Institute of Medicine, 2006, IMPR QUAL HLTH CAR M; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; MERLO LJ, 2008, PSYCHIAT TIMES, V14, P76; Moos R, 1990, ALCOHOLISM TREATMENT; Pomm RM, 2004, PSYCHIAT ANN, V34, P786, DOI 10.3928/0048-5713-20041001-19; ROJAS A, 2007, SACRAMENTO BEE  0617, pA3; Simpson DD, 1997, PSYCHOL ADDICT BEHAV, V11, P294, DOI 10.1037/0893-164X.11.4.294; Smith P C, 1991, J Okla State Med Assoc, V84, P599; TALBOTT GD, 1987, OCCUP MED, V2, P581	16	144	145	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 4	2008	337								a2038	10.1136/bmj.a2038	http://dx.doi.org/10.1136/bmj.a2038			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FA	18984632	hybrid, Green Published			2022-12-28	WOS:000261235900002
J	Richards, T				Richards, Tessa			Copy them in	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 4	2008	337								a2324	10.1136/bmj.a2324	http://dx.doi.org/10.1136/bmj.a2324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FA	18984635				2022-12-28	WOS:000261235900010
J	Brewster, JM; Kaufmann, IM; Hutchison, S; MacWilliam, C				Brewster, Joan M.; Kaufmann, I. Michael; Hutchison, Sarah; MacWilliam, Cynthia			Characteristics and outcomes of doctors in a substance dependence monitoring programme in Canada: prospective descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG PROBLEMS; PHYSICIANS; ALCOHOL; CARE	Objective To describe the characteristics at enrolment and outcomes of doctors in a substance dependence monitoring programme in Canada. Design Prospective descriptive study. Setting Provincial physician health programme, Canada. Participants All 100 doctors consecutively admitted to a substance dependence monitoring programme and followed until completion of monitoring or on leaving the programme. Main outcome measure Relapse during long term monitoring for five years. Results Ninety per cent of the doctors enrolled on the programme were men, 66% were married or living with a partner, 44% had had previous treatment for substance dependence, and 36% had had previous psychiatric treatment. Smokers were over- represented compared with the general population of US doctors ( 38% v 5%). During the monitoring period 71% of participants had no known relapse. An additional 14% went on to complete the programme, after some form of relapse. In total, 85% of the doctors successfully completed the programme. Conclusion In this cohort of doctors enrolled on the Ontario Physician Health Program for substance dependence, most were men who were dependent on alcohol or opioids. Smokers were over- represented compared with the general population of US doctors. Eighty five per cent successfully completed the programme.	[Brewster, Joan M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Kaufmann, I. Michael; Hutchison, Sarah; MacWilliam, Cynthia] Ontario Med Assoc, Ontario Phys Hlth Program, Toronto, ON, Canada	University of Toronto	Brewster, JM (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.	jmbrewster@sympatico.ca			Ontario Physician Health Program	Ontario Physician Health Program	This research was funded by the Ontario Physician Health Program. JMB was paid as a consultant to carry out data analyses and write the paper. The other authors are employees of the Ontario Physician Health Program or the Ontario Medical Association, and their participation in the research was part of their employment. The research interpretation and outcomes are independent of the funding.	Bohigian GM, 1996, SOUTHERN MED J, V89, P1078, DOI 10.1097/00007611-199611000-00010; *BRIT MED ASS, 2008, DOCT HLTH WELLB; *CAN MED ASS, 2008, CAN PHYS HLTH NETW; GALANTER M, 1990, AM J PSYCHIAT, V147, P64; GLASER FB, 1986, CAN FAM PHYSICIAN, V32, P993; Gossop M, 2001, ALCOHOL ALCOHOLISM, V36, P160, DOI 10.1093/alcalc/36.2.160; MANSKY PA, 2003, PSYCHIAT TIMES  0201, P20; Nelson HD, 1996, WESTERN J MED, V165, P31; Reading E G, 1992, Md Med J, V41, P325; Smith DR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-115; 2008, FEDERATION STATE PHY	11	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2008	337								a2098	10.1136/bmj.a2098	http://dx.doi.org/10.1136/bmj.a2098			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377EZ	18981018	Green Published, hybrid			2022-12-28	WOS:000261235800001
J	Marois, C; Macintosh, B; Barman, T; Zuckerman, B; Song, IS; Patience, J; Lafreniere, D; Doyon, R				Marois, Christian; Macintosh, Bruce; Barman, Travis; Zuckerman, B.; Song, Inseok; Patience, Jennifer; Lafreniere, David; Doyon, Rene			Direct Imaging of Multiple Planets Orbiting the Star HR 8799	SCIENCE			English	Article							DUSTY DEBRIS DISKS; A-TYPE STARS; DETERMINISTIC MODEL; GIANT PLANETS; LUMINOSITY; SEARCH; SYSTEM; BOOTIS; DWARF; GAS	Direct imaging of exoplanetary systems is a powerful technique that can reveal Jupiter- like planets in wide orbits, can enable detailed characterization of planetary atmospheres, and is a key step toward imaging Earth- like planets. Imaging detections are challenging because of the combined effect of small angular separation and large luminosity contrast between a planet and its host star. High- contrast observations with the Keck and Gemini telescopes have revealed three planets orbiting the star HR 8799, with projected separations of 24, 38, and 68 astronomical units. Multi- epoch data show counter clockwise orbital motion for all three imaged planets. The low luminosity of the companions and the estimated age of the system imply planetary masses between 5 and 13 times that of Jupiter. This system resembles a scaled- up version of the outer portion of our solar system.	[Marois, Christian] Natl Res Council Canada, Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Marois, Christian; Macintosh, Bruce] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Marois, Christian] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Barman, Travis] Lowell Observ, Flagstaff, AZ 86001 USA; [Zuckerman, B.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Zuckerman, B.] Univ Calif Los Angeles, Ctr Astrobiol, Los Angeles, CA 90095 USA; [Song, Inseok] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Patience, Jennifer] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; [Lafreniere, David] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Doyon, Rene] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Doyon, Rene] Univ Montreal, Observ Mont Megant, Montreal, PQ H3C 3J7, Canada	National Research Council Canada; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia; University of Exeter; University of Toronto; Universite de Montreal; Laval University; Universite de Montreal	Marois, C (corresponding author), Natl Res Council Canada, Herzberg Inst Astrophys, 5071 W Saanich Rd, Victoria, BC V9E 2E7, Canada.	christian.marois@nrc-cnrc.gc.ca		Lafreniere, David/0000-0002-6780-4252; Macintosh, Bruce/0000-0003-1212-7538	Fonds Quebecois de la Recherche sur la Nature et les Technologies; U. S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NSF Science and Technology CfAO; University of California-Santa Cruz [AST 98-76783]; NASA; UCLA; Lowell Observatory; Natural Sciences and Engineering Research Council of Canada; STFC [ST/F003277/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F003277/1] Funding Source: researchfish	Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); U. S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NSF Science and Technology CfAO(National Science Foundation (NSF)); University of California-Santa Cruz(University of California System); NASA(National Aeronautics & Space Administration (NASA)); UCLA; Lowell Observatory; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the Keck and Gemini staff, particularly T. Armandroff, B. Goodrich, and J.-R. Roy, for support with the follow-up observations. We thank the University of California- Los Angeles ( UCLA) galactic center team, especially J. Lu, for the NIRC2 plate scale and North orientation errors. We are indebted to E. Becklin and R. Racine for their contributions in the earliest stages of this research. C.M. and D.L. are supported in part through postdoctoral fellowships from the Fonds Quebecois de la Recherche sur la Nature et les Technologies. Portions of this research were performed under the auspices of the U. S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344 and also supported in part by the NSF Science and Technology CfAO, managed by the University of California-Santa Cruz under cooperative agreement AST 98-76783. We acknowledge support by NASA grants to UCLA and Lowell Observatory. R. D. is supported through a grant from the Natural Sciences and Engineering Research Council of Canada. The data were obtained at the W. M. Keck and Gemini Observatories. This publication makes use of data products from the Two Micron All Sky Survey and the SIMBAD database (http://simbad. u-strasbg.fr/simbad).	Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; Bujarrabal V, 2008, ASTRON ASTROPHYS, V483, P839, DOI 10.1051/0004-6361:20079273; Casewell SL, 2007, MON NOT R ASTRON SOC, V378, P1131, DOI 10.1111/j.1365-2966.2007.11848.x; Chauvin G, 2004, ASTRON ASTROPHYS, V425, pL29, DOI 10.1051/0004-6361:200400056; DEMING D, P IAU S IN PRESS, V253; Ducourant C, 2008, ASTRON ASTROPHYS, V477, pL1, DOI 10.1051/0004-6361:20078886; Golimowski DA, 2004, ASTRON J, V127, P3516, DOI 10.1086/420709; Gray RO, 2002, ASTRON J, V124, P989, DOI 10.1086/341609; Gray RO, 1999, ASTRON J, V118, P2993, DOI 10.1086/301134; Ida S, 2005, ASTROPHYS J, V626, P1045, DOI 10.1086/429953; Ida S, 2004, ASTROPHYS J, V616, P567, DOI 10.1086/424830; Johnson JA, 2007, ASTROPHYS J, V670, P833, DOI 10.1086/521720; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; Kalas P, 2008, SCIENCE, V322, P1345, DOI 10.1126/science.1166609; Krisciunas K, 1995, MON NOT R ASTRON SOC, V277, P1404, DOI 10.1093/mnras/277.4.1404; LAFRENIERE D, ASTROPHYS J IN PRESS; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; LISSAUER JJ, 1987, ICARUS, V69, P249, DOI 10.1016/0019-1035(87)90104-7; Mannings V, 1997, ASTROPHYS J, V490, P792, DOI 10.1086/304897; Marley MS, 2007, ASTROPHYS J, V655, P541, DOI 10.1086/509759; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Moor A, 2006, ASTROPHYS J, V644, P525, DOI 10.1086/503381; Najita J, 2005, ASTROPHYS J, V635, P625, DOI 10.1086/497159; NAKAJIMA T, 1995, NATURE, V378, P463, DOI 10.1038/378463a0; RAFIKOV R, 2005, APJ, V621, P69; Rhee JH, 2007, ASTROPHYS J, V660, P1556, DOI 10.1086/509912; Rice WKM, 2003, ASTROPHYS J, V598, pL55, DOI 10.1086/380390; Royer F, 2007, ASTRON ASTROPHYS, V463, P671, DOI 10.1051/0004-6361:20065224; SADAKANE K, 1986, PUBL ASTRON SOC PAC, V98, P685, DOI 10.1086/131813; SAUMON D, 2008, ASTROPHYS J; Stauffer JR, 1998, ASTROPHYS J, V499, pL199, DOI 10.1086/311379; TORRES CAO, HDB STAR FO IN PRESS, V2; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; WEIDENSCHILLING SJ, 1977, ASTROPHYS SPACE SCI, V51, P153, DOI 10.1007/BF00642464; Williams JP, 2006, ASTROPHYS J, V653, P1480, DOI 10.1086/508919; WILSON RE, 1953, PUBL CARNEGIE I, V601; Zuckerman B, 2004, ANNU REV ASTRON ASTR, V42, P685, DOI 10.1146/annurev.astro.42.053102.134111; Zuckerman B, 2004, ASTROPHYS J, V603, P738, DOI 10.1086/381700; Zuckerman B, 2001, ANNU REV ASTRON ASTR, V39, P549, DOI 10.1146/annurev.astro.39.1.549; ZUCKERMAN B, ASTRON ASTR IN PRESS	41	1292	1297	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2008	322	5906					1348	1352		10.1126/science.1166585	http://dx.doi.org/10.1126/science.1166585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19008415	Green Submitted			2022-12-28	WOS:000261170600030
J	Duncan, CW; Watson, DPB; Stein, A				Duncan, C. W.; Watson, D. P. B.; Stein, A.		Guideline Dev Grp	Diagnosis and management of headache in adults: summary of SIGN guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTAL FINDINGS; MIGRAINE; PREVALENCE; PHYSICIAN; BURDEN		[Stein, A.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Duncan, C. W.] Aberdeen Royal Infirm, Aberdeen, Scotland; [Watson, D. P. B.] Hamilton Med Grp, Aberdeen, Scotland	University of Aberdeen	Stein, A (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	ailsa.stein@nhs.net		Hilton Boon, Michele/0000-0002-2240-7923				Boardman HF, 2003, CEPHALALGIA, V23, P129, DOI 10.1046/j.1468-2982.2003.00468.x; *BRIT ASS STUD HEA, 2007, GUID ALL HEALTHC PRO; Diamond ML, 2002, NEUROLOGY, V58, pS3, DOI 10.1212/WNL.58.9_suppl_6.S3; Frishberg BM, 2000, EVIDENCE BASED GUIDE; *INT HEAD SOC HEAD, 2004, CEPHALALGIA S1, V24, P8; Karli N, 2007, CEPHALALGIA, V27, P41, DOI 10.1111/j.1468-2982.2006.01245.x; Katsarava Z, 2004, NEUROLOGY, V62, P788, DOI 10.1212/01.WNL.0000113747.18760.D2; Larner A., 2006, HEADACHE CARE, V3, P1; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; LIPTON RB, 1992, ARCH INTERN MED, V152, P1273, DOI 10.1001/archinte.152.6.1273; Lipton RB, 2002, NEUROLOGY, V58, pA100; Matharu MS, 2003, DRUGS, V63, P1637, DOI 10.2165/00003495-200363160-00002; PATTERSON VH, 1993, J NEUROL NEUROSUR PS, V56, P830, DOI 10.1136/jnnp.56.7.830; *SIGN, 2008, 107 SIGN; SMITH TR, 2004, HEADACHE CARE, V1, P195; Steiner TJ, 2003, CEPHALALGIA, V23, P519, DOI 10.1046/j.1468-2982.2003.00568.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tepper SJ, 2004, HEADACHE, V44, P856, DOI 10.1111/j.1526-4610.2004.04167.x; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Watson DPB, 2008, BRIT J GEN PRACT, V58, P77, DOI 10.3399/bjgp08X264009; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008	21	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2329	10.1136/bmj.a2329	http://dx.doi.org/10.1136/bmj.a2329			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397HS	19022842				2022-12-28	WOS:000262654100005
J	Creyghton, MP; Markoulaki, S; Levine, SS; Hanna, J; Lodato, MA; Sha, K; Young, RA; Jaenisch, R; Boyer, LA				Creyghton, Menno P.; Markoulaki, Styliani; Levine, Stuart S.; Hanna, Jacob; Lodato, Michael A.; Sha, Ky; Young, Richard A.; Jaenisch, Rudolf; Boyer, Laurie A.			H2AZ Is Enriched at Polycomb Complex Target Genes in ES Cells and Is Necessary for Lineage Commitment	CELL			English	Article							HISTONE VARIANT H2A.Z; EMBRYONIC STEM-CELLS; EARLY MAMMALIAN DEVELOPMENT; METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; NUCLEOSOME SURFACE; CHROMATIN STATE; X-INACTIVATION; HUMAN GENOME; PROMOTERS	Elucidating how chromatin influences gene expression patterns and ultimately cell fate is fundamental to understanding development and disease. The histone variant H2AZ has emerged as a key regulator of chromatin function and plays an essential but unknown role during mammalian development. Here, genome-wide analysis reveals that H2AZ occupies the promoters of developmentally important genes in a manner that is remarkably similar to that of the Polycomb group (PcG) protein Suz12. By using RNAi, we demonstrate a role for H2AZ in regulating target gene expression, find that H2AZ and PcG protein occupancy is interdependent at promoters, and further show that H2AZ is necessary for ES cell differentiation. Notably, H2AZ occupies a different subset of genes in lineage-committed cells, suggesting that its dynamic redistribution is necessary for cell fate transitions. Thus, H2AZ, together with PcG proteins, may establish specialized chromatin states in ES cells necessary for the proper execution of developmental gene expression programs.	[Lodato, Michael A.; Sha, Ky; Young, Richard A.; Jaenisch, Rudolf; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Creyghton, Menno P.; Markoulaki, Styliani; Levine, Stuart S.; Hanna, Jacob; Lodato, Michael A.; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu	Hanna, Jacob/K-1339-2012; Lodato, Michael/AAX-9211-2021; Young, Richard A/F-6495-2012	Hanna, Jacob/0000-0003-2042-9974; Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X; Lodato, Michael/0000-0003-4175-1073	NCI NIH HHS [R37 CA084198-09, R37 CA084198-08, R37 CA084198, 5 R37CA084198] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668, R01 HG002668-05, R01HG002668] Funding Source: Medline; NICHD NIH HHS [R01 HD045022, R01 HD045022-06] Funding Source: Medline; PHS HHS [5-RO1-HDO45022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Deschamps J, 2007, CURR OPIN GENET DEV, V17, P422, DOI 10.1016/j.gde.2007.07.008; Dunn RK, 2007, MOL CELL, V28, P708, DOI 10.1016/j.molcel.2007.11.022; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Glaser T, 2005, TRENDS NEUROSCI, V28, P397, DOI 10.1016/j.tins.2005.05.008; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raisner RM, 2006, CURR OPIN GENET DEV, V16, P119, DOI 10.1016/j.gde.2006.02.005; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; ZILBERMAN D, 2008, NATURE IN PRESS	68	248	252	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					649	661		10.1016/j.cell.2008.09.056	http://dx.doi.org/10.1016/j.cell.2008.09.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	18992931	Bronze, Green Accepted			2022-12-28	WOS:000260886900016
J	Kim, BJ; Tersoff, J; Kodambaka, S; Reuter, MC; Stach, EA; Ross, FM				Kim, B. J.; Tersoff, J.; Kodambaka, S.; Reuter, M. C.; Stach, E. A.; Ross, F. M.			Kinetics of Individual Nucleation Events Observed in Nanoscale Vapor-Liquid-Solid Growth	SCIENCE			English	Article							FIELD-EFFECT TRANSISTOR; SEMICONDUCTOR NANOWIRES; ALLOY; CRYSTALLIZATION	We measured the nucleation and growth kinetics of solid silicon ( Si) from liquid gold- silicon (AuSi) catalyst particles as the Si supersaturation increased, which is the first step of the vapor- liquid- solid growth of nanowires. Quantitative measurements agree well with a kinetic model, providing a unified picture of the growth process. Nucleation is heterogeneous, occurring consistently at the edge of the AuSi droplet, yet it is intrinsic and highly reproducible. We studied the critical supersaturation required for nucleation and found no observable size effects, even for systems down to 12 nanometers in diameter. For applications in nanoscale technology, the reproducibility is essential, heterogeneity promises greater control of nucleation, and the absence of strong size effects simplifies process design.	[Kim, B. J.; Stach, E. A.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Kim, B. J.; Stach, E. A.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Tersoff, J.; Kodambaka, S.; Reuter, M. C.; Ross, F. M.] IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; International Business Machines (IBM)	Stach, EA (corresponding author), Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.	eastach@purdue.edu; fmross@us.ibm.com	Stach, Eric A/D-8545-2011; Stach, Eric Andrew/M-6455-2019; Kim, Bong-Joong/AAU-9941-2020; Ross, Frances/P-8919-2015	Stach, Eric A/0000-0002-3366-2153; Stach, Eric Andrew/0000-0002-3366-2153; Kim, Bong-Joong/0000-0002-5335-4342; Ross, Frances/0000-0003-0838-9770	NSF [DMR-0606395]	NSF(National Science Foundation (NSF))	We acknowledge A. Ellis and K. B. Reuter of IBM for their assistance with experimental aspects of this work, M. Comer of Purdue with assistance in image analysis, and financial assistance from NSF under grant DMR-0606395.	Adhikari H, 2006, NANO LETT, V6, P318, DOI 10.1021/nl052231f; Clement T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364121; Eswaramoorthy SK, 2007, SCIENCE, V318, P1437, DOI 10.1126/science.1146511; Hammar M, 1996, SURF SCI, V349, P129, DOI 10.1016/0039-6028(95)01068-8; Hayden O, 2007, SMALL, V3, P230, DOI 10.1002/smll.200600325; Hofmann S, 2008, NAT MATER, V7, P372, DOI 10.1038/nmat2140; Kalache B, 2006, JPN J APPL PHYS 2, V45, pL190, DOI 10.1143/JJAP.45.L190; Kodambaka S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.096105; Lee JG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.235501; Lu KC, 2007, NANO LETT, V7, P2389, DOI 10.1021/nl071046u; Lu W, 2006, J PHYS D APPL PHYS, V39, pR387, DOI 10.1088/0022-3727/39/21/R01; Perepezko JH, 2002, MAT SCI ENG A-STRUCT, V326, P144, DOI 10.1016/S0921-5093(01)01430-7; Ross FM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146104; Schmidt V, 2006, SMALL, V2, P85, DOI 10.1002/smll.200500181; Sear RP, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/3/033101; Shpyrko OG, 2006, SCIENCE, V313, P77, DOI 10.1126/science.1128314; Sutter E, 2008, NANO LETT, V8, P411, DOI 10.1021/nl0719630; Sutter PW, 2007, NAT MATER, V6, P363, DOI 10.1038/nmat1894; TAKAHASHI T, 1969, ACTA METALL MATER, V17, P643, DOI 10.1016/0001-6160(69)90124-2; Thelander C, 2006, MATER TODAY, V9, P28, DOI 10.1016/S1369-7021(06)71651-0; TURNBULL D, 1950, J APPL PHYS, V21, P804, DOI 10.1063/1.1699763; TURNBULL D, 1949, J CHEM PHYS, V17, P71, DOI 10.1063/1.1747055; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wu YY, 2001, J AM CHEM SOC, V123, P3165, DOI 10.1021/ja0059084	24	181	183	1	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1070	1073		10.1126/science.1163494	http://dx.doi.org/10.1126/science.1163494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008438				2022-12-28	WOS:000260867700029
J	Dulcis, D; Spitzer, NC				Dulcis, Davide; Spitzer, Nicholas C.			Illumination controls differentiation of dopamine neurons regulating behaviour	NATURE			English	Article							ACTIVITY-DEPENDENT REGULATION; SEASONAL AFFECTIVE-DISORDER; XENOPUS-LAEVIS; MELANOTROPE CELLS; TYROSINE-HYDROXYLASE; SUPRACHIASMATIC NUCLEUS; EXPRESSION; PLASTICITY; ZEBRAFISH; SYSTEM	Specification of the appropriate neurotransmitter is a crucial step in neuronal differentiation because it enables signalling among populations of neurons. Experimental manipulations demonstrate that both autonomous and activity- dependent genetic programs contribute to this process during development, but whether natural environmental stimuli specify transmitter expression in a neuronal population is unknown. We investigated neurons of the ventral suprachiasmatic nucleus that regulate neuroendocrine pituitary function in response to light in teleosts, amphibia and primates. Here we show that altering light exposure, which changes the sensory input to the circuit controlling adaptation of skin pigmentation to background, changes the number of neurons expressing dopamine in larvae of the amphibian Xenopus laevis in a circuit- specific and activity- dependent manner. Neurons newly expressing dopamine then regulate changes in camouflage colouration in response to illumination. Thus, physiological activity alters the numbers of behaviourally relevant amine- transmitter- expressing neurons in the brain at postembryonic stages of development. The results may be pertinent to changes in cognitive states that are regulated by biogenic amines.	[Dulcis, Davide; Spitzer, Nicholas C.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Dulcis, Davide; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Mol Genet, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dulcis, D (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ddulcis@biomail.ucsd.edu	Dulcis, Davide/GSN-9883-2022	Dulcis, Davide/0000-0003-4672-7996; Spitzer, Nicholas/0000-0002-3523-1103	N.C.S.; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015918] Funding Source: NIH RePORTER	N.C.S.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Berg, L. Borodinsky and R. Levine for critical comments on the manuscript and I-T. Hsieh and D. Boassa for technical support. This work was supported by a grant to N.C.S. from the National Institutes of Health.	Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Akopian A, 1996, J NEUROPHYSIOL, V76, P1828, DOI 10.1152/jn.1996.76.3.1828; Baquet ZC, 2005, J NEUROSCI, V25, P6251, DOI 10.1523/JNEUROSCI.4601-04.2005; Berghs CAFM, 1997, J HISTOCHEM CYTOCHEM, V45, P1673, DOI 10.1177/002215549704501211; Borodinsky LN, 2007, P NATL ACAD SCI USA, V104, P335, DOI 10.1073/pnas.0607450104; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brosenitsch TA, 2002, MOL CELL NEUROSCI, V20, P447, DOI 10.1006/mcne.2002.1135; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; Catalano SM, 1997, J NEUROSCI, V17, P8376; El Majdoubi M, 2000, BIOCHEM CELL BIOL, V78, P317; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gomez-Lira G, 2005, J NEUROSCI, V25, P6939, DOI 10.1523/JNEUROSCI.1674-05.2005; GONZALEZ A, 1991, J COMP NEUROL, V303, P457, DOI 10.1002/cne.903030311; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Green CB, 1999, DEV BRAIN RES, V117, P109, DOI 10.1016/S0165-3806(99)00109-1; HESS EJ, 1991, NEURON, V6, P123, DOI 10.1016/0896-6273(91)90127-L; Jenks BG, 2007, NEUROENDOCRINOLOGY, V85, P177, DOI 10.1159/000101434; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kolk SM, 2001, ENDOCRINOLOGY, V142, P1950, DOI 10.1210/en.142.5.1950; Kramer BMR, 2001, MICROSC RES TECHNIQ, V54, P188, DOI 10.1002/jemt.1132; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Lam R., 1999, CANADIAN CONSENSUS G; Lam RW, 2001, NEUROPSYCHOPHARMACOL, V25, pS97, DOI 10.1016/S0893-133X(01)00337-2; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Li L, 2000, J NEUROSCI, V20, P1893; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; Michel S, 2002, J NEUROPHYSIOL, V88, P817, DOI 10.1152/jn.2002.88.2.817; Mueller NK, 2005, ENDOCRINOLOGY, V146, P348, DOI 10.1210/en.2004-0539; NORDLAND JJ, 2006, PIGMENTARY SYSTEM PH; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; OLIVE S, 1995, BRAIN RES, V689, P271, DOI 10.1016/0006-8993(95)00555-5; Roubos EW, 2005, ANN NY ACAD SCI, V1040, P172, DOI 10.1196/annals.1327.022; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; TONOSAKI Y, 1995, ENDOCRINOLOGY, V136, P5260, DOI 10.1210/en.136.12.5260; TUINHOF R, 1994, NEUROSCIENCE, V61, P411, DOI 10.1016/0306-4522(94)90241-0; Ubink R, 1998, J COMP NEUROL, V397, P60; Vazquez-Martinez R, 2001, ENDOCRINOLOGY, V142, P3060, DOI 10.1210/en.142.7.3060; WALICKE PA, 1981, J NEUROSCI, V1, P343; Wang Y, 1997, J NEUROPHYSIOL, V78, P439, DOI 10.1152/jn.1997.78.1.439; Wullimann MF, 2001, DEV BRAIN RES, V131, P173, DOI 10.1016/S0165-3806(01)00270-X; Zhang H, 2008, GEN COMP ENDOCR, V156, P104, DOI 10.1016/j.ygcen.2007.12.005	46	89	90	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					195	U20		10.1038/nature07569	http://dx.doi.org/10.1038/nature07569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005547	Green Accepted			2022-12-28	WOS:000261039300031
J	Manary, MJ; Sandige, HL				Manary, Mark J.; Sandige, Heidi L.			Management of acute moderate and severe childhood malnutrition	BRITISH MEDICAL JOURNAL			English	Review							USE THERAPEUTIC FOOD; HOME-BASED THERAPY; MALNOURISHED CHILDREN; MALAWIAN CHILDREN; MORTALITY; HIV; UNDERNUTRITION; CONSEQUENCES; DIARRHEA; HEALTH	Acute childhood malnutrition affects about a tenth of the world's children under 5 years of age, particularly those living in circumstances of extreme poverty in the developing world.(1 2) Malnutrition is typically the result of an inadequate diet and is one of the most common diagnoses in children in health facilities in sub- Saharan Africa and south Asia. Acute childhood malnutrition leads to greater risk of death or disability from common paediatric illnesses such as pneumonia and diarrhoeal disease, and it shapes long term health by compromising physical and intellectual development.(3) The condition carries a case fatality rate of 5-60%.(4 5) This review describes how best to manage cases of acute childhood malnutrition in light of recent changes in standard recommendations.	[Manary, Mark J.; Sandige, Heidi L.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Manary, MJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	manary@kids.wustl.edu		Manary, Mark/0000-0003-2733-9568				Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; ALLEYNE GAO, 1966, CLIN SCI, V30, P553; Amadi B, 2001, J PEDIATR GASTR NUTR, V32, P550, DOI 10.1097/00005176-200105000-00011; Bachou Hanifa, 2006, BMC Pediatr, V6, P7, DOI 10.1186/1471-2431-6-7; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brewster DR, 2006, J PAEDIATR CHILD H, V42, P575, DOI 10.1111/j.1440-1754.2006.00932.x; BRIEND A, 1986, BRIT MED J, V293, P373, DOI 10.1136/bmj.293.6543.373; BRIEND A, 1986, NUTR RES, V6, P249, DOI 10.1016/S0271-5317(86)80129-4; CHRISTIE CDC, 1988, J TROP MED HYG, V91, P173; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Ciliberto MA, 2006, ACTA PAEDIATR, V95, P1012, DOI 10.1080/08035250600606803; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; GILLEPSE SR, 1999, SUPPLEMENTARY FEEDIN; Graham SM, 2007, ANN TROP PAEDIATR, V27, P243, DOI 10.1179/146532807X245625; Linneman Z, 2007, MATERN CHILD NUTR, V3, P206, DOI 10.1111/j.1740-8709.2007.00095.x; Manary MJ, 2006, FOOD NUTR BULL, V27, pS83, DOI 10.1177/15648265060273S305; Manary MJ, 2000, ACTA PAEDIATR, V89, P203, DOI 10.1080/080352500750028843; NAVARROCOLORADO C, 2007, RETROSPECTIVE STUDY; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; UNICEF, 2007, STAT WORLDS CHILDR 2; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Waterlow JC, 1992, PROTEIN ENERGY MALNU; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY	26	40	40	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 13	2008	337								a2180	10.1136/bmj.a2180	http://dx.doi.org/10.1136/bmj.a2180			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008271	Green Submitted			2022-12-28	WOS:000261784500005
J	Pischon, T; Boeing, H; Hoffmann, K; Bergmann, M; Schulze, MB; Overvad, K; van der Schouw, YT; Spencer, E; Moons, KGM; Tjonneland, A; Halkjaer, J; Jensen, MK; Stegger, J; Clavel-Chapelon, F; Boutron-Ruault, MC; Chajes, V; Linseisen, J; Kaaks, R; Trichopoulou, A; Trichopoulos, D; Bamia, C; Sieri, S; Palli, D; Tumino, R; Vineis, P; Panico, S; Peeters, PHM; May, AM; Bueno-De-Mesquita, HB; van Duijnhoven, FJB; Hallmans, G; Weinehall, L; Manjer, J; Hedblad, B; Lund, E; Agudo, A; Arriola, L; Barricarte, A; Navarro, C; Martinez, C; Quiros, JR; Key, T; Bingham, S; Khaw, KT; Boffetta, P; Jenab, M; Ferrari, P; Riboli, E				Pischon, T.; Boeing, H.; Hoffmann, K.; Bergmann, M.; Schulze, M. B.; Overvad, K.; van der Schouw, Y. T.; Spencer, E.; Moons, K. G. M.; Tjonneland, A.; Halkjaer, J.; Jensen, M. K.; Stegger, J.; Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.; Linseisen, J.; Kaaks, R.; Trichopoulou, A.; Trichopoulos, D.; Bamia, C.; Sieri, S.; Palli, D.; Tumino, R.; Vineis, P.; Panico, S.; Peeters, P. H. M.; May, A. M.; Bueno-de-Mesquita, H. B.; van Duijnhoven, F. J. B.; Hallmans, G.; Weinehall, L.; Manjer, J.; Hedblad, B.; Lund, E.; Agudo, A.; Arriola, L.; Barricarte, A.; Navarro, C.; Martinez, C.; Quiros, J. R.; Key, T.; Bingham, S.; Khaw, K. T.; Boffetta, P.; Jenab, M.; Ferrari, P.; Riboli, E.			General and Abdominal Adiposity and Risk of Death in Europe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; PREDICTING MORTALITY; WAIST CIRCUMFERENCE; TISSUE DISTRIBUTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; ROC CURVE; FOLLOW-UP; OBESITY	BACKGROUND Previous studies have relied predominantly on the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) to assess the association of adiposity with the risk of death, but few have examined whether the distribution of body fat contributes to the prediction of death. METHODS We examined the association of BMI, waist circumference, and waist-to-hip ratio with the risk of death among 359,387 participants from nine countries in the European Prospective Investigation into Cancer and Nutrition (EPIC). We used a Cox regression analysis, with age as the time variable, and stratified the models according to study center and age at recruitment, with further adjustment for educational level, smoking status, alcohol consumption, physical activity, and height. RESULTS During a mean follow-up of 9.7 years, 14,723 participants died. The lowest risks of death related to BMI were observed at a BMI of 25.3 for men and 24.3 for women. After adjustment for BMI, waist circumference and waist-to-hip ratio were strongly associated with the risk of death. Relative risks among men and women in the highest quintile of waist circumference were 2.05 (95% confidence interval [CI], 1.80 to 2.33) and 1.78 (95% CI, 1.56 to 2.04), respectively, and in the highest quintile of waist-to-hip ratio, the relative risks were 1.68 (95% CI, 1.53 to 1.84) and 1.51 (95% CI, 1.37 to 1.66), respectively. BMI remained significantly associated with the risk of death in models that included waist circumference or waist-to-hip ratio (P<0.001). CONCLUSIONS These data suggest that both general adiposity and abdominal adiposity are associated with the risk of death and support the use of waist circumference or waist-tohip ratio in addition to BMI in assessing the risk of death.	[Pischon, T.; Boeing, H.; Hoffmann, K.; Bergmann, M.; Schulze, M. B.] German Inst Human Nutr, Dept Epidemiol, D-14558 Potsdam, Germany; [Overvad, K.; Jensen, M. K.] Aalborg Hosp, Aarhus Univ Hosp Syst, Dept Clin Epidemiol, Aalborg, Denmark; [Overvad, K.; Stegger, J.] Aalborg Hosp, Aarhus Univ Hosp Syst, Dept Cardiol, Aalborg, Denmark; [van der Schouw, Y. T.; Moons, K. G. M.; Peeters, P. H. M.; May, A. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Spencer, E.; Key, T.] Univ Oxford, Canc Res UK Epidemiol Unit, Oxford, England; [Tjonneland, A.; Halkjaer, J.] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.] INSERM, ERI 20, EA 4045, Villejuif, France; [Clavel-Chapelon, F.; Boutron-Ruault, M. -C.; Chajes, V.] Inst Gustave Roussy, Villejuif, France; [Linseisen, J.; Kaaks, R.] German Canc Res Ctr, Div Clin Epidemiol, D-6900 Heidelberg, Germany; [Trichopoulou, A.; Bamia, C.] Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; [Trichopoulos, D.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, D.] Hellen Hlth Fdn, Athens, Greece; [Sieri, S.] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Palli, D.] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Tumino, R.] Azienda Osped Civile MP Arezzo, Canc Registry, Ragusa, Italy; [Vineis, P.; Riboli, E.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Vineis, P.] Univ Turin, Turin, Italy; [Panico, S.] Univ Naples Federico 2, Naples, Italy; [Bueno-de-Mesquita, H. B.; van Duijnhoven, F. J. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr & Hlth, NL-3720 BA Bilthoven, Netherlands; [Hallmans, G.; Weinehall, L.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Manjer, J.] Malmo Univ Hosp, Dept Surg, Malmo, Sweden; [Hedblad, B.] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Lund, E.] Univ Tromso, Inst Community Med, Tromso, Norway; [Agudo, A.] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Arriola, L.] Publ Hlth Dept Gipuzkoa, San Sebastian, Spain; [Barricarte, A.] Publ Hlth Inst Navarra, Pamplona, Spain; [Navarro, C.] Murcia Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, C.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Martinez, C.] Escuela Andaluza Salud Publ, Granada, Spain; [Quiros, J. R.] Publ Hlth & Hlth Planning Directorate, Hlth Informat Unit, Asturias, Spain; [Bingham, S.] Univ Cambridge, Ctr Nutr & Canc, Cambridge, England; [Khaw, K. T.] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Boffetta, P.; Jenab, M.; Ferrari, P.] WHO, Int Agcy Res Canc, Lyon, France	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Utrecht University; Utrecht University Medical Center; Cancer Research UK; University of Oxford; Danish Cancer Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Imperial College London; University of Turin; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Umea University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; UiT The Arctic University of Tromso; Catalan Institute of Oncology; Public Health Institute of Navarra; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Escuela Andaluza de Salud Publica; University of Cambridge; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC)	Pischon, T (corresponding author), German Inst Human Nutr, Dept Epidemiol, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	pischon@dife.de	Pischon, Tobias/HGE-8577-2022; Panico, Salvatore/K-6506-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; van der Schouw, Yvonne T./F-8327-2014; Schulze, Matthias B/AAH-6906-2021; Sieri, Sabina/K-4667-2016; Boutron-Ruault, Marie-Christine/H-3936-2014; Clavel-Chapelon, Francoise/G-6733-2014; Khaw, Kay-Tee/AAZ-3209-2021; May, Anne M/G-9183-2011; Agudo, Antonio/J-1805-2016; Linseisen, Jakob/B-5353-2014; van Duijnhoven, Fränzel/GWC-0059-2022; Boffetta, Paolo/AAI-7767-2021	Pischon, Tobias/0000-0003-1568-767X; Panico, Salvatore/0000-0002-5498-8312; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; van der Schouw, Yvonne T./0000-0002-4605-435X; Schulze, Matthias B/0000-0002-0830-5277; Sieri, Sabina/0000-0001-5201-172X; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Agudo, Antonio/0000-0001-9900-5677; Linseisen, Jakob/0000-0002-9386-382X; Boffetta, Paolo/0000-0002-3811-2791; Lund, Eiliv/0000-0002-8071-8711; Overvad, Kim/0000-0001-6429-7921; Spencer, Elizabeth/0000-0002-9079-8006; PALLI, Domenico/0000-0002-5558-2437; tumino, rosario/0000-0003-2666-414X; Weinehall, Lars/0000-0003-3025-2690; Tjonneland, Anne/0000-0003-4385-2097; Riboli, Elio/0000-0001-6795-6080; Chajes, Veronique/0000-0003-1297-3064; Arriola, Larraitz/0000-0001-8487-7181; Jensen, Majken Karoline/0000-0003-4729-7545; Jenab, Mazda/0000-0002-0573-1852; Navarro, Carmen/0000-0001-8896-7483	European Commission: Public Health and Consumer Protection Directorate; Research Directorate-General; Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09); Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East; Maastricht of the Netherlands; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; 3M Company; Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; Institut National de la Sante et de la Recherche Medicale, France.	European Commission: Public Health and Consumer Protection Directorate(European CommissionEuropean Commission Joint Research Centre); Research Directorate-General; Deutsche Krebshilfe; German Cancer Research Center(Deutsche Krebshilfe); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09)(Instituto de Salud Carlos III); Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK(Cancer Research UK); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association, United Kingdom; British Heart Foundation(British Heart Foundation); Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom(Wellcome Trust); Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education(Greek Ministry of Development-GSRT); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East; Maastricht of the Netherlands; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; 3M Company(3M); Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; Institut National de la Sante et de la Recherche Medicale, France.(Institut National de la Sante et de la Recherche Medicale (Inserm))	Supported by grants from the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005-present; Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund of the Spanish Ministry of Health (Network of Centers of Research in Epidemiology and Public Health C03/09); the Spanish Regional Governments of Andalucia, Asturia, Basque Country, Murcia, and Navarra; Cancer Research UK; Medical Research Council, United Kingdom; the Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; the Wellcome Trust, United Kingdom; Greek Ministry of Health and Social Solidarity and Hellenic Health Foundation; Greek Ministry of Education; Italian Association for Research on Cancer; Dutch Ministry of Public Health, Welfare, and Sports; National Cancer Registry and the Regional Cancer Registries Amsterdam, East, and Maastricht of the Netherlands; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; French League Against Cancer; the 3M Company; Mutuelle Generale de l'Education Nationale, France; Institut Gustave Roussy, France; and Institut National de la Sante et de la Recherche Medicale, France.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P1254; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Friedenreich C, 2006, CANCER EPIDEM BIOMAR, V15, P2398, DOI 10.1158/1055-9965.EPI-06-0595; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu FB, 2007, ARCH INTERN MED, V167, P875, DOI 10.1001/archinte.167.9.875; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kalmijn S, 1999, INT J OBESITY, V23, P395, DOI 10.1038/sj.ijo.0800832; Katzmarzyk PT, 2002, INT J OBESITY, V26, P1054, DOI 10.1038/sj.ijo.0802057; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Poulain M, 2006, CAN MED ASSOC J, V174, P1293, DOI 10.1503/cmaj.051299; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; WORLD H, 2000, WHO TECH REP SER, V894, P1; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	40	1397	1437	2	142	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2105	2120		10.1056/NEJMoa0801891	http://dx.doi.org/10.1056/NEJMoa0801891			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005195	Green Published			2022-12-28	WOS:000260823900009
J	Talmor, D; Sarge, T; Malhotra, A; O'Donnell, CR; Ritz, R; Lisbon, A; Novack, V; Loring, SH				Talmor, Daniel; Sarge, Todd; Malhotra, Atul; O'Donnell, Carl R.; Ritz, Ray; Lisbon, Alan; Novack, Victor; Loring, Stephen H.			Mechanical Ventilation Guided by Esophageal Pressure in Acute Lung Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; TRANSPULMONARY PRESSURES; VOLUME CURVE; RECRUITMENT; STRATEGY; DERECRUITMENT; CYTOKINES; OUTCOMES; MODEL	Background: Survival of patients with acute lung injury or the acute respiratory distress syndrome (ARDS) has been improved by ventilation with small tidal volumes and the use of positive end-expiratory pressure (PEEP); however, the optimal level of PEEP has been difficult to determine. In this pilot study, we estimated transpulmonary pressure with the use of esophageal balloon catheters. We reasoned that the use of pleural-pressure measurements, despite the technical limitations to the accuracy of such measurements, would enable us to find a PEEP value that could maintain oxygenation while preventing lung injury due to repeated alveolar collapse or overdistention. Methods: We randomly assigned patients with acute lung injury or ARDS to undergo mechanical ventilation with PEEP adjusted according to measurements of esophageal pressure (the esophageal-pressure-guided group) or according to the Acute Respiratory Distress Syndrome Network standard-of-care recommendations (the control group). The primary end point was improvement in oxygenation. The secondary end points included respiratory-system compliance and patient outcomes. Results: The study reached its stopping criterion and was terminated after 61 patients had been enrolled. The ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen at 72 hours was 88 mm Hg higher in the esophageal-pressure-guided group than in the control group (95% confidence interval, 78.1 to 98.3; P=0.002). This effect was persistent over the entire follow-up time (at 24, 48, and 72 hours; P=0.001 by repeated-measures analysis of variance). Respiratory-system compliance was also significantly better at 24, 48, and 72 hours in the esophageal-pressure-guided group (P=0.01 by repeated-measures analysis of variance). Conclusions: As compared with the current standard of care, a ventilator strategy using esophageal pressures to estimate the transpulmonary pressure significantly improves oxygenation and compliance. Multicenter clinical trials are needed to determine whether this approach should be widely adopted. (ClinicalTrials.gov number, NCT00127491.).	[Talmor, Daniel; Sarge, Todd; Ritz, Ray; Lisbon, Alan; Loring, Stephen H.] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; [O'Donnell, Carl R.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Malhotra, Atul] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Malhotra, Atul] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Novack, Victor] Harvard Univ, Harvard Clin Res Inst, Boston, MA 02115 USA; [Talmor, Daniel; Sarge, Todd; Malhotra, Atul; O'Donnell, Carl R.; Lisbon, Alan; Loring, Stephen H.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Talmor, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, 1 Deaconess Rd,CC-470, Boston, MA 02215 USA.	dtalmor@bidmc.harvard.edu		O'Donnell, Carl/0000-0003-1788-006X	National Heart, Lung, and Blood Institute [HL-52586]; Respironics; INO Therapeutics; Tri-anim; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052586, K24HL093218] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Respironics; INO Therapeutics; Tri-anim; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by a grant from the National Heart, Lung, and Blood Institute (HL-52586). Dr. Malhotra reports receiving consulting fees from Respironics. Mr. Ritz reports receiving consulting fees from INO Therapeutics and lecture fees from Tri-anim and serving on the advisory boards of Cardinal Health and Respironics. No other potential conflict of interest relevant to this article was reported.	*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BEYER J, 1982, INTENS CARE MED, V8, P75, DOI 10.1007/BF01694870; Brower RG, 2004, NEW ENGL J MED, V351, P327; Chieveley-Williams S, 2002, CHEST, V121, P533, DOI 10.1378/chest.121.2.533; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; COLEBATCH HJH, 1979, J APPL PHYSIOL, V47, P683, DOI 10.1152/jappl.1979.47.4.683; de Chazal I, 2003, BRIT J ANAESTH, V91, P81, DOI 10.1093/bja/aeg146; FARIDY EE, 1966, J APPL PHYSIOL, V21, P1453, DOI 10.1152/jappl.1966.21.5.1453; Gattinoni L, 2003, EUR RESPIR J, V22, p15S, DOI 10.1183/09031936.03.00021303; Grasso S, 2005, AM J RESP CRIT CARE, V171, P1002, DOI 10.1164/rccm.200407-940OC; Harris RS, 2000, AM J RESP CRIT CARE, V161, P432; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jonson B, 1999, AM J RESP CRIT CARE, V159, P1172, DOI 10.1164/ajrccm.159.4.9801088; Maggiore SM, 2001, AM J RESP CRIT CARE, V164, P795, DOI 10.1164/ajrccm.164.5.2006071; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Malbrain MLNG, 1999, INTENS CARE MED, V25, P1453, DOI 10.1007/s001340051098; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; MILICEMILI J, 1964, J APPL PHYSIOL, V19, P207, DOI 10.1152/jappl.1964.19.2.207; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Nishida T, 2004, CRIT CARE MED, V32, P1358, DOI 10.1097/01.CCM.0000128573.28173.2E; Pelosi P, 2001, AM J RESP CRIT CARE, V164, P122, DOI 10.1164/ajrccm.164.1.2007010; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Shapiro NI, 2006, CRIT CARE MED, V34, P1025, DOI 10.1097/01.CCM.0000206104.18647.A8; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Talmor D, 2006, CRIT CARE MED, V34, P1389, DOI 10.1097/01.CCM.0000215515.49001.A2; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Villar J, 2007, AM J RESP CRIT CARE, V176, P795, DOI 10.1164/rccm.200610-1534OC; Washko GR, 2006, J APPL PHYSIOL, V100, P753, DOI 10.1152/japplphysiol.00697.2005; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; WYSZOGRODSKI I, 1975, J APPL PHYSIOL, V38, P461, DOI 10.1152/jappl.1975.38.3.461; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	36	654	722	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2095	2104		10.1056/NEJMoa0708638	http://dx.doi.org/10.1056/NEJMoa0708638			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19001507	Green Accepted			2022-12-28	WOS:000260823900008
J	Islam, F				Islam, Faisal			Pipe dreamer	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Islam, Faisal] Channel 4 News, London, England		Islam, F (corresponding author), Channel 4 News, London, England.	faisal.islam@itn.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 12	2008	337								a2236	10.1136/bmj.a2236	http://dx.doi.org/10.1136/bmj.a2236			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AD	19004883				2022-12-28	WOS:000261784400012
J	Hartig, T				Hartig, Terry			Green space, psychological restoration, and health inequality	LANCET			English	Editorial Material							ENVIRONMENTAL PREFERENCES; STRESS		[Hartig, Terry] Uppsala Univ, Inst Housing & Urban Res, SE-80129 Gavle, Sweden	Uppsala University	Hartig, T (corresponding author), Uppsala Univ, Inst Housing & Urban Res, SE-80129 Gavle, Sweden.	terry.hartig@ibf.uu.se	Hartig, Terry/AAC-5676-2021					Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Frumkin P, 2001, AM J PREV MED, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Hartig T, 2003, J SOC ISSUES, V59, P611, DOI 10.1111/1540-4560.00080; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; HARTIG T, 1993, LANDSCAPE URBAN PLAN, V25, P17, DOI 10.1016/0169-2046(93)90120-3; HARTIG T, 2008, BRINGING BUILDINGS L; Hartig T, 2006, J ENVIRON PSYCHOL, V26, P215, DOI 10.1016/j.jenvp.2006.07.007; Kaplan R, 1989, EXPERIENCE NATURE PS; KNOPF RC, 1987, HDB ENV PSYCHOL, V1; Kuo FE, 1998, AM J COMMUN PSYCHOL, V26, P823, DOI 10.1023/A:1022294028903; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Staats H, 2004, J ENVIRON PSYCHOL, V24, P199, DOI 10.1016/j.jenvp.2003.12.005; Staats H, 2003, J ENVIRON PSYCHOL, V23, P147, DOI 10.1016/S0272-4944(02)00112-3	15	118	122	2	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1614	1615		10.1016/S0140-6736(08)61669-4	http://dx.doi.org/10.1016/S0140-6736(08)61669-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994650				2022-12-28	WOS:000260899900007
J	Sawicki, PT; Bastian, H				Sawicki, Peter T.; Bastian, Hilda			German health care: a bit of Bismarck plus more science	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRICES		[Sawicki, Peter T.; Bastian, Hilda] German Inst Qual & Efficiency Hlth Care, D-51105 Cologne, Germany		Bastian, H (corresponding author), German Inst Qual & Efficiency Hlth Care, Dillenburger Str 27, D-51105 Cologne, Germany.	hilda.bastian@iqwig.de		Bastian, Hilda/0000-0001-8544-7386				Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; BRAMLEYHARKER E, 2004, COMP PHYS EARNINGS C; *BUND JUST, 2008, SOZ SGB FUNFT BUCH 5; Danzon PM, 2008, HEALTH AFFAIR, V27, P221, DOI 10.1377/hlthaff.27.1.221; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; DIERKS ML, 2006, PUBLIC PATIENT ORIEN; *EUR COMM, 2007, HLTH EUR UN SPEC EUR; *FOR GES, EV 4 SELF HELP GROUP; Forster R, 2007, GESUNDHEITSWESEN, V69, P98, DOI 10.1055/s-2007-970403; Garattini L, 2008, HEALTH POLICY, V85, P305, DOI 10.1016/j.healthpol.2007.08.005; *GEM BUND, 2007, GERM HLTH CAR SYST F; Green DG, 2002, BRIT MED J, V325, P488; HAUSCHILD W, 2006, COST STRUCTURES MED; Hennock EP, 2007, ORIGIN OF THE WELFARE STATE IN ENGLAND AND GERMANY, 1850-1914: SOCIAL POLICIES COMPARED, P1; Lang FR, 2007, DEUT MED WOCHENSCHR, V132, P2558, DOI 10.1055/s-2007-993097; *MIN HLTH SOC INS, PAT RIGHTS GERM GUID; Nowak D, 2006, NEW ENGL J MED, V355, P1520, DOI 10.1056/NEJMp068148; *ORG EC COOP DEV, 2007, SCI TECHN SCOR; *ORG EC COOP DEV, 2007, OECD HLTH DAT 2007; Organisation for Economic Co-operation and Development (OECD), HLTH CAR QUAL IND PR; Perleth M, 2000, INT J TECHNOL ASSESS, V16, P412, DOI 10.1017/S0266462300101072; Sawicki PT, 2005, MED KLIN, V100, P755, DOI 10.1007/s00063-005-1105-2; Scholen MS, 2005, HLTH AFF MILLWOOD W, V3, P509; van der Zee J, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-94; VEIT C, 2007, BQS QUAL REP 2006	25	19	19	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2008	337								a1997	10.1136/bmj.a1997	http://dx.doi.org/10.1136/bmj.a1997			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FD	18996937				2022-12-28	WOS:000261236200010
J	Gostin, LO				Gostin, Lawrence O.			President's Emergency Plan for AIDS Relief Health Development at the Crossroads	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Oneill Inst Natl Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; GARRETT L, 2008, INT HERALD TRIB 0730; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P225, DOI 10.1001/jama.298.2.225; *GOV ACC OFF, 2008, GLOB HIV AIDS MOR CO; *HJ KAIS FAM FDN, 2008, REAUTH PEPFAR US LEA; *I MED, 2007, PEPFAR IMPL PROGR PR; Jaffe HW, 2008, JAMA-J AM MED ASSOC, V300, P573, DOI 10.1001/jama.300.5.573; *ON CAMP, 2008, DAT REP 2008 KEEP G8; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schleber GJ, 2007, HEALTH AFFAIR, V26, P921, DOI 10.1377/hlthaff.26.4.921; *UNAIDS, 2008, UN ACC SCAL PRIOR HI; *UNAIDS, 2005, 3 5 IN TREAT 3 MILL	13	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2046	2048		10.1001/jama.2008.588	http://dx.doi.org/10.1001/jama.2008.588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984892				2022-12-28	WOS:000260605400026
J	Wilkinson, AN; Viola, R; Brundage, MD				Wilkinson, Anna N.; Viola, Raymond; Brundage, Michael D.			Managing skeletal related events resulting from bone metastases	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RADIOFREQUENCY ABLATION; PALLIATIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER PAIN; BISPHOSPHONATES; TRIAL		[Wilkinson, Anna N.] Ottawa Hosp Canc Ctr, Dept Oncol, Ottawa, ON K1H 1C4, Canada; [Viola, Raymond] Queens Univ, Dept Med, Palliat Care Med Program, Kingston, ON K7L 3J7, Canada; [Brundage, Michael D.] Queens Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON K7L 3N6, Canada	University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada	Wilkinson, AN (corresponding author), Ottawa Hosp Canc Ctr, Dept Oncol, 503 Smyth Rd, Ottawa, ON K1H 1C4, Canada.	anwilkinson@toh.on.ca						Blamey R, 1999, EUR J SURG ONCOL, V25, P3; *CANC CAR ONT NEUR, 2004, 99 CANC CAR ONT NEUR; Chang VT, 2006, J PALLIAT MED, V9, P1414, DOI 10.1089/jpm.2006.9.1414; Chow E, 2007, SUPPORT CARE CANCER, V15, P643, DOI 10.1007/s00520-007-0217-z; Chow E, 2007, J CLIN ONCOL, V25, P1423, DOI 10.1200/JCO.2006.09.5281; Colvin L, 2006, BRIT MED J, V332, P1081, DOI 10.1136/bmj.332.7549.1081; Crook J, 2006, UROL CLIN N AM, V33, P219, DOI 10.1016/j.ucl.2005.12.004; EISENBERG E, 1994, J CLIN ONCOL, V12, P2756, DOI 10.1200/JCO.1994.12.12.2756; Falkmer U, 2003, ACTA ONCOL, V42, P620, DOI 10.1080/02841860310014895; Finlay OG, 2005, LANCET ONCOL, V6, P392, DOI 10.1016/S1470-2045(05)70206-0; Gainford MC, 2005, BMJ-BRIT MED J, V330, P769, DOI 10.1136/bmj.330.7494.769; Gilbert SM, 2003, CURR OPIN UROL, V13, P133, DOI 10.1097/00042307-200303000-00008; Goetz MP, 2004, J CLIN ONCOL, V22, P300, DOI 10.1200/JCO.2004.03.097; Hardy JR, 2002, CLIN ONCOL-UK, V14, P132, DOI 10.1053/clon.2001.0054; Healey John H., 2000, Cancer, V88, P2940, DOI 10.1002/1097-0142(20000615)88:12+<2940::AID-CNCR10>3.0.CO;2-W; Higdon ML, 2006, AM FAM PHYSICIAN, V74, P1873; Lecouvet FE, 2007, J CLIN ONCOL, V25, P3281, DOI 10.1200/JCO.2006.09.2940; LIASLAN H, 2006, ORTHOP CLIN N AM, V37, P375; Martinez MJ, 2003, COCHRANE DB SYST REV; McNicol ED, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006332.pub2; MCQUAY HJ, 1988, COCHRANE DB SYST REV; Powles T, 2002, J CLIN ONCOL, V20, P3219, DOI 10.1200/JCO.2002.11.080; Riccio AI, 2007, AM FAM PHYSICIAN, V76, P1489; ROCQUE M, 2003, COCHRANE DB SYST REV; Roos DE, 2003, RADIOTHER ONCOL, V67, P207, DOI 10.1016/S0167-8140(03)00026-4; Ross JR, 2003, BMJ-BRIT MED J, V327, P469, DOI 10.1136/bmj.327.7413.469; Sze WM, 2003, CLIN ONCOL-UK, V15, P345, DOI 10.1016/S0936-6555(03)00113-4; Thanos L, 2008, SKELETAL RADIOL, V37, P189, DOI 10.1007/s00256-007-0404-5; *WHO, 1990, WHO TECHN REP SER, V804; Wong R., 2002, COCHRANE DB SYST REV, V2002, pCD002068, DOI [DOI 10.1002/14651858.CD002068, 10.1002/14651858.CD002068]	30	15	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2008	337								a2041	10.1136/bmj.a2041	http://dx.doi.org/10.1136/bmj.a2041			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377EZ	18981017				2022-12-28	WOS:000261235800003
J	Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M				Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Bonhoeffer, Tobias; Huebener, Mark			Experience leaves a lasting structural trace in cortical circuits	NATURE			English	Article							OCULAR DOMINANCE PLASTICITY; MOUSE VISUAL-CORTEX; LONG-TERM POTENTIATION; NEOCORTEX IN-VIVO; DENDRITIC SPINES; ADULT CORTEX; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; RESPONSES; STABILITY	Sensory experiences exert a powerful influence on the function and future performance of neuronal circuits in the mammalian neocortex(1-3). Restructuring of synaptic connections is believed to be one mechanism by which cortical circuits store information about the sensory world(4,5). Excitatory synaptic structures, such as dendritic spines, are dynamic entities(6-8) that remain sensitive to alteration of sensory input throughout life(6,9). It remains unclear, however, whether structural changes at the level of dendritic spines can outlast the original experience and thereby provide a morphological basis for long- term information storage. Here we follow spine dynamics on apical dendrites of pyramidal neurons in functionally defined regions of adult mouse visual cortex during plasticity of eye- specific responses induced by repeated closure of one eye ( monocular deprivation). The first monocular deprivation episode doubled the rate of spine formation, thereby increasing spine density. This effect was specific to layer-5 cells located in binocular cortex, where most neurons increase their responsiveness to the non-deprived eye(3,10). Restoring binocular vision returned spine dynamics to baseline levels, but absolute spine density remained elevated and many monocular deprivation-induced spines persisted during this period of functional recovery. However, spine addition did not increase again when the same eye was closed for a second time. This absence of structural plasticity stands out against the robust changes of eye- specific responses that occur even faster after repeated deprivation(3). Thus, spines added during the first monocular deprivation experience may provide a structural basis for subsequent functional shifts. These results provide a strong link between functional plasticity and specific synaptic rearrangements, revealing a mechanism of how prior experiences could be stored in cortical circuits.	[Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Bonhoeffer, Tobias; Huebener, Mark] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X	Max Planck Society; Wellcome Trust; Humboldt Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome TrustEuropean Commission); Humboldt Foundation(Alexander von Humboldt Foundation)	We thank T. Keck for contributing control data for Supplementary Fig. 7a, and M. Sperling and B. Pichler for programming help. This work was supported by the Max Planck Society, the Wellcome Trust and the Humboldt Foundation.	BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Gordon JA, 1996, J NEUROSCI, V16, P3274; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	30	359	366	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					313	U4		10.1038/nature07487	http://dx.doi.org/10.1038/nature07487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19005470	Green Accepted			2022-12-28	WOS:000262440900039
J	Bornholdt, ZA; Prasad, BVV				Bornholdt, Zachary A.; Prasad, B. V. Venkataram			X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus	NATURE			English	Article							ANTIVIRAL CYTOKINE RESPONSES; DOUBLE-STRANDED-RNA; PRE-MESSENGER-RNAS; A VIRUS; EFFECTOR DOMAIN; PROTEIN; BINDING; INTERFERON; ACTIVATION; INFECTION	The recent emergence of highly pathogenic avian (H5N1) influenza viruses, their epizootic and panzootic nature, and their association with lethal human infections have raised significant global health concerns(1,2). Several studies have underlined the importance of non-structural protein NS1 in the increased pathogenicity and virulence of these strains(3,4). NS1, which consists of two domains a double-stranded RNA (dsRNA) binding domain(5,6) and the effector domain(7), separated through a linker - is an antagonist of antiviral type-I interferon response in the host(8,9). Here we report the X-ray structure of the full- length NS1 from an H5N1 strain (A/Vietnam/1203/2004) that was associated with 60% of human deaths in an outbreak in Vietnam(1,2). Compared to the individually determined structures of the RNA binding domain and the effector domain from non- H5N1 strains, the RNA binding domain within H5N1 NS1 exhibits modest structural changes, while the H5N1 effector domain shows significant alteration, particularly in the dimeric interface. Although both domains in the full- length NS1 individually participate in dimeric interactions, an unexpected finding is that these interactions result in the formation of a chain of NS1 molecules instead of distinct dimeric units. Three such chains in the crystal interact with one another extensively to form a tubular organization of similar dimensions to that observed in the cryo- electron microscopy images of NS1 in the presence of dsRNA. The tubular oligomeric organization of NS1, in which residues implicated in dsRNA binding face a 20-angstrom-wide central tunnel, provides a plausible mechanism for how NS1 sequesters varying lengths of dsRNA, to counter cellular antiviral dsRNA response pathways, while simultaneously interacting with other cellular ligands during an infection.	[Bornholdt, Zachary A.; Prasad, B. V. Venkataram] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Prasad, B. V. Venkataram] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Prasad, BVV (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	vprasad@bcm.tmc.edu		Bornholdt, Zachary/0000-0002-7557-9219; Prasad, B.V.Venkataram/0000-0002-1172-2071	NIH [AI36040, AI07471, RR002250]; Robert Welch Foundation; US Department of Energy,; Basic Energy Sciences; Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036040, T32AI007471, R37AI036040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); US Department of Energy,(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Palese for providing us clones of A/Vietnam/1203/2004 H5N1 and A/PR8/34 (H1N1) NS1. This work was supported by the NIH (AI36040) and the Robert Welch Foundation (to B.V.V.P.). Z.A.B. acknowledges support from an NIH virology training grant (AI07471). We thank P. Palese, A. Rice, M. Schmid and B. Carrillo for discussions and comments on the manuscript and H. Chen for technical assistance with cryo-EM. We acknowledge the use of cryo-EM facilities at the National Center for Macromolecular Imaging ( Baylor College of Medicine) supported by the National Institutes of Health (RR002250 to W. Chiu); we also acknowledge the Center for Advanced Microstructures & Devices (CAMD), Baton Rouge, Los Angeles, and H. Bellamy, and the SBC- CAT 19ID beam line at the Advanced Photon Source (supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38) and its staff for their help during data collection.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000	33	116	126	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					985	U85		10.1038/nature07444	http://dx.doi.org/10.1038/nature07444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18987632	Green Accepted			2022-12-28	WOS:000261768300053
J	Vernes, SC; Newbury, DF; Abrahams, BS; Winchester, L; Nicod, J; Groszer, M; Alarcon, M; Oliver, PL; Davies, KE; Geschwind, DH; Monaco, AP; Fisher, SE				Vernes, Sonja C.; Newbury, Dianne F.; Abrahams, Brett S.; Winchester, Laura; Nicod, Jerome; Groszer, Matthias; Alarcon, Maricela; Oliver, Peter L.; Davies, Kay E.; Geschwind, Daniel H.; Monaco, Anthony P.; Fisher, Simon E.			A Functional Genetic Link between Distinct Developmental Language Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONWORD REPETITION; FOXP2 EXPRESSION; SEVERE SPEECH; HUMAN BRAIN; IMPAIRMENT; AUTISM; ASSOCIATION; PREVALENCE; CHILDREN; CNTNAP2	Background: Rare mutations affecting the FOXP2 transcription factor cause a monogenic speech and language disorder. We hypothesized that neural pathways downstream of FOXP2 influence more common phenotypes, such as specific language impairment. Methods: We performed genomic screening for regions bound by FOXP2 using chromatin immunoprecipitation, which led us to focus on one particular gene that was a strong candidate for involvement in language impairments. We then tested for associations between single-nucleotide polymorphisms (SNPs) in this gene and language deficits in a well-characterized set of 184 families affected with specific language impairment. Results: We found that FOXP2 binds to and dramatically down-regulates CNTNAP2, a gene that encodes a neurexin and is expressed in the developing human cortex. On analyzing CNTNAP2 polymorphisms in children with typical specific language impairment, we detected significant quantitative associations with nonsense-word repetition, a heritable behavioral marker of this disorder (peak association, P=5.0 x 10(-5) at SNP rs17236239). Intriguingly, this region coincides with one associated with language delays in children with autism. Conclusions: The FOXP2-CNTNAP2 pathway provides a mechanistic link between clinically distinct syndromes involving disrupted language.	[Vernes, Sonja C.; Newbury, Dianne F.; Winchester, Laura; Nicod, Jerome; Groszer, Matthias; Monaco, Anthony P.; Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Vernes, Sonja C.; Oliver, Peter L.; Davies, Kay E.] Univ Oxford, Med Res Council Funct Genom Unit, Oxford OX3 7BN, England; [Abrahams, Brett S.; Alarcon, Maricela; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fisher, SE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	simon.fisher@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Oliver, Peter/F-1453-2010; Groszer, Matthias/P-6291-2017; Vernes, Sonja/E-8454-2012; Fisher, Simon E./E-9130-2012; Simonoff, Emily A/B-7593-2011	Monaco, Anthony P/0000-0001-7480-3197; Vernes, Sonja/0000-0003-0305-4584; Fisher, Simon E./0000-0002-3132-1996; Groszer, Matthias/0000-0002-6209-305X; Oliver, Peter/0000-0003-3347-2461	Wellcome Trust; Autism Speaks; National Institute of Mental Health [MH75028-R21, MH081754-RO1, MH60233-R37, HD055784-P50]; Christopher Welch Biological Sciences Scholarship; University of Oxford; Tourette Syndrome Association; Marie Curie Intra-European Fellowship; Wellcome Trust Principal Research Fellow; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH060233, R01MH060233, R01MH081754, R21MH075028, R37MH060233] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Christopher Welch Biological Sciences Scholarship; University of Oxford; Tourette Syndrome Association; Marie Curie Intra-European Fellowship(European Commission); Wellcome Trust Principal Research Fellow(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by project and program grants from the Wellcome Trust (to Drs. Fisher and Monaco, respectively), a pilot grant from Autism Speaks (to Dr. Fisher), awards (MH75028-R21, MH081754-RO1, MH60233-R37, and HD055784-P50) from the National Institute of Mental Health (to Dr. Geschwind), a Christopher Welch Biological Sciences Scholarship from the University of Oxford (to Dr. Vernes), a postdoctoral fellowship from the Tourette Syndrome Association (to Dr. Abrahams), and a Marie Curie Intra-European Fellowship (to Dr. Nicod). Dr. Monaco is a Wellcome Trust Principal Research Fellow, and Dr. Fisher is a Royal Society Research Fellow. Drs. Newbury, Monaco, and Fisher and Ms. Winchester are members of the Specific Language Impairment Consortium.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bishop DVM, 2003, NOVART FDN SYMP, V251, P213; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Burden V, 1996, DEV MED CHILD NEUROL, V38, P613; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Clark A, 2007, ARCH DIS CHILD, V92, P614, DOI 10.1136/adc.2006.101758; COHEN NJ, 2001, LANGUAGE IMPAIRMENT; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G, 2006, J CHILD PSYCHOL PSYC, V47, P621, DOI 10.1111/j.1469-7610.2005.01584.x; De Fosse L, 2004, ANN NEUROL, V56, P757, DOI 10.1002/ana.20275; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Harel S, 1996, PEDIATR NEUROL, V15, P305, DOI 10.1016/S0887-8994(96)00222-6; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Newbury DF, 2005, TRENDS COGN SCI, V9, P528, DOI 10.1016/j.tics.2005.09.002; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Newbury DF, 2002, AM J HUM GENET, V70, P384; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Rasband MN, 2004, J NEUROSCI RES, V76, P749, DOI 10.1002/jnr.20073; Semel EM, 1992, CLIN EVALUATION LANG; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Whitehouse AJO, 2007, J CHILD PSYCHOL PSYC, V48, P822, DOI 10.1111/j.1469-7610.2007.01765.x; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110	45	471	486	2	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2337	2345		10.1056/NEJMoa0802828	http://dx.doi.org/10.1056/NEJMoa0802828			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	18987363	Green Published, Green Accepted			2022-12-28	WOS:000261270300005
J	Wang, ET; Sandberg, R; Luo, SJ; Khrebtukova, I; Zhang, L; Mayr, C; Kingsmore, SF; Schroth, GP; Burge, CB				Wang, Eric T.; Sandberg, Rickard; Luo, Shujun; Khrebtukova, Irina; Zhang, Lu; Mayr, Christine; Kingsmore, Stephen F.; Schroth, Gary P.; Burge, Christopher B.			Alternative isoform regulation in human tissue transcriptomes	NATURE			English	Article							MESSENGER-RNA; SPLICING REGULATION; MICRORNA TARGETS; PROTEIN; GENOME; EXPRESSION; BINDING; FOX-1; MICROARRAYS; HOMOLOGS	Through alternative processing of pre- messenger RNAs, individual mammalian genes often produce multiple mRNA and protein isoforms that may have related, distinct or even opposing functions. Here we report an in- depth analysis of 15 diverse human tissue and cell line transcriptomes on the basis of deep sequencing of complementary DNA fragments, yielding a digital inventory of gene and mRNA isoform expression. Analyses in which sequence reads are mapped to exon - exon junctions indicated that 92 - 94% of human genes undergo alternative splicing,, 86% with a minor isoform frequency of 15% or more. Differences in isoform- specific read densities indicated that most alternative splicing and alternative cleavage and polyadenylation events vary between tissues, whereas variation between individuals was approximately twofold to threefold less common. Extreme or 'switch-like' regulation of splicing between tissues was associated with increased sequence conservation in regulatory regions and with generation of full- length open reading frames. Patterns of alternative splicing and alternative cleavage and polyadenylation were strongly correlated across tissues, suggesting coordinated regulation of these processes, and sequence conservation of a subset of known regulatory motifs in both alternative introns and 39 untranslated regions suggested common involvement of specific factors in tissue- level regulation of both splicing and polyadenylation.	[Wang, Eric T.; Sandberg, Rickard; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wang, Eric T.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Luo, Shujun; Khrebtukova, Irina; Zhang, Lu; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Mayr, Christine] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA	Massachusetts Institute of Technology (MIT); Harvard University; Karolinska Institutet; Illumina; Massachusetts Institute of Technology (MIT); Whitehead Institute; National Center for Genome Resources (NCGR)	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020	Sandberg, Rickard/0000-0001-6473-1740; Kingsmore, Stephen/0000-0001-7180-2527; kingsmore, stephen/0000-0002-3758-4631	NIH; Knut & Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Anderson, D. Black, B. Friedman, and members of the Burge laboratory for comments on the manuscript, N. Spies for analyses, J. Mudge, G. D. May, N. A. Miller, E. Vermaas, T. Kerelska, J. Yan and V. Quijano for assistance in generating the mRNA- Seq data, and R. C. Roberts and N. Perrone- Bizzozero for supplying cerebellar cortex RNA samples. This research was supported by an NIH training grant ( E. T. W.), and by grants from the Knut & Alice Wallenberg Foundation and the Swedish Foundation for Strategic Research ( R. S.) and from the NIH ( C. B. B.).	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; *ILL INC, 2008, TRANSCR AN MRNA SEQ; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kim HH, 2008, MOL CELL, V29, P151, DOI 10.1016/j.molcel.2008.01.005; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Ladd AN, 2002, GENOME BIOL, V3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; PAN Q, NATURE GENE IN PRESS; Paz RD, 2006, AM J PSYCHIAT, V163, P1829, DOI 10.1176/appi.ajp.163.10.1829; SCHROTH GP, METHODS MOL IN PRESS; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xing Y, 2005, PLOS GENET, V1, P323, DOI 10.1371/journal.pgen.0010034; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200	41	3372	3547	7	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					470	476		10.1038/nature07509	http://dx.doi.org/10.1038/nature07509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18978772	Green Accepted			2022-12-28	WOS:000261170500031
J	Hagerman, RJ; Hagerman, PJ				Hagerman, Randi J.; Hagerman, Paul J.			Testing for Fragile X Gene Mutations Throughout the Life Span	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TREMOR/ATAXIA-SYNDROME; PREMUTATION; FXTAS		[Hagerman, Randi J.] Univ Calif Davis, Sch Med, MIND Inst, Davis, CA 95616 USA; [Hagerman, Randi J.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Hagerman, Paul J.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hagerman, RJ (corresponding author), Univ Calif Davis Hlth Syst, 2825 50th St, Sacramento, CA 95817 USA.	randi.hagerman@ucdmc.ucdavis.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071, P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RL1AG032119, RL1AG032115] Funding Source: NIH RePORTER; NIA NIH HHS [RL1 AG032119-01, RL1 AG032115, RL1 AG032115-01, AG032115, AG032119, RL1 AG032119] Funding Source: Medline; NICHD NIH HHS [HD02274, R01 HD036071, P30 HD002274-36S1, HD036071, R01 HD036071-10, P30 HD002274] Funding Source: Medline; NIDCR NIH HHS [DE19583, UL1 DE019583, UL1 DE019583-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bailey DB, 2003, PEDIATRICS, V111, P407, DOI 10.1542/peds.111.2.407; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Coffey SM, 2008, AM J MED GENET A, V146A, P1009, DOI 10.1002/ajmg.a.32060; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; Greco CM, 2007, J UROLOGY, V177, P1434, DOI 10.1016/j.juro.2006.11.097; Hagerman RJ, 2008, CLIN INTERV AGING, V3, P251, DOI 10.2147/CIA.S1794; HAGERMAN RJ, IN PRESS PEDIATRICS; Hall DA, 2005, NEUROLOGY, V65, P299, DOI 10.1212/01.wnl.0000168900.86323.9c; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; ROBERTS JE, AM J MED GENET B, DOI DOI 10.1002/AIMG.B.30786; Song FJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073	15	27	27	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2419	2421		10.1001/jama.2008.684	http://dx.doi.org/10.1001/jama.2008.684			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033593	Green Accepted			2022-12-28	WOS:000261150800025
J	Moylan, CA; Brady, CW; Johnson, JL; Smith, AD; Tuttle-Newhall, JE; Muir, AJ				Moylan, Cynthia A.; Brady, Carla W.; Johnson, Jeffrey L.; Smith, Alastair D.; Tuttle-Newhall, Janet E.; Muir, Andrew J.			Disparities in Liver Transplantation Before and After Introduction of the MELD Score	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association	MAY 19-25, 2007	Washington, DC	Amer Gastroenterol Assoc, Amer Assoc Study Liver Dis, Amer Soc Gastrointestinal Endoscopy, Soc Surg Alimentary Tract			HEPATOCELLULAR-CARCINOMA; UNITED-STATES; MODEL; ALLOCATION; MORTALITY; SURVIVAL; ACCESS; RISK; 1ST	Context In February 2002, the allocation system for liver transplantation became based on the Model for End- Stage Liver Disease ( MELD) score. Before MELD, black patients were more likely to die or become too sick to undergo liver transplantation compared with white patients. Little information exists regarding sex and access to liver transplantation. Objective To determine the association between race, sex, and liver transplantation following introduction of the MELD system. Design, Setting, and Patients A retrospective cohort of black and white patients ( >= 18 years) registered on the United Network for Organ Sharing liver transplantation waiting list between January 1, 1996, and December 31, 2000 ( pre- MELD cohort, n= 21 895) and between February 28, 2002, and March 31, 2006 ( post- MELD cohort, n= 23 793). Main Outcome Measures Association between race, sex, and receipt of a liver transplant. Separate multivariable analyses evaluated cohorts within each period to identify predictors of time to death and the odds of dying or receiving liver transplantation within 3 years of listing. Patients with hepatocellular carcinoma were analyzed separately. Results Black patients were younger ( mean [ SD], 49.2 [ 10.7] vs 52.4 [ 9.2] years; P <. 001) and sicker ( MELD score at listing: median [ interquartile range], 16 [ 12- 22] vs 14 [ 11- 19]; P <. 001) than white patients on the waiting list for both periods. In the pre- MELD cohort, black patients were more likely to die or become too sick for liver transplantation than white patients ( 27.0% vs 21.7%) within 3 years of registering on the waiting list ( odds ratio [ OR], 1.51; 95% confidence interval ( CI), 1.15- 1.98; P=. 003). In the post- MELD cohort, black race was no longer associated with increased likelihood of death or becoming too sick for liver transplantation ( 26.5% vs 22.0%, respectively; OR, 0.96; 95% CI, 0.74- 1.26; P=. 76). Black patients were also less likely to receive a liver transplant than white patients within 3 years of registering on the waiting list pre- MELD ( 61.6% vs 66.9%; OR, 0.75; 95% CI, 0.59- 0.97; P=. 03), whereas post- MELD, race was no longer significantly associated with receipt of a liver transplant ( 47.5% vs 45.5%, respectively; OR, 1.04; 95% CI, 0.84- 1.28; P=. 75). Women were more likely than men to die or become too sick for liver transplantation post-MELD ( 23.7% vs 21.4%; OR, 1.30; 95% CI, 1.08- 1.47; P=. 003) vs pre- MELD ( 22.4% vs 21.9%; OR, 1.08; 95% CI, 0.91- 1.26; P=. 37). Similarly, women were less likely than men to receive a liver transplant within 3 years both pre- MELD ( 64.8% vs 67.6%; OR, 0.80; 95% CI, 0.70- 0.92; P=. 002) and post- MELD ( 39.9% vs 48.7%; OR, 0.70; 95% CI, 0.62- 0.79; P <. 001). Conclusion Following introduction of the MELD score to the liver transplantation allocation system, race was no longer associated with receipt of a liver transplant or death on the waiting list, but disparities based on sex remain.	[Moylan, Cynthia A.; Brady, Carla W.; Smith, Alastair D.; Muir, Andrew J.] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA; [Johnson, Jeffrey L.] Duke Univ, Med Ctr, Ctr Comprehens Canc, Durham, NC 27710 USA; [Tuttle-Newhall, Janet E.] Duke Univ, Med Ctr, Div Gen Surg & Crit Care, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Moylan, CA (corresponding author), Duke Univ, Med Ctr, Div Gastroenterol, POB 3913, Durham, NC 27710 USA.	moyla003@mc.duke.edu	Brady, Carla/AAV-3249-2020; Brady, Carla/AAH-7144-2020	Brady, Carla/0000-0003-3088-3118; Moylan, Cynthia/0000-0001-8454-7086	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007568] Funding Source: NIH RePORTER; NIDDK NIH HHS [5T32-DK07568-17, T32 DK007568] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad J, 2007, ANN INTERN MED, V146, P707, DOI 10.7326/0003-4819-146-10-200705150-00004; Allison P. D., 1995, SURVIVAL ANAL USING; Axelrod DA, 2008, JAMA-J AM MED ASSOC, V299, P202, DOI 10.1001/jama.2007.50; Barshes NR, 2007, LIVER TRANSPLANT, V13, P747, DOI 10.1002/lt.21158; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cholongitas E, 2007, AM J TRANSPLANT, V7, P685, DOI 10.1111/j.1600-6143.2007.01666.x; Eckhoff DE, 1998, LIVER TRANSPLANT SUR, V4, P499, DOI 10.1002/lt.500040606; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Floden A, 2006, TRANSPLANT P, V38, P2673, DOI 10.1016/j.transproceed.2006.07.030; Freeman RB, 2004, LIVER TRANSPLANT, V10, P7, DOI 10.1002/lt.20024; FREEMAN RB, 2002, AM J TRANSPLANT, V2, pS251; Institute of Medicine Committee on Organ Procurement and Transplantation Policy, 1999, ORG PROC TRANSPL ASS, P1; Institute of Medicine (US). Committee on Organ Procurement and Transplantation Policy, 1999, ORG PROC TRANSPL ASS; Julapalli VR, 2005, LIVER TRANSPLANT, V11, P1370, DOI 10.1002/lt.20434; Kanwal F, 2005, GASTROENTEROLOGY, V128, pA701; Kanwal F, 2005, ALIMENT PHARM THER, V21, P169, DOI 10.1111/j.1365-2036.2005.02321.x; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Merion RM, 2003, LIVER TRANSPLANT, V9, P12, DOI 10.1053/jlts.2003.50009; Reid AE, 2004, LIVER TRANSPLANT, V10, P834, DOI 10.1002/lt.20174; Schaffer RL, 2003, LIVER TRANSPLANT, V9, P1211, DOI 10.1053/jlts.2003.50192; Siegel AB, 2008, AM J GASTROENTEROL, V103, P120, DOI 10.1111/j.1572-0241.2007.01634.x; Wei Y L, 1997, Liver Transpl Surg, V3, P10; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	27	222	222	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2371	2378		10.1001/jama.2008.720	http://dx.doi.org/10.1001/jama.2008.720			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	375YX	19033587	Bronze, Green Accepted			2022-12-28	WOS:000261150800019
J	Moldoveanu, T; Gehring, K; Green, DR				Moldoveanu, Tudor; Gehring, Kalle; Green, Douglas R.			Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains	NATURE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; DOMAIN-VI; ACTIVATION; REVEALS; PEPTIDE; ENZYME; COMPLEXES	The Ca2+-dependent cysteine proteases, calpains, regulate cell migration(1), cell death(2), insulin secretion(3), synaptic function(4) and muscle homeostasis(5). Their endogenous inhibitor, calpastatin, consists of four inhibitory repeats, each of which neutralizes an activated calpain with exquisite specificity and potency(6). Despite the physiological importance of this interaction, the structural basis of calpain inhibition by calpastatin is unknown(7). Here we report the 3.0 angstrom structure of Ca2+-bound m-calpain in complex with the first calpastatin repeat, both from rat, revealing the mechanism of exclusive specificity. The structure highlights the complexity of calpain activation by Ca2+ illustrating key residues in a peripheral domain that serve to stabilize the protease core on Ca2+ binding. Fully activated calpain binds ten Ca2+ atoms, resulting in several conformational changes allowing recognition by calpastatin. Calpain inhibition is mediated by the intimate contact with three critical regions of calpastatin. Two regions target the penta- EF- hand domains of calpain and the third occupies the substrate- binding cleft, projecting a loop around the active site thiol to evade proteolysis.	[Moldoveanu, Tudor; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	St Jude Children's Research Hospital; McGill University	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Gehring, Kalle/I-4403-2013; Green, Douglas R/N-8083-2018; Gehring, Kalle/N-2945-2019; Moldoveanu, Tudor/N-8173-2018	Gehring, Kalle/0000-0001-6500-1184; Green, Douglas R/0000-0002-7332-1417; Gehring, Kalle/0000-0001-6500-1184; Moldoveanu, Tudor/0000-0003-0791-318X	US National Institute of Health; National Cancer Institute; Canadian Institute of Health Research; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828, R01AI047891, R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. L. Davies for facilitating the initial stages of this work and for sharing the coordinates for the calpastatin repeat 4 - calpain complex, M. Osborne for help with the NMR analysis, B. Schulman for collecting the ALS synchrotron data, the staff at Brookhaven National Light Source beam X29 and APS SERCAT for help with data collection, S. White and D. Miller for advice and sharing of synchrotron time, and C. Hosfield, A. Tocilj and R. Kriwacki for reviewing our manuscript. Funding was provided by the US National Institute of Health and National Cancer Institute, the Canadian Institute of Health Research and the American Lebanese Syrian Associated Charities.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Betts R, 2004, BIOCHEMISTRY-US, V43, P2596, DOI 10.1021/bi0359832; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Cuerrier D, 2007, J BIOL CHEM, V282, P9600, DOI 10.1074/jbc.M610372200; Davis TL, 2007, J MOL BIOL, V366, P216, DOI 10.1016/j.jmb.2006.11.037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutt P, 2000, BIOCHEM J, V348, P37, DOI 10.1042/0264-6021:3480037; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kiss R, 2008, FEBS LETT, V582, P2149, DOI 10.1016/j.febslet.2008.05.032; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Pal GP, 2003, STRUCTURE, V11, P1521, DOI 10.1016/j.str.2003.11.007; Reverter D, 2002, BIOL CHEM, V383, P1415, DOI 10.1515/BC.2002.160; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	37	112	121	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					404	U73		10.1038/nature07353	http://dx.doi.org/10.1038/nature07353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020622	Green Accepted			2022-12-28	WOS:000261039600047
J	DeKosky, ST; Williamson, JD; Fitzpatrick, AL; Kronmal, RA; Ives, DG; Saxton, JA; Lopez, OL; Burke, G; Carlson, MC; Fried, LP; Kuller, LH; Robbins, JA; Tracy, RP; Woolard, NF; Dunn, L; Snitz, BE; Nahin, RL; Furberg, CD				DeKosky, Steven T.; Williamson, Jeff D.; Fitzpatrick, Annette L.; Kronmal, Richard A.; Ives, Diane G.; Saxton, Judith A.; Lopez, Oscar L.; Burke, Gregory; Carlson, Michelle C.; Fried, Linda P.; Kuller, Lewis H.; Robbins, John A.; Tracy, Russell P.; Woolard, Nancy F.; Dunn, Leslie; Snitz, Beth E.; Nahin, Richard L.; Furberg, Curt D.		GEM Study Investigators	Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXTRACT EGB 761; MILD COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; ALZHEIMERS-DISEASE; CLINICAL-CRITERIA; DOUBLE-BLIND; EFFICACY; DIAGNOSIS; MEMORY; CONSENSUS	Context Ginkgo biloba is widely used for its potential effects on memory and cognition. To date, adequately powered clinical trials testing the effect of G biloba on dementia incidence are lacking. Objective To determine effectiveness of G biloba vs placebo in reducing the incidence of all- cause dementia and Alzheimer disease ( AD) in elderly individuals with normal cognition and those with mild cognitive impairment ( MCI). Design, Setting, and Participants Randomized, double- blind, placebo-controlled clinical trial conducted in 5 academic medical centers in the United States between 2000 and 2008 with a median follow- up of 6.1 years. Three thousand sixty- nine community volunteers aged 75 years or older with normal cognition ( n= 2587) or MCI ( n= 482) at study entry were assessed every 6 months for incident dementia. Intervention Twice- daily dose of 120- mg extract of G biloba ( n= 1545) or placebo ( n= 1524). Main Outcome Measures Incident dementia and AD determined by expert panel consensus. Results Five hundred twenty- three individuals developed dementia ( 246 receiving placebo and 277 receiving G biloba) with 92% of the dementia cases classified as possible or probable AD, or AD with evidence of vascular disease of the brain. Rates of dropout and loss to follow- up were low ( 6.3%), and the adverse effect profiles were similar for both groups. The overall dementia rate was 3.3 per 100 person-years in participants assigned to G biloba and 2.9 per 100 person- years in the placebo group. The hazard ratio ( HR) for G biloba compared with placebo for all cause dementia was 1.12 ( 95% confidence interval [ CI], 0.94- 1.33; P=. 21) and for AD, 1.16 ( 95% CI, 0.97- 1.39; P=. 11). G biloba also had no effect on the rate of progression to dementia in participants with MCI ( HR, 1.13; 95% CI, 0.85- 1.50; P=. 39). Conclusions In this study, G biloba at 120 mg twice a day was not effective in reducing either the overall incidence rate of dementia or AD incidence in elderly individuals with normal cognition or those with MCI. Trial Registration clinicaltrials. gov Identifier: NCT00010803.	[DeKosky, Steven T.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [DeKosky, Steven T.; Ives, Diane G.; Saxton, Judith A.; Lopez, Oscar L.; Kuller, Lewis H.; Dunn, Leslie; Snitz, Beth E.] Univ Pittsburgh, Pittsburgh, PA USA; [Williamson, Jeff D.; Burke, Gregory; Woolard, Nancy F.; Furberg, Curt D.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Fitzpatrick, Annette L.; Kronmal, Richard A.] Univ Washington, Seattle, WA 98195 USA; [Carlson, Michelle C.; Fried, Linda P.] Johns Hopkins Univ, Baltimore, MD USA; [Robbins, John A.] Univ Calif Davis, Sacramento, CA 95817 USA; [Tracy, Russell P.] Univ Vermont, Burlington, VT USA; [Nahin, Richard L.] Natl Ctr Complementary & Alternat Med, Bethesda, MD USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; University of Washington; University of Washington Seattle; Johns Hopkins University; University of California System; University of California Davis; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	DeKosky, ST (corresponding author), Univ Virginia, Sch Med, POB 800793, Charlottesville, VA 22908 USA.	dekosky@virginia.edu		Nahin, Richard/0000-0002-3682-4816; DeKosky, Steven/0000-0003-3743-2758	National Center for Complementary and Alternative Medicine [U01 AT000162]; Office of Dietary Supplements; National Institute on Aging; National Heart, Lung, and Blood Institute; University of Pittsburgh Alzheimer's Disease Research Center [P50AG05133]; Roena Kulynych Center for Memory and Cognition Research; Wake Forest University School of Medicine; National Institute of Neurological Disorders and Stroke; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT000162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005133] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Pittsburgh Alzheimer's Disease Research Center(University of Pittsburgh); Roena Kulynych Center for Memory and Cognition Research; Wake Forest University School of Medicine; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grant U01 AT000162 from the National Center for Complementary and Alternative Medicine (NCCAM) and the Office of Dietary Supplements and National Institute on Aging; National Heart, Lung, and Blood Institute; University of Pittsburgh Alzheimer's Disease Research Center (P50AG05133); Roena Kulynych Center for Memory and Cognition Research; Wake Forest University School of Medicine; and National Institute of Neurological Disorders and Stroke. Schwabe Pharmaceuticals, Karlsruhe, Germany, donated the G biloba tablets and identical placebos in blister packs for the study.	Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1991, JAMA, V265, P3255; AUGUET M, 1982, GEN PHARMACOL-VASC S, V13, P169, DOI 10.1016/0306-3623(82)90075-1; Bastianetto S, 2000, EUR J NEUROSCI, V12, P1882, DOI 10.1046/j.1460-9568.2000.00069.x; BECKER JT, 1987, CORTEX, V23, P59, DOI 10.1016/S0010-9452(87)80019-9; BIRKS J, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003120; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brunetti L, 2006, PLANTA MED, V72, P1296, DOI 10.1055/s-2006-951688; Chen X, 1997, CLIN EXP PHARMACOL P, V24, P958, DOI 10.1111/j.1440-1681.1997.tb02727.x; Chui HC, 2000, ARCH NEUROL-CHICAGO, V57, P191, DOI 10.1001/archneur.57.2.191; DeKosky ST, 2006, CONTEMP CLIN TRIALS, V27, P238, DOI 10.1016/j.cct.2006.02.007; Delis DC., 2000, CALIFORNIA VERBAL LE; Dodge HH, 2008, NEUROLOGY, V70, P1809, DOI 10.1212/01.wnl.0000303814.13509.db; ERKINJUNTTI T, 1994, DEMENTIA, V5, P189, DOI 10.1159/000106721; Fitzpatrick AL, 2006, CONTEMP CLIN TRIALS, V27, P541, DOI 10.1016/j.cct.2006.06.007; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Guralnik J M, 1997, J Am Med Womens Assoc (1972), V52, P113; Kanowski S, 1996, PHARMACOPSYCHIATRY, V29, P47, DOI 10.1055/s-2007-979544; Kawas CH, 2001, NEW ENGL J MED, V344, P1160, DOI 10.1056/NEJM200104123441509; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; Lopez OL, 2003, NEUROEPIDEMIOLOGY, V22, P1, DOI 10.1159/000067110; Lopez OL, 2006, J NEUROL NEUROSUR PS, V77, P159, DOI 10.1136/jnnp.2004.045567; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Magsi H, 2005, J AM GERIATR SOC, V53, P295, DOI 10.1111/j.1532-5415.2005.53117.x; Mahady Gail B, 2002, J Cardiovasc Nurs, V16, P21; MARCOCCI L, 1994, BIOCHEM BIOPH RES CO, V201, P748, DOI 10.1006/bbrc.1994.1764; Maurer K, 1997, J PSYCHIATR RES, V31, P645, DOI 10.1016/S0022-3956(97)00022-8; McCarney R, 2008, INT J GERIATR PSYCH, V23, P1222, DOI 10.1002/gps.2055; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mohs R C, 1996, Int Psychogeriatr, V8, P195, DOI 10.1017/S1041610296002578; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409; *PENT MED INC, 2006, NUTR BUS J S; Pietri S, 1997, J MOL CELL CARDIOL, V29, P733, DOI 10.1006/jmcc.1996.0316; Raven J. C., 1956, GUIDE USING COLOURED; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; ROCKWOOD K, 1994, CAN J NEUROL SCI, V21, P358, DOI 10.1017/S0317167100040968; Saxton J, 2000, CLIN NEUROPSYCHOL, V14, P526, DOI 10.1076/clin.14.4.526.7204; Schneider Lon S., 2005, Current Alzheimer Research, V2, P541, DOI 10.2174/156720505774932287; SNITZ BE, 2009, AGING MENT IN PRESS, V13; Spreen O, 1998, COMPENDIUM NEUROPSYC; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Trenerry MR., 1989, STROOP NEUROPSYCHOLO; Vellas B, 2006, NEUROLOGY, V67, pS6, DOI 10.1212/WNL.67.9_suppl_3.S6; Wechsler D, 1988, WECHSLER ADULT INTEL; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	49	432	457	2	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2253	2262		10.1001/jama.2008.683	http://dx.doi.org/10.1001/jama.2008.683			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017911	Green Accepted			2022-12-28	WOS:000260965500025
J	Zhang, LJ; Liu, Y; Ni, DX; Li, Q; Yu, YL; Yu, XJ; Wan, KL; Li, DX; Liang, GD; Jiang, XG; Jing, HQ; Run, J; Luan, MC; Fu, XP; Zhang, JS; Yang, WZ; Wang, Y; Dumler, JS; Feng, ZJ; Ren, J; Xu, JG				Zhang, Lijuan; Liu, Yan; Ni, Daxin; Li, Qun; Yu, Yanlin; Yu, Xue-jie; Wan, Kanglin; Li, Dexin; Liang, Guodong; Jiang, Xiugao; Jing, Huaiqi; Run, Jing; Luan, Mingchun; Fu, Xiuping; Zhang, Jingshan; Yang, Weizhong; Wang, Yu; Dumler, J. Stephen; Feng, Zijian; Ren, Jun; Xu, Jianguo			Nosocomial Transmission of Human Granulocytic Anaplasmosis in China	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IXODES-PERSULCATUS TICKS; HEALTH-CARE WORKERS; EHRLICHIA-CHAFFEENSIS; PHAGOCYTOPHILUM INFECTION; OCCUPATIONAL BLOOD; ETIOLOGIC AGENT; KOREAN PATIENTS; AREA; RICKETTSIA; EXPOSURE	Context Human granulocytic anaplasmosis (HGA) is an emerging tick- borne disease in China. A cluster of cases among health care workers and family members following exposure to a patient with fulminant disease consistent with HGA prompted investigation. Objective To investigate the origin and transmission of apparent nosocomial cases of febrile illness in the Anhui Province. Design, Setting, and Patients After exposure to an index patient whose fatal illness was characterized by fever and hemorrhage at a primary care hospital and regional tertiary care hospital's isolation ward, secondary cases with febrile illness who were suspected of being exposed were tested for antibodies against Anaplasma phago-cytophilum and by polymerase chain reaction ( PCR) and DNA sequencing for A phago-cytophilum DNA. Potential sources of exposure were investigated. Main Outcome Measure Cases with serological or PCR evidence of HGA were compared with uninfected contacts to define the attack rate, relative risk of illness, and potential risks for exposure during the provision of care to the index patient. Results In a regional hospital of Anhui Province, China, between November 9 and 17, 2006, a cluster of 9 febrile patients with leukopenia, thrombocytopenia, and elevated serum aminotransferase levels were diagnosed with HGA by PCR for A phago-cytophilum DNA in peripheral blood and by seroconversion to A phagocytophilum. No patients had tick bites. All 9 patients had contact with the index patient within 12 hours of her death from suspected fatal HGA while she experienced extensive hemorrhage and underwent endotracheal intubation. The attack rate was 32.1% vs 0% ( P=. 04) among contacts exposed at 50 cm or closer, 45% vs 0% ( P =.001) among those exposed for more than 2 hours, 75% vs 0% ( P <. 001) among those reporting contact with blood secretions, and 87.5% vs 0% ( P=. 004) among those reporting contact with respiratory secretions from the index patient. Conclusion We report the identification of HGA in China and likely nosocomial transmission of HGA from direct contact with blood or respiratory secretions.	[Zhang, Lijuan; Wan, Kanglin; Jiang, Xiugao; Jing, Huaiqi; Luan, Mingchun; Fu, Xiuping; Zhang, Jingshan; Xu, Jianguo] China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China; [Liu, Yan; Li, Qun; Ren, Jun] Anhui Ctr Dis Control & Prevent, Hefei 230061, Anhui, Peoples R China; [Ni, Daxin; Yang, Weizhong; Wang, Yu; Feng, Zijian] Chinese Ctr Dis Prevent & Control, Beijing, Peoples R China; [Yu, Yanlin; Run, Jing] Yijishan Hosp, Wuhu, Anhui, Peoples R China; [Yu, Xue-jie] Univ Texas Galveston, Med Branch, Dept Pathol, Galveston, TX 77550 USA; [Li, Dexin; Liang, Guodong] China CDC, Natl Inst Viral Dis Prevent & Control, Beijing, Peoples R China; [Wan, Kanglin; Li, Dexin; Liang, Guodong; Jing, Huaiqi; Xu, Jianguo] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Dumler, J. Stephen] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Wannan Medical College; University of Texas System; University of Texas Medical Branch Galveston; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Johns Hopkins University	Xu, JG (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, POB 5, Beijing 102206, Peoples R China.	rj@ahcdc.com.ch; xujianguo@icdc.cn	Yu, Xuejie/AAP-9246-2021; Yang, Wei/HIA-0360-2022		Ministry of Science and Technology [2005CB522904, 200802016]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants 2005CB522904 and 200802016 ( Dr Xu) from the Ministry of Science and Technology and by emerging response found from National Institute of Communicable Disease Control and Prevention, China CDC, Beijing, China.	Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bakken JS, 1996, CLIN INFECT DIS, V23, P198, DOI 10.1093/clinids/23.1.198; Bakken JS, 1998, CLIN INFECT DIS, V27, P1491, DOI 10.1086/515048; BAKKEN JS, 1994, JAMA-J AM MED ASSOC, V272, P212, DOI 10.1001/jama.272.3.212; Bayard-Mc Neeley M, 2004, J CLIN PATHOL, V57, P499, DOI 10.1136/jcp.2003.011775; Bell CA, 2005, DIAGN MICR INFEC DIS, V53, P301, DOI 10.1016/j.diagmicrobio.2005.06.019; Cao WC, 2003, AM J TROP MED HYG, V68, P547, DOI 10.4269/ajtmh.2003.68.547; Cao WC, 2000, J CLIN MICROBIOL, V38, P4208, DOI 10.1128/JCM.38.11.4208-4210.2000; Cao WC, 2006, AM J TROP MED HYG, V75, P664, DOI 10.4269/ajtmh.2006.75.664; Chae JS, 2003, ANN NY ACAD SCI, V990, P118, DOI 10.1111/j.1749-6632.2003.tb07349.x; Chahan B, 2005, VET PARASITOL, V134, P273, DOI 10.1016/j.vetpar.2005.07.024; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Denis MA, 2003, J OCCUP ENVIRON MED, V45, P283, DOI 10.1097/01.jom.0000052961.59271.9d; Dumler JS, 2007, CLIN INFECT DIS, V45, P199, DOI 10.1086/518834; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; Dumler JS, 2005, ANN NY ACAD SCI, V1063, P361, DOI 10.1196/annals.1355.069; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Gao D, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P137; HAWKINS JA, 1982, AM J VET RES, V43, P732; Heo EJ, 2002, J CLIN MICROBIOL, V40, P3082, DOI 10.1128/JCM.40.8.3082-3085.2002; Horowitz HW, 1998, NEW ENGL J MED, V339, P375, DOI 10.1056/NEJM199808063390604; IJdo JW, 2000, J INFECT DIS, V181, P1388, DOI 10.1086/315389; KENYON RH, 1979, INFECT IMMUN, V25, P580, DOI 10.1128/IAI.25.2.580-582.1979; Kim CM, 2006, APPL ENVIRON MICROB, V72, P5766, DOI 10.1128/AEM.00431-06; Kim CM, 2003, VECTOR-BORNE ZOONOT, V3, P17, DOI 10.1089/153036603765627424; Leiby DA, 2004, TRANSFUS MED REV, V18, P293, DOI 10.1016/j.tmrv.2004.07.001; MAEDA K, 1987, NEW ENGL J MED, V316, P853, DOI 10.1056/NEJM198704023161406; MCNABB SJN, 2006, MMWR-MORBID MORTAL W, V54, P2; Ohashi N, 2005, EMERG INFECT DIS, V11, P1780, DOI 10.3201/eid1111.050407; OSTER CN, 1977, NEW ENGL J MED, V297, P859, DOI 10.1056/NEJM197710202971604; Park J, 2003, CLIN DIAGN LAB IMMUN, V10, P1059, DOI 10.1128/CDLI.10.6.1059-1064.2003; Petrovec M, 1997, J CLIN MICROBIOL, V35, P1556, DOI 10.1128/JCM.35.6.1556-1559.1997; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; RUIZ AD, 1988, KLIN WOCHENSCHR, V66, P1212, DOI 10.1007/BF01727425; Shpynov S, 2006, ANN NY ACAD SCI, V1078, P378, DOI 10.1196/annals.1374.075; Tarantola A, 2003, AM J INFECT CONTROL, V31, P357, DOI 10.1016/S0196-6553(03)00040-3; Tate CM, 2005, J CLIN MICROBIOL, V43, P3595, DOI 10.1128/JCM.43.8.3595-3601.2005; Wen BH, 2003, ANN NY ACAD SCI, V990, P45, DOI 10.1111/j.1749-6632.2003.tb07335.x; Wen BH, 2002, J CLIN MICROBIOL, V40, P3286, DOI 10.1128/JCM.40.9.3286-3290.2002; Zhang LJ, 2008, EMERG INFECT DIS, V14, P938, DOI 10.3201/eid1406.071502; ZHAOQM, 2005, ZHONGHUA LIU XING BI, V26, P9	42	121	183	3	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2263	2270		10.1001/jama.2008.626	http://dx.doi.org/10.1001/jama.2008.626			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017912	Bronze			2022-12-28	WOS:000260965500026
J	Hongoh, Y; Sharma, VK; Prakash, T; Noda, S; Toh, H; Taylor, TD; Kudo, T; Sakaki, Y; Toyoda, A; Hattori, M; Ohkuma, M				Hongoh, Yuichi; Sharma, Vineet K.; Prakash, Tulika; Noda, Satoko; Toh, Hidehiro; Taylor, Todd D.; Kudo, Toshiaki; Sakaki, Yoshiyuki; Toyoda, Atsushi; Hattori, Masahira; Ohkuma, Moriya			Genome of an Endosymbiont Coupling N-2 Fixation to Cellulolysis Within Protist Cells in Termite Gut	SCIENCE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; COPTOTERMES-FORMOSANUS; NITROGEN-FIXATION; PHYLOGENETIC DIVERSITY; BACTERIA; RHINOTERMITIDAE; COMMUNITY; ISOPTERA	Termites harbor diverse symbiotic gut microorganisms, the majority of which are as yet uncultivable and their interrelationships unclear. Here, we present the complete genome sequence of the uncultured Bacteroidales endosymbiont of the cellulolytic protist Pseudotrichonympha grassii, which accounts for 70% of the bacterial cells in the gut of the termite Coptotermes formosanus. Functional annotation of the chromosome ( 1,114,206 base pairs) unveiled its ability to fix dinitrogen and recycle putative host nitrogen wastes for biosynthesis of diverse amino acids and cofactors, and import glucose and xylose as energy and carbon sources. Thus, nitrogen fixation and cellulolysis are coupled within the protist's cells. This highly evolved symbiotic system probably underlies the ability of the worldwide pest termites Coptotermes to use wood as their sole food.	[Hongoh, Yuichi; Noda, Satoko; Kudo, Toshiaki; Ohkuma, Moriya] RIKEN, Adv Sci Inst, Ecomol Biorecycling Sci Res Team, Wako, Saitama 3510198, Japan; [Sharma, Vineet K.; Prakash, Tulika; Toh, Hidehiro; Taylor, Todd D.; Sakaki, Yoshiyuki; Toyoda, Atsushi; Hattori, Masahira] RIKEN, Genom Sci Ctr, Kanagawa 2300045, Japan; [Sharma, Vineet K.; Prakash, Tulika; Toh, Hidehiro; Taylor, Todd D.] RIKEN, MetaSyst Res Team, Adv Sci Inst, Kanagawa 2300045, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Hattori, Masahira] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Chiba 2778561, Japan	RIKEN; RIKEN; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo	Hongoh, Y (corresponding author), RIKEN, Adv Sci Inst, Ecomol Biorecycling Sci Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yhongo@riken.jp; atoyoda@lab.nig.ac.jp	Hongoh, Yuichi/A-2303-2014; Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016; Srivastava, Tulika/A-7207-2009; Ohkuma, Moriya/A-8100-2011; sharma, vineet/A-7199-2009; Hattori, Masahira/AAD-3785-2019	Hongoh, Yuichi/0000-0002-5901-9625; Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; K. Sharma, Vineet/0000-0002-2958-6215	President's Discretionary Fund of RIKEN; RIKEN GSC; Bioarchitect Research Program; Eco Molecular Science Research Program; Discovery Research Institute Research Grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	President's Discretionary Fund of RIKEN; RIKEN GSC; Bioarchitect Research Program; Eco Molecular Science Research Program; Discovery Research Institute Research Grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to all the technical staff of the Sequence Technology Team at RIKEN Genomic Sciences Center (GSC) and the Ecomolecular Biorecycling Science Research Team for their assistance. This work was supported in part by a grant for the President's Discretionary Fund of RIKEN; a Special Fund for RIKEN GSC; grants for the Bioarchitect Research Program and the Eco Molecular Science Research Program from RIKEN; a Discovery Research Institute Research Grant to Y. H. from RIKEN; a Grant- in- Aid for Scientific Research on Priority Areas " Comprehensive Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to M. H.; and a Grant- inAid for Scientific Research from Japan Society for the Promotion of Science to Y. H. and M. O. The authors declare no competing financial interests. The sequence data have been deposited in GenBank/DDBJ/EMBL under accession numbers AP010656-60.	BREZNAK JA, 1973, NATURE, V244, P577, DOI 10.1038/244577a0; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Inoue JI, 2007, EUKARYOT CELL, V6, P1925, DOI 10.1128/EC.00251-07; Lax AR, 2003, PEST MANAG SCI, V59, P788, DOI 10.1002/ps.721; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Noda S, 2005, APPL ENVIRON MICROB, V71, P8811, DOI 10.1128/AEM.71.12.8811-8817.2005; Noda Satoko, 2002, Microbes and Environments, V17, P139, DOI 10.1264/jsme2.17.139; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Shinzato N, 2005, BIOSCI BIOTECH BIOCH, V69, P1145, DOI 10.1271/bbb.69.1145; Su NY, 2003, SOCIOBIOLOGY, V41, P7; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; Tsunoda K, 2003, SOCIOBIOLOGY, V41, P27; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yoshimura Tsuyoshi, 1995, Wood Research, V82, P68	18	148	293	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1108	1109		10.1126/science.1165578	http://dx.doi.org/10.1126/science.1165578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008447				2022-12-28	WOS:000260867700039
J	Tomas-Loba, A; Flores, I; Fernandez-Marcos, PJ; Cayuela, ML; Maraver, A; Tejera, A; Borras, C; Matheu, A; Klatt, P; Flores, JM; Vina, J; Serrano, M; Blasco, MA				Tomas-Loba, Antonia; Flores, Ignacio; Fernandez-Marcos, Pablo J.; Cayuela, Maria L.; Maraver, Antonio; Tejera, Agueda; Borras, Consuelo; Matheu, Ander; Klatt, Peter; Flores, Juana M.; Vina, Jose; Serrano, Manuel; Blasco, Maria A.			Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice	CELL			English	Article							STEM-CELLS; DYSKERATOSIS-CONGENITA; CELLULAR SENESCENCE; PULMONARY-FIBROSIS; TUMOR-SUPPRESSOR; RNA COMPONENT; HUMAN-DISEASE; DNA-DAMAGE; LIFE-SPAN; IN-VIVO	Telomerase confers limitless proliferative potential to most human cells through its ability to elongate telomeres, the natural ends of chromosomes, which otherwise would undergo progressive attrition and eventually compromise cell viability. However, the role of telomerase in organismal aging has remained unaddressed, in part because of the cancer-promoting activity of telomerase. To circumvent this problem, we have constitutively expressed telomerase reverse transcriptase (TERT), one of the components of telomerase, in mice engineered to be cancer resistant by means of enhanced expression of the tumor suppressors p53, p16, and p19ARF. In this context, TERT over-expression improves the fitness of epithelial barriers, particularly the skin and the intestine, and produces a systemic delay in aging accompanied by extension of the median life span. These results demonstrate that constitutive expression of Tert provides antiaging activity in the context of a mammalian organism.	[Tomas-Loba, Antonia; Flores, Ignacio; Cayuela, Maria L.; Tejera, Agueda; Klatt, Peter; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain; [Fernandez-Marcos, Pablo J.; Maraver, Antonio; Matheu, Ander; Klatt, Peter; Serrano, Manuel] Spanish Natl Canc Ctr CNIO, Tumor Suppress Grp, Mol Oncol Program, Madrid 28029, Spain; [Borras, Consuelo; Vina, Jose] Univ Valencia, Dept Physiol, Valencia 46010, Spain; [Tomas-Loba, Antonia; Flores, Ignacio] Univ Complutense Madrid, Dept Anim Surg & Med, E-28040 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Valencia; Complutense University of Madrid	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	matheu, ander/G-9906-2014; Blasco, Maria A./M-1694-2014; Serrano, Manuel/H-2634-2015; Vina, Jose/AAB-3069-2021; Loba, Antonia Tomas/AAB-6814-2019; Tejera, Agueda/L-1946-2015; Maraver, Antonio/G-2666-2015; Tejera, Agueda M./AAU-2000-2021; Flores, Ignacio/E-8304-2016; Tomas-Loba, Antonia/N-6828-2016; Tejera, Agueda/Z-1938-2019; Fernandez, Pablo J/F-1840-2016; borras, consuelo/Y-3407-2019	matheu, ander/0000-0002-1848-0781; Blasco, Maria A./0000-0002-4211-233X; Serrano, Manuel/0000-0001-7177-9312; Vina, Jose/0000-0001-9709-0089; Flores, Ignacio/0000-0001-8789-6396; Tomas-Loba, Antonia/0000-0002-6440-3373; Fernandez, Pablo J/0000-0003-3515-4125; borras, consuelo/0000-0003-4606-1792; Flores, Juana M/0000-0002-7995-4426; Maraver, Antonio/0000-0002-5527-5680; Tejera, Agueda M/0000-0002-6703-9466				Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Canela A, 2004, MOL CELL BIOL, V24, P4275, DOI 10.1128/MCB.24.10.4275-4293.2004; Cayuela ML, 2005, EMBO REP, V6, P268, DOI 10.1038/sj.embor.7400359; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Flores I, 2006, MOL CELL BIOL, V26, P6130, DOI 10.1128/MCB.00543-06; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAMMERMAN MR, 1987, ENDOCRIN METAB CLIN, V16, P995, DOI 10.1016/S0889-8529(18)30455-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; INGRAM DK, 1986, EXP AGING RES, V12, P155; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yuen KCJ, 2007, DIABETES OBES METAB, V9, P11, DOI 10.1111/j.1463-1326.2006.00591.x; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	61	310	331	0	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					609	622		10.1016/j.cell.2008.09.034	http://dx.doi.org/10.1016/j.cell.2008.09.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013273	Bronze			2022-12-28	WOS:000260886900013
J	Mallet, L; Polosan, M; Jaafari, N; Baup, N; Welter, ML; Fontaine, D; du Montcel, ST; Yelnik, J; Chereau, I; Arbus, C; Raoul, S; Aouizerate, B; Damier, P; Chabardes, S; Czernecki, V; Ardouin, C; Krebs, MO; Bardinet, E; Chaynes, P; Burbaud, P; Cornu, P; Derost, P; Bougerol, T; Bataille, B; Mattei, V; Dormont, D; Devaux, B; Verin, M; Houeto, JL; Pollak, P; Benabid, AL; Agid, Y; Krack, P; Millet, B; Pelissolo, A				Mallet, Luc; Polosan, Mircea; Jaafari, Nematollah; Baup, Nicolas; Welter, Marie-Laure; Fontaine, Denys; du Montcel, Sophie Tezenas; Yelnik, Jerome; Chereau, Isabelle; Arbus, Christophe; Raoul, Sylvie; Aouizerate, Bruno; Damier, Philippe; Chabardes, Stephan; Czernecki, Virginie; Ardouin, Claire; Krebs, Marie-Odile; Bardinet, Eric; Chaynes, Patrick; Burbaud, Pierre; Cornu, Philippe; Derost, Philippe; Bougerol, Thierry; Bataille, Benoit; Mattei, Vianney; Dormont, Didier; Devaux, Bertrand; Verin, Marc; Houeto, Jean-Luc; Pollak, Pierre; Benabid, Alim-Louis; Agid, Yves; Krack, Paul; Millet, Bruno; Pelissolo, Antoine		STOC Study Grp	Subthalamic Nucleus Stimulation in Severe Obsessive-Compulsive Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP BRAIN-STIMULATION; PARKINSONS-DISEASE; ELECTRICAL-STIMULATION; CAPSULAR STIMULATION; FOLLOW-UP; DSM-IV; RELIABILITY; INTERVIEW; SCALE; INTERRATER	Background: Severe, refractory obsessive-compulsive disorder (OCD) is a disabling condition. Stimulation of the subthalamic nucleus, a procedure that is already validated for the treatment of movement disorders, has been proposed as a therapeutic option. Methods: In this 10-month, crossover, double-blind, multicenter study assessing the efficacy and safety of stimulation of the subthalamic nucleus, we randomly assigned eight patients with highly refractory OCD to undergo active stimulation of the subthalamic nucleus followed by sham stimulation and eight to undergo sham stimulation followed by active stimulation. The primary outcome measure was the severity of OCD, as assessed by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), at the end of two 3-month periods. General psychopathologic findings, functioning, and tolerance were assessed with the use of standardized psychiatric scales, the Global Assessment of Functioning (GAF) scale, and neuropsychological tests. Results: After active stimulation of the subthalamic nucleus, the Y-BOCS score (on a scale from 0 to 40, with lower scores indicating less severe symptoms) was significantly lower than the score after sham stimulation (mean [+/-SD], 19+/-8 vs. 28+/-7; P=0.01), and the GAF score (on a scale from 1 to 90, with higher scores indicating higher levels of functioning) was significantly higher (56+/-14 vs. 43+/-8, P=0.005). The ratings of neuropsychological measures, depression, and anxiety were not modified by stimulation. There were 15 serious adverse events overall, including 1 intracerebral hemorrhage and 2 infections; there were also 23 nonserious adverse events. Conclusions: These preliminary findings suggest that stimulation of the subthalamic nucleus may reduce the symptoms of severe forms of OCD but is associated with a substantial risk of serious adverse events. (ClinicalTrials.gov number, NCT00169377.).	[Mallet, Luc; Welter, Marie-Laure; Yelnik, Jerome; Czernecki, Virginie; Bardinet, Eric; Agid, Yves] CHU Pitie Salpetriere, INSERM, Avenir Team Behav Emot & Basal Ganglia IFR 70, Ctr Invest Clin,Assistance Publ Hop Paris, F-75013 Paris, France; [Polosan, Mircea; Bougerol, Thierry] Grenoble Univ Hosp, Dept Psychiat, Grenoble, France; [Chabardes, Stephan; Benabid, Alim-Louis] Grenoble Univ Hosp, Dept Neurosurg, Grenoble, France; [Ardouin, Claire; Pollak, Pierre; Krack, Paul] Grenoble Univ Hosp, Dept Neurol, Grenoble, France; [Jaafari, Nematollah] Univ Hosp Poitiers, Dept Psychiat, Poitiers, France; [Bataille, Benoit] Univ Hosp Poitiers, Dept Neurosurg, Poitiers, France; [Baup, Nicolas; Krebs, Marie-Odile] Univ Paris 05, INSERM, U796, Univ Dept Psychiat, Paris, France; [Devaux, Bertrand] Hop St Anne, Dept Neurosurg, F-75674 Paris, France; [Fontaine, Denys] Univ Hosp, Dept Neurosurg, Nice, France; [Mattei, Vianney] Univ Hosp, Dept Psychiat, Nice, France; [du Montcel, Sophie Tezenas] Univ Paris 06, Pitie Salpetriere Univ Hosp, Biostat & Med Informat Unit, Modeling Clin Res EA 3974, Paris, France; [du Montcel, Sophie Tezenas] Univ Paris 06, Pitie Salpetriere Univ Hosp, Clin Res Unit, Modeling Clin Res EA 3974, Paris, France; [Yelnik, Jerome; Agid, Yves] Univ Paris 06, INSERM, Inst Fed Rech Neurosci Unite Mixte Rech S679, U679, Paris, France; [Chereau, Isabelle] Univ Hosp Clermont Ferrand, Dept Psychiat, Clermont Ferrand, France; [Damier, Philippe] Univ Hosp Clermont Ferrand, Dept Neurol, Clermont Ferrand, France; [Arbus, Christophe] Univ Hosp Toulouse, Dept Psychiat, Toulouse, France; [Chaynes, Patrick] Univ Hosp Toulouse, Dept Neurosurg, Toulouse, France; [Raoul, Sylvie] Univ Hosp Nantes, Dept Neurosurg, Nantes, France; [Damier, Philippe] Univ Hosp Nantes, Dept Neurol, Nantes, France; [Aouizerate, Bruno] Univ Bordeaux 2, Charles Perrens Hosp, Dept Psychiat, F-33076 Bordeaux, France; [Aouizerate, Bruno; Burbaud, Pierre] Univ Bordeaux 2, CNRS, UMR5543, F-33076 Bordeaux, France; [Czernecki, Virginie] Pitie Salpetriere Univ Hosp, INSERM, U610, Paris, France; [Chaynes, Patrick] Pitie Salpetriere Univ Hosp, Dept Neurosurg, Paris, France; [Dormont, Didier] Pitie Salpetriere Univ Hosp, Dept Radiol, Paris, France; [Welter, Marie-Laure; Agid, Yves] Pitie Salpetriere Univ Hosp, Federat Malad Syst Nerveux, Paris, France; [Pelissolo, Antoine] Pitie Salpetriere Univ Hosp, Dept Psychiat, Paris, France; [Bardinet, Eric] CNRS, Unite Propre Rech, Lab Neurosci Cognit & Imagerie Cerebrale, LENA 640, Paris, France; [Verin, Marc] Univ Hosp, Dept Neurol, Rennes, France; [Millet, Bruno] Univ Hosp, Dept Psychiat, Rennes, France; [Houeto, Jean-Luc] Univ Poitiers, CHU Poitiers, Dept Neurol, EA 3808, Poitiers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU de Toulouse; CHU de Toulouse; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CHU Rennes; CHU Rennes; CHU Poitiers; Universite de Poitiers	Mallet, L (corresponding author), CHU Pitie Salpetriere, INSERM, Avenir Team Behav Emot & Basal Ganglia IFR 70, Ctr Invest Clin,Assistance Publ Hop Paris, 47 Blvd Hop, F-75013 Paris, France.	luc.mallet@psl.aphp.fr	Sauleau, Paul/ABC-4459-2020; Damier, Philippe/T-7829-2019; Coste, Jérôme/D-2070-2013; Verin, Marc/ABC-6924-2020; Mallet, Luc/F-7156-2013; Krebs, Marie-Odile/O-2104-2017; Benabid, Alim L/Q-3506-2017; Dormont, Didier/F-5492-2012; dormont, didier/B-2175-2012; Yelnik, Jérôme/F-7153-2013; Tezenas du Montcel, Sophie/A-6207-2012	Coste, Jérôme/0000-0002-3262-0867; Mallet, Luc/0000-0001-8061-1167; Krebs, Marie-Odile/0000-0002-4715-9890; Tezenas du Montcel, Sophie/0000-0002-2866-4330; PELISSOLO, Antoine/0000-0003-0465-5648; YELNIK, Jerome/0000-0003-4814-708X; /0000-0002-7092-7747; Krack, Paul/0000-0002-3508-7295; Worbe, Yulia/0000-0001-5903-9370; Fontaine, Denys/0000-0001-5012-6769	Programme Hospitalier de la Recherche Clinique Assistance Publique-Hopitaux de Paris [AOM 03141]; Agence Nationale de la Recherche Program for Young Researchers [R05121DS]; Medtronic	Programme Hospitalier de la Recherche Clinique Assistance Publique-Hopitaux de Paris; Agence Nationale de la Recherche Program for Young Researchers(French National Research Agency (ANR)); Medtronic(Medtronic)	Supported by grants from the Programme Hospitalier de la Recherche Clinique Assistance Publique-Hopitaux de Paris (AOM 03141) and the Agence Nationale de la Recherche Program for Young Researchers (R05121DS). The stimulators were purchased from Medtronic, which had no role in the study. Medtronic provided funds for the meetings of the investigators of the study. Dr. Cornu reports receiving consulting fees from Medtronic; Dr. Houeto, lecture fees from Medtronic; Dr. Benadid, lecture fees and grant support from Medtronic; Dr. Agid, consulting fees from Medtronic; Dr. Krack, consulting and lecture fees from Medtronic; and Dr. Millet, grant support from Medtronic. No other potential conflict of interest relevant to this article was reported.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Alegret M, 2001, ARCH NEUROL-CHICAGO, V58, P1223, DOI 10.1001/archneur.58.8.1223; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson D, 2003, J NEUROSURG, V98, P1104, DOI 10.3171/jns.2003.98.5.1104; Aouizerate B, 2004, J NEUROSURG, V101, P682, DOI 10.3171/jns.2004.101.4.0682; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Ardouin C, 2006, MOVEMENT DISORD, V21, P1941, DOI 10.1002/mds.21098; Bejjani BP, 2000, J NEUROSURG, V92, P615, DOI 10.3171/jns.2000.92.4.0615; Benabid AL, 2005, CR BIOL, V328, P177, DOI 10.1016/j.crvi.2004.10.011; Benabid AL, 2002, MOVEMENT DISORD, V17, pS123, DOI 10.1002/mds.10153; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; Fontaine D, 2004, J NEUROSURG, V100, P1084, DOI 10.3171/jns.2004.100.6.1084; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2394, DOI 10.1038/sj.npp.1301201; Guy W., 1976, ECDEU ASSESSMENT MAN, P218; Houeto JL, 2006, ARCH NEUROL-CHICAGO, V63, P1090, DOI 10.1001/archneur.63.8.1090; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Jones B., 1989, DESIGN ANAL CROSS OV, P16; Karachi C, 2005, MOVEMENT DISORD, V20, P172, DOI 10.1002/mds.20302; Karachi C, 2002, J COMP NEUROL, V450, P122, DOI 10.1002/cne.10312; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lipsman N, 2007, NEUROSURGERY, V61, P1, DOI 10.1227/01.neu.0000279719.75403.f7; Maffei C, 1997, J PERS DISORD, V11, P279, DOI 10.1521/pedi.1997.11.3.279; Mallet L, 2002, LANCET, V360, P1302, DOI 10.1016/S0140-6736(02)11339-0; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; Mattis S, 1988, DEMENTIA RATING SCAL; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Nuttin BJ, 2003, NEUROSURGERY, V52, P1263, DOI 10.1227/01.NEU.0000064565.49299.9A; Pallanti S, 2006, PROG NEURO-PSYCHOPH, V30, P400, DOI 10.1016/j.pnpbp.2005.11.028; PILLON B, 2001, HDB NEUROPSYCHOLOGY, V6, P311; Pollak P, 2002, MOVEMENT DISORD, V17, pS155, DOI 10.1002/mds.10158; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Rezai AR, 2006, MOVEMENT DISORD, V21, pS197, DOI 10.1002/mds.20956; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Stein DJ, 2002, LANCET, V360, P397, DOI 10.1016/S0140-6736(02)09620-4; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturm V, 2003, J CHEM NEUROANAT, V26, P293, DOI 10.1016/j.jchemneu.2003.09.003; TYRER P, 1984, J NEUROL NEUROSUR PS, V47, P970, DOI 10.1136/jnnp.47.9.970; WESCHLER D, 1997, WECHSLER MEMORY SCAL; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026	48	580	587	0	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2121	2134		10.1056/NEJMoa0708514	http://dx.doi.org/10.1056/NEJMoa0708514			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005196				2022-12-28	WOS:000260823900010
J	Levens, ED; DeCherney, AH				Levens, Eric D.; DeCherney, Alan H.			Human Oocyte Research The Ethics of Donation and Donor Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IVF		[Levens, Eric D.; DeCherney, Alan H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Levens, ED (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bldg 10,CRC,Room E1-3140,10 Ctr Dr, Bethesda, MD 20892 USA.	levense@mail.nih.gov	DeCherney, Alan H/AAS-2944-2020		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		*AM SOC REPR MED P, 2006, FERTIL STERIL, V86, pS38; Blyth E, 2002, HUM REPROD, V17, P3254, DOI 10.1093/humrep/17.12.3254; BROOM H, 1875, W BLACKSTONE COLLECT; Byrd Louise M, 2002, Hum Fertil (Camb), V5, P175, DOI 10.1080/1464727022000199082; Covington SN, 2007, FERTIL STERIL, V87, P1001, DOI 10.1016/j.fertnstert.2006.12.037; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Holder AR, 2008, J ADOLESCENT HEALTH, V42, P1, DOI 10.1016/j.jadohealth.2007.10.014; Institute of Medicine, 2007, ASS MED RISKS HUM OO; Magnus D, 2005, SCIENCE, V308, P1747, DOI 10.1126/science.1114454; Moreno JD, 2005, NAT BIOTECHNOL, V23, P793, DOI 10.1038/nbt0705-793; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; Roberts C, 2008, SOC SCI MED, V66, P159, DOI 10.1016/j.socscimed.2007.08.011; Robertson JA, 2006, FERTIL STERIL, V86, P1573, DOI 10.1016/j.fertnstert.2006.08.084	15	10	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2174	2176		10.1001/jama.2008.601	http://dx.doi.org/10.1001/jama.2008.601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001629				2022-12-28	WOS:000260793800028
J	Ogawa, H; Nakayama, M; Morimoto, T; Uemura, S; Kanauchi, M; Doi, N; Jinnouchi, H; Sugiyama, S; Saito, Y				Ogawa, Hisao; Nakayama, Masafumi; Morimoto, Takeshi; Uemura, Shiro; Kanauchi, Masao; Doi, Naofumi; Jinnouchi, Hideaki; Sugiyama, Seigo; Saito, Yoshihiko		Japanese Primary Prevention Athero	Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR EVENTS; RISK PROFILE; DISEASE; GLUCOSE; METAANALYSIS; GUIDELINES; STROKE	Context Previous trials have investigated the effects of low- dose aspirin on primary prevention of cardiovascular events, but not in patients with type 2 diabetes. Objective To examine the efficacy of low- dose aspirin for the primary prevention of atherosclerotic events in patients with type 2 diabetes. Design, Setting, and Participants Multicenter, prospective, randomized, open-label, blinded, end- point trial conducted from December 2002 through April 2008 at 163 institutions throughout Japan, which enrolled 2539 patients with type 2 diabetes without a history of atherosclerotic disease and had a median follow- up of 4.37 years. Interventions Patients were assigned to the low- dose aspirin group ( 81 or 100 mg per day) or the nonaspirin group. Main Outcome Measures Primary end points were atherosclerotic events, including fatal or nonfatal ischemic heart disease, fatal or nonfatal stroke, and peripheral arterial disease. Secondary end points included each primary end point and combinations of primary end points as well as death from any cause. Results A total of 154 atherosclerotic events occurred: 68 in the aspirin group ( 13.6 per 1000 person- years) and 86 in the nonaspirin group ( 17.0 per 1000 person- years) ( hazard ratio [ HR], 0.80; 95% confidence interval [ CI], 0.58- 1.10; log- rank test, P=. 16). The combined end point of fatal coronary events and fatal cerebrovascular events occurred in 1 patient ( stroke) in the aspirin group and 10 patients ( 5 fatal myocardial infarctions and 5 fatal strokes) in the nonaspirin group ( HR, 0.10; 95% CI, 0.01- 0.79; P=. 0037). A total of 34 patients in the aspirin group and 38 patients in the nonaspirin group died from any cause ( HR, 0.90; 95% CI, 0.57- 1.14; log- rank test, P=. 67). The composite of hemorrhagic stroke and significant gastrointestinal bleeding was not significantly different between the aspirin and nonaspirin groups. Conclusion In this study of patients with type 2 diabetes, low- dose aspirin as primary prevention did not reduce the risk of cardiovascular events. Trial Registration clinicaltrials. gov Identifier: NCT00110448.	[Ogawa, Hisao; Nakayama, Masafumi; Sugiyama, Seigo] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Morimoto, Takeshi] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto, Japan; [Uemura, Shiro; Kanauchi, Masao; Doi, Naofumi; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Nara, Japan; [Jinnouchi, Hideaki] Jinnouchi Hosp, Kumamoto, Japan	Kumamoto University; Kyoto University; Nara Medical University	Ogawa, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ogawah@kumamoto-u.ac.jp		Shimabukuro, Michio/0000-0001-7835-7665	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Ministry of Health, Labour and Welfare of Japan.	[Anonymous], 1988, J AM COLL CARDIOL, V12, pA3; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bartolucci AA, 2006, AM J CARDIOL, V98, P746, DOI 10.1016/j.amjcard.2006.04.012; *CAN DIAB ASS CLIN, CAN DIAB ASS 2003 CL; Colwell John A, 2003, Diabetes Care, V26 Suppl 1, pS87; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Fujishima M, 1996, DIABETES, V45, pS14, DOI 10.2337/diab.45.3.S14; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HUTCHISON A, 2002, CLIN GUIDELINES EVID; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Morimoto T, 2004, AM J MED, V117, P459, DOI 10.1016/j.amjmed.2004.04.017; Morimoto T, 2007, J ATHEROSCLER THROMB, V14, P159, DOI 10.5551/jat.E482; Murabito JM, 1997, CIRCULATION, V96, P44; *NAT MED RES COUNC, 2004, NAT EV BAS GUID MAN; New Zealand Guidelines Group, 2003, EV BAS BEST PRACT GU; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Sirois C, 2008, INT J CARDIOL, V129, P172, DOI 10.1016/j.ijcard.2008.01.030; Sone H, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12151-4; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Tsalikian E, 2004, DIABETES CARE, V27, P722; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WALLENTIN L, 1990, LANCET, V336, P827; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamada Y, 2008, STROKE, V39, P2211, DOI 10.1161/STROKEAHA.107.507459; Yasue H, 1999, AM J CARDIOL, V83, P1308, DOI 10.1016/S0002-9149(99)00091-0	37	596	632	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2134	2141		10.1001/jama.2008.623	http://dx.doi.org/10.1001/jama.2008.623			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	18997198	Bronze			2022-12-28	WOS:000260793800023
J	Zuckerman, B; Sandel, M; Lawton, E				Zuckerman, Barry; Sandel, Megan; Lawton, Ellen			Medical-legal partnerships: transforming health care	LANCET			English	Editorial Material							CHILD HEALTH		[Zuckerman, Barry; Sandel, Megan; Lawton, Ellen] Boston Univ, Sch Med, Dept Pediat, Boston Med Ctr, Boston, MA 02118 USA	Boston Medical Center; Boston University	Zuckerman, B (corresponding author), Boston Univ, Sch Med, Dept Pediat, Boston Med Ctr, Boston, MA 02118 USA.	Barry.Zuckerman@bmc.org		Sandel, Megan/0000-0001-7324-6325; Zuckerman, Barry/0000-0002-0044-2592				Carey C., 2008, TIPPING BALANCE WHY; Cherayil M, 2005, CLEARINGHOUSE REV, V39, P65; HOUSEMAN AW, 2005, FUTURE CIVIL LEGAL A; Kenyon C, 2007, PEDIATRICS, V120, pE734, DOI 10.1542/peds.2006-2495; Lawton E, 2008, PUBLIC ADM PUBLIC PO, V140, P419; SHULMAN D, 2008, PUBLIC HLTH LEGAL SE; Zuckerman B, 2004, PEDIATRICS, V114, P224, DOI 10.1542/peds.114.1.224; Zuckerman B, 2007, ARCH DIS CHILD, V92, P100, DOI 10.1136/adc.2006.110361	8	49	49	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1615	1617		10.1016/S0140-6736(08)61670-0	http://dx.doi.org/10.1016/S0140-6736(08)61670-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994651				2022-12-28	WOS:000260899900008
J	Dickson, BJ				Dickson, Barry J.			Wired for Sex: The Neurobiology of Drosophila Mating Decisions	SCIENCE			English	Review							DETERMINATION GENE FRUITLESS; PHEROMONE-SENSITIVE NEURONS; MALE COURTSHIP BEHAVIOR; CENTRAL-NERVOUS-SYSTEM; REPRODUCTIVE-BEHAVIOR; FEMALE DROSOPHILA; NEURAL CIRCUITRY; CUTICULAR HYDROCARBONS; EXPRESSION PATTERNS; ODORANT RECEPTORS	Decisions about whom to mate with can sometimes be difficult, but making the right choice is critical for an animal's reproductive success. The ubiquitous fruit fly, Drosophila, is clearly very good at making these decisions. Upon encountering another fly, a male may or may not choose to court. He estimates his chances of success primarily on the basis of pheromone signals and previous courtship experience. The female decides whether to accept or reject the male, depending on her perception of his pheromone and acoustic signals, as well as her own readiness to mate. This simple and genetically tractable system provides an excellent model to explore the neurobiology of decision making.	[Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; Anand A, 2001, GENETICS, V158, P1569; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dukas R, 2005, BEHAV ECOL, V16, P800, DOI 10.1093/beheco/ari057; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, GENETICA, V97, P73, DOI 10.1007/BF00132583; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GEWECKE M, 1970, Z VERGL PHYSIOL, V67, P325, DOI 10.1007/BF00340955; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goodwin SF, 2000, GENETICS, V154, P725; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; HALL JC, 1977, BEHAV GENET, V7, P291, DOI 10.1007/BF01066800; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kvitsiani D, 2006, CURR BIOL, V16, pR355, DOI 10.1016/j.cub.2006.04.025; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; MANNING A, 1967, ANIM BEHAV, V15, P239, DOI 10.1016/0003-3472(67)90006-1; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; PAILLETTE M, 1991, Bioacoustics, V3, P247; Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Reif M, 2002, ANIM BEHAV, V63, P143, DOI 10.1006/anbe.2001.1876; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Rybak F, 2002, P ROY SOC B-BIOL SCI, V269, P695, DOI 10.1098/rspb.2001.1919; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stoop R, 2008, CHAOS, V18, DOI 10.1063/1.2918912; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; TAYLOR BJ, 1992, DEVELOPMENT, V114, P625; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; TOMPKINS L, 1983, GENETICS, V103, P179; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Villella A, 1997, GENETICS, V147, P1107; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; VONSCHILCHER F, 1976, BEHAV BIOL, V17, P187, DOI 10.1016/S0091-6773(76)90444-2; VONSCHILCHER F, 1979, J COMP PHYSIOL, V129, P85, DOI 10.1007/BF00679915; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Weiner J., 1999, TIME LOVE MEMORY GRE; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	92	209	211	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					904	909		10.1126/science.1159276	http://dx.doi.org/10.1126/science.1159276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988843				2022-12-28	WOS:000260674100036
J	Coulehan, J				Coulehan, Jack			Worms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jcoulehan@notes.cc.sunysb.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					1976	1977		10.1001/jama.2008.593	http://dx.doi.org/10.1001/jama.2008.593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984878				2022-12-28	WOS:000260605400001
J	de Waal, A				de Waal, Alex			The art of medicine On famine crimes and tragedies	LANCET			English	Editorial Material									[de Waal, Alex] Social Sci Res Council, New York, NY 10019 USA; [de Waal, Alex] Harvard Humanitarian Initiat, Cambridge, MA 02138 USA	Harvard University	de Waal, A (corresponding author), Social Sci Res Council, New York, NY 10019 USA.	dewaal@ssrc.org							0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1538	1539		10.1016/S0140-6736(08)61641-4	http://dx.doi.org/10.1016/S0140-6736(08)61641-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18988330	Bronze			2022-12-28	WOS:000260590500013
J	Shah, IM; Laaberki, MH; Popham, DL; Dworkin, J				Shah, Ishita M.; Laaberki, Maria-Halima; Popham, David L.; Dworkin, Jonathan			A Eukaryotic-like Ser/Thr Kinase Signals Bacteria to Exit Dormancy in Response to Peptidoglycan Fragments	CELL			English	Article							BACILLUS-SUBTILIS SPORE; MYCOBACTERIUM-TUBERCULOSIS; CELL-WALL; PROTEIN-KINASES; CLOSTRIDIUM-DIFFICILE; RECOGNITION PROTEINS; VEGETATIVE CELLS; BINDING DOMAIN; BETA-LACTAM; GERMINATION	Bacteria can respond to adverse environmental conditions by drastically reducing or even ceasing metabolic activity. They must then determine that conditions have improved before exiting dormancy, and one indication of such a change is the growth of other bacteria in the local environment. Growing bacteria release muropeptide fragments of the cell wall into the extracellular milieu, and we report here that these muropeptides are potent germinants of dormant Bacillus subtilis spores. The ability of a muropeptide to act as a germinant is determined by the identity of a single amino acid. A well-conserved, eukaryotic-like Ser/Thr membrane kinase containing an extracellular domain capable of binding peptidoglycan is necessary for this response, and a small molecule that stimulates related eukaryotic kinases is sufficient to induce germination. Another small molecule, staurosporine, that inhibits related eukaryotic kinases blocks muropeptide-dependent germination. Thus, in contrast to traditional antimicrobials that inhibit metabolically active cells, staurosporine acts by blocking germination of dormant spores.	[Shah, Ishita M.; Laaberki, Maria-Halima; Dworkin, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; [Popham, David L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Columbia University; Virginia Polytechnic Institute & State University	Dworkin, J (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA.	jonathan.dworkin@columbia.edu	Popham, David L/F-8066-2015; Laaberki, Maria-Halima/M-6369-2014	Popham, David L/0000-0002-2614-143X; Laaberki, Maria-Halima/0000-0001-5796-5995	Department of Microbiology, Columbia University; NIH [GM56695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056695, R01GM081368] Funding Source: NIH RePORTER	Department of Microbiology, Columbia University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Aaron Mitchell and Howard Shuman for helpful discussions and Adriano Henriques, Marjorie Russel, Howard Shuman, and Leslie Vosshall for critically reading the manuscript. We thank C. Price and P. Setlow for B. subtilis strains and D. Garsin, F. Lowy, D. Portnoy, and A. Ratner for additional bacterial strains. This work was supported by startup funds from the Department of Microbiology, Columbia University to J.D. and by NIH grant GM56695 to D. L. P. J.D. is an Irma T. Hirschl Trust Scholar.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hecht DW, 2007, ANTIMICROB AGENTS CH, V51, P2716, DOI 10.1128/AAC.01623-06; Hudson KD, 2001, J BACTERIOL, V183, P4317, DOI 10.1128/JB.183.14.4317-4322.2001; HUNGERER KD, 1969, BIOCHEMISTRY-US, V8, P3577, DOI 10.1021/bi00837a013; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Keep NH, 2006, TRENDS MICROBIOL, V14, P271, DOI 10.1016/j.tim.2006.04.003; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MAUCK J, 1971, J BIOL CHEM, V246, P1820; McPherson DC, 2003, J BACTERIOL, V185, P1423, DOI 10.1128/JB.185.4.1423-1431.2003; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1970, J BIOL CHEM, V245, P3645; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	49	358	381	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					486	496		10.1016/j.cell.2008.08.039	http://dx.doi.org/10.1016/j.cell.2008.08.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984160	Bronze, Green Accepted			2022-12-28	WOS:000260536300019
J	Vezys, V; Yates, A; Casey, KA; Lanier, G; Ahmed, R; Antia, R; Masopust, D				Vezys, Vaiva; Yates, Andrew; Casey, Kerry A.; Lanier, Gibson; Ahmed, Rafi; Antia, Rustom; Masopust, David			Memory CD8 T-cell compartment grows in size with immunological experience	NATURE			English	Article							VIRAL-INFECTIONS; IMMUNITY; HOMEOSTASIS; VACCINATION; POPULATION; PROTECTION; PHENOTYPE; ATTRITION; SURVIVAL; SUBSETS	Memory CD8 T cells, generated by natural pathogen exposure or intentional vaccination, protect the host against specific viral infections(1). It has long been proposed that the number of memory CD8 T cells in the host is inflexible, and that individual cells are constantly competing for limited space(2,3). Consequently, vaccines that introduce over- abundant quantities of memory CD8 T cells specific for an agent of interest could have catastrophic consequences for the host by displacing memory CD8 T cells specific for all previous infections(4-6). To test this paradigm, we developed a vaccination regimen in mice that introduced as many new long- lived memory CD8 T cells specific for a single vaccine antigen as there were memory CD8 T cells in the host before vaccination. Here we show that, in contrast to expectations, the size of the memory CD8 T- cell compartment doubled to accommodate these new cells, a change due solely to the addition of effector memory CD8 T cells. This increase did not affect the number of CD4 T cells, B cells or naive CD8 T cells, and pre- existing memory CD8 T cells specific for a previously encountered infection were largely preserved. Thus, the number of effector memory CD8 T cells in the mammalian host adapts according to immunological experience. Developing vaccines that abundantly introduce new memory CD8 T cells should not necessarily ablate pre- existing immunity to other infections.	[Vezys, Vaiva; Casey, Kerry A.; Masopust, David] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Vezys, Vaiva; Casey, Kerry A.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Vezys, Vaiva; Lanier, Gibson; Ahmed, Rafi; Masopust, David] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Yates, Andrew; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; Emory University	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	Vezys, Vaiva/N-3144-2013; masopust, david/B-5027-2008; Casey, Kerry A/B-5274-2011; Casey, Kerry A/N-1456-2019	Casey, Kerry A/0000-0001-7194-8585; Vezys, Vaiva/0000-0002-2520-809X	University of Minnesota Medical School; NIH [AI30048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER	University of Minnesota Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Jameson, E.J. Wherry and A. Haase for critical discussions and reading of the manuscript, and J. W. Yewdell for recombinant vaccinia virus. This research was supported by start-up funds from the University of Minnesota Medical School (V.V. and D.M.) and NIH grant AI30048 (R. Ahmed).	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 2002, MICROBES INFECT, V4, P539, DOI 10.1016/S1286-4579(02)01570-8; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; HUNTER RL, 1995, J IMMUNOL, V154, P1762; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jackola DR, 1998, MECH AGEING DEV, V105, P241, DOI 10.1016/S0047-6374(98)00089-X; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Lefrancois L, 1999, J EXP MED, V190, P1275, DOI 10.1084/jem.190.9.1275; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Sad S, 2003, CRIT REV IMMUNOL, V23, P129, DOI 10.1615/CritRevImmunol.v23.i12.70; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009	26	174	176	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					196	U90		10.1038/nature07486	http://dx.doi.org/10.1038/nature07486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19005468				2022-12-28	WOS:000262360200033
J	Garnett, GP; Baggaley, RF				Garnett, Geoffrey P.; Baggaley, Rebecca F.			Treating our way out of the HIV pandemic: could we, would we, should we?	LANCET			English	Editorial Material									[Garnett, Geoffrey P.; Baggaley, Rebecca F.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Garnett, GP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	g.garnett@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008	Baggaley, Rebecca/0000-0002-4688-3924				ANDERSON R M, 1991; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Granich R.M., 2008, LANCET          1126, DOI [10.1016/S0140-6736(08)61697-9, DOI 10.1016/S0140-6736(08)61697-9]; Looker KJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-14; Molyneux DH, 2004, TRENDS PARASITOL, V20, P347, DOI 10.1016/j.pt.2004.06.004; Porter D., 1988, AIDS BURDENS HIST, P97; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Wilkin TJ, 2008, CLIN INFECT DIS, V47, P1580, DOI 10.1086/593311	8	68	69	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					9	11		10.1016/S0140-6736(08)61698-0	http://dx.doi.org/10.1016/S0140-6736(08)61698-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19038439	Green Accepted			2022-12-28	WOS:000262183800008
J	Lu, JH; Marnell, LL; Marjon, KD; Mold, C; Du Clos, TW; Sun, PD				Lu, Jinghua; Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.; Sun, Peter D.			Structural recognition and functional activation of Fc gamma R by innate pentraxins	NATURE			English	Article							C-REACTIVE PROTEIN; AMYLOID-P-COMPONENT; HUMAN MONOCYTES; CRYSTAL-STRUCTURE; RECEPTOR-II; SERUM; CELLS; RIIA; PHAGOCYTOSIS; EXPRESSION	Pentraxins are a family of ancient innate immune mediators conserved throughout evolution. The classical pentraxins include serum amyloid P component ( SAP) and C- reactive protein, which are two of the acute- phase proteins synthesized in response to infection(1,2). Both recognize microbial pathogens and activate the classical complement pathway through C1q ( refs 3 and 4). More recently, members of the pentraxin family were found to interact with cell- surface Fc gamma receptors (Fc gamma R) and activate leukocyte-mediated phagocytosis(5-8). Here we describe the structural mechanism for pentraxin's binding to Fc gamma R and its functional activation of Fc gamma R- mediated phagocytosis and cytokine secretion. The complex structure between human SAP and Fc gamma RIIa reveals a diagonally bound receptor on each SAP pentamer with both D1 and D2 domains of the receptor contacting the ridge helices from two SAP subunits. The 1: 1 stoichiometry between SAP and Fc gamma RIIa infers the requirement for multivalent pathogen binding for receptor aggregation. Mutational and binding studies show that pentraxins are diverse in their binding specificity for Fc gamma R isoforms but conserved in their recognition structure. The shared binding site for SAP and IgG results in competition for Fc gamma R binding and the inhibition of immune- complex- mediated phagocytosis by soluble pentraxins. These results establish antibody- like functions for pentraxins in the Fc gamma R pathway, suggest an evolutionary overlap between the innate and adaptive immune systems, and have new therapeutic implications for autoimmune diseases.	[Lu, Jinghua; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Marnell, Lorraine L.; Marjon, Kristopher D.; Mold, Carolyn; Du Clos, Terry W.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Du Clos, Terry W.] Vet Adm Med Ctr, Albuquerque, NM 87108 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of New Mexico; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sun, PD (corresponding author), NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	psun@nih.gov	lu, jinghua/G-5872-2012		US Department of Energy; Basic Energy Sciences; Office of Science [W-31-109-Eng-83]; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Veterans Affairs;  [RO1 AI28358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853, T32AI007538, R01AI028358] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Klinman, G. Cheng, P. W. Dempsey and S. Bolland for providing the bone marrow from the Myd88 2/2, RIP2 2/2 and wild- type C57BL/6 mice, respectively; M. Pancera and B. Dey for technical support in the isothermal titration calorimetry experiments; V. Deretic and S. Master for assistance with confocal microscopy; and B. Bottazzi for providing PTX-3. The X-ray SER-CAT beamlines (www.ser-cat.org/members.html) at the Advanced Photon Source is supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-83. This work was supported by intramural research funding from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and by RO1 AI28358 and by the Department of Veterans Affairs.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLES VV, 1994, BLOOD, V84, P3483; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bodman-Smith KB, 2002, IMMUNOLOGY, V107, P252, DOI 10.1046/j.1365-2567.2002.01481.x; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARK MR, 1991, EUR J IMMUNOL, V21, P1911, DOI 10.1002/eji.1830210820; DeLano W.L, PYMOL MOL GRAPHICS S; DUCLOS TW, 1989, J IMMUNOL, V143, P2553; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; MARNELL LL, 1995, J IMMUNOL, V155, P2185; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Mold C, 2002, J AUTOIMMUN, V19, P147, DOI 10.1006/jaut.2002.0615; Mold C, 2006, J IMMUNOL, V176, P7598, DOI 10.4049/jimmunol.176.12.7598; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Sondermann P, 1999, BIOL CHEM, V380, P717, DOI 10.1515/BC.1999.090; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Stein MP, 2000, J CLIN INVEST, V105, P369, DOI 10.1172/JCI7817; TAX WJM, 1983, NATURE, V304, P445, DOI 10.1038/304445a0; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Xia DY, 1997, P NATL ACAD SCI USA, V94, P2575, DOI 10.1073/pnas.94.6.2575; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412	41	221	231	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					989	U86		10.1038/nature07468	http://dx.doi.org/10.1038/nature07468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011614	Green Accepted			2022-12-28	WOS:000261768300054
J	Pomerantz, RT; O'Donnell, M				Pomerantz, Richard T.; O'Donnell, Mike			The replisome uses mRNA as a primer after colliding with RNA polymerase	NATURE			English	Article							STALLED REPLICATION FORKS; DISCONTINUOUS DNA-REPLICATION; ESCHERICHIA-COLI; LAGGING-STRAND; LEADING-STRAND; CHAIN GROWTH; TRANSCRIPTION; REPAIR; ORGANIZATION; ELONGATION	Replication forks are impeded by DNA damage and protein - nucleic acid complexes such as transcribing RNA polymerase. For example, head- on collision of the replisome with RNA polymerase results in replication fork arrest. However, co- directional collision of the replisome with RNA polymerase has little or no effect on fork progression. Here we examine co- directional collisions between a replisome and RNA polymerase in vitro. We show that the Escherichia coli replisome uses the RNAtranscript as a primer to continue leading- strand synthesis after the collision with RNA polymerase that is displaced from the DNA. This action results in a discontinuity in the leading strand, yet the replisome remains intact and bound to DNA during the entire process. These findings underscore the notable plasticity by which the replisome operates to circumvent obstacles in its path and may explain why the leading strand is synthesized discontinuously in vivo.	[Pomerantz, Richard T.; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	odonnell@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health; Marie-Josee and Henry Kravis Fellowship at the Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R37GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie-Josee and Henry Kravis Fellowship at the Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to W. T. McAllister and R. Castagna for providing T7 RNAP, and to S. Darst and L. Westblade for providing E. coli RNAP proteins and plasmids. This work was supported by a grant from the National Institutes of Health (M.O.D.) and by a Marie-Josee and Henry Kravis Fellowship at the Rockefeller University (R.T.P.).	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOTTESMAN MM, 1973, J MOL BIOL, V77, P531, DOI 10.1016/0022-2836(73)90221-0; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2003; KONRAD EB, 1973, J MOL BIOL, V77, P519, DOI 10.1016/0022-2836(73)90220-9; KORNBERG A, 1992, DNA REPLICATION, P246; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU B, 1994, P NATL ACAD SCI USA, V91, P10660, DOI 10.1073/pnas.91.22.10660; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; OLIVERA BM, 1974, NATURE, V250, P513, DOI 10.1038/250513a0; PAULING C, 1969, P NATL ACAD SCI USA, V64, P1195, DOI 10.1073/pnas.64.4.1195; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; STERNGLANZ R, 1976, BIOCHEMISTRY-US, V15, P1838, DOI 10.1021/bi00654a008; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104; WANG TCV, 1994, BIOCHEM BIOPH RES CO, V198, P844, DOI 10.1006/bbrc.1994.1120; Wang TCV, 2005, BIOESSAYS, V27, P633, DOI 10.1002/bies.20233; WANG TCV, 1989, BIOCHEM BIOPH RES CO, V165, P685, DOI 10.1016/S0006-291X(89)80020-8	50	142	145	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					762	U51		10.1038/nature07527	http://dx.doi.org/10.1038/nature07527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19020502	Green Accepted			2022-12-28	WOS:000261559900042
J	Crook, ED; Hundley, TJ				Crook, Errol D.; Hundley, Terry J.			Is the grass greener? From health statistics to policy decisions	LANCET			English	Editorial Material							DISPARITIES; LIFE; AGE		[Crook, Errol D.; Hundley, Terry J.] Univ S Alabama, Dept Internal Med, Mobile, AL 36617 USA; [Crook, Errol D.; Hundley, Terry J.] Univ S Alabama, Ctr Healthy Communities, Mobile, AL 36617 USA	University of South Alabama; University of South Alabama	Crook, ED (corresponding author), Univ S Alabama, Dept Internal Med, Mobile, AL 36617 USA.	ecrook@usouthal.edu						Bauld L, 2008, INT J HEALTH SERV, V38, P439, DOI 10.2190/HS.38.3.d; Christopher G, 2008, AM J MED SCI, V335, P251, DOI 10.1097/MAJ.0b013e3181690302; Crook ED, 2008, AM J MED SCI, V335, P266, DOI 10.1097/MAJ.0b013e31816902f1; Hacker JS, 2008, NEW ENGL J MED, V359, P1085, DOI 10.1056/NEJMp0805482; Irvine L, 2006, J R SOC PROMO HEALTH, V126, P73, DOI 10.1177/1466424006063182; JAGGER C, 2008, LANCET          1117, DOI DOI 10.1016/S0140-6736(08)61594-9; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Strandberg AY, 2008, ARCH INTERN MED, V168, P1968, DOI 10.1001/archinte.168.18.1968; Williams DR, 2008, J PUBLIC HEALTH MAN, pS8, DOI 10.1097/01.PHH.0000338382.36695.42; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2090	2092		10.1016/S0140-6736(08)61595-0	http://dx.doi.org/10.1016/S0140-6736(08)61595-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19010527				2022-12-28	WOS:000261894000005
J	Redberg, RF; Walsh, J				Redberg, Rita F.; Walsh, Judith			Pay Now, Benefits May Follow - The Case of Cardiac Computed Tomographic Angiography	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Redberg, Rita F.; Walsh, Judith] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Redberg, Rita F.] Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; *COMM FUND COMM HI, 2008, PUBL COMM FUND COMM, V1150; *CTR MED MED SERV, 2008, MED NAT COV DET MAN; *CTR MED MED SERV, 2007, PROP DEC MEM COMP TO	4	86	87	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2309	2311		10.1056/NEJMp0805920	http://dx.doi.org/10.1056/NEJMp0805920			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	19038877				2022-12-28	WOS:000261270300002
J	Shimada, A; Ueguchi-Tanaka, M; Nakatsu, T; Nakajima, M; Naoe, Y; Ohmiya, H; Kato, H; Matsuoka, M				Shimada, Asako; Ueguchi-Tanaka, Miyako; Nakatsu, Toru; Nakajima, Masatoshi; Naoe, Youichi; Ohmiya, Hiroko; Kato, Hiroaki; Matsuoka, Makoto			Structural basis for gibberellin recognition by its receptor GID1	NATURE			English	Article							HORMONE-SENSITIVE LIPASE; PROTEIN; MECHANISM	Gibberellins ( GAs) are phytohormones essential for many developmental processes in plants(1). A nuclear GA receptor, GIBBERELLIN INSENSITIVEDWARF1 ( GID1), has a primary structure similar to that of the hormone- sensitive lipases (HSLs)(2,3). Here we analyse the crystal structure of Oryza sativa GID1 (OsGID1) bound with GA(4) and GA(3) at 1.9 angstrom resolution. The overall structure of both complexes shows an alpha/beta-hydrolase fold similar to that of HSLs except for an amino- terminal lid. The GA- binding pocket corresponds to the substrate- binding site of HSLs. On the basis of the OsGID1 structure, we mutagenized important residues for GA binding and examined their binding activities. Almost all of them showed very little or no activity, confirming that the residues revealed by structural analysis are important for GA binding. The replacement of Ile 133 with Leu or Val - residues corresponding to those of the lycophyte Selaginella moellendorffii GID1s - caused an increase in the binding affinity for GA(34), a 2 beta-hydroxylated GA(4). These observations indicate that GID1 originated from HSL and was further modified to have higher affinity and more strict selectivity for bioactive GAs by adapting the amino acids involved in GA binding in the course of plant evolution.	[Nakatsu, Toru; Naoe, Youichi; Kato, Hiroaki] Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shimada, Asako; Ueguchi-Tanaka, Miyako; Ohmiya, Hiroko; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Nakatsu, Toru; Kato, Hiroaki] RIKEN, Harima Inst SPring 8, Mikazuki, Hyogo 6795148, Japan; [Nakajima, Masatoshi] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Kyoto University; Nagoya University; RIKEN; University of Tokyo	Kato, H (corresponding author), Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	katohiro@pharm.kyoto-u.ac.jp; makoto@nuagr1.agr.nagoya-u.ac.jp		Nakatsu, Toru/0000-0002-9582-4023; Kato, Hiroaki/0000-0002-5993-4532	Target Protein Research Program; Scientific Research; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Target Protein Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Kawamura, M. Hattori, Y. Yamamoto, K. Aya and T. Matsubara for technical assistance; R. L. Ordonio and M. Tanrikulu for editing of this manuscript; and T. Shimizu, RIKEN, and N. Shimizu, JASRI at SPring- 8, for assistance with data collection. This project was funded by the Target Protein Research Program (M.M. and H.K.), Scientific Research ( M.M., and M.U.-T.), and Special Coordination Funds for Promoting Science and Technology (H.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by research fellowships from the Japan Society for the Promotion of Science (A.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Davies P.J., 2004, PLANT HORMONES BIOSY; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; HOLM C, 1994, FEBS LETT, V344, P234, DOI 10.1016/0014-5793(94)00403-X; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Itoh H, 2008, INT REV CEL MOL BIO, V268, P191, DOI 10.1016/S1937-6448(08)00806-X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; ROUSSEL A, 1991, SILICON GRAPHICS GEO, V81, P77; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811	19	232	258	5	78	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					520	U44		10.1038/nature07546	http://dx.doi.org/10.1038/nature07546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037316				2022-12-28	WOS:000261170500042
J	Browne, J				Browne, Janet			Birthdays to remember	NATURE			English	Editorial Material									[Browne, Janet] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Browne, J (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	jbrowne@fas.harvard.edu						MOORE JR, 1982, BIOL J LINN SOC, V17, P97, DOI 10.1111/j.1095-8312.1982.tb02016.x; Richmond ML, 2006, ISIS, V97, P447, DOI 10.1086/508076; SMOCOVITIS VB, 1999, OSIRIS, V14, P1	3	10	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					324	325		10.1038/456324a	http://dx.doi.org/10.1038/456324a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020602	Bronze, Green Submitted			2022-12-28	WOS:000261039600023
J	Kim, M; Cui, ML; Cubas, P; Gillies, A; Lee, K; Chapman, MA; Abbott, RJ; Coen, E				Kim, Minsung; Cui, Min-Long; Cubas, Pilar; Gillies, Amanda; Lee, Karen; Chapman, Mark A.; Abbott, Richard J.; Coen, Enrico			Regulatory Genes Control a Key Morphological and Ecological Trait Transferred Between Species	SCIENCE			English	Article							SENECIO-VULGARIS; RADIATE GROUNDSEL; MATING SYSTEMS; CYCLOIDEA GENE; TCP DOMAIN; MADS-BOX; ORIGIN; HIBERNICUS; EVOLUTION	Hybridization between species can lead to introgression of genes from one species to another, providing a potential mechanism for preserving and recombining key traits during evolution. To determine the molecular basis of such transfers, we analyzed a natural polymorphism for flowerhead development in Senecio. We show that the polymorphism arose by introgression of a cluster of regulatory genes, the RAY locus, from the diploid species S. squalidus into the tetraploid S. vulgaris. The RAY genes are expressed in the peripheral regions of the inflorescence meristem, where they promote flower asymmetry and lead to an increase in the rate of outcrossing. Our results highlight how key morphological and ecological traits controlled by regulatory genes may be gained, lost, and regained during evolution.	[Kim, Minsung; Cui, Min-Long; Cubas, Pilar; Lee, Karen; Coen, Enrico] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Gillies, Amanda; Chapman, Mark A.; Abbott, Richard J.] Univ St Andrews, Sch Biol, St Andrews KY16 9TH, Fife, Scotland; [Kim, Minsung] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Cubas, Pilar] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Chapman, Mark A.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of St Andrews; University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University System of Georgia; University of Georgia	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk	Lee, Karen/GVT-9602-2022; Cubas, Pilar/M-2268-2015; Chapman, Mark/E-5260-2011; cui, min/HGD-8340-2022; Cubas, Pilar/ABE-8670-2020	Cubas, Pilar/0000-0003-4679-2173; Chapman, Mark/0000-0002-7151-723X; Cubas, Pilar/0000-0003-4679-2173; Lee, Karen/0000-0003-4544-5217	EMBO; HFSP long-term fellowship; BBSRC [BB-D017742, G10929]; NERC/S/A/2000/03636; NERC [NE/D014166/1] Funding Source: UKRI; Natural Environment Research Council [NE/D014166/1] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); HFSP long-term fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC/S/A/2000/03636(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Walton for critical discussion. Supported by EMBO and HFSP long-term fellowship (M.K.), BBSRC grant BB-D017742 (M.C.), BBSRC grant G10929 (R.J.A.) and NERC/S/A/2000/03636 studentship (M.A.C.). GenBank accession numbers for RAY1 and RAY2 are FJ356698 to FJ356704.	ABBOTT RJ, 1992, HEREDITY, V68, P425, DOI 10.1038/hdy.1992.62; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Clark JI, 2002, PLANT J, V30, P639, DOI 10.1046/j.1365-313X.2002.01310.x; COEN ES, 1995, PHILOS T R SOC B, V350, P35, DOI 10.1098/rstb.1995.0134; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Harris S. A., 2002, Watsonia, V24, P31; HOLSINGER KE, 1991, AM NAT, V138, P606, DOI 10.1086/285237; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; INGRAM R, 1980, NEW PHYTOL, V84, P543, DOI 10.1111/j.1469-8137.1980.tb04561.x; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kramer EM, 1999, NATURE, V399, P144, DOI 10.1038/20172; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Lowe AJ, 2000, AM J BOT, V87, P1159, DOI 10.2307/2656652; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; MARSHALL DF, 1980, HEREDITY, V45, P133, DOI 10.1038/hdy.1980.57; STACE CA, 1977, HEREDITY, V39, P383, DOI 10.1038/hdy.1977.80; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; TAJIMA F, 1989, GENETICS, V123, P585; Trow AH, 1912, J GENET, V2, P239, DOI 10.1007/BF02981542	28	194	202	2	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1116	1119		10.1126/science.1164371	http://dx.doi.org/10.1126/science.1164371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008450				2022-12-28	WOS:000260867700042
J	Mott, ML; Erzberger, JP; Coons, MM; Berger, JM				Mott, Melissa L.; Erzberger, Jan P.; Coons, Mary M.; Berger, James M.			Structural Synergy and Molecular Crosstalk between Bacterial Helicase Loaders and Replication Initiators	CELL			English	Article							ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; N-TERMINAL DOMAIN; AAA PLUS ATPASES; ORIGIN RECOGNITION; CRYSTAL-STRUCTURE; ATP-HYDROLYSIS; PROTEIN COMPLEX; POLYMERASE-III; BINDING	The loading of oligomeric helicases onto replication origins marks an essential step in replisome assembly. In cells, dedicated AAA+ ATPases regulate loading, however, the mechanism by which these factors recruit and deposit helicases has remained unclear. To better understand this process, we determined the structure of the ATPase region of the bacterial helicase loader DnaC from Aquifex aeolicus to 2.7 angstrom resolution. The structure shows that DnaC is a close paralog of the bacterial replication initiator, DnaA, and unexpectedly shares an ability to form a helical assembly similar to that of ATP-bound DnaA. Complementation and ssDNA-binding assays validate the importance of homomeric DnaC interactions, while pull-down experiments show that the DnaC and DnaA AAA+ domains interact in a nucleotide-dependent manner. These findings implicate DnaC as a molecular adaptor that uses ATP-activated DnaA as a docking site for regulating the recruitment and correct spatial deposition of the DnaB helicase onto origins.	[Mott, Melissa L.; Coons, Mary M.; Berger, James M.] Univ Calif Berkeley, Quantitat Biosci Inst, Mol & Cell Biol Dept, Berkeley, CA 94720 USA; [Erzberger, Jan P.] ETH, Inst Mol Biol Biophys, CH-8093 Zurich, Switzerland	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich	Berger, JM (corresponding author), Univ Calif Berkeley, Quantitat Biosci Inst, Mol & Cell Biol Dept, 374D Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			NIGMS NIH HHS [R01 GM071747-04, R01 GM071747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN GC, 1991, J BIOL CHEM, V266, P22096; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Biswas SB, 2004, BIOCHEM J, V379, P553, DOI 10.1042/BJ20031255; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Galletto R, 2000, BIOCHEMISTRY-US, V39, P12959, DOI 10.1021/bi0012484; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ioannou C, 2006, NUCLEIC ACIDS RES, V34, P5247, DOI 10.1093/nar/gkl690; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Marszalek J, 1996, J BIOL CHEM, V271, P18535, DOI 10.1074/jbc.271.31.18535; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; SALUJA D, 1995, J BACTERIOL, V177, P1104, DOI 10.1128/jb.177.4.1104-1111.1995; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Shin JH, 2008, J BACTERIOL, V190, P4091, DOI 10.1128/JB.00233-08; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998	64	90	90	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					623	634		10.1016/j.cell.2008.09.058	http://dx.doi.org/10.1016/j.cell.2008.09.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013274	Green Accepted, Bronze			2022-12-28	WOS:000260886900014
J	Smukalla, S; Caldara, M; Pochet, N; Beauvais, A; Guadagnini, S; Yan, C; Vinces, MD; Jansen, A; Prevost, MC; Latge, JP; Fink, GR; Foster, KR; Verstrepen, KJ				Smukalla, Scott; Caldara, Marina; Pochet, Nathalie; Beauvais, Anne; Guadagnini, Stephanie; Yan, Chen; Vinces, Marcelo D.; Jansen, An; Prevost, Marie Christine; Latge, Jean-Paul; Fink, Gerald R.; Foster, Kevin R.; Verstrepen, Kevin J.			FLO1 Is a Variable Green Beard Gene that Drives Biofilm-like Cooperation in Budding Yeast	CELL			English	Article							CANDIDA; EXPRESSION; RESISTANCE; EVOLUTION; GROWTH	The budding yeast, Saccharomyces cerevisiae, has emerged as an archetype of eukaryotic cell biology. Here we show that S. cerevisiae is also a model for the evolution of cooperative behavior by revisiting flocculation, a self-adherence phenotype lacking in most laboratory strains. Expression of the gene FLO1 in the laboratory strain S288C restores flocculation, an altered physiological state, reminiscent of bacterial biofilms. Flocculation protects the FLO1 expressing cells from multiple stresses, including antimicrobials and ethanol. Furthermore, FLO1(+) cells avoid exploitation by nonexpressing flo1 cells by self/non-self recognition: FLO1(+) cells preferentially stick to one another, regardless of genetic relatedness across the rest of the genome. Flocculation, therefore, is driven by one of a few known "green beard genes,'' which direct cooperation toward other carriers of the same gene. Moreover, FLO1 is highly variable among strains both in expression and in sequence, suggesting that flocculation in S. cerevisiae is a dynamic, rapidly evolving social trait.	[Smukalla, Scott; Caldara, Marina; Pochet, Nathalie; Yan, Chen; Vinces, Marcelo D.; Foster, Kevin R.; Verstrepen, Kevin J.] Harvard Univ, FAS Ctr Syst Biol, Northwest Lab, Cambridge, MA 02138 USA; [Pochet, Nathalie] Univ Ghent, Bioinformat & Evolutionary Genom Grp, B-9052 Ghent, Belgium; [Pochet, Nathalie] Univ Ghent, Quantiat Genom Grp, Dept Plant Syst Biol, Flanders Inst Biotechnol VIB, B-9052 Ghent, Belgium; [Pochet, Nathalie] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Beauvais, Anne; Latge, Jean-Paul] Inst Pasteur, Aspergillus Unit, F-75724 Paris, France; [Guadagnini, Stephanie; Prevost, Marie Christine] Inst Pasteur, Elect Microscopy Platform, F-75724 Paris, France; [Jansen, An; Fink, Gerald R.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Jansen, An; Verstrepen, Kevin J.] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Mol & Microbial Syst, B-3001 Heverlee, Belgium; [Verstrepen, Kevin J.] Katholieke Univ Leuven, Lab Syst Biol, Flanders Inst Biotechnol VIB, B-3001 Heverlee, Belgium	Harvard University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Massachusetts Institute of Technology (MIT); Whitehead Institute; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	Verstrepen, KJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Northwest Lab, 52 Oxford St, Cambridge, MA 02138 USA.	kevin.verstrepen@biw.kuleuven.be	Pochet, Nathalie/Q-1322-2017; Verstrepen, Kevin/AAA-4343-2021; Latge, Jean Paul/C-9846-2014; Jansen, An/T-9228-2018; Beauvais, Anne/A-6358-2012	Pochet, Nathalie/0000-0003-1820-5656; Jansen, An/0000-0003-2412-0456; Foster, Kevin/0000-0003-4687-6633; Verstrepen, Kevin/0000-0002-3077-6219; Smukalla, Scott/0000-0002-8260-5606; Yan, Chen/0000-0002-3266-0578	NIGMS NIH HHS [5P50GM068763, R01 GM040266, P50 GM068763-01, GM40266, P50 GM068763, P50 GM068763-06] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, P50GM068763] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Arthington-Skaggs BA, 2002, ANTIMICROB AGENTS CH, V46, P2477, DOI 10.1128/AAC.46.8.2477-2481.2002; Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458; D'Hautcourt O, 1999, J AM SOC BREW CHEM, V57, P123; Dawkins Richard, 1976, SELFISH GENE; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Foster KR, 2001, ANN ZOOL FENN, V38, P229; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; GIMENO CJ, 1993, DIMORPHIC FUNGI BIOL; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Kobayashi O, 1998, J BACTERIOL, V180, P6503, DOI 10.1128/JB.180.24.6503-6510.1998; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; MORTIMER RK, 1986, GENETICS, V113, P35; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Palkova Z, 2004, EMBO REP, V5, P470, DOI 10.1038/sj.embor.7400145; Palkova Z, 2006, FEMS MICROBIOL REV, V30, P806, DOI 10.1111/j.1574-6976.2006.00034.x; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Reynolds TB, 2006, EUKARYOT CELL, V5, P1266, DOI 10.1128/EC.00022-06; SHERMAN F, 1991, METHODS YEAST GENETI; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson DA, 2006, CURR BIOL, V16, P1581, DOI 10.1016/j.cub.2006.06.070; TREJO WH, 1963, J BACTERIOL, V85, P436, DOI 10.1128/JB.85.2.436-439.1963; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	36	304	313	1	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					726	737		10.1016/j.cell.2008.09.037	http://dx.doi.org/10.1016/j.cell.2008.09.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013280	Green Accepted, Bronze			2022-12-28	WOS:000260886900022
J	Bodenheimer, T				Bodenheimer, Thomas			The Future of Primary Care: Transforming Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bodenheimer, Thomas] Univ Calif San Francisco, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							Bodenheimer T., 2007, IMPROVING PRIMARY CA; Bodenheimer T, 2007, ANN FAM MED, V5, P457, DOI 10.1370/afm.731; Bodenheimer T, 2007, JAMA-J AM MED ASSOC, V298, P2048, DOI 10.1001/jama.298.17.2048; Dorr David A, 2006, Dis Manag, V9, P1, DOI 10.1089/dis.2006.9.1; NEUWIRTH EB, 2007, PERMANENTE J, V11, P16	5	71	72	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2086	+		10.1056/NEJMp0805631	http://dx.doi.org/10.1056/NEJMp0805631			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005190				2022-12-28	WOS:000260823900003
J	Spindler, KP; Wright, RW				Spindler, Kurt P.; Wright, Rick W.			Anterior Cruciate Ligament Tear	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MENISCAL LESIONS; TENDON-BONE; INJURIES; RECONSTRUCTION; KNEE; AUTOGRAFTS; ALLOGRAFT; DIAGNOSIS; RISK; EPIDEMIOLOGY		[Spindler, Kurt P.] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Med, Nashville, TN 37232 USA; [Wright, Rick W.] Washington Univ, Sch Med, Dept Orthoped Surg, Barnes Jewish Hosp, St Louis, MO USA	Vanderbilt University; Barnes-Jewish Hospital; Washington University (WUSTL)	Spindler, KP (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Sports Med, 4200 Med Ctr E,South Tower,1215 21st Ave S, Nashville, TN 37232 USA.	kurt.spindler@vanderbilt.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR053684-01-Al]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053684] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by a Kenneth D. Schermerhorn Endowed Chair (to Dr. Spindler) and by a grant (R01-AR053684-01-Al) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Dr. Spindler reports receiving grant support from Smith and Nephew and holding two patents related to biologic replacement for fibrin clots (U.S. patent application numbers 10/378,285 and 11/092,992). No other potential conflict of interest relevant to this article was reported.	Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; ANDERSSON C, 1989, J BONE JOINT SURG AM, V71A, P965, DOI 10.2106/00004623-198971070-00002; Barrett G, 2005, AM J SPORT MED, V33, P1505, DOI 10.1177/0363546504274202; Benjammse A, 2006, J ORTHOP SPORT PHYS, V36, P267, DOI 10.2519/jospt.2006.2011; Beynnon BD, 2005, AM J SPORT MED, V33, P1751, DOI 10.1177/0363546505279922; Beynnon BD, 2005, AM J SPORT MED, V33, P1579, DOI 10.1177/0363546505279913; Biau DJ, 2007, CLIN ORTHOP RELAT R, P180, DOI 10.1097/BLO.0b013e31803dcd6b; Biau DJ, 2006, BRIT MED J, V332, P995, DOI 10.1136/bmj.38784.384109.2F; Bjordal JM, 1997, AM J SPORT MED, V25, P341, DOI 10.1177/036354659702500312; Bowers AL, 2005, CLIN J SPORT MED, V15, P9, DOI 10.1097/00042752-200501000-00003; Chang SKY, 2003, ARTHROSCOPY, V19, P453, DOI 10.1053/jars.2003.50103; Crawford R, 2007, BRIT MED BULL, V84, P5, DOI 10.1093/bmb/ldm022; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; DEHAVEN KE, 1980, AM J SPORT MED, V8, P9, DOI 10.1177/036354658000800102; ENGEBRETSEN L, 1990, AM J SPORT MED, V18, P585, DOI 10.1177/036354659001800605; George MS, 2007, CLIN ORTHOP RELAT R, P158, DOI 10.1097/BLO.0b013e31802eb45f; Gottlob CA, 1999, CLIN ORTHOP RELAT R, P272, DOI 10.1097/00003086-199910000-00034; Harner CD, 1996, CLIN ORTHOP RELAT R, P134; Hewett TE, 2006, AM J SPORT MED, V34, P490, DOI 10.1177/0363546505282619; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2007, AM J SPORT MED, V35, P659, DOI 10.1177/0363546506295699; Hurd WJ, 2008, AM J SPORT MED, V36, P42, DOI 10.1177/0363546507308190; Kaeding C, 2005, ARTHROSCOPY, V21, P147, DOI 10.1016/j.arthro.2004.09.012; Kleipool A E, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P224, DOI 10.1007/s001670050104; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Mountcastle SB, 2007, AM J SPORT MED, V35, P1635, DOI 10.1177/0363546507302917; NOYES FR, 1980, J BONE JOINT SURG AM, V62, P687, DOI 10.2106/00004623-198062050-00001; Peterson RK, 2001, ARTHROSCOPY, V17, P9, DOI 10.1053/jars.2001.19965; Piasecki DP, 2003, AM J SPORT MED, V31, P601, DOI 10.1177/03635465030310042101; Rudolph KS, 1998, J ELECTROMYOGR KINES, V8, P349, DOI 10.1016/S1050-6411(97)00042-4; SADDEMI SR, 1993, ARTHROSCOPY, V9, P519, DOI 10.1016/S0749-8063(05)80398-6; SANDBERG R, 1987, J BONE JOINT SURG AM, V69A, P1120, DOI 10.2106/00004623-198769080-00002; SPEER KP, 1992, AM J SPORT MED, V20, P382, DOI 10.1177/036354659202000403; SPINDLER KP, 1993, AM J SPORT MED, V21, P551, DOI 10.1177/036354659302100412; Spindler KP, 2003, AM J SPORT MED, V31, P929, DOI 10.1177/03635465030310063101; Spindler KR, 2004, AM J SPORT MED, V32, P1986, DOI 10.1177/0363546504271211; VELLET AD, 1991, RADIOLOGY, V178, P271, DOI 10.1148/radiology.178.1.1984319; Victor J, 1997, INT ORTHOP, V21, P93, DOI 10.1007/s002640050127; Wright Rick W, 2008, J Knee Surg, V21, P225; Wright Rick W, 2008, J Knee Surg, V21, P217; Wright RW, 2007, AM J SPORT MED, V35, P1131, DOI 10.1177/0363546507301318	41	289	298	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2135	2142		10.1056/NEJMcp0804745	http://dx.doi.org/10.1056/NEJMcp0804745			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005197	Green Accepted			2022-12-28	WOS:000260823900011
J	Zwarenstein, M; Treweek, S; Gagnier, JJ; Altman, DG; Tunis, S; Haynes, B; Oxman, AD; Moher, D				Zwarenstein, Merrick; Treweek, Shaun; Gagnier, Joel J.; Altman, Douglas G.; Tunis, Sean; Haynes, Brian; Oxman, Andrew D.; Moher, David		CONSORT Grp; Pragmatic Trials Healthcare Practi	Improving the reporting of pragmatic trials: an extension of the CONSORT statement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; UNDERSTANDING-CONTROLLED-TRIALS; PRACTICAL CLINICAL-TRIALS; EVIDENCE-BASED MEDICINE; DECISION-MAKING; INTERVENTION; CARE; EXPLANATION; INFECTIONS; CHILDREN	Background The CONSORT statement is intended to improve reporting of randomised controlled trials and focuses on minimising the risk of bias ( internal validity). The applicability of a trial's results ( generalisability or external validity) is also important, particularly for pragmatic trials. A pragmatic trial ( a term first used in 1967 by Schwartz and Lellouch) can be broadly defined as a randomised controlled trial whose purpose is to inform decisions about practice. This extension of the CONSORT statement is intended to improve the reporting of such trials and focuses on applicability. Methods At two, two- day meetings held in Toronto in 2005 and 2008, we reviewed the CONSORT statement and its extensions, the literature on pragmatic trials and applicability, and our experiences in conducting pragmatic trials. Recommendations We recommend extending eight CONSORT checklist items for reporting of pragmatic trials: the background, participants, interventions, outcomes, sample size, blinding, participant flow, and generalisability of the findings. These extensions are presented, along with illustrative examples of reporting, and an explanation of each extension. Adherence to these reporting criteria will make it easier for decision makers to judge how applicable the results of randomised controlled trials are to their own conditions. Empirical studies are needed to ascertain the usefulness and comprehensiveness of these CONSORT checklist item extensions. In the meantime we recommend that those who support, conduct, and report pragmatic trials should use this extension of the CONSORT statement to facilitate the use of trial results in decisions about health care. Pragmatic trials are designed to inform decisions about practice, but poor reporting can reduce their usefulness. The CONSORT and Practihc groups describe modifications to the CONSORT guidelines to help readers assess the applicability of the results Randomised controlled trials are used to assess the benefits and harms of interventions in health care. If conducted properly, they minimise the risk of bias ( threats to internal validity), particularly selection bias.(1 2) There is, however, considerable evidence that trials are not always well reported, (3 4) and this can be associated with bias, such as selective reporting of outcomes.(5) The usefulness of a trial report also depends on the clarity with which it details the relevance of its interventions, participants, outcomes, and design to the clinical, health service, or policy question it examines. Furthermore, a trial may be valid and useful in the healthcare setting in which it was conducted but have limited applicability (also known as generalisability or external validity) beyond this because of differences between the trial setting and other settings to which its results are to be extrapolated. Schwartz and Lellouch(6) coined the terms " pragmatic" to describe trials designed to help choose between options for care, and " explanatory" to describe trials designed to test causal research hypotheses - for example, that an intervention causes a particular biological change. Table 1+ shows some key differences between explanatory and pragmatic trials. Table 2+ compares a trial that was highly explanatory in attitude(7) with one that was highly pragmatic.(8) There is a continuum rather than a dichotomy between explanatory and pragmatic trials. In fact, Schwartz and Lellouch characterised pragmatism as an attitude to trial design rather than a characteristic of the trial itself. The pragmatic attitude favours design choices that maximise applicability of the trial's results to usual care settings, rely on unarguably important outcomes such as mortality and severe morbidity, and are tested in a wide range of participants.(9) (10) (11) As Schwartz and Lellouch wrote: " Most trials done hitherto have adopted the explanatory approach without question; the pragmatic approach would often have been more justifiable."	[Zwarenstein, Merrick] Sunnybrook Med Ctr, Hlth Serv Sci, Toronto, ON, Canada; [Zwarenstein, Merrick] Univ Toronto, Inst Clin Evaluat Sci, Toronto Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Zwarenstein, Merrick] Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden; [Treweek, Shaun] Univ Dundee, Dundee, Scotland; [Treweek, Shaun; Gagnier, Joel J.; Oxman, Andrew D.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Gagnier, Joel J.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Tunis, Sean] Ctr Med Technol Policy, Baltimore, MD USA; [Tunis, Sean] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Tunis, Sean] Stanford Univ, Sch Med, Ctr Healthcare Policy, Palo Alto, CA 94304 USA; [Haynes, Brian] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Haynes, Brian] McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON, Canada; [Moher, David] Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Karolinska Institutet; University of Dundee; Norwegian Knowledge Centre for Health Services; University of Toronto; University of Oxford; Johns Hopkins University; Stanford University; McMaster University; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Zwarenstein, M (corresponding author), Sunnybrook Med Ctr, Hlth Serv Sci, Toronto, ON, Canada.	merrick.zwarenstein@ices.on.ca	Treweek, Shaun/AAE-8006-2019; Zwarenstein, Merrick F/P-5210-2014; Oxman, Andrew/Y-3004-2019	Treweek, Shaun/0000-0002-7239-7241; Zwarenstein, Merrick F/0000-0003-0162-7027; Oxman, Andrew/0000-0002-5608-5061; Moher, David/0000-0003-2434-4206	European Commission's 5th Framework INCO [ICA4CT-2001-10019]; Canadian Institutes for Health Research [FRN 63095]; UK Medical Research Council; Centre for Health Services Sciences at Sunnybrook Hospital, Toronto, Canada,; Centre for Medical Technology Policy, Balitimore, Maryland, USA; National Institute for Health and Clinical Excellence, UK; University of Ottawa; Cancer Research UK	European Commission's 5th Framework INCO(European Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Health Services Sciences at Sunnybrook Hospital, Toronto, Canada,; Centre for Medical Technology Policy, Balitimore, Maryland, USA; National Institute for Health and Clinical Excellence, UK; University of Ottawa; Cancer Research UK(Cancer Research UK)	The Practihc group was supported by the European Commission's 5th Framework INCO programme, contract ICA4CT-2001-10019. The 2005 Toronto meeting was supported by the Canadian Institutes for Health Research grant number FRN 63095. The 2008 Toronto meeting was supported by the UK Medical Research Council, the Centre for Health Services Sciences at Sunnybrook Hospital, Toronto, Canada, the Centre for Medical Technology Policy, Balitimore, Maryland, USA and the National Institute for Health and Clinical Excellence, UK. DM is supported by a University of Ottawa research chair; much of his contribution to this paper was while he was with the Children's Hospital of Eastern Ontario Research Institute. DA is supported by Cancer Research UK.	ALGRA A, 1999, NED TIJDSCHR GENEES, V6, P514; Altman DG, 1999, BRIT MED J, V318, P1209; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Andersen B, 1971, Nord Med, V86, P1434; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Califf RM, 1997, EUR HEART J, V18, P367; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; CHARLTON BG, 1994, FAM PRACT, V11, P243, DOI 10.1093/fampra/11.3.243; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; *CONSORT GROUP, 2007, CONSORT TRANSL; *CONSORT GROUP, 2007, CONSORT END J; *CONSORT GROUP, CONSORT STAT 2007; Coutinho Evandro da Silva Freire, 2003, Cad. Saúde Pública, V19, P1189, DOI 10.1590/S0102-311X2003000400039; Crotty M, 2005, BMJ-BRIT MED J, V331, P1110, DOI 10.1136/bmj.38638.441933.63; Davidoff F, 2000, ANN INTERN MED, V133, P229, DOI 10.7326/0003-4819-133-3-200008010-00017; Edwards A, 2004, FAM PRACT, V21, P347, DOI 10.1093/fampra/cmh402; Engel CC, 2006, CNS SPECTRUMS, V11, P225, DOI 10.1017/S1092852900014395; Ernst E, 2005, POSTGRAD MED J, V81, P203, DOI 10.1136/pgmj.2004.026807; ESCHWEGE E, 1994, REV MED INTERNE, V15, P357, DOI 10.1016/S0248-8663(05)81445-6; Figueiras A, 2006, JAMA-J AM MED ASSOC, V296, P1086, DOI 10.1001/jama.296.9.1086; FLAMANT R, 1987, B CANCER, V74, P169; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasgow RE, 2005, MED CARE, V43, P551, DOI 10.1097/01.mlr.0000163645.41407.09; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jarman B, 2002, BRIT MED J, V324, P1072, DOI 10.1136/bmj.324.7345.1072; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; LIBERATI A, 1994, STAT MED, V13, P1485, DOI 10.1002/sim.4780131326; Lieberman JA, 2003, SCHIZOPHRENIA BULL, V29, P1; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; MacPherson H, 2004, COMPLEMENT THER MED, V12, P136, DOI 10.1016/j.ctim.2004.07.043; Marson A, 1997, BRIT MED J, V314, P1764, DOI 10.1136/bmj.314.7096.1764a; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Mutrie N, 2007, BMJ-BRIT MED J, V334, P517, DOI 10.1136/bmj.39094.648553.AE; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Resch KL, 1998, FORSCH KOMPLEMENTMED, V5, P136, DOI 10.1159/000057335; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Roland R, 1998, BMJ-BRIT MED J, V317, P1075; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Scheel IB, 2002, SPINE, V27, P2734, DOI 10.1097/00007632-200212010-00014; SCHROTER S, BMJ IN PRESS; Schulz KF, 2007, BRIT MED J, V334, P918, DOI 10.1136/bmj.39199.461644.3A; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; SILVERMAN WA, 1987, AM J PERINAT, V4, P129, DOI 10.1055/s-2007-999754; Skinner GRB, 1997, BRIT MED J, V314, P1764, DOI 10.1136/bmj.314.7096.1764; Steinsbekk A, 2005, COMPLEMENT THER MED, V13, P231, DOI 10.1016/j.ctim.2005.06.007; Tansella M, 2006, PSYCHOL MED, V36, P711, DOI 10.1017/S003329170600715X; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; THORPE KE, J CLIN EPID IN PRESS; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Vallve C, 2003, MED CLIN-BARCELONA, V121, P384, DOI 10.1157/13052554; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Walker JM, 1999, BRIT MED J, V319, P1070, DOI 10.1136/bmj.319.7216.1070; Whittaker K, 2006, J EPIDEMIOL COMMUN H, V60, P858, DOI 10.1136/jech.2005.044214; Williams H, 1999, BRIT MED J, V319, P1070, DOI 10.1136/bmj.319.7216.1070a; Wright NMJ, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-3; Wu JYF, 2006, BMJ-BRIT MED J, V333, P522, DOI 10.1136/bmj.38905.447118.2F; Zarin DA, 2005, SOC PSYCH PSYCH EPID, V40, P27, DOI 10.1007/s00127-005-0838-9	71	1148	1168	3	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2008	337								a2390	10.1136/bmj.a2390	http://dx.doi.org/10.1136/bmj.a2390			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	385AA	19001484	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000261784100012
J	Zeng, LX; Cheng, Y; Dang, SN; Yan, H; Dibley, MJ; Chang, SY; Kong, LZ				Zeng, Lingxia; Cheng, Yue; Dang, Shaonong; Yan, Hong; Dibley, Michael J.; Chang, Suying; Kong, Lingzhi			Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTRAUTERINE GROWTH-RETARDATION; IRON SUPPLEMENTATION; PRETERM BIRTH; FETAL LOSS; CONSEQUENCES; ANEMIA; STATES; NEPAL	Objective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester. Design Cluster randomised double blind controlled trial. Setting Two rural counties in north west China. Participants 5828 pregnant women and 4697 live births. Interventions Villages were randomised for all pregnant women to take either daily folic acid ( control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals. Main outcome measures Birth weight, length, and head circumference measured within 72 hours after delivery. Neonatal survival assessed at the six week follow- up visit. Results Birth weight was 42 g ( 95% confidence interval 7 to 78 g) higher in the multiple micronutrients group compared with the folic acid group. Duration of gestation was 0.23 weeks ( 0.10 to 0.36 weeks) longer in the iron-folic acid group and 0.19 weeks ( 0.06 to 0.32 weeks) longer in the multiple micronutrients group. Iron- folic acid was associated with a significantly reduced risk of early preterm delivery (< 34 weeks) ( relative risk 0.50, 0.27 to 0.94, P= 0.031). There was a significant increase in haemoglobin concentration in both iron- folic acid ( 5.0 g/ l, 2.0 to 8.0 g/ l, P= 0.001) and multiple micronutrients ( 6.9 g/ l, 4.1 to 9.6 g/ l, P< 0.001) groups compared with folic acid alone. In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% ( relative risk 0.46, 0.21 to 0.98). Conclusion In rural populations in China antenatal supplementation with iron- folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid. Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality. Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality. Trial registration ISRCTN08850194.	[Zeng, Lingxia; Cheng, Yue; Dang, Shaonong; Yan, Hong] Xi An Jiao Tong Univ, Coll Med, Dept Publ Hlth, Xian 710061, Peoples R China; [Dibley, Michael J.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Dibley, Michael J.] George Inst Int Hlth, Sydney, NSW 2050, Australia; [Chang, Suying] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Kong, Lingzhi] Minist Hlth, Bur Dis Prevent & Control, Beijing 100044, Peoples R China	Xi'an Jiaotong University; University of Sydney; University of Sydney; Chinese Center for Disease Control & Prevention	Yan, H (corresponding author), Xi An Jiao Tong Univ, Coll Med, Dept Publ Hlth, POB 46, Xian 710061, Peoples R China.	xjtu_yh.paper@yahoo.com.cn	Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169	United Nations Children's Fund [YH101-H12/03]; UNICEF; Centers for Disease Control and Prevention, Atlanta, US; National Natural Science of Foundation of China, Beijing, China [30271131]	United Nations Children's Fund; UNICEF; Centers for Disease Control and Prevention, Atlanta, US(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Natural Science of Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC))	This work was supported by the United Nations Children's Fund (grant No YH101-H12/03) through a cooperative agreement between UNICEF and the Centers for Disease Control and Prevention, Atlanta, US, and the National Natural Science of Foundation of China (grant No 30271131), Beijing, China. Sight and Life and DSM Nutritional Products, China, provided the nutrient supplement, which was manufactured by Beijing Vita Nutritious Products, Beijing, China.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Arifeen SE, 2000, AM J CLIN NUTR, V72, P1010; BARROS FC, 1992, PEDIATRICS, V90, P238; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Cogswell ME, 2003, AM J CLIN NUTR, V78, P773, DOI 10.1093/ajcn/78.4.773; *COMM NUTR STAT PR, 1990, NUTR PREGN 1; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; HALL S, 2005, A0502 SOUTH STAT SCI; HUFFMAN SL, 1998, CASE PROMOTING MULTI; Jamison DT, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P427; Kaestel P, 2005, EUR J CLIN NUTR, V59, P1081, DOI 10.1038/sj.ejcn.1602215; KRAMER M, 2001, LOW BIRTH WEIGHT PER; Ladipo OA, 2000, AM J CLIN NUTR, V72, p280S, DOI 10.1093/ajcn/72.1.280S; LING L, 2002, CHIN J PREV MED, V36, P149; MATA LJ, 1975, AM J DIS CHILD, V129, P561, DOI 10.1001/archpedi.1975.02120420017006; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; Scanlon KS, 2000, OBSTET GYNECOL, V96, P741, DOI 10.1016/S0029-7844(00)00982-0; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Scholl TO, 2000, J NUTR, V130, p443S, DOI 10.1093/jn/130.2.443S; SCHOLL TO, 1994, PEDIATRICS, V94, P243; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; Sharman A, 2000, ANEMIA TESTING POPUL; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; *UNICEF, 1999, UNICEF WHO UNU WORKS; *UNICEF WHO UNFPA, 2006, JOINT REV MAT CHILD; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhou LM, 1998, AM J EPIDEMIOL, V148, P998	33	167	175	4	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2008	337								a2001	10.1136/bmj.a2001	http://dx.doi.org/10.1136/bmj.a2001			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FD	18996930	hybrid, Green Published			2022-12-28	WOS:000261236200002
J	Weiss, BP; Berdahl, JS; Elkins-Tanton, L; Stanley, S; Lima, EA; Carporzen, L				Weiss, Benjamin P.; Berdahl, James S.; Elkins-Tanton, Linda; Stanley, Sabine; Lima, Eduardo A.; Carporzen, Laurent			Magnetism on the Angrite Parent Body and the Early Differentiation of Planetesimals	SCIENCE			English	Article							DOS-REIS; METEORITES; DORBIGNY; FIELDS	Angrites are among the oldest known pristine basaltic meteorites and record the earliest stages of planet formation and differentiation. Our paleomagnetic analysis of three angrites found that they record a past magnetic field of similar to 10 microteslas on the angrite parent body extending from 4564 to at least 4558 million years ago. Because the angrite paleomagnetic record extends beyond the expected lifetime of the early circumstellar disk, these paleofields were probably generated internally on the angrite parent body, possibly by an early dynamo in a rapidly formed metallic core.	[Weiss, Benjamin P.; Berdahl, James S.; Elkins-Tanton, Linda; Lima, Eduardo A.; Carporzen, Laurent] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Stanley, Sabine] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	Massachusetts Institute of Technology (MIT); University of Toronto	Weiss, BP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 54-814,77 Massachusetts Ave, Cambridge, MA 02139 USA.	bpweiss@mit.edu	Elkins-Tanton, Linda/C-5508-2008	Elkins-Tanton, Linda/0000-0003-4008-1098; Lima, Eduardo/0000-0002-5667-0033	NSF Instrumentation and Facilities Program; Division Of Astronomical Sciences [0747154] Funding Source: National Science Foundation	NSF Instrumentation and Facilities Program(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank T. Irving for introducing us to angrites and G. Hup, for providing NWA 2999, NWA 4801, and NWA 4931; E. Jagoutz and La Memoire de la Terre for D'Orbigny; D. Ebel and M. Zucolotto for Angra dos Reis; and the National Institute of Polar Research in Japan for A-881371. L. Bei and C. Ross gave us access to their vibrating sample magnetometer for rock magnetic analyses, N. Chatterjee assisted with electron microscopy, and D. Shim assisted with Raman spectroscopy. We also thank T. Bosak and M. Zuber for advice, M. Varela for information on the handling history of D'Orbigny, and K. Willis for administrative help. This study relied on automated paleomagnetic technology shared by J. Kirschvink. This work was partially supported by the NSF Instrumentation and Facilities Program (to B.P.W.).	Amelin Y, 2008, GEOCHIM COSMOCHIM AC, V72, P221, DOI 10.1016/j.gca.2007.09.034; Balbus SA, 2003, ANNU REV ASTRON ASTR, V41, P555, DOI 10.1146/annurev.astro.41.081401.155207; Busemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5403, DOI 10.1016/j.gca.2006.08.015; COLLINSON DW, 1994, EARTH PLANET SC LETT, V126, P421, DOI 10.1016/0012-821X(94)90122-8; Crawford DA, 1999, INT J IMPACT ENG, V23, P169, DOI 10.1016/S0734-743X(99)00070-6; DERBY OA, 1988, REV OBSERVATORIO, V3, P33; Desch SJ, 2000, ICARUS, V143, P87, DOI 10.1006/icar.1999.6245; Dunlop DJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004572; GARRICKBETHELL I, 2007, LUNAR PLANET SCI C, V38, P2405; Gattacceca J, 2008, PHYS EARTH PLANET IN, V166, P1, DOI 10.1016/j.pepi.2007.09.005; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; HALE CJ, 1987, EARTH PLANET SC LETT, V86, P354, DOI 10.1016/0012-821X(87)90232-9; Hevey PJ, 2006, METEORIT PLANET SCI, V41, P95, DOI 10.1111/j.1945-5100.2006.tb00195.x; Hood LL, 2008, ICARUS, V193, P485, DOI 10.1016/j.icarus.2007.08.023; KUEHNER S, 2006, LPS, V37, P1344; Kurat G, 2004, GEOCHIM COSMOCHIM AC, V68, P1901, DOI 10.1016/j.gca.2003.10.016; Markowski A, 2007, EARTH PLANET SC LETT, V262, P214, DOI 10.1016/j.epsl.2007.07.035; McKay G., 1988, LUNAR PLANETARY SCI, P762; McKay G., 1993, LUNAR PLANET SCI, V24, P967; MIKOUCHI T, 2001, 64 ANN MET SOC M; MITTELFEHLDT DW, 1998, PLANETARY MAT; Mittlefehldt D. W., 2007, TREATISE GEOCHEMISTR, V1, P1, DOI DOI 10.1016/B0-08-043751-6/01064-1; PRINZ M, 1977, EARTH PLANET SC LETT, V35, P317, DOI 10.1016/0012-821X(77)90134-0; Righter K., 2008, LUNAR PLANET SCI, V38; Russell SS., 2006, METEORITES EARLY SOL; SPIVAKBIRNDORF L, 2005, 68 ANN MET SOC M; Stanley S, 2005, EARTH PLANET SC LETT, V234, P27, DOI 10.1016/j.epsl.2005.02.040; Stevenson DJ, 2003, EARTH PLANET SC LETT, V208, P1, DOI 10.1016/S0012-821X(02)01126-3; STORZER D, 1977, EARTH PLANET SC LETT, V35, P285, DOI 10.1016/0012-821X(77)90132-7; Vallee JP, 2003, NEW ASTRON REV, V47, P85, DOI 10.1016/S1387-6473(03)00060-5; WARREN PH, 1995, ANTARCTIC METEORITES, V20, P257; Weiss BP, 2002, EARTH PLANET SC LETT, V201, P449, DOI 10.1016/S0012-821X(02)00728-8; Yanai K., 1994, ANTARCT METEOR RES, V7, P30; ZARTMAN RE, 2006, LUNAR PLANET SCI, V38, P1580; [No title captured]	35	84	84	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					713	716		10.1126/science.1162459	http://dx.doi.org/10.1126/science.1162459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974346				2022-12-28	WOS:000260605200040
J	Liu, HT; Yu, XH; Li, KW; Klejnot, J; Yang, HY; Lisiero, D; Lin, CT				Liu, Hongtao; Yu, Xuhong; Li, Kunwu; Klejnot, John; Yang, Hongyun; Lisiero, Dominique; Lin, Chentao			Photoexcited CRY2 Interacts with CIB1 to Regulate Transcription and Floral Initiation in Arabidopsis	SCIENCE			English	Article							BLUE-LIGHT PHOTORECEPTORS; SIGNAL-TRANSDUCTION; DNA PHOTOLYASE; CIRCADIAN CLOCK; FLOWERING TIME; CRYPTOCHROMES; THALIANA; PROTEIN; FAMILY; COP1	Cryptochromes (CRY) are photolyase- like blue- light receptors that mediate light responses in plants and animals. How plant cryptochromes act in response to blue light is not well understood. We report here the identification and characterization of the Arabidopsis CIB1 ( cryptochrome- interacting basic- helix- loop- helix) protein. CIB1 interacts with CRY2 ( cryptochrome 2) in a blue light- specific manner in yeast and Arabidopsis cells, and it acts together with additional CIB1- related proteins to promote CRY2- dependent floral initiation. CIB1 binds to G box ( CACGTG) in vitro with a higher affinity than its interaction with other E- box elements ( CANNTG). However, CIB1 stimulates FT messenger RNA expression, and it interacts with chromatin DNA of the FT gene that possesses various E- box elements except G box. We propose that the blue light- dependent interaction of cryptochrome( s) with CIB1 and CIB1- related proteins represents an early photoreceptor signaling mechanism in plants.	[Liu, Hongtao; Yu, Xuhong; Li, Kunwu; Klejnot, John; Yang, Hongyun; Lisiero, Dominique; Lin, Chentao] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Lin, CT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clin@mcdb.ucla.edu	Liu, Hongtao/A-7556-2010		NIH [GM56265]; University of California-Los Angeles; Sol Leshin UCLA-BGU Academic Cooperation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056265, R01GM056265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Los Angeles(University of California System); Sol Leshin UCLA-BGU Academic Cooperation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Ecker, Z. Wang, W. Laing, S. Poethig, G. Chen, L. Johnson, S. Jacobsen, S. Knowles, E. Tobin, and R. Goldberg for materials and technical assistance. This work is supported in part by NIH (GM56265 to C.L.), University of California-Los Angeles faculty research, and Sol Leshin UCLA-BGU Academic Cooperation programs.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yu X, 2007, PLANT CELL, V19, P3146, DOI 10.1105/tpc.107.053017; Yu XH, 2007, P NATL ACAD SCI USA, V104, P7289, DOI 10.1073/pnas.0701912104	30	474	522	11	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1535	1539		10.1126/science.1163927	http://dx.doi.org/10.1126/science.1163927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	18988809				2022-12-28	WOS:000261377400047
J	Miller, JM; Rochitte, CE; Dewey, M; Arbab-Zadeh, A; Niinuma, H; Gottlieb, I; Paul, N; Clouse, ME; Shapiro, EP; Hoe, J; Lardo, AC; Bush, DE; de Roos, A; Cox, C; Brinker, J; Lima, JAC				Miller, Julie M.; Rochitte, Carlos E.; Dewey, Marc; Arbab-Zadeh, Armin; Niinuma, Hiroyuki; Gottlieb, Ilan; Paul, Narinder; Clouse, Melvin E.; Shapiro, Edward P.; Hoe, John; Lardo, Albert C.; Bush, David E.; de Roos, Albert; Cox, Christopher; Brinker, Jeffery; Lima, Joao A. C.			Diagnostic Performance of Coronary Angiography by 64-Row CT	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION TASK-FORCE; COMPUTED-TOMOGRAPHY; ARTERY-DISEASE; AMERICAN-COLLEGE; COMMITTEE; SURGERY; INTERVENTION; GUIDELINES; THERAPY; RISK	Background: The accuracy of multidetector computed tomographic (CT) angiography involving 64 detectors has not been well established. Methods: We conducted a multicenter study to examine the accuracy of 64-row, 0.5-mm multidetector CT angiography as compared with conventional coronary angiography in patients with suspected coronary artery disease. Nine centers enrolled patients who underwent calcium scoring and multidetector CT angiography before conventional coronary angiography. In 291 patients with calcium scores of 600 or less, segments 1.5 mm or more in diameter were analyzed by means of CT and conventional angiography at independent core laboratories. Stenoses of 50% or more were considered obstructive. The area under the receiver-operating-characteristic curve (AUC) was used to evaluate diagnostic accuracy relative to that of conventional angiography and subsequent revascularization status, whereas disease severity was assessed with the use of the modified Duke Coronary Artery Disease Index. Results: A total of 56% of patients had obstructive coronary artery disease. The patient-based diagnostic accuracy of quantitative CT angiography for detecting or ruling out stenoses of 50% or more according to conventional angiography revealed an AUC of 0.93 (95% confidence interval [CI], 0.90 to 0.96), with a sensitivity of 85% (95% CI, 79 to 90), a specificity of 90% (95% CI, 83 to 94), a positive predictive value of 91% (95% CI, 86 to 95), and a negative predictive value of 83% (95% CI, 75 to 89). CT angiography was similar to conventional angiography in its ability to identify patients who subsequently underwent revascularization: the AUC was 0.84 (95% CI, 0.79 to 0.88) for multidetector CT angiography and 0.82 (95% CI, 0.77 to 0.86) for conventional angiography. A per-vessel analysis of 866 vessels yielded an AUC of 0.91 (95% CI, 0.88 to 0.93). Disease severity ascertained by CT and conventional angiography was well correlated (r=0.81; 95% CI, 0.76 to 0.84). Two patients had important reactions to contrast medium after CT angiography. Conclusions: Multidetector CT angiography accurately identifies the presence and severity of obstructive coronary artery disease and subsequent revascularization in symptomatic patients. The negative and positive predictive values indicate that multidetector CT angiography cannot replace conventional coronary angiography at present. (ClinicalTrials.gov number, NCT00738218.).	[Miller, Julie M.; Arbab-Zadeh, Armin; Gottlieb, Ilan; Shapiro, Edward P.; Lardo, Albert C.; Bush, David E.; Brinker, Jeffery; Lima, Joao A. C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Cox, Christopher] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Rochitte, Carlos E.] Univ Sao Paulo, InCor Sao Paulo Heart Inst, Sao Paulo, Brazil; [Dewey, Marc] Humboldt Univ, Charite Med Sch, Berlin, Germany; [Dewey, Marc] Free Univ Berlin, D-1000 Berlin, Germany; [Niinuma, Hiroyuki] Iwate Med Univ, Morioka, Iwate 020, Japan; [Paul, Narinder] Toronto Gen Hosp, Toronto, ON, Canada; [Clouse, Melvin E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Hoe, John] Mt Elizabeth Hosp, Singapore, Singapore; [de Roos, Albert] Leiden Univ, Med Ctr, Leiden, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade de Sao Paulo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Iwate Medical University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lima, JAC (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Blalock 524, Baltimore, MD 21287 USA.	jlima@jhmi.edu	Miller, Julie/B-6492-2009; GOTTLIEB, ILAN/ABD-2216-2021; Shapiro, Edward/AAG-1611-2020	Gottlieb, Ilan/0000-0003-0402-5769; Hoe, John/0000-0003-2591-5648; Dewey, Marc/0000-0002-4402-2733	Toshiba Medical Systems; Doris Duke Charitable Foundation; National Heart, Lung, and Blood Institute [RO1-HL66075-01, HO1-HC95162-01]; National Institute on Aging [RO1-AG021570-01]; Donald W. Reynolds Foundation; Bayer and Schering; GE Healthcare; Bracco; Vital Images; GE Biosciences; CT Core Laboratory; BristolMyers Squibb; Sanofi-Aventis; GE Medical Systems; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095162] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083813, R01HL066075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021570] Funding Source: NIH RePORTER	Toshiba Medical Systems; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Donald W. Reynolds Foundation; Bayer and Schering(Bayer AG); GE Healthcare(General ElectricGE Healthcare); Bracco; Vital Images; GE Biosciences(General Electric); CT Core Laboratory; BristolMyers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); GE Medical Systems(General Electric); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from Toshiba Medical Systems; the Doris Duke Charitable Foundation; the National Heart, Lung, and Blood Institute (RO1-HL66075-01 and HO1-HC95162-01); the National Institute on Aging (RO1-AG021570-01); and the Donald W. Reynolds Foundation.; Drs. Miller, Dewey, Paul, Shapiro, Lardo, and Lima report receiving grant support from Toshiba Medical Systems; Drs. Dewey, Paul, Hoe, Lardo, Bush, and Lima, speakers' fees from Toshiba Medical Systems; Dr. Dewey, speaker's fees from Bayer and Schering and grant support from GE Healthcare and Bracco; and Dr. Paul, advisory fees from Vital Images. Dr. Hoe reports serving as director of the Cardiac CT Training Course sponsored by Toshiba Medical Systems, Asia, and receiving speaker's fees from GE Biosciences. Dr. Lardo reports receiving grant support from CT Core Laboratory; Dr. Bush, speaker's fees from BristolMyers Squibb and Sanofi-Aventis; and Dr. Lima, grant support from GE Medical Systems. No other potential conflict of interest relevant to this article was reported.	Achenbach S, 2000, CIRCULATION, V102, P2823; ALDERMAN EL, 1992, CORONARY ARTERY DIS, V3, P1189; ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; Austen W G, 1975, Circulation, V51, P5; Becker CR, 2000, RADIOLOGE, V40, P118, DOI 10.1007/s001170050019; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Coles DR, 2006, J AM COLL CARDIOL, V47, P1840, DOI 10.1016/j.jacc.2005.11.078; Dewey M, 2004, INVEST RADIOL, V39, P223, DOI 10.1097/01.rli.0000115201.27096.6e; Efron B., 1994, MONOGRAPHS STAT APPL; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; ELLIS S, 1988, J AM COLL CARDIOL, V11, P908, DOI 10.1016/S0735-1097(98)90044-4; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; Garcia MJ, 2006, JAMA-J AM MED ASSOC, V296, P403, DOI 10.1001/jama.296.4.403; Hamon M, 2007, RADIOLOGY, V245, P720, DOI 10.1148/radiol.2453061899; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Jacobs Jill E, 2006, J Am Coll Radiol, V3, P677, DOI 10.1016/j.jacr.2006.06.006; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; Meijboom WB, 2007, J AM COLL CARDIOL, V50, P1469, DOI 10.1016/j.jacc.2007.07.007; Nieman K, 2001, LANCET, V357, P599, DOI 10.1016/S0140-6736(00)04058-7; Paetsch I, 2004, CIRCULATION, V110, P835, DOI 10.1161/01.CIR.0000138927.00357.FB; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Scanlon PJ, 1999, CIRCULATION, V99, P2345, DOI 10.1161/01.CIR.99.17.2345; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Wilde P, 2001, HEART, V85, P127, DOI 10.1136/heart.85.2.127; YUSUF, 1994, LANCET, V344, P1446; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	29	1340	1443	2	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2324	2336		10.1056/NEJMoa0806576	http://dx.doi.org/10.1056/NEJMoa0806576			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377SG	19038879				2022-12-28	WOS:000261270300004
J	Doria, A; Wojcik, J; Xu, R; Gervino, EV; Hauser, TH; Johnstone, MT; Nolan, D; Hu, FB; Warram, JH				Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Gervino, Ernest V.; Hauser, Thomas H.; Johnstone, Michael T.; Nolan, David; Hu, Frank B.; Warram, James H.			Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ADIPONECTIN GENE; META-ANALYSIS; INSULIN; EPIDEMIOLOGY; POLYMORPHISM; MELLITUS; SUSCEPTIBILITY	Context A common allele on chromosome 9p21 has been repeatedly associated with increased risk of coronary artery disease ( CAD) in the general population. However, the magnitude of this effect in the population with diabetes has not been well characterized. Objective To examine the association of the 9p21 variant with CAD in individuals with type 2 diabetes and evaluate its interaction with poor glycemic control. Design, Setting, and Participants ( 1) Case- control study of 734 type 2 diabetes patients ( 322 with angiographically diagnosed CAD and 412 with no evidence of CAD) who were recruited between 2001 and 2006 at the Joslin Clinic, Beth Israel Deaconess Medical Center; and ( 2) independent cohort study of 475 type 2 diabetes patients from the Joslin Clinic whose survival status was monitored from their recruitment between 1993 and 1996 until December 31, 2004. Participants for both studies were genotyped for a representative single- nucleotide polymorphism at 9p21 ( rs2383206) and characterized for their long- term glycemic control by averaging multiple hemoglobin A(1c) ( HbA(1c)) measurements taken in the years before study entry. Main Outcome Measures For the case- control study, association between single-nucleotide polymorphism rs2383206 and CAD defined as angiographically documented stenosis greater than 50% in a major coronary artery or a main branch thereof was assessed and for the cohort study, cumulative 10- year mortality was documented. Results Individuals who were homozygous for the risk allele were significantly more frequent among case than control participants ( 42.3% vs 28.9P=. 0002). This association was unaffected by adjustment for cardiovascular risk factors, but the effect of the risk genotype was significantly magnified ( adjusted P for interaction=. 048) in the presence of poor glycemic control ( worst tertile of the distribution of HbA(1c) at examination). Relative to the CAD risk for patients with neither a 9p21 risk allele nor poor glycemic control, the CAD odds for participants having 2 risk alleles but not poor glycemic control were increased 2- fold ( odds ratio [ OR], 1.99; 95% confidence interval [ CI], 1.17- 3.41), whereas the odds for study participants with the same genotype and with poor glycemic control were increased 4- fold ( OR, 4.27; 95% CI, 2.26- 8.01). The interaction was stronger ( adjusted P=. 005) when a measure of long- term glycemic control ( 7- year average rather than most recent HbA(1c)) was used with ORs of 7.83 ( 95% CI, 3.49- 17.6) for participants having 2 risk alleles and a history of poor glycemia and 1.54 ( 95% CI, 0.72- 3.30) for participants with the same genotype but without this exposure. A similar interaction between 9p21 variant and poor glycemic control was observed with respect to cumulative 10- year mortality in the cohort study ( 43.6% in patients with 2 risk alleles and poor glycemic control, 23.1% in individuals with only the 2 risk alleles, 30.0% in individuals with only poor glycemic control, and 31.6% in individuals with neither factor, P for interaction, =. 036). Conclusion In this study population, the CAD risk associated with the 9p21 variant was increased in the presence of poor glycemic control in type 2 diabetes.	[Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Nolan, David; Warram, James H.] Joslin Diabet Ctr, Div Res, Sect Genet & Epidemiol, Boston, MA 02215 USA; [Doria, Alessandro; Wojcik, Joanna; Xu, Rui; Gervino, Ernest V.; Hauser, Thomas H.; Hu, Frank B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gervino, Ernest V.; Hauser, Thomas H.] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Johnstone, Michael T.] Caritas St Elizabeth Med Ctr, Boston, MA USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Doria, Alessandro; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; St. Elizabeth's Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Doria, A (corresponding author), Joslin Diabet Ctr, Div Res, Sect Genet & Epidemiol, 1 Joslin Pl, Boston, MA 02215 USA.	alessandro.doria@joslin.harvard.edu	Doria, Alessandro/H-9157-2018	Doria, Alessandro/0000-0002-3830-4304; Wojcik-Odyniec, Joanna/0000-0002-8495-4316	National Institutes of Health [HL73168, HL71981]; Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center [DK36836]; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168, R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants HL73168, HL71981, and DK36836 (Genetics Core of the Diabetes and Endocrinology Research Center at the Joslin Diabetes Center), and a grant from the Donald W. Reynolds Foundation. Role of the Sponsors: None of the funding agencies had any role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	ABBOTT RD, 1990, AM J MED, V88, P376, DOI 10.1016/0002-9343(90)90492-V; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; Bacci S, 2005, DIABETES, V54, P3021, DOI 10.2337/diabetes.54.10.3021; Bacci S, 2004, DIABETES CARE, V27, P2015, DOI 10.2337/diacare.27.8.2015; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DETRANO R, 1989, PROG CARDIOVASC DIS, V32, P173, DOI 10.1016/0033-0620(89)90025-X; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Freire MBS, 1998, HYPERTENSION, V31, P896, DOI 10.1161/01.HYP.31.4.896; Gavin JR, 1997, DIABETES CARE, V20, P1183; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Haffner SM, 1999, DIABETES CARE, V22, pC54; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KAMB A, 1994, SCIENCE, V264, P440; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; Lacquemant C, 2004, DIABETIC MED, V21, P776, DOI 10.1111/j.1464-5491.2004.01224.x; Lange LA, 2002, STROKE, V33, P1876, DOI 10.1161/01.STR.0000019909.71547.AA; Libby P, 2002, CIRCULATION, V106, P2760, DOI 10.1161/01.CIR.0000037282.92395.AE; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qi L, 2005, DIABETES, V54, P1607, DOI 10.2337/diabetes.54.5.1607; Rask-Madsen C, 2005, ARTERIOSCL THROM VAS, V25, P487, DOI 10.1161/01.ATV.0000155325.41507.e0; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Wagenknecht LE, 2001, DIABETES, V50, P861, DOI 10.2337/diabetes.50.4.861; Warram JH, 1997, ENDOCRIN METAB CLIN, V26, P165, DOI 10.1016/S0889-8529(05)70239-5; Wild SH, 1999, DIABETES-METAB RES, V15, P197, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<197::AID-DMRR28>3.0.CO;2-F; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	95	97	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2389	2397		10.1001/jama.2008.649	http://dx.doi.org/10.1001/jama.2008.649			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033589	Green Accepted, Bronze			2022-12-28	WOS:000261150800021
J	Agayev, A; Yilmaz, S				Agayev, Ayaz; Yilmaz, Sabri			Cavernous Sinus Thrombosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Agayev, Ayaz; Yilmaz, Sabri] Istanbul Univ, Fac Med, Istanbul, Turkey	Istanbul University	Agayev, A (corresponding author), Istanbul Univ, Fac Med, Istanbul, Turkey.	ayazagayev@gmail.com							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2266	2266		10.1056/NEJMicm067696	http://dx.doi.org/10.1056/NEJMicm067696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020328				2022-12-28	WOS:000260994000010
J	Green, RC; Annas, GJ				Green, Robert C.; Annas, George J.			The Genetic Privacy of Presidential Candidates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Green, Robert C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Med, Dept Med Genet, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Publ Hlth, Dept Med Genet, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University	Green, RC (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.			Annas, George/0000-0001-5836-7831	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG027841] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000533, M01 RR000533-370391, M01 RR000533-360391] Funding Source: Medline; NHGRI NIH HHS [R01 HG002213-04, R01 HG002213, R01 HG002213-01] Funding Source: Medline; NIA NIH HHS [K24 AG027841-01A1, K24 AG027841] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANNAS GJ, 1995, NEW ENGL J MED, V333, P945, DOI 10.1056/NEJM199510053331420; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P1466; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Venter J Craig, 2007, LIFE DECODED MY GENO; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2192	2193		10.1056/NEJMp0808100	http://dx.doi.org/10.1056/NEJMp0808100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020322	Green Accepted			2022-12-28	WOS:000260994000002
J	Jekely, G; Colombelli, J; Hausen, H; Guy, K; Stelzer, E; Nedelec, F; Arendt, D				Jekely, Gaspar; Colombelli, Julien; Hausen, Harald; Guy, Keren; Stelzer, Ernst; Nedelec, Francois; Arendt, Detlev			Mechanism of phototaxis in marine zooplankton	NATURE			English	Article							PLATYNEREIS-DUMERILII; CHLAMYDOMONAS-REINHARDTII; SPONGE LARVA; BEHAVIOR; ANNELIDA; EYE; NANOSURGERY; POLYCHAETA; ORGANISMS; EVOLUTION	The simplest animal eyes are eyespots composed of two cells only: a photoreceptor and a shading pigment cell. They resemble Darwin's 'proto-eyes', considered to be the first eyes to appear in animal evolution(1-4). Eyespots cannot form images but enable the animal to sense the direction of light. They are characteristic for the zooplankton larvae of marine invertebrates and are thought to mediate larval swimming towards the light. Phototaxis of invertebrate larvae contributes to the vertical migration of marine plankton(5), which is thought to represent the biggest biomass transport on Earth(6,7). Yet, despite its ecological and evolutionary importance, the mechanism by which eyespots regulate phototaxis is poorly understood. Here we show how simple eyespots in marine zooplankton mediate phototactic swimming, using the marine annelid Platynereis dumerilii as a model(8). We find that the selective illumination of one eyespot changes the beating of adjacent cilia by direct cholinergic innervation resulting in locally reduced water flow. Computer simulations of larval swimming show that these local effects are sufficient to direct the helical swimming trajectories towards the light. The computer model also shows that axial rotation of the larval body is essential for phototaxis and that helical swimming increases the precision of navigation. These results provide, to our knowledge, the first mechanistic understanding of phototaxis in a marine zooplankton larva and show how simple eyespots regulate it. We propose that the underlying direct coupling of light sensing and ciliary locomotor control was a principal feature of the proto- eye and an important landmark in the evolution of animal eyes.	[Jekely, Gaspar; Guy, Keren; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Colombelli, Julien; Stelzer, Ernst; Nedelec, Francois] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Hausen, Harald] Free Univ Berlin, Inst Biol Systemat & Evolut Tiere, D-14195 Berlin, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Free University of Berlin	Jekely, G (corresponding author), Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	gaspar.jekely@tuebingen.mpg.de; arendt@embl.de	Stelzer, Ernst H K/A-7648-2011; Jékely, Gáspár/I-8708-2012; Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019	Stelzer, Ernst H K/0000-0003-1545-0736; Jékely, Gáspár/0000-0001-8496-9836; Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Colombelli, Julien/0000-0002-2784-4276	Center for Modelling and Simulation in the Biosciences; Deutsche Forschungsgemeinschaft [HA 4443/1-1, DA Ar387/1-1]; FEBS Long Term Fellowship	Center for Modelling and Simulation in the Biosciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FEBS Long Term Fellowship	We thank K. Miura for advice on behavioural assays and digital image processing, K. Tessmar- Raible for identifying FVRI- amide in our expressed- sequence- tag collection, G. Plickert for advice on antibody production, D. Nilsson for advice on action spectra, and H. Snyman for technical assistance. This work was supported by Center for Modelling and Simulation in the Biosciences and by grants from Deutsche Forschungsgemeinschaft (HA 4443/1-1 and DA Ar387/1-1). G. J. was supported by a FEBS Long Term Fellowship during the initial phase of the project	Angel MV, 2000, HYDROBIOLOGIA, V440, P161, DOI 10.1023/A:1004115010030; [Anonymous], 1861, ORIGIN SPECIES MEANS; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; BRANDENBURGER JL, 1973, Z ZELLFORSCH MIK ANA, V142, P89, DOI 10.1007/BF00306706; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Colombelli J, 2007, METHOD CELL BIOL, V82, P267, DOI 10.1016/S0091-679X(06)82008-X; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Denny M. W., 1993, AIR WATER BIOL PHYS; DORRESTEIJN AWC, 1993, ROUX ARCH DEV BIOL, V202, P260, DOI 10.1007/BF00363215; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Jennings HS, 1901, AM NAT, V35, P369, DOI 10.1086/277922; Josef K, 2005, CELL MOTIL CYTOSKEL, V61, P97, DOI 10.1002/cm.20069; Josef K, 2006, CELL MOTIL CYTOSKEL, V63, P758, DOI 10.1002/cm.20158; LACALLI TC, 1988, CAN J ZOOL, V66, P1004, DOI 10.1139/z88-148; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; MARSDEN JR, 1984, MAR BIOL, V83, P13, DOI 10.1007/BF00393081; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; RHODE B, 1992, J MORPHOL, V212, P71, DOI 10.1002/jmor.1052120108; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; THORSON G, 1964, OPHELIA, V1, P167, DOI DOI 10.1080/00785326.1964.10416277; Witman George B., 1993, Trends in Cell Biology, V3, P403, DOI 10.1016/0962-8924(93)90091-E	29	190	191	10	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					395	U62		10.1038/nature07590	http://dx.doi.org/10.1038/nature07590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020621	Bronze			2022-12-28	WOS:000261039600045
J	Wynne, K; Chaudhri, O; Gorrigan, R; Tan, T; Meeran, K				Wynne, K.; Chaudhri, O.; Gorrigan, R.; Tan, T.; Meeran, K.			A case of severe hyponatraemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wynne, K.; Chaudhri, O.; Tan, T.; Meeran, K.] Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, London, England; [Gorrigan, R.] Barts & London NHS Trust, London, England	Imperial College London; Barts Health NHS Trust	Wynne, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, London, England.	k.meeran@imperial.ac.uk	Tan, Tricia/ABD-5502-2020; Tan, Tricia M.M./C-7140-2011	Tan, Tricia M.M./0000-0001-5873-3432				Diederich S, 2003, EUR J ENDOCRINOL, V148, P609, DOI 10.1530/eje.0.1480609; Dokmetas HS, 2006, GYNECOL ENDOCRINOL, V22, P279, DOI 10.1080/09513590600630504; Feinberg EC, 2005, FERTIL STERIL, V84, P975, DOI 10.1016/j.fertnstert.2005.04.034; Huang YY, 2000, GYNECOL ENDOCRINOL, V14, P99, DOI 10.3109/09513590009167667; ISHIKAWA S, 1982, KIDNEY INT, V22, P587, DOI 10.1038/ki.1982.216; Kelestimur Fahrettin, 2003, Pituitary, V6, P181, DOI 10.1023/B:PITU.0000023425.20854.8e; Saito T, 2000, AM J PHYSIOL-RENAL, V279, pF502, DOI 10.1152/ajprenal.2000.279.3.F502; Sert M, 2003, ENDOCR J, V50, P297, DOI 10.1507/endocrj.50.297; Sheehan HL, 1937, J PATHOL BACTERIOL, V45, P189, DOI 10.1002/path.1700450118; Zargar AH, 2005, FERTIL STERIL, V84, P523, DOI 10.1016/j.fertnstert.2005.02.022	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2008	337								a2377	10.1136/bmj.a2377	http://dx.doi.org/10.1136/bmj.a2377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397HR	19019877				2022-12-28	WOS:000262654000001
J	Albert, MA; Wells, JR				Albert, Michael A., Jr.; Wells, Jill R.			Ocular Myiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Albert, Michael A., Jr.] Retina Consultants Alabama, Birmingham, AL 35233 USA; [Wells, Jill R.] Univ Alabama, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Albert, MA (corresponding author), Retina Consultants Alabama, Birmingham, AL 35233 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					E25	E25		10.1056/NEJMicm075735	http://dx.doi.org/10.1056/NEJMicm075735			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005188				2022-12-28	WOS:000260823900014
J	Cantillon, P; Sargeant, J				Cantillon, Peter; Sargeant, Joan			Giving feedback in clinical settings	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE		[Cantillon, Peter] Natl Univ Ireland Univ Coll Galway, Dept Gen Practice, Galway, Ireland; [Sargeant, Joan] Dalhousie Univ, Div Med Educ, Program Dev & Evaluat Continuing Med Educ, Halifax, NS, Canada	Ollscoil na Gaillimhe-University of Galway; Dalhousie University	Cantillon, P (corresponding author), Natl Univ Ireland Univ Coll Galway, Dept Gen Practice, Galway, Ireland.	peter.cantillon@nuigalway.ie						BRUNING RH, 2004, COGNITIVE PSYCHOL IN; Dobbie A, 2005, FAM MED, V37, P617; Dudek NL, 2005, ACAD MED, V80, pS84, DOI 10.1097/00001888-200510001-00023; ENDE J, 1983, JAMA-J AM MED ASSOC, V250, P777, DOI 10.1001/jama.250.6.777; Ertmer P. A., 2013, PERFORMANCE IMPROVEM, V6, P3, DOI [10.1111/j.1937-8327.1993.tb00605.x, 10.1002/piq.21143, DOI 10.1111/J.1937-8327.1993.TB00605.X]; HARGREAVES DH, 1997, ON THE JOB TRAINING; Henderson Penny, 2005, BMC Med Educ, V5, P11, DOI 10.1186/1472-6920-5-11; Hesketh EA, 2002, MED TEACH, V24, P245, DOI 10.1080/014215902201409911; IRBY DM, 1995, ACAD MED, V70, P898, DOI 10.1097/00001888-199510000-00014; ISAA, 1995, J GEN INTERN MED S4, V10, pS89; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Liberman AS, 2005, MED TEACH, V27, P470, DOI 10.1080/0142590500129183; Menachery EP, 2006, J GEN INTERN MED, V21, P440, DOI 10.1111/j.1525-1497.2006.00424.x; Pendleton D, 2003, CONSULTATION APPROAC; RAMAPRASAD A, 1983, BEHAV SCI, V28, P4, DOI 10.1002/bs.3830280103; Rees C, 2005, MED EDUC, V39, P30, DOI 10.1111/j.1365-2929.2004.02030.x; SARGEANT J, 2008, REFLECTION LINK RECE; SARGEANT J, 2007, ASS MED ED EUR AUG 2; Silverman J, 1997, ED GEN PRACTICE, V8, P16; Taras M, 2005, BRIT J EDUC STUD, V53, P466, DOI 10.1111/j.1467-8527.2005.00307.x; Thorndike EL, 1931, HUMAN LEARNING; Veloski J, 2006, MED TEACH, V28, P117, DOI 10.1080/01421590600622665	22	234	237	1	55	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 10	2008	337								a1961	10.1136/bmj.a1961	http://dx.doi.org/10.1136/bmj.a1961			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384ZZ	19001006				2022-12-28	WOS:000261784000001
J	Pandey, A; Guyot-Sionnest, P				Pandey, Anshu; Guyot-Sionnest, Philippe			Slow Electron Cooling in Colloidal Quantum Dots	SCIENCE			English	Article							PHONON BOTTLENECK; ENERGY RELAXATION; NANOCRYSTALS; MECHANISM	Hot electrons in semiconductors lose their energy very quickly ( within picoseconds) to lattice vibrations. Slowing this energy loss could prove useful for more efficient photovoltaic or infrared devices. With their well- separated electronic states, quantum dots should display slow relaxation, but other mechanisms have made it difficult to observe. We report slow intraband relaxation (> 1 nanosecond) in colloidal quantum dots. The small cadmium selenide ( CdSe) dots, with an intraband energy separation of similar to 0.25 electron volts, are capped by an epitaxial zinc selenide ( ZnSe) shell. The shell is terminated by a CdSe passivating layer to remove electron traps and is covered by ligands of low infrared absorbance ( alkane thiols) at the intraband energy. We found that relaxation is markedly slowed with increasing ZnSe shell thickness.	[Pandey, Anshu; Guyot-Sionnest, Philippe] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of Chicago	Guyot-Sionnest, P (corresponding author), Univ Chicago, James Franck Inst, 929 E 57th St, Chicago, IL 60637 USA.	pgs@uchicago.edu	Pandey, Anshu/GPK-7753-2022	Pandey, Anshu/0000-0003-3195-1522	NSF [DMR-0706268]; NSF Materials Research Science and Engineering Centers [DMR-0213745]	NSF(National Science Foundation (NSF)); NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF))	Supported by NSF grant DMR-0706268 and by NSF Materials Research Science and Engineering Centers program grant DMR-0213745.	BENISTY H, 1991, PHYS REV B, V44, P10945, DOI 10.1103/PhysRevB.44.10945; BOCKELMANN U, 1990, PHYS REV B, V42, P8947, DOI 10.1103/PhysRevB.42.8947; EFROS AL, 1995, SOLID STATE COMMUN, V93, P281, DOI 10.1016/0038-1098(94)00780-2; Guyot-Sionnest P, 1999, PHYS REV B, V60, pR2181, DOI 10.1103/PhysRevB.60.R2181; Guyot-Sionnest P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2004818; Hendry E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057408; Inoshita T, 1996, PHYSICA B, V227, P373, DOI 10.1016/0921-4526(96)00445-0; INOSHITA T, 1992, PHYS REV B, V46, P7260, DOI 10.1103/PhysRevB.46.7260; Klimov VI, 2000, PHYS REV B, V61, P13349, DOI 10.1103/PhysRevB.61.R13349; Klimov VI, 1999, PHYS REV B, V60, P13740, DOI 10.1103/PhysRevB.60.13740; Klimov VI, 1998, PHYS REV LETT, V80, P4028, DOI 10.1103/PhysRevLett.80.4028; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Pandey A, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766957; Reiss P, 2002, NANO LETT, V2, P781, DOI 10.1021/nl025596y; Sauvage S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.177402; Schroeter DF, 1996, PHYS REV B, V54, P1486, DOI 10.1103/PhysRevB.54.1486; Toda Y, 1999, PHYS REV LETT, V82, P4114, DOI 10.1103/PhysRevLett.82.4114; Urayama J, 2001, PHYS REV LETT, V86, P4930, DOI 10.1103/PhysRevLett.86.4930; Verzelen O, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.081308; Wang LW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.056404; Yang YA, 2005, ANGEW CHEM INT EDIT, V44, P6712, DOI 10.1002/anie.200502279	22	431	433	4	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					929	932		10.1126/science.1159832	http://dx.doi.org/10.1126/science.1159832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988849				2022-12-28	WOS:000260674100042
J	Redondo, P; Prieto, J; Munoz, IG; Alibes, A; Stricher, F; Serrano, L; Cabaniols, JP; Daboussi, F; Arnould, S; Perez, C; Duchateau, P; Paques, F; Blanco, FJ; Montoya, G				Redondo, Pilar; Prieto, Jesus; Munoz, Ines G.; Alibes, Andreu; Stricher, Francois; Serrano, Luis; Cabaniols, Jean-Pierre; Daboussi, Fayza; Arnould, Sylvain; Perez, Christophe; Duchateau, Philippe; Paques, Frederic; Blanco, Francisco J.; Montoya, Guillermo			Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases	NATURE			English	Article							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; HOMING ENDONUCLEASES; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; DIRECTED EVOLUTION; SITE-SPECIFICITY; CRE RECOMBINASE; GENE CORRECTION; I-CREI	Xeroderma pigmentosum is a monogenic disease characterized by hypersensitivity to ultraviolet light. The cells of xeroderma pigmentosum patients are defective in nucleotide excision repair, limiting their capacity to eliminate ultraviolet- induced DNA damage, and resulting in a strong predisposition to develop skin cancers(1). The use of rare cutting DNA endonucleases - such as homing endonucleases, also known as meganucleases - constitutes one possible strategy for repairing DNA lesions. Homing endonucleases have emerged as highly specific molecular scalpels that recognize and cleave DNA sites, promoting efficient homologous gene targeting through double- strand- break- induced homologous recombination. Here we describe two engineered heterodimeric derivatives of the homing endonuclease I- CreI, produced by a semi- rational approach. These two molecules - Amel3 - Amel4 and Ini3 - Ini4 cleave DNA from the human XPC gene ( xeroderma pigmentosum group C), in vitro and in vivo. Crystal structures of the I- CreI variants complexed with intact and cleaved XPC target DNA suggest that the mechanism of DNA recognition and cleavage by the engineered homing endonucleases is similar to that of the wild- type I- CreI. Furthermore, these derivatives induced high levels of specific gene targeting in mammalian cells while displaying no obvious genotoxicity. Thus, homing endonucleases can be designed to recognize and cleave the DNA sequences of specific genes, opening up new possibilities for genome engineering and gene therapy in xeroderma pigmentosum patients whose illness can be treated ex vivo.	[Redondo, Pilar; Munoz, Ines G.; Montoya, Guillermo] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Macromol Crystallog Grp, Madrid 28029, Spain; [Prieto, Jesus; Blanco, Francisco J.] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, NMR Grp, Madrid 28029, Spain; [Alibes, Andreu; Stricher, Francois; Serrano, Luis] UPF, European Mol Biol Lab, CRG Syst Biol Unit, CRG, Barcelona 08003, Spain; [Serrano, Luis] ICREA, F-93235 Romainville, France; [Cabaniols, Jean-Pierre; Daboussi, Fayza; Arnould, Sylvain; Perez, Christophe; Duchateau, Philippe; Paques, Frederic] CELLECTIS SA, F-93235 Romainville, France	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Blanco, FJ (corresponding author), CIC bioGUNE, Parque Tecnol Vizcaya,Edificio 800, Derio 48160, Spain.	fblanco@cicbiogune.es; gmontoya@cnio.es	Stricher, François/L-2688-2015; Redondo, Pilar/L-7612-2014; Blanco, Francisco J/D-4401-2009; Alibés, Andreu/A-5790-2008; Serrano, Luis/B-3355-2013; Munoz, Ines G/M-3285-2014	Stricher, François/0000-0003-0150-0878; Redondo, Pilar/0000-0002-6723-0818; Blanco, Francisco J/0000-0003-2545-4319; Alibés, Andreu/0000-0002-0055-3014; Serrano, Luis/0000-0002-5276-1392; Munoz, Ines G/0000-0001-6732-4059; Daboussi, Fayza/0000-0001-7689-7975	EU MEGATOOL [LSHG-CT-2006-037226]; CRG-Novartis fellowship	EU MEGATOOL; CRG-Novartis fellowship	We would like to thank J. Casado and D. Megias for technical support and the beamline staff at the ESRF and SLS for advice during data collection. This project received financial support from the EU MEGATOOL project (LSHG-CT-2006-037226). A.A. is partly funded by a CRG-Novartis fellowship.	Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Prieto J, 2007, NUCLEIC ACIDS RES, V35, P3262, DOI 10.1093/nar/gkm183; Rimseliene R, 2003, J MOL BIOL, V327, P383, DOI 10.1016/S0022-2836(03)00142-6; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Samuelson JC, 2002, J MOL BIOL, V319, P673, DOI 10.1016/S0022-2836(02)00343-1; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Silva GH, 2004, NUCLEIC ACIDS RES, V32, P3156, DOI 10.1093/nar/gkh618; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Voziyanov Y, 2003, J MOL BIOL, V326, P65, DOI 10.1016/S0022-2836(02)01364-5; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	33	134	145	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					107	U8		10.1038/nature07343	http://dx.doi.org/10.1038/nature07343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987743				2022-12-28	WOS:000260674000050
J	Adamson, SJ; Bland, JM; Hay, EM; Johnson, RE; Jones, GT; Kitchener, H; Moffett, JAK; Macfarlane, GJ; MacPherson, H; McLean, S; Nelson, L; Salisbury, C; Thomas, E; Tilbrook, HE; Torgerson, DJ				Adamson, Simon J.; Bland, J. Martin; Hay, Elaine M.; Johnson, Ruth E.; Jones, Gareth T.; Kitchener, Henry; Moffett, Jennifer A. Klaber; Macfarlane, Gary J.; MacPherson, Hugh; McLean, Sionnadh; Nelson, Linsey; Salisbury, Chris; Thomas, Elaine; Tilbrook, Helen E.; Torgerson, David J.		Preference Collaborative Review Gr	Patients' preferences within randomised trials: systematic review and patient level meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOW-BACK-PAIN; NECK PAIN; USUAL PHYSIOTHERAPY; EXERCISE; DEPRESSION; PARTICIPANTS; OUTCOMES; THERAPY	Objective To systematically review fully randomised patient preference trials and to explore the impact of preferences on attrition and outcome by meta- analysis of patient level data. Data sources Citation search using Science Citation Index and Google Scholar and search of the main electronic databases ( Medline, CINAHL, Embase, and AMED) with a combination of key words. Study selection Fully randomised patient preference trials that compared treatments for any clinical condition were included. Other types of preference trials and crossover trials were excluded. Other inclusion criteria: participants aged 16 years and over; primary, self- reported outcomes measured on a continuous numerical scale. From 167 studies identified and screened, 17 were identified as fully randomised patient preference trials. Data synthesis Of the 17 trials identified, 11 authors provided raw data for the meta- analysis. Data collected were baseline and follow- up data for the main outcome, randomised allocation data, preference data, and demographic data. Baseline and first post- intervention follow- up data for the main outcome were standardised. To improve homogeneity, data for only the eight musculoskeletal trials ( n= 1594) were combined. To estimate the effects of preferences on outcomes and attrition, three groups were compared: patients who had a preference and were randomly allocated to their preferred treatment; patients who had a preference and were randomly allocated to the treatment they did not prefer; and patients who had no preference. Results Patients who were randomised to their preferred treatment had a standardised effect size greater than that of those who were indifferent to the treatment assignment ( effect size 0.162, 95% confidence interval 0.011 to 0.314; P= 0.04). Participants who received their preferred treatment also did better than participants who did not receive their preferred treatment ( effect size 0.152, - 0.035 to 0.339), although this was not statistically significant ( P= 0.11). Participants allocated to their undesired treatment had outcomes that were no different from those who were indifferent. Participants who were allocated to their undesired treatment were less likely to be lost to first follow- up compared with indifferent participants ( odds ratio 1.70, 1.076 to 2.693; P=0.02). No difference was found in attrition between patients allocated to their preference and those who were indifferent. Conclusions Preferences among patients in musculoskeletal trials are associated with treatment effects. In open randomised trials, preferences should be ascertained before randomisation.	[Tilbrook, Helen E.] Univ York, York Trials Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Tilbrook, HE (corresponding author), Univ York, York Trials Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	het2@york.ac.uk	Torgerson, David/L-4566-2019; Jones, Gareth/T-1755-2019; Salisbury, Chris/C-6724-2008; Macfarlane, Gary J/I-9521-2014	Torgerson, David/0000-0002-1667-4275; Jones, Gareth/0000-0003-0016-7591; Salisbury, Chris/0000-0002-4378-3960; Macfarlane, Gary J/0000-0003-2322-3314; McLean, Sionnadh/0000-0002-9307-8565; MacPherson, Hugh/0000-0003-4255-4768	National Institute for Health Research [CSA/03/07/010] Funding Source: researchfish; Department of Health [CSA/03/07/010] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Adamson SJ, 2005, DRUG ALCOHOL REV, V24, P209, DOI 10.1080/09595230500167502; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; Carr JL, 2005, DISABIL REHABIL, V27, P929, DOI 10.1080/09638280500030639; Halpern SD, 2003, J CLIN EPIDEMIOL, V56, P109, DOI 10.1016/S0895-4356(02)00598-X; HARDY GE, 1995, BRIT J CLIN PSYCHOL, V34, P555, DOI 10.1111/j.2044-8260.1995.tb01489.x; Hay EM, 2003, ANN RHEUM DIS, V62, P394, DOI 10.1136/ard.62.5.394; Howard L, 2006, BRIT J PSYCHIAT, V188, P303, DOI 10.1192/bjp.188.4.303; Johnson RE, 2007, SPINE, V32, P1578, DOI 10.1097/BRS.0b013e318074f890; Kendrick T, 2005, HEALTH TECHNOL ASSES, V9, P1; King M, 2005, HEALTH TECHNOL ASSES, V9, P1; King M, 2005, JAMA-J AM MED ASSOC, V293, P1089, DOI 10.1001/jama.293.9.1089; Kitchener HC, 2006, BJOG-INT J OBSTET GY, V113, P1007, DOI 10.1111/j.1471-0528.2006.01035.x; Klaber Moffett J, 2006, RHEUMATOLOGY, V45, P1514, DOI 10.1093/rheumatology/kel339; Manca A, 2006, INT J TECHNOL ASSESS, V22, P67, DOI 10.1017/S0266462306050859; MCLEAN S, RANDOMISED IN PRESS; McPherson K, 1998, BRIT MED J, V317, P78, DOI 10.1136/bmj.317.7150.78; McPherson K, 1997, J ROY SOC MED, V90, P652, DOI 10.1177/014107689709001205; Moffett JAK, 2005, BRIT MED J, V330, P75, DOI 10.1136/bmj.38286.493206.82; Moffett JK, 1999, BRIT MED J, V319, P279, DOI 10.1136/bmj.319.7205.279; PEPPER J, IN PRESS BMC WOMENS; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Salisbury C, 2005, BMJ-BRIT MED J, V331, P1441, DOI 10.1136/bmj.38670.494734.7C; Salter GC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-99; SHAPIRO DA, 1994, J CONSULT CLIN PSYCH, V62, P522, DOI 10.1037/0022-006X.62.3.522; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Silverman WA, 1996, LANCET, V347, P171, DOI 10.1016/S0140-6736(96)90347-5; Simpson S, 2000, Health Technol Assess, V4, P1; Thomas E, 2004, BRIT J GEN PRACT, V54, P93; Torgerson D J, 1996, J Health Serv Res Policy, V1, P194; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836	32	185	188	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2008	337								a1864	10.1136/bmj.a1864	http://dx.doi.org/10.1136/bmj.a1864			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375RA	18977792	Green Published, hybrid			2022-12-28	WOS:000261129800001
J	van de Koppel, J; Gascoigne, JC; Theraulaz, G; Rietkerk, M; Mooij, WM; Herman, PMJ				van de Koppel, Johan; Gascoigne, Joanna C.; Theraulaz, Guy; Rietkerk, Max; Mooij, Wolf M.; Herman, Peter M. J.			Experimental Evidence for Spatial Self-Organization and Its Emergent Effects in Mussel Bed Ecosystems	SCIENCE			English	Article							PATTERN-FORMATION; SEMIARID VEGETATION; LOCAL INTERACTIONS; SCALE; DYNAMICS; WAVES	Spatial self- organization is the main theoretical explanation for the global occurrence of regular or otherwise coherent spatial patterns in ecosystems. Using mussel beds as a model ecosystem, we provide an experimental demonstration of spatial self- organization. Under homogeneous laboratory conditions, mussels developed regular patterns, similar to those in the field. An individual- based model derived from our experiments showed that interactions between individuals explained the observed patterns. Furthermore, a field study showed that pattern formation affected ecosystem- level processes in terms of improved growth and resistance to wave action. Our results imply that spatial self- organization is an important determinant of the structure and functioning of ecosystems, and it needs to be considered in their conservation.	[van de Koppel, Johan; Herman, Peter M. J.] Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; [Gascoigne, Joanna C.] Univ Wales Bangor, Sch Ocean Sci, Menai Bridge LL59 5AB, Gwynedd, Wales; [Theraulaz, Guy] Univ Toulouse 3, CNRS, Ctr Rech Cognit Animale, UMR 5169, F-31062 Toulouse 04, France; [Rietkerk, Max] Univ Utrecht, Dept Environm Sci, Copernicus Inst, NL-3508 TC Utrecht, Netherlands; [Mooij, Wolf M.] Netherlands Inst Ecol, Aquat Food Webs Dept, NL-3631 AC Nieuwersluis, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Bangor University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van de Koppel, J (corresponding author), Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, POB 140, NL-4400 AC Yerseke, Netherlands.	J.vandeKoppel@nioo.knaw.nl	Theraulaz, Guy/H-8464-2016; Herman, Peter M.J./A-9018-2011; Mooij, Wolf M/C-2677-2008; Rietkerk, Max/H-6235-2011; Van de Koppel, Johan/E-7266-2010	Theraulaz, Guy/0000-0002-3062-4215; Herman, Peter M.J./0000-0003-2188-6341; Mooij, Wolf M/0000-0001-5586-8200; Rietkerk, Max/0000-0002-2698-3848	Schure-Beijerinck-Popping; Royal Dutch Academy of Sciences; Vidi; Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW); Biotechnology and Biological Sciences Research Council [D18866]	Schure-Beijerinck-Popping; Royal Dutch Academy of Sciences; Vidi(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Koutstaal, B. Koutstaal, A. Matkin, and J. van Soelen for their assistance during the field work and lab experiments; K. Mould and J. Wilson for access to their mussel lots; and A. Altieri, M. Bertness, T. Bouma, F. Guichard, M. de Jager, A.-M. Neutel, P. de Ruiter, and B. Silliman for critical discussions and reading of the manuscript. The field work at Bangor was supported by a grant from the Schure-Beijerinck-Popping fund of the Royal Dutch Academy of Sciences to J.v.d.K. The research of M. R. is supported by a personal Vidi grant from the Netherlands Organization of Scientific Research/Earth and Life Sciences (NWO-ALW). J.C.G. was supported by Biotechnology and Biological Sciences Research Council contract D18866. This is publication 4410 of the Netherlands Institute of Ecology (NIOO-KNAW).	Bertness MD, 1998, ECOLOGY, V79, P1382, DOI 10.2307/176750; BERTNESS MD, 1985, OECOLOGIA, V67, P192, DOI 10.1007/BF00384283; Bjornstad ON, 2002, SCIENCE, V298, P1020, DOI 10.1126/science.1075182; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Gascoigne JC, 2005, OECOLOGIA, V145, P371, DOI 10.1007/s00442-005-0137-x; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; Jonsson PR, 2005, LIMNOL OCEANOGR, V50, P1989, DOI 10.4319/lo.2005.50.6.1989; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Levin S., 1999, FRAGILE DOMINION; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; Nicolis G, 1977, SELF ORG NONEQUILIBR; Rietkerk M, 2004, AM NAT, V163, P699, DOI 10.1086/383065; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; SOLE RV, 2006, SELF ORG COMPLEX ECO; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; TYSON JJ, 1989, DEVELOPMENT, V106, P421; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2006, AM NAT, V168, pE136, DOI 10.1086/508671; Wager H, 1911, PHILOS T R SOC LON B, V201; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595	27	178	181	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					739	742		10.1126/science.1163952	http://dx.doi.org/10.1126/science.1163952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974353	Green Submitted			2022-12-28	WOS:000260605200048
J	Gros, J; Serralbo, O; Marcelle, C				Gros, Jerome; Serralbo, Olivier; Marcelle, Christophe			WNT11 acts as a directional cue to organize the elongation of early muscle fibres	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; CELL POLARITY; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAYS; PLANAR POLARITY; NEURAL-TUBE; GASTRULATION; PRICKLE; MEDIATE; CHICK	The early vertebrate skeletal muscle is a well- organized tissue in which the primitive muscle fibres, the myocytes, are all parallel and aligned along the antero- posterior axis of the embryo. How myofibres acquire their orientation during development is unknown. Here we show that during early chick myogenesis WNT11 has an essential role in the oriented elongation of the myocytes. We find that the neural tube, known to drive WNT11 expression in the medial border of somites(1), is necessary and sufficient to orient myocyte elongation. We then show that the specific inhibition of WNT11 function in somites leads to the disorganization of myocytes. We establish that WNT11 mediates this effect through the evolutionary conserved planar cell polarity ( PCP) pathway, downstream of the WNT/beta-catenin-dependent pathway, required to initiate the myogenic program of myocytes and WNT11 expression. Finally, we demonstrate that a localized ectopic source of WNT11 can markedly change the orientation of myocytes, indicating that WNT11 acts as a directional cue in this process. All together, these data show that the sequential action of the WNT/ PCP and the WNT/beta-catenin pathways is necessary for the formation of fully functional embryonic muscle fibres. This study also provides evidence that WNTs can act as instructive cues to regulate the PCP pathway in vertebrates.	[Gros, Jerome; Serralbo, Olivier; Marcelle, Christophe] Univ Aix Marseille 2, CNRS, Dev Biol Inst Marseille Luminy IBDML, UMR 6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marcelle, C (corresponding author), Univ Aix Marseille 2, CNRS, Dev Biol Inst Marseille Luminy IBDML, UMR 6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	marcelle@ibdm.univ-mrs.fr		Gros, Jerome/0000-0002-2264-2851; Serralbo, Olivier/0000-0003-0808-3464	Actions Concertees Incitatives; Agence Nationale de la Recherche; Association Francaise contre les Myopathies; EU 6th Framework Programme Network of Excellence MYORES	Actions Concertees Incitatives; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); EU 6th Framework Programme Network of Excellence MYORES(European Commission)	We thank C. Tabin for critical reading of the manuscript. The help of P. Weber for the two- photon imaging, and of the Zeiss team, are acknowledged. We are grateful to M. Manceau for Supplementary Fig. 1d, and to R. Kanadia for his help. This study was funded by grants from the Actions Concertees Incitatives (ACI), the Agence Nationale de la Recherche (ANR), the Association Francaise contre les Myopathies (AFM) and by the EU 6th Framework Programme Network of Excellence MYORES. J. G. was a Fellow of the AFM.	Anakwe K, 2002, J Anat, V201, P421; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cooper O, 2008, DEV DYNAM, V237, P1442, DOI 10.1002/dvdy.21490; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Ikeya M, 1998, DEVELOPMENT, V125, P4969; Jiang D, 2005, CURR BIOL, V15, P79; Kahane N, 2007, DEV BIOL, V305, P439, DOI 10.1016/j.ydbio.2007.02.030; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Linker C, 2005, DEVELOPMENT, V132, P3895, DOI 10.1242/dev.01961; Linker C, 2003, DEVELOPMENT, V130, P4797, DOI 10.1242/dev.00688; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Montross WT, 2000, J CELL SCI, V113, P1759; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Tada M, 2000, DEVELOPMENT, V127, P2227; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017	35	142	149	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					589	U97		10.1038/nature07564	http://dx.doi.org/10.1038/nature07564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	18987628				2022-12-28	WOS:000262852200043
J	Hilf, RJC; Dutzler, R				Hilf, Ricarda J. C.; Dutzler, Raimund			Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHARGED AMINO-ACIDS; CYS-LOOP; GATING MECHANISM; MONO-VALENT; BINDING; SELECTIVITY; DOMAIN; SOFTWARE; REVEALS	The X- ray structure of a pentameric ligand- gated ion channel from Erwinia chrysanthemi ( ELIC) has recently provided structural insight into this family of ion channels at high resolution(1). The structure shows a homo- pentameric protein with a barrel- stave architecture that defines an ion- conduction pore located on the fivefold axis of symmetry. In this structure, the wide aqueous vestibule that is encircled by the extracellular ligand- binding domains of the five subunits narrows to a discontinuous pore that spans the lipid bilayer. The pore is constricted by bulky hydrophobic residues towards the extracellular side, which probably serve as barriers that prevent the diffusion of ions. This interrupted pore architecture in ELIC thus depicts a non- conducting conformation of a pentameric ligand- gated ion channel, the thermodynamically stable state in the absence of bound ligand. As ligand binding promotes pore opening in these ion channels and the specific ligand for ELIC has not yet been identified, we have turned our attention towards a homologous protein from the cyanobacterium Gloebacter violaceus ( GLIC). GLIC was shown to form proton- gated channels that are activated by a pH decrease on the extracellular side and that do not desensitize after activation(2). Both prokaryotic proteins, ELIC and GLIC form ion channels that are selective for cations over anions with poor discrimination among monovalent cations(1,2), characteristics that resemble the conduction properties of the cation- selective branch of the family that includes acetylcholine and serotonin receptors(3,4). Here we present the X- ray structure of GLIC at 3.1 angstrom resolution. The structure reveals a conformation of the channel that is distinct from ELIC and that probably resembles the open state. In combination, both structures suggest a novel gating mechanism for pentameric ligand- gated ion channels where channel opening proceeds by a change in the tilt of the pore- forming helices.	[Hilf, Ricarda J. C.; Dutzler, Raimund] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch			National Center for Competence in Research; EC FP7	National Center for Competence in Research; EC FP7(European Commission)	We thank B. Blattmann and C. Stutz-Duocommun for assistance with crystal screening, C. Schulze-Briese and the staff of the XO6SA beamline for support during data collection, the protein analysis group at the functional genomics centre of the University of Zurich for help with mass spectrometry, R. MacKinnon for comments on the manuscript and members of the Dutzler laboratory for help in all stages of the project. Data collection was performed at the Swiss Light Source of the Paul Scherrer Institute. The research leading to these results was supported by a grant from the National Center for Competence in Research ( NCCR) in Structural Biology and by an EC FP7 grant for the EDICT consortium (HEALTH-201924). R.J.C.H. is affiliated with the Molecular Life Sciences Ph.D. programme of the University/ETH Zurich.	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; COWTAN K, 1994, AUTOMATED PROCEDURE, P34; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; DANI JA, 1989, J NEUROSCI, V9, P884; DANI JA, 1987, J GEN PHYSIOL, V89, P959, DOI 10.1085/jgp.89.6.959; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leslie AGW, 1992, RECENT CHANGES MOSFL; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tasneem A, 2005, GENOME BIOL, V6; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	42	465	469	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					115	U122		10.1038/nature07461	http://dx.doi.org/10.1038/nature07461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18987630				2022-12-28	WOS:000262104900042
J	Schomer, DL; Black, PM				Schomer, Donald L.; Black, Peter M.			A 24-Year-Old Woman With Intractable Seizures Review of Surgery for Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FRONTAL-LOBE EPILEPSY; LOCALIZATION-RELATED EPILEPSY; REFRACTORY PARTIAL SEIZURES; VAGUS NERVE-STIMULATION; TONIC CLONIC SEIZURES; PRESURGICAL EVALUATION; CONTROLLED-TRIAL; DOUBLE-BLIND; ANTIEPILEPTIC DRUGS; TEMPORAL LOBECTOMY		[Schomer, Donald L.] Beth Israel Deaconess Med Ctr, Div Clin Neurophysiol, Clin Neurophysiol Lab, Boston, MA 02215 USA; [Schomer, Donald L.] Beth Israel Deaconess Med Ctr, Comprehens Epilepsy Program, Boston, MA 02215 USA; [Schomer, Donald L.; Black, Peter M.] Harvard Univ, Sch Med, Boston, MA USA; [Black, Peter M.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Black, Peter M.] Childrens Hosp, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Schomer, DL (corresponding author), Beth Israel Deaconess Med Ctr, Div Clin Neurophysiol, Clin Neurophysiol Lab, 330 Brookline Ave,Baker 504, Boston, MA 02215 USA.	dschomer@bidmc.harvard.edu						AARTS JHP, 1984, BRAIN, V107, P293, DOI 10.1093/brain/107.1.293; Arroyo Santiago, 1993, P377; Assaf BA, 2003, EPILEPSIA, V44, P1320, DOI 10.1046/j.1528-1157.2003.14303.x; AWAD IA, 1991, EPILEPSIA, V32, P179, DOI 10.1111/j.1528-1157.1991.tb05242.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; BARTH DS, 1984, SCIENCE, V223, P293, DOI 10.1126/science.6422552; Begley CE, 2000, EPILEPSIA, V41, P342, DOI 10.1111/j.1528-1157.2000.tb00166.x; BenMenachem E, 1996, EPILEPSIA, V37, P539, DOI 10.1111/j.1528-1157.1996.tb00606.x; Berg A, 2007, EPILEPSY COMPREHENSI, P1929; Berkovic Samuel F., 1993, P233; Blume WT, 2004, EPILEPSIA, V45, P46, DOI 10.1111/j.0013-9580.2004.11203.x; Boon P, 2002, EPILEPSY RES, V48, P77, DOI 10.1016/S0920-1211(01)00323-0; BOURGEOIS BFD, 2006, EPILEPSY SURG PRINCI, V18, P142; Brodie MJ, 2005, EPILEPSIA, V46, P31; BRODIE MJ, 1994, EPILIPSIA, V35, P69; CALLAGHAN N, 1985, J NEUROL NEUROSUR PS, V48, P639, DOI 10.1136/jnnp.48.7.639; CHEE MWL, 1993, NEUROLOGY, V43, P2519, DOI 10.1212/WNL.43.12.2519; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; COHEN AA, 2006, EPILEPSY SURG PRINCI, P100; DAM M, 1997, EPILEPSY COMPREHENSI, P1103; Devinsky O, 2003, JAMA-J AM MED ASSOC, V290, P381, DOI 10.1001/jama.290.3.381; DEVINSKY O, 1993, NEUROL CLIN, V11, P127, DOI 10.1016/S0733-8619(18)30173-7; Duchowny MS, 2007, EPILEPSY COMPREHENSI, P1751; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Engel J, 1993, SURG TREATMENT EPILE, P609; Fenwick Peter B. C., 1993, P273; Fukuchi T, 2002, EPILEPSY RES, V51, P233, DOI 10.1016/S0920-1211(02)00151-1; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; GILCHRIST JM, 1985, NEUROLOGY, V35, P1503, DOI 10.1212/WNL.35.10.1503; Hakimian S, 2006, EPILEPSY SURG PRINCI, P721; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HELMERS SL, 2006, EPILEPSY SURG PRINCI, P597; Henry Thomas R., 1993, P211; HENRY TR, 2007, EPILEPSY COMPREHENSI, P945; Hermann BP, 2002, PROG BRAIN RES, V135, P429; HOUTKOOPER MA, 1987, EPILEPSIA, V28, P693, DOI 10.1111/j.1528-1157.1987.tb03702.x; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; JACKSON GD, 2007, EPILEPSY COMPREHENSI, P917; Jeha LE, 2007, BRAIN, V130, P574, DOI 10.1093/brain/awl364; Jokeit H, 2002, PROG BRAIN RES, V135, P455; JONESGOTMAN M, 1993, SURG TREATMENT EPILE, P273; KAZEMI NJ, 2007, EPILEPSY COMPREHENSI, P965; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Knake S, 2005, NEUROLOGY, V65, P1026, DOI 10.1212/01.wnl.0000179355.04481.3c; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lambert MV, 1999, EPILEPSIA, V40, pS21, DOI 10.1111/j.1528-1157.1999.tb00884.x; LASKOWITZ DT, 1995, NEUROLOGY, V45, P780, DOI 10.1212/WNL.45.4.780; Lee SK, 2005, ANN NEUROL, V58, P525, DOI 10.1002/ana.20569; Leppik I, 2003, EPILEPSIA, V44, P1350, DOI 10.1046/j.1528-1157.2003.62802.x; Loring DW, 2004, NEUROLOGY, V62, P872, DOI 10.1212/01.WNL.0000115653.82763.07; LORING DW, 2007, EPILEPSY COMPREHENSI, P1057; Lucas TH, 2006, EPILEPSY SURG PRINCI, P541; Marson AG, 2001, EPILEPSY RES, V46, P259, DOI 10.1016/S0920-1211(01)00287-X; MATTHEWS WS, 1981, PSYCHOSOMATICS, V22, P515; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; MAYER CL, 2006, EPILEPSY EPILEPSY SU, P353; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; MORRIS HH, 1988, NEUROLOGY, V38, P1075, DOI 10.1212/WNL.38.7.1075; Mosewich RK, 2000, EPILEPSIA, V41, P843, DOI 10.1111/j.1528-1157.2000.tb00251.x; Mueller SG, 2003, EPILEPSIA, V44, P977, DOI 10.1046/j.1528-1157.2003.50202.x; MUELLER SG, 2006, EPILEPSY SURG PRINCI, P347; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; Natelson BH, 1998, ARCH NEUROL-CHICAGO, V55, P857, DOI 10.1001/archneur.55.6.857; Nilsson L, 2002, EPILEPSIA, V43, P644, DOI 10.1046/j.1528-1157.2002.40001.x; Ojemann George A., 1993, P399; OLIVIER A, 1995, ADV NEUROL, V66, P321; PACIA SV, 1994, NEUROLOGY, V44, P1408, DOI 10.1212/WNL.44.8.1408; Picard F, 1999, EPILEPSIA, V40, P1198, DOI 10.1111/j.1528-1157.1999.tb00848.x; POLKEY CE, 2008, EPILEPSY COMPREHENSI, P1921; Privitera M, 1996, NEUROLOGY, V46, P1678, DOI 10.1212/WNL.46.6.1678; RAUSCH R, 2006, EPILEPSY SURG PRINCI, P183; REINIKAINEN KJ, 1987, EPILEPSY RES, V1, P284, DOI 10.1016/0920-1211(87)90003-9; REYNOLDS EH, 1975, EPILEPSIA, V16, P319, DOI 10.1111/j.1528-1157.1975.tb06062.x; ROBERTS DW, 2007, EPILEPSY COMPREHENSI, P1907; ROWE CC, 2006, EPILEPSY SURG PRINCI, P383; SALANOVA V, 1993, ARCH NEUROL-CHICAGO, V50, P294, DOI 10.1001/archneur.1993.00540030058015; SCHACHTER SC, 1995, J EPILEPSY, V8, P201, DOI 10.1016/0896-6974(95)00034-B; Schachter SC, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.6_suppl_4.S15; Schiller Y, 1998, EPILEPSIA, V39, P380, DOI 10.1111/j.1528-1157.1998.tb01390.x; SCHMIDT D, 1983, EPILEPSIA, V24, P368, DOI 10.1111/j.1528-1157.1983.tb04900.x; SCHMIDT D, 1983, J NEUROL, V229, P221, DOI 10.1007/BF00313550; Schramm J, 2002, NEUROSURGERY, V51, P644, DOI 10.1097/00006123-200209000-00008; Shimizu H, 2000, NEUROSURGERY, V47, P367, DOI 10.1097/00006123-200008000-00018; Siegel AM, 2001, EPILEPSIA, V42, P883, DOI 10.1046/j.1528-1157.2001.042007883.x; SILANPAA ML, 2006, EPILEPSY SURG PRINCI, P153; SINGH B, 1993, EPILEPSIA, V34, P901, DOI 10.1111/j.1528-1157.1993.tb02109.x; Smith JR, 1997, STEREOT FUNCT NEUROS, V69, P202, DOI 10.1159/000099875; SMITH JR, 2006, EPILEPSY SURG PRINCI, P730; SORELL TC, 1971, LANCET, V2, P1233; Spencer S. S., 2007, EPILEPSY COMPREHENSI, P1791; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; Spencer SS, 1996, EPILEPSIA, V37, P807, DOI 10.1111/j.1528-1157.1996.tb00032.x; SPENCER SS, 1995, MAGN RESON IMAGING, V13, P1119, DOI 10.1016/0730-725X(95)02021-K; Spencer Susan S., 1993, P359; Stefan H, 2000, J CLIN NEUROPHYSIOL, V17, P190, DOI 10.1097/00004691-200003000-00008; Tassinari K., 2007, EPILEPSY COMPREHENSI, P585; TAYLOR DC, 1968, BRIT J PSYCHIAT, V114, P1247, DOI 10.1192/bjp.114.515.1247; Tellez-Zenteno JF, 2007, BRAIN, V130, P334, DOI 10.1093/brain/awl316; Tozer K, 2006, EPILEPSY SURG PRINCI, P507; WESTERVELD M, 2006, EPILEPSY SURG PRINCI, P148; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; WIESER HG, 1995, ADV NEUROL, V66, P297; WIESER HG, 2007, EPILEPSY COMPREHENSI, P1779; Williamson Peter D., 1993, P65; Won HJ, 1999, AM J NEURORADIOL, V20, P593	107	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2008	300	21					2527	2538		10.1001/jama.2008.709	http://dx.doi.org/10.1001/jama.2008.709			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377XR	18984876				2022-12-28	WOS:000261286200021
J	Kahn, SR; Shrier, I; Julian, JA; Ducruet, T; Arsenault, L; Miron, MJ; Roussin, A; Desmarais, S; Joyal, F; Kassis, J; Solymoss, S; Desjardins, L; Lamping, DL; Johri, M; Ginsberg, JS				Kahn, Susan R.; Shrier, Ian; Julian, Jim A.; Ducruet, Thierry; Arsenault, Louise; Miron, Marie-Jose; Roussin, Andre; Desmarais, Sylvie; Joyal, France; Kassis, Jeannine; Solymoss, Susan; Desjardins, Louis; Lamping, Donna L.; Johri, Mira; Ginsberg, Jeffrey S.			Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; VEIN THROMBOSIS; COMPRESSION STOCKINGS; RISK-FACTORS; ASSOCIATION; DIAGNOSIS; DISEASE; ULCERS; IMPACT; TRIAL	Background: The reason some patients with deep venous thrombosis (DVT) develop the postthrombotic syndrome is not well understood. Objective: To determine the frequency, time course, and predictors of the postthrombotic syndrome after acute DVT. Design: Prospective, multicenter cohort study. Setting: 8 Canadian hospital centers. Patients: 387 outpatients and inpatients who received an objective diagnosis of acute symptomatic DVT were recruited from 2001 to 2004. Measurements: Standardized assessments for the postthrombotic syndrome using the Villalta scale at 1, 4, 8, 12, and 24 months after enrollment. Mean postthrombotic score and severity category at each interval was calculated. Predictors of postthrombotic score profiles over time since diagnosis of DVT were identified by using linear mixed modeling. Results: At all study intervals, about 30% of patients had mild (score, 5 to 9), 10% had moderate (score, 10 to 14), and 3% had severe (score >14 or ulcer) postthrombotic syndrome. Greater postthrombotic severity category at the 1-month visit strongly predicted higher mean postthrombotic scores throughout 24 months of follow-up (1.97, 5.03, and 7.00 increase in Villalta score for mild, moderate, and severe 1-month severity categories, respectively, vs. none; P < 0.001). Additional predictors of higher scores over time were venous thrombosis of the common femoral or iliac vein (2.23 increase in score vs. distal [calf] venous thrombosis; P < 0.001), higher body mass index (0.14 increase in score per kg/m(2); P < 0.001), previous ipsilateral venous thrombosis (1.78 increase in score; P = 0.001), older age (0.30 increase in score per 10-year age increase; P = 0.011), and female sex (0.79 increase in score; P = 0.020). Limitations: Decisions to prescribe compression stockings were left to treating physicians rather than by protocol. Because international normalized ratio data were unavailable, the relationship between anticoagulation quality and Villalta scores could not be assessed. Conclusion: The postthrombotic syndrome occurs frequently after DVT. Patients with extensive DVT and those with more severe postthrombotic manifestations 1 month after DVT have poorer long-term outcomes.	[Kahn, Susan R.] Sir Mortimer B Davis Jewish Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Ctr Hlth, Montreal, PQ H3T 1E2, Canada; Ctr Hosp Univ Montreal, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada; McMaster Univ, Med Ctr, Hamilton, ON, Canada; McMaster Univ, Henderson Res Ctr, Hamilton, ON, Canada; Ctr Hosp Pierre Boucher, Longueuil, PQ, Canada; Univ Laval, Quebec City, PQ, Canada; London Sch Hyg & Trop Med, Res Unit, Hlth Serv, London WC1, England	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McMaster University; McMaster University; Laval University; University of London; London School of Hygiene & Tropical Medicine	Kahn, SR (corresponding author), Sir Mortimer B Davis Jewish Hosp, Ctr Clin Epidemiol & Community Studies, 3755 Cote St Catherine,Room A-127, Montreal, PQ H3T 1E2, Canada.	susan.kahn@mcgill.ca	Shrier, Ian/AAI-6502-2020; ginsberg, jeffrey s/ABC-1065-2020; Johri, Mira/D-5104-2013	Shrier, Ian/0000-0001-9914-3498; Johri, Mira/0000-0001-5642-787X				[Anonymous], 1994, HAEMOSTASIS S1; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Campbell A, 2007, BMJ-BRIT MED J, V334, P674, DOI 10.1136/bmj.39098.583356.55; Hyers TM, 2001, CHEST, V119, p176S, DOI 10.1378/chest.119.1_suppl.176S; Kahn SR, 2005, ARCH INTERN MED, V165, P1173, DOI 10.1001/archinte.165.10.1173; Kahn SR, 2005, J THROMB HAEMOST, V3, P718, DOI 10.1111/j.1538-7836.2005.01216.x; Kahn SR, 2002, ARCH INTERN MED, V162, P1144, DOI 10.1001/archinte.162.10.1144; Kahn SR, 2006, BRIT J HAEMATOL, V134, P357, DOI 10.1111/j.1365-2141.2006.06200.x; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kolbach DN, 2005, EUR J VASC ENDOVASC, V30, P404, DOI 10.1016/j.ejvs.2005.06.006; LENSING AWA, 1992, THROMB HAEMOSTASIS, V67, P8; O'Donnell MJ, 2008, THROMB HAEMOSTASIS, V99, P623, DOI 10.1160/TH07-09-0546; Piovella F, 2002, HAEMATOLOGICA, V87, P515; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2005, J THROMB HAEMOST, V3, P401, DOI 10.1111/j.1538-7836.2004.01106.x; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rodger MA, 2008, THROMB HAEMOSTASIS, V100, P164, DOI 10.1160/TH07-11-0678; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Ruckley CV, 1997, ANGIOLOGY, V48, P67, DOI 10.1177/000331979704800111; Smith JJ, 2000, J VASC SURG, V31, P642, DOI 10.1067/mva.2000.104103; Stain M, 2005, J THROMB HAEMOST, V3, P2671, DOI 10.1111/j.1538-7836.2005.01648.x; Van Dongen CJJ, 2005, J THROMB HAEMOST, V3, P939; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Yamamoto K, 2005, CARDIOVASC RES, V66, P276, DOI 10.1016/j.cardiores.2004.11.013	27	570	605	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2008	149	10					698	U7		10.7326/0003-4819-149-10-200811180-00004	http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373FL	19017588				2022-12-28	WOS:000260956300002
J	Creager, ANH				Creager, Angela N. H.			Atomic transfiguration	LANCET			English	Editorial Material									[Creager, Angela N. H.] Princeton Univ, Dept Hist, Princeton, NJ 08544 USA; [Creager, Angela N. H.] Princeton Univ, Program Hist Sci, Princeton, NJ 08544 USA	Princeton University; Princeton University	Creager, ANH (corresponding author), Princeton Univ, Dept Hist, Princeton, NJ 08544 USA.	creager@princeton.edu		Creager, Angela/0000-0002-7763-6432	NLM NIH HHS [5G13LM009100-2, G13 LM009100-02, G13 LM009100] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [G13LM009100] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Creager ANH, 2006, J HIST BIOL, V39, P649, DOI 10.1007/s10739-006-9108-2; Heilbron J., 1989, LAWRENCE HIS LAB HIS, DOI DOI 10.1525/9780520341081; Rentetzi M, 2007, TRAFFICKING MAT GEND; Walker J. Samuel, 2000, PERMISSIBLE DOSE HIS; Welsome Eileen, 1999, PLUTONIUM FILES AM S	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1726	1727		10.1016/S0140-6736(08)61721-3	http://dx.doi.org/10.1016/S0140-6736(08)61721-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19018613	Green Accepted			2022-12-28	WOS:000261077900013
J	Polo, S; Di Fiore, PP				Polo, Simona; Di Fiore, Pier Paolo			Finding the Right Partner: Science or ART?	CELL			English	Editorial Material							UBIQUITIN	In response to environmental cues, certain plasma membrane proteins are ubiquitinated, signaling their endocytosis and degradation. In the budding yeast, a single enzyme, Rsp5, is charged with this task. Lin et al. (2008) now identify an arrestin-related family of Rsp5 adaptor proteins called ARTs that confer specificity on the ubiquitination of plasma membrane proteins and contribute to the maintenance of the correct cell surface protein repertoire.	[Polo, Simona; Di Fiore, Pier Paolo] Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Polo, Simona; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirur & Odontoiatria, I-20122 Milan, Italy; [Di Fiore, Pier Paolo] Ist Europeo Oncol, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO)	Polo, S (corresponding author), Ist FIRC Oncol Mol, IFOM, Via Adamello 16, I-20139 Milan, Italy.	simona.polo@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Polo, Simona/P-3509-2014; Di Fiore, Pier Paolo/K-2130-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Polo, Simona/0000-0001-5536-9399	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050	8	27	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					590	592		10.1016/j.cell.2008.10.032	http://dx.doi.org/10.1016/j.cell.2008.10.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013267	Bronze			2022-12-28	WOS:000260886900007
J	Shah, NS; Pratt, R; Armstrong, L; Robison, V; Castro, KG; Cegielski, JP				Shah, N. Sarita; Pratt, Robert; Armstrong, Lori; Robison, Valerie; Castro, Kenneth G.; Cegielski, J. Peter			Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	National-TB-Controllers-Association Meeting 2006	JUN 13, 2006	Atlanta, GA	Natl TB Controllers Assoc			MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; SURVEILLANCE; PREVENTION; LIMA; TB	Context Worldwide emergence of extensively drug-resistant tuberculosis (XDR-TB) has raised global public health concern, given the limited therapy options and high mortality. Objectives To describe the epidemiology of XDR-TB in the United States and to identify unique characteristics of XDR- TB cases compared with multidrug- resistant TB (MDR-TB) and drug- susceptible TB cases. Design, Setting, and Patients Descriptive analysis of US TB cases reported from 1993 to 2007. Extensively drug- resistant TB was defined as resistance to isoniazid, a rifamycin, a fluoroquinolone, and at least 1 of amikacin, kanamycin, or capreomycin based on drug susceptibility test results from initial and follow- up specimens. Main Outcome Measures Extensively drug- resistant TB case counts and trends, risk factors for XDR- TB, and overall survival. Results A total of 83 cases of XDR- TB were reported in the United States from 1993 to 2007. The number of XDR- TB cases declined from 18 ( 0.07% of 25 107 TB cases) in 1993 to 2 ( 0.02% of 13 293 TB cases) in 2007, reported to date. Among those with known human immunodeficiency virus ( HIV) test results, 31 ( 53%) were HIV- positive. Compared with MDR- TB cases, XDR- TB cases were more likely to have disseminated TB disease ( prevalence ratio [ PR], 2.06; 95% confidence interval [ CI], 1.19- 3.58), less likely to convert to a negative sputum culture ( PR, 0.55; 95% CI, 0.33-0.94), and had a prolonged infectious period ( median time to culture conversion, 183 days vs 93 days for MDR- TB; P <. 001). Twenty- six XDR- TB cases ( 35%) died during treatment, of whom 21 ( 81%) were known to be HIV- infected. Mortality was higher among XDR- TB cases than among MDR- TB cases ( PR, 1.82; 95% CI, 1.10- 3.02) and drug- susceptible TB cases ( PR, 6.10; 95% CI, 3.65- 10.20). Conclusion Although the number of US XDR- TB cases has declined since 1993, coinciding with improved TB and HIV/ AIDS control, cases continue to be reported each year.	[Shah, N. Sarita; Pratt, Robert; Armstrong, Lori; Robison, Valerie; Castro, Kenneth G.; Cegielski, J. Peter] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Cegielski, JP (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, 1600 Clifton Rd,Mailstop E-10, Atlanta, GA 30333 USA.	gzc2@cdc.gov	Castro, Kenneth G/P-1882-2018	Castro, Kenneth G/0000-0001-7964-6354				Albalak R, 2007, ARCH INTERN MED, V167, P2443, DOI 10.1001/archinte.167.22.2443; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P741; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P245; Balabanova Y, 2005, EUR J CLIN MICROBIOL, V24, P136, DOI 10.1007/s10096-004-1268-4; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Blower S, 2007, LANCET INFECT DIS, V7, P443, DOI 10.1016/S1473-3099(07)70143-3; Curtis AB, 2001, AM J PREV MED, V20, P108, DOI 10.1016/S0749-3797(00)00284-1; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Kam KM, 2004, INT J TUBERC LUNG D, V8, P760; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Migliori GB, 2007, EUROSURVEILLANCE, V12, P5, DOI DOI 10.2807/ESW.12.20.03194-EN; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; Pardini M, 2005, EMERG INFECT DIS, V11, P501, DOI 10.3201/eid1103.040903; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Prammananan T, 2005, INT J TUBERC LUNG D, V9, P216; Rajbhandary SS, 2004, INT J TUBERC LUNG D, V8, P1012; Raviglione MC, 2008, NEW ENGL J MED, V359, P636, DOI 10.1056/NEJMe0804906; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Shah N. S., 2007, Morbidity and Mortality Weekly Report, V56, P250; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Snider DE, 1998, NEW ENGL J MED, V338, P1689, DOI 10.1056/NEJM199806043382309; Sprinson JE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-217; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Timperi R, 2005, INT J TUBERC LUNG D, V9, P175; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; Ward HA, 2005, INT J TUBERC LUNG D, V9, P164; WHO, 2008, GLOBAL TUBERCULOSIS; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	40	84	92	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2153	2160		10.1001/jama.300.18.2153	http://dx.doi.org/10.1001/jama.300.18.2153			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	370WM	19001626	Bronze			2022-12-28	WOS:000260793800025
J	Grabbe, C; Dikic, I				Grabbe, Caroline; Dikic, Ivan			CELL BIOLOGY Going Global on Ubiquitin	SCIENCE			English	Editorial Material							PROTEOMICS APPROACH; PROTEASOME SYSTEM; PROTEINS; DEGRADATION; SIGNALS		[Grabbe, Caroline; Dikic, Ivan] Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; [Dikic, Ivan] Mediterranean Inst Life Sci, Split 21000, Croatia; [Dikic, Ivan] Univ Split, Sch Med, Dept Immunol, Split 21000, Croatia	Goethe University Frankfurt; University of Split	Grabbe, C (corresponding author), Univ Frankfurt, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511				Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Ota K, 2008, GENES CELLS, V13, P1075, DOI 10.1111/j.1365-2443.2008.01228.x; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peng JM, 2008, BMB REP, V41, P177, DOI 10.5483/BMBRep.2008.41.3.177; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	14	3	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					872	873		10.1126/science.1166845	http://dx.doi.org/10.1126/science.1166845			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988833				2022-12-28	WOS:000260674100028
J	Takahashi, JS; Shimomura, K; Kumar, V				Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek			Searching for Genes Underlying Behavior: Lessons from Circadian Rhythms	SCIENCE			English	Editorial Material							DROSOPHILA PERIOD GENE; INDIVIDUAL FIBROBLASTS; PHENOTYPIC VARIATION; REVEALS PERSISTENT; CLOCK GENE; MOUSE; MICE; MUTAGENESIS; EXPRESSION; CLONING	The success of forward genetic ( from phenotype to gene) approaches to uncover genes that drive the molecular mechanism of circadian clocks and control circadian behavior has been unprecedented. Links among genes, cells, neural circuits, and circadian behavior have been uncovered in the Drosophila and mammalian systems, demonstrating the feasibility of finding single genes that have major effects on behavior. Why was this approach so successful in the elucidation of circadian rhythms? This article explores the answers to this question and describes how the methods used successfully for identifying the molecular basis of circadian rhythms can be applied to other behaviors such as anxiety, addiction, and learning and memory.	[Takahashi, Joseph S.; Kumar, Vivek] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Takahashi, Joseph S.; Shimomura, Kazuhiro; Kumar, Vivek] Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Northwestern University	Takahashi, JS (corresponding author), Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Kumar, Vivek/0000-0001-6643-7465	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078024, P50MH074924, U01MH061915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [F32 DA024556] Funding Source: Medline; NIMH NIH HHS [R01 MH078024, P50 MH074924, U01 MH61915, U01 MH061915] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Beier DR, 2000, MAMM GENOME, V11, P594, DOI 10.1007/s003350010113; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kile BT, 2005, NAT REV GENET, V6, P557, DOI 10.1038/nrg1636; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Matynia A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002121; Moortgat KT, 2000, J NEUROPHYSIOL, V83, P971, DOI 10.1152/jn.2000.83.2.971; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Strunk KE, 2004, GENETICS, V167, P1821, DOI 10.1534/genetics.103.020495; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thomsen M, 2007, BEHAV GENET, V37, P101, DOI 10.1007/s10519-006-9097-0; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	43	70	72	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					909	912		10.1126/science.1158822	http://dx.doi.org/10.1126/science.1158822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988844	Green Accepted			2022-12-28	WOS:000260674100037
J	Weixlbaumer, A; Jin, H; Neubauer, C; Voorhees, RM; Petry, S; Kelley, AC; Ramakrishnan, V				Weixlbaumer, Albert; Jin, Hong; Neubauer, Cajetan; Voorhees, Rebecca M.; Petry, Sabine; Kelley, Ann C.; Ramakrishnan, Venki			Insights into Translational Termination from the Structure of RF2 Bound to the Ribosome	SCIENCE			English	Article							PEPTIDYL-TRANSFER-RNA; POLYPEPTIDE RELEASE FACTORS; STOP CODON RECOGNITION; GGQ MOTIF; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BOND FORMATION; MESSENGER-RNA; 70S RIBOSOME; HYDROLYSIS	The termination of protein synthesis occurs through the specific recognition of a stop codon in the A site of the ribosome by a release factor ( RF), which then catalyzes the hydrolysis of the nascent protein chain from the P- site transfer RNA. Here we present, at a resolution of 3.5 angstroms, the crystal structure of RF2 in complex with its cognate UGA stop codon in the 70S ribosome. The structure provides insight into how RF2 specifically recognizes the stop codon; it also suggests a model for the role of a universally conserved GGQ motif in the catalysis of peptide release.	[Weixlbaumer, Albert; Jin, Hong; Neubauer, Cajetan; Voorhees, Rebecca M.; Petry, Sabine; Kelley, Ann C.; Ramakrishnan, Venki] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Weixlbaumer, Albert/AAI-8474-2021; Neubauer, Cajetan/B-8935-2016; Weixlbaumer, Albert/P-3587-2016	Weixlbaumer, Albert/0000-0001-9635-3844; Neubauer, Cajetan/0000-0002-5348-5609; Weixlbaumer, Albert/0000-0001-9635-3844; VOORHEES, REBECCA/0000-0003-1640-2293; Ramakrishnan, V/0000-0002-4699-2194; Jin, Hong/0000-0003-2027-9435	MRC UK; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Boehringer-Ingelheim fellowship; Gates-Cambridge fellowship; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Boehringer-Ingelheim fellowship(Boehringer Ingelheim); Gates-Cambridge fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Schmeing for his useful comments and M. Fuchs and C. Schulze-Briese for their help and advice with data collection at the Swiss Light Source. This work was supported by MRC UK, a program grant from the Wellcome Trust, and awards from the Agouron Institute and Louis- Jeantet Foundation. C.N. is supported by a Boehringer-Ingelheim fellowship and R.M.V. is supported by a Gates-Cambridge fellowship. Coordinates for the structure have been deposited in the Protein Data Bank with accession codes 2jl5 to 2jl8. V.R. holds stock options in Rib-X Pharmaceuticals, a company that develops antibacterial drugs that target the ribosome.	Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Ejby M, 2007, P NATL ACAD SCI USA, V104, P19410, DOI 10.1073/pnas.0706558104; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zoldak G, 2007, NUCLEIC ACIDS RES, V35, P1343, DOI 10.1093/nar/gkl696	30	232	282	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					953	956		10.1126/science.1164840	http://dx.doi.org/10.1126/science.1164840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988853	Green Accepted			2022-12-28	WOS:000260674100050
J	Meulenbeld, HJ; Peters, W				Meulenbeld, Hielke J.; Peters, Wim			Binocular Proptosis in Orbital Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Meulenbeld, Hielke J.; Peters, Wim] Catharina Ziekenhuis Eindhoven, NL-5623 Eindhoven, Netherlands	Catharina Hospital	Meulenbeld, HJ (corresponding author), Catharina Ziekenhuis Eindhoven, NL-5623 Eindhoven, Netherlands.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					E23	E23		10.1056/NEJMicm072496	http://dx.doi.org/10.1056/NEJMicm072496			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987365				2022-12-28	WOS:000260632700009
J	Davidoff, F; Batalden, P; Stevens, D; Ogrinc, G; Mooney, S				Davidoff, Frank; Batalden, Paul; Stevens, David; Ogrinc, Greg; Mooney, Susan		SQUIRE Dev Grp	Publication Guidelines for Improvement Studies in Health Care: Evolution of the SQUIRE Project	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; QUALITY IMPROVEMENT; STANDARDS; STEP	In 2005, draft guidelines were published for reporting studies of quality improvement as the initial step in a consensus process for development of a more definitive version. The current article contains the revised version, which we refer to as Standards for QUality Improvement Reporting Excellence (SQUIRE). This narrative progress report summarizes the special features of improvement that are reflected in SQUIRE and describes major differences between SQUIRE and the initial draft guidelines. It also explains the development process, which included formulation of responses to informal feedback, written commentaries, and input from publication guideline developers; ongoing review of the literature on the epistemology of improvement and methods for evaluating complex social programs; and a meeting of stakeholders for critical review of the guidelines' content and wording, followed by commentary on sequential versions from an expert consultant group. Finally, the report discusses limitations of and unresolved questions about SQUIRE; ancillary supporting documents and alternative versions under development; and plans for dissemination, testing, and further development of SQUIRE.	Inst Healthcare Improvement, Cambridge, MA USA; Dartmouth Inst Hlth Policy & Clin Practice, Ctr Leadership & Improvement, Lebanon, NH USA	Institute for Healthcare Improvement; Dartmouth College	Davidoff, F (corresponding author), 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088; Barbour, Virginia/0000-0002-2358-2440; Boutron, Isabelle/0000-0002-5263-6241; von Elm, Erik/0000-0002-7412-0406; Ravaud, Philippe/0000-0001-8264-9206	Robert Wood Johnson Foundation [58073]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	The SQUIRE project was supported in part by grant 58073 from the Robert Wood Johnson Foundation.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Baker GR, 2006, QUAL SAF HEALTH CARE, V15, P150, DOI 10.1136/qshc.2005.017103; Batalden P, 2007, JAMA-J AM MED ASSOC, V298, P1059, DOI 10.1001/jama.298.9.1059; Berwick DM, 2005, QUAL SAF HEALTH CARE, V14, P315, DOI 10.1136/qshc.2005.015669; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Chin MH, 2006, QUAL SAF HEALTH CARE, V15, P79, DOI 10.1136/qshc.2006.017749; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; DAY RA, 1989, J AM MED WRITERS ASS, V4, P16; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; *EQUATOR NETW, ENH QUALITY TRANSP H; Gawande Atul, 2007, New Yorker, P86; GLOUBERMAN S, 2004, HLTH CARE SERVICES P; HUTH EJ, 1999, WRITING PUBLISHING M, P63; JADAD AR, 2007, RANDOMIZED CONTROLLE; JANISSE T, 2007, PERMANENTE J, V11, P1; JENNINGS B, 2007, HLTH CARE QUALITY IM; Keech A., 2007, INTERPRETING REPORTI; Kolb D.A, 2014, EXPERIENTIAL LEARNIN, V2nd ed., DOI DOI 10.1016/B978-0-7506-7223-8.50017-4; Lynn J, 2007, ANN INTERN MED, V146, P666, DOI 10.7326/0003-4819-146-9-200705010-00155; Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058; Pawson R., 1997, REALISTIC EVALUATION; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Pronovost P, 2006, QUAL SAF HEALTH CARE, V15, P152, DOI 10.1136/qshc.2006.018432; *QUAL SAF HLTH CAR, GUID AUTH GUID SUBM; RENNIE D, 1995, JAMA-J AM MED ASSOC, V273, P1054, DOI 10.1001/jama.273.13.1054; RUTLEDGE A, CREATIVITY; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; Thomson RG, 2005, QUAL SAF HEALTH CARE, V14, P317, DOI 10.1136/qshc.2005.015727; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Walshe K, 2002, QUAL SAF HEALTH CARE, V11, P85, DOI 10.1136/qhc.11.1.85; WILLIAMS JW, 1995, JAMA-J AM MED ASSOC, V273, P1015, DOI 10.1001/jama.273.13.1015	33	93	93	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					670	+		10.7326/0003-4819-149-9-200811040-00009	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18981488				2022-12-28	WOS:000260585700007
J	Gruen, RL; Elliott, JH; Nolan, ML; Lawton, PD; Parkhill, A; McLaren, CJ; Lavis, JN				Gruen, Russell L.; Elliott, Julian H.; Nolan, Monica L.; Lawton, Paul D.; Parkhill, Anne; McLaren, Cameron J.; Lavis, John N.			Sustainability science: an integrated approach for health-programme planning	LANCET			English	Article							PROMOTION INTERVENTIONS; SERVICE ORGANIZATIONS; ABORIGINAL COMMUNITY; REMOTE AUSTRALIA; DIABETES CARE; POLICY-MAKERS; FOLLOW-UP; PROJECTS; POPULATION; AFRICA	Planning for programme sustainability is a key contributor to health and development, especially in low-income and middle-income countries. A consensus evidence-based operational framework would facilitate policy and research advances in understanding, measuring, and improving programme sustainability. We did a systematic review of both conceptual frameworks and empirical studies about health-programme sustainability. On the basis of the review, we propose that sustainable health programmes are regarded as complex systems that encompass programmes, health problems targeted by programmes, and programmes' drivers or key stakeholders, all of which interact dynamically within any given context. We show the usefulness of this approach with case studies drawn from the authors' experience.	[Gruen, Russell L.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia; [Elliott, Julian H.] Monash Univ, Alfred Hosp, Infect Dis Unit, Melbourne, Vic 3181, Australia; [Elliott, Julian H.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3181, Australia; [Nolan, Monica L.] Mothers2mothers, Cape Town, South Africa; [Lawton, Paul D.] Royal Darwin Hosp, No Terr Rebal Serv, Darwin, NT, Australia; [Parkhill, Anne] Aptly Informat Design, Melbourne, Vic, Australia; [McLaren, Cameron J.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Lavis, John N.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Lavis, John N.] McMaster Univ, Dept Polit Sci, Hamilton, ON, Canada; [Lavis, John N.] McMaster Univ, Ctr Hlth Econ & Policy, Hamilton, ON, Canada	Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; Burnet Institute; University of New South Wales Sydney; McMaster University; McMaster University; McMaster University	Gruen, RL (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Ctr Med Res Bldg, Parkville, Vic 3050, Australia.	rgruen@unimelb.edu.au	Lavis, John N/I-7555-2013; Lawton, Paul/AAF-4345-2019; Parkhill, Anne/Y-4377-2019	Lavis, John N/0000-0001-7917-3657; Lawton, Paul/0000-0002-5754-4821; McLaren, Cameron/0000-0001-6742-4762; Parkhill, Anne/0000-0001-9419-0017	National Health and Medical Research Council Career Development Award; Canada Research Chair in Knowledge Transfer and Exchange	National Health and Medical Research Council Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Canada Research Chair in Knowledge Transfer and Exchange(Canada Research Chairs)	RLG is supported by a National Health and Medical Research Council Career Development Award, and JNL receives salary support is the Canada Research Chair in Knowledge Transfer and Exchange.	Ah Kit J, 2003, AUSTR J PRIMARY HLTH, V9, P168, DOI DOI 10.1071/PY03043; Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bailie RS, 2007, MED J AUSTRALIA, V186, P525, DOI 10.5694/j.1326-5377.2007.tb01028.x; Barnett LM, 2004, HEALTH PROMOT INT, V19, P281, DOI 10.1093/heapro/dah302; Baum F, 2006, HEALTH PROMOT INT, V21, P259, DOI 10.1093/heapro/dal023; Blasinsky M, 2006, ADM POLICY MENT HLTH, V33, P718, DOI 10.1007/s10488-006-0086-7; Bloom BR, 2007, P NATL ACAD SCI USA, V104, P15969, DOI 10.1073/pnas.0704701104; BOSSERT TJ, 1990, SOC SCI MED, V30, P1015, DOI 10.1016/0277-9536(90)90148-L; BRACHT N, 1994, HEALTH EDUC RES, V9, P243, DOI 10.1093/her/9.2.243; Buse K, 2008, HEALTH POLICY PLANN, V23, P351, DOI 10.1093/heapol/czn026; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Edwards NC, 2006, CAN J PUBLIC HEALTH, V97, P45, DOI 10.1007/BF03405214; Elder JP, 1998, AM J HEALTH PROMOT, V12, P391, DOI 10.4278/0890-1171-12.6.391; Eliason RN, 1999, HEALTH PROMOT INT, V14, P301, DOI 10.1093/heapro/14.4.301; Elshaug AG, 2008, INT J TECHNOL ASSESS, V24, P1, DOI 10.1017/S0266462307080014; Evashwick C, 2003, FAM COMMUNITY HEALTH, V26, P177, DOI 10.1097/00003727-200307000-00003; Farmer J, 2003, SOC SCI MED, V57, P673, DOI 10.1016/S0277-9536(02)00410-0; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Friedman AR, 2006, HEALTH PROMOT PRACT, V7, pS140, DOI 10.1177/1524839906287058; GLASER EM, 1981, KNOWLEDGE, V3, P167, DOI 10.1177/107554708100300204; Goodman RM, 1989, FAM COMMUNITY HEALTH, V11, P63, DOI DOI 10.1097/00003727-198902000-00009; Goodson P, 2001, AM J PREV MED, V20, P184, DOI 10.1016/S0749-3797(00)00310-X; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gruen RL, 2005, B WORLD HEALTH ORGAN, V83, P480; Gruen RL, 2002, J EPIDEMIOL COMMUN H, V56, P517, DOI 10.1136/jech.56.7.517; Gruen RL, 2006, LANCET, V368, P130, DOI 10.1016/S0140-6736(06)68812-0; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Hii Jeffrey L. K., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P512; Hoque BA, 1996, B WORLD HEALTH ORGAN, V74, P431; Humphreys John S, 2006, Aust J Rural Health, V14, P33, DOI 10.1111/j.1440-1584.2006.00750.x; *INSR ORC MACR, 2008, RWAND MIN HLTH SURV; *INSR ORC MACR, 2006, RWAND DEM HLTH SURV; Israr SM, 2006, INT J HEALTH PLAN M, V21, P313, DOI 10.1002/hpm.852; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Knippenberg R, 1997, INT J HEALTH PLAN M, V12, pS9, DOI 10.1002/(SICI)1099-1751(199706)12:1+<S9::AID-HPM471>3.3.CO;2-U; Lafond AK, 1995, HEALTH POLICY PLANN, V10, P63; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; LEE AJ, 1995, MED J AUSTRALIA, V162, P632, DOI 10.5694/j.1326-5377.1995.tb126048.x; Lee PW, 2007, J AM BOARD FAM MED, V20, P427, DOI 10.3122/jabfm.2007.05.070045; Lengeler C, 1999, TROP MED INT HEALTH, V4, P409, DOI 10.1046/j.1365-3156.1999.00422.x; LODL K, 2002, J EXTENSION, V40, P1; Mann S, 1999, AUSTR J PRIMARY HLTH, V5, P43, DOI [10.1071/PY99032, DOI 10.1071/PY99032]; McDermott R, 2003, BMJ-BRIT MED J, V327, P428, DOI 10.1136/bmj.327.7412.428; McMichael AJ, 2003, SCIENCE, V302, P1919; McMichael AJ, 2006, EUR J PUBLIC HEALTH, V16, P579, DOI 10.1093/eurpub/ckl102; McPake B., 2006, RECOGNISING PATTERNS; *MIN SUMM HLTH RES, 2004, MEX STAT HLTH RES KN; Nilsen P, 2005, SAFETY SCI, V43, P815, DOI 10.1016/j.ssci.2005.08.015; O'Loughlin J, 1998, PREV MED, V27, P702, DOI 10.1006/pmed.1998.0348; Olsen IT, 1998, HEALTH POLICY PLANN, V13, P287, DOI 10.1093/heapol/13.3.287; Peden M., 2004, WORLD REPORT ROAD TR; Plochg T, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-37; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Pluye P, 2004, EVAL PROGRAM PLANN, V27, P121, DOI 10.1016/j.evalprogplan.2004.01.001; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; Rosenberg A, 2008, EVAL PROGRAM PLANN, V31, P51, DOI 10.1016/j.evalprogplan.2007.08.005; Rowley KG, 2000, AUST NZ J PUBL HEAL, V24, P136, DOI 10.1111/j.1467-842X.2000.tb00133.x; Sarriot EG, 2004, INT J HEALTH PLAN M, V19, P3, DOI 10.1002/hpm.743; Scheirer MA, 2005, AM J EVAL, V26, P320, DOI 10.1177/1098214005278752; SCHEIRER MA, 1990, J HEALTH SOC BEHAV, V31, P203, DOI 10.2307/2137173; Sebotsa MLD, 2007, FOOD NUTR BULL, V28, P337, DOI 10.1177/156482650702800310; Shediac-Rizkallah MC, 1998, HEALTH EDUC RES, V13, P87, DOI 10.1093/her/13.1.87; Stefanini A, 1995, World Health Forum, V16, P42; Stroul BA, 2007, J BEHAV HEALTH SER R, V34, P237, DOI 10.1007/s11414-007-9065-3; Swerissen H, 2004, HEALTH PROMOT INT, V19, P123, DOI 10.1093/heapro/dah113; Tannenbaum Terry-Nan, 2002, Can Respir J, V9, P387; *UN MILL DEV CAMP, M MDG GOALS PEOPL AS; Vemon R, 2007, INT FAM PLAN PERSPEC, V33, P182, DOI 10.1363/ifpp.33.182.07; VISRUTARATNA S, 1995, AIDS, V9, pS69; Wakerman J, 2005, MED J AUSTRALIA, V183, pS64; Whitford DL, 2004, DIABETIC MED, V21, P1221, DOI 10.1111/j.1464-5491.2004.01324.x; *WHO, 2002, WHOAPOCMG021; WILLIAMS B, 1997, J ECON SURV, V11, P71, DOI DOI 10.1111/1467-6419.00024; Wong Li-Chuen, 2002, Australas J Dermatol, V43, P274, DOI 10.1046/j.1440-0960.2002.00626.x; Wong ML, 1998, PREV MED, V27, P891, DOI 10.1006/pmed.1998.0398	76	234	241	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1579	1589		10.1016/S0140-6736(08)61659-1	http://dx.doi.org/10.1016/S0140-6736(08)61659-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984192	Green Submitted			2022-12-28	WOS:000260590500031
J	Matlin, SA; Evans, T; Hasler, J; Ijsselmuiden, C; Pannenborg, O; Toure, OI				Matlin, Stephen A.; Evans, Tim; Hasler, Julia; Ijsselmuiden, Carel; Pannenborg, Ok; Toure, Oumar Ibrahima		Bamako Steering Comm	Signposts to research for health	LANCET			English	Editorial Material									[Matlin, Stephen A.] Global Forum Hlth Res, CH-1211 Geneva 2, Switzerland; [Evans, Tim] WHO, CH-1211 Geneva, Switzerland; [Hasler, Julia] UNESCO, Paris, France; [Ijsselmuiden, Carel] Council Hlth Res Dev, Geneva, Switzerland; [Pannenborg, Ok] World Bank, Washington, DC 20433 USA; [Toure, Oumar Ibrahima] Govt Mali, Bamako, Mali	World Health Organization; The World Bank	Matlin, SA (corresponding author), Global Forum Hlth Res, CH-1211 Geneva 2, Switzerland.	stephen.matlin@globalforumhealth.org						Declaration of Alma-Ata, 1978, INT C PRIM HLTH CAR; *GLOB FOR HLTH RES, 2008, RES HLTH; *MIN SUMM HLTH RES, 2004, ID CHALL INF ACT COR; *OTT CHART HLTH PR, 1986, 1 INT C HLTH PROM; *REP COMM MACR HLT, 2001, MACR HLTH INV HLTH E; *REP COMM SOC DET, 2008, CLOS GAP GEN HLTH EQ; *UN GEN ASS, 1981, RES AD GEN ASS 36 43; WHO, 2008, PHARMAFORUM 0121; World Bank, 1993, WORLD DEV REP INV HL; World Health Assembly, 2006, CONST WHO; World Health Assembly, 2008, GLOB STRAT PLAN ACT	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1521	1522		10.1016/S0140-6736(08)61630-X	http://dx.doi.org/10.1016/S0140-6736(08)61630-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984171				2022-12-28	WOS:000260590500004
J	Chari, A; Golas, MM; Klingenhager, M; Neuenkirchen, N; Sander, B; Englbrecht, C; Sickmann, A; Stark, H; Fischer, U				Chari, Ashwin; Golas, Monika M.; Klingenhaeger, Michael; Neuenkirchen, Nils; Sander, Bjoern; Englbrecht, Clemens; Sickmann, Albert; Stark, Holger; Fischer, Utz			An Assembly Chaperone Collaborates with the SMN Complex to Generate Spliceosomal SnRNPs	CELL			English	Article							NUCLEAR RIBONUCLEOPROTEIN PARTICLE; ELECTRON-MICROSCOPY; CORE STRUCTURE; PROTEINS; RNA; BIOGENESIS; PATHWAY; PICLN; CLAMP; DNA	Spliceosomal small nuclear ribonucleoproteins (snRNPs) are essential components of the nuclear pre-mRNA processing machinery. A hallmark of these particles is a ring-shaped core domain generated by the binding of Sm proteins onto snRNA. PRMT5 and SMN complexes mediate the formation of the core domain in vivo. Here, we have elucidated the mechanism of this reaction by both biochemical and structural studies. We show that pICln, a component of the PRMT5 complex, induces the formation of an otherwise unstable higher-order Sm protein unit. In this state, the Sm proteins are kinetically trapped, preventing their association with snRNA. The SMN complex subsequently binds to these Sm protein units, dissociates pICln, and catalyzes ring closure on snRNA. Our data identify pICln as an assembly chaperone and the SMN complex as a catalyst of spliceosomal snRNP formation. The mode of action of this combined chaperone/catalyst system is reminiscent of the mechanism employed by DNA clamp loaders.	[Chari, Ashwin; Klingenhaeger, Michael; Neuenkirchen, Nils; Englbrecht, Clemens; Fischer, Utz] Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany; [Golas, Monika M.; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, Res Grp Electron Cryomicroscopy 3D, D-37070 Gottingen, Germany; [Sickmann, Albert] Rudolf Virchow Ctr Expt Med, D-97078 Wurzburg, Germany	University of Wurzburg; Max Planck Society	Fischer, U (corresponding author), Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de	Sander, Bjoern/AAO-9021-2021; Fischer, Utz/AAT-8422-2020; Chari, Ashwin/ABC-5304-2020; Fischer, Utz/A-4090-2016; Sickmann, Albert/A-1010-2011	Sander, Bjoern/0000-0001-8495-2321; Fischer, Utz/0000-0002-1465-6591; Chari, Ashwin/0000-0001-6220-9828; Fischer, Utz/0000-0002-1465-6591; Sickmann, Albert/0000-0002-2388-5265; Holger, Stark/0000-0002-6161-1118	DFG [SFB581, TP B18]; AFM [ID11730]; BMBF; European "3D Repertoire''	DFG(German Research Foundation (DFG)); AFM(Association Francaise contre les Myopathies); BMBF(Federal Ministry of Education & Research (BMBF)); European "3D Repertoire''	We thank T. Muller, P. Stayton, C. Kambach, J. Steitz, and I. Mattaj for reagents; J. Ohmer for technical assistance; and B. Laggerbauer, M. Kroiss, G. Matera, S. Jentsch, S. Rospert, F. U. Hartl, and R. Luhrmann for comments. This work was supported by grants of the DFG (SFB581, TP B18) and AFM (ID11730) to U. F. and grants of the BMBF and European "3D Repertoire'' to H.S.	Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Ellison V, 2001, CELL, V106, P655, DOI 10.1016/S0092-8674(01)00498-6; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FISHER DE, 1985, CELL, V42, P751, DOI 10.1016/0092-8674(85)90271-5; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1989, EMBO J, V8, P277, DOI 10.1002/j.1460-2075.1989.tb03374.x; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI [10.1016/j.jsb.2005.04.004, 10.1016/j.jsb,2005.04.004]; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	43	154	174	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					497	509		10.1016/j.cell.2008.09.020	http://dx.doi.org/10.1016/j.cell.2008.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984161	Bronze, Green Submitted			2022-12-28	WOS:000260536300020
J	Wang, ZP; Edwards, JG; Riley, N; Provance, DW; Karcher, R; Li, XD; Davison, IG; Ikebe, M; Mercer, JA; Kauer, JA; Ehlers, MD				Wang, Zhiping; Edwards, Jeffrey G.; Riley, Nathan; Provance, D. William, Jr.; Karcher, Ryan; Li, Xiang-dong; Davison, Ian G.; Ikebe, Mitsuo; Mercer, John A.; Kauer, Julie A.; Ehlers, Michael D.			Myosin Vb Mobilizes Recycling Endosomes and AMPA Receptors for Postsynaptic Plasticity	CELL			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTIC TRANSMISSION; FAMILY INTERACTING PROTEIN-2; GLOBULAR TAIL DOMAIN; DENDRITIC SPINES; ENDOCYTIC ZONES; TRAFFICKING; VA; MEMBRANE; CALCIUM	Learning-related plasticity at excitatory synapses in the mammalian brain requires the trafficking of AMPA receptors and the growth of dendritic spines. However, the mechanisms that couple plasticity stimuli to the trafficking of postsynaptic cargo are poorly understood. Here we demonstrate that myosin Vb (MyoVb), a Ca2+-sensitive motor, conducts spine trafficking during long-term potentiation (LTP) of synaptic strength. Upon activation of NMDA receptors and corresponding Ca2+ influx, MyoVb associates with recycling endosomes (REs), triggering rapid spine recruitment of endosomes and local exocytosis in spines. Disruption of MyoVb or its interaction with the RE adaptor Rab11-FIP2 abolishes LTP-induced exocytosis from REs and prevents both AMPA receptor insertion and spine growth. Furthermore, induction of tight binding of MyoVb to actin using an acute chemical genetic strategy eradicates LTP in hippocampal slices. Thus, Ca2+-activated MyoVb captures and mobilizes REs for AMPA receptor insertion and spine growth, providing a mechanistic link between the induction and expression of postsynaptic plasticity.	[Wang, Zhiping; Davison, Ian G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wang, Zhiping; Davison, Ian G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Edwards, Jeffrey G.; Riley, Nathan; Kauer, Julie A.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Provance, D. William, Jr.; Karcher, Ryan; Mercer, John A.] McLaughlin Res Inst, Great Falls, MT 59405 USA; [Li, Xiang-dong; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA	Duke University; Duke University; Howard Hughes Medical Institute; Brown University; McLaughlin Research Institute for Biomedical Sciences, Inc.; University of Massachusetts System; University of Massachusetts Worcester	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Provance, David W/D-5294-2013	Provance, David W/0000-0002-9824-0672; Mercer, John/0000-0003-0307-4438; Kauer, Julie/0000-0002-3362-1642	NIH; American Heart Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402, R01NS047574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kavita Shah for supplying PE-ADP. We thank Rytis Prekeris for providing Rab11-FIP2 reagents. We thank Marguerita Klein, Irina Lebedeva, and Haiwei Zhang for excellent technical assistance. We thank Benjamin Arenkiel, Kathryn Condon, Ian Davison, Xing Guo, Cyril Hanus, Tom Helton, Juliet Hernandez, Hyun-Soo Je, Matthew Kennedy, Ming-Chia Lee, Jiuyi Lu, Angela Mabb, Thomas Newpher, Mikyoung Park, Ben Philpot, Sridhar Raghavachari, Tingting Wang, Ryohei Yasuda, and Jason Yi for critical discussions of the data and review of the manuscript. This work was supported by grants from the NIH (to M.D.E, J.A.K., J.A.M., and M. I.) and a grant from American Heart Association (to X.d.L.). M. D. E. is an Investigator of the Howard Hughes Medical Institute.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Provance DW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-44; Provance DW, 2004, P NATL ACAD SCI USA, V101, P1868, DOI 10.1073/pnas.0305895101; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	48	353	361	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					535	548		10.1016/j.cell.2008.09.057	http://dx.doi.org/10.1016/j.cell.2008.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984164	Green Accepted, Bronze			2022-12-28	WOS:000260536300023
J	Koerich, LB; Wang, XY; Clark, AG; Carvalho, AB				Koerich, Leonardo B.; Wang, Xiaoyun; Clark, Andrew G.; Carvalho, Antonio Bernardo			Low conservation of gene content in the Drosophila Y chromosome	NATURE			English	Article							SEX-CHROMOSOME; MELANOGASTER; GENOME; EVOLUTION; SEQUENCE; DEGENERATION; ELEMENTS; REGION; SCALE	Chromosomal organization is sufficiently evolutionarily stable that large syntenic blocks of genes can be recognized even between species as distantly related as mammals and puffer fish ( 450 million years (Myr) of divergence)(1-7). In Diptera, the gene content of the X chromosome and the autosomes is well conserved: in Drosophila more than 95% of the genes have remained on the same chromosome arm in the 12 sequenced species ( 63 Myr of divergence, traversing 400 Myr of evolution) 2,4,6, and the same linkage groups are clearly recognizable in mosquito genomes (260 Myr of divergence)(3,5,7). Here we investigate the conservation of Y- linked gene content among the 12 sequenced Drosophila species. We found that only a quarter of the Drosophila melanogaster Y- linked genes ( 3 out of 12) are Y- linked in all sequenced species, and that most of them ( 7 out of 12) were acquired less than 63 Myr ago. Hence, whereas the organization of other Drosophila chromosomes traces back to the common ancestor with mosquitoes, the gene content of the D. melanogaster Y chromosome is much younger. Gene losses are known to have an important role in the evolution of Y chromosomes(8-10), and we indeed found two such cases. However, the rate of gene gain in the Drosophila Y chromosomes investigated is 10.9 times higher than the rate of gene loss ( 95% confidence interval: 2.3 - 52.5), indicating a clear tendency of the Y chromosomes to increase in gene content. In contrast with the mammalian Y chromosome, gene gains have a prominent role in the evolution of the Drosophila Y chromosome.	[Koerich, Leonardo B.; Carvalho, Antonio Bernardo] Univ Fed Rio de Janeiro, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; [Wang, Xiaoyun; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidade Federal do Rio de Janeiro; Cornell University	Carvalho, AB (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Caixa Postal 68011, BR-21944970 Rio De Janeiro, Brazil.	bernardo@biologia.ufrj.br	Carvalho, Antonio/D-5402-2013; Koerich, Leonardo/J-7004-2014; Koerich, Leonardo/B-8554-2008	Carvalho, Antonio/0000-0001-8959-6469; Koerich, Leonardo/0000-0002-5668-3934; Koerich, Leonardo/0000-0002-5668-3934; Clark, Andrew/0000-0001-7159-8511	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-CAPES; FAPERJ; FIC-NIH [TW007604-02]; NIH [GM64590]; FOGARTY INTERNATIONAL CENTER [R03TW007604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064590] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIC-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kumar, P. O'Grady, T. Markow, A. J. Bhutkar, S. C. Vaz, E. Betran, A. A. Peixoto, P. H. Krieger and P. Paiva for comments on the manuscript and/or for sharing their unpublished results. We also thank T. Pinhao, A. Bastos and F. Krsticevic for help with the experiments, K. Krishnamoorthy for statistical advice and M. Fetchko for help with GenBank submission. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Coordenacao de Aperfeicoamento do Pessoal de Ensino Superior- CAPES, FAPERJ, FIC-NIH grant TW007604-02 (A.B.C.) and NIH grant GM64590 (A.G.C.).	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ASHBURNER M, 2005, DROSOPHILA LAB HDB, P607; Bachtrog D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r30; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Bhutkar A, 2007, GENOME RES, V17, P1880, DOI 10.1101/gr.7062307; Carvalho AB, 2000, P NATL ACAD SCI USA, V97, P13239, DOI 10.1073/pnas.230438397; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Carvalho AB, 2003, GENETICA, V117, P227, DOI 10.1023/A:1022900313650; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; CARVALHO AB, 2003, 44 ANN DROS RES C PH, P113; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; GEPNER J, 1993, P NATL ACAD SCI USA, V90, P11132, DOI 10.1073/pnas.90.23.11132; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; HACKSTEIN JHP, 1995, TRENDS GENET, V11, P195, DOI 10.1016/S0168-9525(00)89043-5; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; HURST LD, 1992, GENETICS, V130, P229; KENNISON JA, 1981, GENETICS, V98, P529; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Sturtevant AH, 1941, GENETICS, V26, P517; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Vibranovski MD, 2008, GENETICS, V179, P2325, DOI 10.1534/genetics.108.086819; YEATES DK, 2005, EVOLUTIONARY BIOL FL, P35; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	30	111	121	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					949	951		10.1038/nature07463	http://dx.doi.org/10.1038/nature07463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19011613	Green Accepted			2022-12-28	WOS:000261768300045
J	Gowaty, PA; Serageldin, I; Persson, PE; Eldredge, N; Lynch, M; Nei, M; Kutschera, U; Akyol, M; Nesse, R; Greaves, M				Gowaty, Patricia Adair; Serageldin, Ismail; Persson, Per-Edvin; Eldredge, Niles; Lynch, Michael; Nei, Masatoshi; Kutschera, Ulrich; Akyol, Mustafa; Nesse, Randolph; Greaves, Mel			Darwin 200: Great expectations	NATURE			English	Editorial Material									[Gowaty, Patricia Adair] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Gowaty, Patricia Adair] Univ Calif Los Angeles, Inst Environm, Los Angeles, CA USA; [Serageldin, Ismail] New Lib Alexandria, Alexandria, Egypt; [Persson, Per-Edvin] Heureka, Finnish Sci Ctr, Vantaa, Finland; [Eldredge, Niles] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN USA; [Nei, Masatoshi] Penn State Univ, Inst Mol Evolut Genet, University Pk, PA 16802 USA; [Kutschera, Ulrich] Univ Kassel, Inst Biol, Kassel, Germany; [Nesse, Randolph] Univ Michigan, Ann Arbor, MI 48109 USA; [Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; American Museum of Natural History (AMNH); Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universitat Kassel; University of Michigan System; University of Michigan; University of London; Institute of Cancer Research - UK									0	1	1	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					317	318		10.1038/456317a	http://dx.doi.org/10.1038/456317a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020598	Green Submitted, Bronze			2022-12-28	WOS:000261039600020
J	Yamamoto, N; Tsutsui, K; Yamamoto, M; Arakaki, H; Kurumaji, A; Nishikawa, T				Yamamoto, Naoki; Tsutsui, Keita; Yamamoto, Makiko; Arakaki, Hiroshi; Kurumaji, Akeo; Nishikawa, Toru			Sliding doors (but not with beans or tofu)	LANCET			English	Editorial Material							GENE		[Yamamoto, Naoki; Tsutsui, Keita; Yamamoto, Makiko; Arakaki, Hiroshi; Kurumaji, Akeo; Nishikawa, Toru] Tokyo Med & Dent Univ, Grad Sch & Med Hosp, Sect Psychiat & Behav Sci, Bunkyo Ku, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Yamamoto, N (corresponding author), Tokyo Med & Dent Univ, Grad Sch & Med Hosp, Sect Psychiat & Behav Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	n_yamamoto.psyc@tmd.ac.jp						INOSE T, 1952, J NEUROPATHOL EXP NE, V4, P401; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Lu YB, 2005, J HUM GENET, V50, P338, DOI 10.1007/s10038-005-0262-8; Saheki T, 2008, J INHERIT METAB DIS, V31, P386, DOI 10.1007/s10545-008-0752-x; Segura-Bruna N, 2006, ACTA NEUROL SCAND, V114, P1, DOI 10.1111/j.1600-0404.2006.00655.x	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1782	1782		10.1016/S0140-6736(08)61731-6	http://dx.doi.org/10.1016/S0140-6736(08)61731-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19013320				2022-12-28	WOS:000261077900028
J	Sarafianos, SG; Arnold, E				Sarafianos, Stefan G.; Arnold, Eddy			BIOCHEMISTRY RT Slides Home ...	SCIENCE			English	Editorial Material							HIV-1 REVERSE-TRANSCRIPTASE; VIRUS NUCLEOCAPSID PROTEIN; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; STRAND TRANSFER; RNASE-H; INHIBITOR; COMPLEX; DNA		[Sarafianos, Stefan G.] Univ Missouri, Christopher S Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	University of Missouri System; University of Missouri Columbia; Rutgers State University New Brunswick	Sarafianos, SG (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, 1201 Rollins St, Columbia, MO 65211 USA.	sarafianoss@missouri.edu; arnold@cabm.rutgers.edu		Sarafianos, Stefan G/0000-0002-5840-154X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027690] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Coffin J, 1997, RETROVIRUSES; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; RODRIGUEZRODRIGUEZ L, 1995, J BIOL CHEM, V270, P15005, DOI 10.1074/jbc.270.25.15005; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Wisniewski M, 2000, J BIOL CHEM, V275, P37664, DOI 10.1074/jbc.M007381200; YOU JC, 1994, J BIOL CHEM, V269, P31491	13	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1059	1060		10.1126/science.1167454	http://dx.doi.org/10.1126/science.1167454			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008434				2022-12-28	WOS:000260867700024
J	Cowan, JA; McGillicuddy, JE				Cowan, John A., Jr.; McGillicuddy, John E.			Reversal of Traumatic Quadriplegia after Closed Reduction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cowan, John A., Jr.; McGillicuddy, John E.] Univ Michigan, Med Ctr, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Cowan, JA (corresponding author), Univ Michigan, Med Ctr, Ann Arbor, MI 48104 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2154	2154		10.1056/NEJMicm064490	http://dx.doi.org/10.1056/NEJMicm064490			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005199				2022-12-28	WOS:000260823900013
J	Deary, I				Deary, Ian			Why do intelligent people live longer?	NATURE			English	Editorial Material							CHILDHOOD IQ; SOCIAL-CLASS; MORTALITY; RISK; LIFE		[Deary, Ian] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh	Deary, I (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland.	i.deary@ed.ac.uk	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X	Medical Research Council [G0700704B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2008, DIABETOLOGIA, V51, P436, DOI 10.1007/s00125-007-0908-5; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; BATTY GD, EPIDEMIOLOG IN PRESS; Deary I. J., 2020, INTELLIGENCE VERY SH, V2nd; Deary IJ, 2008, PSYCHOL SCI, V19, P874, DOI 10.1111/j.1467-9280.2008.02171.x; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; OTOOLE BI, 1992, PERS INDIV DIFFER, V13, P699, DOI 10.1016/0191-8869(92)90241-G; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	11	102	104	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					175	176		10.1038/456175a	http://dx.doi.org/10.1038/456175a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	374JJ	19005537	Bronze			2022-12-28	WOS:000261039300019
J	Forde, I; Raine, R				Forde, Ian; Raine, Rosalind			Placing the individual within a social determinants approach to health inequity	LANCET			English	Editorial Material							CARE; COMMUNICATION; PATIENT		[Forde, Ian; Raine, Rosalind] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Forde, I (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.	i.forde@ucl.ac.uk		Raine, Rosalind/0000-0003-0904-749X	MRC [G0701333] Funding Source: UKRI; Medical Research Council [G0701333] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alford J, 2002, ADMIN SOC, V34, P32, DOI 10.1177/0095399702034001004; [Anonymous], 2008, FIN REP COMM SOC DET; *CENTR, DIS AUSTR APPR WAG S; *CIT BALT, BALT CITISTAT; *DEP CHILDR SCH FA, PAR INV; Department of Health, OUR HLTH OUR CAR OUR; Dovidio JF, 2008, SOC SCI MED, V67, P478, DOI 10.1016/j.socscimed.2008.03.019; *JONK COUNT COUNC, PASS LIF PROGR; Kaufman JS, 2000, ANNU REV PUBL HEALTH, V21, P101, DOI 10.1146/annurev.publhealth.21.1.101; Krieger N, 2008, AM J PUBLIC HEALTH, V98, P221, DOI 10.2105/AJPH.2007.111278; LIEBEMAN M, 2007, RESTORATIVE JUSTICE; *MIN PLANN GOV CHI, PUENT PROGR; Parker Simon, 2007, COLLABORATIVE STATE; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Pestoff V, 2006, PUBLIC MANAG REV, V8, P503, DOI 10.1080/14719030601022882; Rowe J., 1992, TIME DOLLARS NEW CUR; Schouten BC, 2006, PATIENT EDUC COUNS, V64, P21, DOI 10.1016/j.pec.2005.11.014; Stewart M, 2000, J FAM PRACTICE, V49, P796; Susser M, 1996, AM J PUBLIC HEALTH, V86, P674, DOI 10.2105/AJPH.86.5.674; *WHO, 2007, INT STAT COMM SOC DE; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Wolff J., 2007, DISADVANTAGE	22	24	24	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1694	1696		10.1016/S0140-6736(08)61695-5	http://dx.doi.org/10.1016/S0140-6736(08)61695-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994669				2022-12-28	WOS:000260899900033
J	Cotton, RGH; Auerbach, AD; Axton, M; Barash, CI; Berkovic, SF; Brookes, AJ; Burn, J; Cutting, G; den Dunnen, JT; Flicek, P; Freimer, N; Greenblatt, MS; Howard, HJ; Katz, M; Macrae, FA; Maglott, D; Moslein, G; Povey, S; Ramesar, RS; Richards, CS; Seminara, D; Smith, TD; Sobrido, MJ; Solbakk, JH; Tanzi, RE; Tavtigian, SV; Taylor, GR; Utsunomiya, J; Watson, M				Cotton, Richard G. H.; Auerbach, Arleen D.; Axton, Myles; Barash, Carol Isaacson; Berkovic, Samuel F.; Brookes, Anthony J.; Burn, John; Cutting, Garry; den Dunnen, Johan T.; Flicek, Paul; Freimer, Nelson; Greenblatt, Marc S.; Howard, Heather J.; Katz, Michael; Macrae, Finlay A.; Maglott, Donna; Moeslein, Gabriela; Povey, Sue; Ramesar, Rajkumar S.; Richards, Carolyn S.; Seminara, Daniela; Smith, Timothy D.; Sobrido, Maria-Jesus; Solbakk, Jan Helge; Tanzi, Rudolph E.; Tavtigian, Sean V.; Taylor, Graham R.; Utsunomiya, Joji; Watson, Michael			GENETICS The Human Variome Project	SCIENCE			English	Editorial Material									[Cotton, Richard G. H.; Howard, Heather J.; Smith, Timothy D.] Howard Florey Inst Expt Physiol & Med, Genom Disorders Res Ctr, Melbourne, Vic, Australia; [Berkovic, Samuel F.] Univ Melbourne, Austin Hlth W, Epilepsy Res Ctr, Heidelberg, Vic, Australia; [Freimer, Nelson] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Sobrido, Maria-Jesus] Fdn Publ Galega Med Xenomica, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus] Inst Hlth Carlos III, Ctr Network Biomed Res Rare Dis CIBERER, Madrid, Spain; [Tanzi, Rudolph E.] Harvard Univ, Sch Med, Charlestown, MA USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA	Florey Institute of Neuroscience & Mental Health; Austin Research Institute; University of Melbourne; University of California System; University of California Los Angeles; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Harvard University; Harvard University; Massachusetts General Hospital	Cotton, RGH (corresponding author), Howard Florey Inst Expt Physiol & Med, Genom Disorders Res Ctr, Melbourne, Vic, Australia.	cotton@unimelb.edu.au	Ramesar, Raj S/I-6941-2015; Axton, Myles/AAZ-4093-2020; jiang, yu/HGU-0029-2022; dunnen, johan den/ABH-4228-2020; Tanzi, Rudolph/AAE-9622-2019; Smith, Timothy/A-2873-2009	Ramesar, Raj S/0000-0001-5688-1634; Axton, Myles/0000-0002-8042-4131; dunnen, johan den/0000-0002-6304-1710; Tanzi, Rudolph/0000-0002-7032-1454; Flicek, Paul/0000-0002-3897-7955; Auerbach, Arleen/0000-0002-6911-8379; Burn, John/0000-0002-9823-2322; Smith, Timothy/0000-0001-9068-4642; Berkovic, Samuel/0000-0003-4580-841X	NIDDK NIH HHS [R37 DK044003-19, R37 DK044003] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044003] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2007, NAT GENET, V39, P423; Baraitser M, 2001, LONDON DYSMORPHOLOGY; COSTA T, 1985, AM J MED GENET, V21, P231, DOI 10.1002/ajmg.1320210205; Cotton RGH, 2007, NAT GENET, V39, P433, DOI 10.1038/ng2024; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Ring Huijun Z, 2006, Pharmacogenomics, V7, P969, DOI 10.2217/14622416.7.7.969	6	46	49	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					861	862		10.1126/science.1167363	http://dx.doi.org/10.1126/science.1167363			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988827	Green Accepted			2022-12-28	WOS:000260674100022
J	Zhao, J; Sun, BK; Erwin, JA; Song, JJ; Lee, JT				Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.			Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome	SCIENCE			English	Article							INACTIVE-X; XIST RNA; DOMAINS; RECRUITMENT; METHYLATION; TSIX	To equalize X- chromosome dosages between the sexes, the female mammal inactivates one of her two X chromosomes. X- chromosome inactivation ( XCI) is initiated by expression of Xist, a 17- kb noncoding RNA ( ncRNA) that accumulates on the X in cis. Because interacting factors have not been isolated, the mechanism by which Xist induces silencing remains unknown. We discovered a 1.6- kilobase ncRNA ( RepA) within Xist and identified the Polycomb complex, PRC2, as its direct target. PRC2 is initially recruited to the X by RepA RNA, with Ezh2 serving as the RNA binding subunit. The antisense Tsix RNA inhibits this interaction. RepA depletion abolishes full- length Xist induction and trimethylation on lysine 27 of histone H3 of the X. Likewise, PRC2 deficiency compromises Xist up- regulation. Therefore, RepA, together with PRC2, is required for the initiation and spread of XCI. We conclude that a ncRNA cofactor recruits Polycomb complexes to their target locus.	[Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02493 USA; [Zhao, Jing; Sun, Bryan K.; Erwin, Jennifer A.; Song, Ji-Joon; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	lee@molbio.mgh.harvard.edu	Song, Ji-Joon/C-1721-2011	Sun, Bryan/0000-0002-0740-0125; Erwin, Jennifer/0000-0002-6784-9290	Massachusetts General Hospital Fund for Medical Discovery; NSF predoctoral award; Jane Coffin Childs Fellowship; NIH [R01GM58839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839, R01GM110090] Funding Source: NIH RePORTER	Massachusetts General Hospital Fund for Medical Discovery; NSF predoctoral award(National Science Foundation (NSF)); Jane Coffin Childs Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Spencer and Y. Jeon for unpublished data and technical advice and Y. Ogawa for critical reading of the manuscript. Grant support: Massachusetts General Hospital Fund for Medical Discovery (J.Z.), NSF predoctoral award (J.A.E.), Jane Coffin Childs Fellowship (J.J.S.), and NIH- R01GM58839 (J.T.L.). J.T.L. is an Investigator of the HHMI. The transcript WRepAW for Repeat A has GenBank accession number FJ361197.	BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sado T, 2001, DEVELOPMENT, V128, P1275; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	19	1203	1290	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					750	756		10.1126/science.1163045	http://dx.doi.org/10.1126/science.1163045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974356	Green Accepted			2022-12-28	WOS:000260605200052
J	De Cock, KM; Gilks, CF; Lo, YR; Guerma, T				De Cock, Kevin M.; Gilks, Charles F.; Lo, Ying-Ru; Guerma, Teguest			Can antiretroviral therapy eliminate HIV transmission?	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; TUBERCULOSIS; STRATEGIES; EPIDEMIC; HIV/AIDS; ACCESS; ERA		[De Cock, Kevin M.; Gilks, Charles F.; Guerma, Teguest] WHO, HIV AIDS Dept, Antiretroviral Treatment & HIV Care Unit, CH-1211 Geneva 27, Switzerland; [Lo, Ying-Ru] WHO, HIV AIDS Dept, Prevent Hlth Sector Unit, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	De Cock, KM (corresponding author), WHO, HIV AIDS Dept, Antiretroviral Treatment & HIV Care Unit, CH-1211 Geneva 27, Switzerland.	Decockk@who.int	Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123				Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen J, 2008, SCIENCE, V321, P902, DOI 10.1126/science.321.5891.902; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich R.M., 2008, LANCET          1126, DOI [10.1016/S0140-6736(08)61697-9, DOI 10.1016/S0140-6736(08)61697-9]; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hirsch MS, 2008, J INFECT DIS, V197, pS252, DOI 10.1086/533416; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; PHILLIPS A, 2008, 15 C RETR OPP INF BO, V8; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; *WHO, 2008, UN ACC SCAL PRIOR HI; *WHO UNAIDS, NEW DAT MAL CIRC HIV; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Health Organization, 2007, ESSENTIAL PREVENTION	19	57	59	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					7	9		10.1016/S0140-6736(08)61732-8	http://dx.doi.org/10.1016/S0140-6736(08)61732-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19038440				2022-12-28	WOS:000262183800007
J	Eid, J; Fehr, A; Gray, J; Luong, K; Lyle, J; Otto, G; Peluso, P; Rank, D; Baybayan, P; Bettman, B; Bibillo, A; Bjornson, K; Chaudhuri, B; Christians, F; Cicero, R; Clark, S; Dalal, R; Dewinter, A; Dixon, J; Foquet, M; Gaertner, A; Hardenbol, P; Heiner, C; Hester, K; Holden, D; Kearns, G; Kong, XX; Kuse, R; Lacroix, Y; Lin, S; Lundquist, P; Ma, CC; Marks, P; Maxham, M; Murphy, D; Park, I; Pham, T; Phillips, M; Roy, J; Sebra, R; Shen, G; Sorenson, J; Tomaney, A; Travers, K; Trulson, M; Vieceli, J; Wegener, J; Wu, D; Yang, A; Zaccarin, D; Zhao, P; Zhong, F; Korlach, J; Turner, S				Eid, John; Fehr, Adrian; Gray, Jeremy; Luong, Khai; Lyle, John; Otto, Geoff; Peluso, Paul; Rank, David; Baybayan, Primo; Bettman, Brad; Bibillo, Arkadiusz; Bjornson, Keith; Chaudhuri, Bidhan; Christians, Frederick; Cicero, Ronald; Clark, Sonya; Dalal, Ravindra; deWinter, Alex; Dixon, John; Foquet, Mathieu; Gaertner, Alfred; Hardenbol, Paul; Heiner, Cheryl; Hester, Kevin; Holden, David; Kearns, Gregory; Kong, Xiangxu; Kuse, Ronald; Lacroix, Yves; Lin, Steven; Lundquist, Paul; Ma, Congcong; Marks, Patrick; Maxham, Mark; Murphy, Devon; Park, Insil; Pham, Thang; Phillips, Michael; Roy, Joy; Sebra, Robert; Shen, Gene; Sorenson, Jon; Tomaney, Austin; Travers, Kevin; Trulson, Mark; Vieceli, John; Wegener, Jeffrey; Wu, Dawn; Yang, Alicia; Zaccarin, Denis; Zhao, Peter; Zhong, Frank; Korlach, Jonas; Turner, Stephen			Real-Time DNA Sequencing from Single Polymerase Molecules	SCIENCE			English	Article							PHOSPHATE-LABELED NUCLEOTIDES; HUMAN GENOME; MODE; FLUORESCENCE; SPECTROSCOPY; RESOLUTION; ALGORITHM; SUBSTRATE	We present single- molecule, real- time sequencing data obtained from a DNA polymerase performing uninterrupted template- directed synthesis using four distinguishable fluorescently labeled deoxyribonucleoside triphosphates (dNTPs). We detected the temporal order of their enzymatic incorporation into a growing DNA strand with zero- mode waveguide nanostructure arrays, which provide optical observation volume confinement and enable parallel, simultaneous detection of thousands of single- molecule sequencing reactions. Conjugation of fluorophores to the terminal phosphate moiety of the dNTPs allows continuous observation of DNA synthesis over thousands of bases without steric hindrance. The data report directly on polymerase dynamics, revealing distinct polymerization states and pause sites corresponding to DNA secondary structure. Sequence data were aligned with the known reference sequence to assay biophysical parameters of polymerization for each template position. Consensus sequences were generated from the single- molecule reads at 15- fold coverage, showing a median accuracy of 99.3%, with no systematic error beyond fluorophore- dependent error rates.	[Eid, John; Fehr, Adrian; Gray, Jeremy; Luong, Khai; Lyle, John; Otto, Geoff; Peluso, Paul; Rank, David; Baybayan, Primo; Bettman, Brad; Bibillo, Arkadiusz; Bjornson, Keith; Chaudhuri, Bidhan; Christians, Frederick; Cicero, Ronald; Clark, Sonya; Dalal, Ravindra; deWinter, Alex; Dixon, John; Foquet, Mathieu; Gaertner, Alfred; Hardenbol, Paul; Heiner, Cheryl; Hester, Kevin; Holden, David; Kearns, Gregory; Kong, Xiangxu; Kuse, Ronald; Lacroix, Yves; Lin, Steven; Lundquist, Paul; Ma, Congcong; Marks, Patrick; Maxham, Mark; Murphy, Devon; Park, Insil; Pham, Thang; Phillips, Michael; Roy, Joy; Sebra, Robert; Shen, Gene; Sorenson, Jon; Tomaney, Austin; Travers, Kevin; Trulson, Mark; Vieceli, John; Wegener, Jeffrey; Wu, Dawn; Yang, Alicia; Zaccarin, Denis; Zhao, Peter; Zhong, Frank; Korlach, Jonas; Turner, Stephen] Pacific Biosci, Menlo Pk, CA 94025 USA		Korlach, J (corresponding author), Pacific Biosci, 1505 Adams Dr, Menlo Pk, CA 94025 USA.	jkorlach@pacificbiosciences.com; sturner@pacificbiosciences.com	Turner, Stephen/GXM-4654-2022; chen, qi/C-8585-2011	Marks, Patrick/0000-0002-3231-7163; Sorenson, Jon/0000-0002-5301-8306; Rank, David/0000-0001-9213-6965; Eid, John/0000-0002-2099-8344	National Human Genome Research Institute [R01HG003710]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003710] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the entire staff at Pacific Biosciences, and J. Puglisi, M. Hunkapiller, R. Kornberg, K. Johnson, D. Haussler, W. Webb, and H. Craighead for many helpful discussions. Supported by National Human Genome Research Institute grant R01HG003710.	BALASUBRAMANIAN S, 2001, Patent No. 01057248; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Bosiers JT, 2008, PROC SPIE, V6996, DOI 10.1117/12.785847; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; CHAN EY, 2001, Patent No. 6210896; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Foquet M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831366; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gusfield D., 1997, ALGORITHMS STRINGS T; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Ju JY, 2006, P NATL ACAD SCI USA, V103, P19635, DOI 10.1073/pnas.0609513103; KAO CC, 2002, Patent No. 6399335; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Kornberg A., 1992, DNA REPLICATION; KORTACH J, 2008, NUCLEOS NUCLEOT, V27, P1072; Kumar S, 2005, NUCLEOS NUCLEOT NUCL, V24, P401, DOI 10.1081/NCN-200059823; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lieto AM, 2003, BIOPHYS J, V85, P3294, DOI 10.1016/S0006-3495(03)74748-1; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mulder BA, 2005, NUCLEIC ACIDS RES, V33, P4865, DOI 10.1093/nar/gki779; Reynolds B, 2008, NUCLEOS NUCLEOT NUCL, V27, P18, DOI 10.1080/15257770701571768; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sood A, 2005, J AM CHEM SOC, V127, P2394, DOI 10.1021/ja043595x; TABOR S, 1987, J BIOL CHEM, V262, P16212; Themissen AJP, 2008, SOLID STATE ELECTRON, V52, P1401, DOI 10.1016/j.sse.2008.04.012; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108	40	2285	2733	31	700	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					133	138		10.1126/science.1162986	http://dx.doi.org/10.1126/science.1162986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19023044				2022-12-28	WOS:000262104100059
J	Stockmann, C; Doedens, A; Weidemann, A; Zhang, N; Takeda, N; Greenberg, JI; Cheresh, DA; Johnson, RS				Stockmann, Christian; Doedens, Andrew; Weidemann, Alexander; Zhang, Na; Takeda, Norihiko; Greenberg, Joshua I.; Cheresh, David A.; Johnson, Randall S.			Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis	NATURE			English	Article							BREAST-CANCER; MOUSE MODEL; MACROPHAGES; EXPRESSION; ANGIOGENESIS; VEGF; MICE	Angiogenesis and the development of a vascular network are required for tumour progression, and they involve the release of angiogenic factors, including vascular endothelial growth factor ( VEGF-A), from both malignant and stromal cell types(1). Infiltration by cells of the myeloid lineage is a hallmark of many tumours, and in many cases the macrophages in these infiltrates express VEGF-A(2). Here we show that the deletion of inflammatory-cell-derived VEGF- A attenuates the formation of a typical high-density vessel network, thus blocking the angiogenic switch in solid tumours in mice. Vasculature in tumours lacking myeloid- cell-derived VEGF-A was less tortuous, with increased pericyte coverage and decreased vessel length, indicating vascular normalization. In addition, loss of myeloid-derived VEGF- A decreases the phosphorylation of VEGF receptor 2 (VEGFR2) in tumours, even though overall VEGF- A levels in the tumours are unaffected. However, deletion of myeloid- cell VEGF- A resulted in an accelerated tumour progression in multiple subcutaneous isograft models and an autochthonous transgenic model of mammary tumorigenesis, with less overall tumour cell death and decreased tumour hypoxia. Furthermore, loss of myeloid- cell VEGF- A increased the susceptibility of tumours to chemotherapeutic cytotoxicity. This shows that myeloid- derived VEGF- A is essential for the tumorigenic alteration of vasculature and signalling to VEGFR2, and that these changes act to retard, not promote, tumour progression.	[Stockmann, Christian; Doedens, Andrew; Weidemann, Alexander; Zhang, Na; Takeda, Norihiko; Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Greenberg, Joshua I.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Cheresh, David A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Johnson, RS (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	rsjohnson@ucsd.edu	Stockmann, Christian/L-6956-2017; Johnson, Randall/AAM-1189-2021; Stockmann, Christian/Q-1615-2017	Johnson, Randall/0000-0002-4084-6639; Doedens, Andrew/0000-0003-2461-3496; Stockmann, Christian/0000-0002-9726-6838	Deutsche Forschungsgemeinschaft [STO 787/1-1, WE 4275/1-1]; Susan G. Komen Dissertation Research Award [DISS0402406]; National Institutes of Health [CA82515, CA118165, AI060840]; NATIONAL CANCER INSTITUTE [R01CA082515, R01CA118165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060840] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Susan G. Komen Dissertation Research Award(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. DuRose, N. Ferrara, L. Iruela- Arispe, L. Coussens, M. Karin, V. Nizet and H.- P. Gerber for helpful conversations. Financial support was provided by the Deutsche Forschungsgemeinschaft to C. S. (STO 787/1-1) and A. W. (WE 4275/ 1- 1), a Susan G. Komen Dissertation Research Award ( DISS0402406) to A. D., and National Institutes of Health grants CA82515, CA118165 and AI060840 to R. S. J.	Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Grunstein J, 1999, CANCER RES, V59, P1592; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hurwitz HI, 2006, CLIN COLORECTAL CANC, V6, P66, DOI 10.3816/CCC.2006.n.023; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Mayer Erica L, 2007, J Natl Compr Canc Netw, V5, P314	12	344	359	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					814	U107		10.1038/nature07445	http://dx.doi.org/10.1038/nature07445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18997773	Green Submitted, Green Accepted			2022-12-28	WOS:000261559900054
J	Hopkins, M; Harrison, TM; Manning, CE				Hopkins, Michelle; Harrison, T. Mark; Manning, Craig E.			Low heat flow inferred from > 4 Gyr zircons suggests Hadean plate boundary interactions	NATURE			English	Article							JACK-HILLS; WESTERN-AUSTRALIA; DETRITAL ZIRCONS; ANCIENT ZIRCONS; CRUST; GA; DELTA-O-18; TECTONICS; EVOLUTION; DIAMONDS	The first similar to 600 million years of Earth history ( the 'Hadean' eon) remain poorly understood, largely because there is no rock record dating from that era. Detrital Hadean igneous zircons from the Jack Hills(1), Western Australia, however, can potentially provide insights into the conditions extant on our planet at that time. Results of geochemical investigations(2-13) using these ancient grains have been interpreted to suggest the presence of a hydrosphere(2-4,7,8) and continental crust(9,10) before 4Gyr. An underexploited characteristic of the >4 Gyr zircons is their diverse assemblage of mineral inclusions(14-17). Here we present an examination of over 400 Hadean zircons from Jack Hills, which shows that some inclusion assemblages are conducive to thermobarometry. Our thermobarometric analyses of 4.02 - 4.19- Gyr- old inclusion- bearing zircons constrain their magmatic formation conditions to about 700 degrees C and 7 kbar. This result implies a near- surface heat flow of similar to 75 mW m(-2), about three to five times lower than estimates of Hadean global heat flow. As the only site of magmatism on modern Earth that is characterized by heat flow of about one- quarter of the global average is above subduction zones, we suggest that the magmas from which the Jack Hills Hadean zircons crystallized were formed largely in an under thrust environment, perhaps similar to modern convergent margins.	[Hopkins, Michelle; Harrison, T. Mark; Manning, Craig E.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Hopkins, Michelle; Harrison, T. Mark; Manning, Craig E.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Harrison, TM (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	tmh@oro.ess.ucla.edu	Manning, Craig E/A-1118-2009; Harrison, Timothy M/E-7443-2012	Manning, Craig E/0000-0002-1463-3701; 	NSF [EAR-0635969]; ARC [DP0666497]; Instrumentation and Facilities Program of the National Science Foundation	NSF(National Science Foundation (NSF)); ARC(Australian Research Council); Instrumentation and Facilities Program of the National Science Foundation(National Science Foundation (NSF))	This work was supported by NSF grant EAR-0635969 and ARC grant DP0666497. We acknowledge facility support from the Instrumentation and Facilities Program of the National Science Foundation. We thank R. Powell for advice on using THERMOCALC, F. Kyte for assistance with the EMPA analyses, A. Schmitt and P. Holden for assistance with the ion microprobe analyses, and W. Schopf and A. Kudryavtsev for confocal Raman imaging.	ABBOTT DH, 1984, TECTONICS, V3, P429, DOI 10.1029/TC003i004p00429; Amelin Y, 2004, CHEM GEOL, V211, P375, DOI 10.1016/j.chemgeo.2004.07.004; Anderson JL, 1996, T ROY SOC EDIN-EARTH, V87, P125, DOI 10.1017/S0263593300006544; Bedini RM, 2004, EARTH PLANET SC LETT, V223, P99, DOI 10.1016/j.epsl.2004.04.012; BICKLE MJ, 1978, EARTH PLANET SC LETT, V40, P301, DOI 10.1016/0012-821X(78)90155-3; Blackwell D. B., 1991, NEOTECTONICS N AM, P423; Caro G, 2008, CHEM GEOL, V247, P253, DOI 10.1016/j.chemgeo.2007.10.018; Cavosie AJ, 2004, PRECAMBRIAN RES, V135, P251, DOI 10.1016/j.precamres.2004.09.001; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Coggon R, 2002, J METAMORPH GEOL, V20, P683, DOI 10.1046/j.1525-1314.2002.00395.x; Harrison TM, 2008, EARTH PLANET SC LETT, V268, P476, DOI 10.1016/j.epsl.2008.02.011; Harrison TM, 2007, EARTH PLANET SC LETT, V261, P9, DOI 10.1016/j.epsl.2007.05.016; Harrison TM, 2005, SCIENCE, V310, P1947, DOI 10.1126/science.1117926; HELZ RT, 1976, J PETROL, V17, P139, DOI 10.1093/petrology/17.2.139; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; MAAS R, 1991, GEOCHIM COSMOCHIM AC, V55, P1915, DOI 10.1016/0016-7037(91)90033-2; MAAS R, 1992, GEOCHIM COSMOCHIM AC, V56, P1281, DOI 10.1016/0016-7037(92)90062-N; Massonne HJ, 1997, LITHOS, V41, P229, DOI 10.1016/S0024-4937(97)82014-2; McLaren S, 2006, J PETROL, V47, P2281, DOI 10.1093/petrology/egl044; Menneken M, 2007, NATURE, V448, P917, DOI 10.1038/nature06083; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; POLLACK HN, 1993, REV GEOPHYS, V31, P267, DOI 10.1029/93RG01249; Sleep NH, 2000, J GEOPHYS RES-PLANET, V105, P17563, DOI 10.1029/2000JE001240; SMITH JV, 1981, PHILOS T R SOC A, V301, P401, DOI 10.1098/rsta.1981.0120; Spaggiari CV, 2007, PRECAMBRIAN RES, V155, P261, DOI 10.1016/j.precamres.2007.02.004; Trail D, 2004, GEOCHIM COSMOCHIM AC, V68, pA743; Trail D, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001449; Turcotte D L, 2002, GEODYNAMICS, P133; Turner G, 2004, SCIENCE, V306, P89, DOI 10.1126/science.1101014; Turner G, 2007, EARTH PLANET SC LETT, V261, P491, DOI 10.1016/j.epsl.2007.07.014; Watson EB, 2005, SCIENCE, V308, P841, DOI 10.1126/science.1110873; White RW, 2001, J METAMORPH GEOL, V19, P139, DOI 10.1046/j.0263-4929.2000.00303.x	32	198	209	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					493	496		10.1038/nature07465	http://dx.doi.org/10.1038/nature07465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037314				2022-12-28	WOS:000261170500036
J	Lawrence, A; Clark, L; Labuzetta, JN; Sahakian, B; Vyakarnum, S				Lawrence, Andrew; Clark, Luke; Labuzetta, Jamie Nicole; Sahakian, Barbara; Vyakarnum, Shai			The innovative brain	NATURE			English	Editorial Material							DECISION-MAKING		[Lawrence, Andrew; Clark, Luke; Labuzetta, Jamie Nicole; Sahakian, Barbara] Univ Cambridge, Dept Expt Psychol, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Lawrence, Andrew; Clark, Luke; Labuzetta, Jamie Nicole; Sahakian, Barbara] Univ Cambridge, Dept Psychiat, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Vyakarnum, Shai] Univ Cambridge, Judge Business Sch, Ctr Entrepreneurial Learning, Cambridge CB2 1QA, England	University of Cambridge; University of Cambridge; University of Cambridge	Lawrence, A (corresponding author), Univ Cambridge, Dept Expt Psychol, MRC Wellcome Trust Behav & Clin Neurosci Inst, Downing St, Cambridge CB2 3EB, England.	lc260@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; LaBuzetta, Jamie/0000-0002-7498-524X; Lawrence, Andrew/0000-0002-1420-3381; Clark, Luke/0000-0003-1103-2422	Medical Research Council [G0001354B] Funding Source: researchfish; Medical Research Council [G0001354] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; DICKMAN SJ, 1990, J PERS SOC PSYCHOL, V58, P95, DOI 10.1037/0022-3514.58.1.95; Hisrich R, 2007, AM PSYCHOL, V62, P575, DOI 10.1037/0003-066X.62.6.575; Myint YM, 2005, STRATEG CHANG, V14, P165, DOI 10.1002/jsc.718; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Roiser J, 2003, PSYCHIATRY, V2, P43	11	40	42	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					168	169		10.1038/456168a	http://dx.doi.org/10.1038/456168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005531				2022-12-28	WOS:000261039300012
J	Thombs, BD; de Jonge, P; Coyne, JC; Whooley, MA; Frasure-Smith, N; Mitchell, AJ; Zuidersma, M; Eze-Nliam, C; Lima, BB; Smith, CG; Soderlund, K; Ziegelstein, RC				Thombs, Brett D.; de Jonge, Peter; Coyne, James C.; Whooley, Mary A.; Frasure-Smith, Nancy; Mitchell, Alex J.; Zuidersma, Marij; Eze-Nliam, Chete; Lima, Bruno B.; Smith, Cheri G.; Soderlund, Karl; Ziegelstein, Roy C.			Depression Screening and Patient Outcomes in Cardiovascular Care A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; CASE-FINDING INSTRUMENTS; COLLABORATIVE CARE; MAJOR DEPRESSION; ARTERY-DISEASE; ANTIDEPRESSANT TREATMENT; HOSPITAL ANXIETY; SOCIAL SUPPORT; CARDIAC EVENTS	Context Several practice guidelines recommend that depression be evaluated and treated in patients with cardiovascular disease, but the potential benefits of this are unclear. Objective To evaluate the potential benefits of depression screening in patients with cardiovascular disease by assessing ( 1) the accuracy of depression screening instruments; ( 2) the effect of depression treatment on depression and cardiac outcomes; and ( 3) the effect of screening on depression and cardiac outcomes in patients in cardiovascular care settings. Data Sources MEDLINE, PsycINFO, CINAHL, EMBASE, ISI, SCOPUS, and Cochrane databases from inception to May 1, 2008; manual journal searches; reference list reviews; and citation tracking of included articles. Study Selection We included articles in any language about patients in cardiovascular care settings that ( 1) compared a screening instrument to a valid major depressive disorder criterion standard; ( 2) compared depression treatment with placebo or usual care in a randomized controlled trial; or ( 3) assessed the effect of screening on depression identification and treatment rates, depression, or cardiac outcomes. Data Extraction Methodological characteristics and outcomes were extracted by 2 investigators. Results We identified 11 studies about screening accuracy, 6 depression treatment trials, but no studies that evaluated the effects of screening on depression or cardiovascular outcomes. In studies that tested depression screening instruments using a priori-defined cutoff scores, sensitivity ranged from 39% to 100% ( median, 84%) and specificity ranged from 58% to 94% ( median, 79%). Depression treatment with medication or cognitive behavioral therapy resulted in modest reductions in depressive symptoms ( effect size, 0.20- 0.38; r(2), 1%- 4%). There was no evidence that depression treatment improved cardiac outcomes. Among patients with depression and history of myocardial infarction in the ENRICHD trial, there was no difference in event- free survival between participants treated with cognitive behavioral therapy supplemented by an antidepressant vs usual care ( 75.5% vs 74.7%, respectively). Conclusions Depression treatment with medication or cognitive behavioral therapy in patients with cardiovascular disease is associated with modest improvement in depressive symptoms but no improvement in cardiac outcomes. No clinical trials have assessed whether screening for depression improves depressive symptoms or cardiac outcomes in patients with cardiovascular disease.	[Thombs, Brett D.] Sir Mortimer B Davis Jewish Hosp, Dept Psychiat, Montreal, PQ H3T 1E4, Canada; [Thombs, Brett D.; Frasure-Smith, Nancy] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Frasure-Smith, Nancy] McGill Univ, Dept Nursing, Montreal, PQ, Canada; [de Jonge, Peter; Zuidersma, Marij] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychiat Epidemiol, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychiat Epidemiol, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [de Jonge, Peter] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, Dept Med Psychol, NL-5000 LE Tilburg, Netherlands; [Coyne, James C.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Frasure-Smith, Nancy] Ctr Hosp Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada; [Mitchell, Alex J.] Leicester Royal Infirm, Dept Canc & Mol Med, Leicester, Leics, England; [Eze-Nliam, Chete] Interfaith Med Ctr, Brooklyn, NY USA; [Lima, Bruno B.] Fed Univ Ceara Sch Med, Fortaleza, Ceara, Brazil; [Smith, Cheri G.] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Harold E Harrison Med Lib, Baltimore, MD USA; [Soderlund, Karl; Ziegelstein, Roy C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA	McGill University; McGill University; McGill University; University of Groningen; University of Groningen; Tilburg University; University of Pennsylvania; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Universite de Montreal; University of Leicester; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Thombs, BD (corresponding author), Sir Mortimer B Davis Jewish Hosp, Dept Psychiat, 4333 Cote Ste Catherine Rd, Montreal, PQ H3T 1E4, Canada.	brett.thombs@mcgill.ca	de Jonge, peter/L-6395-2013; Smith, Cheri/B-3268-2008; Mitchell, Alex/Z-1920-2019; Mitchell, Alex J/A-3090-2009; Lima, Bruno/AAB-2807-2021; Lima, Bruno/GWQ-4050-2022	de Jonge, peter/0000-0002-0866-6929; Mitchell, Alex/0000-0001-6014-598X; Mitchell, Alex J/0000-0001-6014-598X; Lima, Bruno/0000-0001-5540-932X; Thombs, Brett D./0000-0002-5644-8432	New Investigator Award from the Canadian Institutes of Health Research; Etablissement de Jeunes Chercheurs; Fonds de la Recherche en Sante Quebec; VIDI; Dutch Medical Research Council [016.086.397]; National Center for Complementary & Alternative Medicine [R24AT004641]; Miller Family Scholar Program; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R24AT004641] Funding Source: NIH RePORTER	New Investigator Award from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Etablissement de Jeunes Chercheurs; Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); VIDI(Netherlands Organization for Scientific Research (NWO)); Dutch Medical Research Council(Danish Medical Research Council); National Center for Complementary & Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Miller Family Scholar Program; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Dr Thombs is supported by a New Investigator Award from the Canadian Institutes of Health Research and an Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec. Dr de Jonge and Ms Zuidersma are supported by a VIDI grant from the Dutch Medical Research Council ( grant 016.086.397). Dr Whooley has received career development support from the Department of Veterans Affairs Health Services Research and Development Service, the Robert Wood Johnson Foundation, and the American Federation of Aging Research. Dr Ziegelstein is supported by grant R24AT004641 from the National Center for Complementary & Alternative Medicine and by the Miller Family Scholar Program.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Bakkalbasi Nisa, 2006, Biomed Digit Libr, V3, P7, DOI 10.1186/1742-5581-3-7; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Berg AO, 2002, ANN INTERN MED, V136, P760, DOI 10.7326/0003-4819-136-10-200205210-00012; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Davidson KW, 2006, PSYCHOSOM MED, V68, P645, DOI 10.1097/01.psy.0000233233.48738.22; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; de Jonge P, 2006, AM J PSYCHIAT, V163, P138, DOI 10.1176/appi.ajp.163.1.138; de Leon CFM, 1999, PSYCHOSOM MED, V61, P738, DOI 10.1097/00006842-199911000-00002; Denollet J, 2006, PSYCHOTHER PSYCHOSOM, V75, P346, DOI 10.1159/000095440; Dickens CM, 2004, PSYCHOL MED, V34, P1083, DOI 10.1017/S0033291704001965; Donoghue J, 2001, BRIT J PSYCHIAT, V179, pS9, DOI 10.1192/bjp.179.42.s9; Fairman KA, 1998, PSYCHIATR SERV, V49, P1180, DOI 10.1176/ps.49.9.1180; First M.B., 1996, STRUCTURED CLIN INTE, DOI DOI 10.1037/T07827-000; Frasure-Smith N, 2005, PSYCHOSOM MED, V67, pS19, DOI 10.1097/01.psy.0000162253.07959.db; Frasure-Smith N, 1998, CIRCULATION, V97, P708; Frasure-Smith N, 2000, J PSYCHOSOM RES, V48, P471, DOI 10.1016/S0022-3999(99)00088-4; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; Freedland KE, 2003, PSYCHOSOM MED, V65, P119, DOI 10.1097/01.PSY.0000038938.67401.85; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gilbody S, 2006, BMJ-BRIT MED J, V332, P1027, DOI 10.1136/bmj.332.7548.1027; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; GUTIERREZ RC, 1999, CAN J CARDIOVASC NUR, V10, P29; Harris RG, 2001, INT J MANAG REV, V3, P21, DOI 10.1111/1468-2370.00052; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Honig A, 2007, PSYCHOSOM MED, V69, P606, DOI 10.1097/PSY.0b013e31814b260d; Huffman JC, 2006, HEART, V92, P1656, DOI 10.1136/hrt.2005.087213; Irvine J, 1999, PSYCHOSOM MED, V61, P729, DOI 10.1097/00006842-199911000-00001; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Katon W, 2006, ARCH INTERN MED, V166, P2304, DOI 10.1001/archinte.166.21.2304; Katon WJ, 2008, J OCCUP ENVIRON MED, V50, P459, DOI 10.1097/JOM.0b013e318168efb7; Katzelnick DJ, 2000, ARCH FAM MED, V9, P345, DOI 10.1001/archfami.9.4.345; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lane D, 2003, J AM COLL CARDIOL, V42, P1808, DOI 10.1016/j.jacc.2003.08.018; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Linden W, 1996, ARCH INTERN MED, V156, P745, DOI 10.1001/archinte.156.7.745; Linden W, 2007, EUR HEART J, V28, P2972, DOI 10.1093/eurheartj/ehm504; Low GD, 2007, SOC INDIC RES, V82, P527, DOI 10.1007/s11205-006-9049-3; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Palmer SC, 2003, J PSYCHOSOM RES, V54, P279, DOI 10.1016/S0022-3999(02)00640-2; PIGNONE M, AHRQ02S002; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Richards DA, 2008, PSYCHOL MED, V38, P279, DOI 10.1017/S0033291707001365; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Rumsfeld JS, 2005, CIRCULATION, V111, P250, DOI 10.1161/01.CIR.0000154573.62822.89; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65; Sorensen C, 2005, PSYCHOTHER PSYCHOSOM, V74, P69, DOI 10.1159/000083165; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stafford L, 2007, GEN HOSP PSYCHIAT, V29, P417, DOI 10.1016/j.genhosppsych.2007.06.005; Strik JJMH, 2001, PSYCHOSOMATICS, V42, P423, DOI 10.1176/appi.psy.42.5.423; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	82	345	346	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2161	2171		10.1001/jama.2008.667	http://dx.doi.org/10.1001/jama.2008.667			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001627	Bronze			2022-12-28	WOS:000260793800026
J	Versmissen, J; Oosterveer, DM; Yazdanpanah, M; Defesche, JC; Basart, DCG; Liem, AH; Heeringa, J; Witteman, JC; Lansberg, PJ; Kastelein, JJP; Sijbrands, EJG				Versmissen, Jorie; Oosterveer, Daniella M.; Yazdanpanah, Mojgan; Defesche, Joep C.; Basart, Dick C. G.; Liem, Anho H.; Heeringa, Jan; Witteman, Jacqueline C.; Lansberg, Peter J.; Kastelein, John J. P.; Sijbrands, Eric J. G.			Efficacy of statins in familial hypercholesterolaemia: a long term cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; GUIDELINES; MORTALITY; CHILDREN; SAFETY; TRIAL	Objective To determine the efficacy of statin treatment on risk of coronary heart disease in patients with familial hypercholesterolaemia. Design Cohort study with a mean follow- up of 8.5 years. Setting 27 outpatient lipid clinics. Subjects 2146 patients with familial hypercholesterolaemia without prevalent coronary heart disease before 1 January 1990. Main outcome measures Risk of coronary heart disease in treated and "untreated" ( delay in starting statin treatment) patients compared with a Cox regression model in which statin use was a time dependent variable. Results In January 1990, 413 ( 21%) of the patients had started statin treatment, and during follow- up another 1294 patients ( 66%) started after a mean delay of 4.3 years. Most patients received simvastatin ( n= 1167, 33 mg daily) or atorvastatin ( n= 211, 49 mg daily). We observed an overall risk reduction of 76% ( hazard ratio 0.24 ( 95% confidence interval 0.18 to 0.30), P< 0.001). In fact, the risk of myocardial infarction in these statin treated patients was not significantly greater than that in an age- matched sample from the general population ( hazard ration 1.44 ( 0.80 to 2.60), P= 0.23). Conclusion Lower statin doses than those currently advised reduced the risk of coronary heart disease to a greater extent than anticipated in patients with familial hypercholesterolaemia. With statin treatment, such patients no longer have a risk of myocardial infarction significantly different from that of the general population.	[Versmissen, Jorie; Oosterveer, Daniella M.; Yazdanpanah, Mojgan; Sijbrands, Eric J. G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Defesche, Joep C.; Lansberg, Peter J.; Kastelein, John J. P.] Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands; [Basart, Dick C. G.] Westfries Gasthuis, Dept Cardiol, NL-1620 AR Hoorn, Netherlands; [Liem, Anho H.] Oosterschelde Hosp, Dept Cardiol, NL-4460 BB Goes, Netherlands; [Heeringa, Jan; Witteman, Jacqueline C.] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Sijbrands, EJG (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.sijbrands@erasmusmc.nl	Kastelein, John/AAF-7950-2020; Oosterveer, Daniella M/AAQ-7584-2021; Sijbrands, Eric/A-1065-2009; Oosterveer, Daniella/AAA-5778-2022	Sijbrands, Eric/0000-0001-8857-7389; Oosterveer, Daniella/0000-0003-1540-6903	Netherlands Heart Foundation [2006B190]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was funded by the Netherlands Heart Foundation (2006B190). JJPK and EJGS have received research funding from pharmaceutical manufacturers, but they did not receive industry funding for the present study. All authors declare they are independent from funders.	Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Jansen ACM, 2005, J CLIN EPIDEMIOL, V58, P269, DOI 10.1016/j.jclinepi.2004.07.006; Jansen ACM, 2004, J INTERN MED, V256, P482, DOI 10.1111/j.1365-2796.2004.01405.x; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; Mohrschladt MF, 2004, ATHEROSCLEROSIS, V172, P329, DOI 10.1016/j.atherosclerosis.2003.11.007; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; Neil HAW, 2004, BRIT MED J, V328, P500, DOI 10.1136/bmj.328.7438.500; *NIH CLIN EXC, 2008, CLIN GUID NIH CLIN E, V71; Rodenburg J, 2007, CIRCULATION, V116, P664, DOI 10.1161/CIRCULATIONAHA.106.671016; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; van Wissen S, 2005, AM J CARDIOL, V95, P264, DOI 10.1016/j.amjcard.2004.09.015; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331	17	524	531	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2008	337								a2423	10.1136/bmj.a2423	http://dx.doi.org/10.1136/bmj.a2423			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AA	19001495	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000261784100002
J	Liljas, A				Liljas, Anders			BIOCHEMISTRY Getting Close to Termination	SCIENCE			English	Editorial Material							RELEASE FACTORS; MESSENGER-RNA; 70S RIBOSOME; FACTOR RF2; DISTINCT; COMPLEX; CODON		[Liljas, Anders] Lund Univ, Dept Mol Biophys, S-22100 Lund, Sweden	Lund University	Liljas, A (corresponding author), Lund Univ, Dept Mol Biophys, S-22100 Lund, Sweden.	anders.liljas@mbfys.lu.se						Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	13	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					863	865		10.1126/science.1166913	http://dx.doi.org/10.1126/science.1166913			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988828				2022-12-28	WOS:000260674100023
J	Park, KK; Liu, K; Hu, Y; Smith, PD; Wang, C; Cai, B; Xu, BG; Connolly, L; Kramvis, I; Sahin, M; He, ZG				Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang			Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway	SCIENCE			English	Article							TUBEROUS SCLEROSIS; GROWTH; INJURY; MTOR; HYPOXIA; CELLS; TSC1	The failure of axons to regenerate is a major obstacle for functional recovery after central nervous system (CNS) injury. Removing extracellular inhibitory molecules results in limited axon regeneration in vivo. To test for the role of intrinsic impediments to axon regrowth, we analyzed cell growth control genes using a virus- assisted in vivo conditional knockout approach. Deletion of PTEN ( phosphatase and tensin homolog), a negative regulator of the mammalian target of rapamycin ( mTOR) pathway, in adult retinal ganglion cells ( RGCs) promotes robust axon regeneration after optic nerve injury. In wild- type adult mice, the mTOR activity was suppressed and new protein synthesis was impaired in axotomized RGCs, which may contribute to the regeneration failure. Reactivating this pathway by conditional knockout of tuberous sclerosis complex 1, another negative regulator of the mTOR pathway, also leads to axon regeneration. Thus, our results suggest the manipulation of intrinsic growth control pathways as a therapeutic approach to promote axon regeneration after CNS injury.	[Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Park, Kevin Kyungsuk; Liu, Kai; Hu, Yang; Smith, Patrice D.; Wang, Chen; Cai, Bin; Xu, Bengang; Connolly, Lauren; Kramvis, Ioannis; Sahin, Mustafa; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	He, ZG (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953; Smith, Patrice/0000-0002-0731-2803; Liu, Kai/0000-0001-9351-1640; Hu, Yang/0000-0002-7980-1649	Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke; Wings for Life, and Adelson Foundation; Ruth L. Kirschstein National Research Service Award; Canadian Institute of Health Research; NINDS; Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058956, R01NS051788] Funding Source: NIH RePORTER	Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wings for Life, and Adelson Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Hasegawa and F. Wang for providing Rosa-stop-PLAP mice, D. Kwiatkowski for proving TSC1<SUP>f/f</SUP> mice, C. Deng for Smad4<SUP>f/f</SUP> mice, M. Ericsson and L. Bu for microscopic analysis, and L. Benowitz, M. Greenberg, T. Hensch and J. Kanter for reading the manuscript. This study was supported by grants from Craig H. Neilson Foundation (to K. K. P.); National Institute of Neurological Disorders and Stroke ( NINDS), Wings for Life, and Adelson Foundation (to Z.H.); Ruth L. Kirschstein National Research Service Award (NRSA) (to Y.H.); Canadian Institute of Health Research (to P.D.S.); and NINDS and Tuberous Sclerosis Alliance (to M.S.).	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Marino S, 2000, GENE DEV, V14, P994; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Namikawa K, 2000, J NEUROSCI, V20, P2875; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Weinberg RA, 2007, BIOL CANC, P209; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	27	1086	1139	3	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					963	966		10.1126/science.1161566	http://dx.doi.org/10.1126/science.1161566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988856	Green Accepted			2022-12-28	WOS:000260674100053
J	Zhang, PZ; Cheng, H; Edwards, RL; Chen, FH; Wang, YJ; Yang, XL; Liu, J; Tan, M; Wang, XF; Liu, JH; An, CL; Dai, ZB; Zhou, J; Zhang, DZ; Jia, JH; Jin, LY; Johnson, KR				Zhang, Pingzhong; Cheng, Hai; Edwards, R. Lawrence; Chen, Fahu; Wang, Yongjin; Yang, Xunlin; Liu, Jian; Tan, Ming; Wang, Xianfeng; Liu, Jinghua; An, Chunlei; Dai, Zhibo; Zhou, Jing; Zhang, Dezhong; Jia, Jihong; Jin, Liya; Johnson, Kathleen R.			A Test of Climate, Sun, and Culture Relationships from an 1810-Year Chinese Cave Record	SCIENCE			English	Article							INTERTROPICAL CONVERGENCE ZONE; SOLAR VARIABILITY; MONSOON; TEMPERATURES; SPELEOTHEMS; RESOLUTION; FREQUENCY; DROUGHT	A record from Wanxiang Cave, China, characterizes Asian Monsoon ( AM) history over the past 1810 years. The summer monsoon correlates with solar variability, Northern Hemisphere and Chinese temperature, Alpine glacial retreat, and Chinese cultural changes. It was generally strong during Europe's Medieval Warm Period and weak during Europe's Little Ice Age, as well as during the final decades of the Tang, Yuan, and Ming Dynasties, all times that were characterized by popular unrest. It was strong during the first several decades of the Northern Song Dynasty, a period of increased rice cultivation and dramatic population increase. The sign of the correlation between the AM and temperature switches around 1960, suggesting that anthropogenic forcing superseded natural forcing as the major driver of AM changes in the late 20th century.	[Cheng, Hai; Edwards, R. Lawrence; Wang, Xianfeng] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; [Zhang, Pingzhong; Chen, Fahu; Yang, Xunlin; Liu, Jinghua; An, Chunlei; Dai, Zhibo; Zhou, Jing; Zhang, Dezhong; Jia, Jihong; Jin, Liya] Lanzhou Univ, Key Lab Western Chinas Environm Syst, Minist Educ, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Wang, Yongjin] Nanjing Normal Univ, Coll Geog Sci, Nanjing 210097, Peoples R China; [Liu, Jian] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing 210008, Peoples R China; [Tan, Ming] Chinese Acad Sci, Inst Geol & Geophys, Beijing 100029, Peoples R China; [Johnson, Kathleen R.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of Minnesota System; University of Minnesota Twin Cities; Lanzhou University; Nanjing Normal University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; University of California System; University of California Irvine	Cheng, H (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.	cheng021@umn.edu	Fahu, Chen/B-2788-2011; Edwards, R. Lawrence/I-3124-2014; Wang, Xianfeng/F-1233-2014; CHENG, HAI/H-3413-2017; Chen, Fahu/E-9491-2010; Johnson, Kathleen/B-2017-2013	Edwards, R. Lawrence/0000-0002-7027-5881; Wang, Xianfeng/0000-0002-8614-5627; CHENG, HAI/0000-0002-5305-9458; Johnson, Kathleen/0000-0003-1291-198X; Chen, Fahu/0000-0002-8874-1035	National Science Foundations of the United States [ESH 0502535]; NSFC [40421101, 40471137, 40721061, 40225007]; Gary Comer Science and Education Foundation [CC8, CP41]; Ministry of Science and Technology of China [2006CB400503]; Chinese Academy of Sciences [KZCX2-YW316]	National Science Foundations of the United States(National Science Foundation (NSF)); NSFC(National Natural Science Foundation of China (NSFC)); Gary Comer Science and Education Foundation; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank R. S. Bradley for his comments that improved this manuscript considerably and W. S. Broecker and the late G. Comer for their support of our work. This work was supported by the National Science Foundations of the United States (grant NSF ESH 0502535 to R.L.E. and H.C.) and China (grants NSFC 40421101, 40471137, and 40721061 to P.Z. and 40225007 to Y.J.W. and H.C.), the Gary Comer Science and Education Foundation (grants CC8 and CP41 to R.L.E.), the Ministry of Science and Technology of China (grant 2006CB400503 to M.T.), and the Chinese Academy of Sciences (grant KZCX2-YW316 to M.T.).	Ammann CM, 2007, P NATL ACAD SCI USA, V104, P3713, DOI 10.1073/pnas.0605064103; Banner JL, 1996, GEOLOGY, V24, P1049, DOI 10.1130/0091-7613(1996)024<1049:HRTROH>2.3.CO;2; Bard E, 2006, EARTH PLANET SC LETT, V248, P1, DOI 10.1016/j.epsl.2006.06.016; Cheng H, 2006, GEOLOGY, V34, P217, DOI 10.1130/G22289.1; Curtis JH, 1996, QUATERNARY RES, V46, P37, DOI 10.1006/qres.1996.0042; DASGUPTA S, 2008, THESIS U MINNESOTA M; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Hodell DA, 2001, SCIENCE, V292, P1367, DOI 10.1126/science.1057759; Holzhauser H, 2005, HOLOCENE, V15, P789, DOI 10.1191/0959683605hl853ra; Lau KM, 2006, CLIM DYNAM, V26, P855, DOI 10.1007/s00382-006-0114-2; LOCKWOOD M, 2007, P ROY SOC LOND A MAT, V463, P2086; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; McMillan EA, 2005, J QUATERNARY SCI, V20, P423, DOI 10.1002/jqs.943; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Muscheler R, 2007, QUATERNARY SCI REV, V26, P82, DOI 10.1016/j.quascirev.2006.07.012; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; Robertson FM, 2006, NANOMED-NANOTECHNOL, V2, P295, DOI 10.1016/j.nano.2006.10.084; Rotstayn LD, 2002, J CLIMATE, V15, P2103, DOI 10.1175/1520-0442(2002)015&lt;2103:TRTATI&gt;2.0.CO;2; Tan LC, 2008, CLIM PAST, V4, P19; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Webster JW, 2007, PALAEOGEOGR PALAEOCL, V250, P1, DOI 10.1016/j.palaeo.2007.02.022; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Zhang D, 2007, NATURE, V450, pE7, DOI 10.1038/nature06338	28	690	909	26	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					940	942		10.1126/science.1163965	http://dx.doi.org/10.1126/science.1163965			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988851	Green Submitted			2022-12-28	WOS:000260674100046
J	Blobel, G				Blobel, Guenter			George Emil Palade (1912-2008) Obituary	NATURE			English	Biographical-Item									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	blobel@mail.rockefeller.edu							0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					52	52		10.1038/456052a	http://dx.doi.org/10.1038/456052a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987733	Bronze			2022-12-28	WOS:000260674000038
J	Keenan, HT; Hall, GC; Marshall, SW				Keenan, Heather T.; Hall, Gillian C.; Marshall, Stephen W.			Early head injury and attention-deficit/hyperactivity disorder: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; DEFICIT-HYPERACTIVITY DISORDER; CHILDREN; SYMPTOMS; ILLNESS	Objective To explore the hypothesis that medically attended head injury in young children may be causal in the later development of attention- deficit/ hyperactivity disorder. Design Retrospective cohort study. Setting Health improvement network database ( 1988-2003), a longitudinal UK general practice dataset. Participants All children registered in the database from birth until their 10th birthday. Main outcome measures Risk of a child with a head injury before age 2 developing attention- deficit/ hyperactivity disorder before age 10 compared with children with a burn injury before age 2 and children with neither a burn nor a head injury. Results Of the 62 088 children who comprised the cohort, 2782 ( 4.5%) had a head injury and 1116 ( 1.8%) had a burn injury. The risk of diagnosis of attention- deficit/ hyperactivity disorder before 10 years of age after adjustment for sex, prematurity, socioeconomic status, and practice identification number was similar in the head injury ( relative risk 1.9, 95% confidence interval 1.5 to 2.5) and burn injury groups ( 1.7, 1.2 to 2.5) compared with all other children. Discussion Medically attended head injury before 2 years of age does not seem to be causal in the development of attention- deficit/ hyperactivity disorder. Medically attended injury before 2 years of age may be a marker for subsequent diagnosis of attention- deficit/ hyperactivity disorder.	[Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27699 USA	Utah System of Higher Education; University of Utah	Keenan, HT (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu		Marshall, Stephen/0000-0002-2664-9233				Bourke Alison, 2004, Inform Prim Care, V12, P171; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Huff N, 1999, J PUBLIC HEALTH MED, V21, P81, DOI 10.1093/pubmed/21.1.81; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	14	33	33	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2008	337								a1984	10.1136/bmj.a1984	http://dx.doi.org/10.1136/bmj.a1984			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FC	18988644	Green Published, hybrid			2022-12-28	WOS:000261236100001
J	Park, KS; Cho, YS				Park, Kyung-Su; Cho, Young-Seok			Ankylosing Spondylitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Park, Kyung-Su; Cho, Young-Seok] Uijeongbu St Marys Hosp, Uijongbu 480717, Gyeonggi Do, South Korea		Park, KS (corresponding author), Uijeongbu St Marys Hosp, Uijongbu 480717, Gyeonggi Do, South Korea.								0	1	2	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2034	2034		10.1056/NEJMicm072124	http://dx.doi.org/10.1056/NEJMicm072124			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987371				2022-12-28	WOS:000260632700008
J	Steinbrook, R				Steinbrook, Robert			Saying No Isn't Nice - The Travails of Britain's National Institute for Health and Clinical Excellence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						[Anonymous], 2008, GUID METH TECHN APPR; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Rawlins MD, 2004, NEW ENGL J MED, V351, P1383, DOI 10.1056/NEJMp048221	4	68	68	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1977	1981		10.1056/NEJMp0806862	http://dx.doi.org/10.1056/NEJMp0806862			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987366				2022-12-28	WOS:000260632700001
J	Di Gallo, A; Kuehne, T				Di Gallo, Alain; Kuehne, Thomas			Ghost in the tree	LANCET			English	Editorial Material									[Di Gallo, Alain] Univ Psychiat Hosp, Dept Child & Adolescent Psychiat, Basel, Switzerland; [Kuehne, Thomas] Univ Childrens Hosp, Dept Oncol & Haematol, Basel, Switzerland		Di Gallo, A (corresponding author), Kinder & Jugendpsychiat Klin, Schaffhauserrheinweg 55, CH-4058 Basel, Switzerland.	alain.digallo@unibas.ch	Kuehne, Thomas/I-6143-2019	Kuehne, Thomas/0000-0002-7387-7028					0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1570	1570						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984190	Bronze			2022-12-28	WOS:000260590500029
J	Stuckler, D; King, L; Robinson, H; McKee, M				Stuckler, David; King, Lawrence; Robinson, Helen; McKee, Martin			WHO's budgetary allocations and burden of disease: a comparative analysis	LANCET			English	Article							DEVELOPING-COUNTRIES; GLOBAL HEALTH; POPULATION; PREVENTION; MORTALITY; WORLD; COSTS; CARE	Background Ministers of health, donor agencies, philanthropists, and international agencies will meet at Bamako, Mali, in November, 2008, to review global priorities for health research. These individuals and organisations previously set health priorities for WHO, either through its regular budget or extra-budgetary funds. We asked what insights can be gained as to their priorities from previous decisions within the context of WHO. Methods We compared the WHO biennial budgetary allocations with the burden of disease from 1994-95 to 2008-09. We obtained data from publicly available WHO sources and examined whether WHO allocations varied with the burden of disease (defined by death and disability-adjusted life years) by comparing two WHO regions-Western Pacific and Africa-that are at differing stages of epidemiological transition. We further assessed whether the allocations differed on the basis of the source of funds (assessed and voluntary contributions) and the mechanism for deciding how funds were spent. Findings We noted that WHO budget allocations were heavily skewed toward infectious diseases. In 2006-07, WHO allocated 87% of its total budget to infectious diseases, 12% to non-communicable diseases, and less than 1% to injuries and violence. We recorded a similar distribution of funding in Africa, where nearly three-quarters of mortality is from infectious disease, and in Western Pacific, where three-quarters of mortality is from non-communicable disease. In both regions, injuries received only 1% of total resources. The skew towards infectious diseases was substantially greater for the WHO extra-budget, which is allocated by donors and has risen greatly in recent years, than for the WHO regular budget, which is decided on by member states through democratic mechanisms and has been held at zero nominal growth. Interpretation Decision makers at Bamako should consider the implications of the present misalignment of global health priorities and disease burden for health research worldwide. Funds allocated by external donors substantially differ from those allocated by WHO member states. The meeting at Bamako provides an opportunity to consider how this disparity might be addressed. Funding None.	[Stuckler, David] Univ Oxford Christ Church, Dept Sociol, Oxford OX1 1DP, England; [Stuckler, David; King, Lawrence; Robinson, Helen] Univ Cambridge, Dept Sociol, Fac Social & Polit Sci, Cambridge, England; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	University of Oxford; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Stuckler, D (corresponding author), Univ Oxford Christ Church, Dept Sociol, Oxford OX1 1DP, England.	david.stuckler@chch.ox.ac.uk	Stuckler, David/H-2261-2012; McKee, Marc D/E-2187-2011; Swaibu, Ramadhani A/H-3164-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; King, Lawrence/0000-0002-5714-406X; Stuckler, David/0000-0002-1288-8401				[Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], [No title captured]; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beran D, 2005, DIABETES CARE, V28, P2136, DOI 10.2337/diacare.28.9.2136; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; GODAL T, 1996, INVESTING HLTH RES D; Ijsselmuiden C, 2008, LANCET, V371, P91, DOI 10.1016/S0140-6736(08)60080-X; Keck ME., 2014, ACTIVISTS BORDERS AD; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MAIZELS A, 1984, WORLD DEV, V12, P879, DOI 10.1016/0305-750X(84)90046-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKee M, 2008, EUR J PUBLIC HEALTH, V18, P107, DOI 10.1093/eurpub/ckm115; Murray, 2002, SUMMARY MEASURES POP, P205; Shiffman J, 2006, HEALTH POLICY PLANN, V21, P411, DOI 10.1093/heapol/czl028; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Suhrcke M, 2005, CONTRIBUTION HLTH EC; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Vaughan JP, 1996, HEALTH POLICY, V35, P229, DOI 10.1016/0168-8510(95)00786-5; *WHO, 2004, REP MIN SUMM HLTH RE, P16; *WHO, 2000, WORLD HLTH ASS 53 17; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; World Health Organization, 2004, WORLD HLTH REP CHANG; World Health Organization, 2004, GLOB STRAT DIET PHYS	25	123	123	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1563	1569		10.1016/S0140-6736(08)61656-6	http://dx.doi.org/10.1016/S0140-6736(08)61656-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984189	Bronze, Green Published			2022-12-28	WOS:000260590500028
J	Walsh, CA; Morrow, EM; Rubenstein, JLR				Walsh, Christopher A.; Morrow, Eric M.; Rubenstein, John L. R.			Autism and Brain Development	CELL			English	Article							MENTAL-RETARDATION; MOUSE MODEL; MUTATIONS; GENES; MECP2; TRANSCRIPTION; DISRUPTION; PLASTICITY; DISORDERS; CHILDREN	Genetic studies are refining our understanding of neurodevelopmental mechanisms in autism. Some autism-related mutations appear to disrupt genes regulated by neuronal activity, which are especially important in development of the postnatal nervous system. Gene replacement studies in mice indicate that the developmental window to ameliorate symptoms may be wider than previously anticipated.	[Walsh, Christopher A.; Morrow, Eric M.] Childrens Hosp, Dept Neurol, Div Genet, Boston, MA 02115 USA; [Walsh, Christopher A.; Morrow, Eric M.] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; [Morrow, Eric M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Walsh, CA (corresponding author), Childrens Hosp, Dept Neurol, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Morrow, Eric/J-2767-2013; Warfield, Simon/B-3352-2009	Morrow, Eric/0000-0003-3430-3520; Warfield, Simon/0000-0002-7659-3880	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH083565, K23 MH080954-05, R01 MH49428, K23 MH080954, R01 MH049428, 1R01 MH083565, 1K23MH080954, R01 MH083565-02] Funding Source: Medline; NINDS NIH HHS [R01 NS034661, R01 NS34661] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, R01MH083565, K23MH080954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034661, R01NS035129] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gomot M, 2006, NEUROIMAGE, V29, P475, DOI 10.1016/j.neuroimage.2005.07.027; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamilton SP, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-52; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scearce-Levie K, 2008, GENES BRAIN BEHAV, V7, P344, DOI 10.1111/j.1601-183X.2007.00357.x; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Turner G, 2002, AM J MED GENET, V112, P405, DOI 10.1002/ajmg.10714; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	42	133	140	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					396	400		10.1016/j.cell.2008.10.015	http://dx.doi.org/10.1016/j.cell.2008.10.015			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984148	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000260536300007
J	Murase, K; Hirano, Y; Sun, TP; Hakoshima, T				Murase, Kohji; Hirano, Yoshinori; Sun, Tai-ping; Hakoshima, Toshio			Gibberellin-induced DELLA recognition by the gibberellin receptor GID1	NATURE			English	Article							BOX PROTEIN TIR1; F-BOX; ARABIDOPSIS-THALIANA; FLORAL DEVELOPMENT; SIGNALING PATHWAY; SEED-GERMINATION; GENE ENCODES; EXPRESSION; REPRESSOR; TARGETS	Gibberellins control a range of growth and developmental processes in higher plants and have been widely used in the agricultural industry. By binding to a nuclear receptor, GIBBERELLIN INSENSITIVE DWARF1 (GID1), gibberellins regulate gene expression by promoting degradation of the transcriptional regulator DELLA proteins, including GIBBERELLIN INSENSITIVE ( GAI). The precise manner in which GID1 discriminates and becomes activated by bioactive gibberellins for specific binding to DELLA proteins remains unclear. Here we present the crystal structure of a ternary complex of Arabidopsis thaliana GID1A, a bioactive gibberellin and the amino- terminal DELLA domain of GAI. In this complex, GID1A occludes gibberellin in a deep binding pocket covered by its N- terminal helical switch region, which in turn interacts with the DELLA domain containing DELLA, VHYNP and LExLE motifs. Our results establish a structural model of a plant hormone receptor that is distinct from the mechanism of the hormone perception and effector recognition of the known auxin receptors.	[Murase, Kohji; Hirano, Yoshinori; Hakoshima, Toshio] Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan; [Sun, Tai-ping] Duke Univ, Dept Biol, Durham, NC 27708 USA	Nara Institute of Science & Technology; Duke University	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.	hakosima@bs.naist.jp	Hirano, Yoshinori/ABC-6876-2020	Hirano, Yoshinori/0000-0001-9888-1616	Mitsubishi Foundation, Japan; Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; National Science Foundation of the United States [IBN-0348814]; Young Scientists from the Japan Society for the Promotion of Science; Global COE Program in NAIST; MEXT of Japan.	Mitsubishi Foundation, Japan; Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Science Foundation of the United States(National Science Foundation (NSF)); Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program in NAIST(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S. Terawaki and T. Mori for technical advice and J. Tsukamoto for technical support in performing the matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy analysis, and the beamline staff of BL41XU of SPring-8 at Harima for help with the data collection. We also acknowledge A. Isogai for advice and encouragement. This work was supported by a research grant in the natural sciences from the Mitsubishi Foundation, Japan ( to T.H.), and in part by a Grant-in-Aid for Scientific Research (A) and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to T. H.). This work was also supported in part by grants from the National Science Foundation of the United States (IBN-0348814 to T.-p.S.). K.M. is a recipient of a postdoctoral fellowship for Young Scientists from the Japan Society for the Promotion of Science and an international research fellowship from the Global COE Program in NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment) from MEXT of Japan.	ALBERTS B, 2008, MOL BIOL CELL, P395; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DERKX MPM, 1994, PLANT GROWTH REGUL, V15, P223, DOI 10.1007/BF00029895; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; HAKOSHIMA T, 2003, NATURE ENCY HUMAN GE, V3, P679; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Iuchi S, 2007, PLANT J, V50, P958, DOI 10.1111/j.1365-313X.2007.03098.x; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; King KE, 2001, GENETICS, V159, P767; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; MacMillan J, 2001, J PLANT GROWTH REGUL, V20, P387, DOI 10.1007/s003440010038; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; RADLEY M, 1956, NATURE, V178, P1070, DOI 10.1038/1781070a0; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; TALON M, 1990, P NATL ACAD SCI USA, V87, P7983, DOI 10.1073/pnas.87.20.7983; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Yabuta T., 1938, J AGR CHEM SOC JAPAN, V14, P1526, DOI DOI 10.1271/NOGEIKAGAKU1924.14.12_1526; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999	49	453	514	16	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					459	U15		10.1038/nature07519	http://dx.doi.org/10.1038/nature07519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037309				2022-12-28	WOS:000261170500029
J	Gladwin, MT; Vichinsky, E				Gladwin, Mark T.; Vichinsky, Elliott			Pulmonary Complications of Sickle Cell Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE CHEST SYNDROME; NITRIC-OXIDE BIOAVAILABILITY; REGURGITANT JET VELOCITY; ENDOTHELIAL DYSFUNCTION; THALASSEMIA-INTERMEDIA; RISK-FACTORS; FETAL-HEMOGLOBIN; FAT-EMBOLISM; MOUSE MODEL; LEG ULCERS		[Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Gladwin, Mark T.] Univ Pittsburgh, Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA 15213 USA; [Vichinsky, Elliott] Childrens Hosp & Res Ctr, Oakland, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gladwin, MT (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, NW 168 Montefiore Hosp,354 5th Ave, Pittsburgh, PA 15213 USA.	gladwinmt@upmc.edu	Vichinsky, Elliott P/F-8541-2011	Vichinsky, Elliott P/0000-0002-0500-9579	U. S. government; INO Therapeutics; Intramural Research Division of the National Heart, Lung, and Blood Institute; Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania	U. S. government; INO Therapeutics; Intramural Research Division of the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania	Dr. Gladwin reports receiving grant support from the U. S. government and INO Therapeutics in the form of a Collaborative Research and Development Agreement, from the Intramural Research Division of the National Heart, Lung, and Blood Institute, and from the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania. No other potential conflict of interest was reported.	AESSOPOS A, 1995, CHEST, V107, P50, DOI 10.1378/chest.107.1.50; Aessopos A, 2001, BLOOD, V97, P3411, DOI 10.1182/blood.V97.11.3411; Aliyu ZY, 2008, AM J HEMATOL, V83, P485, DOI 10.1002/ajh.21162; Ambrusko SJ, 2006, PEDIATR BLOOD CANCER, V47, P907, DOI 10.1002/pbc.20791; Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Ataga KI, 2004, AM J MED, V117, P665, DOI 10.1016/j.amjmed.2004.03.034; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; BELLET PS, 1995, NEW ENGL J MED, V333, P699, DOI 10.1056/NEJM199509143331104; BENSINGER TA, 1974, ARCH INTERN MED, V133, P624, DOI 10.1001/archinte.133.4.624; Boyd JH, 2006, BLOOD, V108, P2923, DOI 10.1182/blood-2006-01-011072; BRITTENHAM GM, 1985, BLOOD, V65, P183; Bryant Rosalind, 2005, J Pediatr Health Care, V19, P157, DOI 10.1016/j.pedhc.2004.12.003; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Burnett AL, 2008, J SEX MED, V5, P237, DOI 10.1111/j.1743-6109.2007.00631.x; Butler AR, 1998, BBA-GEN SUBJECTS, V1425, P168, DOI 10.1016/S0304-4165(98)00065-8; Castro O, 1996, HEMATOL ONCOL CLIN N, V10, P1289, DOI 10.1016/S0889-8588(05)70401-9; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Derchi G, 1999, AM HEART J, V138, P384, DOI 10.1016/S0002-8703(99)70129-8; Dessap AM, 2008, AM J RESP CRIT CARE, V177, P646, DOI 10.1164/rccm.200710-1606OC; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Du ZD, 1997, AM HEART J, V134, P532, DOI 10.1016/S0002-8703(97)70091-7; Eberhardt RT, 2003, AM J HEMATOL, V74, P104, DOI 10.1002/ajh.10387; Field JJ, 2008, AM J HEMATOL, V83, P574, DOI 10.1002/ajh.21176; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Frenette PS, 2002, CURR OPIN HEMATOL, V9, P101, DOI 10.1097/00062752-200203000-00003; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Gladwin MT, 2000, LANCET, V355, P1476, DOI 10.1016/S0140-6736(00)02157-7; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Haque AK, 2002, HUM PATHOL, V33, P1037, DOI 10.1053/hupa.2002.128059; Hayag-Barin JE, 1998, AM J HEMATOL, V57, P82, DOI 10.1002/(SICI)1096-8652(199801)57:1<82::AID-AJH15>3.0.CO;2-B; HEBBEL RP, 1985, CLIN HAEMATOL, V14, P129; HIRUMA H, 1995, AM J PHYSIOL-HEART C, V268, pH2003, DOI 10.1152/ajpheart.1995.268.5.H2003; Holtzclaw JD, 2004, AM J RESP CRIT CARE, V169, P687, DOI 10.1164/rccm.200302-224OC; Hsu, 2008, BLOOD, V111, P1772; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, PEDIATR HEMAT ONCOL, V24, P159, DOI 10.1080/08880010601185892; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kato GJ, 2006, AM J HEMATOL, V81, P503, DOI 10.1002/ajh.20642; Kaul DK, 2004, J CLIN INVEST, V114, P1136, DOI 10.1172/JCI200421633; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Kaul DK, 2000, J CLIN INVEST, V106, P715, DOI 10.1172/JCI9225E1; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Klings ES, 2006, AM J RESP CRIT CARE, V173, P1264, DOI 10.1164/rccm.200601-125OC; Knight-Madden JM, 2005, THORAX, V60, P206, DOI 10.1136/thx.2004.029165; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lechapt E, 2003, AM J RESP CRIT CARE, V168, P1373, DOI 10.1164/rccm.200302-174OC; Liem RI, 2007, HAEMATOLOGICA, V92, P1549, DOI 10.3324/haematol.11576; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Machado RF, 2005, BRIT J HAEMATOL, V129, P449, DOI 10.1111/j.1365-2141.2005.05432.x; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310; McMahon LEC, 1997, NEW ENGL J MED, V337, P1293, DOI 10.1056/NEJM199710303371808; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Mohamed N, 1998, BLOOD REV, V12, P163, DOI 10.1016/S0268-960X(98)90014-5; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris CR, 2005, ANN NY ACAD SCI, V1054, P481, DOI 10.1196/annals.1345.058; NAGEL RL, 1971, J BIOL CHEM, V246, P69; Nath KA, 2000, AM J PHYSIOL-REG I, V279, pR1949, DOI 10.1152/ajpregu.2000.279.6.R1949; NOGUCHI CT, 1993, BAILLIERE CLIN HAEM, V6, P57, DOI 10.1016/S0950-3536(05)80066-6; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Nolan VG, 2005, BRIT J HAEMATOL, V128, P266, DOI 10.1111/j.1365-2141.2004.05295.x; Nordness Mark E, 2005, Clin Mol Allergy, V3, P2, DOI 10.1186/1476-7961-3-2; Ohene-Frempong K, 1998, BLOOD, V91, P288; Onyekwere OC, 2008, PEDIATR CARDIOL, V29, P309, DOI 10.1007/s00246-007-9018-x; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Pashankar FD, 2008, PEDIATRICS, V121, P777, DOI 10.1542/peds.2007-0730; Pegelow CH, 1997, AM J MED, V102, P171; Perronne Veronique, 2002, Hematol J, V3, P56, DOI 10.1038/sj.thj.6200147; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; Platt OS, 2000, NEW ENGL J MED, V342, P1904, DOI 10.1056/NEJM200006223422510; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; PLATT OS, 2000, NEW ENGL J MED, V343, P591; Prabhakaran Karti, 2007, Can J Urol, V14, P3702; Raghavachari N, 2007, CIRCULATION, V115, P1551, DOI 10.1161/CIRCULATIONAHA.106.658641; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; REPKA T, 1991, BLOOD, V78, P2753; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Schechter AN, 2003, NEW ENGL J MED, V348, P1483, DOI 10.1056/NEJMcibr023045; Setty BNY, 2001, BLOOD, V98, P3228, DOI 10.1182/blood.V98.12.3228; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Styles LA, 1996, BLOOD, V87, P2573, DOI 10.1182/blood.V87.6.2573.bloodjournal8762573; Sylvester KP, 2007, PEDIATR PULM, V42, P103, DOI 10.1002/ppul.20430; Taher A, 2006, BLOOD CELL MOL DIS, V37, P12, DOI 10.1016/j.bcmd.2006.04.005; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Thuret I, 1996, AM J HEMATOL, V51, P133; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; van Beers EJ, 2008, HAEMATOLOGICA, V93, pE42, DOI 10.3324/haematol.12632; VANSCHEIDT W, 1990, DERMATOLOGICA, V181, P56, DOI 10.1159/000247863; VICHINSKY E, 1994, BLOOD, V83, P3107; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Vichinsky EP, 2004, NEW ENGL J MED, V350, P857, DOI 10.1056/NEJMp038250; Vichinsky EP, 2000, NEW ENGL J MED, V343, P824; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x; Wood KC, 2005, FASEB J, V19, P989, DOI 10.1096/fj.04-3218fje; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yu B, 2008, CIRCULATION, V117, P1982, DOI 10.1161/CIRCULATIONAHA.107.729137; 1983, N ENGL J MED, V309, P1627	123	301	305	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2254	2265		10.1056/NEJMra0804411	http://dx.doi.org/10.1056/NEJMra0804411			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020327	Green Published			2022-12-28	WOS:000260994000008
J	Bernstein, AS; Ludwig, DS				Bernstein, Aaron S.; Ludwig, David S.			The Importance of Biodiversity to Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NATURAL-PRODUCTS; DISEASE; EMERGENCE; RISK		[Bernstein, Aaron S.; Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Bernstein, Aaron S.] Harvard Univ, Sch Med, Ctr Hlth & Global Environm, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bernstein, AS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	aaron.bernstein@childrens.harvard.edu	Bernstein, Aaron/AAF-3522-2021	Bernstein, Aaron/0000-0003-1703-1041; Ludwig, David/0000-0003-3307-8544				Becker S, 2008, APPL MICROBIOL BIOT, V79, P1, DOI 10.1007/s00253-008-1385-6; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Chivian E, 2008, SUSTAINING LIFE HUMA; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Klotz U, 2006, INT J CLIN PHARM TH, V44, P478; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Oberlies NH, 2004, J NAT PROD, V67, P129, DOI 10.1021/np030498t; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; *PRACT GREENH, WAST RED; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102	14	11	11	4	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2297	2299		10.1001/jama.2008.655	http://dx.doi.org/10.1001/jama.2008.655			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017916				2022-12-28	WOS:000260965500030
J	Califf, RM; Ginsburg, GS				Califf, Robert M.; Ginsburg, Geoffrey S.			Organizational Improvements to Enhance Modern Clinical Epidemiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREDICTION; DISEASE		[Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA; [Ginsburg, Geoffrey S.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University; Duke University	Califf, RM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, Box 3850, Durham, NC 27710 USA.	calif001@mc.duke.edu			NCRR NIH HHS [1 UL1 RR024128-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Califf RM, 2007, HEALTH AFFAIR, V26, P62, DOI 10.1377/hlthaff.26.1.62; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Ginsburg GS, 2008, JAMA-J AM MED ASSOC, V299, P1359, DOI 10.1001/jama.299.11.1359; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kush RD, 2008, NEW ENGL J MED, V358, P1738, DOI 10.1056/NEJMsb0800209; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Stead E A Jr, 1984, J Med Syst, V8, P3, DOI 10.1007/BF02221861; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Weinfurt KP, 2003, CLIN THER, V25, P671, DOI 10.1016/S0149-2918(03)80104-2; Windish DM, 2007, JAMA-J AM MED ASSOC, V298, P1010, DOI 10.1001/jama.298.9.1010; Wishart DS, 2005, DRUG METAB REV, V37, P279, DOI 10.1081/DMR-200055225	13	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2300	2302		10.1001/jama.2008.638	http://dx.doi.org/10.1001/jama.2008.638			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017917				2022-12-28	WOS:000260965500031
J	Gartlehner, G; Gaynes, BN; Hansen, RA; Thieda, P; DeVeaugh-Geiss, A; Krebs, EE; Moore, CG; Morgan, L; Lohr, KN				Gartlehner, Gerald; Gaynes, Bradley N.; Hansen, Richard A.; Thieda, Patricia; DeVeaugh-Geiss, Angela; Krebs, Erin E.; Moore, Charity G.; Morgan, Laura; Lohr, Kathleen N.			Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							MAJOR DEPRESSIVE DISORDER; PLACEBO-CONTROLLED TRIAL; SEROTONIN-REUPTAKE INHIBITORS; LONG-TERM TREATMENT; BUPROPION SUSTAINED-RELEASE; VENLAFAXINE EXTENDED-RELEASE; DOUBLE-BLIND TRIAL; QUALITY-OF-LIFE; TRAZODONE PROLONGED-RELEASE; ALCOHOL-DEPENDENT PATIENTS	Background: Second-generation antidepressants dominate the management of major depressive disorder, dysthymia, and subsyndromal depression. Evidence on the comparative benefits and harms is still accruing. Purpose: To compare the benefits and harms of second-generation antidepressants (bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone, and venlafaxine) for the treatment of depressive disorders in adults. Data Sources: MEDLINE, EMBASE, PsychLit, Cochrane Central Register of Controlled Trials, and International Pharmaceutical Abstracts from 1980 to April 2007, limited to English-language articles. Reference lists of pertinent review articles were manually searched and the Center for Drug Evaluation and Research database was explored to identify unpublished research. Study Selection: Abstracts and full-text articles were independently reviewed by 2 persons. Six previous good- or fair-quality systematic reviews or meta-analyses were included, as were 155 good- or fair-quality double-blind, placebo-controlled, or head-to-head randomized, controlled trials of at least 6 weeks' duration. For harms, 35 observational studies with at least 100 participants and follow-up of at least 12 weeks were also included. Data Extraction: Using a standard protocol, investigators abstracted data on study design and quality-related details, funding, settings, patients, and outcomes. Data Synthesis: If data were sufficient, meta-analyses of head-to-head trials were conducted to determine the relative benefit of response to treatment and the weighted mean differences on specific depression rating scales. If sufficient evidence was not available, adjusted indirect comparisons were conducted by using meta-regressions and network meta-analyses. Second-generation antidepressants did not substantially differ in efficacy or effectiveness for the treatment of major depressive disorder on the basis of 203 studies; however, the incidence of specific adverse events and the onset of action differed. The evidence is insufficient to draw conclusions about the comparative efficacy, effectiveness, or harms of these agents for the treatment of dysthymia and subsyndromal depression. Limitation: Adjusted indirect comparisons have methodological limitations and cannot conclusively rule out differences in efficacy. Conclusion: Current evidence does not warrant the choice of one second-generation antidepressant over another on the basis of differences in efficacy and effectiveness. Other differences with respect to onset of action and adverse events may be relevant for the choice of a medication.	[Gartlehner, Gerald] Danube Univ, A-3500 Krems, Austria; Univ N Carolina, Chapel Hill, NC USA; Indiana Univ, Sch Med, Roudebush Vet Affairs Med Ctr, Indianapolis, IN USA; Regenstrief Inst Hlth Care, Indianapolis, IN USA; Univ Pittsburgh, Pittsburgh, PA USA; RTI Int, Res Triangle Pk, NC USA	Danube University Krems; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Research Triangle Institute	Gartlehner, G (corresponding author), Danube Univ, Karl Dorrek Str, A-3500 Krems, Austria.	gerald.gartlehner@donau-uni.ac.at	Gartlehner, Gerald/AAY-2801-2021	Gartlehner, Gerald/0000-0001-5531-3678; Lohr, Kathleen/0000-0002-3825-0713; Hansen, Richard/0000-0002-4578-6698; Krebs, Erin/0000-0003-0843-7410; Gaynes, Bradley/0000-0002-8283-5030; Patterson, Charity/0000-0002-0060-0124	PHS HHS [290-02-0016] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aberg-Wistedt A, 2000, J CLIN PSYCHOPHARM, V20, P645, DOI 10.1097/00004714-200012000-00010; Addington D, 2002, J CLIN PSYCHOPHARM, V22, P20, DOI 10.1097/00004714-200202000-00004; AGUGLIA E, 1993, INT CLIN PSYCHOPHARM, V8, P197, DOI 10.1097/00004850-199300830-00010; Allard P, 2004, INT J GERIATR PSYCH, V19, P1123, DOI 10.1002/gps.1190; ALVES C, 1999, PRIMARY CARE PSYCHIA, V5, P57; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amini H, 2005, J CLIN PHARM THER, V30, P133, DOI 10.1111/j.1365-2710.2004.00585.x; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; [Anonymous], 2001, UND SYST REV RES EFF; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Aursnes I, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-14; Baldomero EB, 2005, DEPRESS ANXIETY, V22, P68, DOI 10.1002/da.20080; Baldwin DS, 2006, INT CLIN PSYCHOPHARM, V21, P159, DOI 10.1097/01.yic.0000194377.88330.1d; Baldwin DS, 1996, J CLIN PSYCHIAT, V57, P46; Balk EM, 2005, J HEPATOL, V43, P729, DOI 10.1016/j.jhep.2005.07.005; Ballus C, 2000, INT CLIN PSYCHOPHARM, V15, P43, DOI 10.1097/00004850-200015010-00007; Barret JE, 2001, J FAM PRACTICE, V50, P405; BEASLEY CM, 1991, J CLIN PSYCHIAT, V52, P294; BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behnke K, 2003, J CLIN PSYCHOPHARM, V23, P358, DOI 10.1097/01.jcp.0000085408.08426.05; Benkert O, 2000, J CLIN PSYCHIAT, V61, P656, DOI 10.4088/JCP.v61n0911; BENNIE EH, 1995, J CLIN PSYCHIAT, V56, P229; Bielski RJ, 2004, J CLIN PSYCHIAT, V65, P1190, DOI 10.4088/JCP.v65n0906; Boulenger JP, 2006, CURR MED RES OPIN, V22, P1331, DOI 10.1185/030079906X115513; Boyer P, 1998, PHARMACOECONOMICS, V13, P157, DOI 10.2165/00019053-199813010-00015; Brambilla P, 2005, PHARMACOPSYCHIATRY, V38, P69, DOI 10.1055/s-2005-837806; Brannan SK, 2005, J PSYCHIATR RES, V39, P43, DOI 10.1016/j.jpsychires.2004.04.011; Brown ES, 2005, BIOL PSYCHIAT, V58, P865, DOI 10.1016/j.biopsych.2005.04.030; Buckley NA, 2002, BRIT MED J, V325, P1332, DOI 10.1136/bmj.325.7376.1332; Burke WJ, 2002, J CLIN PSYCHIAT, V63, P331, DOI 10.4088/JCP.v63n0410; Burke WJ, 2001, J CLIN PSYCHIAT, V62, P38; Burt VK, 2005, PSYCHOSOMATICS, V46, P345, DOI 10.1176/appi.psy.46.4.345; Bush D E, 2005, Evid Rep Technol Assess (Summ), P1; BYERLEY WF, 1988, J CLIN PSYCHOPHARM, V8, P112; Cassano GB, 2002, J CLIN PSYCHIAT, V63, P396, DOI 10.4088/JCP.v63n0504; Chouinard G, 1999, J AFFECT DISORDERS, V54, P39, DOI 10.1016/S0165-0327(98)00188-8; Cipriani A, 2006, J CLIN PSYCHIAT, V67, P850, DOI 10.4088/JCP.v67n0601; CLAGHORN J, 1992, INT CLIN PSYCHOPHARM, V6, P25, DOI 10.1097/00004850-199206004-00006; CLAGHORN JL, 1995, J AFFECT DISORDERS, V34, P165, DOI 10.1016/0165-0327(95)00014-E; CLAGHORN JL, 1993, J CLIN PSYCHOPHARM, V13, pS23; CLAGHORN JL, 1992, J CLIN PSYCHIAT, V53, P33; Claghorn JL, 1996, J CLIN PSYCHOPHARM, V16, P113, DOI 10.1097/00004714-199604000-00003; CLAGHORN JL, 1992, J CLIN PSYCHIAT, V53, P434; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; Clayton AH, 2006, J CLIN PSYCHIAT, V67, P736, DOI 10.4088/JCP.v67n0507; CLERC GE, 1994, INT CLIN PSYCHOPHARM, V9, P139, DOI 10.1097/00004850-199409000-00001; Cohn CK, 1996, J CLIN PSYCHIAT, V57, P15; COHN JB, 1990, PSYCHOPHARMACOL BULL, V26, P185; COHN JB, 1992, J CLIN PSYCHIAT, V53, P52; Coleman C C, 1999, Ann Clin Psychiatry, V11, P205, DOI 10.3109/10401239909147072; Coleman CC, 2001, CLIN THER, V23, P1040, DOI 10.1016/S0149-2918(01)80090-4; Colonna L, 2005, CURR MED RES OPIN, V21, P1659, DOI 10.1185/030079905X65484; *COMM SAF MED, 2004, REP CSM EXP WORK GRO; Coogan PF, 2005, AM J EPIDEMIOL, V162, P835, DOI 10.1093/aje/kwi301; Corrigan MH, 2000, DEPRESS ANXIETY, V11, P58, DOI 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H; COSTA E, 1998, J CLIN PSYCHIAT, V59, P352; Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4; Croft H, 2002, CLIN THER, V24, P662, DOI 10.1016/S0149-2918(02)85141-4; Cunningham L A, 1997, Ann Clin Psychiatry, V9, P157, DOI 10.3109/10401239709147791; CUNNINGHAM LA, 1994, J CLIN PSYCHOPHARM, V14, P99; Dalery J, 2003, HUM PSYCHOPHARM CLIN, V18, P379, DOI 10.1002/hup.490; Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807; De Nayer A, 2002, INT J NEUROPSYCHOPH, V5, P115, DOI 10.1017/S1461145702002857; Deeks J J, 2003, Health Technol Assess, V7, piii; Delgado PL, 2005, J CLIN PSYCHIAT, V66, P686, DOI 10.4088/JCP.v66n0603; Detke MJ, 2002, J PSYCHIATR RES, V36, P383, DOI 10.1016/S0022-3956(02)00060-2; Detke MJ, 2002, J CLIN PSYCHIAT, V63, P308, DOI 10.4088/JCP.v63n0407; Detke MJ, 2004, EUR NEUROPSYCHOPHARM, V14, P457, DOI 10.1016/j.euroneuro.2004.01.002; Devanand DP, 2005, AM J GERIAT PSYCHIAT, V13, P59, DOI 10.1176/appi.ajgp.13.1.59; DEWILDE J, 1993, ACTA PSYCHIAT SCAND, V87, P141; Dickens C, 2000, PSYCHOSOMATICS, V41, P490, DOI 10.1176/appi.psy.41.6.490; Didham RC, 2005, BRIT J CLIN PHARMACO, V60, P519, DOI 10.1111/j.1365-2125.2005.02480.x; Dierick M, 1996, PROG NEURO-PSYCHOPH, V20, P57, DOI 10.1016/0278-5846(95)00292-8; Dinan TG, 2001, J CLIN PSYCHIAT, V62, P48; DOOGAN DP, 1992, BRIT J PSYCHIAT, V160, P217, DOI 10.1192/bjp.160.2.217; DUNBAR GC, 1991, BRIT J PSYCHIAT, V159, P394, DOI 10.1192/bjp.159.3.394; DUNBAR GC, 1993, ACTA PSYCHIAT SCAND, V87, P302, DOI 10.1111/j.1600-0447.1993.tb03376.x; Dunner DL, 1998, J CLIN PSYCHIAT, V59, P366, DOI 10.4088/JCP.v59n0705; Ekselius L, 1997, INT CLIN PSYCHOPHARM, V12, P323, DOI 10.1097/00004850-199711000-00005; Ekselius L, 2001, J CLIN PSYCHOPHARM, V21, P154, DOI 10.1097/00004714-200104000-00006; Elliott AJ, 1998, AM J PSYCHIAT, V155, P367; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; Evans M, 1997, INT J GERIATR PSYCH, V12, P817, DOI 10.1002/(SICI)1099-1166(199708)12:8<817::AID-GPS645>3.0.CO;2-4; Fabre L, 1996, INT CLIN PSYCHOPHARM, V11, P119, DOI 10.1097/00004850-199611020-00006; FABRE LF, 1987, J CLIN PSYCHIAT, V48, P406; FABRE LF, 1992, J CLIN PSYCHIAT, V53, P40; Falk W E, 1989, J Geriatr Psychiatry Neurol, V2, P208, DOI 10.1177/089198878900200407; Fava M, 2000, J CLIN PSYCHIAT, V61, P863, DOI 10.4088/JCP.v61n1109; Fava M, 2005, J CLIN PSYCHOPHARM, V25, P441, DOI 10.1097/01.jcp.0000178416.60426.29; Fava M, 1998, Ann Clin Psychiatry, V10, P145; Fava M, 2002, J CLIN PSYCHOPHARM, V22, P137, DOI 10.1097/00004714-200204000-00006; Fava M, 2000, J AFFECT DISORDERS, V59, P119, DOI 10.1016/S0165-0327(99)00131-7; Fava M, 1997, AM J PSYCHIAT, V154, P1760, DOI 10.1176/ajp.154.12.1760; *FDA CTR DRUG EV R, 2001, STAT REV NDA; Feiger A, 1996, J CLIN PSYCHIAT, V57, P53; Feiger AD, 1999, INT CLIN PSYCHOPHARM, V14, P19, DOI 10.1097/00004850-199901000-00002; Feighner J, 1998, J CLIN PSYCHIAT, V59, P246, DOI 10.4088/JCP.v59n0508; FEIGHNER JP, 1992, J CLIN PSYCHIAT, V53, P44; FEIGHNER JP, 1993, J AFFECT DISORDERS, V28, P71, DOI 10.1016/0165-0327(93)90035-I; FEIGHNER JP, 1991, J CLIN PSYCHIAT, V52, P329; FEIGHNER JP, 1992, INT CLIN PSYCHOPHARM, V6, P31, DOI 10.1097/00004850-199206004-00007; Feighner JP, 1999, J CLIN PSYCHIAT, V60, P824, DOI 10.4088/JCP.v60n1204; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P24, DOI 10.4088/JCP.v62n0106; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Ferrando SJ, 1997, GEN HOSP PSYCHIAT, V19, P89, DOI 10.1016/S0163-8343(96)00172-7; Finkel SI, 1999, AM J GERIAT PSYCHIAT, V7, P221, DOI 10.1097/00019442-199908000-00006; Flament MF, 2001, INT J PSYCHIAT CLIN, V5, P103, DOI 10.1080/136515001300374830; Flament MF, 1999, INT CLIN PSYCHOPHARM, V14, P259; FONTAINE R, 1994, J CLIN PSYCHIAT, V55, P234; Franchini L, 2000, J AFFECT DISORDERS, V58, P233, DOI 10.1016/S0165-0327(99)00113-5; Franchini L, 1997, J CLIN PSYCHIAT, V58, P104, DOI 10.4088/JCP.v58n0303; GAGIANO CA, 1993, BR J CLIN RES, V4, P145; Gartlehner G, 2007, COMP EFFECTIVENESS R; Gartlehner G, 2006, J CLIN EPIDEMIOL, V59, P1040, DOI 10.1016/j.jclinepi.2006.01.011; Gelenberg AJ, 2003, BIOL PSYCHIAT, V54, P806, DOI 10.1016/S0006-3223(02)01971-6; GERETSEGGER C, 1994, INT CLIN PSYCHOPHARM, V9, P25, DOI 10.1097/00004850-199400910-00004; Gilaberte I, 2001, J CLIN PSYCHOPHARM, V21, P417, DOI 10.1097/00004714-200108000-00009; Gillin JC, 1997, J CLIN PSYCHIAT, V58, P185, DOI 10.4088/JCP.v58n0502; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Goldstein DJ, 2002, J CLIN PSYCHIAT, V63, P225, DOI 10.4088/JCP.v63n0309; Goldstein DJ, 1997, J CLIN PSYCHOPHARM, V17, P365, DOI 10.1097/00004714-199710000-00005; Goldstein DJ, 2004, J CLIN PSYCHOPHARM, V24, P389, DOI 10.1097/01.jcp.0000132448.65972.d9; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Greist J, 2004, CLIN THER, V26, P1446, DOI 10.1016/j.clinthera.2004.09.010; Grigoriadis S, 2003, J CLIN PSYCHOPHARM, V23, P405, DOI 10.1097/01.jcp.0000085415.08426.c6; Gual A, 2003, ALCOHOL ALCOHOLISM, V38, P619, DOI 10.1093/alcalc/agg124; Guelfi JD, 2001, J CLIN PSYCHOPHARM, V21, P425, DOI 10.1097/00004714-200108000-00010; Gulseren L, 2005, ARCH MED RES, V36, P159, DOI 10.1016/j.arcmed.2004.12.018; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Haffmans PMJ, 1996, INT CLIN PSYCHOPHARM, V11, P157, DOI 10.1097/00004850-199609000-00002; HALIKAS JA, 1995, HUM PSYCHOPHARM CLIN, V10, pS125, DOI 10.1002/hup.470100807; Hansen RA, 2005, ANN INTERN MED, V143, P415, DOI 10.7326/0003-4819-143-6-200509200-00006; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; HARTO NE, 1988, PSYCHOPHARMACOL BULL, V24, P220; Heiligenstein J H, 1995, Int Psychogeriatr, V7 Suppl, P125, DOI 10.1017/S1041610295002407; Hernandez-Avila CA, 2004, ALCOHOL CLIN EXP RES, V28, P433, DOI 10.1097/01.ALC.0000118313.63897.EE; Hicks JA, 2002, BRIT J PSYCHIAT, V180, P528, DOI 10.1192/bjp.180.6.528; Hochstrasser B, 2001, BRIT J PSYCHIAT, V178, P304, DOI 10.1192/bjp.178.4.304; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; JICK H, 1992, PHARMACOTHERAPY, V12, P451; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; JOHNSTON A, 1991, J CLIN PSYCHIAT, V52, P450; Joliat MJ, 2004, J CLIN PSYCHIAT, V65, P373; Judd LL, 2004, AM J PSYCHIAT, V161, P1864, DOI 10.1176/appi.ajp.161.10.1864; Judge R, 2002, INT CLIN PSYCHOPHARM, V17, P217, DOI 10.1097/00004850-200209000-00002; Kasper S, 2005, AM J GERIAT PSYCHIAT, V13, P884, DOI 10.1176/appi.ajgp.13.10.884; Kasper S, 2005, CURR MED RES OPIN, V21, P1139, DOI 10.1185/030079905X53243; Kavoussi RJ, 1997, J CLIN PSYCHIAT, V58, P532, DOI 10.4088/JCP.v58n1204; Keller MB, 1998, JAMA-J AM MED ASSOC, V280, P1665, DOI 10.1001/jama.280.19.1665; Kennedy SH, 2006, CAN J PSYCHIAT, V51, P234, DOI 10.1177/070674370605100405; Kennedy SH, 2000, J CLIN PSYCHIAT, V61, P276, DOI 10.4088/JCP.v61n0406; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KHAN A, 1991, PSYCHOPHARMACOL BULL, V27, P141; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Khan A, 1998, J CLIN PSYCHOPHARM, V18, P19, DOI 10.1097/00004714-199802000-00004; Kiev A, 1997, J CLIN PSYCHIAT, V58, P146, DOI 10.4088/JCP.v58n0402; Kirby D, 2002, INT J GERIATR PSYCH, V17, P231, DOI 10.1002/gps.591; Klysner R, 2002, BRIT J PSYCHIAT, V181, P29, DOI 10.1192/bjp.181.1.29; Kocsis JH, 2002, ARCH GEN PSYCHIAT, V59, P723, DOI 10.1001/archpsyc.59.8.723; Kocsis JH, 1997, AM J PSYCHIAT, V154, P390; Kornstein SG, 2006, J CLIN PSYCHIAT, V67, P1767, DOI 10.4088/JCP.v67n1115; Kranzler HR, 2006, J CLIN PSYCHOPHARM, V26, P13, DOI 10.1097/01.jcp.0000194620.61868.35; Krishnan KRR, 2001, PROG NEURO-PSYCHOPH, V25, P347; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Lader M, 2005, HUM PSYCHOPHARM CLIN, V20, P349, DOI 10.1002/hup.694; Landen M, 2005, J CLIN PSYCHIAT, V66, P100, DOI 10.4088/JCP.v66n0114; LAPIERRE YD, 1987, J CLIN PSYCHIAT, V48, P65; Lepine JP, 2004, AM J PSYCHIAT, V161, P836, DOI 10.1176/appi.ajp.161.5.836; Lepola UM, 2003, INT CLIN PSYCHOPHARM, V18, P211, DOI 10.1097/00004850-200307000-00003; LINEBERRY CG, 1990, J CLIN PSYCHIAT, V51, P194; LOPEZLIBOR, 1993, EUR PSYCHIAT, V8, pS17; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521; LYDIARD RB, 1989, PSYCHOPHARMACOL BULL, V25, P68; Lydiard RB, 1997, J CLIN PSYCHIAT, V58, P484, DOI 10.4088/JCP.v58n1104; Lyketsos CG, 2003, ARCH GEN PSYCHIAT, V60, P737, DOI 10.1001/archpsyc.60.7.737; Mackay FJ, 1997, PHARMACOEPIDEM DR S, V6, P235, DOI 10.1002/(SICI)1099-1557(199707)6:4<235::AID-PDS293>3.3.CO;2-V; Mackay FJ, 1999, BRIT J GEN PRACT, V49, P871; Mackay FR, 1999, BRIT J GEN PRACT, V49, P892; Magai C, 2000, AM J GERIAT PSYCHIAT, V8, P66, DOI 10.1097/00019442-200002000-00009; Mallinckrodt CH, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-1; MARCH JS, 1990, J CLIN PSYCHIAT, V51, P200; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; McGrath PJ, 2000, AM J PSYCHIAT, V157, P344, DOI 10.1176/appi.ajp.157.3.344; MCPARTLIN GM, 1998, PRIMARY CARE PSYCHIA, P127; Mehtonen OP, 2000, J CLIN PSYCHIAT, V61, P95, DOI 10.4088/JCP.v61n0204; Meijer WEE, 2002, PHARMACOEPIDEM DR S, V11, P655, DOI 10.1002/pds.752; MENDELS J, 1995, J CLIN PSYCHIAT, V56, P30; MENDELS J, 1993, PSYCHOPHARMACOL BULL, V29, P169; MESTERS P, 1993, INT CLIN PSYCHOPHARM, V8, P337, DOI 10.1097/00004850-199300840-00024; Michelson D, 1999, AM J PSYCHIAT, V156, P1170; Moak DH, 2003, J CLIN PSYCHOPHARM, V23, P553, DOI 10.1097/01.jcp.0000095346.32154.41; Montejo AL, 2001, J CLIN PSYCHIAT, V62, P10; MONTGOMERY SA, 1992, INT CLIN PSYCHOPHARM, V6, P65, DOI 10.1097/00004850-199206005-00007; Montgomery SA, 2004, NEUROPSYCHOBIOLOGY, V50, P57, DOI 10.1159/000078225; MONTGOMERY SA, 1993, INT CLIN PSYCHOPHARM, V8, P189, DOI 10.1097/00004850-199300830-00009; MONTGOMERY SA, 1992, INT CLIN PSYCHOPHARM, V6, P71, DOI 10.1097/00004850-199206005-00008; Moore N, 2005, INT CLIN PSYCHOPHARM, V20, P131, DOI 10.1097/00004850-200505000-00002; Morishita S, 2003, EUR PSYCHIAT, V18, P418, DOI 10.1016/j.eurpsy.2003.05.002; MUIJEN M, 1988, ACTA PSYCHIAT SCAND, V78, P384, DOI 10.1111/j.1600-0447.1988.tb06353.x; Munizza C, 2006, CURR MED RES OPIN, V22, P1703, DOI 10.1185/030079906X121039; Murray V, 2005, J CLIN PSYCHIAT, V66, P708, DOI 10.4088/JCP.v66n0606; Nemeroff CB, 1995, DEPRESSION, V3, P163, DOI 10.1002/depr.3050030402; Nemeroff CB, 2007, J PSYCHIATR RES, V41, P351, DOI 10.1016/j.jpsychires.2005.07.009; Newhouse Paul A., 2000, Journal of Clinical Psychiatry, V61, P559; Nierenberg AA, 2007, CURR MED RES OPIN, V23, P401, DOI 10.1185/030079906X167453; Nieuwstraten CE, 2001, ANN PHARMACOTHER, V35, P1608; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; NYTH AL, 1992, ACTA PSYCHIAT SCAND, V86, P138, DOI 10.1111/j.1600-0447.1992.tb03242.x; Olie JP, 1997, EUR PSYCHIAT, V12, P34, DOI 10.1016/S0924-9338(97)86377-8; Oslin DW, 2003, J CLIN PSYCHIAT, V64, P875, DOI 10.4088/JCP.v64n0804; Patris M, 1996, INT CLIN PSYCHOPHARM, V11, P129, DOI 10.1097/00004850-199611020-00007; Pedersen AG, 2005, INT CLIN PSYCHOPHARM, V20, P139, DOI 10.1097/00004850-200505000-00003; Perahia DGS, 2006, EUR PSYCHIAT, V21, P367, DOI 10.1016/j.eurpsy.2006.03.004; Perahia DG, 2005, J AFFECT DISORDERS, V89, P207, DOI 10.1016/j.jad.2005.09.003; PERRY PJ, 1989, J CLIN PSYCHIAT, V50, P290; Petracca GM, 2001, INT PSYCHOGERIATR, V13, P233, DOI 10.1017/S104161020100761X; Petrakis I, 1998, DRUG ALCOHOL DEPEN, V50, P221, DOI 10.1016/S0376-8716(98)00032-5; Philipp M, 2000, EUR NEUROPSYCHOPHARM, V10, P305, DOI 10.1016/S0924-977X(00)00085-7; Poirier MF, 1999, BRIT J PSYCHIAT, V175, P12, DOI 10.1192/bjp.175.1.12; Rabkin JG, 2004, J CLIN PSYCHOPHARM, V24, P379, DOI 10.1097/01.jcp.0000132442.35478.3c; Rabkin JG, 1999, AM J PSYCHIAT, V156, P101, DOI 10.1176/ajp.156.1.101; Rapaport M, 1996, J CLIN PSYCHOPHARM, V16, P373, DOI 10.1097/00004714-199610000-00005; Rapaport MH, 2004, J CLIN PSYCHIAT, V65, P44; Rapaport MH, 2003, J CLIN PSYCHIAT, V64, P1065, DOI 10.4088/JCP.v64n0912; Ravid Uzi, 1995, Flavour and Fragrance Journal, V10, P281, DOI 10.1002/ffj.2730100409; Ravindran AV, 2000, J CLIN PSYCHIAT, V61, P821, DOI 10.4088/JCP.v61n1103; REIMHERR FW, 1988, PSYCHOPHARMACOL BULL, V24, P200; Reimherr FW, 1998, CLIN THER, V20, P505, DOI 10.1016/S0149-2918(98)80060-X; REIMHERR FW, 1990, J CLIN PSYCHIAT, V51, P18; Reimherr FW, 1998, AM J PSYCHIAT, V155, P1247, DOI 10.1176/ajp.155.9.1247; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; RICKELS K, 1994, BRIT J PSYCHIAT, V164, P802, DOI 10.1192/bjp.164.6.802; RICKELS K, 1989, ACTA PSYCHIAT SCAND, V80, P117, DOI 10.1111/j.1600-0447.1989.tb07188.x; RICKELS K, 1992, J CLIN PSYCHIAT, V53, P30; RICKELS K, 1982, AM J PSYCHIAT, V139, P803; ROBERT P, 1995, INT CLIN PSYCHOPHARM, V10, P29, DOI 10.1097/00004850-199503001-00006; Rocca P, 2005, J CLIN PSYCHIAT, V66, P360, DOI 10.4088/JCP.v66n0313; Roose SP, 2004, AM J PSYCHIAT, V161, P2050, DOI 10.1176/appi.ajp.161.11.2050; Roscoe JA, 2005, BREAST CANCER RES TR, V89, P243, DOI 10.1007/s10549-004-2175-1; Rosenbaum JF, 1998, BIOL PSYCHIAT, V44, P77, DOI 10.1016/S0006-3223(98)00126-7; Rossini D, 2005, J CLIN PSYCHOPHARM, V25, P471, DOI 10.1097/01.jcp.0000177548.28961.e7; ROTH D, 1990, PROG NEURO-PSYCHOPH, V14, P929, DOI 10.1016/0278-5846(90)90078-U; Roy-Byrne PP, 2000, J CLIN PSYCHOPHARM, V20, P129, DOI 10.1097/00004714-200004000-00003; Rudolph RL, 1998, J CLIN PSYCHIAT, V59, P116, DOI 10.4088/JCP.v59n0305; Rudolph RL, 1999, J AFFECT DISORDERS, V56, P171, DOI 10.1016/S0165-0327(99)00067-1; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 1998, BIOL PSYCHIAT, V44, P3, DOI 10.1016/S0006-3223(98)00092-4; Rush AJ, 2001, J AFFECT DISORDERS, V64, P81, DOI 10.1016/S0165-0327(00)00250-0; Rush AJ, 2001, NEUROPSYCHOPHARMACOL, V25, P131, DOI 10.1016/S0893-133X(00)00249-9; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Schatzberg A, 2006, AM J GERIAT PSYCHIAT, V14, P361, DOI 10.1097/01.JGP.0000194645.70869.3b; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; Schmidt ME, 2000, J CLIN PSYCHIAT, V61, P851, DOI 10.4088/JCP.v61n1107; Schmitz JM, 2001, DRUG ALCOHOL DEPEN, V63, P207, DOI 10.1016/S0376-8716(00)00208-8; Schneider LS, 2003, AM J PSYCHIAT, V160, P1277, DOI 10.1176/appi.ajp.160.7.1277; SCHONE W, 1993, J CLIN PSYCHOPHARM, V13, pS34; SCHWEIZER E, 1991, J CLIN PSYCHOPHARM, V11, P233; Sechter D, 1999, EUR PSYCHIAT, V14, P41, DOI 10.1016/S0924-9338(99)80714-7; Segraves RT, 2000, J CLIN PSYCHOPHARM, V20, P122, DOI 10.1097/00004714-200004000-00002; Sheikh JI, 2004, J AM GERIATR SOC, V52, P86, DOI 10.1111/j.1532-5415.2004.52015.x; Shelton RC, 2006, J CLIN PSYCHIAT, V67, P1674, DOI 10.4088/JCP.v67n1102; SHRIVASTAVA RK, 1992, J CLIN PSYCHIAT, V53, P48; Silverstone PH, 1999, J CLIN PSYCHIAT, V60, P22, DOI 10.4088/JCP.v60n0105; Simon JS, 2004, J PSYCHIATR RES, V38, P249, DOI 10.1016/j.jpsychires.2003.10.004; Sir A, 2005, J CLIN PSYCHIAT, V66, P1312, DOI 10.4088/JCP.v66n1015; Small GW, 1996, J AM GERIATR SOC, V44, P1220, DOI 10.1111/j.1532-5415.1996.tb01373.x; SMITH WT, 1990, PSYCHOPHARMACOL BULL, V26, P191; SMITH WT, 1992, J CLIN PSYCHIAT, V53, P36; Stahl SM, 2000, BIOL PSYCHIAT, V48, P894, DOI 10.1016/S0006-3223(00)00957-4; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Szegedi A, 2003, J CLIN PSYCHIAT, V64, P413, DOI 10.4088/JCP.v64n0410; Terra JL, 1998, INT CLIN PSYCHOPHARM, V13, P55, DOI 10.1097/00004850-199803000-00001; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; Thase ME, 1997, J CLIN PSYCHIAT, V58, P393, DOI 10.4088/JCP.v58n0904; Thase ME, 2005, J WOMENS HEALTH, V14, P609, DOI 10.1089/jwh.2005.14.609; Thase ME, 2005, J CLIN PSYCHOPHARM, V25, P132, DOI 10.1097/01.jcp.0000155815.44338.95; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; Thase ME, 1996, ARCH GEN PSYCHIAT, V53, P777; Thase ME, 2001, J CLIN PSYCHIAT, V62, P782, DOI 10.4088/JCP.v62n1006; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; TIGNOL J, 1993, J CLIN PSYCHOPHARM, V13, pS18; Tollefson G D, 1995, Int Psychogeriatr, V7, P89, DOI 10.1017/S1041610295001888; TOLLEFSON GD, 1993, INT CLIN PSYCHOPHARM, V8, P253, DOI 10.1097/00004850-199300840-00008; TOLLEFSON GD, 1994, J CLIN PSYCHOPHARM, V14, P163; Trivedi MH, 2004, J CLIN PSYCHIAT, V65, P1356, DOI 10.4088/JCP.v65n1010; Trivedi MH, 2001, J CLIN PSYCHIAT, V62, P776, DOI 10.4088/JCP.v62n1005; TYLEE A, 1997, PRIMARY CARE PSYCHIA, V3, P51; Tzanakaki M, 2000, INT CLIN PSYCHOPHARM, V15, P29, DOI 10.1097/00004850-200015010-00004; Vanelle JM, 1997, BRIT J PSYCHIAT, V170, P345, DOI 10.1192/bjp.170.4.345; VANMOFFAERT M, 1995, HUM PSYCHOPHARM CLIN, V10, P393, DOI 10.1002/hup.470100505; VANMOFFAERT M, 1995, INT CLIN PSYCHOPHARM, V10, P3, DOI 10.1097/00004850-199503000-00001; VARTIAINEN H, 1994, EUR NEUROPSYCHOPHARM, V4, P145, DOI 10.1016/0924-977X(94)90008-6; *VENL 335 STUD GRO, 2004, J CLIN PSYCHIAT, V65, P328; Ventura D, 2007, CURR MED RES OPIN, V23, P245, DOI 10.1185/030079906X167273; Versiani M, 2005, CNS DRUGS, V19, P137, DOI 10.2165/00023210-200519020-00004; Wade A, 2003, INT CLIN PSYCHOPHARM, V18, P133, DOI 10.1097/01.yic.0000068045.82050.00; Wade A, 2002, INT CLIN PSYCHOPHARM, V17, P95, DOI 10.1097/00004850-200205000-00001; Wagner GJ, 1998, PSYCHIAT SERV, V49, P239, DOI 10.1176/ps.49.2.239; Walczak D D, 1996, Ann Clin Psychiatry, V8, P139, DOI 10.3109/10401239609147751; Weihs KL, 2000, J CLIN PSYCHIAT, V61, P196, DOI 10.4088/JCP.v61n0309; Weihs KL, 2002, BIOL PSYCHIAT, V51, P753, DOI 10.1016/S0006-3223(01)01317-8; WEISLER RH, 1994, J CLIN PSYCHOPHARM, V14, P170; WERNICKE JF, 1987, PSYCHOPHARMACOL BULL, V23, P164; Wheatley DP, 1998, J CLIN PSYCHIAT, V59, P306, DOI 10.4088/JCP.v59n0606; Whyte IM, 2003, QJM-INT J MED, V96, P369, DOI 10.1093/qjmed/hcg062; Williams JW, 2000, ANN INTERN MED, V132, P743, DOI 10.7326/0003-4819-132-9-200005020-00011; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519; Wilson KCM, 2003, BRIT J PSYCHIAT, V182, P492, DOI 10.1192/bjp.182.6.492; Winokur A, 2003, J CLIN PSYCHIAT, V64, P1224, DOI 10.4088/JCP.v64n1013; Zajecka J, 1998, J CLIN PSYCHOPHARM, V18, P193, DOI 10.1097/00004714-199806000-00003; Zanardi R, 1996, AM J PSYCHIAT, V153, P1631; 2004, CLIN STUDY SUMMARY S	317	157	161	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2008	149	10					734	U313		10.7326/0003-4819-149-10-200811180-00008	http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00008			39	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373FL	19017592				2022-12-28	WOS:000260956300006
J	Frank, E; Elon, L; Naimi, T; Brewer, R				Frank, Erica; Elon, Lisa; Naimi, Timothy; Brewer, Robert			Alcohol consumption and alcohol counselling behaviour among US medical students: cohort study	BRITISH MEDICAL JOURNAL			English	Article							NATIONAL-SURVEY; BINGE DRINKING; UNITED-STATES; SUBSTANCE USE; HEALTH; PHYSICIANS; CARE; INTERVENTION; ATTITUDES; SMOKING	Objective To determine which factors affect alcohol counselling practices among medical students. Design Cohort study. Setting Nationally representative medical schools ( n= 16) in the United States. Participants Medical students who graduated in 2003. Interventions Questionnaires were completed ( response rate 83%) at the start of students' first year ( n= 1846/ 2080), entrance to wards ( typically during the third year of training) ( n= 1630/ 1982), and their final ( fourth) year ( n= 1469/ 1901). Main outcome measures Previously validated questions on alcohol consumption and counselling. Results 78% ( 3777/ 4847) of medical students reported drinking in the past month, and a third ( 1668/ 4847) drank excessively; these proportions changed little over time. The proportion of those who believed alcohol counselling was highly relevant to care of patients was higher at entrance to wards ( 61%; 919/ 1516) than in final year students ( 46%; 606/ 1329). Although students intending to enter primary care were more likely to believe alcohol counselling was highly relevant, only 28% of final year students ( 391/ 1393) reported usually or always talking to their general medical patients about their alcohol consumption. Excessive drinkers were somewhat less likely than others to counsel patients or to think it relevant to do so. In multivariate models, extensive training in alcohol counselling doubled the frequency of reporting that alcohol counselling would be clinically relevant ( odds ratio 2.3, 95% confidence interval 1.6 to 3.3) and of reporting doing counselling ( 2.2, 1.5 to 3.3). Conclusions Excessive drinking and binge drinking among US medical students is common, though somewhat less prevalent than among comparably aged adults in the US general population. Few students usually discussed alcohol use with patients, but greater training and confidence about alcohol counselling predicted both practising and believing in the relevance of alcohol counselling. Medical schools should consider routinely training students to screen and counsel patients for alcohol misuse and consider discouraging excessive drinking.	[Frank, Erica] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Frank, Erica] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Frank, Erica] Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA 30303 USA; [Elon, Lisa] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Naimi, Timothy; Brewer, Robert] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	University of British Columbia; University of British Columbia; Emory University; Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA	Frank, E (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, 5804 Fairview Ave, Vancouver, BC V5Z 1M9, Canada.	efrank@emory.edu		Naimi, Timothy/0000-0001-9849-4413	American Cancer Society; Annenberg Physician Training Program; Canada Research Chair Program; Michael Smith Foundation for Health Research	American Cancer Society(American Cancer Society); Annenberg Physician Training Program; Canada Research Chair Program(Canada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the American Cancer Society, Annenberg Physician Training Program, Canada Research Chair Program, and the Michael Smith Foundation for Health Research.	*AM ASS MED COLL, FACTS APPL MATR GRAD; *AM ASS MED COLL, AAMC DAT WAR STUD RE; *AM ASS MED COLL, MATR AG ANT MATR 199; Babor TF, 2005, REV PANAM SALUD PUBL, V18, P327; Babor TF, 2003, ALCOHOL NO ORDINARY; BALDWIN DC, 1991, JAMA-J AM MED ASSOC, V265, P2074, DOI 10.1001/jama.265.16.2074; Cape G, 2006, ADDICTION, V101, P841, DOI 10.1111/j.1360-0443.2006.01476.x; *CDC, 2004, ALC REL DIS IMP ARDI; *CDCP, 2008, ALC GUID COMM PREV S; *CDCP, 1990, ALC PUBL HLTH; Chen C. M., 2007, TRENDS ALCOHOL RELAT; Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7; Committee on Treatment of Alcohol Problems, 1990, BROAD BAS TREATM ALC; Cruess SR, 2008, MED EDUC, V42, P755, DOI 10.1111/j.1365-2923.2008.03134.x; D'Amico EJ, 2005, MED CARE, V43, P229, DOI 10.1097/00005650-200503000-00005; Delnevo CD, 1996, AM J PREV MED, V12, P38, DOI 10.1016/S0749-3797(18)30368-4; Denny CH, 2003, AM J PREV MED, V24, P71, DOI 10.1016/S0749-3797(02)00568-8; Dillman D.A., 2007, MAIL INTERNET SURVEY, V2nd; FORNEY MA, 1988, INT J ADDICT, V23, P767, DOI 10.3109/10826088809058838; Frank E, 2005, MedGenMed, V7, P2; Frank E, 2004, JAMA-J AM MED ASSOC, V291, P637, DOI 10.1001/jama.291.5.637; Frank E, 1998, ARCH INTERN MED, V158, P342, DOI 10.1001/archinte.158.4.342; Frank Erica, 2005, MedGenMed, V7, P4; Frank E, 2006, AM J PREV MED, V31, P499, DOI 10.1016/j.amepre.2006.08.009; Frank Erica, 2007, MedGenMed, V9, P58; FRIED VM, 2003, CHARTBOOK TRENDS HLT; Friedmann PD, 2000, J GEN INTERN MED, V15, P84, DOI 10.1046/j.1525-1497.2000.03379.x; Frost-Pineda K, 2004, J ADDICT DIS, V23, P1, DOI 10.1300/J069v23n02_01; Gill JS, 2002, ALCOHOL ALCOHOLISM, V37, P109, DOI 10.1093/alcalc/37.2.109; Hoffmann NG, 2000, J ADDICT DIS, V19, P1, DOI 10.1300/J069v19n03_01; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUGHES PH, 1991, JAMA-J AM MED ASSOC, V265, P2069, DOI 10.1001/jama.265.16.2069; Isaacson JH, 2000, J STUD ALCOHOL, V61, P912, DOI 10.15288/jsa.2000.61.912; Keller S, 2007, ADDICT BEHAV, V32, P505, DOI 10.1016/j.addbeh.2006.05.017; Mangus RS, 1998, JAMA-J AM MED ASSOC, V280, P1192, DOI 10.1001/jama.280.13.1192; McCarty CA, 2004, PEDIATRICS, V114, P714, DOI 10.1542/peds.2003-0864-L; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; *NIH, 2005, SUPP US MED SCH FISC; Roche AM, 1996, PREV MED, V25, P251, DOI 10.1006/pmed.1996.0054; SHAH BV, 2006, SUDAAN PROGRAM; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Spencer EH, 2005, J AM DIET ASSOC, V105, P802, DOI 10.1016/j.jada.2005.02.003; Town Machell, 2006, Prev Chronic Dis, V3, pA53; U.S. Preventive Service Task Force, 2004, SCREEN BEH COUNS INT; VARGA M, 1994, ALCOHOL ALCOHOLISM, V29, P591; Wechsler H, 2000, J AM COLL HEALTH, V48, P199, DOI 10.1080/07448480009599305; WESTERMEYER J, 1988, AM J DRUG ALCOHOL AB, V14, P393, DOI 10.3109/00952998809001559; White KL., 1990, MED SCH MISSION POPU	50	65	67	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 7	2008	337								a2155	10.1136/bmj.a2155	http://dx.doi.org/10.1136/bmj.a2155			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FD	18996938	hybrid, Green Published			2022-12-28	WOS:000261236200001
J	Masip, J; Mebazaa, A; Filippatos, GS				Masip, Josep; Mebazaa, Alexandre; Filippatos, Gerasimos S.			Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							METAANALYSIS; PRESSURE		[Masip, Josep] Consorci Sanit Integral, Barcelona 08025, Spain; [Mebazaa, Alexandre] Univ Paris 07, F-75010 Paris, France; [Filippatos, Gerasimos S.] Univ Athens, Athens 12461, Greece	UDICE-French Research Universities; Universite Paris Cite; National & Kapodistrian University of Athens	Masip, J (corresponding author), Consorci Sanit Integral, Barcelona 08025, Spain.		Nicholl, Jon/B-8257-2008; Filippatos, Gerasimos/ABA-4656-2021					Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Nieminen MS, 2005, EUR HEART J, V26, P384; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Plaisance P, 2007, EUR HEART J, V28, P2895, DOI 10.1093/eurheartj/ehm502; Winck JC, 2006, CRIT CARE, V10, DOI 10.1186/cc4905	5	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2068	2069						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18990784				2022-12-28	WOS:000260632700022
J	Agogue, H; Brink, M; Dinasquet, J; Herndl, GJ				Agogue, Helene; Brink, Maaike; Dinasquet, Julie; Herndl, Gerhard J.			Major gradients in putatively nitrifying and non-nitrifying Archaea in the deep North Atlantic	NATURE			English	Article							AMMONIA-OXIDIZING BACTERIA; WATER MASSES; PLANKTONIC ARCHAEA; AMINO-ACIDS; OCEAN; SEA; NITRIFICATION; CRENARCHAEOTA; OXIDATION; ABUNDANCE	Aerobic nitrification of ammonia to nitrite and nitrate is a key process in the oceanic nitrogen cycling mediated by prokaryotes(1). Apart from Bacteria belonging to the beta- and gamma-Proteobacteria involved in the first nitrification step, Crenarchaeota have recently been recognized as main drivers of the oxidation of ammonia to nitrite in soil as well as in the ocean, as indicated by the dominance of archaeal ammonia monooxygenase (amoA) genes over bacterial amoA(2,3). Evidence is accumulating that archaeal amoA genes are common in a wide range of marine systems(3-6). Essentially, all these reports focused on surface and mesopelagic (200-1,000 m depth) waters, where ammonia concentrations are higher than in waters below 1,000 m depth. However, Crenarchaeota are also abundant in the water column below 1,000 m, where ammonia concentrations are extremely low. Here we show that, throughout the NorthAtlantic Ocean, the abundance of archaeal amoA genes decreases markedly from subsurface waters to 4,000 m depth, and from subpolar to equatorial deep waters, leading to pronounced vertical and latitudinal gradients in the ratio of archaeal amoA to crenarchaeal 16S ribosomal RNA ( rRNA) genes. The lack of significant copy numbers of amoA genes and the very low fixation rates of dark carbon dioxide in the bathypelagic North Atlantic suggest that most bathypelagic Crenarchaeota are not autotrophic ammonia oxidizers: most likely, they utilize organic matter and hence live heterotrophically.	[Agogue, Helene; Brink, Maaike; Dinasquet, Julie; Herndl, Gerhard J.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, NL-1790 AB Den Burg, Texel, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Herndl, GJ (corresponding author), Univ Vienna, Vienna Ecol Ctr, Dept Marine Biol, Waehringer Guertel 18, A-1090 Vienna, Austria.	herndl@nioz.nl	Herndl, Gerhard J./S-3011-2019; Herndl, Gerhard J./B-1513-2013; Agogué, Hélène/O-4122-2014; chen, qi/C-8585-2011	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Agogué, Hélène/0000-0002-1078-0130; 	Marie Curie Fellowship of the European Community; Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects); 6th Framework Program of the European Union	Marie Curie Fellowship of the European Community(European Commission); Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects)(Netherlands Organization for Scientific Research (NWO)); 6th Framework Program of the European Union(European Commission)	We thank the captain and crew of the RV Pelagia for their help during work at sea. We thank H. M. van Aken for the characterization of the water masses, J.M. Arrieta for collecting the samples during the TRANSAT-1 cruise, B. Abbas, J. van Bleijswijk and H. Witte for technical discussions about the qPCR and phylogenetic analyses, and T. Reinthaler for discussions. We also thank A. Hunting, A. M. Schmitz and W. D. Lienhart for help with data processing. This research was supported by a Marie Curie Fellowship of the European Community to H. A. Shiptimewas provided through grants of the Earth and Life Science Division of the Dutch Science Foundation (ALW-NWO) (TRANSAT and ARCHIMEDES projects) to G. J. H. The work was performed within the frame of the 'Networks of Excellence' MarBef and EurOceans supported by the 6th Framework Program of the European Union.	Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Hollibaugh JT, 2002, APPL ENVIRON MICROB, V68, P1478, DOI 10.1128/AEM.68.3.1478-1484.2002; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Nakagawa T, 2007, MICROBES ENVIRON, V22, P365, DOI 10.1264/jsme2.22.365; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Rhein M, 2002, J PHYS OCEANOGR, V32, P648, DOI 10.1175/1520-0485(2002)032<0648:LSWPCI>2.0.CO;2; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Smethie WM, 2001, DEEP-SEA RES PT I, V48, P189, DOI 10.1016/S0967-0637(00)00048-0; Teira E, 2006, LIMNOL OCEANOGR, V51, P60, DOI 10.4319/lo.2006.51.1.0060; Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131; van Aken HM, 2000, DEEP-SEA RES PT I, V47, P757, DOI 10.1016/S0967-0637(99)00092-8; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward BB, 2007, OCEANOGRAPHY, V20, P101, DOI 10.5670/oceanog.2007.53; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	29	205	217	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					788	U72		10.1038/nature07535	http://dx.doi.org/10.1038/nature07535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	19037244	Green Submitted			2022-12-28	WOS:000261559900048
J	Winter, J; Ilbert, M; Graf, PCF; Ozcelik, D; Jakob, U				Winter, J.; Ilbert, M.; Graf, P. C. F.; Oezcelik, D.; Jakob, U.			Bleach Activates a Redox-Regulated Chaperone by Oxidative Protein Unfolding	CELL			English	Article							HYPOCHLOROUS ACID; HEAT-SHOCK; METHIONINE SULFOXIDE; SWITCH DOMAIN; CROSS-LINKING; STRESS; DNAK; HSP33; MYELOPEROXIDASE; INACTIVATION	Hypochlorous acid (HOCl), the active ingredient in household bleach, is an effective antimicrobial produced by the mammalian host defense to kill invading microorganisms. Despite the widespread use of HOCl, surprisingly little is known about its mode of action. In this study, we demonstrate that low molar ratios of HOCl to protein cause oxidative protein unfolding in vitro and target thermolabile proteins for irreversible aggregation in vivo. As a defense mechanism, bacteria use the redox-regulated chaperone Hsp33, which responds to bleach treatment with the reversible oxidative unfolding of its C-terminal redox switch domain. HOCl-mediated unfolding turns inactive Hsp33 into a highly active chaperone holdase, which protects essential Escherichia coli proteins against HOCl-induced aggregation and increases bacterial HOCl resistance. Our results substantially improve our molecular understanding about HOCl's functional mechanism. They suggest that the antimicrobial effects of bleach are largely based on HOCl's ability to cause aggregation of essential bacterial proteins.	[Winter, J.; Ilbert, M.; Graf, P. C. F.; Oezcelik, D.; Jakob, U.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Graf, P. C. F.; Jakob, U.] Univ Michigan, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Özcelik, Dennis/M-9961-2019; Ilbert, marianne/ABG-5015-2021	Özcelik, Dennis/0000-0002-7185-4690; ilbert, marianne/0000-0002-9070-2334; Graf, Paul/0000-0002-1094-7498	NIGMS NIH HHS [R01 GM065318-06A1, GM065318, R01 GM065318] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; Aliev G, 2002, BRAIN PATHOL, V12, P21; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Britigan BE, 1996, BBA-GEN SUBJECTS, V1290, P231, DOI 10.1016/0304-4165(96)00014-1; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dukan S, 1996, APPL ENVIRON MICROB, V62, P4003, DOI 10.1128/AEM.62.11.4003-4008.1996; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Grimshaw JPA, 2003, J BIOL CHEM, V278, P19048, DOI 10.1074/jbc.M300924200; Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jayaraman S, 2008, BIOCHEMISTRY-US, V47, P3875, DOI 10.1021/bi7023783; Khor HK, 2004, J BIOL CHEM, V279, P19486, DOI 10.1074/jbc.M310045200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Lide D.R., 1994, CRC HDB CHEM PHYS; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	34	270	277	3	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					691	701		10.1016/j.cell.2008.09.024	http://dx.doi.org/10.1016/j.cell.2008.09.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013278	Green Accepted, Bronze			2022-12-28	WOS:000260886900019
J	Zehr, JP; Bench, SR; Carter, BJ; Hewson, I; Niazi, F; Shi, T; Tripp, HJ; Affourtit, JP				Zehr, Jonathan P.; Bench, Shellie R.; Carter, Brandon J.; Hewson, Ian; Niazi, Faheem; Shi, Tuo; Tripp, H. James; Affourtit, Jason P.			Globally Distributed Uncultivated Oceanic N-2-Fixing Cyanobacteria Lack Oxygenic Photosystem II	SCIENCE			English	Article							NITROGEN-FIXATION; UNICELLULAR CYANOBACTERIA; RHOPALODIA-GIBBA; N-2; DIAZOTROPHS; EXPRESSION; EVOLUTION; PATTERNS		[Zehr, Jonathan P.; Bench, Shellie R.; Carter, Brandon J.; Hewson, Ian; Shi, Tuo; Tripp, H. James] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Niazi, Faheem; Affourtit, Jason P.] Life Sci 454, Branford, CT 06405 USA	University of California System; University of California Santa Cruz	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, 1156 High St, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	shi, tuo/E-6948-2017; Hewson, Ian/B-4871-2013; Shi, Tuo/T-7926-2017; Zehr, Jonathan P/B-3513-2014; Bench, Shellie R/E-7679-2010	shi, tuo/0000-0003-3362-8163; Shi, Tuo/0000-0003-3362-8163; Zehr, Jonathan P/0000-0002-5691-5408; 	Gordon and Betty Moore Foundation; Microbial Environmental Genomics; Modeling, Experimentation and Remote Sensing (MEGAMER) facility; NSF [OCE0425363]; NSF Center for Microbial Oceanography Research and Education [CCF424599]; 454 Life Sciences; Roche Company	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Microbial Environmental Genomics; Modeling, Experimentation and Remote Sensing (MEGAMER) facility; NSF(National Science Foundation (NSF)); NSF Center for Microbial Oceanography Research and Education(National Science Foundation (NSF)); 454 Life Sciences; Roche Company	We thank J. Montoya, D. Karl, M.J. Church, J.K. Doggett, the Hawaii Ocean Time- series crew, and the captain and crew of the R/V Kilo Moana for facilitating sample collection and analysis. We also thank E. Mondragon, P. Moisander, M. Hogan, K. Pennebaker, R. Beinart, and the Zehr laboratory for technical support. This work was partially supported by the Gordon and Betty Moore Foundation [J.P.Z. and the Microbial Environmental Genomics: Modeling, Experimentation and Remote Sensing (MEGAMER) facility], NSF (OCE0425363) (J.P.Z.), and the NSF Center for Microbial Oceanography Research and Education (CCF424599) (J.P.Z.). Support for sequencing was provided by 454 Life Sciences, a Roche Company. The GenBank accession numbers of the sequences generated from PCR in this study are EU187504 to EU187629 and FJ189800 to FJ190047. For a complete list of GenBank accessions, please see the supporting online material (21).	Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; COHEN Y, 1986, APPL ENVIRON MICROB, V51, P398, DOI 10.1128/AEM.51.2.398-407.1986; Falcon LI, 2002, APPL ENVIRON MICROB, V68, P5760, DOI 10.1128/AEM.68.11.5760-5764.2002; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hansell DA, 2004, MAR CHEM, V84, P243, DOI 10.1016/j.marchem.2003.08.004; Kneip C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-30; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LaRoche J, 2005, J SEA RES, V53, P67, DOI 10.1016/j.seares.2004.05.005; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Misra HS, 2003, J PLANT PHYSIOL, V160, P33, DOI 10.1078/0176-1617-00846; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Prechtl J, 2004, MOL BIOL EVOL, V21, P1477, DOI 10.1093/molbev/msh086; Shi T, 2005, MOL BIOL EVOL, V22, P2179, DOI 10.1093/molbev/msi216; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; VENRICK EL, 1974, LIMNOL OCEANOGR, V19, P437, DOI 10.4319/lo.1974.19.3.0437; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	25	244	256	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1110	1112		10.1126/science.1165340	http://dx.doi.org/10.1126/science.1165340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008448				2022-12-28	WOS:000260867700040
J	Crowley, TJ; Hyde, WT				Crowley, Thomas J.; Hyde, William T.			Transient nature of late Pleistocene climate variability	NATURE			English	Article							ICE-AGE CYCLE; CARBON-DIOXIDE; SNOWBALL EARTH; MODEL; TRENDS; RECORD; MA; TEMPERATURE; INSTABILITY; GLACIATION	Climate in the early Pleistocene(1) varied with a period of 41 kyr and was related to variations in Earth's obliquity. About 900 kyr ago, variability increased and oscillated primarily at a period of similar to 100 kyr, suggesting that the link was then with the eccentricity of Earth's orbit. This transition has often(2-5) been attributed to a non-linear response to small changes in external boundary conditions. Here we propose that increasing variablility within the past million years may indicate that the climate system was approaching a second climate bifurcation point, after which it would transition again to a new stable state characterized by permanent mid- latitude Northern Hemisphere glaciation. From this perspective the past million years can be viewed as a transient interval in the evolution of Earth's climate. We support our hypothesis using a coupled energy balance/ ice- sheet model, which furthermore predicts that the future transition would involve a large expansion of the Eurasian ice sheet. The process responsible for the abrupt change seems to be the albedo discontinuity at the snow - ice edge. The best- fit model run, which explains almost 60% of the variance in global ice volume(6) during the past 400 kyr, predicts a rapid transition in the geologically near future to the proposed glacial state. Should it be attained, this state would be more 'symmetric' than the present climate, with comparable areas of ice/ sea- ice cover in each hemisphere, and would represent the culmination of 50 million years of evolution from bipolar nonglacial climates to bipolar glacial climates.	[Crowley, Thomas J.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Hyde, William T.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	University of Edinburgh; University of Toronto	Crowley, TJ (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland.	thomas.crowley@ed.ac.uk			Scottish Alliance for Geoscience, the Environment, and Society ( SAGES); US National Science Foundation	Scottish Alliance for Geoscience, the Environment, and Society ( SAGES); US National Science Foundation(National Science Foundation (NSF))	This research received partial support the Scottish Alliance for Geoscience, the Environment, and Society ( SAGES) and from the US National Science Foundation. We thank G. North for numerous discussions over the years and S. Obrochta for valuable assistance.	Baum SK, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017333; Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BUDYKO MI, 1969, TELLUS, V21, P611, DOI 10.3402/tellusa.v21i5.10109; Calov R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024518; CROWLEY TJ, 1988, SCIENCE, V240, P996, DOI 10.1126/science.240.4855.996; CROWLEY TJ, 1991, GEOLOGY, V19, P975, DOI 10.1130/0091-7613(1991)019<0975:ECSLFF>2.3.CO;2; Crowley TJ, 2001, GEOPHYS RES LETT, V28, P283, DOI 10.1029/2000GL011836; CROWLEY TJ, 1994, CLIM DYNAM, V10, P363, DOI 10.1007/BF00219476; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; HANSEN J, 1987, J GEOPHYS RES-ATMOS, V92, P13345, DOI 10.1029/JD092iD11p13345; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; Hyde WT, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000669; HYDE WT, 1985, J ATMOS SCI, V42, P2170, DOI 10.1175/1520-0469(1985)042<2170:SEWAMO>2.0.CO;2; Jamieson S.S.R., 2008, ANTARCTICA KEYSTONE, P39, DOI DOI 10.3133/0F2007-1047.KP05; Kukla G, 1996, PALAEOGEOGR PALAEOCL, V120, P171, DOI 10.1016/0031-0182(95)00040-2; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lisiecki LE, 2007, QUATERNARY SCI REV, V26, P56, DOI 10.1016/j.quascirev.2006.09.005; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MAASCH KA, 1990, J GEOPHYS RES-ATMOS, V95, P1955, DOI 10.1029/JD095iD02p01955; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; NORTH GR, 1983, J GEOPHYS RES-OCEANS, V88, P6576, DOI 10.1029/JC088iC11p06576; NORTH GR, 1984, J ATMOS SCI, V41, P3390, DOI 10.1175/1520-0469(1984)041<3390:TSICII>2.0.CO;2; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Tarasov L, 1997, J GEOPHYS RES-ATMOS, V102, P21665, DOI 10.1029/97JD01766; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	46	49	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					226	230		10.1038/nature07365	http://dx.doi.org/10.1038/nature07365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005552				2022-12-28	WOS:000261039300037
J	Lee, TH				Lee, Thomas H.			The Future of Primary Care: The Need for Reinvention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Thomas H.] Partners Health Care Syst, Boston, MA USA	Partners Healthcare System	Lee, TH (corresponding author), Partners Health Care Syst, Boston, MA USA.								0	19	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2085	2086		10.1056/NEJMp0805766	http://dx.doi.org/10.1056/NEJMp0805766			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005189				2022-12-28	WOS:000260823900001
J	Westin, S				Westin, Steinar			Welfare for all - or only for the needy?	LANCET			English	Editorial Material							HEALTH		[Westin, Steinar] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Med Tech Res Ctr, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Westin, S (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Med Tech Res Ctr, N-7489 Trondheim, Norway.	steinar.westin@ntnu.no						[Anonymous], 1997, LANCET, V350, P229; Berkman L.F., 2000, SOCIAL EPIDEMIOLOGY, P3; *COMM SOC DET HLTH, 2008, CLOS GAP 1 GEN HLTH; DAHL E, 2006, HLTH INEQUALITIES EU, P193; Lundberg O., 2008, NORDIC EXPERIENCE WE; Lundberg O, 2008, LANCET, V372, P1633, DOI 10.1016/S0140-6736(08)61686-4; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; *MIN HLTH CAR SERV, 2007, 20 MIN HLTH CAR SERV; Moene K.-O., 2001, ECON GOV, V2, P3, DOI DOI 10.1007/PL00011019	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1609	1610		10.1016/S0140-6736(08)61666-9	http://dx.doi.org/10.1016/S0140-6736(08)61666-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994647				2022-12-28	WOS:000260899900004
J	Davis, SR; Moreau, M; Kroll, R; Bouchard, C; Panay, N; Gass, M; Braunstein, GD; Hirschberg, AL; Rodenberg, C; Pack, S; Koch, H; Moufarege, A; Studd, J				Davis, Susan R.; Moreau, Michele; Kroll, Robin; Bouchard, Celine; Panay, Nick; Gass, Margery; Braunstein, Glenn D.; Hirschberg, Angelica Linden; Rodenberg, Cynthia; Pack, Simon; Koch, Helga; Moufarege, Alain; Studd, John		APHRODITE Study Team	Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOACTIVE SEXUAL DESIRE; SURGICALLY MENOPAUSAL WOMEN; ANDROGEN LEVELS; PATCH; DISORDER; THERAPY; PROLIFERATION; REPLACEMENT; EFFICACY; BREAST	Background: The efficacy and safety of testosterone treatment for hypoactive sexual desire disorder in postmenopausal women not receiving estrogen therapy are unknown. Methods: We conducted a double-blind, placebo-controlled, 52-week trial in which 814 women with hypoactive sexual desire disorder were randomly assigned to receive a patch delivering 150 or 300 mu g of testosterone per day or placebo. Efficacy was measured to week 24; safety was evaluated over a period of 52 weeks, with a subgroup of participants followed for an additional year. The primary end point was the change from baseline to week 24 in the 4-week frequency of satisfying sexual episodes. Results: At 24 weeks, the increase in the 4-week frequency of satisfying sexual episodes was significantly greater in the group receiving 300 mu g of testosterone per day than in the placebo group (an increase of 2.1 episodes vs. 0.7, P<0.001) but not in the group receiving 150 mu g per day (1.2 episodes, P=0.11). As compared with placebo, both doses of testosterone were associated with significant increases in desire (300 mu g per day, P<0.001; 150 mu g per day, P=0.04) and decreases in distress (300 mu g per day, P<0.001; 150 mu g per day, P=0.04). The rate of androgenic adverse events - primarily unwanted hair growth - was higher in the group receiving 300 mu g of testosterone per day than in the placebo group (30.0% vs. 23.1%). Breast cancer was diagnosed in four women who received testosterone (as compared with none who received placebo); one of the four received the diagnosis in the first 4 months of the study period, and one, in retrospect, had symptoms before undergoing randomization. Conclusions: In postmenopausal women not receiving estrogen therapy, treatment with a patch delivering 300 mu g of testosterone per day resulted in a modest but meaningful improvement in sexual function. The long-term effects of testosterone, including effects on the breast, remain uncertain. (ClinicalTrials.gov number, NCT00131495.).	[Davis, Susan R.] Monash Univ, Alfred Hosp, Dept Med, Womens Hlth Program, Prahran, Vic 3181, Australia; [Moreau, Michele] Ctr Etud Clin, Montreal, PQ, Canada; [Kroll, Robin] Womens Clin Res Ctr, Seattle, WA USA; [Kroll, Robin] Menopause Ctr Seattle, Seattle, WA USA; [Bouchard, Celine] Univ Laval, Quebec City, PQ, Canada; [Panay, Nick] Queen Charlottes & Chelsea Hosp, London W6 0XG, England; [Gass, Margery] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Braunstein, Glenn D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Hirschberg, Angelica Linden] Karolinska Univ Hosp, Stockholm, Sweden; [Rodenberg, Cynthia; Pack, Simon; Koch, Helga] Procter & Gamble Pharmaceut, Mason, OH USA; [Moufarege, Alain] Debiopharm Grp, Charenton Le Pont, France; [Studd, John] Chelsea & Westminster Hosp, London, England	Florey Institute of Neuroscience & Mental Health; Monash University; Laval University; Imperial College London; University System of Ohio; University of Cincinnati; Cedars Sinai Medical Center; Karolinska Institutet; Karolinska University Hospital; Procter & Gamble; Debiopharm; Imperial College London	Davis, SR (corresponding author), Monash Univ, Alfred Hosp, Dept Med, Womens Hlth Program, Commercial Rd, Prahran, Vic 3181, Australia.	susan.davis@med.monash.edu.au	Bouchard, Celine/ABE-5810-2021; Davis, Susan R/A-3111-2009; Hirschberg, Angelica/AAK-6693-2020; Davis, Susan D/GZL-2361-2022	Bouchard, Celine/0000-0003-2258-058X; Davis, Susan R/0000-0002-2955-0415; 	Procter & Gamble Pharmaceuticals; Acrux; AstraZeneca Oncology Australia; Organon; AstraZeneca Pharmaceuticals; Novartis Oncology Australia; BioSante; Canadian Advisory Board of Procter & Gamble Pharmaceuticals; Palatin Technologies; Upsher-Smith Laboratories; Wyeth Pharmaceuticals; Boehringer Ingelheim; Novartis; Mattern Pharmaceuticals; Esoterix; Abbott Diagnostics; BioSante Pharmaceuticals	Procter & Gamble Pharmaceuticals(Procter & Gamble); Acrux; AstraZeneca Oncology Australia(AstraZeneca); Organon; AstraZeneca Pharmaceuticals(AstraZeneca); Novartis Oncology Australia; BioSante; Canadian Advisory Board of Procter & Gamble Pharmaceuticals; Palatin Technologies; Upsher-Smith Laboratories; Wyeth Pharmaceuticals(Wyeth); Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Mattern Pharmaceuticals; Esoterix; Abbott Diagnostics(Abbott Laboratories); BioSante Pharmaceuticals	Supported by research grants from Procter & Gamble Pharmaceuticals. Dr. Davis reports receiving consulting fees from Acrux, AstraZeneca Oncology Australia, Organon, and Procter & Gamble Pharmaceuticals, lecture fees from AstraZeneca Oncology Australia and Organon, and grant support from AstraZeneca Pharmaceuticals, Novartis Oncology Australia, and Procter & Gamble Pharmaceuticals; Dr. Kroll, grant support from BioSante and Procter & Gamble Pharmaceuticals; Dr. Bouchard, consulting fees for the Canadian Advisory Board of Procter & Gamble Pharmaceuticals and sponsorship from Procter & Gamble Pharmaceuticals to attend one European Society for Sexual Medicine Annual Meeting and one International Society for the Study of Women's Sexual Health Meeting; Dr. Panay, consulting and lecture fees from Procter & Gamble Pharmaceuticals; Dr. Gass, consulting fees from Palatin Technologies, Procter & Gamble Pharmaceuticals, Upsher-Smith Laboratories, and Wyeth Pharmaceuticals and grant support from Boehringer Ingelheim, Procter & Gamble Pharmaceuticals, and Wyeth Pharmaceuticals; and Dr. Braunstein, consulting fees from Novartis, Mattern Pharmaceuticals, Esoterix, and Abbott Diagnostics and grant support from Procter & Gamble Pharmaceuticals and BioSante Pharmaceuticals. Drs. Rodenberg, Pack, and Koch report being employed by Procter & Gamble Pharmaceuticals. Dr. Moufarege reports being a former employee of Procter & Gamble Pharmaceuticals and owning stock options in the company. No other potential conflict of interest relevant to this article was reported. We thank Akshay Buch, Ph. D., for help with the study design and data review, Chad Melson for his contribution to the data analysis, and Richard Helmchen for assistance in the preparation of the manuscript.	Alexander JL, 2004, MENOPAUSE, V11, P749, DOI 10.1097/01.GME.0000142887.31811.97; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], SCAND J SEXOL, DOI DOI 10.1176/APPI.AJP.2008.08050714; BLITZER J, 2008, MATURITAS, V59, P209; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Buster JE, 2005, OBSTET GYNECOL, V105, P944, DOI 10.1097/01.AOG.0000158103.27672.0d; DAVIS SR, 1995, MATURITAS, V21, P227, DOI 10.1016/0378-5122(94)00898-H; Davis SR, 2005, JAMA-J AM MED ASSOC, V294, P91, DOI 10.1001/jama.294.1.91; Davis S, 2008, ANN INTERN MED, V148, P569, DOI 10.7326/0003-4819-148-8-200804150-00001; Davis SR, 2006, MENOPAUSE, V13, P387, DOI 10.1097/01.gme.0000179049.08371.c7; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; Dennerstein L, 2001, FERTIL STERIL, V76, P456, DOI 10.1016/S0015-0282(01)01978-1; Derogatis L, 2004, J SEX MARITAL THER, V30, P25, DOI 10.1080/00926230490247183; Derogatis L, 2004, ANN M INT SOC STUD W; Fugl-Meyer KS, 2004, J SEX MED, V1, P278, DOI 10.1111/j.1743-6109.04040.x; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P2264; Hankinson SE, 2007, J STEROID BIOCHEM, V106, P24, DOI 10.1016/j.jsbmb.2007.05.012; Hofling M, 2007, MENOPAUSE, V14, P183, DOI 10.1097/01.gme.0000232033.92411.51; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JUDD HL, 1974, J CLIN ENDOCR METAB, V39, P1020, DOI 10.1210/jcem-39-6-1020; Kingsberg S, 2007, J SEX MED, V4, P1001, DOI 10.1111/j.1743-6109.2007.00526.x; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P1174; Leiblum SR, 2006, MENOPAUSE, V13, P46, DOI 10.1097/01.gme.0000172596.76272.06; LORENZO EM, 1970, J CLIN ENDOCR METAB, V31, P556, DOI 10.1210/jcem-31-5-556; Manderson L, 2005, MENOPAUSE, V12, P361, DOI 10.1097/01.GME.0000170604.63022.AC; MCCOY NL, 1985, MATURITAS, V7, P203, DOI 10.1016/0378-5122(85)90041-6; McHorney CA, 2004, MENOPAUSE, V11, P474, DOI 10.1097/01.GME.0000109316.11228.77; Mercer CH, 2003, BRIT MED J, V327, P649; NATHORSTBOOS J, 1992, GYNECOL OBSTET INVES, V34, P97, DOI 10.1159/000292735; PALATSI R, 1984, ACTA DERM-VENEREOL, V64, P517; SCHMIDT CW, 1994, DIAGNOSTIC STAT MANU, P496; Shifren JL, 2007, MENOPAUSE, V14, P157; Shifren JL, 2006, MENOPAUSE, V13, P770, DOI 10.1097/01.gme.0000227400.60816.52; Shifren JL, 2000, NEW ENGL J MED, V343, P682, DOI 10.1056/NEJM200009073431002; Simon J, 2005, J CLIN ENDOCR METAB, V90, P5226, DOI 10.1210/jc.2004-1747; Somboonporn W, 2004, ENDOCR REV, V25, P374, DOI 10.1210/er.2003-0016; Symonds T, 2007, J SEX MED, V4, P1328, DOI 10.1111/j.1743-6109.2007.00562.x; Tangen CM, 2001, STAT MED, V20, P2585, DOI 10.1002/sim.731; WALSH BW, 1991, NEW ENGL J MED, V325, P1196, DOI 10.1056/NEJM199110243251702; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Wierman ME, 2006, J CLIN ENDOCR METAB, V91, P3697, DOI 10.1210/jc.2006-1121; Zang H, 2007, J CLIN ENDOCR METAB, V92, P2169, DOI 10.1210/jc.2006-2171; Zhou J, 2000, FASEB J, V14, P1725, DOI 10.1096/fj.99-0863com; ZUSSMAN L, 1981, AM J OBSTET GYNECOL, V140, P725, DOI 10.1016/0002-9378(81)90730-4	46	291	294	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2005	2017		10.1056/NEJMoa0707302	http://dx.doi.org/10.1056/NEJMoa0707302			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987368				2022-12-28	WOS:000260632700005
J	Nass, R; Pezzoli, SS; Oliveri, MC; Patrie, JT; Harrell, FE; Clasey, JL; Heymsfield, SB; Bach, MA; Vance, ML; Thorner, MO				Nass, Ralf; Pezzoli, Suzan S.; Oliveri, Mary Clancy; Patrie, James T.; Harrell, Frank E., Jr.; Clasey, Jody L.; Heymsfield, Steven B.; Bach, Mark A.; Vance, Mary Lee; Thorner, Michael O.			Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SKELETAL-MUSCLE MASS; GROWTH-HORMONE GH; ABDOMINAL VISCERAL FAT; BONE-MINERAL DENSITY; WEIGHT-LOSS; INSULIN SENSITIVITY; SECRETAGOGUE MK-677; REPLACEMENT THERAPY; AGED WOMEN; MEN	Background: Growth hormone secretion and muscle mass decline from midpuberty throughout life, culminating in sarcopenia, frailty, decreased function, and loss of independence. The decline of growth hormone in the development of sarcopenia is one of many factors, and its etiologic role needs to be demonstrated. Objective: To determine whether MK-677, an oral ghrelin mimetic, increases growth hormone secretion into the young-adult range without serious adverse effects, prevents the decline of fat-free mass, and decreases abdominal visceral fat in healthy older adults. Design: 2-year, double-blind, randomized, placebo-controlled, modified-crossover clinical trial. Setting: General clinical research center study performed at a university hospital. Participants: 65 healthy adults (men, women receiving hormone replacement therapy, and women not receiving hormone replacement therapy) ranging from 60 to 81 years of age. Intervention: Oral administration of MK-677, 25 mg, or placebo once daily. Measurements: Growth hormone and insulin-like growth factor I levels. Fat-free mass and abdominal visceral fat were the primary end points after 1 year of treatment. Other end points were body weight, fat mass, insulin sensitivity, lipid and cortisol levels, bone mineral density, limb lean and fat mass, isokinetic strength, function, and quality of life. All end points were assessed at baseline and every 6 months. Results: Daily administration of MK-677 significantly increased growth hormone and insulin-like growth factor I levels to those of healthy young adults without serious adverse effects. Mean fat-free mass decreased in the placebo group but increased in the MK-677 group (change, -0.5 kg [95% CI, -1.1 to 0.2 kg] vs. 1.1 kg [CI, 0.7 to 1.5 kg], respectively; P < 0.001), as did body cell mass, as reflected by intracellular water ( change, -1.0 kg [ CI, -2.1 to 0.2 kg] vs. 0.8 kg [CI, -0.1 to 1.6 kg], respectively; P = 0.021). No significant differences were observed in abdominal visceral fat or total fat mass; however, the average increase in limb fat was greater in the MK-677 group than the placebo group (1.1 kg vs. 0.24 kg; P = 0.001). Body weight increased 0.8 kg (CI, -0.3 to 1.8 kg) in the placebo group and 2.7 kg (CI, 2.0 to 3.5 kg) in the MK-677 group (P = 0.003). Fasting blood glucose level increased an average of 0.3 mmol/L (5 mg/dL) in the MK-677 group (P = 0.015), and insulin sensitivity decreased. The most frequent side effects were an increase in appetite that subsided in a few months and transient, mild lower-extremity edema and muscle pain. Low-density lipoprotein cholesterol levels decreased in the MK-677 group relative to baseline values (change, -0.14 mmol/L [CI, -0.27 to -0.01 mmol/L]; -5.4 mg/dL [CI, -10.4 to -0.4 mg/dL]; P = 0.026); no differences between groups were observed in total or high-density lipoprotein cholesterol levels. Cortisol levels increased 47 nmol/L (CI, 28 to 71 nmol/L (1.7 mu g/dL [CI, 1.0 to 2.6 mu g/dL]) in MK-677 recipients (P = 0.020). Changes in bone mineral density consistent with increased bone remodeling occurred in MK-677 recipients. Increased fat-free mass did not result in changes in strength or function. Two-year exploratory analyses confirmed the 1-year results. Limitation: Study power (duration and participant number) was insufficient to evaluate functional end points in healthy elderly persons. Conclusion: Over 12 months, the ghrelin mimetic MK-677 enhanced pulsatile growth hormone secretion, significantly increased fat-free mass, and was generally well tolerated. Long-term functional and, ultimately, pharmacoeconomic, studies in elderly persons are indicated.	[Thorner, Michael O.] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Univ Kentucky, Lexington, KY USA; Merck Res Labs, Rahway, NJ USA	University of Virginia; Vanderbilt University; University of Kentucky; Merck & Company	Thorner, MO (corresponding author), Univ Virginia Hlth Syst, Dept Med, Box 801411,450 Ray C Hunt Dr,Aurbach Bldg,Room 23, Charlottesville, VA 22908 USA.	mot@virginia.edu	Heymsfield, Steven B/N-1968-2017	Heymsfield, Steven B/0000-0003-1127-9425	National Institutes of Health [DK-32632, RR-00847]; Deutsche Forschungsgemeinschaft [Na 317/1-1, Na 317/12]; University of Alabama at Birmingham, Birmingham, Alabama [NIH P30-DK 56336]; Columbia University, New York, New York [NIH PO1-DK42618]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032632, P30DK056336, P01DK042618, R01DK076037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Alabama at Birmingham, Birmingham, Alabama; Columbia University, New York, New York; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By National Institutes of Health grants DK-32632 (Dr. Thorner) and RR-00847 (GCRC). Dr. Nass was supported in part by a grant from Deutsche Forschungsgemeinschaft (Na 317/1-1, Na 317/12). Merck Research Laboratories provided MK-677 and placebo. Additional support for assays was provided by grants NIH P30-DK 56336 (University of Alabama at Birmingham, Birmingham, Alabama) and NIH PO1-DK42618 (Columbia University, New York, New York).	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; Buchner DM, 1996, AGE AGEING, V25, P386, DOI 10.1093/ageing/25.5.386; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chapman IM, 1996, J CLIN ENDOCR METAB, V81, P4249, DOI 10.1210/jc.81.12.4249; CHAPMAN IM, 1994, J CLIN ENDOCR METAB, V78, P1312, DOI 10.1210/jc.78.6.1312; Clasey JL, 1997, OBES RES, V5, P395, DOI 10.1002/j.1550-8528.1997.tb00661.x; Clasey JL, 1999, J APPL PHYSIOL, V86, P1728, DOI 10.1152/jappl.1999.86.5.1728; del Rincon JP, 2007, DIABETES, V56, P1638, DOI 10.2337/db06-0299; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; Despres JP, 1999, CLIN BIOCHEM, V32, P157, DOI 10.1016/S0009-9120(98)00106-4; Fantin F, 2007, J GERONTOL A-BIOL, V62, P1375, DOI 10.1093/gerona/62.12.1375; Franco C, 2005, J CLIN ENDOCR METAB, V90, P1466, DOI 10.1210/jc.2004-1657; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gotherstrom G, 2007, EUR J ENDOCRINOL, V156, P55, DOI 10.1530/eje.1.02317; Gotherstrom G, 2005, CLIN ENDOCRINOL, V62, P105, DOI 10.1111/j.1365-2265.2004.02181.x; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Janssen I, 2000, J APPL PHYSIOL, V89, P81; JOHNSON ML, 2006, 88 M END SOC BOST MA, P459; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Landin-Wilhelmsen K, 2003, J BONE MINER RES, V18, P393, DOI 10.1359/jbmr.2003.18.3.393; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Morley JE, 2003, J GERONTOL A-BIOL, V58, P131; Morley JE, 2007, CURR PHARM DESIGN, V13, P3637, DOI 10.2174/138161207782794149; Munzer T, 2001, J CLIN ENDOCR METAB, V86, P3604, DOI 10.1210/jc.86.8.3604; MURDEN RA, 1994, J GEN INTERN MED, V9, P648, DOI 10.1007/BF02600311; Murphy MG, 2001, J CLIN ENDOCR METAB, V86, P1116, DOI 10.1210/jc.86.3.1116; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; PLOTKIN D, 1997, ENDOCRINOL METAB SA, V4, P35; RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164; RYAN C, 1995, SOUTHERN MED J, V88, P721, DOI 10.1097/00007611-199507000-00005; Schoeller D.A., 1996, HUMAN BODY COMPOSITI, P25; Silva AM, 2005, J APPL PHYSIOL, V99, P261, DOI 10.1152/japplphysiol.01317.2004; Smith RG, 2005, ENDOCR REV, V26, P346, DOI 10.1210/er.2004-0019; Svensson J, 1998, J CLIN ENDOCR METAB, V83, P362, DOI 10.1210/jc.83.2.362; Tabachnick BG., 2007, USING MULTIVARIATE S, V5, P481; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wang ZM, 2004, AM J PHYSIOL-ENDOC M, V286, pE123, DOI 10.1152/ajpendo.00227.2003; Weltman A, 2003, METABOLISM, V52, P73, DOI 10.1053/meta.2003.50007; ZADIK Z, 1985, J CLIN ENDOCR METAB, V60, P513, DOI 10.1210/jcem-60-3-513	47	176	188	2	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					601	+		10.7326/0003-4819-149-9-200811040-00003	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18981485	Green Accepted			2022-12-28	WOS:000260585700001
J	Perlson, E; Holzbaur, ELF				Perlson, Eran; Holzbaur, Erika L. F.			Myosin Learns to Recruit AMPA Receptors	CELL			English	Editorial Material							SYNAPTIC PLASTICITY; TRAFFICKING; SPINES; VB	The induction of long-term potentiation (LTP) leads to an increase in the density of AMPA receptors at dendritic spines. New work by Wang et al. (2008) reveals the mechanism by which myosin Vb regulates the intracellular trafficking of AMPA receptors from recycling endosomes to synaptic sites during LTP.	[Perlson, Eran; Holzbaur, Erika L. F.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Holzbaur, ELF (corresponding author), Univ Penn, Sch Med, Dept Physiol, D400 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu		Perlson, Eran/0000-0001-6047-9613				Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040	9	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					414	415		10.1016/j.cell.2008.10.013	http://dx.doi.org/10.1016/j.cell.2008.10.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984153	Bronze			2022-12-28	WOS:000260536300012
J	Pugno, PA; Kellerman, R; McGaha, AL				Pugno, Perry A.; Kellerman, Rick; McGaha, Amy L.			The solution to the US health-care crisis	LANCET			English	Editorial Material									[Pugno, Perry A.; Kellerman, Rick; McGaha, Amy L.] Amer Acad Family Phys, Leawood, KS 66211 USA		Pugno, PA (corresponding author), Amer Acad Family Phys, Leawood, KS 66211 USA.	ppugno@aafp.org						*AM AC FAM PHYS, 2006, FAM PHYS WORKF REF R; American College of Physicians, 2006, IMP COLL PRIM CAR ME; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; *COMM FUND, 2007, AIM HIGH RES STAT SC; Fryer GE, 2001, AM FAM PHYSICIAN, V63, P1669; Green LA, 2004, PHYS WORKFORCE US FA; Grumbach K, 2002, NEW ENGL J MED, V346, P1574, DOI 10.1056/NEJM200205163462012; PHILLIPS RL, 2005, HLTH AFF W, V5, P111; *PUBL OP STRAT LAK, 2006, NAT SURV 800 LIK VOT; Pugno PA, 2007, FAM MED, V39, P550; SHI L, 2004, PRIMARY CARE PHYS PO; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; World Health Organization, WORLD HLTH REP 2006	14	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					107	108		10.1016/S0140-6736(08)61600-1	http://dx.doi.org/10.1016/S0140-6736(08)61600-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	18977526				2022-12-28	WOS:000262340900010
J	Malcolmson, SJ; Meek, SJ; Sattely, ES; Schrock, RR; Hoveyda, AH				Malcolmson, Steven J.; Meek, Simon J.; Sattely, Elizabeth S.; Schrock, Richard R.; Hoveyda, Amir H.			Highly efficient molybdenum-based catalysts for enantioselective alkene metathesis	NATURE			English	Article							RING-CLOSING METATHESIS; IMIDO ALKYLIDENE COMPLEXES; OLEFIN-METATHESIS; METAL-COMPLEXES; TUNGSTEN; AMINES; ETHERS; LIGAND	Discovery of efficient catalysts is one of the most compelling objectives of modern chemistry. Chiral catalysts are in particularly high demand, as they facilitate synthesis of enantiomerically enriched small molecules that are critical to developments in medicine, biology and materials science(1). Especially noteworthy are catalysts that promote - with otherwise inaccessible efficiency and selectivity levels - reactions demonstrated to be of great utility in chemical synthesis. Here we report a class of chiral catalysts that initiate alkene metathesis(1) with very high efficiency and enantioselectivity. Such attributes arise from structural fluxionality of the chiral catalysts and the central role that enhanced electronic factors have in the catalytic cycle. The new catalysts have a stereogenic metal centre and carry only monodentate ligands; the molybdenum- based complexes are prepared stereoselectively by a ligand exchange process involving an enantiomerically pure aryloxide, a class of ligands scarcely used in enantioselective catalysis(2,3). We demonstrate the application of the new catalysts in an enantioselective synthesis of the Aspidosperma alkaloid, quebrachamine, through an alkene metathesis reaction that cannot be promoted by any of the previously reported chiral catalysts.	[Malcolmson, Steven J.; Meek, Simon J.; Sattely, Elizabeth S.; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Malcolmson, Steven/C-6220-2015		US National Institutes of Health; Institute of General Medical Sciences [GM-59426]; US National Science Foundation [DBI-0619576]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (grant GM-59426 to A.H.H. and R.R.S.). We are grateful to B. C. Bailey and K. Wampler for assistance in obtaining the X-ray structure of the major diastereomer of molybdenum complex 13b. We thank A. R. Zhugralin for numerous discussions regarding the mechanistic aspects of these investigations and R. Singh for experimental suggestions. Mass spectrometry facilities at Boston College are supported by the US National Science Foundation (grant DBI-0619576).	Alexander JB, 1998, J AM CHEM SOC, V120, P4041, DOI 10.1021/ja974353i; BRUNNER H, 1990, ANGEW CHEM INT EDIT, V29, P1131, DOI 10.1002/anie.199011311; Brunner H, 1999, ANGEW CHEM INT EDIT, V38, P1195, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1194::AID-ANIE1194>3.0.CO;2-X; Brunner H, 1998, TETRAHEDRON-ASYMMETR, V9, P3231, DOI 10.1016/S0957-4166(98)00329-2; DEUTSCH HF, 1994, J PHARMACEUT BIOMED, V12, P1283, DOI 10.1016/0731-7085(94)00066-2; Dolman SJ, 2002, J AM CHEM SOC, V124, P6991, DOI 10.1021/ja012534l; Faller JW, 2001, J AM CHEM SOC, V123, P2525, DOI 10.1021/ja003528c; Fontecave M, 2005, TOP ORGANOMETAL CHEM, V15, P271; Fournier PA, 2007, ORGANOMETALLICS, V26, P2945, DOI 10.1021/om700312c; Funk TW, 2006, J AM CHEM SOC, V128, P1840, DOI 10.1021/ja055994d; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Grubbs R. H., 2003, HDB METATHESIS; HASHIMOTO S, 1979, J CHEM SOC CHEM COMM, P437, DOI 10.1039/c39790000437; Hock AS, 2006, J AM CHEM SOC, V128, P16373, DOI 10.1021/ja0665904; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Kiely AF, 2002, J AM CHEM SOC, V124, P2868, DOI 10.1021/ja012679s; Kozmin SA, 2002, J AM CHEM SOC, V124, P4628, DOI 10.1021/ja017863s; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Poater A, 2007, J AM CHEM SOC, V129, P8207, DOI 10.1021/ja070625y; Sattely ES, 2005, J AM CHEM SOC, V127, P8526, DOI 10.1021/ja051330s; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; SCHROCK RR, 1990, J AM CHEM SOC, V112, P3875, DOI 10.1021/ja00166a023; Singh R, 2007, J AM CHEM SOC, V129, P12654, DOI 10.1021/ja075569f; Solans-Monfort X, 2005, J AM CHEM SOC, V127, P14015, DOI 10.1021/ja053528i; Stewart IC, 2008, ORG LETT, V10, P441, DOI 10.1021/ol702624n; Tayama E, 2002, TETRAHEDRON, V58, P8307, DOI 10.1016/S0040-4020(02)00981-X; Tsang WCP, 2003, J AM CHEM SOC, V125, P2652, DOI 10.1021/ja0210603; Van Veldhuizen JJ, 2005, J AM CHEM SOC, V127, P6877, DOI 10.1021/ja050179j; Van Veldhuizen JJ, 2003, J AM CHEM SOC, V125, P12502, DOI 10.1021/ja0302228	29	213	232	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					933	937		10.1038/nature07594	http://dx.doi.org/10.1038/nature07594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	384TY	19011612	Green Accepted			2022-12-28	WOS:000261768300041
J	Biastoch, A; Boning, CW; Lutjeharms, JRE				Biastoch, A.; Boening, C. W.; Lutjeharms, J. R. E.			Agulhas leakage dynamics affects decadal variability in Atlantic overturning circulation	NATURE			English	Article							NORTH-ATLANTIC; EXCHANGE; RINGS	Predicting the evolution of climate over decadal timescales requires a quantitative understanding of the dynamics that govern the meridional overturning circulation (MOC)(1). Comprehensive ocean measurement programmes aiming to monitor MOC variations have been established in the subtropical North Atlantic(2,3) ( RAPID, at latitude 26.56 degrees N, and MOVE, at latitude 16 degrees N) and show strong variability on intraseasonal to interannual timescales. Observational evidence of longer- term changes in MOC transport remains scarce, owing to infrequent sampling of transoceanic sections over past decades(4,5). Inferences based on long- term sea surface temperature records, however, supported by model simulations, suggest a variability with an amplitude of +/- 1.5-3 Sv ( 1 Sv = 10(6) m(3) s(-1)) on decadal timescales in the subtropics(6). Such variability has been attributed to variations of deep water formation in the sub- arctic Atlantic, particularly the renewal rate of Labrador Sea Water(7). Here we present results from a model simulation that suggest an additional influence on decadal MOC variability having a Southern Hemisphere origin: dynamic signals originating in the Agulhas leakage region at the southern tip of Africa. These contribute a MOC signal in the tropical and subtropical North Atlantic that is of the same order of magnitude as the northern source. A complete rationalization of observed MOC changes therefore also requires consideration of signals arriving from the south.	[Biastoch, A.; Boening, C. W.] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Lutjeharms, J. R. E.] Univ Cape Town, Dept Oceanog, ZA-7700 Rondebosch, South Africa	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Cape Town	Biastoch, A (corresponding author), Leibniz Inst Marine Sci, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	abiastoch@ifm-geomar.de	Biastoch, Arne/B-5219-2014; Boening, Claus W/B-1686-2012; Boening, Claus/AAW-6387-2020; Boening, Claus W/HIR-8996-2022	Biastoch, Arne/0000-0003-3946-4390; Boening, Claus W/0000-0002-6251-5777; Boening, Claus/0000-0002-6251-5777; Boening, Claus W/0000-0002-6251-5777	Alexander von Humboldt-Stiftung	Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	The integration of the experiments was performed at the Hochstleistungsrechenzentrum Stuttgart and the Computing Centre at Kiel University. We thank the NEMO and AGRIF System Teams as well as J.-M. Molines and M. Scheinert for technical support. The analysis was performed under the DFG project no. BO 907/2-2. J.R.E.L. received support from the Alexander von Humboldt-Stiftung.	Biastoch A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035132; BIASTOCH A, 2008, J CLIM IN PRESS, DOI DOI 10.1175/2008JCL12404.1; Boning CW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026906; Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; de Ruijter WPM, 1999, J GEOPHYS RES-OCEANS, V104, P20885, DOI 10.1029/1998JC900099; Debreu L, 2008, COMPUT GEOSCI-UK, V34, P8, DOI 10.1016/j.cageo.2007.01.009; Dong BW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015229; Garzoli SL, 1999, J GEOPHYS RES-OCEANS, V104, P20971, DOI 10.1029/1999JC900060; GENT PR, 1990, J PHYS OCEANOGR, V20, P150, DOI 10.1175/1520-0485(1990)020<0150:IMIOCM>2.0.CO;2; Getzlaff J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021002; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; HSIEH WW, 1983, J PHYS OCEANOGR, V13, P1383, DOI 10.1175/1520-0485(1983)013<1383:TFKWIF>2.0.CO;2; Johnson HL, 2002, J PHYS OCEANOGR, V32, P1121, DOI 10.1175/1520-0485(2002)032<1121:ATFTSA>2.0.CO;2; Kanzow T, 2006, DEEP-SEA RES PT I, V53, P528, DOI 10.1016/j.dsr.2005.12.007; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Large W. G., 2004, NCARTN460 STR CGD DI, DOI [10.5065/D6KK98Q6, DOI 10.5065/D6KK98Q6]; Latif M, 2006, J CLIMATE, V19, P4631, DOI 10.1175/JCLI3876.1; Lutjeharms JRE, 2006, AGULHAS CURRENT; MADEC G, 2006, NEMO OCEAN ENGINE; Maltrud ME, 2005, OCEAN MODEL, V8, P31, DOI 10.1016/j.ocemod.2003.12.001; Marsh R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027815; OLSON DB, 1986, DEEP-SEA RES, V33, P27, DOI 10.1016/0198-0149(86)90106-8; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; RIO MH, 2005, CAHIERS CTR EUROPEEN, V25; van Aken HM, 2003, DEEP-SEA RES PT II, V50, P167, DOI 10.1016/S0967-0645(02)00383-1; van Leeuwen PJ, 2000, J GEOPHYS RES-OCEANS, V105, P6425, DOI 10.1029/1999JC900196; van Sebille E, 2007, J PHYS OCEANOGR, V37, P2305, DOI 10.1175/JPO3108.1; Weijer W, 1999, J PHYS OCEANOGR, V29, P2266, DOI 10.1175/1520-0485(1999)029<2266:IOIEOT>2.0.CO;2; Wunsch C, 2008, NAT GEOSCI, V1, P165, DOI 10.1038/ngeo126	30	199	202	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					489	492		10.1038/nature07426	http://dx.doi.org/10.1038/nature07426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037313				2022-12-28	WOS:000261170500035
J	Kamerow, D				Kamerow, Douglas			Our perfectly designed US healthcare system	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 24	2008	337								a2702	10.1136/bmj.a2702	http://dx.doi.org/10.1136/bmj.a2702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385PZ	19029179				2022-12-28	WOS:000261827400008
J	Kong, MF; Nayyar, V; Jogia, R; Berrington, R; Jackson, S				Kong, Marie-France; Nayyar, Vidhu; Jogia, Rajesh; Berrington, Rachel; Jackson, Stephen			A swollen knee: and the father of hysteria	LANCET			English	Editorial Material							CHARCOT NEUROARTHROPATHY; ARTHROPLASTY		[Kong, Marie-France; Nayyar, Vidhu; Jogia, Rajesh; Berrington, Rachel; Jackson, Stephen] Leicester Gen Hosp, Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Kong, MF (corresponding author), Leicester Gen Hosp, Univ Hosp Leicester NHS Trust, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	marie-france.kong@uhl-tr.nhs.uk						Charcot JM, 1868, ARCH PHYSIOL NORM P, V1, P161; Jude EB, 2001, DIABETOLOGIA, V44, P2032, DOI 10.1007/s001250100008; Lambert AP, 2002, DIABETIC MED, V19, P338, DOI 10.1046/j.1464-5491.2002.00704.x; Myerson M S, 1999, J Am Acad Orthop Surg, V7, P8; Yoshino S, 1993, J Arthroplasty, V8, P335, DOI 10.1016/S0883-5403(06)80098-7	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1854	1854		10.1016/S0140-6736(08)61760-2	http://dx.doi.org/10.1016/S0140-6736(08)61760-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027485				2022-12-28	WOS:000261112000028
J	Bataille, V; de Vries, E				Bataille, Veronique; de Vries, Esther			Melanoma - Part 1: epidemiology, risk factors, and prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CUTANEOUS MELANOMA; MELANOCORTIN-1 RECEPTOR; MALIGNANT-MELANOMA; EXPOSURE; TRENDS; SITE; METAANALYSIS; AUSTRALIA; MORTALITY; SURVIVAL		[Bataille, Veronique] W Hertfordshire Hosp NHS Trust, Hemel Hempstead HP2 4AD, England; [Bataille, Veronique] Kings Coll London, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; [de Vries, Esther] Erasmus MC Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [de Vries, Esther] Erasmus MC Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands	University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bataille, V (corresponding author), W Hertfordshire Hosp NHS Trust, Hemel Hempstead HP2 4AD, England.	bataille@doctors.org.uk	de Vries, Esther/A-6603-2009	de Vries, Esther/0000-0002-5560-2258				*AUSTR I HLTH WELF, 2007, AUSTR CANC INC MORT; Autier P, 2005, EXPERT REV ANTICANC, V5, P821, DOI 10.1586/14737140.5.5.821; Bataille V, 2004, EUR J CANCER, V40, P429, DOI 10.1016/j.ejca.2003.09.030; Bataille W, 2005, EUR J CANCER, V41, P2141, DOI 10.1016/j.ejca.2005.04.038; Bishop JAN, 2007, SEMIN ONCOL, V34, P452, DOI 10.1053/j.seminoncol.2007.09.006; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Bulliard JL, 1997, INT J CANCER, V72, P231, DOI 10.1002/(SICI)1097-0215(19970717)72:2<231::AID-IJC5>3.0.CO;2-S; *CANC RES UK, MEL SKIN CANC; Cho EY, 2005, CANCER EPIDEM BIOMAR, V14, P1241, DOI 10.1158/1055-9965.EPI-04-0632; Coory M, 2006, CANCER CAUSE CONTROL, V17, P21, DOI 10.1007/s10552-005-3637-4; Cress RD, 1997, CANCER CAUSE CONTROL, V8, P246, DOI 10.1023/A:1018432632528; De Vries E, 2008, ANN ONCOL, V19, P583, DOI 10.1093/annonc/mdm498; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Giles GG, 1996, BMJ-BRIT MED J, V312, P1121; Harrison SL, 2000, J NATL CANCER I, V92, P1436, DOI 10.1093/jnci/92.17.1436; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; *MEL MOL MAP PROJ, TNM STAG; Mossner R, 2007, ARCH DERMATOL RES, V298, P371, DOI 10.1007/s00403-006-0708-7; *NCI, SURV EP END RES FAST; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; WESTERDAHL J, 1994, AM J EPIDEMIOL, V140, P691, DOI 10.1093/oxfordjournals.aje.a117317; WHITEMAN DC, 2008, J CANC PREV, V17, P243	24	67	69	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2249	10.1136/bmj.a2249	http://dx.doi.org/10.1136/bmj.a2249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397HS	19022841	Green Submitted			2022-12-28	WOS:000262654100003
J	Qaseem, A; Snow, V; Denberg, TD; Forciea, MA; Owens, DK				Qaseem, Amir; Snow, Vincenza; Denberg, Thomas D.; Forciea, Mary Ann; Owens, Douglas K.		Clinical Efficacy Assessment	Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; SEROTONIN REUPTAKE INHIBITORS; BUPROPION SUSTAINED-RELEASE; LONG-TERM TREATMENT; VENLAFAXINE EXTENDED-RELEASE; RANDOMIZED CONTROLLED-TRIALS; PAROXETINE-CONTROLLED TRIAL; GERIATRIC MAJOR DEPRESSION; LATE-LIFE DEPRESSION; DOUBLE-BLIND	Description: The American College of Physicians developed this guideline to present the available evidence on the pharmacologic management of the acute, continuation, and maintenance phases of major depressive disorder; dysthymia; subsyndromal depression; and accompanying symptoms, such as anxiety, insomnia, or neurovegetative symptoms, by using second-generation antidepressants. Methods: Published literature on this topic was identified by using MEDLINE, EMBASE, PsychLit, the Cochrane Central Register of Controlled Trials, and International Pharmaceutical Abstracts from 1980 to April 2007. Searches were limited to English-language studies in adults older than 19 years of age. Keywords for search included terms for depressive disorders and 12 specific second-generation antidepressants-bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone, and venlafaxine-and their specific trade names. This guideline grades the evidence and recommendations by using the American College of Physicians clinical practice guidelines grading system. Recommendation 1: The American College of Physicians recommends that when clinicians choose pharmacologic therapy to treat patients with acute major depression, they select second-generation antidepressants on the basis of adverse effect profiles, cost, and patient preferences (Grade: strong recommendation; moderate-quality evidence). Recommendation 2: The American College of Physicians recommends that clinicians assess patient status, therapeutic response, and adverse effects of antidepressant therapy on a regular basis beginning within 1 to 2 weeks of initiation of therapy (Grade: strong recommendation; moderate-quality evidence). Recommendation 3: The American College of Physicians recommends that clinicians modify treatment if the patient does not have an adequate response to pharmacotherapy within 6 to 8 weeks of the initiation of therapy for major depressive disorder (Grade: strong recommendation; moderate-quality evidence). Recommendation 4: The American College of Physicians recommends that clinicians continue treatment for 4 to 9 months after a satisfactory response in patients with a first episode of major depressive disorder. For patients who have had 2 or more episodes of depression, an even longer duration of therapy may be beneficial (Grade: strong recommendation; moderate-quality evidence).	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Colorado, Aurora, CO USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA	American College of Physicians; University of Pennsylvania; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org						Aberg-Wistedt A, 2000, J CLIN PSYCHOPHARM, V20, P645, DOI 10.1097/00004714-200012000-00010; Allard P, 2004, INT J GERIATR PSYCH, V19, P1123, DOI 10.1002/gps.1190; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baldomero EB, 2005, DEPRESS ANXIETY, V22, P68, DOI 10.1002/da.20080; Baldwin DS, 1996, J CLIN PSYCHIAT, V57, P46; Barret JE, 2001, J FAM PRACTICE, V50, P405; BEASLEY CM, 1991, J CLIN PSYCHIAT, V52, P294; Behnke K, 2003, J CLIN PSYCHOPHARM, V23, P358, DOI 10.1097/01.jcp.0000085408.08426.05; Benkert O, 2000, J CLIN PSYCHIAT, V61, P656, DOI 10.4088/JCP.v61n0911; Bielski RJ, 2004, J CLIN PSYCHIAT, V65, P1190, DOI 10.4088/JCP.v65n0906; Boyer P, 1998, PHARMACOECONOMICS, V13, P157, DOI 10.2165/00019053-199813010-00015; Brannan SK, 2005, J PSYCHIATR RES, V39, P43, DOI 10.1016/j.jpsychires.2004.04.011; Burke WJ, 2002, J CLIN PSYCHIAT, V63, P331, DOI 10.4088/JCP.v63n0410; Cassano GB, 2002, J CLIN PSYCHIAT, V63, P396, DOI 10.4088/JCP.v63n0504; Chouinard G, 1999, J AFFECT DISORDERS, V54, P39, DOI 10.1016/S0165-0327(98)00188-8; CLERC GE, 1994, INT CLIN PSYCHOPHARM, V9, P139, DOI 10.1097/00004850-199409000-00001; Coleman C C, 1999, Ann Clin Psychiatry, V11, P205, DOI 10.3109/10401239909147072; Coleman CC, 2001, CLIN THER, V23, P1040, DOI 10.1016/S0149-2918(01)80090-4; Colonna L, 2005, CURR MED RES OPIN, V21, P1659, DOI 10.1185/030079905X65484; Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4; CUNNINGHAM LA, 1994, J CLIN PSYCHOPHARM, V14, P99; De Nayer A, 2002, INT J NEUROPSYCHOPH, V5, P115, DOI 10.1017/S1461145702002857; Detke MJ, 2004, EUR NEUROPSYCHOPHARM, V14, P457, DOI 10.1016/j.euroneuro.2004.01.002; Devanand DP, 2005, AM J GERIAT PSYCHIAT, V13, P59, DOI 10.1176/appi.ajgp.13.1.59; Dickens C, 2000, PSYCHOSOMATICS, V41, P490, DOI 10.1176/appi.psy.41.6.490; Didham RC, 2005, BRIT J CLIN PHARMACO, V60, P519, DOI 10.1111/j.1365-2125.2005.02480.x; Ekselius L, 1997, INT CLIN PSYCHOPHARM, V12, P323, DOI 10.1097/00004850-199711000-00005; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; Fava M, 1998, Ann Clin Psychiatry, V10, P145; Fava M, 2002, J CLIN PSYCHOPHARM, V22, P137, DOI 10.1097/00004714-200204000-00006; Fava M, 2000, J AFFECT DISORDERS, V59, P119, DOI 10.1016/S0165-0327(99)00131-7; *FDA CTR DRUG EV R, 2001, STAT REV NDA; FEIGHNER JP, 1991, J CLIN PSYCHIAT, V52, P329; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Ferrando SJ, 1997, GEN HOSP PSYCHIAT, V19, P89, DOI 10.1016/S0163-8343(96)00172-7; Finkel SI, 1999, AM J GERIAT PSYCHIAT, V7, P221, DOI 10.1097/00019442-199908000-00006; Flament MF, 1999, INT CLIN PSYCHOPHARM, V14, P259; Franchini L, 2000, J AFFECT DISORDERS, V58, P233, DOI 10.1016/S0165-0327(99)00113-5; Franchini L, 1997, J CLIN PSYCHIAT, V58, P104, DOI 10.4088/JCP.v58n0303; GAGIANO CA, 1993, BR J CLIN RES, V4, P145; Gartlehner G, 2007, COMP EFFECTIVENESS R; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; GERETSEGGER C, 1994, INT CLIN PSYCHOPHARM, V9, P25, DOI 10.1097/00004850-199400910-00004; Goldstein DJ, 2004, J CLIN PSYCHOPHARM, V24, P389, DOI 10.1097/01.jcp.0000132448.65972.d9; Guelfi JD, 2001, J CLIN PSYCHOPHARM, V21, P425, DOI 10.1097/00004714-200108000-00010; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kasper S, 2005, AM J GERIAT PSYCHIAT, V13, P884, DOI 10.1176/appi.ajgp.13.10.884; Kennedy SH, 2000, J CLIN PSYCHIAT, V61, P276, DOI 10.4088/JCP.v61n0406; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Kiev A, 1997, J CLIN PSYCHIAT, V58, P146, DOI 10.4088/JCP.v58n0402; Kocsis JH, 1997, AM J PSYCHIAT, V154, P390; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Lader M, 2005, HUM PSYCHOPHARM CLIN, V20, P349, DOI 10.1002/hup.694; Leinonen E, 1999, INT CLIN PSYCHOPHARM, V14, P329, DOI 10.1097/00004850-199911000-00002; Lepola UM, 2003, INT CLIN PSYCHOPHARM, V18, P211, DOI 10.1097/00004850-200307000-00003; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; MCPARTLIN GM, 1998, PRIMARY CARE PSYCHIA, V4, P127, DOI DOI 10.1016/J.BIOPSYCH.2007.04.040; Moore N, 2005, INT CLIN PSYCHOPHARM, V20, P131, DOI 10.1097/00004850-200505000-00002; Nemeroff CB, 2007, J PSYCHIATR RES, V41, P351, DOI 10.1016/j.jpsychires.2005.07.009; Newhouse Paul A., 2000, Journal of Clinical Psychiatry, V61, P559; Oslin DW, 2003, J CLIN PSYCHIAT, V64, P875, DOI 10.4088/JCP.v64n0804; Perahia DGS, 2006, EUR PSYCHIAT, V21, P367, DOI 10.1016/j.eurpsy.2006.03.004; Poirier MF, 1999, BRIT J PSYCHIAT, V175, P12, DOI 10.1192/bjp.175.1.12; Rapaport MH, 2003, J CLIN PSYCHIAT, V64, P1065, DOI 10.4088/JCP.v64n0912; Ravindran AV, 2000, J CLIN PSYCHIAT, V61, P821, DOI 10.4088/JCP.v61n1103; Rocca P, 2005, J CLIN PSYCHIAT, V66, P360, DOI 10.4088/JCP.v66n0313; Roose SP, 2004, AM J PSYCHIAT, V161, P2050, DOI 10.1176/appi.ajp.161.11.2050; Rossini D, 2005, J CLIN PSYCHOPHARM, V25, P471, DOI 10.1097/01.jcp.0000177548.28961.e7; Rush AJ, 1998, BIOL PSYCHIAT, V44, P3, DOI 10.1016/S0006-3223(98)00092-4; Rush AJ, 2001, J AFFECT DISORDERS, V64, P81, DOI 10.1016/S0165-0327(00)00250-0; Rush AJ, 2001, NEUROPSYCHOPHARMACOL, V25, P131, DOI 10.1016/S0893-133X(00)00249-9; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; Schneider LS, 2003, AM J PSYCHIAT, V160, P1277, DOI 10.1176/appi.ajp.160.7.1277; SCHONE W, 1993, J CLIN PSYCHOPHARM, V13, pS34; Sechter D, 1999, EUR PSYCHIAT, V14, P41, DOI 10.1016/S0924-9338(99)80714-7; Segraves RT, 2000, J CLIN PSYCHOPHARM, V20, P122, DOI 10.1097/00004714-200004000-00002; Sheikh JI, 2004, J AM GERIATR SOC, V52, P86, DOI 10.1111/j.1532-5415.2004.52015.x; Sir A, 2005, J CLIN PSYCHIAT, V66, P1312, DOI 10.4088/JCP.v66n1015; Small GW, 1996, J AM GERIATR SOC, V44, P1220, DOI 10.1111/j.1532-5415.1996.tb01373.x; Szegedi A, 2003, J CLIN PSYCHIAT, V64, P413, DOI 10.4088/JCP.v64n0410; Thase ME, 2005, J WOMENS HEALTH, V14, P609, DOI 10.1089/jwh.2005.14.609; Thase ME, 2005, J CLIN PSYCHOPHARM, V25, P132, DOI 10.1097/01.jcp.0000155815.44338.95; Thase ME, 1996, ARCH GEN PSYCHIAT, V53, P777; Tollefson G D, 1995, Int Psychogeriatr, V7, P89, DOI 10.1017/S1041610295001888; TOLLEFSON GD, 1993, INT CLIN PSYCHOPHARM, V8, P253, DOI 10.1097/00004850-199300840-00008; Trivedi MH, 2001, J CLIN PSYCHIAT, V62, P776, DOI 10.4088/JCP.v62n1005; Tzanakaki M, 2000, INT CLIN PSYCHOPHARM, V15, P29, DOI 10.1097/00004850-200015010-00004; *US FDA, 2007, ANT MED DEPR OTH SER; Vanelle JM, 1997, BRIT J PSYCHIAT, V170, P345, DOI 10.1192/bjp.170.4.345; VANMOFFAERT M, 1995, HUM PSYCHOPHARM CLIN, V10, P393, DOI 10.1002/hup.470100505; Versiani M, 2005, CNS DRUGS, V19, P137, DOI 10.2165/00023210-200519020-00004; Wagner GJ, 1998, PSYCHIAT SERV, V49, P239, DOI 10.1176/ps.49.2.239; Weihs KL, 2000, J CLIN PSYCHIAT, V61, P196, DOI 10.4088/JCP.v61n0309; Wheatley DP, 1998, J CLIN PSYCHIAT, V59, P306, DOI 10.4088/JCP.v59n0606; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519; 2004, CLIN STUDY SUMMARY S	100	116	121	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2008	149	10					725	U10		10.7326/0003-4819-149-10-200811180-00007	http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	373FL	19017591				2022-12-28	WOS:000260956300005
J	Press, D; Ladd, TD; Zhang, BY; Yamamoto, Y				Press, David; Ladd, Thaddeus D.; Zhang, Bingyang; Yamamoto, Yoshihisa			Complete quantum control of a single quantum dot spin using ultrafast optical pulses	NATURE			English	Article							ELECTRON-SPIN; MANIPULATION	A basic requirement for quantum information processing systems is the ability to completely control the state of a single qubit(1-6). For qubits based on electron spin, a universal single- qubit gate is realized by a rotation of the spin by any angle about an arbitrary axis. Driven, coherent Rabi oscillations between two spin states can be used to demonstrate control of the rotation angle. Ramsey interference, produced by two coherent spin rotations separated by a variable time delay, demonstrates control over the axis of rotation. Full quantum control of an electron spin in a quantum dot has previously been demonstrated using resonant radio- frequency pulses that require many spin precession periods(7-10). However, optical manipulation of the spin allows quantum control on a picosecond or femtosecond timescale(11-18), permitting an arbitrary rotation to be completed within one spin precession period(6). Recent work in optical single-spin control has demonstrated the initialization of a spin state in a quantumdot(19-22), as well as the ultrafast manipulation of coherence in a largely unpolarized single- spin state(17). Here we demonstrate complete coherent control over an initialized electron spin state in a quantum dot using picosecond optical pulses. First we vary the intensity of a single optical pulse to observe over six Rabi oscillations between the two spin states; then we apply two sequential pulses to observe high- contrast Ramsey interference. Such a two- pulse sequence realizes an arbitrary single- qubit gate completed on a picosecond timescale. Along with the spin initialization and final projective measurement of the spin state, these results demonstrate a complete set of all- optical single- qubit operations.	[Press, David; Ladd, Thaddeus D.; Zhang, Bingyang; Yamamoto, Yoshihisa] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Ladd, Thaddeus D.; Yamamoto, Yoshihisa] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018403, Japan	Stanford University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Press, D (corresponding author), Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA.	dlpress@stanford.edu	Yamamoto, Yoshihisa/A-2811-2012; Ladd, Thaddeus D/A-1136-2007; Ladd, Thaddeus D/C-5822-2009	Yamamoto, Yoshihisa/0000-0002-4150-6804; 	JST/SORST; NICT; MEXT; MURI [(ARMY, DAAD 19-03-1-0199)]; Special Coordination Funds for Promoting Science and Technology; Grants-in-Aid for Scientific Research [18001002] Funding Source: KAKEN	JST/SORST(Japan Science & Technology Agency (JST)); NICT; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MURI(MURI); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST/SORST, NICT, MEXT, MURI (ARMY, DAAD 19-03-1-0199) and Special Coordination Funds for Promoting Science and Technology. We thank S. Koseki, S. Gotzinger, C. Santori and Q. Zhang for their assistance.	Atature M, 2007, NAT PHYS, V3, P101, DOI 10.1038/nphys521; Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195315; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Berezovsky J, 2006, SCIENCE, V314, P1916, DOI 10.1126/science.1133862; Carter SG, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.201308; Chen PC, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075320; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Clark SM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.040501; Combescot M, 2004, SOLID STATE COMMUN, V132, P129, DOI 10.1016/j.ssc.2004.06.025; Dutt MVG, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125306; Economou SE, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.205415; Fu KMC, 2008, NAT PHYS, V4, P780, DOI 10.1038/nphys1052; Gerardot BD, 2008, NATURE, V451, P441, DOI 10.1038/nature06472; Greilich A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.233301; Greilich A, 2006, SCIENCE, V313, P341, DOI 10.1126/science.1128215; Gupta JA, 2001, SCIENCE, V292, P2458, DOI 10.1126/science.1061169; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Koppens FHL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236802; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Krizhanovskii DN, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161312; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pryor CE, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206679; Ramsay AJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.197401; Shabaev A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.201305; Tokura Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047202; Wu Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097402; Xu XD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097401	29	685	692	4	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					218	221		10.1038/nature07530	http://dx.doi.org/10.1038/nature07530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005550				2022-12-28	WOS:000261039300035
J	Boseley, S				Boseley, Sarah			Profile Michael Marmot: leader in the social determinants of health	LANCET			English	Biographical-Item												sarah.boseley@guardian.co.uk	Marmot, Michael/Y-3920-2019	Marmot, Michael/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G8802774, G0100222, G19/35, G0601647] Funding Source: Medline; MRC [G0601647] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1625	1625		10.1016/S0140-6736(08)61675-X	http://dx.doi.org/10.1016/S0140-6736(08)61675-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18994652				2022-12-28	WOS:000260899900013
J	Kane, P				Kane, Penny			Sure Start Local Programmes in England	LANCET			English	Editorial Material												pskane@braidwood.net.au						Belsky J, 2006, BMJ-BRIT MED J, V332, P1476, DOI 10.1136/bmj.38853.451748.2F; *DEP ED SKILLS DEP, CHOIC PAR BEST START; HANSEN K, 2006, MILLENNIUM COHORT ST; Melhuish E., 2007, NATL EVALUATION SURE, P3; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6	5	4	4	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1610	1612		10.1016/S0140-6736(08)61667-0	http://dx.doi.org/10.1016/S0140-6736(08)61667-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994648				2022-12-28	WOS:000260899900005
J	Sathasivam, S; Lecky, B				Sathasivam, Sivakumar; Lecky, Bryan			Statin induced myopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SKELETAL-MUSCLE; SAFETY; SIMVASTATIN; THERAPY; RISK		[Sathasivam, Sivakumar; Lecky, Bryan] Walton Ctr Neurol & Neurosurg, Dept Neurol, Liverpool L9 7LJ, Merseyside, England	Walton Centre	Sathasivam, S (corresponding author), Walton Ctr Neurol & Neurosurg, Dept Neurol, Liverpool L9 7LJ, Merseyside, England.	sivakumar.sathasivam@thewaltoncentre.nhs.uk						Baker SK, 2005, MUSCLE NERVE, V31, P572, DOI 10.1002/mus.20291; Baker SK, 2008, CAN J NEUROL SCI, V35, P8, DOI 10.1017/S0317167100007514; Bays H, 2006, AM J CARDIOL, V97, p6C, DOI 10.1016/j.amjcard.2005.12.006; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Davidson MH, 2007, J AM COLL CARDIOL, V49, P1753, DOI 10.1016/j.jacc.2007.01.067; Dirks AJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1208, DOI 10.1152/ajpcell.00226.2006; Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018; Gaist D, 2001, EPIDEMIOLOGY, V12, P565, DOI 10.1097/00001648-200109000-00017; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773; Kelly P, 2005, J AM COLL CARDIOL, V45, p3A; Keogh A, 2000, J HEART LUNG TRANSPL, V19, P529, DOI 10.1016/S1053-2498(00)00077-2; LAAKSONEN R, 1995, CLIN PHARMACOL THER, V57, P62, DOI 10.1016/0009-9236(95)90266-X; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; MELTZER HY, 1974, CLIN CHIM ACTA, V54, P215, DOI 10.1016/0009-8981(74)90239-3; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Pasternak RC, 2002, STROKE, V33, P2337, DOI 10.1161/01.str.0000034125.94759.41; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Radcliffe KA, 2008, CURR NEUROL NEUROSCI, V8, P66, DOI 10.1007/s11910-008-0011-4; Rosenson RS, 2004, AM J MED, V116, P408, DOI 10.1016/j.amjmed.2003.10.033; Rowland L. P., 1980, MUSCULAR DYSTROPHY R, P3; SCOTT RS, 1991, NEW ZEAL MED J, V104, P493; Thompson PD, 2006, AM J CARDIOL, V97, p69C, DOI 10.1016/j.amjcard.2005.12.013; Thompson PD, 1997, METABOLISM, V46, P1206, DOI 10.1016/S0026-0495(97)90218-3; Tsivgoulis G, 2006, ARCH INTERN MED, V166, P1519, DOI 10.1001/archinte.166.14.1519; Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567; Westwood FR, 2005, TOXICOL PATHOL, V33, P246, DOI 10.1080/01926230590908213; [No title captured]	29	94	100	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2008	337								a2286	10.1136/bmj.a2286	http://dx.doi.org/10.1136/bmj.a2286			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FC	18988647				2022-12-28	WOS:000261236100002
J	Boylan, S; Cade, JE; Dolby, VA; Greenwood, DC; Hay, AWM; Kirk, SFL; Shires, S; Simpson, N; Thomas, JD; Walker, J; White, KLM; Wild, CP; Potdar, N; Konje, JC; Taub, N; Charvill, J; Chipps, KC; Kassam, S; Ghandi, C; Cooke, MS				Boylan, Sinead; Cade, Janet E.; Dolby, Vivien A.; Greenwood, Darren C.; Hay, Alastair W. M.; Kirk, Sara F. L.; Shires, Susan; Simpson, Nigel; Thomas, James D.; Walker, James; White, Kay L. M.; Wild, Christopher P.; Potdar, Neelam; Konje, Justin C.; Taub, Nicholas; Charvill, Jim; Chipps, Karen C.; Kassam, Shabira; Ghandi, Chetan; Cooke, Marcus S.		CARE Study Grp	Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; COFFEE CONSUMPTION; SERUM CAFFEINE; ASSOCIATION; CYP1A2; BLOOD; PARAXANTHINE; METABOLITES; EXPOSURE	Objective To examine the association of maternal caffeine intake with fetal growth restriction. Design Prospective longitudinal observational study. Setting Two large UK hospital maternity units. Participants 2635 low risk pregnant women recruited between 8-12 weeks of pregnancy. Investigations Quantification of total caffeine intake from 4 weeks before conception and throughout pregnancy was undertaken with a validated caffeine assessment tool. Caffeine half life ( proxy for clearance) was determined by measuring caffeine in saliva after a caffeine challenge. Smoking and alcohol were assessed by self reported status and by measuring salivary cotinine concentrations. Main outcome measures Fetal growth restriction, as defined by customised birth weight centile, adjusted for alcohol intake and salivary cotinine concentrations. Results Caffeine consumption throughout pregnancy was associated with an increased risk of fetal growth restriction (odds ratios 1.2 ( 95% CI 0.9 to 1.6) for 100- 199 mg/ day, 1.5 ( 1.1 to 2.1) for 200- 299 mg/ day, and 1.4 ( 1.0 to 2.0) for > 300mg/ day compared with < 100mg/ day; test for trend P< 0.001). Mean caffeine consumption decreased in the first trimester and increased in the third. The association between caffeine and fetal growth restriction was stronger in women with a faster compared to a slower caffeine clearance ( test for interaction, P= 0.06). Conclusions Caffeine consumption during pregnancy was associated with an increased risk of fetal growth restriction and this association continued throughout pregnancy. Sensible advice would be to reduce caffeine intake before conception and throughout pregnancy.	[Potdar, Neelam; Konje, Justin C.; Taub, Nicholas; Chipps, Karen C.; Kassam, Shabira; Ghandi, Chetan; Cooke, Marcus S.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE2 7LX, Leics, England; [Potdar, Neelam; Konje, Justin C.; Taub, Nicholas; Charvill, Jim; Chipps, Karen C.; Kassam, Shabira; Ghandi, Chetan; Cooke, Marcus S.] Univ Leicester, Dept Hlth Sci, Leicester LE2 7LX, Leics, England; [Boylan, Sinead; Cade, Janet E.; Dolby, Vivien A.; Greenwood, Darren C.; Hay, Alastair W. M.; Kirk, Sara F. L.; Shires, Susan; Simpson, Nigel; Thomas, James D.; Walker, James; White, Kay L. M.; Wild, Christopher P.] Univ Leeds, Ctr Biostat & Epidemiol, Leeds LS2 9JT, W Yorkshire, England	University of Leicester; University of Leicester; University of Leeds	Konje, JC (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE2 7LX, Leics, England.	j.e.cade@leeds.ac.uk; jck4@le.ac.uk	Cade, Janet E/G-4250-2016; Cooke, Marcus/ABI-1501-2020; Wild, Christopher/ABC-6260-2020; Cooke, Marcus S/D-4517-2013; Greenwood, Darren C/C-3220-2008	Cade, Janet E/0000-0003-3421-0121; Cooke, Marcus/0000-0003-0369-862X; Wild, Christopher/0000-0003-0249-8669; Greenwood, Darren C/0000-0001-7035-3096; Boylan, Sinead/0000-0002-3491-5845	Food Standards Agency, United Kingdom [T01032/33]	Food Standards Agency, United Kingdom	Food Standards Agency, United Kingdom, Grant contract No T01032/33.	ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447; BEAULACBAILLARGEON L, 1987, AM J OBSTET GYNECOL, V157, P1236, DOI 10.1016/S0002-9378(87)80301-0; Bech BH, 2007, BMJ-BRIT MED J, V334, P409, DOI 10.1136/bmj.39062.520648.BE; Bicalho GG, 2002, REV SAUDE PUBL, V36, P180, DOI 10.1590/S0034-89102002000200010; Binnie V, 2004, ORAL DIS, V10, P287, DOI 10.1111/j.1601-0825.2004.01018.x; Boylan SM, 2008, BRIT J NUTR, V100, P875, DOI 10.1017/S0007114508939842; Bracken MB, 2002, EPIDEMIOLOGY, V13, P165, DOI 10.1097/00001648-200203000-00011; BRACKEN MB, 2002, AM J EPIDEMIOL, V155, P429; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429; *COMM TOX CHEM FOO, 2001, COT STAT REPR EFF CA; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; *DIR MFS, 1998, FOOD SURVEILLANCE IN, P144; Eskenazi B, 1999, EPIDEMIOLOGY, V10, P242, DOI 10.1097/00001648-199905000-00009; FENSTER L, 1991, AM J PUBLIC HEALTH, V81, P458, DOI 10.2105/AJPH.81.4.458; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; Gardosi J, 2004, SEMIN PERINATOL, V28, P33, DOI 10.1053/j.semperi.2003.12.002; GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5; Grosso LM, 2006, AM J EPIDEMIOL, V163, P1035, DOI 10.1093/aje/kwj125; Grosso LM, 2001, EPIDEMIOLOGY, V12, P447, DOI 10.1097/00001648-200107000-00015; KALOW W, 1991, CLIN PHARMACOL THER, V50, P508, DOI 10.1038/clpt.1991.176; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; Klebanoff MA, 1999, NEW ENGL J MED, V341, P1639, DOI 10.1056/NEJM199911253412202; Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32; Klebanoff MA, 1998, ANN EPIDEMIOL, V8, P107, DOI 10.1016/S1047-2797(97)00125-7; KOTAKE AN, 1982, CLIN PHARMACOL THER, V32, P261, DOI 10.1038/clpt.1982.157; LINN S, 1982, NEW ENGL J MED, V306, P141, DOI 10.1056/NEJM198201213060304; MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718; Mau G, 1974, Geburtshilfe Frauenheilkd, V34, P1018; *ORG TER INF SPEC, 2006, CAFF PREGN; PEACOCK JL, 1991, J EPIDEMIOL COMMUN H, V45, P159, DOI 10.1136/jech.45.2.159; Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008; ROSENBERG L, 1982, JAMA-J AM MED ASSOC, V247, P1429, DOI 10.1001/jama.247.10.1429; Santos IS, 1998, AM J EPIDEMIOL, V147, P620, DOI 10.1093/oxfordjournals.aje.a009502; SRISUPHAN W, 1986, AM J OBSTET GYNECOL, V154, P14, DOI 10.1016/0002-9378(86)90385-6; *STAT CORP, 2007, STAT STAT SOFTW REL; Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x; Vlajinac HD, 1997, AM J EPIDEMIOL, V145, P335, DOI 10.1093/oxfordjournals.aje.a009110; WEATHERSBEE PS, 1977, POSTGRAD MED, V62, P64, DOI 10.1080/00325481.1977.11714605; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803	41	138	144	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2008	337								a2332	10.1136/bmj.a2332	http://dx.doi.org/10.1136/bmj.a2332			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377EZ	18981029	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000261235800002
J	Bacaj, T; Tevlin, M; Lu, Y; Shaham, S				Bacaj, Taulant; Tevlin, Maya; Lu, Yun; Shaham, Shai			Glia Are Essential for Sensory Organ Function in C-elegans	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NEURONS; CILIA; THERMOTAXIS; CHEMOTAXIS; ASTROCYTES; RESPONSES; ENCODES; PROTEIN; CELLS		[Bacaj, Taulant; Tevlin, Maya; Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu			NINDS NIH HHS [R01 NS064273, R01 NS064273-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064273] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547	24	133	140	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					744	747		10.1126/science.1163074	http://dx.doi.org/10.1126/science.1163074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974354	Green Accepted			2022-12-28	WOS:000260605200050
J	Cella, M; Fuchs, A; Vermi, W; Facchetti, F; Otero, K; Lennerz, JKM; Doherty, JM; Mills, JC; Colonna, M				Cella, Marina; Fuchs, Anja; Vermi, William; Facchetti, Fabio; Otero, Karel; Lennerz, Jochen K. M.; Doherty, Jason M.; Mills, Jason C.; Colonna, Marco			A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity	NATURE			English	Article							GROWTH-FACTOR-BETA; ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; EPITHELIAL-CELLS; HOST-DEFENSE; TGF-BETA; DIFFERENTIATION; INTERLEUKIN-22; INFLAMMATION; CYTOKINES	Natural killer ( NK) cells are classically viewed as lymphocytes that provide innate surveillance against virally infected cells and tumour cells through the release of cytolytic mediators and interferon ( IFN)-gamma. In humans, blood CD56(dim) NKcells specialize in the lysis of cell targets(1). In the lymph nodes, CD56(bright) NK cells secrete IFN-gamma cooperating with dendritic cells and T cells in the generation of adaptive responses(1,2). Here we report the characterization of a human NK cell subset located in mucosa- associated lymphoid tissues, such as tonsils and Peyer's patches, which is hard- wired to secrete interleukin (IL)- 22, IL- 26 and leukaemia inhibitory factor. TheseNKcells, whichwe refer to as NK- 22 cells, are triggered by acute exposure to IL- 23. In vitro, NK- 22- secreted cytokines stimulate epithelial cells to secrete IL- 10, proliferate and express a variety of mitogenic and anti- apoptotic molecules. NK- 22 cells are also found in mouse mucosa- associated lymphoid tissues and appear in the small intestine lamina propria during bacterial infection, suggesting that NK- 22 cells provide an innate source of IL- 22 that may help constrain inflammation and protect mucosal sites.	[Cella, Marina; Fuchs, Anja; Otero, Karel; Lennerz, Jochen K. M.; Doherty, Jason M.; Mills, Jason C.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Vermi, William; Facchetti, Fabio] Univ Brescia, Dept Pathol 1, Spedali Civili, I-25123 Brescia, Italy	Washington University (WUSTL); University of Brescia	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/ABA-8564-2020; Facchetti, Fabio/E-7190-2010; Mills, Jason/AAA-6688-2021; Cella, Marina/G-8850-2011	Facchetti, Fabio/0000-0003-4975-2388; Mills, Jason/0000-0002-0402-4662; Colonna, Marco/0000-0001-5222-4987; VERMI, WILLIAM/0000-0002-2291-2997; Cella, Marina/0000-0003-1230-1313	National Institutes of Health [R01AI056139-05, R21AI067748-02]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK079798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056139, R21AI067748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Hughes, B. Eades and S. Schloehmann for cell sorting; R. Clary and the nursing staff at the Children's Hospital, Washington University School of Medicine, for providing tonsil specimens; S. Lonardi for assistance in immunohistochemistry; J. Pfeifer for providing gut specimens; A. Rapaport and S. McCartney for help in gene chip analysis; and S. Gilfillan for critically reading the manuscript. This work was supported by National Institutes of Health (NIH) grants R01AI056139-05 and R21AI067748-02 (to M.Co.) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK079798 (to J.C.M.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH and NIDDK.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Candiago E, 2000, AM J DERMATOPATH, V22, P1, DOI 10.1097/00000372-200002000-00001; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Kusam S, 2007, IMMUNOL RES, V37, P177, DOI 10.1007/BF02697368; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Strowig T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040027; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	30	960	997	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					722	725		10.1038/nature07537	http://dx.doi.org/10.1038/nature07537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	18978771	Green Accepted			2022-12-28	WOS:000263064700041
J	Keller, GB; Hahnloser, RHR				Keller, Georg B.; Hahnloser, Richard H. R.			Neural processing of auditory feedback during vocal practice in a songbird	NATURE			English	Article							MALE ZEBRA FINCHES; ADULT BIRDSONG; SYSTEM; TELENCEPHALON; PERTURBATION; CONNECTIONS; BEHAVIOR; NEURONS; CORTEX; MODEL	Songbirds are capable of vocal learning and communication(1,2) and are ideally suited to the study of neural mechanisms of complex sensory and motor processing. Vocal communication in a noisy bird colony and vocal learning of a specific song template both require the ability to monitor auditory feedback(3,4) to distinguish self-generated vocalizations from external sounds and to identify mismatches between the developing song and a memorized template acquired from a tutor(5). However, neurons that respond to auditory feedback from vocal output have not been found in song-control areas despite intensive searching(6-8). Here we investigate feedback processing outside the traditional song system, in single auditory forebrain neurons of juvenile zebra finches that were in a late developmental stage of song learning. Overall, we found similarity of spike responses during singing and during playback of the bird's own song, with song responses commonly leading by a few milliseconds. However, brief time- locked acoustic perturbations of auditory feedback revealed complex sensitivity that could not be predicted from passive playback responses. Some neurons that responded to playback perturbations did not respond to song perturbations, which is reminiscent of sensory- motor mirror neurons(8,9). By contrast, some neurons were highly feedback sensitive in that they responded vigorously to song perturbations, but not to unperturbed songs or perturbed playback. These findings suggest that a computational function of forebrain auditory areas may be to detect errors between actual feedback and mirrored feedback deriving from an internal model of the bird's own song or that of its tutor. Such feedback- sensitive spikes could constitute the key signals that trigger adaptive motor responses to song disruptions(10,11) or reinforce exploratory motor gestures for vocal learning(12).	[Keller, Georg B.; Hahnloser, Richard H. R.] Univ Zurich, ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Hahnloser, RHR (corresponding author), Univ Zurich, ETH, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	rich@ini.phys.ethz.ch		Keller, Georg/0000-0002-1401-0117; Hahnloser, Richard/0000-0002-4039-7773	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a Swiss National Science Foundation Professorship Grant to R. H. R. H. We thank K. Martin, R. Mooney and R. Douglas for comments on the manuscript.	Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Foster EF, 1998, J COMP NEUROL, V397, P118; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Immelmann K., 1969, P61; Janata P, 1999, J NEUROSCI, V19, P5108; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KARTEN H J, 1968, Brain Research, V11, P134, DOI 10.1016/0006-8993(68)90078-4; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; THORPE WH, 1975, ACTA NEUROBIOL EXP, V35, P517; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Zeng SJ, 2004, J COMP NEUROL, V470, P192, DOI 10.1002/cne.11042	30	138	139	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					187	U78		10.1038/nature07467	http://dx.doi.org/10.1038/nature07467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19005471				2022-12-28	WOS:000262360200031
J	Bangalore, S; Wetterslev, J; Pranesh, S; Sawhney, S; Gluud, C; Messerli, FH				Bangalore, Sripal; Wetterslev, Jorn; Pranesh, Shruthi; Sawhney, Sabrina; Gluud, Christian; Messerli, Franz H.			Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis	LANCET			English	Article							HIGH-RISK PATIENTS; TRIAL SEQUENTIAL-ANALYSIS; HEART-RATE CONTROL; MYOCARDIAL-ISCHEMIA; CARDIOVASCULAR EVALUATION; PREOPERATIVE METOPROLOL; HYPERTENSIVE PATIENTS; TRACHEAL INTUBATION; CARDIAC EVENTS; BLOOD-PRESSURE	Background American College of Cardiology and American Heart Association (ACC/AHA) guidelines on perioperative assessment recommend perioperative beta blockers for non-cardiac surgery, although results of some clinical trials seem not to support this recommendation. We aimed to critically review the evidence to assess the use of perioperative beta blockers in patients having non-cardiac surgery. Methods We searched Pubmed and Embase for randomised controlled trials investigating the use of beta blockers in non-cardiac surgery. We extracted data for 30-day all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, heart failure, and myocardial ischaemia, safety outcomes of perioperative bradycardia, hypotension, and bronchospasm. Findings 33 trials included 12306 patients. beta blockers were not associated with any significant reduction in the risk of all-cause mortality, cardiovascular mortality, or heart failure, but were associated with a decrease (odds ratio [OR] 0.65, 95% CI 0.54-0.79) in non-fatal myocardial infarction (number needed to treat [NNT] 63) and decrease (OR 0.36, 0.26-0.50) in myocardial ischaemia (NNT 16) at the expense of an increase (OR 2.01, 1.27-3.68) in non-fatal strokes (number needed to harm [NNH] 293). The beneficial effects were driven mainly by trials with high risk of bias. For the safety outcomes, beta blockers were associated with a high risk of perioperative bradycardia requiring treatment (NNH 22), and perioperative hypotension requiring treatment (NNH 17). We recorded no increased risk of bronchospasm. Interpretation Evidence does not support the use of beta-blocker therapy for the prevention of perioperative clinical outcomes in patients having non-cardiac surgery. The ACC/AHA guidelines committee should soften their advocacy for this intervention until conclusive evidence is available. Funding None.	[Pranesh, Shruthi; Sawhney, Sabrina; Messerli, Franz H.] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Cardiol, Coll Phys & Surg,Dept Med, New York, NY 10019 USA; [Bangalore, Sripal] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Wetterslev, Jorn; Gluud, Christian] Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Rigshosp, Copenhagen, Denmark	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Harvard University; Brigham & Women's Hospital; Rigshospitalet; University of Copenhagen	Messerli, FH (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Cardiol, Coll Phys & Surg,Dept Med, New York, NY 10019 USA.	fmesserl@chpnet.org	Wetterslev, Jørn/ABF-1251-2020; Messerli, Franz/AAR-4783-2021; Bangalore, Sripal/B-6246-2013; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022	Wetterslev, Jørn/0000-0001-7778-1771; Gluud, Christian/0000-0002-8861-0799; Bangalore, Sripal/0000-0001-9485-0652				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1435, DOI 10.1001/jama.287.11.1435; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; Bayliff CD, 1999, ANN THORAC SURG, V67, P182, DOI 10.1016/S0003-4975(98)01226-0; Beattie WS, 2008, ANESTH ANALG, V106, P1039, DOI 10.1213/ane.0b013e318163f6a9; Bohm M, 2003, Z KARDIOL, V92, P668, DOI 10.1007/s00392-003-0959-7; Bradburn M, 1998, STATA TECH B REPRINT, V8, P86; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; BURNS JMA, 1988, BRIT J ANAESTH, V61, P345, DOI 10.1093/bja/61.3.345; COLEMAN AJ, 1980, ANAESTHESIA, V35, P972, DOI 10.1111/j.1365-2044.1980.tb04995.x; Cruickshank JM, 2000, EUR HEART J, V21, P354, DOI 10.1053/euhj.1999.1717; CUCCHIARA RF, 1986, ANESTHESIOLOGY, V65, P528, DOI 10.1097/00000542-198611000-00016; DAVIES MJ, 1992, ANAESTH INTENS CARE, V20, P161, DOI 10.1177/0310057X9202000207; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Fleisher LA, 2006, CIRCULATION, V113, P2662, DOI 10.1161/CIRCULATIONAHA.106.176009; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; GIBSON BE, 1988, CLIN PHARMACOL THER, V44, P650, DOI 10.1038/clpt.1988.207; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Inada E, 1989, J Clin Anesth, V1, P207, DOI 10.1016/0952-8180(89)90043-3; Jakobsen CJ, 1997, J CARDIOTHOR VASC AN, V11, P746, DOI 10.1016/S1053-0770(97)90169-5; JAKOBSEN CJ, 1992, EUR J ANAESTH, V9, P209; Jakobsen CJ, 1997, ACTA ANAESTH SCAND, V41, P1324, DOI 10.1111/j.1399-6576.1997.tb04652.x; JAKOBSEN CJ, 1990, ANAESTHESIA, V45, P40, DOI 10.1111/j.1365-2044.1990.tb14502.x; JAKOBSEN CJ, 1986, BRIT J ANAESTH, V58, P261, DOI 10.1093/bja/58.3.261; Juul AB, 2006, BMJ-BRIT MED J, V332, P1482, DOI 10.1136/bmj.332.7556.1482; Lai Ren-Chun, 2006, Ai Zheng, V25, P609; Leslie J B, 1989, J Clin Anesth, V1, P194, DOI 10.1016/0952-8180(89)90041-X; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; LIU PL, 1986, CAN ANAESTH SOC J, V33, P556, DOI 10.1007/BF03014260; Liu Yao, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P249; MACKENZIE JW, 1989, BRIT MED J, V298, P363, DOI 10.1136/bmj.298.6670.363; MAGNUSSON H, 1986, BRIT J ANAESTH, V58, P976, DOI 10.1093/bja/58.9.976; MAGNUSSON J, 1986, BRIT J ANAESTH, V58, P251, DOI 10.1093/bja/58.3.251; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; McFalls EO, 1998, CHEST, V113, P681, DOI 10.1378/chest.113.3.681; McGory ML, 2005, SURGERY, V138, P171, DOI 10.1016/j.surg.2005.03.022; MILLER DR, 1991, CAN J ANAESTH, V38, P849, DOI 10.1007/BF03036959; Miller DR, 1990, J CARDIOTHORAIC A S2, V4, P31; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Neary WD, 2006, SURG-J R COLL SURG E, V4, P139, DOI 10.1016/S1479-666X(06)80083-1; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Powell JT, 2005, J VASC SURG, V41, P602, DOI 10.1016/j.jvs.2005.01.048; Raby KE, 1999, ANESTH ANALG, V88, P477, DOI 10.1097/00000539-199903000-00002; Rosenberg J, 1996, BRIT MED J, V313, P258, DOI 10.1136/bmj.313.7052.258; Schouten O, 2006, CORONARY ARTERY DIS, V17, P173, DOI 10.1097/00019501-200603000-00012; Stanley WC, 1997, CARDIOVASC RES, V33, P243, DOI 10.1016/S0008-6363(96)00245-3; Stevens RD, 2003, ANESTH ANALG, V97, P623, DOI 10.1213/01.ANE.0000074795.68061.16; STONE JG, 1988, ANESTHESIOLOGY, V68, P495, DOI 10.1097/00000542-198804000-00004; STONE JG, 1988, BRIT J ANAESTH, V61, P675, DOI 10.1093/bja/61.6.675; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Urban MK, 2000, ANESTH ANALG, V90, P1257, DOI 10.1097/00000539-200006000-00001; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wiesbauer F, 2007, ANESTH ANALG, V104, P27, DOI 10.1213/01.ane.0000247805.00342.21; Yang H, 2006, AM HEART J, V152, P983, DOI 10.1016/j.ahj.2006.07.024; Yeager MP, 2005, J CARDIOTHOR VASC AN, V19, P237, DOI 10.1053/j.jvca.2004.09.006; Zaugg M, 1999, ANESTHESIOLOGY, V91, P1674, DOI 10.1097/00000542-199912000-00020; Zaugg M, 2007, ANESTHESIOLOGY, V107, P33, DOI 10.1097/01.anes.0000267530.62344.a4	64	260	271	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1962	1976		10.1016/S0140-6736(08)61560-3	http://dx.doi.org/10.1016/S0140-6736(08)61560-3			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19012955				2022-12-28	WOS:000261471600023
J	Drummond, MB; Dasenbrook, EC; Pitz, MW; Murphy, DJ; Fan, E				Drummond, M. Bradley; Dasenbrook, Elliott C.; Pitz, Marshall W.; Murphy, David J.; Fan, Eddy			Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FLUTICASONE PROPIONATE; SALMETEROL/FLUTICASONE PROPIONATE; LUNG-FUNCTION; COPD; SALMETEROL; RISK; BUDESONIDE; EFFICACY; MODERATE; TRIALS	Context Recent studies of inhaled corticosteroid ( ICS) therapy for managing stable chronic obstructive pulmonary disease ( COPD) have yielded conflicting results regarding survival and risk of adverse events. Objective To systematically review and quantitatively synthesize the effects of ICS therapy on mortality and adverse events in patients with stable COPD. Data Sources Search of MEDLINE, CENTRAL, EMBASE, CINAHL, Web of Science, and PsychInfo through February 9, 2008. Study Selection Eligible studies were double- blind, randomized controlled trials comparing ICS therapy for 6 or more months with nonsteroid inhaled therapy in patients with COPD. Data Extraction Two authors independently abstracted data including study characteristics, all- cause mortality, pneumonia, and bone fractures. The (2) statistic was used to assess heterogeneity. Study- level data were pooled using a random- effects model ( when I-2 >= 50%) or a fixed- effects model (when I-2 < 50%). For the primary outcome of all- cause mortality at 1 year, our meta- analysis was powered to detect a 1.0% absolute difference in mortality, assuming a 2- sided alpha of .05 and power of 0.80. Results Eleven eligible randomized controlled trials ( 14 426 participants) were included. In trials with mortality data, no difference was observed in 1- year all- cause mortality ( 128 deaths among 4636 patients in the treatment group and 148 deaths among 4597 patients in the control group; relative risk [ RR], 0.86; 95% confidence interval [ CI], 0.68- 1.09; P=. 20; I-2= 0%). In the trials with data on pneumonia, ICS therapy was associated with a significantly higher incidence of pneumonia ( 777 cases among 5405 patients in the treatment group and 561 cases among 5371 patients in the control group; RR, 1.34; 95% CI, 1.03- 1.75; P=. 03; I-2= 72%). Subgroup analyses indicated an increased risk of pneumonia in the following subgroups: highest ICS dose ( RR, 1.46; 95% CI, 1.10- 1.92; P=. 008; I-2 = 78%), shorter duration of ICS use ( RR, 2.12; 95% CI, 1.47-3.05; P <. 001; I-2= 0%), lowest baseline forced expiratory volume in the first second of expiration ( RR, 1.90; 95% CI, 1.26- 2.85; P=. 002; I-2= 0%), and combined ICS and bronchodilator therapy ( RR, 1.57; 95% CI, 1.35- 1.82; P <. 001; I-2= 24%). Conclusions Among patients with COPD, ICS therapy does not affect 1- year all-cause mortality. ICS therapy is associated with a higher risk of pneumonia. Future studies should determine whether specific subsets of patients with COPD benefit from ICS therapy.	[Drummond, M. Bradley; Dasenbrook, Elliott C.; Murphy, David J.; Fan, Eddy] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Pitz, Marshall W.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada	Johns Hopkins University; University of Manitoba	Fan, E (corresponding author), Johns Hopkins Med Inst, Div Pulm & Crit Care Med, 1830 E Monument St,5th Floor, Baltimore, MD 21287 USA.	eddy.fan@jhmi.edu		Drummond, Michael/0000-0002-6968-4610; Dasenbrook, Elliott/0000-0001-9811-8004	Institute for Clinical and Translational Research (K12) Mentored Career Development Award; National Institutes of Health; Cystic Fibrosis Foundation Clinical Fellowship Research Award [DASENB07A0]; University of Manitoba; R. Samuel McLaughlin/Manitoba Medical Service Foundation Research and Education Fellowship Award in Medicine; National Institutes of Health [T32 HL007534- 26]; Canadian Institutes of Health Research ( Fellowship Award); Royal College of Physicians and Surgeons of Canada (Detweiler Traveling Fellowship); NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023266] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL103192, T32HL007534] Funding Source: NIH RePORTER	Institute for Clinical and Translational Research (K12) Mentored Career Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Clinical Fellowship Research Award; University of Manitoba; R. Samuel McLaughlin/Manitoba Medical Service Foundation Research and Education Fellowship Award in Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research ( Fellowship Award)(Canadian Institutes of Health Research (CIHR)); Royal College of Physicians and Surgeons of Canada (Detweiler Traveling Fellowship); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Drummond is supported by an Institute for Clinical and Translational Research (K12) Mentored Career Development Award from the National Institutes of Health. Dr Dasenbrook is supported by the Cystic Fibrosis Foundation (Clinical Fellowship Research Award DASENB07A0). Dr Pitz is supported by the University of Manitoba (R. Samuel McLaughlin/Manitoba Medical Service Foundation Research and Education Fellowship Award in Medicine). Dr Murphy is supported by an institutional training grant from the National Institutes of Health (T32 HL007534- 26). Dr Fan is supported by the Canadian Institutes of Health Research ( Fellowship Award) and the Royal College of Physicians and Surgeons of Canada ( Detweiler Traveling Fellowship).	Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Altose MD, 2000, NEW ENGL J MED, V343, P1902; [Anonymous], 1980, Ann Intern Med, V93, P391; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blais R, 2001, CHEST, V119, P1316, DOI 10.1378/chest.119.5.1316; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2004, EUR RESPIR J, V24, P1075, DOI 10.1183/09031936.04.00088504; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Cazzola M, 2008, CHEST, V134, P223, DOI 10.1378/chest.08-0855; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; FLENLEY DC, 1981, LANCET, V1, P681; Gartlehner G, 2006, ANN FAM MED, V4, P253, DOI 10.1370/afm.517; Grimes GC, 2007, AM FAM PHYSICIAN, V76, P1141; Hanania NA, 2007, CLIN CHEST MED, V28, P589, DOI 10.1016/j.ccm.2007.06.007; Heaney LG, 2007, CURR MED CHEM, V14, P787; Heron Melonie P, 2007, Natl Vital Stat Rep, V55, P1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hubbard R, 2006, CHEST, V130, P1082, DOI 10.1378/chest.130.4.1082; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nannini LJ, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006826, 10.1002/14651858.CD006826.pub2]; Nelson HS, 2003, J ALLERGY CLIN IMMUN, V112, P29, DOI 10.1067/mai.2003.1558; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Pujades-Rodriguez M, 2007, QJM-INT J MED, V100, P509, DOI 10.1093/qjmed/hcm056; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rello J, 2006, EUR RESPIR J, V27, P1210, DOI 10.1183/09031936.06.00139305; Restrepo MI, 2006, EUR RESPIR J, V28, P346, DOI 10.1183/09031936.06.00131905; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Suissa S, 2008, AM J RESP CRIT CARE, V178, P322, DOI 10.1164/rccm.200805-721ED; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Turner MO, 2008, AM J RESP CRIT CARE, V177, P555, DOI 10.1164/ajrccm.177.5.555b; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Weatherall M, 2008, CLIN EXP ALLERGY, V38, P1451, DOI 10.1111/j.1365-2222.2008.03029.x; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Whitford H, 2000, Ann Transplant, V5, P31; Wilt T J, 2005, Evid Rep Technol Assess (Summ), P1; Woodhead M, 2007, AM J RESP CRIT CARE, V176, P111, DOI 10.1164/rccm.200703-492ED; Wyss D, 2007, BRIT J PHARMACOL, V152, P83, DOI 10.1038/sj.bjp.0707381; Yang IA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub2; Zheng JP, 2007, CHEST, V132, P1756, DOI 10.1378/chest.06-3009	48	260	269	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2407	2416		10.1001/jama.2008.717	http://dx.doi.org/10.1001/jama.2008.717			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033591	Bronze, Green Accepted			2022-12-28	WOS:000261150800023
J	Haine, ER; Moret, Y; Siva-Jothy, MT; Rolff, J				Haine, Eleanor R.; Moret, Yannick; Siva-Jothy, Michael T.; Rolff, Jens			Antimicrobial Defense and Persistent Infection in Insects	SCIENCE			English	Article							INNATE IMMUNITY; DROSOPHILA-MELANOGASTER; TENEBRIO-MOLITOR; HOST-DEFENSE; RESISTANCE; PEPTIDES; SYSTEM	During 400 million years of existence, insects have rarely succumbed to the evolution of microbial resistance against their potent antimicrobial immune defenses. We found that microbial clearance after infection is extremely fast and that induced antimicrobial activity starts to increase only when most of the bacteria (99.5%) have been removed. Our experiments showed that those bacteria that survived exposure to the insect's constitutive immune response were subsequently more resistant to it. These results imply that induced antimicrobial compounds function primarily to protect the insect against the bacteria that persist within their body, rather than to clear microbial infections. These findings suggest that understanding of the management of antimicrobial peptides in natural systems might inform medical treatment strategies that avoid the risk of drug resistance.	[Haine, Eleanor R.; Siva-Jothy, Michael T.; Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Moret, Yannick] Univ Bourgogne 1, CNRS, UMR Biogeosci 5561, F-21000 Dijon, France	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Rolff, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	jor@sheffield.ac.uk	Moret, Yannick/I-9282-2012	Rolff, Jens/0000-0002-1529-5409; Haine Bennett, Eleanor/0000-0001-8777-4532	Leverhulme Trust; The Wellcome Trust	Leverhulme Trust(Leverhulme Trust); The Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Clare, A. Dobson, S. Webster, and A. Williams for laboratory assistance. P. Brakefield, S. Foster, and M. Osborn made valuable comments that improved the manuscript. This research was funded by The Leverhulme Trust, and E. R. H. was also supported by The Wellcome Trust.	BULET P, 1992, EUR J BIOCHEM, V209, P977, DOI 10.1111/j.1432-1033.1992.tb17371.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; DUNN PE, 1986, ANNU REV ENTOMOL, V31, P321, DOI 10.1146/annurev.en.31.010186.001541; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lavine MD, 2005, INSECT BIOCHEM MOLEC, V35, P1335, DOI 10.1016/j.ibmb.2005.08.005; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	23	240	248	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1257	1259		10.1126/science.1165265	http://dx.doi.org/10.1126/science.1165265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023083				2022-12-28	WOS:000261033400045
J	Stenman, JM; Rajagopal, J; Carroll, TJ; Ishibashi, M; McMahon, J; McMahon, AP				Stenman, Jan M.; Rajagopal, Jay; Carroll, Thomas J.; Ishibashi, Makoto; McMahon, Jill; McMahon, Andrew P.			Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature	SCIENCE			English	Article							BETA-CATENIN GENE; ENDOTHELIAL-CELLS; MOUSE DEVELOPMENT; RECEPTOR GENE; EXPRESSION; PROLIFERATION; ANGIOGENESIS; INACTIVATION; DISRUPTION; PATHWAY	Every organ depends on blood vessels for oxygen and nutrients, but the vasculature associated with individual organs can be structurally and molecularly diverse. The central nervous system (CNS) vasculature consists of a tightly sealed endothelium that forms the blood- brain barrier, whereas blood vessels of other organs are more porous. Wnt7a and Wnt7b encode two Wnt ligands produced by the neuroepithelium of the developing CNS coincident with vascular invasion. Using genetic mouse models, we found that these ligands directly target the vascular endothelium and that the CNS uses the canonical Wnt signaling pathway to promote formation and CNS- specific differentiation of the organ's vasculature.	[Stenman, Jan M.; Rajagopal, Jay; Carroll, Thomas J.; Ishibashi, Makoto; McMahon, Jill; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Rajagopal, Jay] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [McMahon, Andrew P.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	mcmahon@mcb.harvard.edu	McMahon, Andrew P/ABE-7520-2020		Wenner-Gren Foundations (Sweden); National Heart, Lung, and Blood Institute [HL076393]; NIH [DK054364]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054364, R37DK054364] Funding Source: NIH RePORTER	Wenner-Gren Foundations (Sweden); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. D'Amore for helpful discussions. Supported by a Wenner-Gren Foundations (Sweden) postdoctoral fellowship (J.M.S.), National Heart, Lung, and Blood Institute grant HL076393 (J.R.), and NIH grant DK054364 (A.P.M.). The authors have a patent pending on the basis of the results reported in this paper. A.P.M. has been a paid consultant for Merck, Genentech, and Wythe in the past 3 years.	Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Brault V, 2001, DEVELOPMENT, V128, P1253; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Goodwin AM, 2007, GROWTH FACTORS, V25, P25, DOI 10.1080/08977190701272933; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Parr BA, 2001, DEV BIOL, V237, P324, DOI 10.1006/dbio.2001.0373; PARR BA, 1993, DEVELOPMENT, V119, P247; Shu WG, 2002, DEVELOPMENT, V129, P4831; Smith, 2006, DEATHS PRELIMINARY D; Suburo A. M., 2006, V176, P71; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Wright M, 1999, BIOCHEM BIOPH RES CO, V263, P384, DOI 10.1006/bbrc.1999.1344; Yano H, 2000, NEUROL RES, V22, P650; Yano H, 2000, NEUROL RES, V22, P527	27	426	433	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1247	1250		10.1126/science.1164594	http://dx.doi.org/10.1126/science.1164594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023080				2022-12-28	WOS:000261033400042
J	Wouters, J				Wouters, Jan			CHEMISTRY Coming Soon to a Library Near You?	SCIENCE			English	Editorial Material							CONSERVATION; PAPER		[Wouters, Jan] Getty Conservat Inst, B-2070 Zwijndrecht, Belgium		Wouters, J (corresponding author), Getty Conservat Inst, Neerbroek 54, B-2070 Zwijndrecht, Belgium.	jan.j.wouters@telenet.be						[Anonymous], 2004, E PRESERV SCI; Baglioni P, 2006, SOFT MATTER, V2, P293, DOI 10.1039/b516442g; Kautek W, 2001, PROC SPIE, V4402, P130, DOI 10.1117/12.445655; Kolar J., 2007, E PRESERV SCI, V4, P19; Malesi J., 2005, E PRESERVATIONSCIENC, V2, P13; NEEVEL JG, 1995, RESTAURATOR, V16, P143, DOI 10.1515/rest.1995.16.3.143; Trafela T, 2007, ANAL CHEM, V79, P6319, DOI 10.1021/ac070392t; [No title captured]; [No title captured]; [No title captured]; [No title captured]	11	13	13	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1196	1198		10.1126/science.1164991	http://dx.doi.org/10.1126/science.1164991			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023071				2022-12-28	WOS:000261033400026
J	Tobias, M; Rodgers, A				Tobias, Martin; Rodgers, Anthony			Can we eliminate inequalities in coronary disease? Absolutely	LANCET			English	Editorial Material							ISCHEMIC-HEART-DISEASE; RISK-FACTORS; BLOOD-PRESSURE; STROKE; CHOLESTEROL; MORTALITY		[Tobias, Martin] Minist Hlth, Hlth & Disabil Intelligence Unit, Hlth & Disabil Syst Strategy Directorate, Wellington, New Zealand; [Rodgers, Anthony] Univ Auckland, Sch Populat Hlth, Clin Trials Res Unit, Auckland 1, New Zealand	University of Auckland	Tobias, M (corresponding author), Minist Hlth, Hlth & Disabil Intelligence Unit, Hlth & Disabil Syst Strategy Directorate, Wellington, New Zealand.	martin_tobias@moh.govt.nz		Rodgers, Anthony/0000-0003-1282-1896				[Anonymous], WORLD HLTH REP 2002; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Tobias M, 2008, AUST NZ J PUBL HEAL, V32, P117, DOI 10.1111/j.1753-6405.2008.00186.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	10	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1612	1613		10.1016/S0140-6736(08)61668-2	http://dx.doi.org/10.1016/S0140-6736(08)61668-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18994649				2022-12-28	WOS:000260899900006
J	Feinmann, J				Feinmann, Jane			Cutting out human error	BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 4	2008	337								a2370	10.1136/bmj.a2370	http://dx.doi.org/10.1136/bmj.a2370			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FA	18984631				2022-12-28	WOS:000261235900009
J	Ghersi, D; Pang, T				Ghersi, Davina; Pang, Tikki			En route to international clinical trial transparency	LANCET			English	Editorial Material									[Ghersi, Davina; Pang, Tikki] WHO, ICTRP, Dept Res Policy & Cooperat, CH-1211 Geneva 27, Switzerland	World Health Organization	Ghersi, D (corresponding author), WHO, ICTRP, Dept Res Policy & Cooperat, CH-1211 Geneva 27, Switzerland.	ghersid@who.int						[Anonymous], 2004, MEXICO STATEMENT HLT; [Anonymous], 2007, BITT PILL RISKS CARR; Chatterjee P, 2008, B WORLD HEALTH ORGAN, V86, P581, DOI 10.2471/BLT.08.010808; Feczko J, 2006, NEW ENGL J MED, V354, P1426; Ghersi D, 2008, B WORLD HEALTH ORGAN, V86, P492, DOI 10.2471/BLT.08.053769; Satyanarayana K, 2008, INDIAN J MED RES, V127, P104; Satyanarayana K, 2006, INDIAN J MED RES, V123, P587; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; WOLFENSOHN J, 1998, 1998 ANN M WORLD BAN; YOUPING L, 2006, CHIN J EVIDENCE BASE, V6, P393	10	18	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1531	1532		10.1016/S0140-6736(08)61635-9	http://dx.doi.org/10.1016/S0140-6736(08)61635-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984176				2022-12-28	WOS:000260590500009
J	Leonhardt, U; Tyc, T				Leonhardt, Ulf; Tyc, Tomas			Broadband Invisibility by Non-Euclidean Cloaking	SCIENCE			English	Article							NEGATIVE REFRACTIVE-INDEX; METAMATERIALS	Invisibility and negative refraction are both applications of transformation optics where the material of a device performs a coordinate transformation for electromagnetic fields. The device creates the illusion that light propagates through empty flat space, whereas in physical space, light is bent around a hidden interior or seems to run backward in space or time. All of the previous proposals for invisibility require materials with extreme properties. Here we show that transformation optics of a curved, non- Euclidean space ( such as the surface of a virtual sphere) relax these requirements and can lead to invisibility in a broad band of the spectrum.	[Leonhardt, Ulf] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Leonhardt, Ulf; Tyc, Tomas] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Tyc, Tomas] Masaryk Univ, Inst Theoret Phys & Astrophys, CS-61137 Brno, Czech Republic	National University of Singapore; University of St Andrews; Masaryk University Brno	Leonhardt, U (corresponding author), Natl Univ Singapore, Dept Phys, 2 Sci Dr 3, Singapore 117542, Singapore.	ulf@st-andrews.ac.uk		Tyc, Tomas/0000-0002-7565-6958	European Union Contract Computing with Mesoscopic Photonic and Atomic States [MSM0021622409, MSM0021622419]; Royal Society Wolfson Research Merit Award; Engineering and Physical Sciences Research Council [EP/C523229/1] Funding Source: researchfish	European Union Contract Computing with Mesoscopic Photonic and Atomic States(European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank N.V. Korolkova for her generous support of this work. We are grateful for funding from European Union Contract Computing with Mesoscopic Photonic and Atomic States, the grants MSM0021622409 and MSM0021622419, and a Royal Society Wolfson Research Merit Award.	Born M, 2005, PRINCIPLES OPTICS, V7th edn; BUCHDAHL HA, 1978, AM J PHYS, V46, P840, DOI 10.1119/1.11200; Cai W, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2783266; Chen H, 2008, J APPL PHYS, V104, DOI 10.1063/1.2967815; DOLIN LS, 1961, IZV VYSSH UCHEBN ZAV, V4, P964; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; Greenleaf A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.183901; LEONHARDT U, 2008, IN PRESS; Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/247; Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/118; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Luneburg R. K., 1964, MATH THEORY OPTICS; Maxwell J. C., 1854, CAMBRIDGE DUBLIN MAT, V8, P188; Milton GW., 2002, THEORY COMPOSITES; Pendry JB, 2008, SCIENCE, V322, P71, DOI 10.1126/science.1162087; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Philbin TG, 2008, SCIENCE, V319, P1367, DOI 10.1126/science.1153625; Sarychev A.K., 2007, ELECTRODYNAMICS META; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Shalaev VM, 2008, SCIENCE, V322, P384, DOI 10.1126/science.1166079; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Yao J, 2008, SCIENCE, V321, P930, DOI 10.1126/science.1157566	24	355	368	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					110	112		10.1126/science.1166332	http://dx.doi.org/10.1126/science.1166332			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19023043				2022-12-28	WOS:000262104100051
J	Bouskra, D; Brezillon, C; Berard, M; Werts, C; Varona, R; Boneca, IG; Eberl, G				Bouskra, Djahida; Brezillon, Christophe; Berard, Marion; Werts, Catherine; Varona, Rosa; Boneca, Ivo Gomperts; Eberl, Gerard			Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis	NATURE			English	Article							ALTERED SCHAEDLER FLORA; BETA-DEFENSINS; FOLLICLE FORMATION; EPITHELIAL-CELLS; B-LYMPHOCYTES; RECEPTOR; GENERATION; EXPRESSION; INDUCTION; INNATE	Intestinal homeostasis is critical for efficient energy extraction from food and protection from pathogens. Its disruption can lead to an array of severe illnesses with major impacts on public health, such as inflammatory bowel disease characterized by self- destructive intestinal immunity. However, the mechanisms regulating the equilibrium between the large bacterial flora and the immune system remain unclear. Intestinal lymphoid tissues generate flora- reactive IgA- producing B cells, and include Peyer's patches and mesenteric lymph nodes, as well as numerous isolated lymphoid follicles (ILFs)(1,2). Here we show that peptidoglycan from Gram- negative bacteria is necessary and sufficient to induce the genesis of ILFs in mice through recognition by the NOD1 ( nucleotide- binding oligomerization domain containing 1) innate receptor in epithelial cells, and beta-defensin 3- and CCL20- mediated signalling through the chemokine receptor CCR6. Maturation of ILFs into large B- cell clusters requires subsequent detection of bacteria by toll- like receptors. In the absence of ILFs, the composition of the intestinal bacterial community is profoundly altered. Our results demonstrate that intestinal bacterial commensals and the immune system communicate through an innate detection system to generate adaptive lymphoid tissues and maintain intestinal homeostasis.	[Bouskra, Djahida; Eberl, Gerard] Inst Pasteur, Lab Lymphoid Tissue Dev, CNRS, URA1961, F-75724 Paris, France; [Brezillon, Christophe] Inst Pasteur, Lab Bacteries Pathogenes Enteriques, F-75724 Paris, France; [Berard, Marion] Inst Pasteur, Anim Centrale, F-75724 Paris, France; [Werts, Catherine; Boneca, Ivo Gomperts] Inst Pasteur, Grp Biol & Genet Bacterial Cell Wall, F-75724 Paris, France; [Varona, Rosa] CSIC, Dept Immunol & Oncol, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Werts, Catherine; Boneca, Ivo Gomperts] INSERM, Grp AVENIR, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Eberl, G (corresponding author), Inst Pasteur, Lab Lymphoid Tissue Dev, CNRS, URA1961, 25 Rue Dr Roux, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Eberl, Gerard/A-1160-2013; Boneca, Ivo G/H-1677-2014; WERTS, Catherine/AAD-5447-2020	Boneca, Ivo G/0000-0001-8122-509X; WERTS, Catherine/0000-0003-3079-5476; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur; CNRS; INSERM; ANR; Fondation de la Recherche Medicale; Mairie de Paris; Marie Curie Excellence; La Fondation de France; Ligue Nationale contre le Cancer	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Mairie de Paris(Region Ile-de-France); Marie Curie Excellence(European Commission); La Fondation de France(Fondation de France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	We thank G. Milon, N. Cerf- Bensussan, P. Sansonetti, P. Cossart, A. Phalipon, D. Philpott, G. Marchal and D. Guy-Grand for discussions and critical reading of the manuscript; N. Huntington for intrahepatic injections; M. Cherrier for biochemistry; J. Perez, E. Maranghi and M. Manich for technical assistance; S. Akira, M. Chignard and V. Balloy for Myd88<SUP>-/-</SUP>, Trif<SUP>-/-</SUP>, Tlr2<SUP>-/-</SUP> or Tlr4<SUP>-/-</SUP> mice, J. P. Hugot for card15<SUP>-/-</SUP> mice, Millennium Pharmaceuticals for card4<SUP>-/-</SUP> mice and D. Philpott for card4<SUP>-/-</SUP> mice backcrossed to C57BL/ 6; J. Browning for LT beta R-Ig and Z. Ge for the 16S rDNA plasmids. This work was supported by Institut Pasteur, CNRS, INSERM, ANR, Fondation de la Recherche Medicale, Mairie de Paris, a Marie Curie Excellence grant, La Fondation de France (D.B.) and la Ligue Nationale contre le Cancer (D.B.).	Antignac A, 2003, J BIOL CHEM, V278, P31521, DOI 10.1074/jbc.M304749200; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Ge ZM, 2006, APPL ENVIRON MICROB, V72, P5100, DOI 10.1128/AEM.01934-05; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Lugering A, 2006, ANN NY ACAD SCI, V1072, P210, DOI 10.1196/annals.1326.015; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Pabst O, 2006, J IMMUNOL, V177, P6824, DOI 10.4049/jimmunol.177.10.6824; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rivas-Santiago B, 2006, J INFECT DIS, V194, P697, DOI 10.1086/506454; Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004; SCHAEDLER RUSSELL W., 1962, JOUR EXPTL MED, V115, P1149, DOI 10.1084/jem.115.6.1149; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	40	731	769	5	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					507	U34		10.1038/nature07450	http://dx.doi.org/10.1038/nature07450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18987631				2022-12-28	WOS:000261170500039
J	Roehr, B				Roehr, Bob			The invisible epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEN; SEX					BobRoehr@aol.com						amfAR, 2008, MSM HIV ROAD UN ACC; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Centers for Disease Control and Prevention, EST NEW HIV INF US; Epstein H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2638; Ottoson Daniel, 2008, STATE SPONSORED HOMO; Roehr Bob, 2008, BMJ, V337, pa1182, DOI 10.1136/bmj.a1182	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2008	337								a2566	10.1136/bmj.a2566	http://dx.doi.org/10.1136/bmj.a2566			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QA	19033333				2022-12-28	WOS:000261827500016
J	Chang, J; Adams, JH; Ahn, HS; Bashindzhagyan, GL; Christl, M; Ganel, O; Guzik, TG; Isbert, J; Kim, KC; Kuznetsov, EN; Panasyuk, MI; Panov, AD; Schmidt, WKH; Seo, ES; Sokolskaya, NV; Watts, JW; Wefel, JP; Wu, J; Zatsepin, VI				Chang, J.; Adams, J. H., Jr.; Ahn, H. S.; Bashindzhagyan, G. L.; Christl, M.; Ganel, O.; Guzik, T. G.; Isbert, J.; Kim, K. C.; Kuznetsov, E. N.; Panasyuk, M. I.; Panov, A. D.; Schmidt, W. K. H.; Seo, E. S.; Sokolskaya, N. V.; Watts, J. W.; Wefel, J. P.; Wu, J.; Zatsepin, V. I.			An excess of cosmic ray electrons at energies of 300-800 GeV	NATURE			English	Article							SPECTRUM; PARTICLE	Galactic cosmic rays consist of protons, electrons and ions, most of which are believed to be accelerated to relativistic speeds in supernova remnants(1-3). All components of the cosmic rays show an intensity that decreases as a power law with increasing energy ( for example as E 22.7). Electrons in particular lose energy rapidly through synchrotron and inverse Compton processes, resulting in a relatively short lifetime ( about 10 5 years) and a rapidly falling intensity, which raises the possibility of seeing the contribution from individual nearby sources ( less than one kiloparsec away)(4). Here we report an excess of galactic cosmic- ray electrons at energies of,300 - 800 GeV, which indicates a nearby source of energetic electrons. Such a source could be an unseen astrophysical object ( such as a pulsar(5) or micro-quasar(6)) that accelerates electrons to those energies, or the electrons could arise from the annihilation of dark matter particles ( such as a Kaluza-Klein particle(7) with a mass of about 620 GeV).	[Guzik, T. G.; Isbert, J.; Wefel, J. P.] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; [Chang, J.] Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Peoples R China; [Chang, J.; Schmidt, W. K. H.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Adams, J. H., Jr.; Christl, M.; Watts, J. W.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Ahn, H. S.; Ganel, O.; Kim, K. C.; Seo, E. S.; Wu, J.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Bashindzhagyan, G. L.; Kuznetsov, E. N.; Panasyuk, M. I.; Panov, A. D.; Sokolskaya, N. V.; Zatsepin, V. I.] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow 119991, Russia	Louisiana State University System; Louisiana State University; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Max Planck Society; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University System of Maryland; University of Maryland College Park; Lomonosov Moscow State University	Wefel, JP (corresponding author), Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA.	wefel@phunds.phys.lsu.edu	Panasyuk, Mikhail I./E-2005-2012; Panov, Alexander/K-3952-2012; Sokolskaya, Natalia/J-4609-2012; Zatsepin, Victor/J-2287-2012; , ES/AAN-2324-2020	Panov, Alexander/0000-0003-2290-6498; Seo, Eun-Suk/0000-0001-8682-805X	NASA; Russian Foundation for Basic Research; National Natural Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported in the USA by NASA, in Russia by the Russian Foundation for Basic Research, and in China by the National Natural Science Foundation. The help of the NASA BPO and CSBF during balloon flights and the US NSF and RPSC for Antarctica operations is gratefully acknowledged.	Aharonian F, 2005, ASTRON ASTROPHYS, V432, pL25, DOI 10.1051/0004-6361:200500022; AHARONIAN FA, 1991, J PHYS G NUCL PARTIC, V17, P1769, DOI 10.1088/0954-3899/17/11/021; Aharonian FA, 2004, NATURE, V432, P75, DOI 10.1038/nature02960; Alcaraz J, 2000, PHYS LETT B, V484, P10, DOI 10.1016/S0370-2693(00)00588-8; Allen GE, 1997, ASTROPHYS J, V487, pL97, DOI 10.1086/310878; Appelquist T, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.055002; Barwick SW, 1997, ASTROPHYS J, V482, pL191, DOI 10.1086/310706; Brun P, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.083506; Busching I, 2008, ASTROPHYS J LETT, V678, pL39, DOI 10.1086/588465; Chang J, 2008, ADV SPACE RES, V42, P431, DOI 10.1016/j.asr.2007.06.012; CHANG J, 2003, P 28 ICRC, P1817; Cheng HC, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.211301; Delahaye T, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.063527; Diemand J, 2008, NATURE, V454, P735, DOI 10.1038/nature07153; DREES M, 2004, PHYS LETT B, V592, P216; Ganel O, 2005, NUCL INSTRUM METH A, V552, P409, DOI 10.1016/j.nima.2005.06.081; Guzik TG, 2004, ADV SPACE RES, V33, P1763, DOI 10.1016/j.asr.2003.05.018; Heinz S, 2002, ASTRON ASTROPHYS, V390, P751, DOI 10.1051/0004-6361:20020615; Hooper D, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.083503; HOOPER D, 2008, INDIRECT SEARCHES DA; Hooper D, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.083012; Kobayashi T, 2004, ASTROPHYS J, V601, P340, DOI 10.1086/380431; Lavalle J, 2008, ASTRON ASTROPHYS, V479, P427, DOI 10.1051/0004-6361:20078723; LI TP, 1983, ASTROPHYS J, V272, P317, DOI 10.1086/161295; Moskalenko IV, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.063003; NISHIMURA J, 1980, ASTROPHYS J, V238, P394, DOI 10.1086/157997; NISHIMURA J, 1997, 25 ICRC DURB, V4, P233; Servant G, 2003, NUCL PHYS B, V650, P391, DOI 10.1016/S0550-3213(02)01012-X; Strong AW, 2001, ADV SPACE RES-SERIES, V27, P717, DOI 10.1016/S0273-1177(01)00112-0; TANG KK, 1984, ASTROPHYS J, V278, P881, DOI 10.1086/161857; Torii S, 2001, ASTROPHYS J, V559, P973, DOI 10.1086/322274; Torii S., 2006, ADV POLAR UPPER ATMO, V20, P52	32	845	873	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					362	365		10.1038/nature07477	http://dx.doi.org/10.1038/nature07477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020615				2022-12-28	WOS:000261039600037
J	Lyssenko, V; Jonsson, A; Almgren, P; Pulizzi, N; Isomaa, B; Tuomi, T; Berglund, G; Altshuler, D; Nilsson, P; Groop, L				Lyssenko, Valeriya; Jonsson, Anna; Almgren, Peter; Pulizzi, Nicolo; Isomaa, Bo; Tuomi, Tiinamaija; Berglund, Goran; Altshuler, David; Nilsson, Peter; Groop, Leif			Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN SENSITIVITY; LOCI; PREDICTION; MELLITUS; GENE; REPLICATION; SECRETION; INDEXES	Background: Type 2 diabetes mellitus is thought to develop from an interaction between environmental and genetic factors. We examined whether clinical or genetic factors or both could predict progression to diabetes in two prospective cohorts. Methods: We genotyped 16 single-nucleotide polymorphisms (SNPs) and examined clinical factors in 16,061 Swedish and 2770 Finnish subjects. Type 2 diabetes developed in 2201 (11.7%) of these subjects during a median follow-up period of 23.5 years. We also studied the effect of genetic variants on changes in insulin secretion and action over time. Results: Strong predictors of diabetes were a family history of the disease, an increased body-mass index, elevated liver-enzyme levels, current smoking status, and reduced measures of insulin secretion and action. Variants in 11 genes (TCF7L2, PPARG, FTO, KCNJ11, NOTCH2, WFS1, CDKAL1, IGF2BP2, SLC30A8, JAZF1, and HHEX) were significantly associated with the risk of type 2 diabetes independently of clinical risk factors; variants in 8 of these genes were associated with impaired beta-cell function. The addition of specific genetic information to clinical factors slightly improved the prediction of future diabetes, with a slight increase in the area under the receiver-operating-characteristic curve from 0.74 to 0.75; however, the magnitude of the increase was significant (P=1.0 x 10(-4)). The discriminative power of genetic risk factors improved with an increasing duration of follow-up, whereas that of clinical risk factors decreased. Conclusions: As compared with clinical risk factors alone, common genetic variants associated with the risk of diabetes had a small effect on the ability to predict the future development of type 2 diabetes. The value of genetic factors increased with an increasing duration of follow-up.	[Lyssenko, Valeriya; Jonsson, Anna; Almgren, Peter; Berglund, Goran; Nilsson, Peter; Groop, Leif] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pulizzi, Nicolo] Univ Pisa, Pisa, Italy; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Altshuler, David] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Boston, MA 02114 USA	Lund University; University of Pisa; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Lyssenko, V (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, CRC, S-20502 Malmo, Sweden.	valeri.lyssenko@med.lu.se		Jonsson, Anna/0000-0003-1252-8673; Altshuler, David/0000-0002-7250-4107; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tuomi, Tiinamaija/0000-0002-8306-6202	Swedish Research Council; Linne [31475113580]; Heart and Lung Foundation; Swedish Diabetes Research Society; Nordic Center of Excellence Grant in Disease Genetics; Diabetes Program at the Lund University; Finnish Diabetes Research Society; Sigrid Juselius Foundation; Pahlsson Foundation; Crafoord Foundation; Folkhalsan Research Foundation; Novo Nordisk Foundation; European Network of Genomic and Genetic Epidemiology; Wallenberg Foundation; European Foundation for the Study of Diabetes; Tethys; Merck; Eisai; MPM Capital; Novartis; Bristol-Myers Squibb Foundation; Eli Lilly; GlaxoSmithKline; Aventis; Sanofi	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linne; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Research Society; Nordic Center of Excellence Grant in Disease Genetics; Diabetes Program at the Lund University; Finnish Diabetes Research Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pahlsson Foundation; Crafoord Foundation; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Network of Genomic and Genetic Epidemiology; Wallenberg Foundation(European Commission); European Foundation for the Study of Diabetes; Tethys; Merck(Merck & Company); Eisai(Eisai Co Ltd); MPM Capital; Novartis(Novartis); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Aventis(Sanofi-Aventis); Sanofi	Supported by grants from the Swedish Research Council (including Linne grant 31475113580), the Heart and Lung Foundation, the Swedish Diabetes Research Society, a Nordic Center of Excellence Grant in Disease Genetics, the Diabetes Program at the Lund University, the Finnish Diabetes Research Society, the Sigrid Juselius Foundation, the Pahlsson Foundation, the Crafoord Foundation, the Folkhalsan Research Foundation, the Novo Nordisk Foundation, the European Network of Genomic and Genetic Epidemiology, the Wallenberg Foundation, and the European Foundation for the Study of Diabetes. Dr. Lyssenko reports receiving consulting fees from Tethys; Dr. Altshuler, receiving consulting fees from Merck, Eisai, and MPM Capital and grant support from Novartis, receiving an unrestricted grant from the Bristol-Myers Squibb Foundation, and having an equity interest in MPM Capital; and Dr. Groop, receiving consulting fees from Tethys, Eli Lilly, GlaxoSmithKline, Aventis, and Sanofi, lecture fees from Aventis and Sanofi, and grant support from Novartis. No other potential conflict of interest relevant to this article was reported. We thank the patients for their participation and Anna Berglund, Margareta Svensson, and Malin Neptin for their excellent technical assistance.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cohen J., 2002, APPL MULTIPLE REGRES, V3rd, DOI 10.4324/9780203774441; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; HEDING LG, 1966, LABELLED PROTEINS TR, P345; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SLEINTHORSDOTTI.VV, 2007, NAT GENET, V39, P770; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; TANG K, 1995, NUCLEIC ACIDS RES, V23, P3126, DOI 10.1093/nar/23.16.3126; Tirosh A, 2006, NEW ENGL J MED, V354, P2401; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	630	661	0	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2220	2232		10.1056/NEJMoa0801869	http://dx.doi.org/10.1056/NEJMoa0801869			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020324	Bronze			2022-12-28	WOS:000260994000005
J	Meigs, JB; Shrader, P; Sullivan, LM; McAteer, JB; Fox, CS; Dupuis, J; Manning, AK; Florez, JC; Wilson, PWF; D'Agostino, RB; Cupples, LA				Meigs, James B.; Shrader, Peter; Sullivan, Lisa M.; McAteer, Jarred B.; Fox, Caroline S.; Dupuis, Josee; Manning, Alisa K.; Florez, Jose C.; Wilson, Peter W. F.; D'Agostino, Ralph B., Sr.; Cupples, L. Adrienne			Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOSE-TOLERANCE; LIFE-STYLE; LOCI; POLYMORPHISMS; MELLITUS; DISEASE; REPLICATION; FAMILIES; CURVE	Background: Multiple genetic loci have been convincingly associated with the risk of type 2 diabetes mellitus. We tested the hypothesis that knowledge of these loci allows better prediction of risk than knowledge of common phenotypic risk factors alone. Methods: We genotyped single-nucleotide polymorphisms (SNPs) at 18 loci associated with diabetes in 2377 participants of the Framingham Offspring Study. We created a genotype score from the number of risk alleles and used logistic regression to generate C statistics indicating the extent to which the genotype score can discriminate the risk of diabetes when used alone and in addition to clinical risk factors. Results: There were 255 new cases of diabetes during 28 years of follow-up. The mean (+/-SD) genotype score was 17.7+/-2.7 among subjects in whom diabetes developed and 17.1+/-2.6 among those in whom diabetes did not develop (P<0.001). The sex-adjusted odds ratio for diabetes was 1.12 per risk allele (95% confidence interval, 1.07 to 1.17). The C statistic was 0.534 without the genotype score and 0.581 with the score (P=>0.01). In a model adjusted for sex and self-reported family history of diabetes, the C statistic was 0.595 without the genotype score and 0.615 with the score (P=0.11). In a model adjusted for age, sex, family history, body-mass index, fasting glucose level, systolic blood pressure, high-density lipoprotein cholesterol level, and triglyceride level, the C statistic was 0.900 without the genotype score and 0.901 with the score (P=0.49). The genotype score resulted in the appropriate risk reclassification of, at most, 4% of the subjects. Conclusions: A genotype score based on 18 risk alleles predicted new cases of diabetes in the community but provided only a slightly better prediction of risk than knowledge of common risk factors alone.	[Meigs, James B.; Shrader, Peter] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Meigs, James B.; Shrader, Peter; Florez, Jose C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [McAteer, Jarred B.; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [McAteer, Jarred B.; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Dept Med, Boston, MA 02114 USA; [Sullivan, Lisa M.; Dupuis, Josee; Manning, Alisa K.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [McAteer, Jarred B.; Florez, Jose C.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA; [Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Emory Program Cardiovasc Outcomes Res & Epidemiol, Atlanta, GA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University; Boston University	Meigs, JB (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Fl, Boston, MA 02114 USA.	jmeigs@partners.org	Wilson, Peter W.F./J-2455-2016; Manning, Alisa Knodle/ABC-7711-2021; Meigs, James/P-3927-2019	Meigs, James/0000-0002-2439-2657; Dupuis, Josee/0000-0003-2871-3603; Sullivan, Lisa/0000-0003-0726-7149; Cupples, L. Adrienne/0000-0003-0273-7965	National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; National Institute for Diabetes and Digestive and Kidney Diseases [R01 DK078616, K24 DK080140, K23 DK65978]; Boston University Linux Cluster for Genetic Analysis; National Institutes of Health National Center for Research Resources Shared Instrumentation [1S10RR163736-01A1]; Sanofi-Aventis; GlaxoSmithKline; Merck; Publicis Healthcare Communications Group; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078616, K24DK080140, K23DK065978] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston University Linux Cluster for Genetic Analysis; National Institutes of Health National Center for Research Resources Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Publicis Healthcare Communications Group; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a contract from the National Heart, Lung, and Blood Institute's Framingham Heart Study (N01-HC-25195), grants from the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) (R01 DK078616 and K24 DK080140, to Dr. Meigs), an NIDDK Research Career Award (K23 DK65978, to Dr. Florez), and the Boston University Linux Cluster for Genetic Analysis, funded by a grant from the National Institutes of Health National Center for Research Resources Shared Instrumentation (1S10RR163736-01A1). Dr. Meigs reports serving on a consultancy board for Interleukin Genetics and receiving grants from Sanofi-Aventis and GlaxoSmithKline; and Dr. Florez, receiving consulting fees from Merck and Publicis Healthcare Communications Group, a global advertising agency engaged by Amylin Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Janssens ACJW, 2006, PLOS MED, V3, P270, DOI 10.1371/journal.pmed.0030114; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; LANGO H, 2008, DIABETES        0630; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Li J, 2007, ARCH INTERN MED, V167, P2528, DOI 10.1001/archinte.167.22.2528-c; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Meigs JB, 2005, J CLIN ENDOCR METAB, V90, P1137, DOI 10.1210/jc.2004-1212; Meigs JB, 1998, ANN INTERN MED, V128, P524, DOI 10.7326/0003-4819-128-7-199804010-00002; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Weijnen CF, 2002, DIABETIC MED, V19, P41, DOI 10.1046/j.1464-5491.2002.00624.x; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zeggini E, 2007, SCIENCE, V317, P1036; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	551	571	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2208	2219		10.1056/NEJMoa0804742	http://dx.doi.org/10.1056/NEJMoa0804742			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020323	Green Accepted			2022-12-28	WOS:000260994000004
J	Ferlin, A; Zuccarello, D; Zuccarello, B; Chirico, MR; Zanon, GF; Foresta, C				Ferlin, Alberto; Zuccarello, Daniela; Zuccarello, Biagio; Chirico, Maria Rosaria; Zanon, Giovanni Franco; Foresta, Carlo			Genetic Alterations Associated With Cryptorchidism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANDROGEN RECEPTOR GENE; MUTATIONS; PATHOGENESIS; EXPRESSION; DESCENT; TESTIS; INSL3; MICE	Context Cryptorchidism is the most frequent congenital birth defect in male children and represents an important risk factor for infertility and testicular cancer. Major regulators of testicular descent are the hormones insulin- like factor 3 ( INSL3) and testosterone, and disruption of these pathways might cause cryptorchidism. Objective To determine the frequency of genetic alterations in cryptorchidism. Design and Setting Case- control study in 2 departments of pediatric surgery in Italy between January 2003 and March 2005. Patients Six hundred male infants with cryptorchidism. Boys were followed up for 2 to 3 years ( through January 2008) and orchidopexy was performed in those who were persistently cryptorchid. We analyzed 300 noncryptorchid male children aged 1 to 4 years as controls. Main Outcome Measures Karyotype anomalies and INSL3, INSL3 receptor, and androgen receptor gene mutations. Results The frequency of genetic alterations in boys with cryptorchidism was low ( 17/ 600 [ 2.8%; 95% confidence interval {CI}, 1.7%- 4.5%]) and was significantly higher in participants with persistent cryptorchidism ( 16/ 303 [ 5.3%; 95% CI, 3.0%- 8.4%]; P=. 001) and those with bilateral cryptorchidism ( 10/ 120 [ 8.3%; 95% CI, 4.1%- 14.8%]; P=. 001) than in controls ( 1/ 300 [ 0.3%; 95% CI, 0.1%-0.8%]). Boys with persistent cryptorchidism had a 17- fold greater odds of having a genetic alteration ( odds ratio, 16.7; 95% CI, 2.2- 126.5). The most common genetic findings in those with cryptorchidism were 8 cases of Klinefelter syndrome and 5 cases of mutations in the INSL3 receptor gene. Genetic alterations were not found in boys with low birth weight or low gestational age, who had frequent spontaneous descent of the testes. Conclusion In a small percentage of the study population, there was a statistically significant association between bilateral and persistent cryptorchidism and genetic alterations, including Klinefelter syndrome and INSL3 receptor gene mutations.	[Ferlin, Alberto; Zuccarello, Daniela; Foresta, Carlo] Univ Padua, Sect Clin Pathol, I-35121 Padua, Italy; [Ferlin, Alberto; Zuccarello, Daniela; Foresta, Carlo] Univ Padua, Ctr Male Gamete Cryopreservat, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; [Zanon, Giovanni Franco] Univ Padua, Dept Pediat Surg, I-35121 Padua, Italy; [Zuccarello, Biagio; Chirico, Maria Rosaria] Univ Messina, Dept Med & Surg Pediat Sci, Unit Pediat Surg, Messina, Italy	University of Padua; University of Padua; University of Padua; University of Messina	Foresta, C (corresponding author), Univ Padua, Sect Clin Pathol, Via Gabelli 63, I-35121 Padua, Italy.	carlo.foresta@unipd.it	zuccarello, daniela/G-4822-2011; Ferlin, Alberto/AAO-3541-2020	zuccarello, daniela/0000-0001-5826-6715; Ferlin, Alberto/0000-0001-5817-8141	Italian Ministry of University [2005062572]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This study was supported by grant 2005062572 from the Italian Ministry of University to Drs Ferlin, Daniela Zuccarello, and Foresta.	Barthold JS, 2000, J UROLOGY, V164, P497, DOI 10.1016/S0022-5347(05)67411-3; Bay K, 2007, J CLIN ENDOCR METAB, V92, P4020, DOI 10.1210/jc.2007-0974; Bogatcheva NV, 2007, AM J PHYSIOL-ENDOC M, V292, pE138, DOI 10.1152/ajpendo.00228.2006; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Boisen KA, 2004, LANCET, V363, P1264, DOI 10.1016/S0140-6736(04)15998-9; Bojesen A, 2007, NAT CLIN PRACT UROL, V4, P192, DOI 10.1038/ncpuro0775; Cortes D, 2001, HORM RES, V55, P21, DOI 10.1159/000049959; Cortes D, 2008, J UROLOGY, V179, P314, DOI 10.1016/j.juro.2007.08.158; Ferlin A, 2006, MOL HUM REPROD, V12, P401, DOI 10.1093/molehr/gal043; Ferlin A, 2005, EUR J ENDOCRINOL, V152, P419, DOI 10.1530/eje.1.01860; Ferlin A, 2003, J CLIN ENDOCR METAB, V88, P4273, DOI 10.1210/jc.2003-030359; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI 10.1359/JBMR.080204; Ferlin A, 2006, CLIN ENDOCRINOL, V65, P606, DOI 10.1111/j.1365-2265.2006.02635.x; Foresta C, 1996, FERTIL STERIL, V66, P624, DOI 10.1016/S0015-0282(16)58579-3; Foresta C, 2008, ENDOCR REV, V29, P560, DOI 10.1210/er.2007-0042; GIWERCMAN A, 1993, EUR UROL, V23, P104; Husmann DA, 2005, UROLOGY, V66, P424, DOI 10.1016/j.urology.2004.10.020; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Nielsen J, 1990, Birth Defects Orig Artic Ser, V26, P209; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x; Suzuki Y, 2001, FERTIL STERIL, V76, P834, DOI 10.1016/S0015-0282(01)02016-7; Truong A, 2003, BIOL REPROD, V69, P1658, DOI 10.1095/biolreprod.103.019166; Virtanen HE, 2008, HUM REPROD UPDATE, V14, P49, DOI 10.1093/humupd/dmm027; Walsh TJ, 2007, J UROLOGY, V178, P1440, DOI 10.1016/j.juro.2007.05.166; Wiener JS, 1998, J UROLOGY, V160, P863, DOI 10.1016/S0022-5347(01)62823-4; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	30	101	105	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2271	2276		10.1001/jama.2008.668	http://dx.doi.org/10.1001/jama.2008.668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017913	Bronze			2022-12-28	WOS:000260965500027
J	Hildner, K; Edelson, BT; Purtha, WE; Diamond, M; Matsushita, H; Kohyama, M; Calderon, B; Schraml, BU; Unanue, ER; Diamond, MS; Schreiber, RD; Murphy, TL; Murphy, KM				Hildner, Kai; Edelson, Brian T.; Purtha, Whitney E.; Diamond, Mark; Matsushita, Hirokazu; Kohyama, Masako; Calderon, Boris; Schraml, Barbara U.; Unanue, Emil R.; Diamond, Michael S.; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.			Batf3 Deficiency Reveals a Critical Role for CD8 alpha(+) Dendritic Cells in Cytotoxic T Cell Immunity	SCIENCE			English	Article							IN-VIVO DEPLETION; CROSS-PRESENTATION; CUTTING EDGE; CD8(+); ANTIGENS; VIRUS; INFECTION; SUBSETS; POPULATION; EXPRESSION	Although in vitro observations suggest that cross- presentation of antigens is mediated primarily by CD8 alpha(+) dendritic cells, in vivo analysis has been hampered by the lack of systems that selectively eliminate this cell lineage. We show that deletion of the transcription factor Batf3 ablated development of CD8 alpha(+) dendritic cells, allowing us to examine their role in immunity in vivo. Dendritic cells from Batf3(-/-) mice were defective in cross- presentation, and Batf3(-/-) mice lacked virus- specific CD8(+) T cell responses to West Nile virus. Importantly, rejection of highly immunogenic syngeneic tumors was impaired in Batf3(-/-) mice. These results suggest an important role for CD8 alpha(+) dendritic cells and cross- presentation in responses to viruses and in tumor rejection.	[Hildner, Kai; Edelson, Brian T.; Diamond, Mark; Matsushita, Hirokazu; Kohyama, Masako; Calderon, Boris; Schraml, Barbara U.; Unanue, Emil R.; Diamond, Michael S.; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hildner, Kai; Kohyama, Masako; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Purtha, Whitney E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Purtha, Whitney E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Diamond, Michael/AAH-1733-2019; Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Diamond, Michael/0000-0002-8791-3165; Schreiber, Robert D/0000-0001-6311-0432; Calderon, Boris/0000-0003-1575-0739; Edelson, Brian/0000-0003-2856-7650; Schraml, Barbara/0000-0002-5801-0151; Schreiber, Robert/0000-0003-1590-2341	Howard Hughes Medical Institute; Emmy Noether Program of the German Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Emmy Noether Program of the German Research Foundation(German Research Foundation (DFG)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund)	This work was supported by the Howard Hughes Medical Institute (K.M.M.), the Emmy Noether Program of the German Research Foundation (K.H.), and a Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.).	Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Iacobelli M, 2000, J IMMUNOL, V165, P860, DOI 10.4049/jimmunol.165.2.860; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wolkers MC, 2001, J IMMUNOL, V167, P3577, DOI 10.4049/jimmunol.167.7.3577; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	29	1306	1344	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1097	1100		10.1126/science.1164206	http://dx.doi.org/10.1126/science.1164206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008445	Green Accepted			2022-12-28	WOS:000260867700036
J	Morgan, DO				Morgan, David O.			SnapShot: Cell-Cycle Regulators I	CELL			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416				Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988	2	11	11	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					764	U15	764.e1	10.1016/j.cell.2008.10.039	http://dx.doi.org/10.1016/j.cell.2008.10.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013283	Bronze			2022-12-28	WOS:000260886900025
J	Mukherjee, S; Orth, K				Mukherjee, Sohini; Orth, Kim			MICROBIOLOGY A Protein Pupylation Paradigm	SCIENCE			English	Editorial Material							PROTEASOME		[Mukherjee, Sohini] Univ Texas Southwestern Med Sch, Dept Immunol, Dallas, TX 75230 USA; [Orth, Kim] Univ Texas Southwestern Med Sch, Dept Mol Biol, Dallas, TX 75230 USA		Mukherjee, S (corresponding author), Univ Texas Southwestern Med Sch, Dept Immunol, Dallas, TX 75230 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620				Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; LUPAS A, 1994, TRENDS BIOCHEM SCI, V19, P533, DOI 10.1016/0968-0004(94)90054-X; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798	6	1	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1062	1063		10.1126/science.1166485	http://dx.doi.org/10.1126/science.1166485			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008436				2022-12-28	WOS:000260867700026
J	Hachinski, V				Hachinski, Vladimir			Shifts in Thinking About Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFETIME RISK; STROKE		[Hachinski, Vladimir] Univ Western Ontario, Dept Clin Neurol Sci, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Hachinski, V (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci, 339 Windermere Rd, London, ON N6A 3K7, Canada.	vladimir.hachinski@lhsc.on.ca						Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hachinski V, 2007, STROKE, V38, P1118, DOI 10.1161/01.STR.0000259385.54832.e4; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Jin YP, 2008, NEUROLOGY, V70, P9, DOI 10.1212/01.wnl.0000284609.77385.03; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Silver FL, 2006, AM J PREV MED, V31, pS235, DOI 10.1016/j.amepre.2006.08.023	16	69	70	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2172	2173		10.1001/jama.2008.525	http://dx.doi.org/10.1001/jama.2008.525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001628				2022-12-28	WOS:000260793800027
J	Atwal, JK; Pinkston-Gosse, J; Syken, J; Stawicki, S; Wu, Y; Shatz, C; Tessier-Lavigne, M				Atwal, Jasvinder K.; Pinkston-Gosse, Julie; Syken, Josh; Stawicki, Scott; Wu, Yan; Shatz, Carla; Tessier-Lavigne, Marc			PirB is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration	SCIENCE			English	Article							NOGO RECEPTOR; NEURITE OUTGROWTH; VISUAL-CORTEX; GLYCOPROTEIN; RECOVERY; GROWTH; INJURY; CELLS; PLASTICITY; LIGAND	A major barrier to regenerating axons after injury in the mammalian central nervous system is an unfavorable milieu. Three proteins found in myelin- Nogo, MAG, and OMgp- inhibit axon regeneration in vitro and bind to the glycosylphosphatidylinositol- anchored Nogo receptor ( NgR). However, genetic deletion of NgR has only a modest disinhibitory effect, suggesting that other binding receptors for these molecules probably exist. With the use of expression cloning, we have found that paired immunoglobulin- like receptor B ( PirB), which has been implicated in nervous system plasticity, is a high- affinity receptor for Nogo, MAG, and OMgp. Interfering with PirB activity, either with antibodies or genetically, partially rescues neurite inhibition by Nogo66, MAG, OMgp, and myelin in cultured neurons. Blocking both PirB and NgR activities leads to near- complete release from myelin inhibition. Our results implicate PirB in mediating regeneration block, identify PirB as a potential target for axon regeneration therapies, and provide an explanation for the similar enhancements of visual system plasticity in PirB and NgR knockout mice.	[Atwal, Jasvinder K.; Pinkston-Gosse, Julie; Tessier-Lavigne, Marc] Genentech Inc, Neurodegenerat Labs & Res Drug Discovery, San Francisco, CA 94080 USA; [Syken, Josh; Shatz, Carla] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Stawicki, Scott; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Shatz, Carla] Stanford Univ, BioX Program, James H Clark Ctr, Stanford, CA 94305 USA	Roche Holding; Genentech; Harvard University; Harvard Medical School; Roche Holding; Genentech; Stanford University	Tessier-Lavigne, M (corresponding author), Genentech Inc, Neurodegenerat Labs & Res Drug Discovery, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com			Genentech	Genentech(Roche HoldingGenentech)	We thank J. Brady and M. Yan for assistance with expression cloning and members of the Tessier-Lavigne and Shatz laboratories for helpful suggestions and discussions. This work was supported by Genentech.	Chen B, 2002, DEV BIOL, V252, P170, DOI 10.1006/dbio.2002.0847; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mehta NR, 2007, J BIOL CHEM, V282, P27875, DOI 10.1074/jbc.M704055200; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Pereira S, 2004, J IMMUNOL, V173, P5757, DOI 10.4049/jimmunol.173.9.5757; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Walmsey AR, 2007, CURR PHARM DESIGN, V13, P2470; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	22	380	402	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					967	970		10.1126/science.1161151	http://dx.doi.org/10.1126/science.1161151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988857				2022-12-28	WOS:000260674100054
J	Leeper, NJ; Dhaliwal, G; Saint, S; Witteles, RM				Leeper, Nicholas J.; Dhaliwal, Gurpreet; Saint, Sanjay; Witteles, Ronald M.			Fool's Gold	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENDOMYOCARDIAL BIOPSY; MAGNETIC-RESONANCE; CARDIOMYOPATHY; MYOCARDITIS		[Leeper, Nicholas J.; Witteles, Ronald M.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Dhaliwal, Gurpreet] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Saint, Sanjay] Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; [Saint, Sanjay] Univ Michigan Hlth Syst, Ann Arbor, MI USA	Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Leeper, NJ (corresponding author), Falk Cardiovasc Res Ctr, 300 Pasteur Dr, Stanford, CA 94305 USA.	nleeper@cvmed.stanford.edu	Saint, Sanjay/AAF-5126-2019		Advanced Career Development Award; Health Services Research and Development Program of the Department of Veterans Affairs	Advanced Career Development Award; Health Services Research and Development Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	Supported by an Advanced Career Development Award from the Health Services Research and Development Program of the Department of Veterans Affairs (to Dr. Saint).	Angelini A, 2000, HEART, V84, P245, DOI 10.1136/heart.84.3.245; Ardehali H, 2004, AM HEART J, V147, P919, DOI 10.1016/j.ahj.2003.09.020; Berry GJ, 2005, PEDIATR BLOOD CANCER, V44, P630, DOI 10.1002/pbc.20346; Celletti F, 1999, AM J CARDIOL, V83, P798, DOI 10.1016/S0002-9149(98)00998-9; Daisley H., 1997, Leukemia (Basingstoke), V11, P522; Frustaci A, 2007, EUR HEART J, V28, P733, DOI 10.1093/eurheartj/ehl525; Vogelsberg H, 2008, J AM COLL CARDIOL, V51, P1022, DOI 10.1016/j.jacc.2007.10.049	7	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2035	2041		10.1056/NEJMcps0802668	http://dx.doi.org/10.1056/NEJMcps0802668			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987372				2022-12-28	WOS:000260632700010
J	Grace, C; Begum, R; Subhani, S; Kopelman, P; Greenhalgh, T				Grace, Clare; Begum, Reha; Subhani, Syed; Kopelman, Peter; Greenhalgh, Trisha			Prevention of type 2 diabetes in British Bangladeshis: qualitative study of community, religious, and professional perspectives	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SELF-DETERMINATION THEORY; HEALTH LITERACY; LIFE-STYLE; DISEASE; ADHERENCE; KNOWLEDGE; RISK; INTERVENTION; POPULATION; PAKISTANI	Objective To understand lay beliefs and attitudes, religious teachings, and professional perceptions in relation to diabetes prevention in the Bangladeshi community. Design Qualitative study ( focus groups and semistructured interviews). Setting Tower Hamlets, a socioeconomically deprived London borough, United Kingdom. Participants Bangladeshi people without diabetes ( phase 1), religious leaders and Islamic scholars ( phase 2), and health professionals ( phase 3). Methods 17 focus groups were run using purposive sampling in three sequential phases. Thematic analysis was used iteratively to achieve progressive focusing and to develop theory. To explore tensions in preliminary data fictional vignettes were created, which were discussed by participants in subsequent phases. The PEN- 3 multilevel theoretical framework was used to inform data analysis and synthesis. Results Most lay participants accepted the concept of diabetes prevention and were more knowledgeable than expected. Practical and structural barriers to a healthy lifestyle were commonly reported. There was a strong desire to comply with cultural norms, particularly those relating to modesty. Religious leaders provided considerable support from Islamic teachings for messages about diabetes prevention. Some clinicians incorrectly perceived Bangladeshis to be poorly informed and fatalistic, although they also expressed concerns about their own limited cultural understanding. Conclusion Contrary to the views of health professionals and earlier research, poor knowledge was not the main barrier to healthy lifestyle choices. The norms and expectations of Islam offer many opportunities for supporting diabetes prevention. Interventions designed for the white population, however, need adaptation before they will be meaningful to many Bangladeshis. Religion may have an important part to play in supporting health promotion in this community. The potential for collaborative working between health educators and religious leaders should be explored further and the low cultural understanding of health professionals addressed.	[Grace, Clare] Queen Mary Univ London, Barts & London Sch Med, London E1 2AT, England; [Kopelman, Peter] Univ London St Georges Hosp, London, England; [Greenhalgh, Trisha] Univ London, Dept Primary Care & Populat Sci, London WC1E 7HU, England	University of London; Queen Mary University London; St Georges University London; University of London; University College London	Grace, C (corresponding author), Queen Mary Univ London, Barts & London Sch Med, London E1 2AT, England.	c.m.grace@qmul.ac.uk	Greiver, Michelle/N-8764-2015; Greenhalgh, Trisha/B-1825-2015	Greiver, Michelle/0000-0001-8957-0285; Greenhalgh, Trisha/0000-0003-2369-8088	Diabetes UK [BDA: RD04/0002780]	Diabetes UK(Diabetes UK)	This work was supported by Diabetes UK grant number BDA: RD04/0002780.	Airhihenbuwa C. O., 1995, HLTH CULTURE W PARAD; Ajzen I., 1985, INTENTIONS ACTIONS T, DOI DOI 10.1007/978-3-642-69746-3_2; Boutin-Foster Carla, 2005, Health Qual Life Outcomes, V3, P52, DOI 10.1186/1477-7525-3-52; Bush H, 1998, SOCIOL HEALTH ILL, V20, P351, DOI 10.1111/1467-9566.00106; Chowdhury TA, 2003, BRIT MED J, V327, P1059, DOI 10.1136/bmj.327.7423.1059; *CLIN EFF GROUP, 2004, CLIN EFF ANN REP 200; Cote J., 2002, IDENTITY FORMATION; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; Dhawan J, 1997, HEART, V78, P550, DOI 10.1136/hrt.78.6.550; *DIR PUBL HLTH TOW, 2007, TOW HAML PUBL HLTH R; Eade John, 1997, LIVING GLOBAL CITY G, P127; ERENS B, 2001, HLTH SURVEY ENGLAND; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Freebody P., 1990, PROSPECT AUSTR J TES, V5, P716; GLASGOW RE, 1988, DIABETES CARE, V11, P377, DOI 10.2337/diacare.11.5.377; Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; HAWTHORNE K, 1990, BRIT J GEN PRACT, V40, P243; Hawthorne K, 1999, DIABETIC MED, V16, P591, DOI 10.1046/j.1464-5491.1999.00102.x; Hayes L, 2002, J PUBLIC HEALTH MED, V24, P170, DOI 10.1093/pubmed/24.3.170; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Hiller, 1996, RES CULTURAL DIFFERE, P220; Johnson M, 2000, BLACK MINORITY ETHNI; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lawton J, 2007, SOCIOL HEALTH ILL, V29, P891, DOI 10.1111/j.1467-9566.2007.01036.x; LEVINE J, 1987, PSYCHOSOM MED, V49, P109, DOI 10.1097/00006842-198703000-00001; MAYCUT P, 1994, BEGINNING QUALITATIV; MIRZA M, 2007, LIVING APART TOGETHE, P53; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; *OFF NAT STAT, 2002, 1 RES POP ENGL WAL 2; PHILLIPSON C, 2003, WOMEN TRANSITION; Rankin J, 2001, PUBLIC HEALTH, V115, P253; REVENSON TA, 1991, SOC SCI MED, V33, P807, DOI 10.1016/0277-9536(91)90385-P; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179; Sher TG, 2002, HEALTH EDUC RES, V17, P597, DOI 10.1093/her/17.5.597; Sherman AM, 2000, CONTROL CLIN TRIALS, V21, p206S, DOI 10.1016/S0197-2456(00)00080-5; SIMMONS D, 1991, DIABETIC MED, V8, P651, DOI 10.1111/j.1464-5491.1991.tb01672.x; SPROTSON K, 2006, HLTH SURVEY ENGLAND; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WHITE M, 1998, EFFECTIVENESS INTERV; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; WILLIAMS R, 1994, INT J EPIDEMIOL, V23, P28, DOI 10.1093/ije/23.1.28; WINTER R, 1986, CAMB J EDUC, V3, P175; [No title captured]	45	77	77	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2008	337								a1931	10.1136/bmj.a1931	http://dx.doi.org/10.1136/bmj.a1931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	377FA	18984633	Green Accepted, hybrid, Green Published, Green Submitted			2022-12-28	WOS:000261235900001
J	Cuttell, L; Vaughan, A; Silva, E; Escaron, CJ; Lavine, M; Van Goethem, E; Eid, JP; Quirin, M; Franc, NC				Cuttell, Leigh; Vaughan, Andrew; Silva, Elizabeth; Escaron, Claire J.; Lavine, Mark; Van Goethem, Emeline; Eid, Jean-Pierre; Quirin, Magali; Franc, Nathalie C.			Undertaker, a Drosophila Junctophilin, Links Draper-Mediated Phagocytosis and Calcium Homeostasis	CELL			English	Article							CELL CORPSE ENGULFMENT; APOPTOTIC CELLS; LYMPHOCYTE-ACTIVATION; RYANODINE RECEPTOR; MEMBRANE-PROTEIN; CA2+ RELEASE; REQUIREMENT; MACROPHAGES; RECOGNITION; MECHANISMS	Phagocytosis is important during development and in the immune response for the removal of apoptotic cells and pathogens, yet its molecular mechanisms are poorly understood. In Caenorhabditis elegans, the CED2/5/10/12 pathway regulates actin during phagocytosis of apoptotic cells, whereas the role of the CED1/6/7 pathway in phagocytosis is unclear. We report that Undertaker (UTA), a Drosophila Junctophilin protein, is required for Draper (CED-1 homolog)-mediated phagocytosis. Junctophilins couple Ca2+ channels at the plasma membrane to those of the endoplasmic reticulum (ER), the Ryanodine receptors. We place Draper, its adaptor drCed-6, UTA, the Ryanodine receptor Rya-r44F, the ER Ca2+ sensor dSTIM, and the Ca2+-release-activated Ca2+ channel dOrai in the same pathway that promotes calcium homeostasis and phagocytosis. Thus, our results implicatea Juncto-philin in phagocytosis and link Draper-mediated phagocytosis to Ca2+ homeostasis, highlighting a previously uncharacterized role for the CED1/6/7 pathway.	[Cuttell, Leigh; Vaughan, Andrew; Silva, Elizabeth; Escaron, Claire J.; Lavine, Mark; Van Goethem, Emeline; Eid, Jean-Pierre; Quirin, Magali; Franc, Nathalie C.] UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London	Franc, NC (corresponding author), UCL, MRC, Mol Cell Biol Lab, Cell Biol Unit, Gower St, London WC1E 6BT, England.	n.franc@ucl.ac.uk	Cuttell, Leigh/F-9281-2011; Franc, Nathalie/C-2208-2009; Silva, Elizabeth/C-1495-2008	Silva, Elizabeth/0000-0002-0684-9473; Franc, Nathalie/0000-0002-1617-385X; QUIRIN, Magali/0000-0001-7967-5622; Silva, Elizabeth/0000-0002-0524-929X	Medical Research Council; MRC Cell Biology Unit; The Genetic Society UK; Medical Research Council [MC_U122665005] Funding Source: researchfish; MRC [MC_U122665005] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Cell Biology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Genetic Society UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Bloomington and Szeged Drosophila stock centers, H. Agaisse, D. Ferrandon, M. Freeman, C. Kocks, B. Lemaitre, K. Mecklenberg, Y. Nakai, Y. Nakanishi, N. Perrimon, A. Rao, and D. Reiff for fly stocks and/or reagents and technical advice; A. V. for his help with Ca<SUP>2+</SUP> imaging, and M. Hallett for his advice on its analysis; V. Keasler and W. Yu for the qPCR; H. Agaisse and members of the DRSC for their help with the RNAi screen, and members of the core staff for their help. N. C. F. thanks S. Brown, C. Desplan, and M. Meister for their critical reading of this manuscript. This research was funded by a programme leader-track grant from the Medical Research Council to N. C. F., core support to the MRC Cell Biology Unit, and a studentship from The Genetic Society UK to M. Q.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Beppu M, 2001, ARCH BIOCHEM BIOPHYS, V390, P243, DOI 10.1006/abbi.2001.2381; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; Dewitt S, 2002, J CELL BIOL, V159, P181, DOI 10.1083/jcb.200206089; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Kindzelskii AL, 2003, J IMMUNOL, V170, P64, DOI 10.4049/jimmunol.170.1.64; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mecklenburg KL, 2007, MOL GENET GENOMICS, V277, P481, DOI 10.1007/s00438-007-0211-7; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Vernon-Wilson EF, 2007, J LEUKOCYTE BIOL, V82, P1278, DOI 10.1189/jlb.0507283; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Xu XH, 2000, BIOPHYS J, V78, P1270, DOI 10.1016/S0006-3495(00)76683-5; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	47	110	112	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					524	534		10.1016/j.cell.2008.08.033	http://dx.doi.org/10.1016/j.cell.2008.08.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984163	Bronze			2022-12-28	WOS:000260536300022
J	Jin, J; Desai, BN; Navarro, B; Donovan, A; Andrews, NC; Clapham, DE				Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Donovan, Adriana; Andrews, Nancy C.; Clapham, David E.			Deletion of Trpm7 Disrupts Embryonic Development and Thymopoiesis Without Altering Mg(2+) Homeostasis	SCIENCE			English	Article							KERATINOCYTE GROWTH-FACTOR; MURINE LYMPHOCYTES-T; POTASSIUM CHANNELS; SECONDARY HYPOCALCEMIA; MIC CHANNELS; PROTEIN; CELLS; HYPOMAGNESEMIA; ACTIVATION; EXPRESSION	The gene transient receptor potential- melastatin- like 7 ( Trpm7) encodes a protein that functions as an ion channel and a kinase. TRPM7 has been proposed to be required for cellular Mg(2+) homeostasis in vertebrates. Deletion of mouse Trpm7 revealed that it is essential for embryonic development. Tissue- specific deletion of Trpm7 in the T cell lineage disrupted thymopoiesis, which led to a developmental block of thymocytes at the double- negative stage and a progressive depletion of thymic medullary cells. However, deletion of Trpm7 in T cells did not affect acute uptake of Mg(2+) or the maintenance of total cellular Mg(2+). Trpm7- deficient thymocytes exhibited dysregulated synthesis of many growth factors that are necessary for the differentiation and maintenance of thymic epithelial cells. The thymic medullary cells lost signal transducer and activator of transcription 3 activity, which accounts for their depletion when Trpm7 is disrupted in thymocytes.	[Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Clapham, David E.] Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Jin, Jie; Desai, Bimal N.; Navarro, Betsy; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Jin, Jie; Donovan, Adriana; Andrews, Nancy C.] Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27702 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27702 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Duke University; Duke University	Clapham, DE (corresponding author), Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Enders Bldg 1309,300 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Andrews, Nancy/0000-0003-0243-4462; /0000-0002-3928-5854	NIH [T32HL007572-20]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH and NIH postdoctoral fellowship T32HL007572-20 (B.N.D.). We thank F. Alt, H. von Boehmer, M. Fleming, G. Krapivinsky, and M. Delling for helpful discussions. Technical assistance from Y. Fujiwara (Division of Hematology Transgenic core facility), D. Campagna (identification of bacterial artificial chromosome clones), G. Losiyev (Brigham Women's Hospital Flow Cytometry core facility), R. Bronson (mouse necropsy), and Z. Chen (ICP-MS) is deeply appreciated.	CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cernkovich ER, 2007, ENDOCRINOLOGY, V148, P1598, DOI 10.1210/en.2006-1106; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P379, DOI 10.1085/jgp.89.3.379; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Erickson M, 2002, BLOOD, V100, P3269, DOI 10.1182/blood-2002-04-1036; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Huang Y, 2008, CELL CYCLE, V7, P1613, DOI 10.4161/cc.7.11.5952; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rossi S, 2002, BLOOD, V100, P682, DOI 10.1182/blood.V100.2.682; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	25	317	319	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					756	760		10.1126/science.1163493	http://dx.doi.org/10.1126/science.1163493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974357	Green Accepted			2022-12-28	WOS:000260605200053
J	Haruyama, J; Ohtake, M; Matsunaga, T; Morota, T; Honda, C; Yokota, Y; Abe, M; Ogawa, Y; Miyamoto, H; Iwasaki, A; Pieters, CM; Asada, N; Demura, H; Hirata, N; Terazono, J; Sasaki, S; Saiki, K; Yamaji, A; Torii, M; Josset, JL				Haruyama, Junichi; Ohtake, Makiko; Matsunaga, Tsuneo; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Abe, Masanao; Ogawa, Yoshiko; Miyamoto, Hideaki; Iwasaki, Akira; Pieters, Carle M.; Asada, Noriaki; Demura, Hirohide; Hirata, Naru; Terazono, Junya; Sasaki, Sho; Saiki, Kazuto; Yamaji, Atsushi; Torii, Masaya; Josset, Jean-Luc			Long-Lived Volcanism on the Lunar Farside Revealed by SELENE Terrain Camera	SCIENCE			English	Article							INNER SOLAR-SYSTEM; MARE BASALTS; STRATIGRAPHY; UNITS; AGES; DISTRIBUTIONS	We determined model ages of mare deposits on the farside of the Moon on the basis of the crater frequency distributions in 10- meter- resolution images obtained by the Terrain Camera on SELENE ( Selenological and Engineering Explorer) ( Kaguya). Most mare volcanism that formed mare deposits on the lunar farside ceased at similar to 3.0 billion years ago, suggesting that mare volcanism on the Moon was markedly reduced globally during this period. However, several mare deposits at various locations on the lunar farside also show a much younger age, clustering at similar to 2.5 billion years ago. These young ages indicate that mare volcanism on the lunar farside lasted longer than was previously considered and may have occurred episodically.	[Haruyama, Junichi; Ohtake, Makiko; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Abe, Masanao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Matsunaga, Tsuneo; Ogawa, Yoshiko] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Miyamoto, Hideaki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Iwasaki, Akira] Univ Tokyo, Dept Aerosp & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Pieters, Carle M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Asada, Noriaki; Demura, Hirohide; Hirata, Naru; Terazono, Junya] Univ Aizu, Fukushima 9658580, Japan; [Sasaki, Sho] Natl Inst Nat Sci, Natl Astron Observ Japan, RISE Project Off, Mizusawa, Iwate 0230861, Japan; [Saiki, Kazuto] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Osaka 5600043, Japan; [Yamaji, Atsushi] Kyoto Univ, Div Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan; [Torii, Masaya] Fujitsu, Chiba 2618588, Japan; [Josset, Jean-Luc] Space Explorat Inst CP 774, CH-2002 Neuchatel, Switzerland	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institute for Environmental Studies - Japan; University of Tokyo; University of Tokyo; Brown University; University of Aizu; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Osaka University; Kyoto University	Haruyama, J (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.	haruyama.junichi@jaxa.jp	Matsunaga, Tsuneo/H-3040-2018; Miyamoto, Hideaki/E-3381-2012; Yamaji, Atsushi/ABB-2815-2021; Miyamoto, Hideaki/B-9666-2008; Sasaki, Sho/S-3845-2019	Matsunaga, Tsuneo/0000-0002-3380-5230; Yamaji, Atsushi/0000-0001-8074-543X; Miyamoto, Hideaki/0000-0001-8013-6124; Sasaki, Sho/0000-0002-7646-5248; Hirata, Naru/0000-0002-2435-604X	KAKENHI [20540416, 19204045, 20-9211]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the contributors to the SELENE ( Kaguya) project, especially members of the project management group ( Y. Takizawa, M. Kato, S. Sasaki, R. Nagashima, K. Tsuruda, and H. Mizutani) and the Lunar Imager/ Spectrometer working group ( H. Otake, H. Kawasaki, R. Nakamura, S. Kodama, S. Minami, S. Takechi, A. Akiyama, M. Shirao, T. Yokota, H. Takeda, T. Arai, T. Sugihara, Y. Yamaguchi, T. Hiroi, T. Hashimoto, T. Michikami, K. Kitazato, M. Higa, P. Pinet, T. Nimura, T. Yamamoto, N. Harada, K. Iseki, T. Hodokuma, S. Kikuchi, S. Kawabe, S. Okuno, and T. Takayama), for their efforts in development, operation, and data processing of SELENE and LISM/TC. We also thank the three anonymous reviewers for their helpful comments. This work was supported by KAKENHI (grant 20540416 to J.H. and C.H.), (19204045 to H.D.), and (20-9211 to T. M.).	GREELEY R, 1993, J GEOPHYS RES-PLANET, V98, P17183, DOI 10.1029/93JE01000; Hartmann WK, 1999, METEORIT PLANET SCI, V34, P167, DOI 10.1111/j.1945-5100.1999.tb01743.x; HARTMANN WK, 1966, ICARUS, V5, P406, DOI 10.1016/0019-1035(66)90054-6; Haruyama J, 2008, EARTH PLANETS SPACE, V60, P243, DOI 10.1186/BF03352788; HEAD JW, 1992, GEOCHIM COSMOCHIM AC, V56, P2155, DOI 10.1016/0016-7037(92)90183-J; Hiesinger H, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001985; Hiesinger H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014847; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P29239, DOI 10.1029/2000JE001244; Hiesinger H., 2006, 37 LUN PLAN SCI C; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Kramer GY, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2006JE002860; McEwen AS, 2006, ANNU REV EARTH PL SC, V34, P535, DOI 10.1146/annurev.earth.34.031405.125018; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Neukum G., 1994, HAZARDS DUE COMETS A, P359; Neukum G., 1983, METEORITENBOMBARDMEN; Pieters CM, 2001, J GEOPHYS RES-PLANET, V106, P28001, DOI 10.1029/2000JE001414; Pike RJ., 1977, IMPACT EXPLOSION CRA, P489; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; TYRIE A, 1988, EARTH MOON PLANETS, V42, P245, DOI 10.1007/BF00058489; WALKER AS, 1982, MOON PLANETS, V27, P91, DOI 10.1007/BF00941559; Wilhelms D, 1987, GEOLOGIC HIST MOON U	23	101	107	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					905	908		10.1126/science.1163382	http://dx.doi.org/10.1126/science.1163382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	18988811				2022-12-28	WOS:000263295400034
J	Liu, JY; O'Brien, KL; Lynch, DM; Simmons, NL; La Porte, A; Riggs, AM; Abbink, P; Coffey, RT; Grandpre, LE; Seaman, MS; Landucci, G; Forthal, DN; Montefiori, DC; Carville, A; Mansfield, KG; Havenga, MJ; Pau, MG; Goudsmit, J; Barouch, DH				Liu, Jinyan; O'Brien, Kara L.; Lynch, Diana M.; Simmons, Nathaniel L.; La Porte, Annalena; Riggs, Ambryice M.; Abbink, Peter; Coffey, Rory T.; Grandpre, Lauren E.; Seaman, Michael S.; Landucci, Gary; Forthal, Donald N.; Montefiori, David C.; Carville, Angela; Mansfield, Keith G.; Havenga, Menzo J.; Pau, Maria G.; Goudsmit, Jaap; Barouch, Dan H.			Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys	NATURE			English	Article							IMMUNODEFICIENCY VIRUS SIVMAC239; SIMIAN-IMMUNODEFICIENCY; ADENOVIRUS VECTORS; REPLICATION; INFECTION; MEMORY; IMMUNOGENICITY; RESPONSES; HIV; MAMU-A-ASTERISK-01	A recombinant adenovirus serotype 5 ( rAd5) vector- based vaccine for HIV-1 has recently failed in a phase 2b efficacy study in humans(1,2). Consistent with these results, preclinical studies have demonstrated that rAd5 vectors expressing simian immunodeficiency virus (SIV) Gag failed to reduce peak or setpoint viral loads after SIV challenge of rhesus monkeys ( Macaca mulatta) that lacked the protective MHC class I allele Mamu-A*01 ( ref. 3). Here we show that an improved T- cell- based vaccine regimen using two serologically distinct adenovirus vectors afforded substantially improved protective efficacy in this challenge model. In particular, a heterologous rAd26 prime/rAd5 boost vaccine regimen expressing SIV Gag elicited cellular immune responses with augmented magnitude, breadth and polyfunctionality as compared with the homologous rAd5 regimen. After SIVMAC251 challenge, monkeys vaccinated with the rAd26/rAd5 regimen showed a 1.4 log reduction of peak and a 2.4 log reduction of setpoint viral loads as well as decreased AIDS- related mortality as compared with control animals. These data demonstrate that durable partial immune control of a pathogenic SIV challenge for more than 500 days can be achieved by a T- cell- based vaccine in Mamu-A*01-negative rhesus monkeys in the absence of a homologous Env antigen. These findings have important implications for the development of next- generation T- cell- based vaccine candidates for HIV- 1.	[Liu, Jinyan; O'Brien, Kara L.; Lynch, Diana M.; Simmons, Nathaniel L.; La Porte, Annalena; Riggs, Ambryice M.; Abbink, Peter; Coffey, Rory T.; Grandpre, Lauren E.; Seaman, Michael S.; Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Sch Med, Irvine, CA 92697 USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Carville, Angela; Mansfield, Keith G.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Havenga, Menzo J.] TNO Biosci, NL-2301 CE Leiden, Netherlands; [Pau, Maria G.; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Irvine; Duke University; Netherlands Organization Applied Science Research; Johnson & Johnson	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019	Simmons, Nathaniel/0000-0001-6080-2783	NIH [AI066305, AI066924, AI078526, AI030034, RR000168]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066924, R01AI058727, U19AI066305, U19AI078526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vogels, J. Custers, L. Holterman, A. Lemckert, F. Stephens, R. Dolin, N. Letvin, J. Schmitz, M. Lifton, K. Furr, L. Picker and M. Pensiero for generous advice, assistance and reagents. The SIV peptide pools were obtained from the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program. We acknowledge support from NIH grants AI066305 ( D. H. B.), AI066924 ( D. H. B.), AI078526 ( D. H. B.), AI030034 ( D. C. M.) and RR000168.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; FAUCI AS, 2007, NIH NEWS        1107, P45704; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM, P45704; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Veazey RS, 2008, J VIROL, V82, P5618, DOI 10.1128/JVI.02748-07; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	30	377	420	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					87	91		10.1038/nature07469	http://dx.doi.org/10.1038/nature07469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18997770	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000262104900036
J	Elrington, G				Elrington, Giles			Commentary: Controversies in SIGN guidance on diagnosing and managing headache in adults	BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTAL FINDINGS		[Elrington, Giles] Barts & London NHS Trust, London E1 1BB, England	Barts Health NHS Trust	Elrington, G (corresponding author), Barts & London NHS Trust, London E1 1BB, England.	elrington@aol.com						*BRIT ASS STUD HEA, 2007, GUID ALL HEALTHC PRO; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Howard L, 2005, J NEUROL NEUROSUR PS, V76, P1558, DOI 10.1136/jnnp.2004.057851; *INT HEAD SOC HEAD, 2004, CEPHALALGIA S1, V24, P8; *SIGN, 2008, 107 SIGN; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 20	2008	337								a2445	10.1136/bmj.a2445	http://dx.doi.org/10.1136/bmj.a2445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HS	19022843				2022-12-28	WOS:000262654100006
J	Ip, SCY; Rass, U; Blanco, MG; Flynn, HR; Skehel, JM; West, SC				Ip, Stephen C. Y.; Rass, Ulrich; Blanco, Miguel G.; Flynn, Helen R.; Skehel, J. Mark; West, Stephen C.			Identification of Holliday junction resolvases from humans and yeast	NATURE			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MUS81/MMS4 ENDONUCLEASE; FLAP ENDONUCLEASE-1; MAMMALIAN-CELLS; GENE CONVERSION; NUCLEASE FAMILY; CROSSING-OVER; IN-VITRO; RECOMBINATION	Four-way DNA intermediates, also known as Holliday junctions, are formed during homologous recombination and DNA repair, and their resolution is necessary for proper chromosome segregation. Here we identify nucleases from Saccharomyces cerevisiae and human cells that promote Holliday junction resolution, in a manner analogous to that shown by the Escherichia coli Holliday junction resolvase RuvC. The human Holliday junction resolvase, GEN1, and its yeast orthologue, Yen1, were independently identified using two distinct experimental approaches: GEN1 was identified by mass spectrometry following extensive fractionation of HeLa cell- free extracts, whereas Yen1 was detected by screening a yeast gene fusion library for nucleases capable of Holliday junction resolution. The eukaryotic Holliday junction resolvases represent a new subclass of the Rad2/ XPG family of nucleases. Recombinant GEN1 and Yen1 resolve Holliday junctions by the introduction of symmetrically related cuts across the junction point, to produce nicked duplex products in which the nicks can be readily ligated.	[Ip, Stephen C. Y.; Rass, Ulrich; Blanco, Miguel G.; West, Stephen C.] Clare Hall Labs, London Res Inst, Canc Res UK, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Flynn, Helen R.; Skehel, J. Mark] Clare Hall Labs, London Res Inst, Canc Res UK, Prot Anal & Proteom Lab, S Mimms EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	West, SC (corresponding author), Clare Hall Labs, London Res Inst, Canc Res UK, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Blanco, Miguel González/J-6424-2012; Blanco, Miguel González/R-5754-2017	Blanco, Miguel González/0000-0002-2883-7326; Blanco, Miguel González/0000-0002-2883-7326; West, Stephen/0000-0001-8848-9418; Flynn, Helen/0000-0001-7002-9130; Rass, Ulrich/0000-0001-9275-9062	Cancer Research UK; Louis-Jeantet Foundation; EU DNA Repair Consortium; Croucher Foundation; Xunta de Galicia; Spanish Ministry of Education	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; EU DNA Repair Consortium; Croucher Foundation; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministry of Education(Spanish Government)	We thank M. Lichten and J. Haber for communication of unpublished work, J.-Y. Bleuyard, A. Deans and other members of our laboratory, past and present, for their input and discussions. We acknowledge the contributions of K. Elborough, H. Hyde, B. Kysela, A. Davies, A. Constantinou and Y. Liu for early studies that underpin this work, which was supported by Cancer Research UK, the Louis-Jeantet Foundation and the EU DNA Repair Consortium. S.C.Y.I. was supported by the Croucher Foundation. M. G. B. is on leave from the University of Santiago de Compostela, and supported by fellowships from the Xunta de Galicia and the Spanish Ministry of Education.	Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; de los Santos T, 2003, GENETICS, V164, P81; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Furukawa T, 2003, PLANT MOL BIOL, V51, P59, DOI 10.1023/A:1020789314722; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HYDE H, 1994, J BIOL CHEM, V269, P5202; Ishikawa G, 2004, NUCLEIC ACIDS RES, V32, P6251, DOI 10.1093/nar/gkh962; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Kanai Y, 2007, FEBS J, V274, P3914, DOI 10.1111/j.1742-4658.2007.05924.x; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Moritoh S, 2005, PLANT CELL PHYSIOL, V46, P699, DOI 10.1093/pcp/pci090; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Smith GR, 2003, GENETICS, V165, P2289; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	43	295	300	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					357	U39		10.1038/nature07470	http://dx.doi.org/10.1038/nature07470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020614				2022-12-28	WOS:000261039600036
J	Kleber, HD				Kleber, Herbert D.			Methadone Maintenance 4 Decades Later Thousands of Lives Saved But Still Controversial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADDICTION		[Kleber, Herbert D.] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Div Substance Abuse, PI Unit 66, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Kleber, HD (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Div Substance Abuse, PI Unit 66, 1051 Riverside, New York, NY 10032 USA.	hdk3@columbia.edu			NIDA NIH HHS [5K05 DA014284] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA014284] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1995, FEDERAL REGULATION M; Ball J.C., 2012, EFFECTIVENESS METHAD; DOLE VP, 1991, ALCOHOL CLIN EXP RES, V15, P749, DOI 10.1111/j.1530-0277.1991.tb00592.x; DOLE VP, 1966, ARCH INTERN MED, V118, P304, DOI 10.1001/archinte.118.4.304; DOLE VP, 1988, JAMA-J AM MED ASSOC, V260, P3025, DOI 10.1001/jama.260.20.3025; DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002; DuPont RL, 2002, ONE HUNDRED YEARS OF HEROIN, P67; Jaffe JH, 2003, DRUG ALCOHOL DEPEN, V70, pS3, DOI 10.1016/S0376-8716(03)00055-3; Jonnes J., 1996, HEP CATS NARCS PIPE; Kleber HD, 2002, ONE HUNDRED YEARS OF HEROIN, P149; Kreek M J, 1978, Ann N Y Acad Sci, V311, P110, DOI 10.1111/j.1749-6632.1978.tb16769.x; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Zanis DA, 1998, DRUG ALCOHOL DEPEN, V52, P257, DOI 10.1016/S0376-8716(98)00097-0	14	110	112	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2303	2305		10.1001/jama.2008.648	http://dx.doi.org/10.1001/jama.2008.648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017918	Bronze			2022-12-28	WOS:000260965500032
J	Cooter, R				Cooter, Roger			Biocitizenship	LANCET			English	Editorial Material									[Cooter, Roger] UCL, Wellcome Trust Ctr Hist Med, London WC1E 6BT, England	University of London; University College London	Cooter, R (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London WC1E 6BT, England.	r.cooter@ucl.ac.uk							0	17	17	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 15	2008	372	9651					1725	1725		10.1016/S0140-6736(08)61719-5	http://dx.doi.org/10.1016/S0140-6736(08)61719-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	19013311				2022-12-28	WOS:000261077900012
J	Hauser, MD; Bever, T				Hauser, Marc D.; Bever, Thomas			BEHAVIOR A Biolinguistic Agenda	SCIENCE			English	Editorial Material							LANGUAGE; SPEECH; FOXP2		[Hauser, Marc D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bever, Thomas] Univ Arizona, Dept Linguist, Psychol & Cognit Sci Program, Tucson, AZ 85721 USA	Harvard University; University of Arizona	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh@wjh.harvard.edu						Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; BATES E, 1994, DISCUSS NEUROSCI, V10, P136; Bever T. G., 1989, NEURONS READING; Boeckx C, 2005, LINGUIST REV, V22, P447, DOI 10.1515/tlir.2005.22.2-4.447; Chan Shiao-Hui, 2007, THESIS U ARIZONA; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Chomsky N., 2002, JANUA LINGUARUM; Deacon T., 1997, SYMBOLIC SPECIES COE; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; HUTTON JT, 1977, CORTEX, V13, P195, DOI 10.1016/S0010-9452(77)80009-9; Jackendoff Ray, 2002, FDN LANGUAGE; Lennenberg E.H., 1967, BIOL FDN LANGUAGE; LURIA AR, 1969, TRAUMATIC APHASIA; Murphy RA, 2008, SCIENCE, V319, P1849, DOI 10.1126/science.1151564; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Pinker Steven., 1984, LANGUAGE LEARNABILIT; Ross DS, 2004, BRAIN LANG, V89, P115, DOI 10.1016/S0093-934X(03)00308-0; Townsend DJ, 2001, BRAIN LANG, V78, P308, DOI 10.1006/brln.2001.2469	22	18	20	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1057	1059		10.1126/science.1167437	http://dx.doi.org/10.1126/science.1167437			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	371YD	19008433				2022-12-28	WOS:000260867700023
J	Heiman, M; Schaefer, A; Gong, S; Peterson, JD; Day, M; Ramsey, KE; Suarez-Farinas, M; Schwarz, C; Stephan, DA; Surmeier, DJ; Greengard, P; Heintz, N				Heiman, Myriam; Schaefer, Anne; Gong, Shiaoching; Peterson, Jayms D.; Day, Michelle; Ramsey, Keri E.; Suarez-farinas, Mayte; Schwarz, Cordelia; Stephan, Dietrich A.; Surmeier, D. James; Greengard, Paul; Heintz, Nathaniel			A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types	CELL			English	Article							INNERVATED BRAIN-REGIONS; CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; RAT-BRAIN; BASAL GANGLIA; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; NUCLEUS-ACCUMBENS; ADENYLYL-CYCLASE	The cellular heterogeneity of the brain confounds efforts to elucidate the biological properties of distinct neuronal populations. Using bacterial artificial chromosome (BAC) transgenic mice that express EGFP-tagged ribosomal protein L10a in defined cell populations, we have developed a methodology for affinity purification of polysomal mRNAs from genetically defined cell populations in the brain. The utility of this approach is illustrated by the comparative analysis of four types of neurons, revealing hundreds of genes that distinguish these four cell populations. We find that even two morphologically indistinguishable, intermixed subclasses of medium spiny neurons display vastly different translational profiles and present examples of the physiological significance of such differences. This genetically targeted translating ribosome affinity purification (TRAP) methodology is a generalizable method useful for the identification of molecular changes in any genetically defined cell type in response to genetic alterations, disease, or pharmacological perturbations.	[Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA; [Heiman, Myriam; Schaefer, Anne; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Schwarz, Cordelia; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Suarez-farinas, Mayte] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Peterson, Jayms D.; Day, Michelle; Surmeier, D. James] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ramsey, Keri E.; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Northwestern University; Feinberg School of Medicine; Translational Genomics Research Institute	Heintz, N (corresponding author), Rockefeller Univ, GENSAT Project, 1230 York Ave, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553; Greengard, Paul/0000-0002-4437-0893	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [5UL1RR024143] Funding Source: Medline; NIA NIH HHS [P01 AG009464-17, P01 AG009464, P01 AG009464-16A1, AG09464] Funding Source: Medline; NIDA NIH HHS [5F32DA021487, F32 DA021487-02, P01 DA010044, P01 DA010044-09, DA10044, F32 DA021487-01, P01 DA010044-11, F32 DA021487, P01 DA010044-10] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-04, P50 MH074866-039002, P50 MH074866-01, P50 MH074866-040005, P50 MH074866, P50 MH074866-029001, P50 MH074866-020001, P50 MH074866-03, P50 MH074866-030001, P50 MH074866-010002, MH074866, P50 MH074866-049001, P50 MH074866-020002, P50 MH074866-049002, P50 MH074866-02, P50 MH074866-019002, P50 MH074866-030005, P50 MH074866-010001, P50 MH074866-039001, P50 MH074866-017204, P50 MH074866-030002, P50 MH074866-040001, P50 MH074866-019001, P50 MH074866-029002, P50 MH074866-020005, P50 MH074866-010005, P50 MH074866-040002] Funding Source: Medline; NINDS NIH HHS [NS34696, R01 NS034696, R37 NS034696-12, R37 NS034696-13, R37 NS034696, R37 NS034696-11] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044, F32DA021487] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; DI CG, 1988, P NATL ACAD SCI USA, V85, P5274; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GIRAULT JA, 1990, J NEUROSCI, V10, P1124; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Ince E, 1997, SYNAPSE, V27, P357, DOI 10.1002/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lobo MK, 2007, NAT NEUROSCI, V10, P1395, DOI 10.1038/nn1987; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mizushima K, 2000, GENOMICS, V69, P314, DOI 10.1006/geno.2000.6340; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; OH JD, 1992, NEUROSCIENCE, V47, P807, DOI 10.1016/0306-4522(92)90031-V; OUIMET CC, 1989, J NEUROSCI, V9, P865; POLLI JW, 1992, P NATL ACAD SCI USA, V89, P11079, DOI 10.1073/pnas.89.22.11079; Ramon y Cajal S., 1899, TEXTURE NERVOUS SYST; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Volkow ND, 1998, AM J PSYCHIAT, V155, P200; WALAAS SI, 1984, J NEUROSCI, V4, P84; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477	56	754	762	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					738	748		10.1016/j.cell.2008.10.028	http://dx.doi.org/10.1016/j.cell.2008.10.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013281	Green Accepted, Bronze			2022-12-28	WOS:000260886900023
J	Foulkes, WD				Foulkes, William D.			Molecular Origins of Cancer: Inherited Susceptibility to Common Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; BREAST-CANCER; LUNG-CANCER; COLORECTAL-CANCER; GERMLINE MUTATIONS; PROSTATE-CANCER; CONFER SUSCEPTIBILITY; SEQUENCE VARIANTS; GENETIC-VARIANTS; HEREDITARY PANCREATITIS		[Foulkes, William D.] McGill Univ, Program Canc Genet, Gerald Bronfman Ctr Canc Res, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Foulkes, William D.] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Foulkes, William D.] McGill Univ, Dept Human Genet, Montreal, PQ H2W 1S6, Canada; [Foulkes, William D.] McGill Univ, Dept Med, Montreal, PQ H2W 1S6, Canada; [Foulkes, William D.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Foulkes, WD (corresponding author), McGill Univ, Program Canc Genet, Gerald Bronfman Ctr Canc Res, Dept Oncol, 546 Pine Ave W, Montreal, PQ H2W 1S6, Canada.	william.foulkes@mcgill.ca	Foulkes, William D./AAR-9586-2021	Foulkes, William D./0000-0001-7427-4651				Agalliu I, 2007, BRIT J CANCER, V97, P826, DOI 10.1038/sj.bjc.6603929; Agalliu I, 2007, CLIN CANCER RES, V13, P839, DOI 10.1158/1078-0432.CCR-06-2164; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bartsch DK, 2002, ANN SURG, V236, P730, DOI 10.1097/00000658-200212000-00005; BAZERMAN MH, 1983, J CONFLICT RESOLUT, V27, P618, DOI 10.1177/0022002783027004003; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carpenter WR, 2008, JNCI-J NATL CANCER I, V100, P158, DOI 10.1093/jnci/djm329; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Cheng I, 2008, EUR J HUM GENET, V16, P496, DOI 10.1038/sj.ejhg.5201959; Croitoru ME, 2007, J SURG ONCOL, V95, P499, DOI 10.1002/jso.20724; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; EVANS JP, 1995, J MED GENET, V32, P330, DOI 10.1136/jmg.32.5.330; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fletcher O, 2004, JNCI-J NATL CANCER I, V96, P357, DOI 10.1093/jnci/djh058; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Foulkes WD, 1995, QJM-MON J ASSOC PHYS, V88, P853; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Frank B, 2008, J NATL CANCER I, V100, P437, DOI 10.1093/jnci/djn037; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Goldstein AM, 2004, J MED GENET, V41, P421, DOI 10.1136/jmg.2004.019349; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hahn SA, 2003, JNCI-J NATL CANCER I, V95, P214, DOI 10.1093/jnci/95.3.214; Haiman CA, 2008, HUM MOL GENET, V17, P825, DOI 10.1093/hmg/ddm354; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hart JT, 2008, BMJ-BRIT MED J, V336, P123, DOI 10.1136/bmj.39461.502581.59; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hung RJ, 2007, CANCER EPIDEM BIOMAR, V16, P2736, DOI 10.1158/1055-9965.EPI-07-0494; Hung RJ, 2007, CARCINOGENESIS, V28, P1334, DOI 10.1093/carcin/bgm067; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hwang SJ, 2003, HUM GENET, V113, P238, DOI 10.1007/s00439-003-0968-7; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; JASS JR, 1992, GUT, V33, P783, DOI 10.1136/gut.33.6.783; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Klein AP, 2007, CANCER BIOL THER, V6, P320, DOI 10.4161/cbt.6.3.3721; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Le Marchand L, 2005, CANCER EPIDEM BIOMAR, V14, P1998, DOI 10.1158/1055-9965.EPI-05-0076; Lim W, 2004, GASTROENTEROLOGY, V126, P1788, DOI 10.1053/j.gastro.2004.03.014; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; LYNCH HT, 1966, ARCH INTERN MED, V117, P206, DOI 10.1001/archinte.117.2.206; Matakidou A, 2006, INT J CANCER, V119, P964, DOI 10.1002/ijc.21931; Mckay JD, 2008, CANCER EPIDEM BIOMAR, V17, P141, DOI 10.1158/1055-9965.EPI-07-0553; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Ozcelik H, 1997, NAT GENET, V16, P17, DOI 10.1038/ng0597-17; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Raimondi S, 2006, AM J EPIDEMIOL, V164, P1027, DOI 10.1093/aje/kwj321; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rozen P, 1999, GASTROENTEROLOGY, V116, P54, DOI 10.1016/S0016-5085(99)70228-3; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; SANDERS BM, 1989, BRIT J CANCER, V60, P358, DOI 10.1038/bjc.1989.285; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Shaw GL, 1998, CANCER EPIDEM BIOMAR, V7, P215; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slater E, 2007, PLOS MED, V4, P774, DOI 10.1371/journal.pmed.0040164; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; TAKEMIYA M, 1987, CLIN GENET, V31, P35; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tilanus-Linthorst M, 2002, INT J CANCER, V102, P91, DOI 10.1002/ijc.10666; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tryggvadottir L, 2007, JNCI-J NATL CANCER I, V99, P929, DOI 10.1093/jnci/djm005; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; van Asperen CJ, 2005, J MED GENET, V42, P711, DOI 10.1136/jmg.2004.028829; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Warner E, 2001, J CLIN ONCOL, V19, P3524, DOI 10.1200/JCO.2001.19.15.3524; Webb EL, 2006, AM J HUM GENET, V79, P768, DOI 10.1086/507912; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wimmer K, 2008, HUM GENET, V124, P105, DOI 10.1007/s00439-008-0542-4; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yamanaka A, 1997, JPN J CLIN ONCOL, V27, P415, DOI 10.1093/jjco/27.6.415; Ye Z, 2006, PLOS MED, V3, P524, DOI 10.1371/journal.pmed.0030091; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zogopoulous G, 2007, HUM GENET, V121, P635, DOI 10.1007/s00439-007-0361-z	110	353	367	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2143	2153		10.1056/NEJMra0802968	http://dx.doi.org/10.1056/NEJMra0802968			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005198				2022-12-28	WOS:000260823900012
J	Goroll, AH				Goroll, Allan H.			The Future of Primary Care: Reforming Physician Payment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERFORMANCE; QUALITY; HEALTH; PAY		[Goroll, Allan H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goroll, Allan H.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Goroll, AH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							American College of Physicians, 2006, IMP COLL PRIM CAR ME; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Pearson SD, 2008, HEALTH AFFAIR, V27, P1167, DOI 10.1377/hlthaff.27.4.1167; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	5	10	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2087	+		10.1056/NEJMp0805765	http://dx.doi.org/10.1056/NEJMp0805765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005194				2022-12-28	WOS:000260823900004
J	Friel, S; Marmot, M; McMichael, AJ; Kjellstrom, T; Vagero, D				Friel, Sharon; Marmot, Michael; McMichael, Anthony J.; Kjellstrom, Tord; Vagero, Denny			Global health equity and climate stabilisation: a common agenda	LANCET			English	Article							FOOD	Although health has improved for many people, the extent of health inequities between and within countries is growing. Meanwhile, humankind is disrupting the global climate and other life-supporting environmental systems, thereby creating serious risks for health and wellbeing, especially in vulnerable populations but ultimately for everybody. Underlying determinants of health inequity and environmental change overlap substantially; they are signs of an economic system predicated on asymmetric growth and competition, shaped by market forces that mostly disregard health and environmental consequences rather than by values of fairness and support. A shift is needed in priorities in economic development towards healthy forms of urbanisation, more efficient and renewable energy sources, and a sustainable and fairer food system. Global interconnectedness and interdependence enable the social and environmental determinants of health to be addressed in ways that will increase health equity, reduce poverty, and build societies that live within environmental limits.	[Friel, Sharon; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, Commission Social Determinants Hlth, Int Inst Soc & Hlth, London WC1E 6BT, England; [Vagero, Denny] Stockholm Univ, Commission Social Determinants Hlth, S-10691 Stockholm, Sweden; [Vagero, Denny] Stockholm Univ, CHESS Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden; [Vagero, Denny] Karolinska Inst, Stockholm, Sweden; [Friel, Sharon; McMichael, Anthony J.; Kjellstrom, Tord] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	University of London; University College London; Stockholm University; Stockholm University; Karolinska Institutet; Australian National University	Friel, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Commission Social Determinants Hlth, Int Inst Soc & Hlth, London WC1E 6BT, England.	s.friel@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Vagero, Denny/0000-0002-1854-2292; Friel, Sharon/0000-0002-8345-5435	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G0100222, G8802774] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alcott B, 2008, ECOL ECON, V64, P770, DOI 10.1016/j.ecolecon.2007.04.015; [Anonymous], 2006, FOOD SECURITY HUNGER; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Dixon J, 2007, J URBAN HEALTH, V84, pI118, DOI 10.1007/s11524-007-9176-4; Epstein Paul, 2005, GLOBALIZATION HLTH E, P239; Friel S, 2007, BRIT MED J, V335, P1241, DOI 10.1136/bmj.39377.622882.47; Garcia FJ, 2007, J INT ECON LAW, V10, P461, DOI 10.1093/jiel/jgm022; Gorham R., 2002, AIR POLLUTION GROUND; Hanlon P, 2008, PUBLIC HEALTH, V122, P647, DOI 10.1016/j.puhe.2008.03.020; Hastings G., 2007, EXTENT NATURE EFFECT; *INT LAB ORG, 2008, GLOB ENV TRENDS; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Kjellstrom T, 2007, J URBAN HEALTH, V84, pI86, DOI 10.1007/s11524-007-9171-9; *KNOWL NETW URB SE, 2007, OUR CIT OUR HLTH OUR; Leon DA, 2008, INT J EPIDEMIOL, V37, P4, DOI 10.1093/ije/dym271; Lobstein T, 2008, LANCET, V372, P628, DOI 10.1016/S0140-6736(08)61270-2; LUNDBERG O, 2007, NORDIC EXPERIENCE WE; McMichael AJ, 2004, LANCET, V364, P2004, DOI 10.1016/S0140-6736(04)17529-6; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; *NNC, 2001, SMART GROWTH NEIGHB; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; Pretty JN, 2005, FOOD POLICY, V30, P1, DOI 10.1016/j.foodpol.2005.02.001; Research Australia, 2007, HLTH PLAN PLAC PEOPL; Royer DL, 2008, TARGET ATMOSPHERIC C; Sachs J., 2005, END POVERTY WE CAN M; Shaffer ER, 2005, AM J PUBLIC HEALTH, V95, P23, DOI 10.2105/AJPH.2004.038091; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; Stern N. H., 2006, STERN REV EC CLIMATE; Stiglitz Joseph, 2006, MAKING GLOBALIZATION; SWAMINATHAN M, 93 IND SCI C 2006 HY; UNDP, 2007, HUM DEV REP FIGHT CL; United Nations, 1948, UN DECL HUM RIGHTS; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; *WORLDWATCH I, 2007, STAT WORLD 2007 OUR; [No title captured]	40	115	115	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1677	1683		10.1016/S0140-6736(08)61692-X	http://dx.doi.org/10.1016/S0140-6736(08)61692-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994666				2022-12-28	WOS:000260899900030
J	Debruyne, R; Schwarz, C; Poinar, H				Debruyne, Regis; Schwarz, Carsten; Poinar, Hendrik			Comment on "Whole-Genome Shotgun Sequencing of Mitochondria from Ancient Hair Shafts"	SCIENCE			English	Editorial Material									[Debruyne, Regis; Schwarz, Carsten; Poinar, Hendrik] McMaster Univ, McMaster Ancient DNA Ctr, Dept Anthropol, Hamilton, ON L8S 4L9, Canada	McMaster University	Debruyne, R (corresponding author), McMaster Univ, McMaster Ancient DNA Ctr, Dept Anthropol, 1280 Main St W, Hamilton, ON L8S 4L9, Canada.	debruyne@mcmaster.ca	Debruyne, Régis/G-7839-2011	Debruyne, Régis/0000-0002-7002-3940				Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Debruyne R, 2003, MOL PHYLOGENET EVOL, V26, P421, DOI 10.1016/S1055-7903(02)00292-0; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2006, FORENSIC SCI INT, V156, P208, DOI 10.1016/j.forsciint.2005.02.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mol D., 2001, P 1 INT C WORLD EL R, P305; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360	11	7	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903								10.1126/science.1158417	http://dx.doi.org/10.1126/science.1158417			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988826				2022-12-28	WOS:000260674100018
J	Szathmary, E; Szamado, S				Szathmary, Eoers; Szamado, Szabolcs			Being Human: Language: a social history of words	NATURE			English	Editorial Material									[Szathmary, Eoers; Szamado, Szabolcs] Eotvos Lorand Univ, Inst Biol, H-1117 Budapest, Hungary; [Szathmary, Eoers] Collegium Budapest, Budapest, Hungary; [Szathmary, Eoers] Parmenides Ctr Study Thinking, Munich, Germany	Eotvos Lorand University	Szathmary, E (corresponding author), Eotvos Lorand Univ, Inst Biol, 1-C Pazmany Peter Setany, H-1117 Budapest, Hungary.	szathmary@colbud.hu	Számadó, Szabolcs/A-9804-2013; Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021	Számadó, Szabolcs/0000-0003-2204-9705; Szathmary, Eors/0000-0001-5227-2997					0	10	11	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					40	41		10.1038/456040a	http://dx.doi.org/10.1038/456040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	369DH	18987725	Bronze			2022-12-28	WOS:000260674000031
J	Robb, ML				Robb, Merlin L.			Failure of the Merck HIV vaccine: an uncertain step forward	LANCET			English	Editorial Material							ANTIBODIES		[Robb, Merlin L.] US Mil HIV Res Program, Rockville, MD 20850 USA	Walter Reed Army Institute of Research (WRAIR)	Robb, ML (corresponding author), US Mil HIV Res Program, Rockville, MD 20850 USA.	mrobb@hivresearch.org						BUCHBINDER SP, 2008, LANCET          1113, DOI DOI 10.1016/S0140-6736(08)61591-3; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Garber DA, 2004, LANCET INFECT DIS, V4, P397, DOI 10.1016/S1473-3099(04)01056-4; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MCELRATH MJ, 2008, LANCET          1113, DOI DOI 10.1016/S0140-6736(08)61592-5; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sullivan PS, 2007, PLOS MED, V4, P1162, DOI 10.1371/journal.pmed.0040223; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759	12	50	53	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2008	372	9653					1857	1858		10.1016/S0140-6736(08)61593-7	http://dx.doi.org/10.1016/S0140-6736(08)61593-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	19012958				2022-12-28	WOS:000261388700004
J	Hamdan, SM; Loparo, JJ; Takahashi, M; Richardson, CC; van Oijen, AM				Hamdan, Samir M.; Loparo, Joseph J.; Takahashi, Masateru; Richardson, Charles C.; van Oijen, Antoine M.			Dynamics of DNA replication loops reveal temporal control of lagging-strand synthesis	NATURE			English	Article							OKAZAKI FRAGMENT SYNTHESIS; BACTERIOPHAGE T7; SINGLE-MOLECULE; POLYMERASE; FORK; PRIMASE; PROCESSIVITY; PROTEINS; DISSOCIATION; EXTENSION	In all organisms, the protein machinery responsible for the replication of DNA, the replisome, is faced with a directionality problem. The antiparallel nature of duplex DNA permits the leading- strand polymerase to advance in a continuous fashion, but forces the lagging- strand polymerase to synthesize in the opposite direction. By extending RNA primers, the lagging- strand polymerase restarts at short intervals and produces Okazaki fragments(1,2).At least in prokaryotic systems, this directionality problem is solved by the formation of a loop in the lagging strand of the replication fork to reorient the lagging- strand DNA polymerase so that it advances in parallel with the leading- strand polymerase. The replication loop grows and shrinks during each cycle of Okazaki fragment synthesis(3). Here we use single- molecule techniques to visualize, in real time, the formation and release of replication loops by individual replisomes of bacteriophage T7 supporting coordinated DNA replication. Analysis of the distributions of loop sizes and lag times between loops reveals that initiation of primer synthesis and the completion of an Okazaki fragment each serve as a trigger for loop release. The presence of two triggers may represent a fail-safe mechanism ensuring the timely reset of the replisome after the synthesis of every Okazaki fragment.	[Hamdan, Samir M.; Loparo, Joseph J.; Takahashi, Masateru; Richardson, Charles C.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	van Oijen, AM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [GM-077248, GM-54397]; National Science Foundation [CAREER 0543784]; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397, R01GM077248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-B. Lee for technical advice and S. Moskowitz for illustrations. This work was supported by the National Institutes of Health (grants GM-077248 to A.M.v.O. and GM-54397 to C.C.R.) and the National Science Foundation (CAREER grant 0543784 to A.M.v.O.). J.J.L. acknowledges the Jane Coffin Childs Memorial Fund for a postdoctoral fellowship.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Carver TE, 1997, BIOCHEMISTRY-US, V36, P14409, DOI 10.1021/bi971423p; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; De Saro FJL, 2003, P NATL ACAD SCI USA, V100, P14689, DOI 10.1073/pnas.2435454100; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hyland EM, 2003, J BIOL CHEM, V278, P7247, DOI 10.1074/jbc.M210605200; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; WU CA, 1992, J BIOL CHEM, V267, P4074; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029	27	117	117	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					336	U9		10.1038/nature07512	http://dx.doi.org/10.1038/nature07512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19029884	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000262440900044
J	Slutsker, L; Newman, RD				Slutsker, Laurence; Newman, Robert D.			Malaria scale-up progress: is the glass half-empty or half-full?	LANCET			English	Editorial Material									[Slutsker, Laurence; Newman, Robert D.] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30307 USA	Centers for Disease Control & Prevention - USA	Slutsker, L (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30307 USA.	lms5@cdc.gov	Tediosi, Fabrizio/L-1505-2015	Tediosi, Fabrizio/0000-0001-8671-9400				Campbell CC, 2008, AM J TROP MED HYG, V78, P851, DOI 10.4269/ajtmh.2008.78.851; Chambers RG, 2008, LANCET, V371, P1399, DOI 10.1016/S0140-6736(08)60609-1; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Lengeler C, 2007, LANCET, V370, P1009, DOI 10.1016/S0140-6736(07)61454-8; *MAL NO MOR, 2009, WORLD LEAD MAK UNPR; NOOR AM, 2008, LANCET          1118, DOI DOI 10.1016/S0140-6736(08)61596-2; Roll Back Malaria, GLOB MAL ACT PLAN; *ROLLB MAL PARTN, 2006, RBM PARTN FRAM; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Steketee RW, 2008, AM J TROP MED HYG, V79, P45, DOI 10.4269/ajtmh.2008.79.45; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; *UNICEF ROLL BACK, 2007, MAL CHILDR PROGR INT; *WORLD BANK, 2008, WORLD BANK GIV 1 BIL; 2008, FAST FACTS PRESIDENT	14	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					11	13		10.1016/S0140-6736(08)61597-4	http://dx.doi.org/10.1016/S0140-6736(08)61597-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19019423				2022-12-28	WOS:000262183800009
J	Karklin, Y; Lewicki, MS				Karklin, Yan; Lewicki, Michael S.			Emergence of complex cell properties by learning to generalize in natural scenes	NATURE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; RECEPTIVE-FIELDS; AREA V4; V1; RESPONSES; MODELS; IMAGES; NORMALIZATION; ORGANIZATION	A fundamental function of the visual system is to encode the building blocks of natural scenes - edges, textures and shapes - that subserve visual tasks such as object recognition and scene understanding. Essential to this process is the formation of abstract representations that generalize from specific instances of visual input. A common view holds that neurons in the early visual system signal conjunctions of image features(1,2), but how these produce invariant representations is poorly understood. Here we propose that to generalize over similar images, higher- level visual neurons encode statistical variations that characterize local image regions. We present a model in which neural activity encodes the probability distribution most consistent with a given image. Trained on natural images, the model generalizes by learning a compact set of dictionary elements for image distributions typically encountered in natural scenes. Model neurons show a diverse range of properties observed in cortical cells. These results provide a new functional explanation for nonlinear effects in complex cells(3-6) and offer insight into coding strategies in primary visual cortex (V1) and higher visual areas.	[Karklin, Yan; Lewicki, Michael S.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Karklin, Yan; Lewicki, Michael S.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Karklin, Y (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	yan.karklin@nyu.edu; michael.lewicki@case.edu			Department of Energy; Computational Science Graduate Fellowship; National Science Foundation [0413152, 0705677]; Office of Naval Research under the Multidisciplinary University Research Initiative [N000140710747]	Department of Energy(United States Department of Energy (DOE)); Computational Science Graduate Fellowship(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research under the Multidisciplinary University Research Initiative(MURI)	This work was supported by the Department of Energy through the Computational Science Graduate Fellowship (to Y.K.), the National Science Foundation Grant under grant numbers 0413152 and 0705677 (to M.S.L.) and the Office of Naval Research under the Multidisciplinary University Research Initiative N000140710747.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Connor CE, 2007, CURR OPIN NEUROBIOL, V17, P140, DOI 10.1016/j.conb.2007.03.002; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hurri J, 2003, NEURAL COMPUT, V15, P663, DOI 10.1162/089976603321192121; Hyvarinen A, 2001, VISION RES, V41, P2413, DOI 10.1016/S0042-6989(01)00114-6; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Yan KL, 2005, NEURAL COMPUT, V17, P397, DOI 10.1162/0899766053011474	31	141	147	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					83	U85		10.1038/nature07481	http://dx.doi.org/10.1038/nature07481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19020501				2022-12-28	WOS:000262104900035
J	Engelkes, T; Morrien, E; Verhoeven, KJF; Bezemer, TM; Biere, A; Harvey, JA; McIntyre, LM; Tamis, WLM; van der Putten, WH				Engelkes, Tim; Morrien, Elly; Verhoeven, Koen J. F.; Bezemer, T. Martijn; Biere, Arjen; Harvey, Jeffrey A.; McIntyre, Lauren M.; Tamis, Wil L. M.; van der Putten, Wim H.			Successful range-expanding plants experience less above-ground and below-ground enemy impact	NATURE			English	Article							CLIMATE-CHANGE; SOIL BIOTA; BRITISH BUTTERFLIES; NATURAL ENEMIES; INVASIVE PLANTS; FEEDBACK; HERBIVORES; RELEASE; COMMUNITIES; PATHOGENS	Many species are currently moving to higher latitudes and altitudes(1-3). However, little is known about the factors that influence the future performance of range- expanding species in their new habitats. Here we show that range- expanding plant species from a riverine area were better defended against shoot and root enemies than were related native plant species growing in the same area. We grew fifteen plant species with and without non- coevolved polyphagous locusts and cosmopolitan, polyphagous aphids. Contrary to our expectations, the locusts performed more poorly on the range- expanding plant species than on the congeneric native plant species, whereas the aphids showed no difference. The shoot herbivores reduced the biomass of the native plants more than they did that of the congeneric range expanders. Also, the range- expanding plants developed fewer pathogenic effects(4,5) in their root- zone soil than did the related native species. Current predictions forecast biodiversity loss due to limitations in the ability of species to adjust to climate warming conditions in their range(6-8). Our results strongly suggest that the plants that shift ranges towards higher latitudes and altitudes may include potential invaders, as the successful range expanders may experience less control by above- ground or below-ground enemies than the natives.	[Engelkes, Tim; Morrien, Elly; Verhoeven, Koen J. F.; Bezemer, T. Martijn; Biere, Arjen; Harvey, Jeffrey A.; van der Putten, Wim H.] Netherlands Inst Ecol, NIOO KNAW, Dept Multitroph Interact, NL-6666 ZG Heteren, Netherlands; [Bezemer, T. Martijn; van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, NL-6700 ES Wageningen, Netherlands; [McIntyre, Lauren M.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [McIntyre, Lauren M.] Univ Florida, Dept Stat, Gainesville, FL 32610 USA; [Tamis, Wil L. M.] Natl Herbarium Nederland, Leiden Univ Branch, NL-2300 RA Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Leiden University; Leiden University - Excl LUMC	van der Putten, WH (corresponding author), Netherlands Inst Ecol, NIOO KNAW, Dept Multitroph Interact, POB 40, NL-6666 ZG Heteren, Netherlands.	w.vanderputten@nioo.knaw.nl	McIntyre, Lauren/J-8414-2012; Biere, Arjen/B-8079-2008; Verhoeven, Koen JF/C-9920-2010; van der Putten, Wim H/C-3707-2011; Bezemer, Martijn/A-4068-2009; Morrien, Elly/H-3527-2011; Harvey, Jeffrey A/B-7439-2008	McIntyre, Lauren/0000-0002-0077-3359; Biere, Arjen/0000-0002-9006-3448; Verhoeven, Koen JF/0000-0003-3002-4102; van der Putten, Wim H/0000-0002-9341-4442; Bezemer, Martijn/0000-0002-2878-3479; Morrien, Elly/0000-0002-6490-2260; Harvey, Jeffrey A/0000-0002-4227-7935	ALW-VICI	ALW-VICI	We thank Staatsbosbeheer Regio Oost for giving us permission to work in Millingerwaard; B. Ode, K. Groen, R. van Grunsven, P. Brinkman and the late R. van der Meijden for discussions; M. Houtekamer for carbon and nitrogen determination; T. Vos, M. Vlag, A. Weerheijm and W. Smant for assistance; L. Koopman for providing the locusts; and L. Young and E. J. Bakker for advice on statistics. This study was funded by an ALW-VICI grant to W.H.v.d.P.	Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Levine JM, 2006, ECOL LETT, V9, P1005, DOI 10.1111/j.1461-0248.2006.00949.x; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; van der Putten WH, 2005, BIOL INVASIONS, V7, P733, DOI 10.1007/s10530-004-1196-3; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van Grunsven RHA, 2007, J ECOL, V95, P1050, DOI 10.1111/j.1365-2745.2007.01282.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	28	209	215	7	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					946	948		10.1038/nature07474	http://dx.doi.org/10.1038/nature07474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19020504				2022-12-28	WOS:000261768300044
J	Cohen, AA; Geva-Zatorsky, N; Eden, E; Frenkel-Morgenstern, M; Issaeva, I; Sigal, A; Milo, R; Cohen-Saidon, C; Liron, Y; Kam, Z; Cohen, L; Danon, T; Perzov, N; Alon, U				Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Sigal, A.; Milo, R.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U.			Dynamic Proteomics of Individual Cancer Cells in Response to a Drug	SCIENCE			English	Article							PROTEIN EXPRESSION; INDUCED APOPTOSIS; GENE-EXPRESSION; SYSTEMS BIOLOGY; TOPOISOMERASE-I; GLOBAL ANALYSIS; BUDDING YEAST; SINGLE-CELL; NOISE; DNA	Why do seemingly identical cells respond differently to a drug? To address this, we studied the dynamics and variability of the protein response of human cancer cells to a chemotherapy drug, camptothecin. We present a dynamic- proteomics approach that measures the levels and locations of nearly 1000 different endogenously tagged proteins in individual living cells at high temporal resolution. All cells show rapid translocation of proteins specific to the drug mechanism, including the drug target ( topoisomerase- 1), and slower, wide- ranging temporal waves of protein degradation and accumulation. However, the cells differ in the behavior of a subset of proteins. We identify proteins whose dynamics differ widely between cells, in a way that corresponds to the outcomes- cell death or survival. This opens the way to understanding molecular responses to drugs in individual cells.	[Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Sigal, A.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Milo, R.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; California Institute of Technology; Weizmann Institute of Science	Issaeva, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	ariel.cohen@weizmann.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021; Sigal, Alex/GWC-7488-2022	Geva-Zatorsky, Naama/0000-0002-7303-854X; Sigal, Alex/0000-0001-8571-2004; Frenkel-Morgenstern, Milana/0000-0002-0329-4599; Milo, Ron/0000-0003-1641-2299	Kahn Family Foundation; Israel Science Foundation; Yeshaya Horowitz Association; Center for Complexity Science	Kahn Family Foundation; Israel Science Foundation(Israel Science Foundation); Yeshaya Horowitz Association; Center for Complexity Science	We thank the Kahn Family Foundation and the Israel Science Foundation for support. We thank E. Zalckvar, J. Bar, I. Glinert, T. Shlapok, and members of the Alon laboratory for discussions. The work of M.F.-M. and E.E. is supported by the Yeshaya Horowitz Association through the Center for Complexity Science.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Clyne PJ, 2003, GENETICS, V165, P1433; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Eggert US, 2006, CURR OPIN CHEM BIOL, V10, P232, DOI 10.1016/j.cbpa.2006.04.010; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; MULLER MT, 1985, EMBO J, V4, P1237, DOI 10.1002/j.1460-2075.1985.tb03766.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Trinkle-Mulcahy L, 2007, SCIENCE, V318, P1402, DOI 10.1126/science.1142033; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	34	436	447	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2008	322	5907					1511	1516		10.1126/science.1160165	http://dx.doi.org/10.1126/science.1160165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379DU	19023046	Green Accepted			2022-12-28	WOS:000261377400041
J	Okie, S				Okie, Susan			Innovation in Primary Care - Staying One Step Ahead of Burnout	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Scott JC, 2004, J AM GERIATR SOC, V52, P1463, DOI 10.1111/j.1532-5415.2004.52408.x; SINSKY CA, 2006, FAMILY PRACTICE MANA, P28	2	26	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2305	2309		10.1056/NEJMp0805759	http://dx.doi.org/10.1056/NEJMp0805759			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377SG	19038876				2022-12-28	WOS:000261270300001
J	Buerhaus, PI				Buerhaus, Peter I.			Current and Future State of the US Nursing Workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BOTTLENECK; TRENDS		[Buerhaus, Peter I.] Vanderbilt Univ, Med Ctr, Ctr Interdisciplinary Hlth Workforce Studies, Inst Med & Publ Hlth,Sch Nursing, Nashville, TN 37203 USA	Vanderbilt University	Buerhaus, PI (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Interdisciplinary Hlth Workforce Studies, Inst Med & Publ Hlth,Sch Nursing, 6th Floor,Ste 600,2525 W End Ave, Nashville, TN 37203 USA.	Peter.Buerhaus@vanderbilt.edu						Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; *AM ASS COLL NURS, MISS PERS MIN HLTH P; Buerhaus PI, 2007, NURS ECON, V25, P69; Buerhaus PI, 2007, NURS ECON, V25, P59; Buerhaus PI, 2000, JAMA-J AM MED ASSOC, V283, P2948, DOI 10.1001/jama.283.22.2948; Buerhaus PI, 2008, FUTURE NURSING WORKF; Hendrich Ann, 2008, Perm J, V12, P25; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P887, DOI 10.1001/jama.300.8.887; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V298, P1623, DOI 10.1001/jama.298.14.1623; Litvak E, 2005, JT COMM J QUAL PATIE, V31, P330, DOI 10.1016/S1553-7250(05)31044-0; Nelson A, 2006, INT J NURS STUD, V43, P717, DOI 10.1016/j.ijnurstu.2005.09.004; Page A., 2004, KEEPING PATIENTS SAF; Schubert M, 2008, INT J QUAL HEALTH C, V20, P227, DOI 10.1093/intqhc/mzn017; Wunderlich G, 1996, NURSING STAFF HOSP N	14	79	79	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2422	2424		10.1001/jama.2008.729	http://dx.doi.org/10.1001/jama.2008.729			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375YX	19033594				2022-12-28	WOS:000261150800026
J	Hernandez, AF; Shea, AM; Milano, CA; Rogers, JG; Hammill, BG; O'Connor, CM; Schulman, KA; Peterson, ED; Curtis, LH				Hernandez, Adrian F.; Shea, Alisa M.; Milano, Carmelo A.; Rogers, Joseph G.; Hammill, Bradley G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.			Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL CIRCULATORY SUPPORT; CHRONIC HEART-FAILURE; TRANSPLANTATION; IMPLANTATION; UPDATE; DESTINATION; MANAGEMENT; COMMITTEE; ACCURACY; ICD-9-CM	Context In 2003, Medicare expanded coverage of ventricular assist devices as destination, or permanent, therapy for end- stage heart failure. Little is known about the long- term outcomes and costs associated with these devices. Objective To examine the acute and long- term outcomes of Medicare beneficiaries receiving ventricular assist devices alone or after open- heart surgery. Design, Setting, and Patients Analysis of inpatient claims from the Centers for Medicare & Medicaid Services for the period 2000 through 2006. Patients were Medicare fee- for- service beneficiaries who received a ventricular assist device between February 2000 and June 2006 alone as primary therapy ( primary device group; n= 1476) or after cardiotomy in the previous 30 days ( postcardiotomy group; n= 1467). Main Outcome Measures Cumulative incidence of device replacement, device removal, heart transplantation, readmission, and death, accounting for censoring and competing risks. Patients were followed up for at least 6 months and factors independently associated with long- term survival were identified. Medicare payments were used to calculate total inpatient costs and costs per day outside the hospital. Results Overall 1- year survival was 51.6% ( n= 669) in the primary device group and 30.8% ( n= 424) in the postcardiotomy group. Among primary device patients, 815 ( 55.2%) were discharged alive with a device. Of those, 450 (55.6%) were readmitted within 6 months and 504 (73.2%) were alive at 1 year. Of the 493 (33.6%) postcardiotomy patients discharged alive with a device, 237 (48.3%) were readmitted within 6 months and 355 (76.6%) were alive at 1 year. Mean 1- year Medicare payments for inpatient care for patients in the 2000- 2005 cohorts were $178714 (SD, $142549) in the primary device group and $ 111769 ( SD, $ 95413) in the postcardiotomy group. Conclusions Among Medicare beneficiaries receiving a ventricular assist device, early mortality, morbidity, and costs remain high. Improving patient selection and reducing perioperative mortality are critical for improving overall outcomes.	[Hernandez, Adrian F.; Shea, Alisa M.; Rogers, Joseph G.; Hammill, Bradley G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Rogers, Joseph G.; O'Connor, Christopher M.; Schulman, Kevin A.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Milano, Carmelo A.] Duke Univ, Sch Med, Dept Surg, Durham, NC 27715 USA	Duke University; Duke University; Duke University	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021	Hernandez, Adrian F/0000-0003-3387-9616; 	National Institute on Aging [1R01AG026038-01A1]; Agency for Healthcare Research and Quality [1U18HS016964-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026038] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by grants 1R01AG026038-01A1 from the National Institute on Aging and 1U18HS016964-01 from the Agency for Healthcare Research and Quality.	Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; *CTR MED MED SERV, DEC MEM VENTR ASS DE; CURTIS LH, IN PRESS ARCH INTERN; Esmore D, 2007, EUR J CARDIO-THORAC, V32, P735, DOI 10.1016/j.ejcts.2007.07.028; Felker GM, 2008, J CARD FAIL, V14, P368, DOI 10.1016/j.cardfail.2008.01.009; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Goldstein DJ, 2003, CIRCULATION, V108, P272, DOI 10.1161/01.cir.0000087387.02218.7e; Helman DN, 1999, ANN THORAC SURG, V68, P1187, DOI 10.1016/S0003-4975(99)00911-X; Hernandez AF, 2007, CIRCULATION, V116, P606, DOI 10.1161/CIRCULATIONAHA.106.666289; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kherani AR, 2003, J THORAC CARDIOV SUR, V126, P1634, DOI 10.1016/S0022-5223(03)00727-X; Kirklin JK, 2008, CIRC-HEART FAIL, V1, P200, DOI 10.1161/CIRCHEARTFAILURE.108.782599; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Long James W, 2005, Congest Heart Fail, V11, P133, DOI 10.1111/j.1527-5299.2005.04540.x; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; *NAT HEART LUNG BL, CLIN US VENTR ASS DE; *NAT HEART LUNG BL, NEXT GEN VENTR ASS D; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rogers JG, 2007, J AM COLL CARDIOL, V50, P741, DOI 10.1016/j.jacc.2007.03.063; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Russo MJ, 2008, J CARD FAIL, V14, P651, DOI 10.1016/j.cardfail.2008.06.005; Showstack J, 1999, JAMA-J AM MED ASSOC, V281, P1381, DOI 10.1001/jama.281.15.1381; Stevenson LW, 2005, CIRCULATION, V112, pE111, DOI 10.1161/CIRCULATIONAHA.104.506451; Stevenson LW, 2004, CIRCULATION, V110, P975, DOI 10.1161/01.CIR.0000139862.48167.23; Tunis SR, 2004, NEW ENGL J MED, V350, P2196, DOI 10.1056/NEJMe048091	30	67	67	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2398	2406		10.1001/jama.2008.716	http://dx.doi.org/10.1001/jama.2008.716			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033590	Green Accepted, Bronze			2022-12-28	WOS:000261150800022
J	Epstein, H				Epstein, Helen			AIDS and the irrational	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONCURRENT SEXUAL PARTNERSHIPS; HIV-INFECTION; TRANSMITTED INFECTIONS; AFRICAN-AMERICANS; YOUNG MEN; BEHAVIOR; RISK; PREVENTION; SPREAD; COMMUNITIES					helenepstein@yahoo.com						Adimora AA, 2004, ANN EPIDEMIOL, V14, P155, DOI 10.1016/S1047-2797(03)00129-7; Adimora AA, 2003, JAIDS-J ACQ IMM DEF, V34, P423, DOI 10.1097/00126334-200312010-00010; ANKRAH M, 1993, AIDS UGANDA ANAL SOC; Baeten JM, 2005, J INFECT DIS, V191, P546, DOI 10.1086/427656; BARTON T, 1997, EPIDEMICS BEHA UNPUB; BECKER MH, 1988, AM J PUBLIC HEALTH, V78, P394, DOI 10.2105/AJPH.78.4.394; BOGART L, 2005, J ACQ IMMUN DEF SYND, V38, P2; CARAEL M, 2001, AFRICAN J REPROD HLT, V5, P83, DOI DOI 10.2307/3583201; Carael M., 1995, SEXUAL BEHAV AIDS DE; Carter MW, 2007, AIDS BEHAV, V11, P822, DOI 10.1007/s10461-006-9203-6; Christakis NA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1675; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Colvin M, 1998, INT J STD AIDS, V9, P548, DOI 10.1258/0956462981922683; Drumright LN, 2004, SEX TRANSM DIS, V31, P437, DOI 10.1097/01.olq.0000129949.30114.37; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; EPSTEIN H, 2004, DISCOVER         FEB; EPSTEIN H, 2005, AIDSLINK         SEP, P93; Epstein Helen, 2008, INVISIBLE CURE AFRIC; *FAM HLTH INT, 2002, SWAZ BEH SURV SURV; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GILGEN D, 2000, NATURAL HIST HIV AID; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2007, S AFR J HIV MED, P19; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; HEATON L, 2006, 16 INT AIDS C 13 18; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; HUDSON CP, 1994, AIDS, V8, P1739, DOI 10.1097/00002030-199412000-00021; Hudson CP, 1996, INT J STD AIDS, V7, P236, DOI 10.1258/0956462961917906; HUDSON CP, 1993, AIDS, V7, P286, DOI 10.1097/00002030-199302000-00024; Human Rights Watch, 2007, HIDD MEAL MEAL GEND; KALEEBA N, 2002, WE MISS YOU ALL AIDS; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; MAH T, 2008, 225 CTR SOC SCI RES; MAH T, 2008, AIDS BEHAV      0722; MAJIRIOGHENE B, 2008, NIGERIANS AM    1013; Matovu JKB, 2007, AIDS BEHAV, V11, P71, DOI 10.1007/s10461-006-9170-y; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; MEYERSON B, TCM EXPOSURE HIV REL; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2001, SEX TRANSM DIS, V28, P504, DOI 10.1097/00007435-200109000-00005; MORRIS M, 2007, SEXUALLY TRANSMITTED; Moszynski P, 2007, BRIT MED J, V334, P712, DOI 10.1136/bmj.39171.431736.DB; MUSINGUZI J, 1996, RESULTS POPULATION B; MUSSA A, 2001, THESIS U WASHINGTON; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; OBBO C, 1993, SOC SCI MED, V36, P949, DOI 10.1016/0277-9536(93)90086-J; Parker W, 2007, CONCURRENT SEXUAL PA; PARKER W, 2007, NAMIBIA MIDTERM HOUS; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; PIOT P, 1994, HIV EPIDEMIOLOGY, P77; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; *POP COUNC, 2006, AD GIRLS SOC SUPP LI; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Roehr B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2566; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; *SO AFR DEV COMM, 2006, REP EXP THINK TANK M; STANDING H, 1989, SEXUAL BEHAV AIDS SU; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; SULLIVAN J, 2006, AIDS; TALLE A, 1995, YOUNG PEOPLE RISK FI; Tuffs A, 2007, BRIT MED J, V334, P712, DOI 10.1136/bmj.39170.736412.DB; *UG MIN HLTH, 1995, UG DEM HLTH SURV 199; UNAIDS, 2001, HIV PREV NEEDS SUCC; *UNAIDS, 2006, REP GLOB AIDS EP 200, P127; *UNAIDS, 2008, REP GLOB AIDS EP 200, P36; Voeten HACM, 2004, SEX TRANSM DIS, V31, P481, DOI 10.1097/01.olq.0000135989.14131.9d; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; *WORLD BANK, 2003, ED HIV AIDS SOUR HIV	73	16	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2008	337								a2638	10.1136/bmj.a2638	http://dx.doi.org/10.1136/bmj.a2638			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QA	19033334				2022-12-28	WOS:000261827500017
J	Sturkenboom, MCJM; Verhamme, KMC; Nicolosi, A; Murray, ML; Neubert, A; Caudri, D; Picelli, G; Sen, EF; Giaquinto, C; Cantarutti, L; Baiardi, P; Felisi, MG; Ceci, A; Wong, ICK				Sturkenboom, Miriam C. J. M.; Verhamme, Katia M. C.; Nicolosi, Alfredo; Murray, Macey L.; Neubert, Antje; Caudri, Daan; Picelli, Gino; Sen, Elif Fatma; Giaquinto, Carlo; Cantarutti, Luigi; Baiardi, Paola; Felisi, Maria-Grazia; Ceci, Adriana; Wong, Ian C. K.		TEDDY European Network Excellence	Drug use in children: cohort study in three European countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL-CONTRACEPTIVE USE; YOUNG SWEDISH WOMEN; INFECTIOUS CONJUNCTIVITIS; VENOUS THROMBOEMBOLISM; PATIENT RECORDS; STROKE; SUPPRESSION; IMPACT; GROWTH; ACID	Objective To provide an overview of drug use in children in three European countries. Design Retrospective cohort study, 2000-5. Setting Primary care research databases in the Netherlands (IPCI), United Kingdom (IMS-DA), and Italy (Pedianet). Participants 675 868 children aged up to 14 (Italy) or 18 (UK and Netherlands). Main outcome measure Prevalence of use per year calculated by drug class (anatomical and therapeutic). Prevalence of "recurrent/chronic" use (three or more prescriptions a year) and "non-recurrent" or "acute" use (less than three prescriptions a year) within each therapeutic class. Descriptions of the top five most commonly used drugs evaluated for off label status within each anatomical class. Results Three levels of drug use could be distinguished in the study population: high (> 10/100 children per year), moderate (1-10/100 children per year), and low (< 1/100 children per year). For all age categories, anti-infective, dermatological, and respiratory drugs were in the high use group, whereas cardiovascular and antineoplastic drugs were always in the low use group. Emollients, topical steroids, and asthma drugs had the highest prevalence of recurrent use, but relative use of low prevalence drugs was more often recurrent than acute. In the top five highest prevalence drugs topical inhaled and systemic steroids, oral contraceptives, and topical or systemic antifungal drugs were most commonly used off label. Conclusion This overview of outpatient paediatric prescription patterns in a large European population could provide information to prioritise paediatric therapeutic research needs.	[Sturkenboom, Miriam C. J. M.; Verhamme, Katia M. C.; Caudri, Daan; Sen, Elif Fatma] Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Sturkenboom, Miriam C. J. M.] Erasmus Univ, Dept Epidemiol, Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Nicolosi, Alfredo] CNR, Inst Biomed Technol, Dept Epidemiol & Med Informat, I-20090 Milan, Italy; [Nicolosi, Alfredo] Columbia Univ, Sch Publ Hlth, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Murray, Macey L.; Neubert, Antje; Wong, Ian C. K.] Univ London, Sch Pharm, Ctr Paediat Pharm Res, London WC1N 1AX, England; [Murray, Macey L.; Neubert, Antje; Wong, Ian C. K.] Univ London, Inst Child Hlth, London WC1N 1AX, England; [Picelli, Gino] Int Pharmacoecon Res Ctr, I-20033 Desio, Italy; [Giaquinto, Carlo] Univ Hosp, Dept Paediat, Padua, Italy; [Cantarutti, Luigi] Soc Servizi Telemat, I-35138 Padua, Italy; [Baiardi, Paola; Felisi, Maria-Grazia; Ceci, Adriana] Consorzio Valutazioni Biol & Farmacol, I-27100 Pavia, Italy	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Columbia University; University of London; University College London; University of London School of Pharmacy; University of London; University College London; University of Padua; Azienda Ospedaliera - Universita di Padova	Sturkenboom, MCJM (corresponding author), Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 CA Rotterdam, Netherlands.	m.sturkenboom@erasmusmc.nl	Baiardi, Paola/AAB-9060-2020; Neubert, Antje/A-7496-2010; Giaquinto, Carlo/AAB-5016-2020; Ceci, Adriana/D-1328-2014	Baiardi, Paola/0000-0002-1622-8400; Verhamme, Katia/0000-0001-8162-4904; Wong, Ian Chi Kei/0000-0001-8242-0014; GIAQUINTO, CARLO/0000-0001-9365-0413; Murray, Macey/0000-0001-6418-0854	European Community's 6th Framework Programme [LSHB-CT-2005-005216]; UK Department of Health Public Health Career Scientist Award	European Community's 6th Framework Programme; UK Department of Health Public Health Career Scientist Award	The study was funded by the European Community's 6th Framework Programme, project No LSHB-CT-2005-005216: TEDDY: Task force in Europe for Drug Development for the Young. The funding agency had no role in the collection of data, the analysis or interpretation of the data, or of the decision to submit. ICKW's post was funded by a UK Department of Health Public Health Career Scientist Award.	Allen David B, 2006, Adv Pediatr, V53, P101, DOI 10.1016/j.yapd.2006.04.006; Allen DB, 1996, ENDOCRIN METAB CLIN, V25, P699, DOI 10.1016/S0889-8529(05)70348-0; Choonara I, 2002, DRUG SAFETY, V25, P1, DOI 10.2165/00002018-200225010-00001; CLAVENNA A, 2008, EUR J PEDIAT    0430; Cromer BA, 2006, J ADOLESCENT HEALTH, V39, P296, DOI 10.1016/j.jadohealth.2006.03.011; David MA, 2005, J PERIPHER NERV SYST, V10, P18; EIGEN H, 1995, J PEDIATR-US, V126, P515, DOI 10.1016/S0022-3476(95)70343-8; *EUR MED AG, 2006, EMEA496772006; European Medicines Agency, 2004, EMEA1263272004; Gulliver T, 2005, IMMUNOL ALLERGY CLIN, V25, P541, DOI 10.1016/j.iac.2005.04.001; Hamerlynck J V T H, 2007, Ned Tijdschr Geneeskd, V151, P594; Hartard M, 2004, BONE, V35, P836, DOI 10.1016/j.bone.2004.05.017; Heinemann LAJ, 1998, CONTRACEPTION, V57, P29, DOI 10.1016/S0010-7824(97)00204-7; Heinemann LAJ, 1997, BRIT MED J, V315, P1502, DOI 10.1136/bmj.315.7121.1502; Horen B, 2002, BRIT J CLIN PHARMACO, V54, P665, DOI 10.1046/j.1365-2125.2002.t01-3-01689.x; Lewis MA, 1998, AM J OBSTET GYNECOL, V179, pS68, DOI 10.1053/ob.1998.v179.a93122; Lloyd T, 2002, OBSTET GYNECOL, V100, P235, DOI 10.1016/S0029-7844(02)02056-2; Madsen H, 2001, EUR J CLIN PHARMACOL, V57, P159, DOI 10.1007/s002280100279; Neubert A, 2004, DRUG SAFETY, V27, P1059, DOI 10.2165/00002018-200427130-00006; NEUBERT A, PHARM RES IN PRESS; Pandolfini C, 2005, EUR J PEDIATR, V164, P552, DOI 10.1007/s00431-005-1698-8; Rietveld RP, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-54; Rietveld RP, 2005, BRIT J GEN PRACT, V55, P924; Rose K., 2006, GUIDE PAEDIAT CLIN R, P33, DOI [10.1159/000097774, DOI 10.1159/000097774]; Rose P, 2007, EXPERT OPIN PHARMACO, V8, P1903, DOI 10.1517/14656566.8.12.1903; Samuelsson E, 2005, EUR J EPIDEMIOL, V20, P509, DOI 10.1007/s10654-005-4266-7; Samuelsson E, 2004, ACTA OBSTET GYN SCAN, V83, P674, DOI 10.1111/j.0001-6349.2004.00574.x; Schirm E, 2000, BRIT J CLIN PHARMACO, V50, P473, DOI 10.1046/j.1365-2125.2000.00275.x; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; Silwer L, 2005, PHARMACOEPIDEM DR S, V14, P813, DOI 10.1002/pds.1124; Sturkenboom M, 2005, PEDIATRICS, V116, pE26, DOI 10.1542/peds.2004-0040; STURKENBOOM MCJ, 2007, PHARMACOVIGILANCE; Sutcliffe AG, 2003, BMJ-BRIT MED J, V326, P64, DOI 10.1136/bmj.326.7380.64; Thrane N, 1999, ACTA PAEDIATR, V88, P1131, DOI 10.1080/08035259950168216; TJONG G, 2002, BRIT MED J, V324, P1314; Todd G, 1996, LANCET, V348, P27, DOI 10.1016/S0140-6736(96)03339-9; *US FDA, 2005, PED EXCL LAB CHANG J; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Watson Rory, 2006, BMJ, V332, P1352, DOI 10.1136/bmj.332.7554.1352-c; WHO, 2007, MAK MED CHILD SIZ; Wong ICK, 2005, BRIT J CLIN PHARMACO, V59, P750, DOI 10.1111/j.1365-2125.2005.02450.x	42	133	135	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2008	337								a2245	10.1136/bmj.a2245	http://dx.doi.org/10.1136/bmj.a2245			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385PZ	19029175	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000261827400001
J	Park, T; Sidorov, VA; Ronning, F; Zhu, JX; Tokiwa, Y; Lee, H; Bauer, ED; Movshovich, R; Sarrao, JL; Thompson, JD				Park, T.; Sidorov, V. A.; Ronning, F.; Zhu, J. -X.; Tokiwa, Y.; Lee, H.; Bauer, E. D.; Movshovich, R.; Sarrao, J. L.; Thompson, J. D.			Isotropic quantum scattering and unconventional superconductivity	NATURE			English	Article							PHASE-TRANSITIONS; CRITICAL-POINT; HEAVY; METALS; CRITICALITY; DISORDER; CERHIN5; SPIN	Superconductivity without phonons has been proposed for strongly correlated electron materials that are tuned close to a zero- temperature magnetic instability of itinerant charge carriers(1). Near this boundary, quantum fluctuations of magnetic degrees of freedom assume the role of phonons in conventional superconductors, creating an attractive interaction that 'glues' electrons into superconducting pairs. Here we show that superconductivity can arise from a very different spectrum of fluctuations associated with a local (or Kondo-breakdown) quantum critical point(2-5) that is revealed in isotropic scattering of charge carriers and a sublinear, temperature-dependent electrical resistivity. At this critical point, accessed by applying pressure to the strongly correlated, local- moment antiferromagnet CeRhIn5, magnetic and charge fluctuations coexist and produce electronic scattering that is maximal at the optimal pressure for superconductivity. This previously unanticipated source of pairing glue(6) opens possibilities for understanding and discovering new unconventional forms of superconductivity.	[Park, T.; Sidorov, V. A.; Ronning, F.; Zhu, J. -X.; Tokiwa, Y.; Lee, H.; Bauer, E. D.; Movshovich, R.; Sarrao, J. L.; Thompson, J. D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Park, T.] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Sidorov, V. A.] RAS, Vereshchagin Inst High Pressure Phys, Troitsk 142190, Russia	United States Department of Energy (DOE); Los Alamos National Laboratory; Sungkyunkwan University (SKKU); Russian Academy of Sciences; Vereshchagin Institute of High Pressure Physics, Russian Academy of Sciences	Park, T (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	tuson@lanl.gov; jdt@lanl.gov	Bauer, Eric D/D-7212-2011; Tokiwa, Yoshifumi/P-6593-2015; Park, Tuson/A-1520-2012	Tokiwa, Yoshifumi/0000-0002-6294-7879; Park, Tuson/0000-0003-2974-8410; Zhu, Jianxin/0000-0001-7991-3918; Ronning, Filip/0000-0002-2679-7957; Bauer, Eric/0000-0003-0017-1937; Movshovich, Roman/0000-0002-3667-634X	Los Alamos Directed Research and Developmental; Russian Foundation for Basic Research [06-02-16590]; Program of the Presidium of RAS on Physics of Strongly Compressed Matter	Los Alamos Directed Research and Developmental; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of the Presidium of RAS on Physics of Strongly Compressed Matter	The authors thank Q. Si, C.D. Batista, A.V. Balatsky, C. Varma, Z. Nussivnov, D. Pines and N.J. Curro for discussions. Work at LosAlamos National Laboratory was performed under the auspices of the US Department of Energy, Office of Science, with support from the Los Alamos Directed Research and Developmental programme. V.A.S. appreciates the support of the Russian Foundation for Basic Research (grant no. 06-02-16590) and the Program of the Presidium of RAS on Physics of Strongly Compressed Matter.	ABRIKOSOV AA, 1961, SOV PHYS JETP-USSR, V12, P1243; Bao W, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.100505; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Flint R, 2008, NAT PHYS, V4, P643, DOI 10.1038/nphys1024; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Hewson A C, 1993, KONDO PROBLEM HEAVY; Mackenzie AP, 1998, PHYS REV LETT, V80, P161, DOI 10.1103/PhysRevLett.80.161; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Monthoux P, 2007, NATURE, V450, P1177, DOI 10.1038/nature06480; Normile PS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.184508; Paglione J, 2007, NAT PHYS, V3, P703, DOI 10.1038/nphys711; Panagopoulos C, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064501; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; Paul I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026402; Pepin C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206401; Rosch A, 1999, PHYS REV LETT, V82, P4280, DOI 10.1103/PhysRevLett.82.4280; Settai R, 2001, J PHYS-CONDENS MAT, V13, pL627, DOI 10.1088/0953-8984/13/27/103; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Yuan HQ, 2003, SCIENCE, V302, P2104, DOI 10.1126/science.1091648	24	84	85	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					366	368		10.1038/nature07431	http://dx.doi.org/10.1038/nature07431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020616	Green Submitted			2022-12-28	WOS:000261039600038
J	Walker, AS; Spiegelhalter, D; Crook, DW; Wyllie, D; Morris, J; Peto, TEA				Walker, A. Sarah; Spiegelhalter, David; Crook, Derrick W.; Wyllie, David; Morris, James; Peto, Tim E. A.			Fairness of financial penalties to improve control of Clostridium difficile	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; STRAIN; REGRESSION; INFECTION; EPIDEMIC; QUALITY; DISEASE; PAY		[Walker, A. Sarah; Crook, Derrick W.; Morris, James; Peto, Tim E. A.] John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England; [Walker, A. Sarah] MRC, Clin Trials Unit, London NW1 2DA, England; [Spiegelhalter, David] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Spiegelhalter, David] Ctr Math Sci, Stat Lab, Cambridge CB3 0WB, England; [Wyllie, David] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; Medical Research Council Clinical Trials Unit; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; University of Oxford	Walker, AS (corresponding author), John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England.	asw@ctu.mrc.ac.uk	Walker, Sarah/HDM-8717-2022	peto, tim/0000-0003-3477-8307	Medical Research Council [MC_U105260557] Funding Source: Medline; MRC [MC_U105260557] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Duckett SJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-72; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; *HEALTHC COMM, STAT BAND NAT TARG I; HEALY MJR, 1978, ANN HUM BIOL, V5, P277, DOI 10.1080/03014467800002891; *HLTH PROT AG, CLOSTR DIFF; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Morton V, 2003, BRIT MED J, V326, P1083, DOI 10.1136/bmj.326.7398.1083; Morton V, 2005, J EVAL CLIN PRACT, V11, P59, DOI 10.1111/j.1365-2753.2004.00505.x; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; *UK DEP HLTH, NAT TARG RED CLOSTR; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258	15	4	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2008	337								a2097	10.1136/bmj.a2097	http://dx.doi.org/10.1136/bmj.a2097			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HS	19022838				2022-12-28	WOS:000262654100001
J	Janes, H; Pepe, MS; Gu, W				Janes, Holly; Pepe, Margaret S.; Gu, Wen			Assessing the Value of Risk Predictions by Using Risk Stratification Tables	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER RISK; CARDIOVASCULAR RISK; ABSOLUTE RISK; ROC CURVE; MODELS; MARKER; RECLASSIFICATION; PREDICTIVENESS; DISEASE; ABILITY	The recent epidemiologic and clinical literature is filled with studies evaluating statistical models for predicting disease or some other adverse event. Risk stratification tables are a new way to evaluate the benefit of adding a new risk marker to a risk prediction model that includes an established set of markers. This approach involves cross-tabulating risk predictions from models with and without the new marker. In this article, the authors use examples to show how risk stratification tables can be used to compare 3 important measures of model performance between the models with and those without the new marker: the extent to which the risks calculated from the models reflect the actual fraction of persons in the population with events (calibration); the proportions in which the population is stratified into clinically relevant risk categories (stratification capacity); and the extent to which participants with events are assigned to high-risk categories and those without events are assigned to low-risk categories (classification accuracy). They detail common misinterpretations and misuses of the risk stratification method and conclude that the information that can be extracted from risk stratification tables is an enormous improvement over commonly reported measures of risk prediction model performance (for example, c-statistics and Hosmer-Lemeshow tests) because it describes the value of the models for guiding medical decisions.	[Janes, Holly] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M2-C200, Seattle, WA 98109 USA.	hjanes@scharp.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054438] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054438-14, R01 GM054438] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENICHOU J, 1995, BIOMETRICS, V51, P182, DOI 10.2307/2533324; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Chlebowski RT, 1999, J CLIN ONCOL, V17, P1939, DOI 10.1200/JCO.1999.17.6.1939; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; COPAS JB, 1983, J R STAT SOC B, V45, P311; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUANG Y, COLLECTION BIOSTATIS; Huang Y, 2007, BIOMETRICS, V63, P1181, DOI 10.1111/j.1541-0420.2007.00814.x; Langholz B, 1997, BIOMETRICS, V53, P767, DOI 10.2307/2533977; Lauer MS, 2007, ANN INTERN MED, V147, P821, DOI 10.7326/0003-4819-147-12-200712180-00001; Levine M, 2001, CAN MED ASSOC J, V164, P1681; Parikh NI, 2008, ANN INTERN MED, V148, P102, DOI 10.7326/0003-4819-148-2-200801150-00005; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2007, JAMA-J AM MED ASSOC, V298, P175, DOI 10.1001/jama.298.2.175; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Pepe MS, 2008, BIOMETRICS, V64, P256; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	26	182	185	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2008	149	10					751	W162		10.7326/0003-4819-149-10-200811180-00009	http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373FL	19017593	Green Accepted			2022-12-28	WOS:000260956300007
J	Tidemalm, D; Langstrom, N; Lichtenstein, P; Runeson, B				Tidemalm, Dag; Langstrom, Niklas; Lichtenstein, Paul; Runeson, Bo			Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DELIBERATE SELF-HARM; MENTAL-DISORDERS; TIME TRENDS; MORTALITY; SCHIZOPHRENIA; REPETITION; PARASUICIDE; DIAGNOSES; BEHAVIOR; BIPOLAR	Objective To investigate the impact of coexistent psychiatric morbidity on risk of suicide after a suicide attempt. Design Cohort study with follow- up for 21- 31 years. Setting Swedish national register based study. Participants 39 685 people ( 53% women) admitted to hospital for attempted suicide during 1973- 82. Main outcome measure Completed suicide during 1973-2003. Results A high proportion of suicides in all diagnostic categories took place within the first year of follow- up ( 14-64% in men, 14- 54% in women); the highest short term risk was associated with bipolar and unipolar disorder ( 64% in men, 42% in women) and schizophrenia ( 56% in men, 54% in women). The strongest psychiatric predictors of completed suicide throughout the entire follow- up were schizophrenia ( adjusted hazard ratio 4.1,95% confidence interval 3.5 to 4.8 in men, 3.5, 2.8 to 4.4 in women) and bipolar and unipolar disorder ( 3.5, 3.0 to 4.2 in men, 2.5, 2.1 to 3.0 in women). Increased risks were also found for other depressive disorder, anxiety disorder, alcohol misuse ( women), drug misuse, and personality disorder. The highest population attributable fractions for suicide among people who had previously attempted suicide were found for other depression in women ( population attributable fraction 9.3), followed by schizophrenia in men ( 4.6), and bipolar and unipolar disorder in women and men ( 4.1 and 4.0, respectively). Conclusion Type of psychiatric disorder coexistent with a suicide attempt substantially influences overall risk and temporality for completed suicide. To reduce this risk, high risk patients need aftercare, especially during the first two years after attempted suicide among patients with schizophrenia or bipolar and unipolar disorder.	[Tidemalm, Dag; Runeson, Bo] Karolinska Inst, Dept Clin Neurosci, Div Psychiat, SE-11281 Stockholm, Sweden; [Langstrom, Niklas] Karolinska Inst, Ctr Violence Prevent, SE-11281 Stockholm, Sweden; [Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-11281 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Tidemalm, D (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Psychiat, SE-11281 Stockholm, Sweden.	dag.tidemalm@ki.se	Langstrom, Niklas/C-5615-2009	Langstrom, Niklas/0000-0002-2686-6799; lichtenstein, paul/0000-0003-3037-5287; Runeson, Bo/0000-0003-4122-4636	Stockholm County Council; Karolinska Institutet; Swedish Prison and Probation Service; Swedish Research Council (Medicine)	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Prison and Probation Service; Swedish Research Council (Medicine)(Swedish Research Council)	Stockholm County Council, the Karolinska Institutet, and the Swedish Prison and Probation Service. NL is funded by the Swedish Research Council (Medicine).	Angst Jules, 2005, Arch Suicide Res, V9, P279, DOI 10.1080/13811110590929488; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3; DeMoore GM, 1996, BRIT J PSYCHIAT, V169, P489, DOI 10.1192/bjp.169.4.489; Goodwin RD, 2003, SOC SCI MED, V56, P1783, DOI 10.1016/S0277-9536(02)00174-0; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawgood J, 2008, CURR OPIN PSYCHIATR, V21, P51, DOI 10.1097/YCO.0b013e3282f2309d; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hawton K, 2005, J CLIN PSYCHIAT, V66, P693, DOI 10.4088/JCP.v66n0604; Hawton K, 1998, BRIT MED J, V317, P441; Jenkins GR, 2002, BRIT MED J, V325, P1155, DOI 10.1136/bmj.325.7373.1155; Kamper-Jorgensen F, 2005, SCAND J PUBLIC HEALT, V33, P46, DOI 10.1080/14034950510033282; McIntyre Roger S, 2008, Curr Psychiatry Rep, V10, P66, DOI 10.1007/s11920-008-0012-7; Miranda R, 2008, J AM ACAD CHILD PSY, V47, P32, DOI 10.1097/chi.0b013e31815a56cb; Mittendorfer-Rutz E, 2008, SOC PSYCH PSYCH EPID, V43, P28, DOI 10.1007/s00127-007-0266-0; Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631; Osby U, 2000, BRIT MED J, V321, P483, DOI 10.1136/bmj.321.7259.483; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Runeson BS, 2002, BMJ-BRIT MED J, V325, P1125; Runeson BS, 1996, ACTA PSYCHIAT SCAND, V93, P35, DOI 10.1111/j.1600-0447.1996.tb10616.x; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Skogman K, 2004, SOC PSYCH PSYCH EPID, V39, P113, DOI 10.1007/s00127-004-0709-9; Suokas J, 2001, ACTA PSYCHIAT SCAND, V104, P117, DOI 10.1034/j.1600-0447.2001.00243.x; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Tejedor MC, 1999, ACTA PSYCHIAT SCAND, V100, P205, DOI 10.1111/j.1600-0447.1999.tb10847.x; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358	30	224	228	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2008	337								a2205	10.1136/bmj.a2205	http://dx.doi.org/10.1136/bmj.a2205			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19018040	hybrid, Green Published			2022-12-28	WOS:000262653900001
J	Campbell, JE; Carmichael, GR; Chai, T; Mena-Carrasco, M; Tang, Y; Blake, DR; Blake, NJ; Vay, SA; Collatz, GJ; Baker, I; Berry, JA; Montzka, SA; Sweeney, C; Schnoor, JL; Stanier, CO				Campbell, J. E.; Carmichael, G. R.; Chai, T.; Mena-Carrasco, M.; Tang, Y.; Blake, D. R.; Blake, N. J.; Vay, S. A.; Collatz, G. J.; Baker, I.; Berry, J. A.; Montzka, S. A.; Sweeney, C.; Schnoor, J. L.; Stanier, C. O.			Photosynthetic Control of Atmospheric Carbonyl Sulfide During the Growing Season	SCIENCE			English	Article							CHEMICAL-TRANSPORT MODEL; GROSS PRIMARY PRODUCTION; ECOSYSTEM RESPIRATION; COS; EXCHANGE; FLUXES; CONSUMPTION; VEGETATION; FEEDBACKS	Climate models incorporate photosynthesis- climate feedbacks, yet we lack robust tools for large- scale assessments of these processes. Recent work suggests that carbonyl sulfide ( COS), a trace gas consumed by plants, could provide a valuable constraint on photosynthesis. Here we analyze airborne observations of COS and carbon dioxide concentrations during the growing season over North America with a three- dimensional atmospheric transport model. We successfully modeled the persistent vertical drawdown of atmospheric COS using the quantitative relation between COS and photosynthesis that has been measured in plant chamber experiments. Furthermore, this drawdown is driven by plant uptake rather than other continental and oceanic fluxes in the model. These results provide quantitative evidence that COS gradients in the continental growing season may have broad use as a measurement- based photosynthesis tracer.	[Campbell, J. E.; Schnoor, J. L.] Univ Iowa, Dept Civil & Environm Engn, Iowa City, IA 52242 USA; [Carmichael, G. R.; Tang, Y.; Stanier, C. O.] Univ Iowa, Ctr Global & Reg Environm Res, Iowa City, IA 52242 USA; [Chai, T.] Sci & Technol Corp, Hampton, VA 23666 USA; [Mena-Carrasco, M.] Univ Andres Bello, Dept Environm Engn, Santiago, Chile; [Mena-Carrasco, M.] MIT, Molina Ctr Energy & Environm, Cambridge, MA 02139 USA; [Blake, D. R.; Blake, N. J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Vay, S. A.] NASA, Langley Res Ctr, Hampton, VA 23681 USA; [Collatz, G. J.] NASA, Goddard Space Flight Ctr, Biospher Sci Branch, Greenbelt, MD 20771 USA; [Baker, I.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Berry, J. A.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Montzka, S. A.] NOAA, Earth Syst Res Lab, Global Monitoring Div, Boulder, CO 80305 USA; [Sweeney, C.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80304 USA	University of Iowa; University of Iowa; Universidad Andres Bello; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Colorado State University; Carnegie Institution for Science; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Campbell, JE (corresponding author), Univ Calif Merced, Coll Engn, Merced, CA 95344 USA.	ecampbell3@ucmerced.edu	Berry, Joseph/ABA-8496-2020; Sweeney, Colm/AAE-9291-2019; Chai, Tianfeng/E-5577-2010; collatz, george j/D-5381-2012; Tang, Youhua/D-5205-2016; Mena-Carrasco, Marcelo/B-8483-2012; montzka, stephen/V-6162-2019; Schnoor, Jerald L/B-1951-2008; Mena-Carrasco, Marcelo/L-9730-2016; Stanier, Charles O/D-4307-2016; Chai, TF/I-5893-2019	Berry, Joseph/0000-0002-5849-6438; Chai, Tianfeng/0000-0003-3520-2641; Tang, Youhua/0000-0001-7089-7915; montzka, stephen/0000-0002-9396-0400; Stanier, Charles O/0000-0001-9924-0853; Chai, TF/0000-0003-3520-2641; Mena, Marcelo/0000-0002-8847-7588; Blake, Donald/0000-0002-8283-5014; Sweeney, Colm/0000-0002-4517-0797	NASA Earth System Science Graduate Fellowship; Center for Global and Regional Environmental Research; NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program; NASA INTEX; NSF Information Technology Research; NATIONAL CANCER INSTITUTE [U54CA151662] Funding Source: NIH RePORTER	NASA Earth System Science Graduate Fellowship; Center for Global and Regional Environmental Research; NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program(National Oceanic Atmospheric Admin (NOAA) - USA); NASA INTEX; NSF Information Technology Research(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Kettle for COS flux data and C. Tebaldi, J. Dungan, T. Campbell, and D. Campbell for critical comments on the manuscript. This research was supported by a NASA Earth System Science Graduate Fellowship, Center for Global and Regional Environmental Research, NOAA Office of Oceanic and Atmospheric Research contribution to the North American Carbon Program, NASA INTEX, and NSF Information Technology Research grants. NOAA observations of COS and CO<INF>2</INF> were made possible by the assistance of P. Tans, C. Sweeney, L. Miller, T. Conway, P. Lang, C. Siso, and B. Hall.	Blake NJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009163; Bowling DR, 2001, GLOBAL CHANGE BIOL, V7, P127, DOI 10.1046/j.1365-2486.2001.00400.x; Campbell JE, 2007, TELLUS B, V59, P199, DOI 10.1111/j.1600-0889.2006.00239.x; Carmichael GR, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003117; CHIN M, 1995, J GEOPHYS RES-ATMOS, V100, P8993, DOI 10.1029/95JD00275; Choi YH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008899; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; CRUTZEN PJ, 1976, GEOPHYS RES LETT, V3, P73, DOI 10.1029/GL003i002p00073; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; FRANCEY RJ, 1987, NATURE, V327, P495, DOI 10.1038/327495a0; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerbig C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003770; Kettle AJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002187; Kettle AJ, 2002, ATMOS CHEM PHYS, V2, P343, DOI 10.5194/acp-2-343-2002; Kjellstrom E, 1998, J ATMOS CHEM, V29, P151, DOI 10.1023/A:1005976511096; Matross DM, 2006, TELLUS B, V58, P344, DOI 10.1111/j.1600-0889.2006.00206.x; Montzka SA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007665; Notholt J, 2003, SCIENCE, V300, P307, DOI 10.1126/science.1080320; NOTHOLT J, 2006, SPARC ASSESSMENT STR, P29; Olsen SC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003968; PROTOSCHILL-KREBS G, 1992, BOT ACTA, V105, P206, DOI 10.1111/j.1438-8677.1992.tb00288.x; ProtoschillKrebs G, 1996, ATMOS ENVIRON, V30, P3151, DOI 10.1016/1352-2310(96)00026-X; Rodgers C.D., 2000, INVERSE METHODS ATMO, P238, DOI [10.5194/amt-7-3233-2014, DOI 10.5194/AMT-7-3233-2014]; Sandoval-Soto L, 2005, BIOGEOSCIENCES, V2, P125, DOI 10.5194/bg-2-125-2005; Singh HB, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007905; Steinbacher M, 2004, ATMOS ENVIRON, V38, P6043, DOI 10.1016/j.atmosenv.2004.06.022; Suyker AE, 2005, AGR FOREST METEOROL, V131, P180, DOI 10.1016/j.agrformet.2005.05.007	30	138	142	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1085	1088		10.1126/science.1164015	http://dx.doi.org/10.1126/science.1164015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008442	Green Submitted			2022-12-28	WOS:000260867700033
J	Lampard, GR; MacAlister, CA; Bergmann, DC				Lampard, Gregory R.; MacAlister, Cora A.; Bergmann, Dominique C.			Arabidopsis Stomatal Initiation Is Controlled by MAPK-Mediated Regulation of the bHLH SPEECHLESS	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNALING PATHWAY; DIFFERENTIATION; UNCOVERS	Stomata, epidermal structures that modulate gas exchange between plants and the atmosphere, play critical roles in primary productivity and the global climate. Positively acting transcription factors and negatively acting mitogen- activated protein kinase ( MAPK) signaling control stomatal development in Arabidopsis; however, it is not known how the opposing activities of these regulators are integrated. We found that a unique domain in a basic helix- loop- helix ( bHLH) stomatal initiating factor, SPEECHLESS, renders it a MAPK phosphorylation target in vitro and modulates its function in vivo. MAPK cascades modulate a diverse set of activities including development, cell proliferation, and response to external stresses. The coupling of MAPK signaling to SPEECHLESS activity provides cell type specificity for MAPK output while allowing the integration of multiple developmental and environmental signals into the production and spacing of stomata.	[Lampard, Gregory R.; MacAlister, Cora A.; Bergmann, Dominique C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dbergmann@stanford.edu		Bergmann, Dominique/0000-0003-0873-3543; MacAlister, Cora/0000-0003-1470-0596	NSF [IOS-0544895]; U. S. Department of Energy [DE-FG02-06ER15810]; Terman award; Stanford Genome Training Program (National Human Genome Research Institute)	NSF(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); Terman award; Stanford Genome Training Program (National Human Genome Research Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank lab members for discussion and comments on the manuscript, The Carnegie Department of Plant Biology for use of microscopes, and L. Smith for identification of maize homologs. Supported by NSF grant IOS- 0544895, U. S. Department of Energy grant DE-FG02-06ER15810, a Terman award, and the Stanford Genome Training Program (National Human Genome Research Institute).	Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Joo S, 2008, PLANT J, V54, P129, DOI 10.1111/j.1365-313X.2008.03404.x; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	24	310	325	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1113	1116		10.1126/science.1162263	http://dx.doi.org/10.1126/science.1162263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008449	Green Published			2022-12-28	WOS:000260867700041
J	Behrens, TEJ; Hunt, LT; Woolrich, MW; Rushworth, MFS				Behrens, Timothy E. J.; Hunt, Laurence T.; Woolrich, Mark W.; Rushworth, Matthew F. S.			Associative learning of social value	NATURE			English	Article							PREDICTION; REWARD; CORTEX; BRAIN; ERROR; TRUST; PAY	Our decisions are guided by information learnt from our environment. This information may come via personal experiences of reward, but also from the behaviour of social partners(1,2). Social learning is widely held to be distinct from other forms of learning in its mechanism and neural implementation; it is often assumed to compete with simpler mechanisms, such as reward- based associative learning, to drive behaviour(3). Recently, neural signals have been observed during social exchange reminiscent of signals seen in studies of associative learning(4). Here we demonstrate that social information may be acquired using the same associative processes assumed to underlie reward- based learning. We find that key computational variables for learning in the social and reward domains are processed in a similar fashion, but in parallel neural processing streams. Two neighbouring divisions of the anterior cingulate cortex were central to learning about social and reward- based information, and for determining the extent to which each source of information guides behaviour. When making a decision, however, the information learnt using these parallel streams was combined within ventromedial prefrontal cortex. These findings suggest that human social valuation can be realized by means of the same associative processes previously established for learning other, simpler, features of the environment.	[Behrens, Timothy E. J.; Hunt, Laurence T.; Woolrich, Mark W.; Rushworth, Matthew F. S.] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; [Behrens, Timothy E. J.; Hunt, Laurence T.; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Behrens, TEJ (corresponding author), Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England.	behrens@fmrib.ox.ac.uk	Hunt, Laurence/ABA-1691-2021	Hunt, Laurence/0000-0002-8393-8533; Woolrich, Mark/0000-0001-8460-8854; Behrens, Timothy/0000-0003-0048-1177	UK MRC; Wellcome Trust; UK EPSRC; MRC [G0501316, G0600994] Funding Source: UKRI; Medical Research Council [G0501316, G0600994] Funding Source: researchfish	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to acknowledge funding from the UK MRC (T.E.J.B., M.F.S.R.), the Wellcome Trust (L.T.H.) and the UK EPSRC (M.W.W.). We thank S. Knight for helping with data acquisition, and K. Watkins for help with figure preparation.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Maynard Smith J., 1982, pi; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	32	608	612	8	159	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					245	U45		10.1038/nature07538	http://dx.doi.org/10.1038/nature07538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005555	Green Accepted			2022-12-28	WOS:000261039300041
J	Donaldson, ZR; Young, LJ				Donaldson, Zoe R.; Young, Larry J.			Oxytocin, Vasopressin, and the Neurogenetics of Sociality	SCIENCE			English	Review							MAMMALIAN MONOGAMY; NEURAL CIRCUITRY; BEHAVIOR; RECEPTOR; EXPRESSION; AVPR1A; EVOLUTION; ISOTOCIN; SYSTEMS; BRAIN	There is growing evidence that the neuropeptides oxytocin and vasopressin modulate complex social behavior and social cognition. These ancient neuropeptides display a marked conservation in gene structure and expression, yet diversity in the genetic regulation of their receptors seems to underlie natural variation in social behavior, both between and within species. Human studies are beginning to explore the roles of these neuropeptides in social cognition and behavior and suggest that variation in the genes encoding their receptors may contribute to variation in human social behavior by altering brain function. Understanding the neurobiology and neurogenetics of social cognition and behavior has important implications, both clinically and for society.	[Donaldson, Zoe R.; Young, Larry J.] Emory Univ, Yerkes Reg Primate Res Ctr, Ctr Behav Neurosci, Atlanta, GA 30322 USA; [Young, Larry J.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA	Emory University; Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Ctr Behav Neurosci, Atlanta, GA 30322 USA.	lyoun03@emory.edu	Donaldson, Zoe/O-8311-2018; Young, Larry/HGE-5031-2022	Donaldson, Zoe/0000-0001-6699-7905; 				Acher R, 1995, ADV EXP MED BIOL, V395, P615; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; [Anonymous], 2006, HDB NEUROCHEMISTRY M; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; De Vries GJ, 2006, NEUROSCIENCE, V138, P947, DOI 10.1016/j.neuroscience.2005.07.050; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Gilligan P, 2003, J NEUROENDOCRINOL, V15, P1027, DOI 10.1046/j.1365-2826.2003.01090.x; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Gupta J, 2008, BRIT J PHARMACOL, V155, P118, DOI 10.1038/bjp.2008.226; Hammock EAD, 2004, MOL BIOL EVOL, V21, P1057, DOI 10.1093/molbev/msh104; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; HO MY, 1995, J BIOL CHEM, V270, P27199, DOI 10.1074/jbc.270.45.27199; Hoyle CHV, 1999, BRAIN RES, V848, P1, DOI 10.1016/S0006-8993(99)01975-7; Insel TR, 2000, CURR OPIN NEUROBIOL, V10, P784, DOI 10.1016/S0959-4388(00)00146-X; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; LOUP F, 1991, BRAIN RES, V555, P220, DOI 10.1016/0006-8993(91)90345-V; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x; Ophir AG, 2008, HORM BEHAV, V54, P694, DOI 10.1016/j.yhbeh.2008.07.009; Ophir AG, 2008, P NATL ACAD SCI USA, V105, P1249, DOI 10.1073/pnas.0709116105; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32; Prichard Zoe M, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9510; Segarra G, 1998, J PHARMACOL EXP THER, V286, P1315; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; Venkatesh B, 1997, P NATL ACAD SCI USA, V94, P12462, DOI 10.1073/pnas.94.23.12462; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 1999, HORM BEHAV, V36, P212, DOI 10.1006/hbeh.1999.1548	41	1091	1115	9	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					900	904		10.1126/science.1158668	http://dx.doi.org/10.1126/science.1158668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988842				2022-12-28	WOS:000260674100035
J	Goldston, D				Goldston, David			America's new leadership	NATURE			English	Editorial Material									Bipartisan Policy Ctr, Washington, DC USA		Goldston, D (corresponding author), Bipartisan Policy Ctr, Washington, DC USA.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					16	16		10.1038/456016a	http://dx.doi.org/10.1038/456016a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369DH	18987708	Bronze			2022-12-28	WOS:000260674000011
J	Cormie, PJ; Nairn, M; Welsh, J				Cormie, P. J.; Nairn, M.; Welsh, J.		Guideline Dev Grp	Control of pain in adults with cancer: summary of SIGN guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VALIDATION; RELIEF; SCALE		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Cormie, P. J.] Stow Hlth Ctr, Stow TD1 2SQ, Galashiels, Scotland; [Welsh, J.] Univ Glasgow, Fac Med, Div Canc Sci, Glasgow, Lanark, Scotland; [Welsh, J.] Beatson W Scotland Canc Ctr, Glasgow G12 0YN, Lanark, Scotland	University of Glasgow; Beatson Oncology Centre	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Nairn, Moray/0000-0001-6474-4410; Colvin, Lesley/0000-0002-1563-8600; Mair, Jane/0000-0001-6617-0203				Caraceni A, 2002, J PAIN SYMPTOM MANAG, V23, P239, DOI 10.1016/S0885-3924(01)00409-2; DUAT R, 1983, PAIN, V17, P197; LARUE F, 1995, BRIT MED J, V310, P1034, DOI 10.1136/bmj.310.6986.1034; Launay-Vacher V, 2005, J PAIN, V6, P137, DOI 10.1016/j.jpain.2004.11.009; Mercadante S, 2004, J PAIN, V5, P2, DOI 10.1016/j.jpain.2003.09.007; Pautex S, 2005, J GERONTOL A-BIOL, V60, P524, DOI 10.1093/gerona/60.4.524; PORTENOY RK, 1989, CANCER, V63, P2298, DOI 10.1002/1097-0142(19890601)63:11<2298::AID-CNCR2820631140>3.0.CO;2-A; Scottish Intercollegiate Guidelines Network (SIGN), 2008, 106 SIGN; VENTAFRIDDA V, 1987, CANCER, V59, P850, DOI 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1; Walker J, 2007, J PSYCHOSOM RES, V63, P83, DOI 10.1016/j.jpsychores.2007.01.009; World Health Organization, 1996, CANC PAIN REL; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M; Zwakhalen Sandra M G, 2006, BMC Geriatr, V6, P3, DOI 10.1186/1471-2318-6-3	13	23	23	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2008	337								a2154	10.1136/bmj.a2154	http://dx.doi.org/10.1136/bmj.a2154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FB	18987038				2022-12-28	WOS:000261236000002
J	Diplas, P; Dancey, CL; Celik, AO; Valyrakis, M; Greer, K; Akar, T				Diplas, Panayiotis; Dancey, Clint L.; Celik, Ahmet O.; Valyrakis, Manousos; Greer, Krista; Akar, Tanju			The Role of Impulse on the Initiation of Particle Movement Under Turbulent Flow Conditions	SCIENCE			English	Article							BED-LOAD TRANSPORT; INCIPIENT MOTION; SEDIMENT; PROBABILITY; HUMANS; IMPACT	Fundamental to our understanding of erosional and transport phenomena in earth- surface dynamics and engineering is knowledge of the conditions under which sediment motion will begin when subjected to turbulent flow. The onset criterion currently in use emphasizes the time- averaged boundary shear stress and therefore is incapable of accounting for the fluctuating forces encountered in turbulent flows. We have validated through laboratory experiments and analytical formulation of the problem a criterion based upon the impulse imparted to a sediment grain. We demonstrate that in addition to the magnitude of the instantaneous turbulent forces applied on a sediment grain, the duration of these turbulent forces is also important in determining the sediment grain's threshold of motion, and that their product, or impulse, is better suited for specifying such conditions.	[Diplas, Panayiotis; Celik, Ahmet O.; Valyrakis, Manousos; Greer, Krista; Akar, Tanju] Virginia Tech, Baker Environ Hydraul Lab, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA; [Dancey, Clint L.] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Diplas, P (corresponding author), Virginia Tech, Baker Environ Hydraul Lab, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA.	pdiplas@vt.edu	Diplas, Panayiotis/AAP-4769-2021; Valyrakis, Manousos/B-8015-2011; Valyrakis, Manousos/AAR-3639-2021; Akar, Tanju/C-2402-2016; Lucas, Elizabeth A/E-2733-2010; Celik, Ahmet/C-3947-2013	Valyrakis, Manousos/0000-0001-9245-8817; Celik, Ahmet/0000-0002-8770-2894	NSF [EAR-0439663]	NSF(National Science Foundation (NSF))	We thank the NSF for financially supporting this study (grant EAR-0439663 to P.D. and C.L.D).	AUTON TR, 1987, J FLUID MECH, V183, P199, DOI 10.1017/S002211208700260X; BAGNOLD RA, 1973, P ROY SOC LOND A MAT, V332, P473, DOI 10.1098/rspa.1973.0038; Buffington JM, 1997, WATER RESOUR RES, V33, P1993, DOI 10.1029/96WR03190; Dancey CL, 2002, J HYDRAUL ENG-ASCE, V128, P1069, DOI 10.1061/(ASCE)0733-9429(2002)128:12(1069); DRAKE TG, 1988, J FLUID MECH, V192, P193, DOI 10.1017/S0022112088001831; EINSTEIN HA, 1949, REV MOD PHYS, V21, P520, DOI 10.1103/RevModPhys.21.520; FRANCIS JRD, 1973, PROC R SOC LON SER-A, V332, P443, DOI 10.1098/rspa.1973.0037; Grass A. J., 1970, J HYDRAULICS DIVISIO, V96, P619; HEATHERSHAW AD, 1985, NATURE, V316, P339, DOI 10.1038/316339a0; Hofland B, 2006, J HYDRAUL ENG-ASCE, V132, P1169, DOI 10.1061/(ASCE)0733-9429(2006)132:11(1169); NELSON JM, 1995, WATER RESOUR RES, V31, P2071, DOI 10.1029/95WR00976; Paintal A S, 1971, J HYDRAUL RES, V9, P527, DOI [10.1080/00221687109500371, DOI 10.1080/00221687109500371]; Papanicolaou AN, 2002, J HYDRAUL ENG, V128, P369, DOI 10.1061/(ASCE)0733-9429(2002)128:4(369); Schmeeckle MW, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000536; SHIELDS A, 1950, PUBLICATION CALTECH, V167, P17712; Sumer BM, 2003, J HYDRAUL ENG-ASCE, V129, P585, DOI 10.1061/(ASCE)0733-9429(2003)129:8(585); SUTHERLA.AJ, 1967, J GEOPHYS RES, V72, P6183, DOI 10.1029/JZ072i024p06183; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Vollmer S, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004919; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1	20	211	220	7	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					717	720		10.1126/science.1158954	http://dx.doi.org/10.1126/science.1158954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974347				2022-12-28	WOS:000260605200041
J	Morin, S; Savarino, J; Frey, MM; Yan, N; Bekki, S; Bottenheim, JW; Martins, JMF				Morin, Samuel; Savarino, Joel; Frey, Markus M.; Yan, Nicolas; Bekki, Slimane; Bottenheim, Jan W.; Martins, Jean M. F.			Tracing the Origin and Fate of NOx in the Arctic Atmosphere Using Stable Isotopes in Nitrate	SCIENCE			English	Article							OZONE DEPLETION; NITROGEN; SNOW; TRENDS; DELTA-O-17; CHEMISTRY; IMPACTS; OXIDES	Atmospheric nitrogen oxides (NOx = NO + NO2) play a pivotal role in the cycling of reactive nitrogen ( ultimately deposited as nitrate) and the oxidative capacity of the atmosphere. Combined measurements of nitrogen and oxygen stable isotope ratios of nitrate collected in the Arctic atmosphere were used to infer the origin and fate of NOx and nitrate on a seasonal basis. In spring, photochemically driven emissions of reactive nitrogen from the snowpack into the atmosphere make local oxidation of NOx by bromine oxide the major contributor to the nitrate budget. The comprehensive isotopic composition of nitrate provides strong constraints on the relative importance of the key atmospheric oxidants in the present atmosphere, with the potential for extension into the past using ice cores.	[Morin, Samuel; Savarino, Joel; Frey, Markus M.; Yan, Nicolas; Bekki, Slimane; Martins, Jean M. F.] Inst Natl Sci, CNRS, Paris, France; [Morin, Samuel; Savarino, Joel; Frey, Markus M.] Univ Grenoble 1, Lab Glaciol & Geophys Environm, Grenoble, France; [Yan, Nicolas; Bekki, Slimane] Univ Paris 06, Serv Aeron, Inst Pierre Simon Laplace, Paris, France; [Bottenheim, Jan W.] Environm Canada, Toronto, ON, Canada; [Martins, Jean M. F.] Univ Grenoble 1, Lab Etud Transferts Hydrol & Environnm, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Environment & Climate Change Canada; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Morin, S (corresponding author), Inst Natl Sci, CNRS, Paris, France.	samuel.morin@ujf-grenoble.fr	Martins, Jean M.F./B-2715-2008; Martins, Jean/AAF-4186-2021; Morin, Samuel/E-8005-2011; bekki, slimane/J-7221-2015; Frey, Markus/G-1756-2012; Savarino, Joel/H-9730-2012; Frey, Markus/AAT-5882-2020	Martins, Jean M.F./0000-0003-0314-1311; Martins, Jean/0000-0003-0314-1311; Morin, Samuel/0000-0002-1781-687X; bekki, slimane/0000-0002-5538-0800; Frey, Markus/0000-0003-0535-0416; Savarino, Joel/0000-0002-6708-9623; Frey, Markus/0000-0003-0535-0416	Institut Polaire-Paul-Emile Victor; Institut National des Sciences de l'Univers LEFE-CHAT; European Science Foundation; EUROCORES Programme; EuroCLIMATE [ERAS-CT2003- 980409]; European Commission, DG Research [FP6]; Ecole National des Ponts et Chaussees	Institut Polaire-Paul-Emile Victor; Institut National des Sciences de l'Univers LEFE-CHAT; European Science Foundation(European Science Foundation (ESF)European Commission); EUROCORES Programme; EuroCLIMATE(European Science Foundation (ESF)); European Commission, DG Research(European CommissionEuropean Commission Joint Research Centre); Ecole National des Ponts et Chaussees	Thanks are due to the Alert Global Atmospheric Watch station personnel for aerosol field sampling in rough conditions; to E. Vince for help with bacterial cultures; to J. Kaiser, D. Sigman, and M. Hastings for their help with setting up the analytical technique; to G. Picard, F. Domine, and M. Thiemens for helpful discussions; and to J.-Ph. Balestrieri for technical support. Funding was provided by the Institut Polaire-Paul-Emile Victor, Institut National des Sciences de l'Univers LEFE-CHAT, and the European Science Foundation under the EUROCORES Programme EuroCLIMATE, through contract no. ERAS-CT2003- 980409 of the European Commission, DG Research, FP6. S. M. acknowledges the Ecole National des Ponts et Chaussees for financial support.	Beine HJ, 2003, ATMOS CHEM PHYS, V3, P335, DOI 10.5194/acp-3-335-2003; Blunier T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023011; Brenninkmeijer CAM, 2003, CHEM REV, V103, P5125, DOI 10.1021/cr020644k; Brown SS, 2006, SCIENCE, V311, P67, DOI 10.1126/science.1120120; CRUTZEN PJ, 1970, Q J ROY METEOR SOC, V96, P320, DOI 10.1002/qj.49709640815; Domine F, 2002, SCIENCE, V297, P1506, DOI 10.1126/science.1074610; Elliott EM, 2007, ENVIRON SCI TECHNOL, V41, P7661, DOI 10.1021/es070898t; FREYER HD, 1993, J GEOPHYS RES-ATMOS, V98, P14791, DOI 10.1029/93JD00874; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Granier C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026180; Grannas AM, 2007, ATMOS CHEM PHYS, V7, P4329, DOI 10.5194/acp-7-4329-2007; Hastings MG, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004991; Heaton THE, 2004, ATMOS ENVIRON, V38, P5611, DOI 10.1016/j.atmosenv.2004.06.028; Honrath RE, 1999, GEOPHYS RES LETT, V26, P695, DOI 10.1029/1999GL900077; Kaiser J, 2007, ANAL CHEM, V79, P599, DOI 10.1021/ac061022s; Kendall C, 2007, STABLE ISOTOPES ECOL; Law KS, 2007, SCIENCE, V315, P1537, DOI 10.1126/science.1137695; Michalski G, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017015; Morin S, 2007, ATMOS CHEM PHYS, V7, P1451, DOI 10.5194/acp-7-1451-2007; Quinn PK, 2007, TELLUS B, V59, P99, DOI 10.1111/j.1600-0889.2006.00236.x; Richter A, 2002, ADV SPACE RES, V29, P1667, DOI 10.1016/S0273-1177(02)00123-0; Savarino J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2917581; Savarino J, 2007, ATMOS CHEM PHYS, V7, P1925, DOI 10.5194/acp-7-1925-2007; Shindell D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030221; Simpson WR, 2007, ATMOS CHEM PHYS, V7, P4375, DOI 10.5194/acp-7-4375-2007; SINGH HB, 1995, NATURE, V378, P50, DOI 10.1038/378050a0; Sirois A, 1999, J GEOPHYS RES-ATMOS, V104, P11599, DOI 10.1029/1999JD900077; Stohl A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006888; Thiemens MH, 2006, ANNU REV EARTH PL SC, V34, P217, DOI 10.1146/annurev.earth.34.031405.125026; Wagenbach D, 1998, J GEOPHYS RES-ATMOS, V103, P11007, DOI 10.1029/97JD03364	30	145	152	7	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					730	732		10.1126/science.1161910	http://dx.doi.org/10.1126/science.1161910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974350				2022-12-28	WOS:000260605200045
J	Sanz-Moreno, V; Gadea, G; Ahn, J; Paterson, H; Marra, P; Pinner, S; Sahai, E; Marshall, CJ				Sanz-Moreno, Victoria; Gadea, Gilles; Ahn, Jessica; Paterson, Hugh; Marra, Pierfrancesco; Pinner, Sophie; Sahai, Erik; Marshall, Christopher J.			Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement	CELL			English	Article							PRESENILIN-BINDING-PROTEIN; PERICELLULAR PROTEOLYSIS; ARP2/3 COMPLEX; CANCER-CELLS; RHO-GTPASES; MIGRATION; INVASION; KINASE; PHOSPHORYLATION; METASTASIS	Tumor cells exhibit two different modes of individual cell movement. Mesenchymal-type movement is characterized by an elongated cellular morphology and requires extracellular proteolysis. In amoeboid movement, cells have a rounded morphology, are less dependent on proteases, and require high Rho-kinase signaling to drive elevated levels of actomyosin contractility. These two modes of cell movement are interconvertible. We show that mesenchymal-type movement in melanoma cells is driven by activation of the GTPase Rac through a complex containing NEDD9, a recently identified melanoma metastasis gene, and DOCK3, a Rac guanine nucleotide exchange factor. Rac signals through WAVE2 to direct mesenchymal movement and suppress amoeboid movement through decreasing actomyosin contractility. Conversely, in amoeboid movement, Rho-kinase signaling activates a Rac GAP, ARH-GAP22, that suppresses mesenchymal movement by inactivating Rac. We demonstrate tight interplay between Rho and Rac in determining different modes of tumor cell movement, revealing how tumor cells switch between different modes of movement.	[Sanz-Moreno, Victoria; Gadea, Gilles; Ahn, Jessica; Paterson, Hugh; Marra, Pierfrancesco; Marshall, Christopher J.] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; [Pinner, Sophie; Sahai, Erik] London Res Inst Canc Res UK, Tumor Cell Biol Lab, London WC2A 3PX, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Marshall, CJ (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	chris.marshall@icr.ac.uk	Acton, Sophie/G-9784-2012; Gilles, Gadea/M-9966-2015	Acton, Sophie/0000-0003-2704-716X; Gilles, Gadea/0000-0001-6325-4866; Sanz-Moreno, Victoria/0000-0002-5096-9456; Sahai, Erik/0000-0002-3932-5086	Cancer Research UK; European Union	Cancer Research UK(Cancer Research UK); European Union(European Commission)	This work was supported by Cancer Research UK and the European Union. V. S. M. is a Marie Curie Intra-European Fellow, and C.J.M. a Cancer Research UK Gibb Fellow. We thank Demelza Bird for technical help, Annette Self for technical advice, Imanol Arozarena, Richard Marais, Mike Olson, and David Schubert for reagents, and Clare Isacke, Pascal Peschard, and Anna Peyker for helpful comments.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Croft DR, 2006, METHOD ENZYMOL, V406, P541, DOI 10.1016/S0076-6879(06)06042-3; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Namekata K, 2002, J NEUROCHEM, V82, P819, DOI 10.1046/j.1471-4159.2002.01039.x; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; ROSAI M, 2004, ROSAI ACKERMANS SURG, P166; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2003, MOL CELL BIOL, V23, P3079, DOI 10.1128/MCB.23.9.3079-3090.2003; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Tsuji K, 2006, CANCER RES, V66, P303, DOI 10.1158/0008-5472.CAN-05-2958; Wang WG, 2002, CANCER RES, V62, P6278; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	38	693	707	1	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					510	523		10.1016/j.cell.2008.09.043	http://dx.doi.org/10.1016/j.cell.2008.09.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984162	Bronze			2022-12-28	WOS:000260536300021
J	Yang, FC; Ingram, DA; Chen, S; Zhu, Y; Yuan, J; Li, XH; Yang, XL; Knowles, S; Horn, W; Li, Y; Zhang, SB; Yang, YZ; Vakili, ST; Yu, MG; Burns, D; Robertson, K; Hutchins, G; Parada, LF; Clapp, DW				Yang, Feng-Chun; Ingram, David A.; Chen, Shi; Zhu, Yuan; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Knowles, Scott; Horn, Whitney; Li, Yan; Zhang, Shaobo; Yang, Yanzhu; Vakili, Saeed T.; Yu, Menggang; Burns, Dennis; Robertson, Kent; Hutchins, Gary; Parada, Luis F.; Clapp, D. Wade			Nf1-Dependent Tumors Require a Microenvironment Containing Nf1(+/-) and c-kit-Dependent Bone Marrow	CELL			English	Article							MAST-CELLS; GROWTH-FACTOR; NEUROFIBROMATOSIS TYPE-1; GENE-PRODUCT; IN-VIVO; RECEPTOR; CANCER; NF1; CARCINOGENESIS; PROLIFERATION	Interactions between tumorigenic cells and their surrounding microenvironment are critical for tumor progression yet remain incompletely understood. Germline mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1 (NF1), a common genetic disorder characterized by complex tumors called neurofibromas. Genetic studies indicate that biallelic loss of Nf1 is required in the tumorigenic cell of origin in the embryonic Schwann cell lineage. However, in the physiologic state, Schwann cell loss of heterozygosity is not sufficient for neurofibroma formation and Nf1 haploinsufficiency in at least one additional nonneoplastic lineage is required for tumor progression. Here, we establish that Nf1 heterozygosity of bone marrow-derived cells in the tumor microenvironment is sufficient to allow neurofibroma progression in the context of Schwann cell Nf1 deficiency. Further, genetic or pharmacologic attenuation of c-kit signaling in Nf1(+/-) hematopoietic cells diminishes neurofibroma initiation and progression. Finally, these studies implicate mast cells as critical mediators of tumor initiation.	[Zhu, Yuan; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Yang, Feng-Chun; Chen, Shi; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Knowles, Scott; Horn, Whitney; Li, Yan; Yang, Yanzhu; Robertson, Kent; Clapp, D. Wade] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Ingram, David A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hutchins, Gary] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA; [Clapp, D. Wade] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhang, Shaobo; Vakili, Saeed T.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yu, Menggang] Indiana Univ, Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Yang, Feng-Chun; Ingram, David A.; Chen, Shi; Yuan, Jin; Li, Xiaohong; Yang, Xianlin; Li, Yan; Yang, Yanzhu; Robertson, Kent; Clapp, D. Wade] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Burns, Dennis] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu; dclapp@iupui.edu	Zhu, Yuan/ABF-8405-2020; Knowles, Scott/F-8197-2015; Parada, luis F/B-9400-2014		Department of Defense [NF020026]; P50 Center of Excellence in Neurofibromatosis [P50 NS 052606]; NCI-MMHC; Anna Fuller Foundation;  [R01 CA74177]; NATIONAL CANCER INSTITUTE [R01CA074177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); P50 Center of Excellence in Neurofibromatosis; NCI-MMHC; Anna Fuller Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Department of Defense (NF020026) to D. W. C. and L.F.P., a P50 Center of Excellence in Neurofibromatosis P50 NS 052606 (L.F.P., D.W.C., F.C.Y., D.A.I., and G.H.) and R01 CA74177 to D.W.C.L.F.P. is an American Cancer Society Professor and also acknowledges support from the NCI-MMHC. Novartis supplied imatinib mesylate to D.W.C. for these studies. The work was also supported by the Anna Fuller Foundation.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; CHANG TL, 1993, PEDIATR DERMATOL, V10, P224, DOI 10.1111/j.1525-1470.1993.tb00366.x; CLAPP DW, 1995, BLOOD, V86, P2113, DOI 10.1182/blood.V86.6.2113.bloodjournal8662113; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; GALLI SJ, 1993, AM J PATHOL, V142, P965; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haneline LS, 1999, BLOOD, V94, P1; Hiatt K, 2004, AM J PATHOL, V164, P1471, DOI 10.1016/S0002-9440(10)63233-6; HIROTA S, 1993, ARCH PATHOL LAB MED, V117, P996; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KACINSKI BM, 1995, ANN MED, V27, P79, DOI 10.3109/07853899509031941; Li F, 2006, HUM MOL GENET, V15, P1921, DOI 10.1093/hmg/ddl114; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mashour GA, 2004, CLIN CANCER RES, V10, P5677, DOI 10.1158/1078-0432.CCR-03-0769; Munchhof AM, 2006, HUM MOL GENET, V15, P1858, DOI 10.1093/hmg/ddl108; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; RYAN JJ, 1994, J NEUROSCI RES, V37, P415, DOI 10.1002/jnr.490370314; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Tay YK, 1998, DERMATOLOGY, V197, P401, DOI 10.1159/000018046; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	33	242	266	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					437	448		10.1016/j.cell.2008.08.041	http://dx.doi.org/10.1016/j.cell.2008.08.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984156	Green Accepted, Bronze			2022-12-28	WOS:000260536300015
J	Ginsberg, J; Mohebbi, MH; Patel, RS; Brammer, L; Smolinski, MS; Brilliant, L				Ginsberg, Jeremy; Mohebbi, Matthew H.; Patel, Rajan S.; Brammer, Lynnette; Smolinski, Mark S.; Brilliant, Larry			Detecting influenza epidemics using search engine query data	NATURE			English	Article								Seasonal influenza epidemics are a major public health concern, causing tens of millions of respiratory illnesses and 250,000 to 500,000 deaths worldwide each year(1). In addition to seasonal influenza, a new strain of influenza virus against which no previous immunity exists and that demonstrates human- to- human transmission could result in a pandemic with millions of fatalities(2). Early detection of disease activity, when followed by a rapid response, can reduce the impact of both seasonal and pandemic influenza(3,4). One way to improve early detection is to monitor health- seeking behaviour in the form of queries to online search engines, which are submitted by millions of users around the world each day. Here we present a method of analysing large numbers of Google search queries to track influenza- like illness in a population. Because the relative frequency of certain queries is highly correlated with the percentage of physician visits in which a patient presents with influenza- like symptoms, we can accurately estimate the current level of weekly influenza activity in each region of the United States, with a reporting lag of about one day. This approach may make it possible to use search queries to detect influenza epidemics in areas with a large population of web search users.	[Ginsberg, Jeremy; Mohebbi, Matthew H.; Patel, Rajan S.; Smolinski, Mark S.; Brilliant, Larry] Google Inc, Mountain View, CA 94043 USA; [Brammer, Lynnette] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Google Incorporated; Centers for Disease Control & Prevention - USA	Ginsberg, J (corresponding author), Google Inc, 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA.	flutrends-support@google.com		Ginsberg, Jeremy/0000-0001-9527-0510				DAVID FN, 1949, BIOMETRIKA, V36, P394, DOI 10.1093/biomet/36.3-4.394; DEAN J, 2004, 6 S OP SYST DES IMP; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FOX S, 2006, PEW INTERNET AM LIFE; Johnson HA, 2004, STUD HEALTH TECHNOL, V107, P1202; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Magruder SF, 2003, J HOPKINS APL TECH D, V24, P349; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; World Health Organization, 2003, INFL FACT SHEET; World Health Organization, 2004, WHO CONS PRIOR PUBL	12	2313	2435	21	64	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1012	U4		10.1038/nature07634	http://dx.doi.org/10.1038/nature07634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19020500				2022-12-28	WOS:000263425400042
J	Boersma, E; Poldermans, D				Boersma, Eric; Poldermans, Don			beta blockers in non-cardiac surgery: haemodynamic data needed	LANCET			English	Editorial Material							HIGH-RISK PATIENTS; MYOCARDIAL-INFARCTION; MORTALITY; PREVENTION; BISOPROLOL; MORBIDITY		[Boersma, Eric] Erasmus MC, Dept Cardiol, NL-3000 CA Rotterdam, Netherlands; [Poldermans, Don] Erasmus MC, Dept Anaesthesiol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Boersma, E (corresponding author), Erasmus MC, Dept Cardiol, NL-3000 CA Rotterdam, Netherlands.	h.boersma@erasmusmc.nl						BANGALORE S, 2008, LANCET          1111, DOI DOI 10.1016/S0140-6736(08)61560-3; Dawood MM, 1996, INT J CARDIOL, V57, P37, DOI 10.1016/S0167-5273(96)02769-6; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Ohtsuka T, 2001, J AM COLL CARDIOL, V37, P412, DOI 10.1016/S0735-1097(00)01121-9; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Schouten O, 2004, AM HEART J, V148, P1047, DOI 10.1016/j.ahj.2004.05.046; Warltier DC, 2000, ANESTHESIOLOGY, V92, P253, DOI 10.1097/00000542-200001000-00038	8	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 6	2008	372	9654					1930	1932		10.1016/S0140-6736(08)61623-2	http://dx.doi.org/10.1016/S0140-6736(08)61623-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	19012956				2022-12-28	WOS:000261471600005
J	Vandenbroucke, JP; Psaty, BM				Vandenbroucke, Jan P.; Psaty, Bruce M.			Benefits and Risks of Drug Treatments How to Combine the Best Evidence on Benefits With the Best Data About Adverse Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEMATIC REVIEWS; RANDOMIZED-TRIALS; HARMS		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Vandenbroucke, Jan P.] Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu	Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, U01HL080295, R01HL087652, R01HL085251, R01HL080295] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL080295, HL087652, HL74745, HL085251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; BACIU A, 2006, FUTURE DRUG SAFETY P; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; JICK H, 1978, AM J EPIDEMIOL, V107, P1; Loke YK, 2008, ALIMENT PHARM THERAP, V27, P31, DOI 10.1111/j.1365-2036.2007.03541.x; Loke YK, 2004, BRIT J CLIN PHARMACO, V57, P616, DOI 10.1111/j.0306-5251.2003.02055.x; Mallett S, 2002, INT J TECHNOL ASSESS, V18, P820, DOI 10.1017/S0266462302000624; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2	15	103	104	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2417	2419		10.1001/jama.2008.723	http://dx.doi.org/10.1001/jama.2008.723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375YX	19033592				2022-12-28	WOS:000261150800024
J	Bowles, S				Bowles, Samuel			Being human: Conflict: Altruism's midwife	NATURE			English	Editorial Material									[Bowles, Samuel] Santa Fe Inst, Behav Sci Program, Santa Fe, NM 87501 USA; [Bowles, Samuel] Univ Siena, Dept Polit Econ, I-53100 Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, Behav Sci Program, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	bowles@santafe.edu							0	94	94	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 20	2008	456	7220					326	327		10.1038/456326a	http://dx.doi.org/10.1038/456326a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020603				2022-12-28	WOS:000261039600024
J	Brass, SD; Durand, ML; Stone, JH; Chen, JW; Stone, JR; Cohen, AB; Harris, NL; Friday, RP; Utz, AL				Brass, Steven D.; Durand, Marlene L.; Stone, John H.; Chen, John W.; Stone, James R.; Cohen, Adam B.; Harris, Nancy Lee; Friday, Robert P.; Utz, Andrea L.			A Man with Chronic Daily Headache Giant-cell arteritis, involving the superficial temporal artery and small dural arteries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBROSPINAL-FLUID LEAKS; SLEEP-APNEA SYNDROME; CRANIAL PACHYMENINGITIS; DIAGNOSIS; SARCOIDOSIS; INVOLVEMENT; PREVENTION; GUIDELINES; PNEUMONIA; THERAPY		[Brass, Steven D.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Durand, Marlene L.; Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chen, John W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Brass, Steven D.] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Stone, John H.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Chen, John W.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Stone, James R.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Brass, SD (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.				Teva Neuroscience; EMD Serono; Biogen; Bayer; Merck; Zymogenetics; Muscle Tech; GlaxoSmithKline; Proteon Therapeutics	Teva Neuroscience(Teva Pharmaceutical Industries); EMD Serono; Biogen(Biogen); Bayer(Bayer AG); Merck(Merck & Company); Zymogenetics; Muscle Tech; GlaxoSmithKline(GlaxoSmithKline); Proteon Therapeutics	Dr. Brass reports receiving consulting fees from Teva Neuroscience, EMD Serono, Biogen, and Bayer; Dr. John Stone, consulting fees from Merck and Zymogenetics; and Dr. James Stone, consulting fees from Merck, Muscle Tech, GlaxoSmithKline, and Proteon Therapeutics. No other potential conflict of interest relevant to this article was reported.	Akahoshi Mitsuteru, 2004, Mod Rheumatol, V14, P179; Al Dhanhani A, 2006, J RHEUMATOL, V33, P364; Alberti A, 2005, ACTA NEUROL SCAND, V111, P309, DOI 10.1111/j.1600-0404.2005.00372.x; ALDRICH MS, 1990, ARCH INTERN MED, V150, P1265, DOI 10.1001/archinte.150.6.1265; ALLSOP CJ, 1981, AM J SURG PATHOL, V5, P317, DOI 10.1097/00000478-198106000-00001; Boyev LR, 1999, AM J OPHTHALMOL, V128, P211, DOI 10.1016/S0002-9394(99)00101-4; Buckley L, 2001, ARTHRITIS RHEUM, V44, P1496; Butany J, 2006, CARDIOVASC PATHOL, V15, P222, DOI 10.1016/j.carpath.2006.02.005; Cizek SM, 2007, CARDIOVASC PATHOL, V16, P344, DOI 10.1016/j.carpath.2007.05.007; Evans Randolph W, 2007, Curr Pain Headache Rep, V11, P47, DOI 10.1007/s11916-007-0021-y; Evans RW, 2005, HDB HEADACHE; FIENBERG R, 1981, HUM PATHOL, V12, P458, DOI 10.1016/S0046-8177(81)80027-5; Grossman RI., 2003, NEURORADIOLOGY REQUI; GUILLEMINAULT C, 1977, ARCH INTERN MED, V137, P296, DOI 10.1001/archinte.137.3.296; HALL S, 1983, LANCET, V2, P1217; HAMILTON SR, 1993, J CLIN NEURO-OPHTHAL, V13, P127; Hayreh SS, 1997, AM J OPHTHALMOL, V123, P285, DOI 10.1016/S0002-9394(14)70123-0; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; Iio M, 2001, AURIS NASUS LARYNX, V28, pS121, DOI 10.1016/S0385-8146(01)00071-2; Joelson E, 2000, ARCH NEUROL-CHICAGO, V57, P119, DOI 10.1001/archneur.57.1.119; Judson MA, 2007, SEMIN RESP CRIT CARE, V28, P83, DOI 10.1055/s-2007-970335; KARAM NE, 1994, J RHEUMATOL, V21, P1960; Kleinschmidt-DeMasters BK, 2001, ARCH PATHOL LAB MED, V125, P880; Kuhn J, 2004, HEADACHE, V44, P1045, DOI 10.1111/j.1526-4610.2004.4200_2.x; Kupersmith MJ, 2004, NEUROLOGY, V62, P686, DOI 10.1212/01.WNL.0000113748.53023.B7; Kushida CA, 2008, J CLIN SLEEP MED, V4, P157; Laigle-Donadey F, 2005, J NEURO-ONCOL, V75, P57, DOI 10.1007/s11060-004-8098-1; Lee MS, 2006, ARTHRITIS RHEUM, V54, P3306, DOI 10.1002/art.22141; LIE JT, 1994, CARDIOVASC PATHOL, V3, P227, DOI 10.1016/1054-8807(94)90033-7; Loh NK, 1999, ARCH INTERN MED, V159, P1765, DOI 10.1001/archinte.159.15.1765; Marano E, 2003, J NEUROL, V250, P98, DOI 10.1007/s00415-003-0914-6; MASSON C, 1993, NEUROLOGY, V43, P1329, DOI 10.1212/WNL.43.7.1329; Mazlumzadeh M, 2006, ARTHRITIS RHEUM, V54, P3310, DOI 10.1002/art.22163; Mokri B, 1999, MAYO CLIN PROC, V74, P1113, DOI 10.4065/74.11.1113; Nagashima T, 2000, NEUROPATHOLOGY, V20, P23, DOI 10.1046/j.1440-1789.2000.00282.x; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Newman LC, 1998, NEUROL CLIN, V16, P285, DOI 10.1016/S0733-8619(05)70065-7; Pless M, 2000, J NEURO-OPHTHALMOL, V20, P216, DOI 10.1097/00041327-200020030-00012; Poceta JS, 1995, HEADACHE, V35, P586, DOI 10.1111/j.1526-4610.1995.hed3510586.x; Ronthal M, 2003, NEW ENGL J MED, V349, P170, DOI 10.1056/NEJMcpc020034; ROSENBERG J, 1995, NEUROLOGY, V45, P1411; ROWLAND LP, 2001, MERRITTS NEUROLOGY; Salvarani C, 2006, ARTHRIT RHEUM-ARTHR, V55, P985, DOI 10.1002/art.22359; Schestatsky P, 2006, SCAND J INFECT DIS, V38, P43, DOI 10.1080/00365540500372895; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Seo P, 2004, AM J MED, V117, P39, DOI 10.1016/j.amjmed.2004.02.030; Seo P, 2004, ARTHRIT RHEUM-ARTHR, V51, P128, DOI 10.1002/art.20083; SHERMAN JL, 1990, AM J ROENTGENOL, V155, P1293, DOI 10.2214/ajr.155.6.2122683; Silberstein, 2001, NEUROLOGY, V56, P142; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 1996, NEUROLOGY, V47, P871, DOI 10.1212/WNL.47.4.871; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; Sowden E, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-42; Ward MM, 1999, ARTHRITIS RHEUM, V42, P780, DOI 10.1002/1529-0131(199904)42:4&lt;780::AID-ANR23&gt;3.0.CO;2-M; Weidner N, 2001, SEMIN DIAGN PATHOL, V18, P24; Wheat LJ, 2005, CLIN INFECT DIS, V40, P844, DOI 10.1086/427880; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103	59	12	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2267	2278		10.1056/NEJMcpc0805313	http://dx.doi.org/10.1056/NEJMcpc0805313			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	19020329				2022-12-28	WOS:000260994000012
J	Bosmans, F; Martin-Eauclaire, MF; Swartz, KJ				Bosmans, Frank; Martin-Eauclaire, Marie-France; Swartz, Kenton J.			Deconstructing voltage sensor function and pharmacology in sodium channels	NATURE			English	Article							ALPHA-SCORPION TOXIN; DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; GATING MODIFIER; SKELETAL-MUSCLE; MOLECULAR DETERMINANTS; TARANTULA TOXINS; IONIC CURRENTS; RAT-BRAIN; DOMAIN IV	Voltage- activated sodium (Na-v) channels are crucial for the generation and propagation of nerve impulses, and as such are widely targeted by toxins and drugs. The four voltage sensors in Na-v channels have distinct amino acid sequences, raising fundamental questions about their relative contributions to the function and pharmacology of the channel. Here we use four- fold symmetric voltage- activated potassium ( K-v) channels as reporters to examine the contributions of individual S3b-S4 paddle motifs within Na-v channel voltage sensors to the kinetics of voltage sensor activation and to forming toxin receptors. Our results uncover binding sites for toxins from tarantula and scorpion venom on each of the four paddle motifs in Nav channels, and reveal how paddle- specific interactions can be used to reshape Na-v channel activity. One paddle motif is unique in that it slows voltage sensor activation, and toxins selectively targeting this motif impede Na-v channel inactivation. This reporter approach and the principles that emerge will be useful in developing new drugs for treating pain and Na-v channelopathies.	[Bosmans, Frank; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Bosmans, Frank] Catholic Univ Louvain, Toxicol Lab, B-3000 Louvain, Belgium; [Martin-Eauclaire, Marie-France] Univ Mediterranee, CNRS, Inst Jean Roche, UMR 6231,CRN2M, Marseille, France	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov	Bosmans, Frank/A-9660-2013; Bosmans, Frank/T-5589-2017	Bosmans, Frank/0000-0002-6476-235X; Bosmans, Frank/0000-0002-6476-235X; Bosmans, Frank/0000-0002-0451-6050	Intramural Research Program; NINDS; NIH; NIH- FWO postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003017] Funding Source: NIH RePORTER	Intramural Research Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH- FWO postdoctoral fellowship(FWO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.W. Kyle, D.A. Hanck and A.L. Goldin for the rNa<INF>v</INF>1.2a, rNa<INF>v</INF>1.4 and beta<INF>1</INF> clones, C. Deutsch for K<INF>v</INF>1.3, M.M. Smith for GxTx-1E, K.M. Blumenthal and J.B. Herrington for ProTx-II, L.D. Possani for a sample of TsVII, the NINDS DNA sequencing facility for DNA sequencing, and the NINDS protein sequencing facility for mass spectrometry and peptide sequencing. We thank A.A. Alabi for helping with Kv and Nav channel alignments and T.-H. Chang for assistance with Nav channel mutants. We also thank A. A. Alabi, M. Holmgren, M. Mayer, M. Milescu, J. Mindell, A. Plested, S. Silberberg and members of the Swartz laboratory for discussions. This work was supported by the Intramural Research Program of the NINDS, NIH (K.J.S.) and by an NIH- FWO postdoctoral fellowship (F.B.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bendahhou S, 1999, J NEUROSCI, V19, P4762; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; CAHALAN MD, 1975, J PHYSIOL-LONDON, V244, P511, DOI 10.1113/jphysiol.1975.sp010810; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; CEARD B, 1992, TOXICON, V30, P105, DOI 10.1016/0041-0101(92)90506-Z; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; KOPPENHOFER E, 1968, PFLUG ARCH EUR J PHY, V303, P150, DOI 10.1007/BF00592632; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MARTIN MF, 1987, TOXICON, V25, P569, DOI 10.1016/0041-0101(87)90293-5; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sheets MF, 2000, J GEN PHYSIOL, V115, P609, DOI 10.1085/jgp.115.5.609; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Spampanato J, 2003, NEUROSCIENCE, V116, P37, DOI 10.1016/S0306-4522(02)00698-X; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TEJEDOR FJ, 1988, P NATL ACAD SCI USA, V85, P8742, DOI 10.1073/pnas.85.22.8742; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Wan XP, 2001, AM J PHYSIOL-HEART C, V280, pH354, DOI 10.1152/ajpheart.2001.280.1.H354; Wang GK, 2000, PFLUG ARCH EUR J PHY, V439, P705, DOI 10.1007/s004240050996; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	62	219	232	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					202	U28		10.1038/nature07473	http://dx.doi.org/10.1038/nature07473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005548	Green Accepted			2022-12-28	WOS:000261039300032
J	Freiberg, JJ; Tybjaerg-Hansen, A; Jensen, JS; Nordestgaard, BG				Freiberg, Jacob J.; Tybjaerg-Hansen, Anne; Jensen, Jan Skov; Nordestgaard, Borge G.			Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETICALLY HYPERLIPIDEMIC RABBITS; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FOLLOW-UP; SELECTIVE RETENTION; ARTERIAL INTIMA; IN-VIVO; PLASMA; MUTATIONS	Context The role of triglycerides in the risk of ischemic stroke remains controversial. Recently, a strong association was found between elevated levels of nonfasting triglycerides, which indicate the presence of remnant lipoproteins, and increased risk of ischemic heart disease. Objective To test the hypothesis that increased levels of nonfasting triglycerides are associated with ischemic stroke in the general population. Design, Setting, and Participants The Copenhagen City Heart Study, a prospective, Danish population - based cohort study initiated in 1976, with follow- up through July 2007. Participants were 13 956 men and women aged 20 through 93 years. A cross- sectional study included 9637 individuals attending the 1991- 1994 examination of the prospective study. Main Outcome Measures Prospective study: baseline levels of nonfasting triglycerides, other risk factors at baseline and at follow- up examinations, and incidence of ischemic stroke. Cross- sectional study: levels of nonfasting triglycerides, levels of remnant cholesterol, and prevalence of ischemic stroke. Results Of the 13 956 participants in the prospective study, 1529 developed ischemic stroke. Cumulative incidence of ischemic stroke increased with increasing levels of nonfasting triglycerides ( log- rank trend, P <. 001). Men with elevated nonfasting triglyceride levels of 89 through 176 mg/ dL had multivariate- adjusted hazard ratios ( HRs) for ischemic stroke of 1.3 ( 95% CI, 0.8- 1.9; 351 events); for 177 through 265 mg/ dL, 1.6 ( 95% CI, 1.0- 2.5; 189 events); for 266 through 353 mg/ dL, 1.5 ( 95% CI, 0.9- 2.7; 73 events); for 354 through 442 mg/ dL, 2.2 ( 95% CI, 1.1- 4.2; 40 events); and for 443 mg/ dL or greater, 2.5 ( 95% CI, 1.3- 4.8; 41 events) vs men with nonfasting levels less than 89 mg/ dL ( HR, 1.0; 85 events) ( P <. 001 for trend). Corresponding values for women were 1.3 ( 95% CI, 0.9- 1.7; 407 events), 2.0 ( 95% CI, 1.3- 2.9; 135 events), 1.4 ( 95% CI, 0.7- 2.9; 26 events), 2.5 ( 95% CI, 1.0- 6.4; 13 events), and 3.8 ( 95% CI, 1.3- 11; 10 events) vs women with nonfasting triglyceride levels less than 89 mg/ dL ( HR, 1.0; 159 events) ( P <. 001 for trend). Absolute 10- year risk of ischemic stroke ranged from 2.6% in men younger than 55 years with nonfasting triglyceride levels of less than 89 mg/ dL to 16.7% in men aged 55 years or older with levels of 443 mg/ dL or greater. Corresponding values in women were 1.9% and 12.2%. In the cross- sectional study, men with a previous ischemic stroke vs controls had nonfasting triglyceride levels of 191 ( IQR, 131- 259) mg/ dL vs 148 ( IQR, 104- 214) mg/ dL ( P <. 01); corresponding values for women were 167 ( IQR, 121- 229) mg/ dL vs 127 ( IQR, 91- 181) mg/ dL ( P <. 05). For remnant cholesterol, corresponding values were 38 ( IQR, 26- 51) mg/ dL vs 29 ( IQR, 20- 42) mg/ dL in men ( P <. 01) and 33 ( IQR, 2445) mg/ dL vs 25 ( IQR, 18- 35) mg/ dL in women ( P <. 05). Conclusion In this study population, nonfasting triglyceride levels were associated with risk of ischemic stroke.	[Freiberg, Jacob J.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Univ Copenhagen Hosp, Bispebjerg Hosp, Copenhagen City Heart Study, DK-2100 Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Jensen, Jan Skov] Univ Copenhagen Hosp, Gentofte Hosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Adiels, Martin/C-9278-2011		University of Copenhagen; Danish Heart Foundation; Danish Medical Research Council; Research Fund at Rigshospitalet; Copenhagen University Hospital; European Union	University of Copenhagen; Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Fund at Rigshospitalet; Copenhagen University Hospital; European Union(European Commission)	This study was supported by the University of Copenhagen, the Danish Heart Foundation, the Danish Medical Research Council, the Research Fund at Rigshospitalet, Copenhagen University Hospital, and the European Union, Sixth Framework Programme Priority (FP-2005-LIFESCIHEALTH-6), contract 037631.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; Bowman TS, 2003, STROKE, V34, P2930, DOI 10.1161/01.STR.0000102171.91292.DC; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COHN JS, 1988, J LIPID RES, V29, P925; Friberg J, 2003, AM J CARDIOL, V92, P1419, DOI 10.1016/j.amjcard.2003.08.050; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; Graham I, 2007, ATHEROSCLEROSIS, V194, P1, DOI 10.1016/j.atherosclerosis.2007.08.024; HAHEIM LL, 1993, STROKE, V24, P1484, DOI 10.1161/01.STR.24.10.1484; Hokanson JE, 1999, CURR OPIN LIPIDOL, V10, P393, DOI 10.1097/00041433-199910000-00003; Kolovou GD, 2005, CURR MED CHEM, V12, P1931, DOI 10.2174/0929867054546609; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11, DOI 10.1136/bmj.309.6946.11; Mahley RW., 2001, METABOLIC MOL BASES, V8th ed, P2835; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; NORDESTGAARD BG, 1992, ARTERIOSCLER THROMB, V12, P6, DOI 10.1161/01.ATV.12.1.6; NORDESTGAARD BG, 1988, J LIPID RES, V29, P1491; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; NORDESTGAARD BG, 1988, ARTERIOSCLEROSIS, V8, P421, DOI 10.1161/01.ATV.8.4.421; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Proctor SD, 2002, CURR OPIN LIPIDOL, V13, P461, DOI 10.1097/00041433-200210000-00001; RIFAI N, 2006, TIETZ TXB CLIN CHEM, P903; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rutledge JC, 2000, CIRC RES, V86, P768, DOI 10.1161/01.RES.86.7.768; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Shahar E, 2003, STROKE, V34, P623, DOI 10.1161/01.STR.0000057812.51734.FF; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Truelsen T, 2002, NEUROEPIDEMIOLOGY, V21, P22, DOI 10.1159/000048610; *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105, DOI [DOI 10.1016/0895-4356(88)90084-4, 10.1016/0895-4356(88)90084-4]; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	40	373	390	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2142	2152		10.1001/jama.2008.621	http://dx.doi.org/10.1001/jama.2008.621			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001625	Bronze			2022-12-28	WOS:000260793800024
J	Sesso, HD; Buring, JE; Christen, WG; Kurth, T; Belanger, C; MacFadyen, J; Bubes, V; Manson, JE; Glynn, RJ; Gaziano, JM				Sesso, Howard D.; Buring, Julie E.; Christen, William G.; Kurth, Tobias; Belanger, Charlene; MacFadyen, Jean; Bubes, Vadim; Manson, Joann E.; Glynn, Robert J.; Gaziano, J. Michael			Vitamins E and C in the Prevention of Cardiovascular Disease in Men The Physicians' Health Study II Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; LONG-TERM SUPPLEMENTATION; BETA-CAROTENE; ANTIOXIDANT VITAMINS; SECONDARY PREVENTION; MYOCARDIAL-INFARCTION; ALPHA-TOCOPHEROL; NATIONAL-HEALTH; UNITED-STATES	Context Basic research and observational studies suggest vitamin E or vitamin C may reduce the risk of cardiovascular disease. However, few long- term trials have evaluated men at initially low risk of cardiovascular disease, and no previous trial in men has examined vitamin C alone in the prevention of cardiovascular disease. Objective To evaluate whether long- term vitamin E or vitamin C supplementation decreases the risk of major cardiovascular events among men. Design, Setting, and Participants The Physicians' Health Study II was a randomized, double- blind, placebo- controlled factorial trial of vitamin E and vitamin C that began in 1997 and continued until its scheduled completion on August 31, 2007. There were 14 641 US male physicians enrolled, who were initially aged 50 years or older, including 754 men ( 5.1%) with prevalent cardiovascular disease at randomization. Intervention Individual supplements of 400 IU of vitamin E every other day and 500 mg of vitamin C daily. Main Outcome Measures A composite end point of major cardiovascular events ( nonfatal myocardial infarction, nonfatal stroke, and cardiovascular disease death). Results During a mean follow- up of 8 years, there were 1245 confirmed major cardiovascular events. Compared with placebo, vitamin E had no effect on the incidence of major cardiovascular events ( both active and placebo vitamin E groups, 10.9 events per 1000 person- years; hazard ratio [ HR], 1.01 [ 95% confidence interval {CI}, 0.90- 1.13]; P=. 86), as well as total myocardial infarction ( HR, 0.90 [ 95% CI, 0.75- 1.07]; P=. 22), total stroke ( HR, 1.07 [ 95% CI, 0.89- 1.29]; P=. 45), and cardiovascular mortality ( HR, 1.07 [ 95% CI, 0.90- 1.28]; P=. 43). There also was no significant effect of vitamin C on major cardiovascular events ( active and placebo vitamin E groups, 10.8 and 10.9 events per 1000 person-years, respectively; HR, 0.99 [ 95% CI, 0.89- 1.11]; P=. 91), as well as total myocardial infarction ( HR, 1.04[ 95% CI, 0.87- 1.24]; P=. 65), total stroke ( HR, 0.89[ 95% CI, 0.74- 1.07]; P=. 21), and cardiovascular mortality ( HR, 1.02 [ 95% CI, 0.85- 1.21]; P=. 86). Neither vitamin E ( HR, 1.07 [ 95% CI, 0.97- 1.18]; P=. 15) nor vitamin C ( HR, 1.07 [ 95% CI, 0.97-1.18]; P=. 16) had a significant effect on total mortality but vitamin E was associated with an increased risk of hemorrhagic stroke ( HR, 1.74 [ 95% CI, 1.04- 2.91]; P=. 04). Conclusions In this large, long- term trial of male physicians, neither vitamin E nor vitamin C supplementation reduced the risk of major cardiovascular events. These data provide no support for the use of these supplements for the prevention of cardiovascular disease in middle- aged and older men. Trial Registration clinicaltrials. gov Identifier: NCT00270647.	[Sesso, Howard D.; Buring, Julie E.; Christen, William G.; Kurth, Tobias; Belanger, Charlene; MacFadyen, Jean; Bubes, Vadim; Manson, Joann E.; Glynn, Robert J.; Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; [Sesso, Howard D.; Buring, Julie E.; Kurth, Tobias; Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02215 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Dis, Boston, MA 02215 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Sesso, Howard D.; Buring, Julie E.; Kurth, Tobias; Manson, Joann E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Sesso, HD (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	hsesso@hsph.harvard.edu	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	National Institutes of Health (Bethesda, Maryland) [CA 97193, CA 34944, CA 40360, HL 26490, HL 34595]; BASF Corporation (Florham Park, New Jersey); NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF Corporation (Florham Park, New Jersey)(BASF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants CA 97193, CA 34944, CA 40360, HL 26490, and HL 34595 from the National Institutes of Health (Bethesda, Maryland), and an investigator-initiated grant from BASF Corporation (Florham Park, New Jersey). Study agents and packaging were provided by BASF Corporation, Wyeth Pharmaceuticals (Madison, New Jersey), and DSM Nutritional Products Inc (formerly Roche Vitamins) (Parsippany, New Jersey).	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Andrews TJ, 2000, J PHARM PHARMACOL, V52, P83, DOI 10.1211/0022357001773544; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; Berger K, 1996, STROKE, V27, P238, DOI 10.1161/01.STR.27.2.238; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Buijsse B, 2008, J NUTR, V138, P344, DOI 10.1093/jn/138.2.344; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; Dietrich M, 2006, J AM COLL NUTR, V25, P292, DOI 10.1080/07315724.2006.10719538; ENSTROM JE, 1992, EPIDEMIOLOGY, V3, P194, DOI 10.1097/00001648-199205000-00003; *FOOD NUTR BOARD S, 2000, DIET REF INT VIT C V; Ford ES, 2005, ANN INTERN MED, V143, P116, DOI 10.7326/0003-4819-143-2-200507190-00010; GILMAN AS, 1985, PHARMACOL BASIS THER, P1586; Hampl JS, 2004, AM J PUBLIC HEALTH, V94, P870, DOI 10.2105/AJPH.94.5.870; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hensley K, 2004, FREE RADICAL BIO MED, V36, P1, DOI 10.1016/j.freeradbiomed.2003.10.009; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Klipstein-Grobusch K, 1999, AM J CLIN NUTR, V69, P261; Knekt P, 2004, AM J CLIN NUTR, V80, P1508, DOI 10.1093/ajcn/80.6.1508; Koh KK, 1999, CIRCULATION, V100, P1851, DOI 10.1161/01.CIR.100.18.1851; Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803; LANG JM, 1991, STAT MED, V10, P1585, DOI 10.1002/sim.4780101010; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Leppala JM, 2000, ARTERIOSCL THROM VAS, V20, P230, DOI 10.1161/01.ATV.20.1.230; Li Y, 2007, J NUTR, V137, P2171, DOI 10.1093/jn/137.10.2171; Lippman SM, 2005, JNCI-J NATL CANCER I, V97, P94, DOI 10.1093/jnci/dji009; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Mabile L, 1999, ATHEROSCLEROSIS, V147, P177, DOI 10.1016/S0021-9150(99)00169-0; Mehta J, 1999, J NUTR, V129, P109, DOI 10.1093/jn/129.1.109; Messerer M, 2008, BRIT J NUTR, V99, P626, DOI 10.1017/S0007114507812049; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Muth M.K., 1999, EC CHARACTERIZATION; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; PACKER L, 1991, AM J CLIN NUTR, V53, pS1050, DOI 10.1093/ajcn/53.4.1050S; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Robinson Irina, 2006, Endocr Pract, V12, P576; Salonen RM, 2003, CIRCULATION, V107, P947, DOI 10.1161/01.CIR.0000050626.25057.51; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Steinberg D, 1997, CIRCULATION, V95, P1062; Steiner M, 1999, NUTR REV, V57, P306, DOI 10.1111/j.1753-4887.1999.tb06903.x; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Tardif JC, 1997, NEW ENGL J MED, V337, P365, DOI 10.1056/NEJM199708073370601; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Tomoda H, 1996, AM J CARDIOL, V78, P1284, DOI 10.1016/S0002-9149(96)00613-3; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virtamo J, 1998, ARCH INTERN MED, V158, P668, DOI 10.1001/archinte.158.6.668; Walker AE, 1981, STROKE S1, V12, P13; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	59	608	635	0	63	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2123	2133		10.1001/jama.2008.600	http://dx.doi.org/10.1001/jama.2008.600			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	18997197	Green Accepted, Bronze			2022-12-28	WOS:000260793800022
J	Wang, MC; O'Rourke, EJ; Ruvkun, G				Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary			Fat Metabolism Links Germline Stem Cells and Longevity in C. elegans	SCIENCE			English	Article							LIFE-SPAN; SEX-DETERMINATION; DAF-16; GLP-1; REPRODUCTION; DROSOPHILA; RECEPTOR; PATHWAY; DFOXO	Fat metabolism, reproduction, and aging are intertwined regulatory axes; however, the mechanism by which they are coupled remains poorly understood. We found that germline stem cells (GSCs) actively modulate lipid hydrolysis in Caenorhabditis elegans, which in turn regulates longevity. GSC arrest promotes systemic lipolysis via induction of a specific fat lipase. Subsequently, fat mobilization is promoted and life span is prolonged. Constitutive expression of this lipase in fat storage tissue generates lean and long- lived animals. This lipase is a key factor in the lipid hydrolysis and increased longevity that are induced by decreased insulin signaling. These results suggest a link between C. elegans fat metabolism and longevity.	[Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Wang, Meng C.; O'Rourke, Eyleen J.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Wang, Meng/F-2951-2019; O'Rourke, Eyleen Jorgelina/AAG-2009-2021	Wang, Meng/0000-0002-5898-6007; O'Rourke, Eyleen Jorgelina/0000-0003-0503-4181	Life Sciences Research Foundation; Ellison Medical Foundation; Human Frontier Science Program; NIH [5R01AG016636, 5R37AG14161]; NATIONAL INSTITUTE ON AGING [R01AG016636, R37AG014161] Funding Source: NIH RePORTER	Life Sciences Research Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Mak, J. Dittman, and J. Avruch for critical reading of the manuscript; N. Ringstad for laser ablation techniques; V. Rottiers, A. Antebi, and the Caenorhabditis Genetics Center for providing strains; A. Fire for GFP vectors; and members of the Ruvkun lab for discussions. Supported by Life Sciences Research Foundation and Ellison Medical Foundation fellowships (M.C.W.), a Human Frontier Science Program fellowship (E.J.O.), and NIH grants 5R01AG016636 and 5R37AG14161 (G.R.).	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARTON MK, 1987, GENETICS, V115, P107; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; FRANCIS R, 1995, GENETICS, V139, P607; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HODGKIN J, 1986, GENETICS, V114, P15; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pepper ASR, 2003, GENETICS, V163, P115; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Tissenbaum HA, 1998, GENETICS, V148, P703; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c	24	274	293	9	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					957	960		10.1126/science.1162011	http://dx.doi.org/10.1126/science.1162011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988854	Green Accepted			2022-12-28	WOS:000260674100051
J	Taylor, P				Taylor, Patrick			Personal genomes: When consent gets in the way	NATURE			English	Editorial Material							PRIVACY RULE; HEALTH		[Taylor, Patrick] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Taylor, Patrick] Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Taylor, P (corresponding author), Harvard Univ, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	patrick.taylor@childrens.harvard.edu						Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Breese P, 2005, JAMA-J AM MED ASSOC, V293, P1593, DOI 10.1001/jama.293.13.1593; Churchill LR, 1999, DAEDALUS, V128, P253; Gostin LO, 2002, MINN LAW REV, V86, P1439; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Huang N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-18; Ingelfinger JR, 2004, NEW ENGL J MED, V350, P1452, DOI 10.1056/NEJMe048027; JONAS H, 1969, DAEDALUS, V98, P219; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; MANOS D, HEALTHCARE IT N 1018; Ness RB, 2007, JAMA-J AM MED ASSOC, V298, P2164, DOI 10.1001/jama.298.18.2164; Westin A. E., 2008, PUBLIC VIEWS PRIVACY	13	30	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					32	33		10.1038/456032a	http://dx.doi.org/10.1038/456032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369DH	18987719				2022-12-28	WOS:000260674000024
J	O'Meara, WP; Bejon, P; Mwangi, TW; Okiro, EA; Peshu, N; Snow, RW; Newton, CRJC; Marsh, K				O'Meara, Wendy P.; Bejon, Phillip; Mwangi, Tabitha W.; Okiro, Emelda A.; Peshu, Norbert; Snow, Robert W.; Newton, Charles R. J. C.; Marsh, Kevin			Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya	LANCET			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; INSECTICIDE-TREATED BEDNETS; PROGNOSTIC INDICATORS; CHILDHOOD MALARIA; SEVERE DISEASE; DRUG POLICY; CHILDREN; AGE; INTENSITY; EXPOSURE	Background As efforts to control malaria are expanded across the world, understanding the role of transmission intensity in determining the burden of clinical malaria is crucial to the prediction and measurement of the effectiveness of interventions to reduce transmission. Furthermore, studies comparing several endemic sites led to speculation that as transmission decreases morbidity and mortality caused by severe malaria might increase. We aimed to assess the epidemiological characteristics of malaria in Kilifi, Kenya, during a period of decreasing transmission intensity. Methods We analyse 18 years (1990-2007) of surveillance data from a paediatric ward in a malaria-endemic region of Kenya. The hospital has a catchment area of 250000 people. Clinical data and blood-film results for more than 61000 admissions are reported. Findings Hospital admissions for malaria decreased from 18-43 per 1000 children in 2003 to 3.42 in 2007. Over 18 years of surveillance, the incidence of cerebral malaria initially increased; however, malaria mortality decreased overall because of a decrease in incidence of severe malarial anaemia since 1997 (4.75 to 0.37 per 1000 children) and improved survival among children admitted with non-severe malaria. Parasite prevalence, the mean age of children admitted with malaria, and the proportion of children with cerebral malaria began to change 10 years before hospitalisation for malaria started to fall. Interpretation Sustained reduction in exposure to infection leads to changes in mean age and presentation of disease similar to those described in multisite studies. Changes in transmission might not lead to immediate reductions incidence of clinical disease. However, longitudinal data do not indicate that reductions in transmission intensity lead to transient increases in morbidity and mortality. Funding Wellcome Trust, Kenya Medical Research Institute.	[O'Meara, Wendy P.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Okiro, Emelda A.; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Program, Nairobi, Kenya; [Bejon, Phillip; Snow, Robert W.; Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Newton, Charles R. J. C.] UCL, Inst Child Hlth, London, England; [O'Meara, Wendy P.; Bejon, Phillip; Mwangi, Tabitha W.; Peshu, Norbert; Newton, Charles R. J. C.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Wellcome Trust Collaborat Program, Kilifi, Kenya	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Kenya Medical Research Institute; University of Oxford; University of London; University College London; Kenya Medical Research Institute	O'Meara, WP (corresponding author), NIH, Fogarty Int Ctr, 16 Ctr Dr, Bethesda, MD 20892 USA.	prudhomw@mail.nih.gov	Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019; Snow, Robert William/AFR-1436-2022	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Snow, Robert William/0000-0003-3725-6088; Okiro, Emelda/0000-0001-9543-8360	Fogarty International Center; Wellcome Trust	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work is published with the permission of the Director of Kenya Medical Research Institute. We wish to thank all the clinical, field, and laboratory staff at the Kenya Medical Research Institute-Wellcome Must Programme who made this study possible. WPO is funded by the Fogarty International Center. CRJCN is funded by the Wellcome Trust. RWS is a Wellcome Trust Principal Research Fellow (#079080).	Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; MOLYNEUX ME, 1989, Q J MED, V71, P441; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; MWANGI TW, 2003, CLIN EPIDEMIOLOGY MA; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; SNOW RW, 1995, PARASITOL TODAY, V11, P188, DOI 10.1016/0169-4758(95)80156-1; SNOW RW, 1992, T ROY SOC TROP MED H, V86, P237, DOI 10.1016/0035-9203(92)90290-S; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6	38	322	323	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1555	1562		10.1016/S0140-6736(08)61655-4	http://dx.doi.org/10.1016/S0140-6736(08)61655-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984188	Green Published			2022-12-28	WOS:000260590500027
J	Whitworth, JAG; Kokwaro, G; Kinyanjui, S; Snewin, VA; Tanner, M; Walport, M; Sewankambo, N				Whitworth, James A. G.; Kokwaro, Gilbert; Kinyanjui, Samson; Snewin, Valerie A.; Tanner, Marcel; Walport, Mark; Sewankambo, Nelson			Strengthening capacity for health research in Africa	LANCET			English	Editorial Material									[Whitworth, James A. G.; Snewin, Valerie A.; Walport, Mark] Wellcome Trust Res Labs, London NW1 2BE, England; [Kokwaro, Gilbert] Kenyatta Natl Hosp, Kenya Med Res Inst, Dept Clin Pharmacol, Nairobi, Kenya; [Kinyanjui, Samson] Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Tanner, Marcel] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Sewankambo, Nelson] Makerere Univ, Fac Med, Kampala, Uganda	Kenya Medical Research Institute; Kenyatta National Hospital; Kenya Medical Research Institute; University of Basel; Swiss Tropical & Public Health Institute; Makerere University	Whitworth, JAG (corresponding author), Wellcome Trust Res Labs, 215 Euston Rd, London NW1 2BE, England.	j.whitworth@wellcome.ac.uk		Sewankambo, Nelson/0000-0001-9362-053X; Walport, Mark/0000-0001-7220-5273				*COUNC HLTH RES DE, 2007, 5 COHRED; EDUARDS K, 2006, SYNTHESIS REPORT; *ENH RES CAP PROGR, DAN RES NETW INT HLT; Harle J., 2007, FRAMEWORKS AFRICA UK; Hyden G., 2006, U FACULTY RES FUNDS; *INT CTR S, S COOP SCI TECHN INN; Maselli D., 2006, IMPROVING IMPACTS RE; Nuyens Y, 2005, NO DEV RES CHALLENGE; OLSSON B, ENHANCING SUPPORT ST; SAWYERR A, AFRICAN U CHALLENGES; Swiss Commission for Research Partnership with Developing Countries, 1998, GUID RES PARTN DEV C; TANNER M, 1994, ACTA TROP, V57, P153, DOI 10.1016/0001-706X(94)90006-X; VEHLO L, BUILDING RES CAPACIT; *WELLC TRUST, HLTH RES CAP STRENGT; WHO, 2007, ALL HLTH POL SYST RE	15	137	137	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1590	1593		10.1016/S0140-6736(08)61660-8	http://dx.doi.org/10.1016/S0140-6736(08)61660-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984193	Green Published, Green Submitted			2022-12-28	WOS:000260590500032
J	Chou, YF; Chen, HH; Eijpe, M; Yabuuchi, A; Chenoweth, JG; Tesar, P; Lu, J; McKay, RDG; Geijsen, N				Chou, Yu-Fen; Chen, Hsu-Hsin; Eijpe, Maureen; Yabuuchi, Akiko; Chenoweth, Joshua G.; Tesar, Paul; Lu, Jun; Mckay, Ronald D. G.; Geijsen, Niels			The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells	CELL			English	Article							PRIMORDIAL GERM-CELLS; E-CADHERIN; REGULATORY CIRCUITRY; SELF-RENEWAL; FREE CULTURE; LINES; DIFFERENTIATION; GENERATION; FIBROBLASTS; DERIVATION	Pluripotent stem cell lines can be derived from blastocyst embryos, which yield embryonic stem cell lines (ES cells), as well as the postimplantation epiblast, which gives rise to epiblast stem cell lines (EpiSCs). Remarkably, ES cells and EpiSCs display profound differences in the combination of growth factors that maintain their pluripotent state. Molecular and functional differences between these two stem cell types demonstrate that the tissue of origin and/or the growth factor milieu may be important determinants of the stem cell identity. We explored how developmental stage of the tissue of origin and culture growth factor conditions affect the stem cell pluripotent state. Our findings indicate that novel stem cell lines, with unique functional and molecular properties, can be generated from murine blastocyst embryos. We demonstrate that the culture growth factor environment and cell-cell interaction play a critical role in defining several unique and stable stem cell ground states.	[Chou, Yu-Fen; Chen, Hsu-Hsin; Geijsen, Niels] Massachusetts Gen Hosp, Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; [Eijpe, Maureen] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Yabuuchi, Akiko] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Chenoweth, Joshua G.; Mckay, Ronald D. G.] Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Tesar, Paul] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Lu, Jun] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Lu, Jun] MIT, Cambridge, MA 02141 USA	Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Case Western Reserve University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Geijsen, N (corresponding author), Massachusetts Gen Hosp, Harvard Stem Cell Inst, Ctr Regenerat Med, CPZN-4256,185 Cambridge St, Boston, MA 02114 USA.	ngeijsen@mgh.harvard.edu	Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155	National Institutes of Health [RO1HD048769-01A1]; Harvard Stem Cell Institute; Dutch Cancer Society (Koningin Wilhelmina Fonds); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Dutch Cancer Society (Koningin Wilhelmina Fonds)(KWF Kankerbestrijding); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. George Daley for his review of our manuscript and help with the blastocyst injections; Dr. Paul Tesar for the EpiSC image; Dr. Roger Tsien for the use of the tdTomato fluorescent reporter; Dr. Keith Orford for critical review of the manuscript; Kelly Shea for providing technical support; and Laura Prickett and Kat Folz-Donahue at the HSCI/MGH Flow Cytometry Core Facility for help with cell purifications. This work was supported by grants from the National Institutes of Health (RO1HD048769-01A1) and the Harvard Stem Cell Institute. M. E. was supported by the Dutch Cancer Society (Koningin Wilhelmina Fonds).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GIBRALTER D, 1985, DEV BIOL, V112, P292, DOI 10.1016/0012-1606(85)90400-2; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Larue L, 1996, DEVELOPMENT, V122, P3185; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rathjen J, 1999, J CELL SCI, V112, P601; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	56	171	188	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					449	461		10.1016/j.cell.2008.08.035	http://dx.doi.org/10.1016/j.cell.2008.08.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984157	Bronze, Green Accepted			2022-12-28	WOS:000260536300016
J	Geschwind, DH				Geschwind, Daniel H.			Autism: Many Genes, Common Pathways?	CELL			English	Article							SPECTRUM DISORDERS; CHROMOSOMAL REARRANGEMENTS; PATERNAL AGE; LINKAGE; CONTACTIN-ASSOCIATED-PROTEIN-LIKE-2; TRANSCRIPTION; ASSOCIATION; CNTNAP2; VARIANT; RISK	Autism is a heterogeneous neurodevelopmental syndrome with a complex genetic etiology. It is still not clear whether autism comprises a vast collection of different disorders akin to intellectual disability or a few disorders sharing common aberrant pathways. Unifying principles among cases of autism are likely to be at the level of brain circuitry in addition to molecular pathways.	Univ Calif Los Angeles, David Geffen Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA.	dhg@ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH068172, R37MH060233, R01MH064547] Funding Source: NIH RePORTER; NICHD NIH HHS [P50 HD055784] Funding Source: Medline; NIMH NIH HHS [R37 MH060233, R37 MH060233-08, U54 MH68172, R37 MH60233, R01 MH64547, U54 MH068172, R01 MH064547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; ABRAHAMS BS, 2008, NAT REV GENET, V9, P493; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Benayed R, 2005, AM J HUM GENET, V77, P851, DOI 10.1086/497705; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	26	225	233	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					391	395		10.1016/j.cell.2008.10.016	http://dx.doi.org/10.1016/j.cell.2008.10.016			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984147	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000260536300006
J	Reilly, KM; Van Dyke, T				Reilly, Karlyne M.; Van Dyke, Terry			It Takes a (Dysfunctional) Village to Raise a Tumor	CELL			English	Editorial Material							MICROENVIRONMENT; CANCER	The tumor microenvironment is known to play an important role in tumorigenesis. In this issue, Yang et al. ( 2008) demonstrate that mast cells heterozygous for the Nf1 gene promote the growth of neurofibromas in a mouse model of neurofibromatosis and that genetic and pharmacological inhibition of these cells is sufficient to block tumor growth.	[Reilly, Karlyne M.; Van Dyke, Terry] NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Van Dyke, Terry] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Reilly, KM (corresponding author), NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA.	kreilly@ncifcrf.gov; vandyket@mail.nih.gov	Reilly, Karlyne/V-4475-2019	Reilly, Karlyne/0000-0001-9109-4409	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010540] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; St Croix B, 2000, SCIENCE, V289, P1197; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346	6	6	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					408	410		10.1016/j.cell.2008.10.009	http://dx.doi.org/10.1016/j.cell.2008.10.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984150	Green Accepted, Bronze			2022-12-28	WOS:000260536300009
J	Setlow, P				Setlow, Peter			Dormant Spores Receive an Unexpected Wake-up call	CELL			English	Editorial Material							CELL-WALLS; PEPTIDOGLYCAN; TURNOVER	Germination of spores of Bacillus bacteria can be triggered by nutrients acting through receptors on the spore's inner membrane. Shah et al. ( 2008) now report that cell wall peptidoglycan fragments can also trigger spore germination by binding to an inner membrane-bound protein kinase.	Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut	Setlow, P (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA.	setlow@nso2.uchc.edu						DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; HUNGERER KD, 1969, BIOCHEMISTRY-US, V8, P4317; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; MAUCK J, 1971, J BIOL CHEM, V246, P1820; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	8	19	22	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					410	412		10.1016/j.cell.2008.10.006	http://dx.doi.org/10.1016/j.cell.2008.10.006			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984151	Bronze			2022-12-28	WOS:000260536300010
J	Ogden, SK; Fei, DL; Schilling, NS; Ahmed, YF; Hwa, J; Robbins, DJ				Ogden, Stacey K.; Fei, Dennis Liang; Schilling, Neal S.; Ahmed, Yashi F.; Hwa, John; Robbins, David J.			G protein G alpha(i) functions immediately downstream of Smoothened in Hedgehog signalling	NATURE			English	Article							HETEROTRIMERIC G-PROTEINS; CUBITUS INTERRUPTUS; DROSOPHILA; EXPRESSION; KINESIN; COMPLEX; TRANSDUCTION; REPRESSOR; ACTIVATOR; RECEPTOR	The hedgehog (Hh) signalling pathway has an evolutionarily conserved role in patterning fields of cells during metazoan development, and is inappropriately activated in cancer(1,2). Hh pathway activity is absolutely dependent on signalling by the seven-transmembrane protein smoothened (Smo), which is regulated by the Hh receptor patched (Ptc). Smo signals to an intracellular multi- protein complex containing the Kinesin related protein Costal2 ( Cos2), the protein kinase Fused ( Fu) and the transcription factor Cubitus interruptus (Ci)(3). In the absence of Hh, this complex regulates the cleavage of full-length Ci to a truncated repressor protein, Ci(75), in a process that is dependent on the proteasome and priming phosphorylations by Protein kinase A (PKA)(4). Binding of Hh to Ptc blocks Ptc-mediated Smo inhibition, allowing Smo to signal to the intracellular components to attenuate Ci cleavage. Because of its homology with the Frizzled family of G-protein-coupled receptors ( GPCR) 5, a likely candidate for an immediate Smo effector would be a heterotrimeric G protein. However, the role that G proteins may have in Hh signal transduction is unclear and quite controversial(6-10), which has led to widespread speculation that Smo signals through a variety of novel G-protein-independent mechanisms. Here we present in vitro and in vivo evidence in Drosophila that Smo activates a G protein to modulate intracellular cyclic AMP levels in response to Hh. Our results demonstrate that Smo functions as a canonical GPCR, which signals through G alpha(i) to regulate Hh pathway activation.	[Ogden, Stacey K.; Fei, Dennis Liang; Schilling, Neal S.; Hwa, John; Robbins, David J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Ahmed, Yashi F.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Hwa, John] Dartmouth Med Sch, Dept Med Cardiol, Hanover, NH 03755 USA; [Ahmed, Yashi F.; Robbins, David J.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Robbins, DJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	david.j.robbins@dartmouth.edu	Ogden, Stacey K/N-2528-2018; Ogden, Stacey K/P-9585-2019	Ogden, Stacey K/0000-0001-8991-3065; Fei, Dennis Liang/0000-0002-1953-0584	National Institutes of Health [CA82628, HL074190]; NATIONAL CANCER INSTITUTE [R01CA082628, R01CA105038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants CA82628 (D.J.R.) and HL074190 (J.H.). We are grateful to J. Knoblich for the G alpha<INF>i</INF> antibody and G alpha<INF>i</INF> flies; X. Yang and W. Chia for G alpha<INF>i</INF> flies; D. Casso and T. Kornberg for Ptc antibody and UAS-Smo5A flies; J. Hooper for UAS-G alpha<INF>i</INF> and UAS-G alpha<INF>i</INF><SUP>Q205L</SUP> flies; K. Basler, D. Kalderon and P. Ingham for smo alleles; and L. Lum for Smo antibody. All additional fly stocks were provided by the Bloomington Stock Center. G alpha<INF>i</INF> and G alpha<INF>o</INF> cDNAs were obtained from the Drosophila Genomics Resource Center, Bloomington. E. Lee provided G alpha<INF>s</INF> cDNA. We thank the Dartmouth microscopy core for their assistance. We would also like to thank K. Black for technical assistance and members of the Robbins laboratory, E. Lee, J. Hutchinson, R. Taussig, R. Ostrom and C. Pikielny for thoughtful discussion during the course of this work.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Muller B, 2000, DEVELOPMENT, V127, P2999; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; PATEL NH, 1989, DEVELOPMENT, V107, P201; Pena-Rangel MT, 2002, GENETICS, V160, P1035; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Stegman MA, 2004, J BIOL CHEM, V279, P7064, DOI 10.1074/jbc.M311794200; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	37	158	165	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					967	U76		10.1038/nature07459	http://dx.doi.org/10.1038/nature07459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18987629	Green Accepted			2022-12-28	WOS:000261768300049
J	Hovhannisyan, Z; Weiss, A; Martin, A; Wiesner, M; Tollefsen, S; Yoshida, K; Ciszewski, C; Curran, SA; Murray, JA; David, CS; Sollid, LM; Koning, F; Teyton, L; Jabri, B				Hovhannisyan, Zaruhi; Weiss, Angela; Martin, Alexandra; Wiesner, Martina; Tollefsen, Stig; Yoshida, Kenji; Ciszewski, Cezary; Curran, Shane A.; Murray, Joseph A.; David, Chella S.; Sollid, Ludvig M.; Koning, Frits; Teyton, Luc; Jabri, Bana			The role of HLA-DQ8 beta 57 polymorphism in the anti-gluten T-cell response in coeliac disease	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II MOLECULES; SMALL-INTESTINAL MUCOSA; GLIADIN; SUSCEPTIBILITY; RECOGNITION; REPERTOIRE; PEPTIDES; MOUSE; GENE	Major histocompatibility complex ( MHC) class II alleles HLA-DQ8 and the mouse homologue I-A(g7) lacking a canonical aspartic acid residue at position beta 57 are associated with coeliac disease(1,2) and type I diabetes(3,4). However, the role of this single polymorphism in disease initiation and progression remains poorly understood. The lack of Asp 57 creates a positively charged P9 pocket, which confers a preference for negatively charged peptides. Gluten lacks such peptides, but tissue transglutaminase ( TG2) introduces negatively charged residues at defined positions into gluten T- cell epitopes by deamidating specific glutamine residues(5,6) on the basis of their spacing to proline residues(7). The commonly accepted model, proposing that HLA-DQ8 simply favours binding of negatively charged peptides, does not take into account the fact that TG2 requires inflammation for activation(8) and that T- cell responses against native gluten peptides are found(9,10), particularly in children(11). Here we show that beta 57 polymorphism promotes the recruitment of T- cell receptors bearing a negative signature charge in the complementary determining region 3 beta (CDR3 beta) during the response against native gluten peptides presented by HLA-DQ8 in coeliac disease. These T cells showed a crossreactive and heteroclitic ( stronger) response to deamidated gluten peptides. Furthermore, gluten peptide deamidation extended the T- cell- receptor repertoire by relieving the requirement for a charged residue in CDR3 beta. Thus, the lack of a negative charge at position beta 57 in MHC class II was met by negatively charged residues in the T- cell receptor or in the peptide, the combination of which might explain the role of HLA-DQ8 in amplifying the T- cell response against dietary gluten.	[Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Hovhannisyan, Zaruhi; Martin, Alexandra; Ciszewski, Cezary; Curran, Shane A.; Jabri, Bana] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Weiss, Angela] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Wiesner, Martina; Koning, Frits] Leiden Univ, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Tollefsen, Stig; Sollid, Ludvig M.] Natl Hosp Norway, Ctr Immune Regulat, Inst Immunol, N-0027 Oslo, Norway; [Yoshida, Kenji; Teyton, Luc] Scripps Res Inst, La Jolla, CA 92037 USA; [Murray, Joseph A.; David, Chella S.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Inst Immunol, N-0027 Oslo, Norway	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Princeton University; Leiden University; Leiden University - Excl LUMC; University of Oslo; National Hospital Norway; Scripps Research Institute; Mayo Clinic; University of Oslo	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Koning, Frits/0000-0002-4007-5715; murray, joseph/0000-0003-1941-9090	Digestive Disease Research Core Center of the University of Chicago [DK42086]; NIH [DK67180, DK55037]; Celiac Disease Consortium; EU MC-RTN [512385]; Research Council of Norway; University of Oslo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R01DK055037, R01DK067180] Funding Source: NIH RePORTER	Digestive Disease Research Core Center of the University of Chicago(University of Chicago); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celiac Disease Consortium; EU MC-RTN; Research Council of Norway(Research Council of Norway); University of Oslo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Sadegh-Nasseri for advice and discussion, and A. Bendelac and M. Mush for critical reading of the manuscript. This work was supported by the Digestive Disease Research Core Center of the University of Chicago (DK42086), NIH DK67180, DK55037, the Celiac Disease Consortium (F.K.), EU MC-RTN 512385 (M.W.), the Research Council of Norway (L.S.) and the University of Oslo (S.T.).	ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Arden Bernhard, 1995, Immunogenetics, V42, P501; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Bankovich AJ, 2004, MOL IMMUNOL, V40, P1033, DOI 10.1016/j.molimm.2003.11.016; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Quinn A, 2006, INT IMMUNOL, V18, P967, DOI 10.1093/intimm/dxl033; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; SOLINGER AM, 1979, J EXP MED, V150, P830, DOI 10.1084/jem.150.4.830; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; SPURKLAND A, 1992, HUM IMMUNOL, V35, P188, DOI 10.1016/0198-8859(92)90104-U; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J	30	69	78	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					534	538		10.1038/nature07524	http://dx.doi.org/10.1038/nature07524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037317	Green Accepted			2022-12-28	WOS:000261170500045
J	Li, C; Wu, XC; Rieppel, O; Wang, LT; Zhao, LJ				Li, Chun; Wu, Xiao-Chun; Rieppel, Olivier; Wang, Li-Ting; Zhao, Li-Jun			An ancestral turtle from the Late Triassic of southwestern China	NATURE			English	Article							CHELYDRA-SERPENTINA REPTILIA; ORIGIN; SHELL; HISTOLOGY; EVOLUTION; GUIZHOU; OSTEODERMS; AREA	The origin of the turtle body plan remains one of the great mysteries of reptile evolution. The anatomy of turtles is highly derived, which renders it difficult to establish the relationships of turtles with other groups of reptiles. The oldest known turtle, Proganochelys from the Late Triassic period of Germany(1), has a fully formed shell and offers no clue as to its origin. Here we describe a new 220- million- year- old turtle from China, somewhat older than Proganochelys, that documents an intermediate step in the evolution of the shell and associated structures. A ventral plastron is fully developed, but the dorsal carapace consists of neural plates only. The dorsal ribs are expanded, and osteoderms are absent. The new species shows that the plastron evolved before the carapace and that the first step of carapace formation is the ossification of the neural plates coupled with a broadening of the ribs. This corresponds to early embryonic stages of carapace formation in extant turtles, and shows that the turtle shell is not derived from a fusion of osteoderms. Phylogenetic analysis places the new species basal to all known turtles, fossil and extant. The marine deposits that yielded the fossils indicate that this primitive turtle inhabited marginal areas of the sea or river deltas.	[Li, Chun] Chinese Acad Sci, Lab Evolut Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Wu, Xiao-Chun] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Rieppel, Olivier] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; [Wang, Li-Ting] Geol Survey Guizhou Prov, Guiyang 550005, Peoples R China; [Zhao, Li-Jun] Zhejiang Museum Nat Hist, Hangzhou 310012, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Field Museum of Natural History (Chicago)	Li, C (corresponding author), Chinese Acad Sci, Lab Evolut Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	lichun@ivpp.ac.cn; xcwu@mus-nature.ca			Major Basic Research Projects [2006CB806400]; Ministry of Science and Technology of China; National Natural Science Foundation [40772015, 40121202]; Chinese Academy of Sciences; Canadian Museum of Nature [RS 34]; CAS/SAFEA International Partnership Program for Creative Research Teams	Major Basic Research Projects; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Canadian Museum of Nature; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	We thank Z. Tang for his help in collecting the specimens; J. Ding and H. Zhou for preparing the specimens; and W. Gao for taking the photos. C.L. and L.-T. W. were supported by the Major Basic Research Projects (2006CB806400) of the Ministry of Science and Technology of China, the National Natural Science Foundation (40772015, 40121202) of China (NNSFC) and a special grant for fossil excavation and preparation of the Chinese Academy of Sciences. X.-C.W. was supported by grants from the Canadian Museum of Nature (RS 34), NNSFC 40772015 and the CAS/SAFEA International Partnership Program for Creative Research Teams. O. R. was supported by a stipend from M. Tang.	GAFFNEY ES, 1990, B AM MUS NAT HIST, P5; Gilbert Scott F., 2008, P1; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Jiang DY, 2005, ACTA GEOL SIN-ENGL, V79, P729; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2003, P ROY SOC LOND B BIO, V271, P1, DOI DOI 10.1098/RSPB.2003.2523); LEE MSY, 1993, SCIENCE, V261, P1716, DOI 10.1126/science.261.5129.1716; Lee MSY, 1996, NATURE, V379, P812, DOI 10.1038/379812a0; LERVRATCALVIAC V, 1986, AM J ANAT, V176, P437; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; MOSS ML, 1969, ACTA ANAT, V73, P510; Procter JB, 1922, P ZOOL SOC LOND, V1922, P483; REISZ RR, 1991, NATURE, V349, P324, DOI 10.1038/349324a0; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; RIEPPEL O, 1993, J ZOOL, V231, P487, DOI 10.1111/j.1469-7998.1993.tb01933.x; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Scheyer TM, 2008, J MORPHOL, V269, P1008, DOI 10.1002/jmor.10637; Scheyer TM, 2007, P ROY SOC B-BIOL SCI, V274, P1885, DOI 10.1098/rspb.2007.0499; Sheil CA, 2005, J ZOOL, V265, P235, DOI 10.1017/S0952836904006296; Sheil CA, 2003, J MORPHOL, V256, P42, DOI 10.1002/jmor.10074; Versluys J., 1914, Palaeontologische Zeitschrift, V1; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Wang LT, 2001, ACTA GEOL SIN-ENGL, V75, P349; Wang XF, 2008, PALAEONTOLOGY, V51, P27, DOI 10.1111/j.1475-4983.2007.00735.x; Wang XF, 2006, LETHAIA, V39, P187, DOI 10.1080/00241160600715321; Weber A, 1945, MON PSYCHIATR NEUROL, V111, P144; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207; Zangerl R, 1939, J MORPHOL, V65, P383, DOI 10.1002/jmor.1050650302; ZYLBERBERG L, 1985, J MORPHOL, V186, P327, DOI 10.1002/jmor.1051860309	30	244	260	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					497	501		10.1038/nature07533	http://dx.doi.org/10.1038/nature07533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	19037315	Green Published			2022-12-28	WOS:000261170500037
J	Maggard, MA; Yermilov, I; Li, Z; Maglione, M; Newberry, S; Suttorp, M; Hilton, L; Santry, HP; Morton, JM; Livingston, EH; Shekelle, PG				Maggard, Melinda A.; Yermilov, Irina; Li, Zhaoping; Maglione, Margaret; Newberry, Sydne; Suttorp, Marika; Hilton, Lara; Santry, Heena P.; Morton, John M.; Livingston, Edward H.; Shekelle, Paul G.			Pregnancy and Fertility Following Bariatric Surgery A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GASTRIC BYPASS-SURGERY; VITAMIN-A-DEFICIENCY; BILIOPANCREATIC DIVERSION; WEIGHT-LOSS; MORBID-OBESITY; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; INTERNAL HERNIA; US CHILDREN	Context Use of bariatric surgery has increased dramatically during the past 10 years, particularly among women of reproductive age. Objectives To estimate bariatric surgery rates among women aged 18 to 45 years and to assess the published literature on pregnancy outcomes and fertility after surgery. Evidence Acquisition Search of the Nationwide Inpatient Sample ( 1998- 2005) and multiple electronic databases ( Medline, EMBASE, Controlled Clinical Trials Register Database, and the Cochrane Database of Reviews of Effectiveness) to identify articles published between 1985 and February 2008 on bariatric surgery among women of reproductive age. Search terms included bariatric procedures, fertility, contraception, pregnancy, and nutritional deficiencies. Information was abstracted about study design, fertility, and nutritional, neonatal, and pregnancy outcomes after surgery. Evidence Synthesis Of 260 screened articles, 75 were included. Women aged 18 to 45 years accounted for 49% of all patients undergoing bariatric surgery ( > 50 000 cases annually for the 3 most recent years). Three matched cohort studies showed lower maternal complication rates after bariatric surgery than in obese women without bariatric surgery, or rates approaching those of nonobese controls. In 1 matched cohort study that compared maternal complication rates in women after laparoscopic adjustable gastric band surgery with obese women without surgery, rates of gestational diabetes ( 0% vs 22.1%, P <. 05) and preeclampsia ( 0% vs 3.1%, P <. 05) were lower in the bariatric surgery group. Findings were supported by 13 other bariatric cohort studies. Neonatal outcomes were similar or better after surgery compared with obese women without laparoscopic adjustable gastric band surgery ( 7.7% vs 7.1% for premature delivery; 7.7% vs 10.6% for low birth weight, P <. 05; 7.7% vs 14.6% for macrosomia, P <. 05). No differences in neonatal outcomes were found after gastric bypass compared with nonobese controls ( 26.3%- 26.9% vs 22.4%- 20.2% for premature delivery, P= not reported [ 1 study] and P=. 43 [ 1 study]; 7.7% vs 9.0% for low birth weight, P= not reported [ 1 study]; and 0% vs 2.6%- 4.3% for macrosomia, P= not reported [ 1 study and P=. 28 [ 1 study]). Findings were supported by 10 other studies. Studies regarding nutrition, fertility, cesarean delivery, and contraception were limited. Conclusion Rates of many adverse maternal and neonatal outcomes may be lower in women who become pregnant after having had bariatric surgery compared with rates in pregnant women who are obese; however, further data are needed from rigorously designed studies.	[Maggard, Melinda A.; Yermilov, Irina; Li, Zhaoping; Maglione, Margaret; Shekelle, Paul G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Maggard, Melinda A.; Maglione, Margaret; Newberry, Sydne; Suttorp, Marika; Hilton, Lara; Shekelle, Paul G.] RAND Corp, Santa Monica, CA USA; [Yermilov, Irina; Li, Zhaoping; Shekelle, Paul G.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Santry, Heena P.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Morton, John M.] Stanford Univ, Sch Med, Dept Surg, Palo Alto, CA 94304 USA; [Livingston, Edward H.] Univ Texas Southwestern Sch Med, Dept Surg, Dallas, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Harvard University; Massachusetts General Hospital; Stanford University	Maggard, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, CHS 72-215,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	mmaggard@mednet.ucla.edu		Santry, Heena/0000-0003-2352-1557	Agency for Healthcare Research and Quality [290-02-0003]; US Department of Health and Human Services to the Southern California Evidence Based Practice Center; Robert Wood Johnson Physician Faculty Scholars program	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Health and Human Services to the Southern California Evidence Based Practice Center; Robert Wood Johnson Physician Faculty Scholars program(Robert Wood Johnson Foundation (RWJF))	This project was funded under contract 290-02-0003 from the Agency for Healthcare Research and Quality, US Department of Health and Human Services to the Southern California Evidence Based Practice Center. Dr Maggard's time was supported in part by a grant from the Robert Wood Johnson Physician Faculty Scholars program. This work was requested by the American College of Obstetricians and Gynecologists.	ADAMI GF, 1992, CLIN NUTR, V11, P106, DOI 10.1016/0261-5614(92)90020-Q; Ahmed AR, 2006, OBES SURG, V16, P1246, DOI 10.1381/096089206778392310; Allison D B, 1995, Endocr Pract, V1, P353; *AM SOC MET BAR SU, BAR SURG SOC TAK NEW; Baker Matthew T, 2005, Surg Obes Relat Dis, V1, P506, DOI 10.1016/j.soard.2005.07.008; Bar-Zohar D, 2006, SURG ENDOSC, V20, P1580, DOI 10.1007/s00464-005-0317-0; Bastounis EA, 1998, EUR SURG RES, V30, P43, DOI 10.1159/000008556; Bellanger Drake E, 2006, Surg Obes Relat Dis, V2, P490, DOI 10.1016/j.soard.2006.04.002; BILENKA B, 1995, ACTA OBSTET GYN SCAN, V74, P42, DOI 10.3109/00016349509009942; BIRON S, 1999, OBES SURG, V9, P126; Campbell C D, 2005, Haematologica, V90, pECR45; Centers for Disease Control and Prevention, OV OB; Charles A, 2005, AM SURGEON, V71, P231; Cools M, 2006, EUR J PEDIATR, V165, P199, DOI 10.1007/s00431-005-0056-1; Courneya KS, 2008, CANCER-AM CANCER SOC, V112, P2475, DOI 10.1002/cncr.23455; Dao T, 2006, AM J SURG, V192, P762, DOI 10.1016/j.amjsurg.2006.08.041; DEITEL M, 1988, J AM COLL NUTR, V7, P147, DOI 10.1080/07315724.1988.10720232; Dixon JB, 2005, OBSTET GYNECOL, V106, P965, DOI 10.1097/01.AOG.0000181821.82022.82; Dixon JB, 2001, OBES SURG, V11, P59, DOI 10.1381/096089201321454123; Ducarme G, 2007, INT J GYNECOL OBSTET, V98, P244, DOI 10.1016/j.ijgo.2007.02.020; Eid George M, 2005, Surg Obes Relat Dis, V1, P77, DOI 10.1016/j.soard.2005.02.008; Erez O, 2004, AM J OBSTET GYNECOL, V191, P1721, DOI 10.1016/j.ajog.2004.03.036; Escobar-Morreale HF, 2005, J CLIN ENDOCR METAB, V90, P6364, DOI 10.1210/jc.2005-1490; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fleser PS, 2003, OBES SURG, V13, P453, DOI 10.1381/096089203765887831; FRIEDMAN D, 1995, OBES SURG, V5, P308, DOI 10.1381/096089295765557692; FRIEDMAN D, 1989, INT J OBESITY, V13, P599; Gaudry P, 2006, Gynecol Obstet Fertil, V34, P407, DOI 10.1016/j.gyobfe.2006.01.040; Gerrits EG, 2003, OBES SURG, V13, P378, DOI 10.1381/096089203765887697; GRANGE DK, 1994, PEDIATR HEMAT ONCOL, V11, P311, DOI 10.3109/08880019409141674; GRAUBARD Z, 1988, S AFR MED J, V73, P127; Gurewitsch ED, 1996, OBSTET GYNECOL, V88, P658, DOI 10.1016/0029-7844(96)00187-1; HADDOW JE, 1986, LANCET, V1, P1330; HCUP Nationwide Inpatient Sample (NIS), 2000, HCUP NAT INP SAMPL N; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heinzen M, 2006, AM J OBSTET GYNECOL, V195, pS208, DOI 10.1016/j.ajog.2006.10.749; Huerta S, 2002, AM J CLIN NUTR, V76, P426, DOI 10.1093/ajcn/76.2.426; Jasaitis Y, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P764; JESTER L, 1997, OBES SURG, V7, P280; Kakarla N, 2005, OBSTET GYNECOL, V105, P1195, DOI 10.1097/01.AOG.0000152352.58688.27; Katzmarzyk PT, 2006, DIABETES CARE, V29, P404, DOI 10.2337/diacare.29.02.06.dc05-1636; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Landsberger E, 2006, AM J OBSTET GYNECOL, V195, pS93, DOI 10.1016/j.ajog.2006.10.303; Loar PV, 2005, AM J OBSTET GYNECOL, V193, P1748, DOI 10.1016/j.ajog.2005.04.041; Marceau P, 2004, OBES SURG, V14, P318, DOI 10.1381/096089204322917819; MARTENS WS, 1990, PEDIATRICS, V86, P777; MARTIN L, 1988, LANCET, V1, P640; Martin LF, 2000, OBSTET GYNECOL, V95, P927, DOI 10.1016/S0029-7844(00)00819-X; MARTIN LF, 1997, OBES SURG, V7, P280; Moore KA, 2004, NEW ENGL J MED, V351, P721, DOI 10.1056/NEJM200408123510722; *NAT CTR HLTH STAT, TEEN BIRTH RAT RIS 1; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Organization W. H, CONTR GLOB OB EP; Parkes E, 2006, AM J MED SCI, V331, P207, DOI 10.1097/00000441-200604000-00007; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; PRINTEN KJ, 1982, AM SURGEON, V48, P363; RAMIREZ MM, 1995, AM J OBSTET GYNECOL, V173, P1630, DOI 10.1016/0002-9378(95)90665-7; Ramos RG, 2008, AM J PUBLIC HEALTH, V98, P1122, DOI 10.2105/AJPH.2007.120055; RAND CSW, 1989, SOUTHERN MED J, V82, P1319, DOI 10.1097/00007611-198910000-00038; RICHARDS DS, 1987, J REPROD MED, V32, P172; Roehrig HR, 2007, OBES SURG, V17, P873, DOI 10.1007/s11695-007-9162-7; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Sheiner E, 2006, AM J OBSTET GYNECOL, V194, P431, DOI 10.1016/j.ajog.2005.08.056; Sheiner E, 2004, AM J OBSTET GYNECOL, V190, P1335, DOI 10.1016/j.ajog.2003.11.004; Skull AJ, 2004, OBES SURG, V14, P230, DOI 10.1381/096089204322857618; Smets KJ, 2006, EUR J PEDIATR, V165, P502, DOI 10.1007/s00431-006-0120-5; St George LI, 2005, MED J AUSTRALIA, V182, P308, DOI 10.5694/j.1326-5377.2005.tb06709.x; Strauss RS, 2001, J PEDIATR-US, V138, P499, DOI 10.1067/mpd.2001.113043; Teitelman M, 2006, OBES SURG, V16, P1457, DOI 10.1381/096089206778870148; Tucker ON, 2007, MED CLIN N AM, V91, P499, DOI 10.1016/j.mcna.2007.01.006; Wang JL, 2007, JPN J APPL PHYS 1, V46, P267, DOI 10.1143/JJAP.46.267; Wax JR, 2008, OBES SURG, V18, P540, DOI 10.1007/s11695-008-9459-1; Wax JR, 2007, OBES SURG, V17, P977, DOI 10.1007/s11695-007-9153-8; Weiner R, 2003, OBES SURG, V13, P427, DOI 10.1381/096089203765887787; Weintraub A, 2007, AM J OBSTET GYNECOL, V197, pS186, DOI 10.1016/j.ajog.2007.10.674; Weiss HG, 2001, OBES SURG, V11, P303, DOI 10.1381/096089201321336647; WEISSMAN A, 1995, J REPROD MED, V40, P813; Wittgrove AC, 1998, OBES SURG, V8, P461, DOI 10.1381/096089298765554368	83	318	324	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2286	2296		10.1001/jama.2008.641	http://dx.doi.org/10.1001/jama.2008.641			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017915	Bronze			2022-12-28	WOS:000260965500029
J	Alley, RB; Fahnestock, M; Joughin, I				Alley, Richard B.; Fahnestock, Mark; Joughin, Ian			CLIMATE CHANGE Understanding Glacier Flow in Changing Times	SCIENCE			English	Editorial Material							GREENLAND ICE-SHEET; SURFACE MELT; ANTARCTICA		[Alley, Richard B.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Alley, Richard B.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Fahnestock, Mark] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Joughin, Ian] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System Of New Hampshire; University of New Hampshire; University of Washington; University of Washington Seattle	Alley, RB (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	rba6@psu.edu	Joughin, Ian R/A-2998-2008; Fahnestock, Mark/N-2678-2013; Joughin, Ian/AAR-7778-2021	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X				ALLEY RB, 1991, SCIENCE, V254, P959, DOI 10.1126/science.254.5034.959; Anandakrishnan S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016329; Bell RE, 2007, NATURE, V445, P904, DOI 10.1038/nature05554; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Fricker HA, 2007, SCIENCE, V315, P1544, DOI 10.1126/science.1136897; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Joughin I, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002960; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000837; Kintisch E, 2008, SCIENCE, V321, P1142, DOI 10.1126/science.321.5893.1142; Parizek BR, 2004, QUATERNARY SCI REV, V23, P1013, DOI 10.1016/j.quascirev.2003.12.024; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	16	20	25	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1061	1062		10.1126/science.1166366	http://dx.doi.org/10.1126/science.1166366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008435				2022-12-28	WOS:000260867700025
J	Choi, EY; Chavakis, E; Czabanka, MA; Langer, HF; Fraemohs, L; Economopoulou, M; Kundu, RK; Orlandi, A; Zheng, YY; Prieto, DA; Ballantyne, CM; Constant, SL; Aird, WC; Papayannopoulou, T; Gahmberg, CG; Udey, MC; Vajkoczy, P; Quertermous, T; Dimmeler, S; Weber, C; Chavakis, T				Choi, Eun Young; Chavakis, Emmanouil; Czabanka, Marcus A.; Langer, Harald F.; Fraemohs, Line; Economopoulou, Matina; Kundu, Ramendra K.; Orlandi, Alessia; Zheng, Ying Yi; Prieto, DaRue A.; Ballantyne, Christie M.; Constant, Stephanie L.; Aird, William C.; Papayannopoulou, Thalia; Gahmberg, Carl G.; Udey, Mark C.; Vajkoczy, Peter; Quertermous, Thomas; Dimmeler, Stefanie; Weber, Christian; Chavakis, Triantafyllos			Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitment	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; INTEGRINS; MIGRATION; PROTEIN; MOLECULE-1; ICAM-1; LFA-1	Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte- endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 ( developmental endothelial locus-1) as an anti-adhesive factor that interferes with the integrin LFA-1-dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA- 1- dependent leukocyte adhesion in vitro and in vivo. Del-1(-/-) mice displayed significantly higher neutrophil accumulation in lipopolysaccharide- induced lung inflammation in vivo, which was reversed in Del- /LFA-1 double- deficient mice. Thus, Del- 1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte- endothelial interactions in disease.	[Choi, Eun Young; Langer, Harald F.; Zheng, Ying Yi; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Chavakis, Emmanouil; Orlandi, Alessia; Dimmeler, Stefanie] Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Czabanka, Marcus A.; Vajkoczy, Peter] Charite Univ Med Berlin, Dept Neurosurg, D-13353 Berlin, Germany; [Fraemohs, Line; Weber, Christian] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany; [Economopoulou, Matina] NCI, Lab Cellular Oncol, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Kundu, Ramendra K.; Quertermous, Thomas] Stanford Univ, Sch Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA; [Prieto, DaRue A.] NCI, Lab Proteom & Anal Technol, SAIC Frederick, Frederick, MD 21701 USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX 77030 USA; [Constant, Stephanie L.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Aird, William C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Papayannopoulou, Thalia] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Gahmberg, Carl G.] Univ Helsinki, Div Biochem, Fac Biosci, Helsinki, Finland; [Udey, Mark C.] NCI, Dermatol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; RWTH Aachen University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; George Washington University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chavakis, T (corresponding author), NCI, Expt Immunol Branch, Canc Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	chavakist@mail.nih.gov	Chavakis, Triantafyllos/ABE-8845-2020; Gahmberg, Carl/AAE-1876-2019; Ballantyne, Christie/A-6599-2008; Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714; Quertermous, Thomas/0000-0002-7645-9067; Ballantyne, Christie/0000-0002-6432-1730; Gahmberg, Carl/0000-0001-9892-9296; Choi, Eun Young/0000-0002-5484-4925; Dimmeler, Stefanie/0000-0002-1045-2436	Intramural Research Program; NIH [AI067254, RO1 HL082927]; NCI; Deutsche Forschungsgemeinschaft [FOR809, TP6, TR-SFB23, Exc 147/1]; NATIONAL CANCER INSTITUTE [ZIABC010790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067254] Funding Source: NIH RePORTER	Intramural Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Feng and M. Sardy for generating the Del-1-Fc protein, N. Hogg for the antibody mAb24, Valentis Inc. for recombinant Del- 1 and the antibody to mouse Del- 1, T. Veenstra for help with mass spectrometry, D. Winkler for help with genotyping, I. Okwumabua for technical assistance, and D. Singer for critically reading the manuscript. This research was supported by the Intramural Research Program of the NIH, NCI (T.C. and M.C.U.); by NIH grants AI067254 (S.L.C.) and RO1 HL082927 (W.C.A.); and by the Deutsche Forschungsgemeinschaft (grants FOR809 and TP6 to C.W.; TR-SFB23 and Exc 147/1 to S.D. and E.C.). A patent application on the anti- inflammatory actions of Del-1 has been filed.	Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Ding ZM, 1999, J IMMUNOL, V163, P5029; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gahmberg CG, 1998, CELL MOL LIFE SCI, V54, P549, DOI 10.1007/s000180050183; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hidai C, 2007, CELL TISSUE RES, V330, P83, DOI 10.1007/s00441-007-0456-9; Ho HKV, 2004, CIRCULATION, V109, P1314, DOI 10.1161/01.CIR.0000118465.36018.2D; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Yonekawa K, 2005, J LEUKOCYTE BIOL, V77, P129, DOI 10.1189/jlb.0804460; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034	23	216	228	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1101	1104		10.1126/science.1165218	http://dx.doi.org/10.1126/science.1165218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008446	Green Accepted			2022-12-28	WOS:000260867700037
J	Chesson, P; Kuang, JJ				Chesson, Peter; Kuang, Jessica J.			The interaction between predation and competition	NATURE			English	Article							APPARENT COMPETITION; ECOLOGICAL COMMUNITIES; TOP PREDATORS; RESOURCE; COEXISTENCE; PREY; DIVERSITY; SYSTEMS; MODELS	Competition and predation are the most heavily investigated species interactions in ecology, dominating studies of species diversity maintenance. However, these two interactions are most commonly viewed highly asymmetrically. Competition for resources is seen as the primary interaction limiting diversity, with predation modifying what competition does(1), although theoretical models have long supported diverse views(1-5). Here we show, using a comprehensive three- trophic- level model, that competition and predation should be viewed symmetrically: these two interactions are equally able to either limit or promote diversity. Diversity maintenance requires within- species density feedback loops to be stronger than between- species feedback loops. We quantify the contributions of predation and competition to these loops in a simple, interpretable form, showing their equivalent potential to strengthen or weaken diversity maintenance. Moreover, we show that competition and predation can undermine each other, with the tendency of the stronger interaction to promote or limit diversity prevailing. The past failure to appreciate the symmetrical effects and interactions of competition and predation has unduly restricted diversity maintenance studies. A multitrophic perspective should be adopted to examine a greater variety of possible effects of predation than generally considered in the past. Conservation and management strategies need to be much more concerned with the implications of changes in the strengths of trophic interactions.	[Chesson, Peter; Kuang, Jessica J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Chesson, P (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	pchesson@u.arizona.edu; jjkuang@u.arizona.edu	Chesson, Peter/GRO-6970-2022; Chesson, Peter/GLN-5790-2022	Chesson, Peter/0000-0001-8931-8012; 	National Science Foundation [DEB-0542991, DEB-0717222]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants DEB-0542991 and DEB-0717222.	Abrams PA, 1998, AM NAT, V152, P114, DOI 10.1086/286153; Borrvall C, 2006, ECOL LETT, V9, P435, DOI 10.1111/j.1461-0248.2006.00893.x; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON P, 1990, THEOR POPUL BIOL, V37, P26, DOI 10.1016/0040-5809(90)90025-Q; Chesson P., 2008, UNITY DIVERSITY REFL, P119; EITHAUS MR, 2008, TRENDS ECOL EVOL, V23, P202; Grover JP, 1998, J THEOR BIOL, V191, P353, DOI 10.1006/jtbi.1997.0562; Haygood R, 2002, THEOR POPUL BIOL, V61, P215, DOI 10.1006/tpbi.2001.1566; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; KOTLER BP, 1989, OIKOS, V54, P256, DOI 10.2307/3565279; Krivan V, 2003, EVOL ECOL RES, V5, P1163; Kuang JJ, 2008, AM NAT, V171, pE119, DOI 10.1086/527484; KUANG JJ, ECOLOGY IN PRESS; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Sala E, 2006, TRENDS ECOL EVOL, V21, P479, DOI 10.1016/j.tree.2006.07.006; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Soule ME, 1999, BIOSCIENCE, V49, P809, DOI 10.2307/1313572	24	313	325	7	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					235	238		10.1038/nature07248	http://dx.doi.org/10.1038/nature07248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005554				2022-12-28	WOS:000261039300039
J	Ford, AC; Talley, NJ; Spiegel, BMR; Foxx-Orenstein, AE; Schiller, L; Quigley, EMM; Moayyedi, P				Ford, Alexander C.; Talley, Nicholas J.; Spiegel, Brennan M. R.; Foxx-Orenstein, Amy E.; Schiller, Lawrence; Quigley, Eamonn M. M.; Moayyedi, Paul			Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLINICAL-TRIALS; VISCERAL SENSATION; NATURAL-HISTORY; SMOOTH-MUSCLE; PREVALENCE; DISORDERS; QUALITY; POPULATION; MANAGEMENT; TRANSIT	Objective To determine the effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome. Design Systematic review and meta- analysis of randomised controlled trials. Data sources Medline, Embase, and the Cochrane controlled trials register up to April 2008. Review methods Randomised controlled trials comparing fibre, antispasmodics, and peppermint oil with placebo or no treatment in adults with irritable bowel syndrome were eligible for inclusion. The minimum duration of therapy considered was one week, and studies had to report either a global assessment of cure or improvement in symptoms, or cure of or improvement in abdominal pain, after treatment. A random effects model was used to pool data on symptoms, and the effect of therapy compared with placebo or no treatment was reported as the relative risk (95% confidence interval) of symptoms persisting. Results 12 studies compared fibre with placebo or no treatment in 591 patients (relative risk of persistent symptoms 0.87, 95% confidence interval 0.76 to 1.00). This effect was limited to ispaghula (0.78, 0.63 to 0.96). Twenty two trials compared antispasmodics with placebo in 1778 patients (0.68, 0.57 to 0.81). Various antispasmodics were studied, but otilonium (four trials, 435 patients, relative risk of persistent symptoms 0.55, 0.31 to 0.97) and hyoscine (three trials, 426 patients, 0.63, 0.51 to 0.78) showed consistent evidence of efficacy. Four trials compared peppermint oil with placebo in 392 patients ( 0.43, 0.32 to 0.59). Conclusion Fibre, antispasmodics, and peppermint oil were all more effective than placebo in the treatment of irritable bowel syndrome.	[Ford, Alexander C.; Moayyedi, Paul] McMaster Univ, Hlth Sci Ctr, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada; [Talley, Nicholas J.] Mayo Clin, Dept Med, Jacksonville, FL 32224 USA; [Spiegel, Brennan M. R.] Univ Calif Los Angeles, VA Ctr Outcomes Res & Educ, Los Angeles, CA USA; [Spiegel, Brennan M. R.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Foxx-Orenstein, Amy E.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Schiller, Lawrence] Baylor Univ, Med Ctr, Digest Hlth Assoc Texas, Dallas, TX USA; [Quigley, Eamonn M. M.] Cork Univ Hosp, Dept Med, Cork, Ireland	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Mayo Clinic; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Mayo Clinic; Baylor University; Baylor University Medical Center; University College Cork	Ford, AC (corresponding author), McMaster Univ, Hlth Sci Ctr, Div Gastroenterol, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	alexf12399@yahoo.com	Moayyedi, Paul/M-6178-2014; Ford, Alexander/K-5491-2012; Talley, Nicholas J/D-5399-2013	Moayyedi, Paul/0000-0002-3616-9292; Ford, Alexander/0000-0001-6371-4359; Talley, Nicholas J/0000-0003-2537-3092	American College of Gastroenterology	American College of Gastroenterology(General Electric)	This study was funded by the American College of Gastroenterology. The authors' work was independent of the funders.	Agreus L, 2000, SCAND J GASTROENTERO, V35, P142; Agreus L, 2001, AM J GASTROENTEROL, V96, P2905; *AM COLL GASTR FUN, 2002, AM J GASTROENTEROL, V97, pS2; Aziz Q, 2000, J NEUROSCI, V20, P2657; Bijkerk CJ, 2004, ALIMENT PHARM THER, V19, P245, DOI 10.1111/j.0269-2813.2004.01862.x; Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford AC, 2008, AM J GASTROENTEROL, V103, P1229, DOI 10.1111/j.1572-0241.2007.01740.x; HARVEY RF, 1973, LANCET, V1, P1278; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hillila MT, 2004, ALIMENT PHARM THERAP, V20, P339, DOI 10.1111/j.1365-2036.2004.02034.x; HILLS JM, 1991, GASTROENTEROLOGY, V101, P55, DOI 10.1016/0016-5085(91)90459-X; Hungin APS, 2003, ALIMENT PHARM THER, V17, P643, DOI 10.1046/j.1365-2036.2003.01456.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jailwala J, 2000, ANN INTERN MED, V133, P136, DOI 10.7326/0003-4819-133-2-200007180-00013; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lesbros-Pantoflickova D, 2004, ALIMENT PHARM THER, V20, P1253, DOI 10.1111/j.1365-2036.2004.02267.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Marciani L, 2007, GASTROENTEROLOGY, V132, pA141; MCKEE DP, 1993, DIGEST DIS SCI, V38, P1761, DOI 10.1007/BF01296097; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; National Institute for Health and Clinical Excellence, 2008, IRR BOW SYNDR AD DIA; Pittler MH, 1998, AM J GASTROENTEROL, V93, P1131, DOI 10.1111/j.1572-0241.1998.00343.x; Poynard T, 2001, ALIMENT PHARM THER, V15, P355, DOI 10.1046/j.1365-2036.2001.00937.x; Quartero AO, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003460.pub2; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Tack J, 2006, ALIMENT PHARM THER, V24, P183, DOI 10.1111/j.1365-2036.2006.02938.x; TRIMBLE KC, 1995, DIGEST DIS SCI, V40, P1607, DOI 10.1007/BF02212678; van Zanten SJOV, 1999, GUT, V45, P69; Wilson S, 2004, BRIT J GEN PRACT, V54, P495	32	318	334	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2008	337								a2313	10.1136/bmj.a2313	http://dx.doi.org/10.1136/bmj.a2313			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008265	Green Published, hybrid			2022-12-28	WOS:000261784500003
J	Mathew, R; Devi, KSS; Rao, G; Thomas, S				Mathew, Roshen; Devi, K. S. Shakuntala; Rao, Ganesh; Thomas, Sheju			An interesting pathological specimen at delivery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VANISHING TWIN; ULTRASONOGRAPHIC PHENOMENON		[Mathew, Roshen] Sree Siddhartha Med Coll, Dept Gen Med & Family Practice, Tumkur, India; [Devi, K. S. Shakuntala; Rao, Ganesh; Thomas, Sheju] Sree Siddhartha Med Coll, Dept Obstet & Gynaecol, Tumkur, India	Sri Siddhartha Medical College, Tumkur; Sri Siddhartha Medical College, Tumkur	Mathew, R (corresponding author), Sree Siddhartha Med Coll, Dept Gen Med & Family Practice, Tumkur, India.	dr_mrn@rediffmail.com	MATHEW, ROSHEN/AAR-2416-2021					BENIRSCHKE K, 1993, SEMIN DIAGN PATHOL, V10, P222; BLUMENFELD Z, 1992, BRIT J OBSTET GYNAEC, V99, P333, DOI 10.1111/j.1471-0528.1992.tb13734.x; GARISSI P, 1983, NATURE, V304, P626; KRAMER R, 1994, VANISHING TWIN; Landy HJ, 1998, HUM REPROD UPDATE, V4, P177, DOI 10.1093/humupd/4.2.177; LEVI S, 1976, Journal of Clinical Ultrasound, V4, P3, DOI 10.1002/jcu.1870040104; Pharoah POD, 1997, DEV MED CHILD NEUROL, V39, P292; RUDNICKI M, 1991, GYNECOL OBSTET INVES, V31, P141, DOI 10.1159/000293133; SAIDI MH, 1988, J REPROD MED, V33, P831; SAIER F, 1975, OBSTET GYNECOL, V45, P217; SULAK LE, 1986, OBSTET GYNECOL, V68, P811; WINN HN, 1939, CLIN MATERNAL FETAL, pCH5	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2008	337								a2453	10.1136/bmj.a2453	http://dx.doi.org/10.1136/bmj.a2453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AD	19004879				2022-12-28	WOS:000261784400017
J	Costa-Mattioli, M				Costa-Mattioli, Mauro			EPPENDORF WINNER Switching Memories ON and OFF	SCIENCE			English	Editorial Material							SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; NEUROSCIENCE; TERM; MECHANISMS; STORAGE		[Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu						BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borges JL., 1962, FUNES MEMORIOUS BORG, V2, P107; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014	21	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					874	875		10.1126/science.1167228	http://dx.doi.org/10.1126/science.1167228			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988834				2022-12-28	WOS:000260674100029
J	Polman, A				Polman, Albert			APPLIED PHYSICS Plasmonics Applied	SCIENCE			English	Editorial Material							NEGATIVE REFRACTION; FREQUENCIES		[Polman, Albert] FOM Inst AMOLF, Ctr Nanophoton, NL-1098 SJ Amsterdam, Netherlands	AMOLF	Polman, A (corresponding author), FOM Inst AMOLF, Ctr Nanophoton, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	polman@amolf.nl	Polman, Albert/D-1490-2011	Polman, Albert/0000-0002-0685-3886				Alu A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.113901; de Waele R, 2007, NANO LETT, V7, P2004, DOI 10.1021/nl070807q; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Laux E, 2008, NAT PHOTONICS, V2, P161, DOI 10.1038/nphoton.2008.1; Lezec HJ, 2007, SCIENCE, V316, P430, DOI 10.1126/science.1139266; Loo C, 2005, NANO LETT, V5, P709, DOI 10.1021/nl050127s; Miyazaki HT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097401; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pillai S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734885; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Sandtke M, 2007, NAT PHOTONICS, V1, P573, DOI 10.1038/nphoton.2007.174; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; Stockman MI, 2007, NAT PHOTONICS, V1, P539, DOI 10.1038/nphoton.2007.169; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Zheludev NI, 2008, NAT PHOTONICS, V2, P351, DOI 10.1038/nphoton.2008.82	15	264	276	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					868	869		10.1126/science.1163959	http://dx.doi.org/10.1126/science.1163959			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988831				2022-12-28	WOS:000260674100026
J	Xie, T				Xie, Ting			PHYSIOLOGY Burn Fat, Live Longer	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS LONGEVITY; LIFE-SPAN; C-ELEGANS; DROSOPHILA; INSULIN/IGF-1; GERMLINE; SIGNALS; DAF-16; DFOXO; BODY		[Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	tgx@stowers-institute.org						Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Yamawaki TM, 2008, GENETICS, V178, P513, DOI 10.1534/genetics.107.083253	15	6	8	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					865	866		10.1126/science.1166150	http://dx.doi.org/10.1126/science.1166150			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988829				2022-12-28	WOS:000260674100024
J	Woody, GE; Poole, SA; Subramaniam, G; Dugosh, K; Bogenschutz, M; Abbott, P; Patkar, A; Publicker, M; McCain, K; Potter, JS; Forman, R; Vetter, V; McNicholas, L; Blaine, J; Lynch, KG; Fudala, P				Woody, George E.; Poole, Sabrina A.; Subramaniam, Geetha; Dugosh, Karen; Bogenschutz, Michael; Abbott, Patrick; Patkar, Ashwin; Publicker, Mark; McCain, Karen; Potter, Jennifer Sharpe; Forman, Robert; Vetter, Victoria; McNicholas, Laura; Blaine, Jack; Lynch, Kevin G.; Fudala, Paul			Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHADONE-MAINTENANCE TREATMENT; DRUG-USERS; DEPENDENCE; ABUSE; PHARMACOLOGY; NALTREXONE; INJECTION; RELAPSE	Context The usual treatment for opioid- addicted youth is detoxification and counseling. Extended medication- assisted therapy may be more helpful. Objective To evaluate the efficacy of continuing buprenorphine- naloxone for 12 weeks vs detoxification for opioid- addicted youth. Design, Setting, and Patients Clinical trial at 6 community programs from July 2003 to December 2006 including 152 patients aged 15 to 21 years who were randomized to 12 weeks of buprenorphine- naloxone or a 14- day taper (detox). Interventions Patients in the 12- week buprenorphine- naloxone group were prescribed up to 24 mg per day for 9 weeks and then tapered to week 12; patients in the detox group were prescribed up to 14 mg per day and then tapered to day 14. All were offered weekly individual and group counseling. Main Outcome Measure Opioid- positive urine test result at weeks 4, 8, and 12. Results The number of patients younger than 18 years was too small to analyze separately, but overall, patients in the detox group had higher proportions of opioidpositive urine test results at weeks 4 and 8 but not at week 12 (chi(2)(2) = 4.93, P =. 09). At week 4, 59 detox patients had positive results ( 61%; 95% confidence interval [CI]= 47%-75%) vs 58 12- week buprenorphine- naloxone patients (26%; 95% CI= 14%- 38%). At week 8, 53 detox patients had positive results ( 54%; 95% CI= 38%- 70%) vs 52 12- week buprenorphine- naloxone patients ( 23%; 95% CI= 11%- 35%). At week 12, 53 detox patients had positive results (51%; 95% CI= 35%- 67%) vs 49 12- week buprenorphine-naloxone patients (43%; 95% CI= 29%-57%). By week 12, 16 of 78 detox patients ( 20.5%) remained in treatment vs 52 of 74 12- week buprenorphine-naloxone patients ( 70%; chi(2)(1) = 32.90, P <. 001). During weeks 1 through 12, patients in the 12- week buprenorphine- naloxone group reported less opioid use (chi(2)(1) = 18.45, P <. 001), less injecting (chi(2)(1) = 6.00, P =. 01), and less nonstudy addiction treatment (chi(2)(1) = 25.82, P <. 001). High levels of opioid use occurred in both groups at follow-up. Four of 83 patients who tested negative for hepatitis C at baseline were positive for hepatitis C at week 12. Conclusions Continuing treatment with buprenorphine- naloxone improved outcome compared with short-term detoxification. Further research is necessary to assess the efficacy and safety of longer- term treatment with buprenorphine for young individuals with opioid dependence. Trial Registration clinicaltrials. gov Identifier: NCT00078130.	[Woody, George E.; Poole, Sabrina A.; Dugosh, Karen; Forman, Robert; McNicholas, Laura; Lynch, Kevin G.; Fudala, Paul] Univ Penn, Dept Psychiat, Treatment Res Inst, Philadelphia, PA 19106 USA; [Subramaniam, Geetha] Johns Hopkins Univ, Div Child & Adolescent Psychiat, Baltimore, MD USA; [Bogenschutz, Michael; Abbott, Patrick] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Bogenschutz, Michael] Univ New Mexico, Ctr Alcoholism Substance Abuse & Addict, Albuquerque, NM 87131 USA; [Abbott, Patrick] Univ New Mexico, Hlth Sci Ctr, Addict Program, Albuquerque, NM 87131 USA; [Abbott, Patrick] Univ New Mexico, Hlth Sci Ctr, Substance Abuse Program, Albuquerque, NM 87131 USA; [Patkar, Ashwin] Duke Univ, Med Ctr, Durham, NC USA; [Publicker, Mark] Mercy Recovery Ctr, Westbrook, ME USA; [McCain, Karen] Duke Univ, Duke Addict Program, Durham, NC USA; [Potter, Jennifer Sharpe] Harvard Univ, Sch Med, Boston, MA USA; [Potter, Jennifer Sharpe] McLean Hosp, Belmont, MA 02178 USA; [Vetter, Victoria] Childrens Hosp Philadelphia, Div Pediat Cardiol, Philadelphia, PA 19104 USA; [Woody, George E.; McNicholas, Laura; Fudala, Paul] Vet Affairs Med Ctr, Philadelphia, PA USA; [Blaine, Jack] NIDA, Ctr Clin Trials Network, Bethesda, MD 20892 USA	University of Pennsylvania; Johns Hopkins University; University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Duke University; Duke University; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Woody, GE (corresponding author), Univ Penn, Dept Psychiat, Treatment Res Inst, 150 S Independence Mall W,Ste 600, Philadelphia, PA 19106 USA.	woody@tresearch.org	Potter, Jennifer Sharpe/C-6720-2008	Potter, Jennifer Sharpe/0000-0002-7250-4422; Dugosh, Karen/0000-0001-8496-2562; Bogenschutz, Michael/0000-0003-4530-3470	National Institute on Drug Abuse [U10-DA013711, U10-DA015831, U10-DA13034, K12-DA000357, U10-DA1533, U10DA13043, KO5-DA17009]; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA022297, U10DA015833, K05DA017009, R37DA001533, K12DA000357, R01DA001533, U10DA013043, U10DA013034, U10DA013711, U10DA015831] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the following grants from the National Institute on Drug Abuse: U10-DA013711 to Duke University (Dr Patkar); U10-DA015831 to Harvard University (Dr Weiss); U10-DA13034 to Johns Hopkins University (Dr Stitzer); K12-DA000357 (Dr Subramaniam); U10-DA1533 to the University of New Mexico (Dr Miller); and U10DA13043 and KO5-DA17009 (Dr Woody). Reckitt Benckiser provided medication for the study.	Alho H, 2007, DRUG ALCOHOL DEPEN, V88, P75, DOI 10.1016/j.drugalcdep.2006.09.012; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Auriacombe M, 2001, JAMA-J AM MED ASSOC, V285, P45, DOI 10.1001/jama.285.1.45; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Clausen T, 2008, DRUG ALCOHOL DEPEN, V94, P151, DOI 10.1016/j.drugalcdep.2007.11.003; DALEY DC, NIH PUBLICATION; DIGGLE PJ, 1996, OXFORD STAT SCI SERI, P13; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; Fals-Stewart W, 2003, J CONSULT CLIN PSYCH, V71, P432, DOI 10.1037/0022-006X.71.3.432; Fiellin DA, 2006, NEW ENGL J MED, V355, P365, DOI 10.1056/NEJMoa055255; Fudala PJ, 1998, DRUG ALCOHOL DEPEN, V50, P1, DOI 10.1016/S0376-8716(98)00008-8; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501; JOHNSON RE, 1992, JAMA-J AM MED ASSOC, V267, P2750, DOI 10.1001/jama.267.20.2750; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Kakko J, 2003, LANCET, V361, P662, DOI 10.1016/S0140-6736(03)12600-1; Krupitsky EM, 2006, J SUBST ABUSE TREAT, V31, P319, DOI 10.1016/j.jsat.2006.05.005; LEPERE B, 2001, ANN MED INTERNE P S3, V152; LEWIS JW, 1985, DRUG ALCOHOL DEPEN, V14, P363, DOI 10.1016/0376-8716(85)90067-5; Ling W, 1998, ADDICTION, V93, P475, DOI 10.1046/j.1360-0443.1998.9344753.x; Magura S, 2007, J ADDICT DIS, V26, P13, DOI 10.1300/J069v26n02_03; Marsch LA, 2005, ARCH GEN PSYCHIAT, V62, P1157, DOI 10.1001/archpsyc.62.10.1157; MERCER DE, NIH PUBLICATION; Metzger DS, 1999, PUBLIC HEALTH, V113, P97; MILLMAN RB, 1970, 3 ANN C METH TREATM; NIGHTINGALE SL, 1970, 3 ANN C METH TREATM; Rosenblum A, 2007, DRUG ALCOHOL DEPEN, V90, P64, DOI 10.1016/j.drugalcdep.2007.02.012; Schottenfeld RS, 1997, ARCH GEN PSYCHIAT, V54, P713; Schwarzlose J, 2007, J SUBST ABUSE TREAT, V33, P221, DOI 10.1016/j.jsat.2007.06.001; Soyka M, 2006, PHARMACOPSYCHIATRY, V39, P85, DOI 10.1055/s-2006-941482; Strain EC, 1996, J CLIN PSYCHOPHARM, V16, P58, DOI 10.1097/00004714-199602000-00010; WALSH SL, 1994, CLIN PHARMACOL THER, V55, P569, DOI 10.1038/clpt.1994.71; Woody GE, 2007, J ADDICT MED, V1, P180, DOI 10.1097/ADM.0b013e318155980e; 1975, MONITORING FUTURE NA, P202	35	259	259	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2003	2011		10.1001/jama.2008.574	http://dx.doi.org/10.1001/jama.2008.574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984887	Green Accepted, Bronze			2022-12-28	WOS:000260605400020
J	Evans, T; Nishtar, S; Atun, R; Etienne, C				Evans, Timothy; Nishtar, Sania; Atun, Rifat; Etienne, Carissa			Scaling up research and learning for health systems: time to act	LANCET			English	Editorial Material									[Evans, Timothy; Etienne, Carissa] WHO, CH-1211 Geneva 27, Switzerland; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England	World Health Organization; Imperial College London	Evans, T (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	evanst@who.int	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				[Anonymous], DEL GLOB PARTN ACH M; [Anonymous], 2004, MEXICO STATEMENT HLT; Bennett S, 2008, LANCET, V372, P1571, DOI 10.1016/S0140-6736(08)61658-X; CHAN M, 2008, SCALING RES LEARNING; *DEP INT DEV, 2007, INT HLTH PART; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; OECD, 2008, ACCR AG ACT; *ROCK FDN, 2008, ROL PRIV SECT HLTH S; *WHO, 2005, HLTH METR NETW; *WHO, 2005, GLOB WORKF ALL; World Health Organization, WORLD HLTH REP 2006; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	12	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1529	1531		10.1016/S0140-6736(08)61634-7	http://dx.doi.org/10.1016/S0140-6736(08)61634-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984175				2022-12-28	WOS:000260590500008
J	Pincock, S				Pincock, Stephen			Ogobara Doumbo: building capacity for malaria research in Africa Profile	LANCET			English	Biographical-Item												stephen.pincock@journalist.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1537	1537		10.1016/S0140-6736(08)61640-2	http://dx.doi.org/10.1016/S0140-6736(08)61640-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984177				2022-12-28	WOS:000260590500012
J	Hanson, M				Hanson, Marta			The art of medicine Maoist public-health campaigns, Chinese medicine, and SARS	LANCET			English	Editorial Material									[Hanson, Marta] Johns Hopkins Univ, Dept Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Hanson, M (corresponding author), Johns Hopkins Univ, Dept Hist Med, Baltimore, MD 21205 USA.	mhanson4@jhmi.edu						Landsberger S., 1995, CHINESE PROPAGANDA P; Rogaski Ruth, 2004, HYGIENIC MODERNITY M; TASCHEN, 2003, CHINESE PROPAGANDA P	3	11	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1457	1458		10.1016/S0140-6736(08)61610-4	http://dx.doi.org/10.1016/S0140-6736(08)61610-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	370ZJ	18975392	Green Published, Bronze			2022-12-28	WOS:000260801300014
J	Boussau, B; Blanquart, S; Necsulea, A; Lartillot, N; Gouy, M				Boussau, Bastien; Blanquart, Samuel; Necsulea, Anamaria; Lartillot, Nicolas; Gouy, Manolo			Parallel adaptations to high temperatures in the Archaean eon	NATURE			English	Article							SEQUENCE ALIGNMENT; EVOLUTION; ORIGIN; BOMBARDMENT; BACTERIA; ANCESTOR; ACCURATE; PROTEIN; MODEL; TIME	Fossils of organisms dating from the origin and diversification of cellular life are scant and difficult to interpret(1), for this reason alternative means to investigate the ecology of the last universal common ancestor ( LUCA) and of the ancestors of the three domains of life are of great scientific value. It was recently recognized that the effects of temperature on ancestral organisms left 'genetic footprints' that could be uncovered in extant genomes(2-4). Accordingly, analyses of resurrected proteins predicted that the bacterial ancestor was thermophilic and that Bacteria subsequently adapted to lower temperatures(3,4). As the archaeal ancestor is also thought to have been thermophilic(5), the LUCA was parsimoniously inferred as thermophilic too. However, an analysis of ribosomal RNAs supported the hypothesis of a non- hyperthermophilic LUCA(2). Here we show that both rRNA and protein sequences analysed with advanced, realistic models of molecular evolution(6,7) provide independent support for two environmental- temperature-related phases during the evolutionary history of the tree of life. In the first period, thermotolerance increased from a mesophilic LUCA to thermophilic ancestors of Bacteria and of Archaea Eukaryota; in the second period, it decreased. Therefore, the two lineages descending from the LUCA and leading to the ancestors of Bacteria and Archaea - Eukaryota convergently adapted to high temperatures, possibly in response to a climate change of the early Earth(1,8,9), and/or aided by the transition from an RNA genome in the LUCA to organisms with more thermostable DNA genomes(10,11). This analysis unifies apparently contradictory results(2-4) into a coherent depiction of the evolution of an ecological trait over the entire tree of life.	[Boussau, Bastien; Necsulea, Anamaria; Gouy, Manolo] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Blanquart, Samuel; Lartillot, Nicolas] CNRS, LIRMM, F-34392 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier	Gouy, M (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, 32 Blvd 11 Novembre, F-69622 Villeurbanne, France.	mgouy@biomserv.univ-lyon1.fr		Boussau, Bastien/0000-0003-0776-4460	Action Concertee Incitative IMPBIO-MODELPHYLO; ANR PlasmoExplore	Action Concertee Incitative IMPBIO-MODELPHYLO; ANR PlasmoExplore(French National Research Agency (ANR))	This work was supported by Action Concertee Incitative IMPBIO-MODELPHYLO and ANR PlasmoExplore. We thank C. Brochier-Armanet and A. Lazcano for help and suggestions, the LIRMM Bioinformatics platform ATGC and the computing facilities of IN2P3.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Blanquart S, 2006, MOL BIOL EVOL, V23, P2058, DOI 10.1093/molbev/msl091; Boussau B, 2006, SYSTEMATIC BIOL, V55, P756, DOI 10.1080/10635150600975218; Brooks DJ, 2004, BIOINFORMATICS, V20, P2251, DOI 10.1093/bioinformatics/bth235; Chessel D, 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Di Giulio M, 2003, J MOL EVOL, V57, P721, DOI 10.1007/s00239-003-2522-6; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; Fournier GP, 2007, J MOL EVOL, V65, P425, DOI 10.1007/s00239-007-9024-x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Gowri-Shankar V, 2006, MOL BIOL EVOL, V23, P352, DOI 10.1093/molbev/msj040; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HILL MO, 1974, ROY STAT SOC C-APP, V23, P340; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Islas S, 2003, INT MICROBIOL, V6, P87, DOI 10.1007/s10123-003-0113-4; Kasting JF, 2006, PHILOS T R SOC B, V361, P917, DOI 10.1098/rstb.2006.1839; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shields GA, 2007, NATURE, V447, pE1, DOI 10.1038/nature05830; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wolf YI, 1999, GENOME RES, V9, P689; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhaxybayeva O, 2005, PROTOPLASMA, V227, P53, DOI 10.1007/s00709-005-0135-1	45	150	154	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					942	U74		10.1038/nature07393	http://dx.doi.org/10.1038/nature07393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19037246	Green Submitted			2022-12-28	WOS:000261768300043
J	Macchiarini, P; Jungebluth, P; Go, T; Asnaghi, MA; Rees, LE; Cogan, TA; Dodson, A; Martorell, J; Bellini, S; Parnigotto, PP; Dickinson, SC; Hollander, AP; Mantero, S; Conconi, MT; Birchall, MA				Macchiarini, Paolo; Jungebluth, Philipp; Go, Tetsuhiko; Asnaghi, M. Adelaide; Rees, Louisa E.; Cogan, Tristan A.; Dodson, Amanda; Martorell, Jaume; Bellini, Silvia; Parnigotto, Pier Paolo; Dickinson, Sally C.; Hollander, Anthony P.; Mantero, Sara; Conconi, Maria Teresa; Birchall, Martin A.			Clinical transplantation of a tissue-engineered airway	LANCET			English	Article							ACELLULAR MATRIX; IN-VITRO; PROSPECTIVE TRIAL; EPITHELIAL-CELLS; HLA ANTIBODIES; CHONDROCYTES; REPLACEMENT; IMPLANTS; ADHESION; IMPROVES	Background The loss of a normal airway is devastating. Attempts to replace large airways have met with serious problems. Prerequisites for a tissue-engineered replacement are a suitable matrix, cells, ideal-mechanical properties, and the absence of antigenicity. We aimed to bicengineer tubular tracheal matrices, using a tissue-engineering protocol, and to assess the application of this technology in a patient with-end-stage airway disease. Methods We removed cells and MHC antigens from a human donor trachea, which was then readily colonised by epithelia] cells and mesenchymal stem-cell.derived chondrocytes that had been cultured from cells taken from the recipient (a 30-year old woman with end-stage bronchomalacia). This graft was then used to replace the recipient's left main bronchus. Findings The graft immediately provided the recipient with a functional airway, improved her quality of life, and had a normal appearance and mechanical properties at 4 months. The patient had no anti-donor antibodies and was not on immunosuppressive drugs. Interpretation The results show that we can produce a cellular, tissue-engineered airway with mechanical properties that allow normal functioning, and which is free from the risks of rejection. The findings suggest that autologous cells combined with appropriate biomaterials might provide successful treatment for patients with serious clinical disorders. Funding Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Spain; Charles Courtenay-Cowlin Fund, University of Bristol; UK Arthritis Research Campaign; and the James Tudor Foundation.	[Macchiarini, Paolo; Jungebluth, Philipp; Go, Tetsuhiko; Martorell, Jaume] Univ Barcelona, Hosp Clin Barcelona, Dept Gen Thorac Surg, E-08036 Barcelona, Spain; [Macchiarini, Paolo] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fdn Clin, Barcelona, Spain; [Macchiarini, Paolo] Univ Barcelona, CIBER Enfermedades Resp, Barcelona, Spain; [Asnaghi, M. Adelaide; Mantero, Sara] Politecn Milan, I-20133 Milan, Italy; [Bellini, Silvia; Parnigotto, Pier Paolo; Conconi, Maria Teresa] Univ Padua, Padua, Italy; [Cogan, Tristan A.; Dickinson, Sally C.; Hollander, Anthony P.] Univ Bristol, Dept Cellular & Mol Med, Bristol, Avon, England; [Rees, Louisa E.; Dodson, Amanda; Birchall, Martin A.] Univ Bristol, Fac Clin Med & Dent, Bristol, Avon, England	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Polytechnic University of Milan; University of Padua; University of Bristol; University of Bristol	Macchiarini, P (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Dept Gen Thorac Surg, C Villarroel 170, E-08036 Barcelona, Spain.	pmacchiarini@ub.edu	Mantero, Sara/F-6587-2013; Macchiarini, Paolo/E-6878-2013	MANTERO, SARA/0000-0002-1264-0465; Asnaghi, Maria Adelaide/0000-0002-4261-3767	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (PI050987), Spain; Charles Courtenay-Cowlin Fund; University of Bristol, UK; UK Arthritis Research Campaign; James Tudor Foundation	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (PI050987), Spain(Instituto de Salud Carlos III); Charles Courtenay-Cowlin Fund; University of Bristol, UK; UK Arthritis Research Campaign(Versus Arthritis); James Tudor Foundation	This work was supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (PI050987), Spain, and the Charles Courtenay-Cowlin Fund, University of Bristol, UK. APH is funded in part by an endowed chair from the UK Arthritis Research Campaign. SCD is funded by a Research Fellowship from the James Tudor Foundation. We thank Laura Morte for her excellent organisation and trouble-shooting; Victor Peinado, and others in his team, for their superb assistance, to whom we are indebted; John Armitage of the Human Tissue Working Group and the Research Enterprise Development team, including Christine Nileshwar, Sean Jauss, Ginny Hope, and Birgit Whitman at the University of Bristol for providing exceptional support and advice on this project; and all the medical and nurse staff at the Institute Clinic of Thorax and Transplant Foundation Services of the Hospital Clinic of Barcelona, without whom accomplishment of this success would have been impossible. None of the authors have any financial interest in the present work.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Birchall M, 2008, TRANSPLANTATION, V85, P1075, DOI 10.1097/TP.0b013e31816a10e4; Burra P, 2004, INT J MOL MED, V14, P511; Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; Conconi MT, 2009, J BIOMED MATER RES A, V89A, P304, DOI 10.1002/jbm.a.31982; Conconi MT, 2005, TRANSPLANT INT, V18, P727, DOI 10.1111/j.1432-2277.2005.00082.x; Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035; Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; JUNGEBLUTH P, J THORAC CA IN PRESS; Kafienah W, 2007, STEM CELLS, V25, P2460, DOI 10.1634/stemcells.2007-0059; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P638, DOI 10.1016/j.jtcvs.2004.02.042; Macchiarini P, 2004, J THORAC CARDIOV SUR, V128, P14, DOI 10.1016/j.jtcvs.2003.11.069; Macchiarini P, 2006, ANN THORAC SURG, V82, P1989, DOI 10.1016/j.athoracsur.2006.07.016; Marzaro M, 2002, INT J MOL MED, V10, P177; Marzaro M, 2006, J BIOMED MATER RES A, V77A, P795, DOI 10.1002/jbm.a.30666; Parnigotto PP, 2000, J PEDIATR SURG, V35, P1304, DOI 10.1053/jpsu.2000.9309; Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020; Rees LE, 2003, CLIN EXP IMMUNOL, V134, P497, DOI 10.1111/j.1365-2249.2003.02301.x; Rees LEN, 2006, MOL IMMUNOL, V43, P725, DOI 10.1016/j.molimm.2005.03.017; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Sato T, 2008, ANN THORAC SURG, V86, P422, DOI 10.1016/j.athoracsur.2008.04.015; Shaari CM, 1998, HEAD NECK-J SCI SPEC, V20, P522, DOI 10.1002/(SICI)1097-0347(199809)20:6<522::AID-HED6>3.0.CO;2-O; Terasaki PI, 2005, TRANSPLANTATION, V80, P1194, DOI 10.1097/01.tp.0000174338.97313.5a; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Zani BG, 2008, P NATL ACAD SCI USA, V105, P7046, DOI 10.1073/pnas.0802463105	27	1059	1158	3	241	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2023	2030		10.1016/S0140-6736(08)61598-6	http://dx.doi.org/10.1016/S0140-6736(08)61598-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19022496				2022-12-28	WOS:000261746900023
J	Kalas, P; Graham, JR; Chiang, E; Fitzgerald, MP; Clampin, M; Kite, ES; Stapelfeldt, K; Marois, C; Krist, J				Kalas, Paul; Graham, James R.; Chiang, Eugene; Fitzgerald, Michael P.; Clampin, Mark; Kite, Edwin S.; Stapelfeldt, Karl; Marois, Christian; Krist, John			Optical Images of an Exosolar Planet 25 Light-Years from Earth	SCIENCE			English	Article							FOMALHAUT; SPECTRA; DEBRIS; PROFILES; COLORS; DISKS; MODEL	Fomalhaut, a bright star 7.7 parsecs ( 25 light- years) from Earth, harbors a belt of cold dust with a structure consistent with gravitational sculpting by an orbiting planet. Here, we present optical observations of an exoplanet candidate, Fomalhaut b. Fomalhaut b lies about 119 astronomical units ( AU) from the star and 18 AU of the dust belt, matching predictions of its location. Hubble Space Telescope observations separated by 1.73 years reveal counterclockwise orbital motion. Dynamical models of the interaction between the planet and the belt indicate that the planet's mass is at most three times that of Jupiter; a higher mass would lead to gravitational disruption of the belt, matching predictions of its location. The flux detected at 0.8 mm is also consistent with that of a planet with mass no greater than a few times that of Jupiter. The brightness at 0.6 mm and the lack of detection at longer wavelengths suggest that the detected flux may include starlight reflected off a circumplanetary disk, with dimension comparable to the orbits of the Galilean satellites. We also observe variability of unknown origin at 0.6 mm.	[Kalas, Paul; Graham, James R.; Chiang, Eugene] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Chiang, Eugene; Kite, Edwin S.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Fitzgerald, Michael P.] Lawrence Livermore Natl Lab, Inst Geophys & Planetary Sci, Livermore, CA 94551 USA; [Clampin, Mark] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; [Stapelfeldt, Karl; Krist, John] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Marois, Christian] Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Research Council Canada	Kalas, P (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	kalas@astron.berkeley.edu	Fitzgerald, Michael/C-2642-2009; Clampin, mark/D-2738-2012; Stapelfeldt, Karl R/D-2721-2012; Kite, Edwin/R-2559-2019	Fitzgerald, Michael/0000-0002-0176-8973; Kalas, Paul/0000-0002-6221-5360; Stapelfeldt, Karl/0000-0002-2805-7338	HST programs [GO-10598, GO- 10539]; NASA [NAS5-26555, AST-0507805]; Space Telescope Science Institute; Michelson Fellowship Program; Berkeley Fellowship; U.S. Department of Energy [DE-AC52- 07NA27344]	HST programs; NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute); Michelson Fellowship Program; Berkeley Fellowship; U.S. Department of Energy(United States Department of Energy (DOE))	Supported by HST programs GO-10598 (P.K.) and GO-10539 (K.S. and J.K.), provided by NASA through a grant from the Space Telescope Science Institute (STScI) under NASA contract NAS5-26555; NSF grant AST-0507805 ( E. C.); the Michelson Fellowship Program, under contract with JPL, funded by NASA ( M. P. F.); and a Berkeley Fellowship (E.S. K.). Work at LLNL was performed under the auspices of the U.S. Department of Energy under contract DE-AC52- 07NA27344. We thank the staff at STScI, Keck, and Gemini for supporting our observations.	BACKMAN DE, 1987, COOL STARS STELLAR S, P340; Burgasser AJ, 2000, ASTRON J, V120, P473, DOI 10.1086/301423; Burrows A, 2003, ASTROPHYS J, V596, P587, DOI 10.1086/377709; CHIANG E, ASTROPHYS J IN PRESS; Davis J, 2005, ASTRON NACHR, V326, P25, DOI 10.1002/asna.200410339; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; Ford EB, 2007, ASTROPHYS J, V661, P602, DOI 10.1086/513598; HARTMANN L, 1994, ASTROPHYS J, V426, P669, DOI 10.1086/174104; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; Marois C, 2007, ASTROPHYS J, V654, pL151, DOI 10.1086/511071; Mouillet D, 1997, MON NOT R ASTRON SOC, V292, P896, DOI 10.1093/mnras/292.4.896; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Navascues DB, 1998, ASTRON ASTROPHYS, V339, P831; PACZYNSKI B, 1977, ASTROPHYS J, V216, P822, DOI 10.1086/155526; Quillen AC, 2006, MON NOT R ASTRON SOC, V372, pL14, DOI 10.1111/j.1745-3933.2006.00216.x; Stapelfeldt KR, 2004, ASTROPHYS J SUPPL S, V154, P458, DOI 10.1086/423135; Strubbe LE, 2006, ASTROPHYS J, V648, P652, DOI 10.1086/505736; Veras D, 2004, MON NOT R ASTRON SOC, V347, P613, DOI 10.1111/j.1365-2966.2004.07239.x; WISDOM J, 1980, ASTRON J, V85, P1122, DOI 10.1086/112778; Wyatt MC, 1999, ASTROPHYS J, V527, P918, DOI 10.1086/308093	21	667	669	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1345	1348		10.1126/science.1166609	http://dx.doi.org/10.1126/science.1166609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	19008414	Green Submitted			2022-12-28	WOS:000261170600029
J	Zender, L; Xue, W; Zuber, J; Semighini, CP; Krasnitz, A; Ma, B; Zender, P; Kubicka, S; Luk, JM; Schirmacher, P; McCombie, WR; Wigler, M; Hicks, J; Hannon, GJ; Powers, S; Lowe, SW				Zender, Lars; Xue, Wen; Zuber, Johannes; Semighini, Camile P.; Krasnitz, Alexander; Ma, Beicong; Zender, Peggy; Kubicka, Stefan; Luk, John M.; Schirmacher, Peter; McCombie, W. Richard; Wigler, Michael; Hicks, James; Hannon, Gregory J.; Powers, Scott; Lowe, Scott W.			An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer	CELL			English	Article							HEPATOCELLULAR-CARCINOMA; NUCLEAR EXPORT; OVARIAN-CANCER; BREAST-CANCER; GENOME; MECHANISM; PATHWAY; CELLS; EXPRESSION; INHIBITORS	Cancers are highly heterogeneous and contain many passenger and driver mutations. To functionally identify tumor suppressor genes relevant to human cancer, we compiled pools of short hairpin RNAs (shRNAs) targeting the mouse orthologs of genes recurrently deleted in a series of human hepatocellular carcinomas and tested their ability to promote tumorigenesis in a mosaic mouse model. In contrast to randomly selected shRNA pools, many deletion-specific pools accelerated hepatocarcinogenesis in mice. Through further analysis, we identified and validated 13 tumor suppressor genes, 12 of which had not been linked to cancer before. One gene, XPO4, encodes a nuclear export protein whose substrate, EIF5A2, is amplified in human tumors, is required for proliferation of XPO4-deficient tumor cells, and promotes hepatocellular carcinoma in mice. Our results establish the feasibility of in vivo RNAi screens and illustrate how combining cancer genomics, RNA interference, and mosaic mouse models can facilitate the functional annotation of the cancer genome.	[Zender, Lars; Xue, Wen; Zuber, Johannes; Semighini, Camile P.; Krasnitz, Alexander; Ma, Beicong; Zender, Peggy; McCombie, W. Richard; Wigler, Michael; Hicks, James; Hannon, Gregory J.; Powers, Scott; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hannon, Gregory J.; Lowe, Scott W.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Kubicka, Stefan] Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany; [Luk, John M.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Hannover Medical School; University of Hong Kong; Ruprecht Karls University Heidelberg	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Zuber, Johannes/E-7517-2011; Luk, John/A-4085-2008	Zuber, Johannes/0000-0001-8810-6835; Luk, John/0000-0002-6323-7940; Wigler, Michael/0000-0003-4396-1971; Powers, Scott/0000-0003-2769-1932; McCombie, W. Richard/0000-0003-1899-0682	Don Monti Memorial Research Foundations; Rebirth Excellence Cluster; Leukemia and Lymphoma Society; National Institutes of Health [CA13106, CA87497, CA105388]; NATIONAL CANCER INSTITUTE [U01CA105388, P01CA087497, P01CA013106, P30CA008748] Funding Source: NIH RePORTER	Don Monti Memorial Research Foundations; Rebirth Excellence Cluster; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ken Nguyen, Stephanie Muller, Kristin Diggins-Lehet, and Lisa Bianco and her team for excellent technical assistance and Ravi Sachidanandam for assistance with computational analyses. We acknowledge members of the Lowe lab for constructive criticism and discussions throughout the course of this work. This work was supported by gifts from the Alan and Edith Seligson and the Don Monti Memorial Research Foundations, grants from the German Research foundation (Emmy Noether Program), the Rebirth Excellence Cluster, the Leukemia and Lymphoma Society (C. P. S.), and grants CA13106, CA87497, and CA105388 from the National Institutes of Health. W. X. is in the Molecular and Cellular Biology graduate program at Stony Brook University. G. J. H. and S. W. L. are Howard Hughes Medical Institute investigators.	BENNE R, 1978, J BIOL CHEM, V253, P3078; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Clement PMJ, 2006, FEBS J, V273, P1102, DOI 10.1111/j.1742-4658.2006.05135.x; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Guan XY, 2001, CANCER RES, V61, P3806; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Lee JS, 2006, ONCOGENE, V25, P3801, DOI 10.1038/sj.onc.1209561; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; PARK MH, 1994, J BIOL CHEM, V269, P27827; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; VONLINDERN M, 1992, BAILLIERE CLIN HAEM, V5, P857, DOI 10.1016/S0950-3536(11)80049-1; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	41	357	365	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 28	2008	135	5					852	864		10.1016/j.cell.2008.09.061	http://dx.doi.org/10.1016/j.cell.2008.09.061			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	376LA	19012953	Green Accepted, Bronze			2022-12-28	WOS:000261183900017
J	Lenz, G; Wright, G; Dave, SS; Xiao, W; Powell, J; Zhao, H; Xu, W; Tan, B; Goldschmidt, N; Iqbal, J; Vose, J; Bast, M; Fu, K; Weisenburger, DD; Greiner, TC; Armitage, JO; Kyle, A; May, L; Gascoyne, RD; Connors, JM; Troen, G; Holte, H; Kvaloy, S; Dierickx, D; Verhoef, G; Delabie, J; Smeland, EB; Jares, P; Martinez, A; Lopez-Guillermo, A; Montserrat, E; Campo, E; Braziel, RM; Miller, TP; Rimsza, LM; Cook, JR; Pohlman, B; Sweetenham, J; Tubbs, RR; Fisher, RI; Hartmann, E; Rosenwald, A; Ott, G; Muller-Hermelink, HK; Wrench, D; Lister, TA; Jaffe, ES; Wilson, WH; Chan, WC; Staudt, LM				Lenz, G.; Wright, G.; Dave, S. S.; Xiao, W.; Powell, J.; Zhao, H.; Xu, W.; Tan, B.; Goldschmidt, N.; Iqbal, J.; Vose, J.; Bast, M.; Fu, K.; Weisenburger, D. D.; Greiner, T. C.; Armitage, J. O.; Kyle, A.; May, L.; Gascoyne, R. D.; Connors, J. M.; Troen, G.; Holte, H.; Kvaloy, S.; Dierickx, D.; Verhoef, G.; Delabie, J.; Smeland, E. B.; Jares, P.; Martinez, A.; Lopez-Guillermo, A.; Montserrat, E.; Campo, E.; Braziel, R. M.; Miller, T. P.; Rimsza, L. M.; Cook, J. R.; Pohlman, B.; Sweetenham, J.; Tubbs, R. R.; Fisher, R. I.; Hartmann, E.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H. -K; Wrench, D.; Lister, T. A.; Jaffe, E. S.; Wilson, W. H.; Chan, W. C.; Staudt, L. M.		Lymphoma Leukemia Mol Profiling Pr	Stromal Gene Signatures in Large-B-Cell Lymphomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; NON-HODGKINS-LYMPHOMA; TISSUE GROWTH-FACTOR; ANGIOGENIC SWITCH; BREAST-CANCER; TUMOR-GROWTH; MOUSE MODEL; EXPRESSION; SURVIVAL; CHEMOTHERAPY	Background: The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma. Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear. Methods: We profiled gene expression in pretreatment biopsy specimens from 181 patients with diffuse large-B-cell lymphoma who received CHOP and 233 patients with this disease who received R-CHOP. A multivariate gene-expression-based survival-predictor model derived from a training group was tested in a validation group. Results: A multivariate model created from three gene-expression signatures - termed ``germinal-center B-cell,'' ``stromal-1,'' and ``stromal-2'' - predicted survival both in patients who received CHOP and patients who received R-CHOP. The prognostically favorable stromal-1 signature reflected extracellular-matrix deposition and histiocytic infiltration. By contrast, the prognostically unfavorable stromal-2 signature reflected tumor blood-vessel density. Conclusions: Survival after treatment of diffuse large-B-cell lymphoma is influenced by differences in immune cells, fibrosis, and angiogenesis in the tumor microenvironment.	[Lenz, G.; Dave, S. S.; Zhao, H.; Xu, W.; Tan, B.; Goldschmidt, N.; Wilson, W. H.; Staudt, L. M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wright, G.] NCI, Biometr Res Branch, Div Canc Treatment & Diagnosis, NIH, Bethesda, MD 20892 USA; [Xiao, W.; Powell, J.] NIH, Bioinformat & Mol Anal Sect, Bethesda, MD 20892 USA; [Jaffe, E. S.] NIH, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; NIH, Computat Biosci & Engn Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Iqbal, J.; Vose, J.; Bast, M.; Fu, K.; Weisenburger, D. D.; Greiner, T. C.; Armitage, J. O.; Chan, W. C.] Univ Nebraska Med Ctr, Omaha, NE USA; [Kyle, A.; May, L.; Gascoyne, R. D.; Connors, J. M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Troen, G.; Delabie, J.] Univ Oslo, Rikshosp Univ Hosp, Pathol Clin, N-0027 Oslo, Norway; [Holte, H.; Kvaloy, S.] Univ Oslo, Rikshosp Univ Hosp, Canc Clin, N-0027 Oslo, Norway; [Smeland, E. B.] Univ Oslo, Rikshosp Univ Hosp, Canc Res Inst, N-0027 Oslo, Norway; [Smeland, E. B.] Univ Oslo, Norwegian Radium Hosp, Ctr Canc Biomed, Fac Div, N-0027 Oslo, Norway; [Dierickx, D.; Verhoef, G.] Katholieke Univ Leuven, Dept Hematol, Louvain, Belgium; [Jares, P.; Martinez, A.; Lopez-Guillermo, A.; Montserrat, E.; Campo, E.] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Braziel, R. M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Braziel, R. M.; Miller, T. P.; Rimsza, L. M.; Cook, J. R.; Tubbs, R. R.; Fisher, R. I.] SW Oncol Grp, Tucson, AZ USA; [Miller, T. P.; Rimsza, L. M.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Pohlman, B.; Sweetenham, J.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Cook, J. R.; Tubbs, R. R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Fisher, R. I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA; [Hartmann, E.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H. -K] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany; [Ott, G.] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Wrench, D.; Lister, T. A.] St Bartholomews Hosp, Canc Res UK, London, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Nebraska System; University of Nebraska Medical Center; British Columbia Cancer Agency; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; KU Leuven; University of Barcelona; Hospital Clinic de Barcelona; Oregon Health & Science University; Southwest Oncology Group; University of Arizona; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Rochester; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Cancer Research UK; University of London; Queen Mary University London	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bldg 10,Rm 4N114, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Jares, Pedro/T-3778-2019; Gascoyne, Randy D/A-6009-2013; Jaffe, Elaine/G-8981-2014; Connors, Joseph/AAF-5284-2019; Lenz, Georg/I-6844-2012; Wright, George W/M-1660-2017; Lopez-Guillermo, Armando/Z-5684-2019; Campo, Elias/AAC-5593-2019; Holte, Harald/AAO-5647-2020; Martinez, Antonio/D-8188-2012; Smeland, Erlend/AAO-3214-2020; Staudt, Louis/AAC-5324-2019	Gascoyne, Randy D/0000-0002-2610-5690; Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Martinez, Antonio/0000-0003-0790-9017; JARES, PEDRO/0000-0002-8401-579X; Iqbal, Javeed/0000-0003-3668-0629; Delabie, Jan/0000-0001-5023-0689	Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; NCI Strategic Partnering to Evaluate Cancer Signature [UO1-CA114778]; German Research Foundation; Genentech; Imedex Future; Ziopharm; L'Oreal; Celgene; Genitope; Biogen Idec; Roche Canada; Schering and Hoffmann-La Roche; Ventana Medical Systems; Roche Molecular Systems; Genentech BioOncology; Genentech BioOncology National Lymphocare Study; Allos Therapeutics; Millennium; Amgen; Pharmion; Roche; Seattle Genetics; Imedex; Eleos; Educational Concepts; Upside Endeavors; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011006, U01CA114778, ZIASC000550] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Strategic Partnering to Evaluate Cancer Signature(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation(German Research Foundation (DFG)); Genentech(Roche HoldingGenentech); Imedex Future; Ziopharm; L'Oreal(L'Oreal Group); Celgene(Bristol-Myers SquibbCelgene Corporation); Genitope; Biogen Idec(Biogen); Roche Canada(Roche Holding); Schering and Hoffmann-La Roche(Hoffmann-La Roche); Ventana Medical Systems; Roche Molecular Systems; Genentech BioOncology; Genentech BioOncology National Lymphocare Study; Allos Therapeutics; Millennium(Takeda Pharmaceutical Company Ltd); Amgen(Amgen); Pharmion; Roche(Roche Holding); Seattle Genetics; Imedex; Eleos; Educational Concepts; Upside Endeavors; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Intramural Research Program of the National Institutes of Health, the National Cancer Institute ( NCI), and the Center for Cancer Research; an NCI Strategic Partnering to Evaluate Cancer Signature grant (UO1-CA114778); and a grant from the German Research Foundation (to Dr. Lenz).; Dr. Vose reports receiving grant support from Genentech; Dr. Greiner, lecture fees from Imedex Future; Dr. Armitage, consulting fees from Ziopharm, L'Oreal, Celgene, Genitope, and Biogen Idec and lecture fees from Genentech; Dr. Gascoyne, consulting fees from Genentech and Roche Canada and lecture fees and grant support from Roche Canada; Dr. Connors, grant support from Roche Canada; Dr. Montserrat, consulting fees from Schering and Hoffmann-La Roche; Dr. Miller, consulting fees and grant support from Genentech and Biogen Idec; Dr. Rimsza, grant support from Ventana Medical Systems; Dr. Cook, consulting fees from Roche Molecular Systems; Dr. Pohlman, consulting fees from Genentech BioOncology and grant support from Genentech BioOncology National Lymphocare Study; Dr. Fisher, consulting fees from Allos Therapeutics, Millennium, Amgen, Pharmion, Celgene, Roche, Genentech, and Seattle Genetics; Dr. Lister, consulting fees from Imedex, Eleos, Educational Concepts, Genentech, and Upside Endeavors and grant support from Millennium; and Dr. Chan, grant support from Roche Molecular Systems. No other potential conflict of interest relevant to this article was reported.; We thank Alexander Kohlmann, Mickey Williams, and Lothar Wieczorek at Roche Molecular Systems for logistical support.	Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Ganjoo KN, 2006, LEUKEMIA LYMPHOMA, V47, P998, DOI 10.1080/10428190600563821; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tagawa H, 2006, BLOOD, V107, P3052; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	33	1245	1280	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2008	359	22					2313	2323		10.1056/NEJMoa0802885	http://dx.doi.org/10.1056/NEJMoa0802885			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377SG	19038878	Green Submitted, Green Accepted			2022-12-28	WOS:000261270300003
J	Boys, C; Cunningham, C; McKenna, D; Robertson, P; Weeks, DJ; Wishart, J				Boys, Carol; Cunningham, Cliff; McKenna, Down; Robertson, Penny; Weeks, Daniel J.; Wishart, Jennifer			Prenatal screening for Down's syndrome: editorial responsibilities	LANCET			English	Editorial Material							AMNIOCENTESIS		[Wishart, Jennifer] Univ Edinburgh, Moray House Sch Educ, Edinburgh EH8 8AQ, Midlothian, Scotland; [Boys, Carol] Downs Syndrome Assoc, Teddington, Middx, England; [Cunningham, Cliff] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [McKenna, Down] Down Syndrome Res Fdn, Vancouver, BC, Canada; [Robertson, Penny] Down Syndrome Int, Jakarta, Indonesia; [Weeks, Daniel J.] Simon Fraser Univ, Dept Psychol, Vancouver, BC, Canada	University of Edinburgh; Liverpool John Moores University; Simon Fraser University	Wishart, J (corresponding author), Univ Edinburgh, Moray House Sch Educ, Edinburgh EH8 8AQ, Midlothian, Scotland.	J.Wishart@ed.ac.uk						[Anonymous], 2007, OBSTET GYNECOL, V110, P1459; BUCKLEY F, 2008, DSRP SCREENING EDITO; Buckley Frank, 2008, Downs Syndr Res Pract, V12, P79, DOI 10.3104/editorials.2087; BUCKLEY S, 2008, PRENATAL SCREENING C; CANADY RL, 1989, FOCUS CHANGE, V1, P1; Caughey AB, 2006, OBSTET GYNECOL, V108, P612, DOI 10.1097/01.AOG.0000232512.46869.fc; *DOWN SYNDR ED INT, 2008, MOR PEOPL DOWN SYNDR; Evans MI, 2008, CURR OPIN OBSTET GYN, V20, P164, DOI 10.1097/GCO.0b013e3282f7321f; FAN HC, 2008, P NATL ACAD SCI 1016; Morris K, 2008, LANCET, V372, P791, DOI 10.1016/S0140-6736(08)61321-5; *NAT DOWN SYNDR CY, 2008, NAT DOWN SYNDR CYT R; Odibo AO, 2008, OBSTET GYNECOL, V111, P589, DOI 10.1097/AOG.0b013e318162eb53; Smith-Bindman R, 2003, AM J OBSTET GYNECOL, V189, P980, DOI 10.1067/S0002-9378(03)00721-X; TABOR A, 1986, LANCET, V1, P1287	14	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1789	1791		10.1016/S0140-6736(08)61742-0	http://dx.doi.org/10.1016/S0140-6736(08)61742-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027473	Green Submitted			2022-12-28	WOS:000261112000007
J	Ismail, K; Thomas, SM; Maissi, E; Chalder, T; Schmidt, U; Bartlett, J; Patel, A; Dickens, CM; Creed, F; Treasure, J				Ismail, Khalida; Thomas, Stephen M.; Maissi, Esther; Chalder, Trudie; Schmidt, Ulrike; Bartlett, Jonathan; Patel, Anita; Dickens, Christopher M.; Creed, Francis; Treasure, Janet			Motivational Enhancement Therapy with and without Cognitive Behavior Therapy to Treat Type 1 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							POOR GLYCEMIC CONTROL; CONTROLLED-TRIAL; DEPRESSION; ADULTS; COMPLICATIONS; PREVALENCE; FEAR; METAANALYSIS; RELAXATION; VALIDATION	Background: Although psychological issues can interfere with diabetes care, the effectiveness of psychological treatments in improving diabetes outcomes is uncertain. Objective: To determine whether motivational enhancement therapy with or without cognitive behavior therapy improves glycemic control in type 1 diabetes compared with usual care. Design: Randomized, controlled trial. Setting: 8 diabetes centers in London and Manchester, United Kingdom. Patients: 344 adults with type 1 diabetes for longer than 2 years, with hemoglobin A(1c) levels of 8.2% to 15%, and without complications or severe comorbid disease. Intervention: Nurse-delivered motivational enhancement therapy (4 sessions over 2 months), motivational enhancement therapy plus cognitive behavior therapy (12 sessions over 6 months), or usual care. Measurements: 12-month change in hemoglobin A1c levels (primary outcome), hypoglycemic events, depression, quality of life, fear of hypoglycemia, diabetes self-care activities, and body mass index (secondary outcomes). Results: In an analysis including all randomly assigned patients, the 12-month change in hemoglobin A(1c) levels compared with usual care was -0.46% (95% CI, -0.81% to -0.11%) in the motivational enhancement therapy plus cognitive behavior therapy group and -0.19% (CI, -0.53% to 0.16%) in the motivational enhancement therapy group alone. There was no evidence of treatment effects on secondary outcomes. Limitations: Of 1659 screened patients, only 507 were eligible and 344 participated. Data on the primary outcome were unavailable for 11.3% of the participants. Study design did not permit distinction of the additive effect of cognitive behavior therapy plus motivational enhancement therapy from the effect of greater intensity and duration of the combined intervention compared with the motivational enhancement therapy alone. Conclusion: Nurse-delivered motivational enhancement therapy and cognitive behavior therapy is feasible for adults with poorly controlled type 1 diabetes. Combined therapy results in modest 12-month improvement in hemoglobin A1c levels compared with usual care, but motivational enhancement therapy alone does not.	Kings Coll London, Guys & St Thomas Hosp, London WC2R 2LS, England; London Sch Hyg & Trop Med, London WC1, England; Univ Manchester, Manchester, Lancs, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of Manchester	Ismail, K (corresponding author), Kings Coll London, Inst Psychiat, Weston Educ Ctr, London WC2R 2LS, England.	khalida.ismail@iop.kcl.ac.uk	Chalder, Trudie/A-5717-2011; Thomas, Stephen/AAD-9141-2021; Patel, Anita/F-9832-2010	Treasure, Janet/0000-0003-0871-4596; Patel, Anita/0000-0003-0769-1732; Dickens, Chris/0000-0001-6326-7544; Ismail, Khalida/0000-0001-6084-449X; Chalder, Trudie/0000-0003-0775-1045; Bartlett, Jonathan/0000-0001-7117-0195	United Kingdom Department of Health's Health Technology Assessment Programme [01/17/05]; National Institute for Health Research [01/17/05] Funding Source: researchfish	United Kingdom Department of Health's Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	By the United Kingdom Department of Health's Health Technology Assessment Programme (project no. 01/17/05).	Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x; Beck A.T., 1979, COGNITIVE THERAPY EM; BLACKBURN IM, 1981, BRIT J PSYCHIAT, V139, P181, DOI 10.1192/bjp.139.3.181; Carpenter J. R., 2007, MISSING DATA CLIN TR; Channon SJ, 2007, DIABETES CARE, V30, P1390, DOI 10.2337/dc06-2260; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; DCCT Res Grp, 1988, DIABETES CARE, V11, P725; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Didjurgeit U, 2002, DIABETIC MED, V19, P814, DOI 10.1046/j.1464-5491.2002.00811.x; Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339; Engum A, 2005, DIABETES CARE, V28, P1904, DOI 10.2337/diacare.28.8.1904; FEINGLOS MN, 1987, DIABETES CARE, V10, P72, DOI 10.2337/diacare.10.1.72; Fosbury JA, 1997, DIABETES CARE, V20, P959, DOI 10.2337/diacare.20.6.959; Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8; Halford WK, 1997, PSYCHOL HEALTH, V12, P231, DOI 10.1080/08870449708407401; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; IRVINE AA, 1991, DIABETES CARE, V14, P76, DOI 10.2337/diacare.14.1.76a; Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; LANG P, 1970, LEARNING APPROACHES; Little R.J.A., 2002, STAT ANAL MISSING DA; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; MANNING RM, 1995, DIABETIC MED, V12, P409, DOI 10.1111/j.1464-5491.1995.tb00504.x; Mannucci E, 2005, J ENDOCRINOL INVEST, V28, P417, DOI 10.1007/BF03347221; Marshall SM, 2000, ANN CLIN BIOCHEM, V37, P45, DOI 10.1258/0004563001901506; MCGRADY A, 1991, DIABETES CARE, V14, P360, DOI 10.2337/diacare.14.5.360; Medical Research Council, 2000, FRAM DEV EV RAND CON; MILLER WR, 2004, DHSS PUBLICATION; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Mollema ED, 2001, J PSYCHOSOM RES, V51, P665, DOI 10.1016/S0022-3999(01)00229-X; MOYERS T, 2008, MOTIVATIONAL INTERVI; Moyers TB, 2005, J SUBST ABUSE TREAT, V28, P19, DOI 10.1016/j.jsat.2004.11.001; *NIH CLIN EXC, TYP 1 DIAB MAN TYP 1; *ORG EC COOP DEV, 2008, PURCH POW PAR COMP P; Petrak F, 2003, DIABETES-METAB RES, V19, P216, DOI 10.1002/dmrr.374; Pickup J, 2002, BMJ-BRIT MED J, V324, P705, DOI 10.1136/bmj.324.7339.705; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stenstrom U, 2003, DIABETES RES CLIN PR, V60, P147, DOI 10.1016/S0168-8227(03)00018-4; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; van der Ven NCW, 2005, DIABETIC MED, V22, P1619; Verbeke G, 2000, LINEAR MIXED MODELS; WEINGER K, 2002, DIABETES S2, V51; Welch G, 2001, DIABETES, V50, pA398; White IR, 2007, CLIN TRIALS, V4, P125, DOI 10.1177/1740774507077849; Winkley K, 2006, BMJ-BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55	53	54	57	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2008	149	10					708	U8		10.7326/0003-4819-149-10-200811180-00005	http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00005			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	373FL	19017589				2022-12-28	WOS:000260956300003
J	Emery, B; Barres, BA				Emery, Ben; Barres, Ben A.			Unlocking CNS Cell Type Heterogeneity	CELL			English	Editorial Material							NEURONS; ATLAS	A major challenge to understanding how cells work together in the central nervous system (CNS) is the heterogeneous cellular composition of the brain. In this issue, Heiman et al. (2008) and Doyle et al. (2008) introduce a new strategy (TRAP) that enables the profiling of translated mRNAs in specific CNS cell populations without the need for purifying cells to homogeneity.	[Emery, Ben; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Emery, B (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	bemery@stanford.edu	Emery, Ben/I-6223-2013	Emery, Ben/0000-0002-9132-3045				Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618	8	12	12	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					596	598		10.1016/j.cell.2008.10.031	http://dx.doi.org/10.1016/j.cell.2008.10.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013270	Bronze			2022-12-28	WOS:000260886900010
J	Kuhns, MS; Davis, MM				Kuhns, Michael S.; Davis, Mark M.			The Safety on the TCR Trigger	CELL			English	Editorial Material								In this issue, Xu et al. (2008) provide evidence for a new mechanism of T cell receptor regulation. Prior to activation, basic residues in the cytoplasmic domain of the signaling subunits of the T cell receptor associate with the plasma membrane such that the key signaling tyrosines are sequestered in the bilayer.	[Kuhns, Michael S.; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI022511-23, R01 AI022511] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022511] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; DeFord-Watts LM, 2007, J BIOL CHEM, V282, P16126, DOI 10.1074/jbc.M609418200; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Muller R, 2000, P NATL ACAD SCI USA, V97, P8451, DOI 10.1073/pnas.97.15.8451; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x	9	36	37	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					594	596		10.1016/j.cell.2008.10.033	http://dx.doi.org/10.1016/j.cell.2008.10.033			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013269	Green Accepted, Bronze			2022-12-28	WOS:000260886900009
J	Booth, CM; Mackillop, WJ				Booth, Christopher M.; Mackillop, William J.			Translating New Medical Therapies Into Societal Benefit The Role of Population-Based Outcome Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; CANCER; IMPACT		[Booth, Christopher M.; Mackillop, William J.] Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Booth, CM (corresponding author), Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, 10 Stuart St, Kingston, ON K7L 3N6, Canada.	boothc@kgh.kari.net						D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Earle CC, 2001, J CLIN ONCOL, V19, P1064, DOI 10.1200/JCO.2001.19.4.1064; Groome PA, 1999, J CLIN EPIDEMIOL, V52, P903; Hennessy S, 1998, CLIN THER, V20, pC32, DOI 10.1016/S0149-2918(98)80006-4; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; KESSLER DA, 1994, NEW ENGL J MED, V331, P1350, DOI 10.1056/NEJM199411173312007; Pearcey R, 2007, J CLIN ONCOL, V25, P2383, DOI 10.1200/JCO.2006.09.1926; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Weiss AP, 2007, AM J PSYCHIAT, V164, P206, DOI 10.1176/appi.ajp.164.2.206; Wen SW, 1999, J CLIN EPIDEMIOL, V52, P7, DOI 10.1016/S0895-4356(98)00136-X	14	66	67	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2177	2179		10.1001/jama.300.18.2177	http://dx.doi.org/10.1001/jama.300.18.2177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001630				2022-12-28	WOS:000260793800029
J	Ro, KEI; Gude, T; Tyssen, R; Aasland, OG				Ro, Karin E. Isaksson; Gude, Tore; Tyssen, Reidar; Aasland, Olaf G.			Counselling for burnout in Norwegian doctors: one year cohort study	BRITISH MEDICAL JOURNAL			English	Article							MENTAL-HEALTH PROBLEMS; JUNIOR HOUSE OFFICERS; JOB STRESS; EMOTIONAL DISTRESS; NATIONWIDE SAMPLE; YOUNG PHYSICIANS; MEDICAL-STUDENTS; SUICIDE RATES; PATIENT-CARE; RESIDENTS	Objective To investigate levels and predictors of change in dimensions of burnout after an intervention for stressed doctors. Design Cohort study followed by self reported assessment at one year. Setting Norwegian resource centre. Participants 227 doctors participating in counselling intervention, 2003- 5. Interventions Counselling ( lasting one day ( individual) or one week ( group based)) aimed at motivating reflection on and acknowledgement of the doctors' situation and personal needs. Main outcome measures Levels of burnout ( Maslach burnout inventory) and predictors of reduction in emotional exhaustion investigated by linear regression. Results 185 doctors ( 81%, 88 men, 97 women) completed one year follow- up. The mean level of emotional exhaustion ( scale 1- 5) was significantly reduced from 3.00 ( SD 0.94) to 2.53 ( SD 0.76) ( t= 6.76, P< 0.001), similar to the level found in a representative sample of 390 Norwegian doctors. Participants had reduced their working hours by 1.6 hours/ week ( SD 11.4). There was a considerable reduction in the proportion of doctors on full time sick leave, from 35% ( 63/ 182) at baseline to 6% ( 10/ 182) at follow- up and a parallel increase in the proportion who had undergone psychotherapy, from 20% ( 36/ 182) to 53% ( 97/ 182). In the whole cohort, reduction in emotional exhaustion was independently associated with reduced number of work hours/ week ( beta= 0.17, P= 0.03), adjusted for sex, age, and personality dimensions. Among men "satisfaction with the intervention" ( beta= 0.25, P= 0.04) independently predicted reduction in emotional exhaustion. Conclusions A short term counselling intervention could contribute to reduction in emotional exhaustion in doctors. This was associated with reduced working hours for the whole cohort and, in men, was predicted by satisfaction with the intervention.	[Ro, Karin E. Isaksson; Gude, Tore] Res Inst, NO-3370 Vikersund, Norway; [Ro, Karin E. Isaksson; Gude, Tore; Tyssen, Reidar] Univ Oslo, Dept Behav Sci Med, Inst Basic Med Sci, Fac Med, NO-0317 Oslo, Norway; [Aasland, Olaf G.] Norwegian Med Assoc, Res Inst, NO-0107 Oslo, Norway; [Aasland, Olaf G.] Univ Oslo, Inst Hlth Management & Hlth Econ, Oslo, Norway	University of Oslo; University of Oslo	Ro, KEI (corresponding author), Res Inst, NO-3370 Vikersund, Norway.	karin.roe@modum-bad.no						Aasland O G, 1994, Tidsskr Nor Laegeforen, V114, P3052; Barnett R C, 1999, J Occup Health Psychol, V4, P307, DOI 10.1037/1076-8998.4.4.307; Barnett R. C., 1999, J APPL BIOBEHAVIORAL, V4, P65, DOI DOI 10.1111/JABR.1999.4.ISSUE-2; Barrack RL, 2006, CLIN ORTHOP RELAT R, P134, DOI 10.1097/01.blo.0000224030.78108.58; Cohen D, 2005, MED EDUC, V39, P476, DOI 10.1111/j.1365-2929.2005.02122.x; COOPER CL, 1989, BRIT MED J, V298, P366, DOI 10.1136/bmj.298.6670.366; DEPUE RA, 1986, PSYCHOL BULL, V99, P36, DOI 10.1037/0033-2909.99.1.36; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; ELLIS JJ, 1988, AM J PSYCHOTHER, V42, P380, DOI 10.1176/appi.psychotherapy.1988.42.3.380; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Falkum E, 2000, Tidsskr Nor Laegeforen, V120, P1122; FALKUM E, 2001, EVALUERING VIRKSOMHE; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; FIRTHCOZENS J, 1997, DEPRESSION PHYSICAL, P95; FRANCIS LJ, 1992, PERS INDIV DIFFER, V13, P443, DOI 10.1016/0191-8869(92)90073-X; Garelick AI, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-26; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; HALL JA, 1988, SOC SCI MED, V27, P935, DOI 10.1016/0277-9536(88)90284-5; Hargreave Marie, 2007, Ugeskr Laeger, V169, P2418; Hem E, 2005, PSYCHOL MED, V35, P873, DOI 10.1017/S0033291704003344; Hem E, 2000, EUR PSYCHIAT, V15, P183, DOI 10.1016/S0924-9338(00)00227-3; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; Holt J, 2006, HEALTH EDUC RES, V21, P501, DOI 10.1093/her/cyh076; HSU K, 1987, AM J PSYCHIAT, V144, P1561; KING MB, 1992, J ROY SOC MED, V85, P605; Kivimaki M, 2001, OCCUP ENVIRON MED, V58, P361, DOI 10.1136/oem.58.6.361; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; MCCRANIE EW, 1988, BEHAV MED, V14, P30, DOI 10.1080/08964289.1988.9935120; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Pitt E, 2004, ACAD MED, V79, P840, DOI 10.1097/00001888-200409000-00005; Ro KEI, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-36; Rosvold EO, 2002, SCAND J PUBLIC HEALT, V30, P125, DOI 10.1080/14034940210133744; Rovik JO, 2007, IND HEALTH, V45, P662, DOI 10.2486/indhealth.45.662; Schattner P, 2004, MED J AUSTRALIA, V181, P348, DOI 10.5694/j.1326-5377.2004.tb06321.x; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Silvester S, 1994, PROVISION MED SERVIC; SIVERTZ K, 1998, B C MED J, V40, P156; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Taub S, 2006, OCCUP MED-OXFORD, V56, P77, DOI 10.1093/occmed/kqj025; Tyssen R, 2004, SOC PSYCH PSYCH EPID, V39, P989, DOI 10.1007/s00127-004-0831-8; Tyssen R, 2000, MED EDUC, V34, P374, DOI 10.1046/j.1365-2923.2000.00540.x; Tyssen R, 1998, ADDICTION, V93, P1341, DOI 10.1046/j.1360-0443.1998.93913415.x; Tyssen R, 2007, IND HEALTH, V45, P599, DOI 10.2486/indhealth.45.599; Tyssen R, 2007, MED EDUC, V41, P781, DOI 10.1111/j.1365-2923.2007.02802.x; Vaglum P, 1999, J AFFECT DISORDERS, V52, P153, DOI 10.1016/S0165-0327(98)00081-0; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071	52	68	67	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2008	337								a2004	10.1136/bmj.a2004	http://dx.doi.org/10.1136/bmj.a2004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	385AA	19001492	hybrid, Green Published			2022-12-28	WOS:000261784100001
J	Mitchell, R; Popham, F				Mitchell, Richard; Popham, Frank			Effect of exposure to natural environment on health inequalities: an observational population study	LANCET			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC INEQUALITIES; AIR-POLLUTION; GREEN SPACE; MORTALITY; DETERMINANTS; RESTORATION; URBANITY; WALKING; STRESS	Background Studies have shown that exposure to the natural environment, or so-called green space, has an independent effect on health and health-related behaviours. We postulated that income-related inequality in health would be less pronounced in populations with greater exposure to green space, since access to such areas can modify pathways through which low socioeconomic position can lead to disease. Methods We classified the population of England at younger than retirement age (n=40 813 236) into groups on the basis of income deprivation and exposure to green space. We obtained individual mortality records (n=366348) to establish whether the association between income deprivation, all-cause mortality, and cause-specific mortality (circulatory disease, lung cancer, and intentional self-harm) in 2001-05, varied by exposure to green space measured in 2001, with control for potential confounding factors. We used stratified models to identify the nature of this variation. Findings The association between income deprivation and mortality differed significantly across the groups of exposure to green space for mortality from all causes (p<0.0001) and circulatory disease (p=0.0212), but not from lung cancer or intentional self-harm. Health inequalities related to income deprivation in all-cause mortality and mortality from circulatory diseases were lower in populations living in the greenest areas. The incidence rate ratio (IRR) for all-cause mortality for the most income deprived quartile compared with the least deprived was 1.93 (95% CI 1.86-2.01) in the least green areas, whereas it was 1.43 (1.34-1.53) in the most green. For circulatory diseases, the IRR was 2.19 (2.04-2.34) in the least green areas and 1.54 (1.38-1.73) in the most green. There was no effect for causes of death unlikely to be affected by green space, such as lung cancer and intentional self-harm. Interpretation Populations that are exposed to the greenest environments also have lowest levels of health inequality related to income deprivation. Physical environments that promote good health might be important to reduce socioeconomic health inequalities.	[Mitchell, Richard] Univ Glasgow, Glasgow G12 8RZ, Lanark, Scotland; [Popham, Frank] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland	University of Glasgow; University of St Andrews	Mitchell, R (corresponding author), Univ Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	r.mitchell@clinmed.gla.ac.uk	Popham, Frank/E-7770-2012; Mitchell, Rich JL/E-8056-2011	Popham, Frank/0000-0002-7263-7954				[Anonymous], 2005, GEN LAND US DAT STAT; Bibby P., 2004, DEV NEW CLASSIFICATI; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Giles-Corti B, 2005, AM J PREV MED, V28, P169, DOI 10.1016/j.amepre.2004.10.018; Grahn Patrik, 2003, Urban Forestry & Urban Greening, V2, P001, DOI 10.1078/1618-8667-00019; Groenewegen PP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-149; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; *HLTH COUNC NETH D, 2004, NAT ENV NAT HLTH INF; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Kaczynski AT, 2007, LEISURE SCI, V29, P315, DOI 10.1080/01490400701394865; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; Krewski D, 2007, J TOXICOL ENV HEAL A, V70, P275, DOI 10.1080/15287390600884859; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Macintyre S, 2007, 17 MRC SOC PUBL HLTH; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Mitchell R, 2002, INT J EPIDEMIOL, V31, P831, DOI 10.1093/ije/31.4.831; Mitchell R, 2007, J EPIDEMIOL COMMUN H, V61, P681, DOI 10.1136/jech.2006.053553; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Popham F, 2007, PREV MED, V45, P182, DOI 10.1016/j.ypmed.2007.06.012; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Prevention CfDCa, 2008, HLTH PLAC TERM; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Smith GD, 2005, CIRCULATION, V112, P332, DOI 10.1161/CIRCULATIONAHA.104.489088; Smith GD, 2000, BRIT MED J, V320, P582, DOI 10.1136/bmj.320.7234.582; Smith GD, 2002, J EPIDEMIOL COMMUN H, V56, P434; Smith GD, 2000, PUBLIC HEALTH, V114, P308, DOI 10.1016/S0033-3506(00)00353-X; Tardon A, 2005, CANCER CAUSE CONTROL, V16, P389, DOI 10.1007/s10552-004-5026-9; *UCLA AC TECHN SER, 2008, AN CORR CLUST DAT; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WILKINSON RG, 1992, AM J PUBLIC HEALTH, V82, P1082, DOI 10.2105/AJPH.82.8.1082; Wilkinson RG., 2001, MIND GAP HIERARCHIES; Wilkinson RG, 2008, AM J PUBLIC HEALTH, V98, P699, DOI 10.2105/AJPH.2007.109637; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Woods LM, 2005, J EPIDEMIOL COMMUN H, V59, P115, DOI 10.1136/jech.2003.013003; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	46	1089	1117	32	445	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1655	1660		10.1016/S0140-6736(08)61689-X	http://dx.doi.org/10.1016/S0140-6736(08)61689-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994663	Green Accepted			2022-12-28	WOS:000260899900027
J	Robinson, GE; Fernald, RD; Clayton, DF				Robinson, Gene E.; Fernald, Russell D.; Clayton, David F.			Genes and Social Behavior	SCIENCE			English	Review							MATERNAL-CARE; EXPRESSION; DROSOPHILA; MICE; VASOPRESSIN; ENVIRONMENT; PLASTICITY; EVOLUTION; RESPONSES; GENETICS	What genes and regulatory sequences contribute to the organization and functioning of neural circuits and molecular pathways in the brain that support social behavior? How does social experience interact with information in the genome to modulate brain activity? Here, we address these questions by highlighting progress that has been made in identifying and understanding two key "vectors of influence" that link genes, the brain, and social behavior: (i) Social information alters gene expression in the brain to influence behavior, and (ii) genetic variation influences brain function and social behavior. We also discuss how evolutionary changes in genomic elements influence social behavior and outline prospects for a systems biology of social behavior.	[Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Robinson, Gene E.; Clayton, David F.] Univ Illinois, Program Neurosci, Urbana, IL 61801 USA; [Robinson, Gene E.; Clayton, David F.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fernald, Russell D.] Stanford Univ, Inst Neurosci, Stanford, CA 94305 USA; [Clayton, David F.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, 505 S Goodwin Ave, Urbana, IL 61801 USA.	generobi@illinois.edu	Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488	NIH [R01 NS051820, NS045264, NS34950, R01 GM073644]; Javits Award; United States-Israel Binational Science Foundation [200596]; NSF Frontiers in Biological Research [EF04-5852]; U.S. Department of Agriculture [AG2003-35302-13490]; Burroughs Wellcome Fund Innovation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034950, R01NS051820, R56NS034950, R01NS034950, R01NS045264] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Javits Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NSF Frontiers in Biological Research(National Science Foundation (NSF)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Burroughs Wellcome Fund Innovation Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Desjardins, A. Fernald, K.A. Hughes, D.B. Kelley, K. Maruska, C. Olin, M.B. Sokolowski, L.J. Stubbs, members of the Clayton and Robinson laboratories, and two anonymous reviewers for reviews of this manuscript and C. Harrell for graphical assistance. Research by the authors cited here was supported by the following grants: NIH R01 NS051820 and NS045264 (D.F.C.); NIH NS34950 Javits Award and United States-Israel Binational Science Foundation 200596 (R.D.F.); and NIH R01 GM073644, NSF Frontiers in Biological Research EF04-5852, U.S. Department of Agriculture AG2003-35302-13490, and a Burroughs Wellcome Fund Innovation Award (G.E.R.).	Abbott A, 2008, NATURE, V454, P154, DOI 10.1038/454154a; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dong S, 2008, GENES BRAIN BEHAV, V7, P802, DOI 10.1111/j.1601-183X.2008.00423.x; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Falconer D.S., 1996, INTRO QUANITATIVE GE; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Floreano D, 2007, CURR BIOL, V17, P514, DOI 10.1016/j.cub.2007.01.058; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hall JC, 2003, J NEUROGENET, V17, P1, DOI 10.1080/01677060390230349; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Lahiri DK, 2006, NAT REV NEUROSCI, V7, DOI 10.1038/nrn2022-c1; Liu H, 2007, DEV NEUROBIOL, V67, P1289, DOI 10.1002/dneu.20404; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; PFAFF D, 1999, DRIVE; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Robinson GE, 2004, SCIENCE, V304, P397, DOI 10.1126/science.1095766; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; Vignal C, 2005, EUR J NEUROSCI, V22, P949, DOI 10.1111/j.1460-9568.2005.04254.x; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475	44	370	379	0	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					896	900		10.1126/science.1159277	http://dx.doi.org/10.1126/science.1159277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988841	Green Accepted			2022-12-28	WOS:000260674100034
J	Yen, HCS; Elledge, SJ				Yen, Hsueh-Chi Sherry; Elledge, Stephen J.			Identification of SCF Ubiquitin Ligase Substrates by Global Protein Stability Profiling	SCIENCE			English	Article							F-BOX PROTEINS; HISTONE MESSENGER-RNA; KAPPA-B-ALPHA; BETA-CATENIN; CYCLIN-E; S-PHASE; DEGRADATION; PATHWAY; COMPLEX; REVEALS	Ubiquitin- mediated proteolysis regulates all aspects of cellular function, and defects in this process are associated with human diseases. The limited number of identified ubiquitin ligase- substrate pairs is a major bottleneck in the ubiquitin field. We established and applied genetic technologies that combine global protein stability ( GPS) profiling and genetic perturbation of E3 activity to screen for substrates of the Skp1- cullin- F- box ( SCF) ubiquitin ligase in mammalian cells. Among the > 350 potential substrates identified, we found most known SCF targets and many previously unknown substrates involved in cell cycle, apoptosis, and signaling pathways. Exploring cell cycle- stage stability, we found that several substrates used the SCF and other E3s in different cell cycle stages. Our results demonstrate the potential of these technologies as general platforms for the global discovery of E3- substrate regulatory networks.	[Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Ctr Genet & Genom,Sch Med, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	Jane Coffin Childs Memorial Fund; NIH [AG 11085]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Vidal, J. W. Harper. J. Jin, and G. Hu for the hORFeome v1.1 library; J. W. Harper for the DNCul1/pcDNA3 construct; D. M. Chou for experimental assistance and discussion; Q. Xu for bioinformatics analysis; M. Schlabach for microarray assistance; J. Daly and S. Lazo-Kallanian for their help with cytometry; and K. Hurov for suggestions. H.-C.S.Y. is a fellow of Jane Coffin Childs Memorial Fund. This work was funded by an NIH grant AG 11085 to J.W. Harper and S.J.E. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kitajima S, 2004, AM J PATHOL, V165, P2147, DOI 10.1016/S0002-9440(10)63264-6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2003, CANCER TREAT REV, V29, P49, DOI 10.1016/S0305-7372(03)00083-5; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Pfleger CM, 2000, GENE DEV, V14, P655; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Schwartz AL, 1999, ANNU REV MED, V50, P57; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tago K, 2000, GENE DEV, V14, P1741; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	37	148	149	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					923	929		10.1126/science.1160462	http://dx.doi.org/10.1126/science.1160462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988848				2022-12-28	WOS:000260674100041
J	Bentley, DR; Balasubramanian, S; Swerdlow, HP; Smith, GP; Milton, J; Brown, CG; Hall, KP; Evers, DJ; Barnes, CL; Bignell, HR; Boutell, JM; Bryant, J; Carter, RJ; Cheetham, RK; Cox, AJ; Ellis, DJ; Flatbush, MR; Gormley, NA; Humphray, SJ; Irving, LJ; Karbelashvili, MS; Kirk, SM; Li, H; Liu, XH; Maisinger, KS; Murray, LJ; Obradovic, B; Ost, T; Parkinson, ML; Pratt, MR; Rasolonjatovo, IMJ; Reed, MT; Rigatti, R; Rodighiero, C; Ross, MT; Sabot, A; Sankar, SV; Scally, A; Schroth, GP; Smith, ME; Smith, VP; Spiridou, A; Torrance, PE; Tzonev, SS; Vermaas, EH; Walter, K; Wu, XL; Zhang, L; Alam, MD; Anastasi, C; Aniebo, IC; Bailey, DMD; Bancarz, IR; Banerjee, S; Barbour, SG; Baybayan, PA; Benoit, VA; Benson, KF; Bevis, C; Black, PJ; Boodhun, A; Brennan, JS; Bridgham, JA; Brown, RC; Brown, AA; Buermann, DH; Bundu, AA; Burrows, JC; Carter, NP; Castillo, N; Catenazzi, MCE; Chang, S; Cooley, RN; Crake, NR; Dada, OO; Diakoumakos, KD; Dominguez-Fernandez, B; Earnshaw, DJ; Egbujor, UC; Elmore, DW; Etchin, SS; Ewan, MR; Fedurco, M; Fraser, LJ; Fajardo, KVF; Furey, WS; George, D; Gietzen, KJ; Goddard, CP; Golda, GS; Granieri, PA; Green, DE; Gustafson, DL; Hansen, NF; Harnish, K; Haudenschild, CD; Heyer, NI; Hims, MM; Ho, JT; Horgan, AM; Hoschler, K; Hurwitz, S; Ivanov, DV; Johnson, MQ; James, T; Jones, TAH; Kang, GD; Kerelska, TH; Kersey, AD; Khrebtukova, I; Kindwall, AP; Kingsbury, Z; Kokko-Gonzales, PI; Kumar, A; Laurent, MA; Lawley, CT; Lee, SE; Lee, X; Liao, AK; Loch, JA; Lok, M; Luo, SJ; Mammen, RM; Martin, JW; McCauley, PG; McNitt, P; Mehta, P; Moon, KW; Mullens, JW; Newington, T; Ning, ZM; Ng, BL; Novo, SM; O'Neill, MJ; Osborne, MA; Osnowski, A; Ostadan, O; Paraschos, LL; Pickering, L; Pike, AC; Pike, AC; Pinkard, DC; Pliskin, DP; Podhasky, J; Quijano, VJ; Raczy, C; Rae, VH; Rawlings, SR; Rodriguez, AC; Roe, PM; Rogers, J; Bacigalupo, MCR; Romanov, N; Romieu, A; Roth, RK; Rourke, NJ; Ruediger, ST; Rusman, E; Sanches-Kuiper, RM; Schenker, MR; Seoane, JM; Shaw, RJ; Shiver, MK; Short, SW; Sizto, NL; Sluis, JP; Smith, MA; Sohna, JES; Spence, EJ; Stevens, K; Sutton, N; Szajkowski, L; Tregidgo, CL; Turcatti, G; vandeVondele, S; Verhovsky, Y; Virk, SM; Wakelin, S; Walcott, GC; Wang, JW; Worsley, GJ; Yan, JY; Yau, L; Zuerlein, M; Rogers, J; Mullikin, JC; Hurles, ME; McCooke, NJ; West, JS; Oaks, FL; Lundberg, PL; Klenerman, D; Durbin, R; Smith, AJ				Bentley, David R.; Balasubramanian, Shankar; Swerdlow, Harold P.; Smith, Geoffrey P.; Milton, John; Brown, Clive G.; Hall, Kevin P.; Evers, Dirk J.; Barnes, Colin L.; Bignell, Helen R.; Boutell, Jonathan M.; Bryant, Jason; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony J.; Ellis, Darren J.; Flatbush, Michael R.; Gormley, Niall A.; Humphray, Sean J.; Irving, Leslie J.; Karbelashvili, Mirian S.; Kirk, Scott M.; Li, Heng; Liu, Xiaohai; Maisinger, Klaus S.; Murray, Lisa J.; Obradovic, Bojan; Ost, Tobias; Parkinson, Michael L.; Pratt, Mark R.; Rasolonjatovo, Isabelle M. J.; Reed, Mark T.; Rigatti, Roberto; Rodighiero, Chiara; Ross, Mark T.; Sabot, Andrea; Sankar, Subramanian V.; Scally, Aylwyn; Schroth, Gary P.; Smith, Mark E.; Smith, Vincent P.; Spiridou, Anastassia; Torrance, Peta E.; Tzonev, Svilen S.; Vermaas, Eric H.; Walter, Klaudia; Wu, Xiaolin; Zhang, Lu; Alam, Mohammed D.; Anastasi, Carole; Aniebo, Ify C.; Bailey, David M. D.; Bancarz, Iain R.; Banerjee, Saibal; Barbour, Selena G.; Baybayan, Primo A.; Benoit, Vincent A.; Benson, Kevin F.; Bevis, Claire; Black, Phillip J.; Boodhun, Asha; Brennan, Joe S.; Bridgham, John A.; Brown, Rob C.; Brown, Andrew A.; Buermann, Dale H.; Bundu, Abass A.; Burrows, James C.; Carter, Nigel P.; Castillo, Nestor; Catenazzi, Maria Chiara E.; Chang, Simon; Cooley, R. Neil; Crake, Natasha R.; Dada, Olubunmi O.; Diakoumakos, Konstantinos D.; Dominguez-Fernandez, Belen; Earnshaw, David J.; Egbujor, Ugonna C.; Elmore, David W.; Etchin, Sergey S.; Ewan, Mark R.; Fedurco, Milan; Fraser, Louise J.; Fajardo, Karin V. Fuentes; Furey, W. Scott; George, David; Gietzen, Kimberley J.; Goddard, Colin P.; Golda, George S.; Granieri, Philip A.; Green, David E.; Gustafson, David L.; Hansen, Nancy F.; Harnish, Kevin; Haudenschild, Christian D.; Heyer, Narinder I.; Hims, Matthew M.; Ho, Johnny T.; Horgan, Adrian M.; Hoschler, Katya; Hurwitz, Steve; Ivanov, Denis V.; Johnson, Maria Q.; James, Terena; Jones, T. A. Huw; Kang, Gyoung-Dong; Kerelska, Tzvetana H.; Kersey, Alan D.; Khrebtukova, Irina; Kindwall, Alex P.; Kingsbury, Zoya; Kokko-Gonzales, Paula I.; Kumar, Anil; Laurent, Marc A.; Lawley, Cynthia T.; Lee, Sarah E.; Lee, Xavier; Liao, Arnold K.; Loch, Jennifer A.; Lok, Mitch; Luo, Shujun; Mammen, Radhika M.; Martin, John W.; McCauley, Patrick G.; McNitt, Paul; Mehta, Parul; Moon, Keith W.; Mullens, Joe W.; Newington, Taksina; Ning, Zemin; Ng, Bee Ling; Novo, Sonia M.; O'Neill, Michael J.; Osborne, Mark A.; Osnowski, Andrew; Ostadan, Omead; Paraschos, Lambros L.; Pickering, Lea; Pike, Andrew C.; Pike, Alger C.; Pinkard, D. Chris; Pliskin, Daniel P.; Podhasky, Joe; Quijano, Victor J.; Raczy, Come; Rae, Vicki H.; Rawlings, Stephen R.; Rodriguez, Ana Chiva; Roe, Phyllida M.; Rogers, John; Bacigalupo, Maria C. Rogert; Romanov, Nikolai; Romieu, Anthony; Roth, Rithy K.; Rourke, Natalie J.; Ruediger, Silke T.; Rusman, Eli; Sanches-Kuiper, Raquel M.; Schenker, Martin R.; Seoane, Josefina M.; Shaw, Richard J.; Shiver, Mitch K.; Short, Steven W.; Sizto, Ning L.; Sluis, Johannes P.; Smith, Melanie A.; Sohna, Jean Ernest Sohna; Spence, Eric J.; Stevens, Kim; Sutton, Neil; Szajkowski, Lukasz; Tregidgo, Carolyn L.; Turcatti, Gerardo; vandeVondele, Stephanie; Verhovsky, Yuli; Virk, Selene M.; Wakelin, Suzanne; Walcott, Gregory C.; Wang, Jingwen; Worsley, Graham J.; Yan, Juying; Yau, Ling; Zuerlein, Mike; Rogers, Jane; Mullikin, James C.; Hurles, Matthew E.; McCooke, Nick J.; West, John S.; Oaks, Frank L.; Lundberg, Peter L.; Klenerman, David; Durbin, Richard; Smith, Anthony J.			Accurate whole human genome sequencing using reversible terminator chemistry	NATURE			English	Article							STRUCTURAL VARIATION; CHROMATIN; MAPS	DNA sequence information underpins genetic research, enabling discoveries of important biological or medical benefit. Sequencing projects have traditionally used long ( 400 - 800 base pair) reads, but the existence of reference sequences for the human and many other genomes makes it possible to develop new, fast approaches to re- sequencing, whereby shorter reads are compared to a reference to identify intraspecies genetic variation. Here we report an approach that generates several billion bases of accurate nucleotide sequence per experiment at low cost. Single molecules of DNA are attached to a flat surface, amplified in situ and used as templates for synthetic sequencing with fluorescent reversible terminator deoxyribonucleotides. Images of the surface are analysed to generate high- quality sequence. We demonstrate application of this approach to human genome sequencing on flow- sorted X chromosomes and then scale the approach to determine the genome sequence of a male Yoruba from Ibadan, Nigeria. We build an accurate consensus sequence from. 303 average depth of paired 35- base reads. We characterize four million single- nucleotide polymorphisms and four hundred thousand structural variants, many of which were previously unknown. Our approach is effective for accurate, rapid and economical whole- genome re- sequencing and many other biomedical applications.	[Bentley, David R.; Swerdlow, Harold P.; Smith, Geoffrey P.; Milton, John; Brown, Clive G.; Hall, Kevin P.; Evers, Dirk J.; Barnes, Colin L.; Bignell, Helen R.; Boutell, Jonathan M.; Bryant, Jason; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony J.; Ellis, Darren J.; Gormley, Niall A.; Humphray, Sean J.; Irving, Leslie J.; Liu, Xiaohai; Maisinger, Klaus S.; Murray, Lisa J.; Obradovic, Bojan; Ost, Tobias; Parkinson, Michael L.; Rasolonjatovo, Isabelle M. J.; Rigatti, Roberto; Rodighiero, Chiara; Ross, Mark T.; Sabot, Andrea; Smith, Mark E.; Smith, Vincent P.; Spiridou, Anastassia; Torrance, Peta E.; Wu, Xiaolin; Anastasi, Carole; Aniebo, Ify C.; Bailey, David M. D.; Bancarz, Iain R.; Barbour, Selena G.; Benoit, Vincent A.; Benson, Kevin F.; Bevis, Claire; Black, Phillip J.; Boodhun, Asha; Brennan, Joe S.; Brown, Rob C.; Brown, Andrew A.; Bundu, Abass A.; Catenazzi, Maria Chiara E.; Cooley, R. Neil; Crake, Natasha R.; Dada, Olubunmi O.; Diakoumakos, Konstantinos D.; Dominguez-Fernandez, Belen; Earnshaw, David J.; Egbujor, Ugonna C.; Fraser, Louise J.; Fajardo, Karin V. Fuentes; Goddard, Colin P.; Green, David E.; Harnish, Kevin; Heyer, Narinder I.; Hims, Matthew M.; Horgan, Adrian M.; Hoschler, Katya; James, Terena; Jones, T. A. Huw; Kang, Gyoung-Dong; Kersey, Alan D.; Kingsbury, Zoya; Kokko-Gonzales, Paula I.; Kumar, Anil; Lee, Sarah E.; Loch, Jennifer A.; Mammen, Radhika M.; McCauley, Patrick G.; Mehta, Parul; Newington, Taksina; Novo, Sonia M.; Osborne, Mark A.; Osnowski, Andrew; Pickering, Lea; Pike, Andrew C.; Raczy, Come; Rae, Vicki H.; Rawlings, Stephen R.; Rodriguez, Ana Chiva; Roe, Phyllida M.; Rogers, John; Bacigalupo, Maria C. Rogert; Romanov, Nikolai; Rourke, Natalie J.; Ruediger, Silke T.; Sanches-Kuiper, Raquel M.; Schenker, Martin R.; Shaw, Richard J.; Smith, Melanie A.; Sohna, Jean Ernest Sohna; Stevens, Kim; Sutton, Neil; Szajkowski, Lukasz; Tregidgo, Carolyn L.; vandeVondele, Stephanie; Wang, Jingwen; Worsley, Graham J.; McCooke, Nick J.; Smith, Anthony J.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Balasubramanian, Shankar; Barnes, Colin L.; Liu, Xiaohai; Earnshaw, David J.; Furey, W. Scott; Osborne, Mark A.; Klenerman, David] Univ Cambridge, Dept Chem, Univ Chem Lab, Cambridge CB2 1EW, England; [Flatbush, Michael R.; Karbelashvili, Mirian S.; Kirk, Scott M.; Pratt, Mark R.; Reed, Mark T.; Sankar, Subramanian V.; Schroth, Gary P.; Tzonev, Svilen S.; Vermaas, Eric H.; Zhang, Lu; Alam, Mohammed D.; Banerjee, Saibal; Baybayan, Primo A.; Bridgham, John A.; Buermann, Dale H.; Burrows, James C.; Castillo, Nestor; Chang, Simon; Elmore, David W.; Etchin, Sergey S.; Ewan, Mark R.; George, David; Golda, George S.; Granieri, Philip A.; Gustafson, David L.; Haudenschild, Christian D.; Ho, Johnny T.; Hurwitz, Steve; Ivanov, Denis V.; Johnson, Maria Q.; Kerelska, Tzvetana H.; Khrebtukova, Irina; Kindwall, Alex P.; Lee, Xavier; Liao, Arnold K.; Lok, Mitch; Luo, Shujun; Martin, John W.; McNitt, Paul; Moon, Keith W.; Mullens, Joe W.; O'Neill, Michael J.; Ostadan, Omead; Paraschos, Lambros L.; Pike, Alger C.; Pinkard, D. Chris; Pliskin, Daniel P.; Podhasky, Joe; Quijano, Victor J.; Roth, Rithy K.; Rusman, Eli; Seoane, Josefina M.; Shiver, Mitch K.; Short, Steven W.; Sizto, Ning L.; Sluis, Johannes P.; Spence, Eric J.; Verhovsky, Yuli; Virk, Selene M.; Wakelin, Suzanne; Walcott, Gregory C.; Yan, Juying; Yau, Ling; Zuerlein, Mike; West, John S.; Oaks, Frank L.; Lundberg, Peter L.] Illumina Hayward, Hayward, CA 94343 USA; [Li, Heng; Scally, Aylwyn; Walter, Klaudia; Carter, Nigel P.; Ning, Zemin; Ng, Bee Ling; Rogers, Jane; Hurles, Matthew E.; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fedurco, Milan; Romieu, Anthony; Turcatti, Gerardo] Manteia Predict Med SA, CH-1267 Coinsins, Switzerland; [Gietzen, Kimberley J.; Laurent, Marc A.; Lawley, Cynthia T.; Ostadan, Omead] Illumina Inc, Corp Headquarters, San Diego, CA 92121 USA; [Hansen, Nancy F.; Mullikin, James C.] NHGRI, NIH, Bethesda, MD 20892 USA	Illumina; University of Cambridge; Illumina; Wellcome Trust Sanger Institute; Illumina; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bentley, DR (corresponding author), Illumina Cambridge Ltd, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England.	dbentley@illumina.com	Christian, Haudenschild C/D-1602-2009; Ning, Zemin/D-2411-2013; Li, Heng/D-9344-2011; Romieu, Anthony/AAU-4128-2021; Balasubramanian, Shankar/C-1671-2009; Durbin, Richard/AAE-7178-2019; Osborne, Mark/F-7666-2016	Li, Heng/0000-0003-4874-2874; Romieu, Anthony/0000-0002-2300-4499; Durbin, Richard/0000-0002-9130-1006; Shaw, Richard/0000-0001-8145-1601; Osborne, Mark/0000-0001-6660-2985; Klenerman, David/0000-0001-7116-6954; Lawley, Cynthia/0000-0001-7001-4705; Cox, Anthony/0000-0002-6534-749X; Swerdlow, Harold/0000-0002-9510-160X; Ning, Zemin/0000-0003-4359-776X; Balasubramanian, Shankar/0000-0002-0281-5815; Walter, Klaudia/0000-0003-4448-0301	The Wellcome Trust; Biotechnology and Biological Sciences Research Council; BBSRC Applied Genomics LINK Programme; Intramural Research Program of the National Human Genome Research Institute; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330] Funding Source: NIH RePORTER; Medical Research Council [G0701805] Funding Source: researchfish; MRC [G0701805] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Applied Genomics LINK Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the advice of A. Williamson, T. Rink, S. Benkovic, J. Berriman, J. Todd, R. Waterston, S. Eletr, W. Jack, M. Cooper, T. Brown, C. Reece and R. Cook during this work; E. Margulies for assistance with data analysis; M. Shumway for assistance with data submission; and the contributions of the administrative and support staff at all the institutions. This research was supported in part by The Wellcome Trust (to H.L., A.Sc., K.W., N.P.C, B.N.L., J.R., M.E.H. and R.D.), the Biotechnology and Biological Sciences Research Council (BBSRC) (to S.B. and D.K.), the BBSRC Applied Genomics LINK Programme (to A.Sp. and C.L.B.) and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (to N.F.H. and J.C.M.). S. Balasubramanian and D. Klenerman are inventors and founders of Solexa Ltd.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MILTON J, 2004, WO2004018497 WORLD I; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; SMITH GP, 2005, WO2005024010 WORLD I; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	32	2317	2738	10	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					53	59		10.1038/nature07517	http://dx.doi.org/10.1038/nature07517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987734	Green Accepted, hybrid			2022-12-28	WOS:000260674000039
J	Hays, JT; Ebbert, JO				Hays, J. Taylor; Ebbert, Jon O.			Varenicline for Tobacco Dependence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; SMOKING-CESSATION; CONTROLLED-TRIAL; NICOTINE PATCH; PLACEBO; EFFICACY; THERAPY; SAFETY		[Hays, J. Taylor; Ebbert, Jon O.] Mayo Clin, Coll Med, Nicotine Dependence Ctr, Rochester, MN 55905 USA	Mayo Clinic	Hays, JT (corresponding author), Mayo Clin, Coll Med, Nicotine Dependence Ctr, 200 1st St SW, Rochester, MN 55905 USA.	hays.taylor@mayo.edu			Pfizer; Department of Veterans Affairs; Mayo Clinic Foundation for Medical Education and Research; American Legacy Foundation; 1998 Master Settlement Agreement; National Institutes of Health; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [R01CA121165] Funding Source: NIH RePORTER	Pfizer(Pfizer); Department of Veterans Affairs(US Department of Veterans Affairs); Mayo Clinic Foundation for Medical Education and Research; American Legacy Foundation; 1998 Master Settlement Agreement; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Hays reports receiving grant support from Pfizer, the Department of Veterans Affairs, the Mayo Clinic Foundation for Medical Education and Research, and the American Legacy Foundation, which is supported by funds from the 1998 Master Settlement Agreement with U. S. tobacco companies; and Dr. Ebbert, grant support from the National Institutes of Health and the Flight Attendant Medical Research Institute. No other potential conflict of interest relevant to this article was reported.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Aubin HJ, 2008, THORAX, V63, P717, DOI 10.1136/thx.2007.090647; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; *CTR DRUG EV RES, 2008, VAR MARK CHANT INF F; *DEP HEW, 1988, DHHS PUBL CDC; Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; Fiore MC, 2008, CLIN PRACTICE GUIDEL; Freedman R, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07020326; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; *I SAF MED PRACT, 2008, STRONG SAF SIGN SEEN; Irvin J E, 2000, Nicotine Tob Res, V2, P79; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P1355; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kessler RC, 2007, J NERV MENT DIS, V195, P369, DOI 10.1097/NMD.0b013e3180303eb8; Kohen I, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07010173; Mendez D, 2000, AM J PUBLIC HEALTH, V90, P401, DOI 10.2105/AJPH.90.3.401; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nakamura M, 2007, CLIN THER, V29, P1040, DOI 10.1016/j.clinthera.2007.06.012; *NAT I HLTH CLIN E, 2007, VAR SMOK CESS; *NAT LIB MED, 2008, EFF SAF VAR SMOK CAR; *NAT LIB MED, 2008, SMOK CESS SUBJ MILD; Nides M, 2006, ARCH INTERN MED, V166, P1561, DOI 10.1001/archinte.166.15.1561; O'Brien CP, 2006, GOODMAN GILMANS PHAR, P607; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; Oncken C, 2006, ARCH INTERN MED, V166, P1571, DOI 10.1001/archinte.166.15.1571; Porter S, 2003, JAMA-J AM MED ASSOC, V289, P2355; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Slater YE, 2003, NEUROPHARMACOLOGY, V44, P503, DOI 10.1016/S0028-3908(03)00025-X; Stapleton JA, 2008, ADDICTION, V103, P146, DOI 10.1111/j.1360-0443.2007.02083.x; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; STEAD LF, 2006, COCHRANE DB SYST REV, V3; Tonnesen P, 2007, EUR RESPIR J, V29, P390, DOI 10.1183/09031936.00060806; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Tsai ST, 2007, CLIN THER, V29, P1027, DOI 10.1016/j.clinthera.2007.06.011; U.S. Preventive Services Task Force, 2003, AHRQ PUBL, V03-515A; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Williams KE, 2007, CURR MED RES OPIN, V23, P793, DOI 10.1185/030079907X182185; Wu P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-300; Zwar N, 2007, SMOKING CESSATION PH; 2002, MMWR MORB MORTAL WKL, V51, P300	44	77	81	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2018	2024		10.1056/NEJMct0800146	http://dx.doi.org/10.1056/NEJMct0800146			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987369	Green Accepted			2022-12-28	WOS:000260632700006
J	Turner, SW				Turner, Stephen W.			A noisy teenager	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN; ASTHMA; WHEEZE		[Turner, Stephen W.] Royal Aberdeen Childrens Hosp, Univ Child Hlth, Aberdeen AB25 2ZG, Scotland	University of Aberdeen	Turner, SW (corresponding author), Royal Aberdeen Childrens Hosp, Univ Child Hlth, Aberdeen AB25 2ZG, Scotland.	s.w.turner@abdn.ac.uk	Turner, Stephen/GXM-4654-2022					Birrell G, 2004, ARCH DIS CHILD, V89, P745, DOI 10.1136/adc.2003.035980; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Noyes BE, 2007, PAEDIATR RESPIR REV, V8, P155, DOI 10.1016/j.prrv.2007.05.004; Saglani S, 2005, ARCH DIS CHILD, V90, P961, DOI 10.1136/adc.2004.071134; Scottish Intercollegiate Guidelines Network, 2008, BRIT GUID MAN ASTHM; Turner SW, 2008, ARCH DIS CHILD, V93, P701, DOI 10.1136/adc.2007.134569; WARNER JO, 1989, ARCH DIS CHILD, V64, P1065, DOI 10.1136/adc.64.7.1065	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 5	2008	337								a2289	10.1136/bmj.a2289	http://dx.doi.org/10.1136/bmj.a2289			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FB	18987033				2022-12-28	WOS:000261236000011
J	Anya, I; Raine, R				Anya, Ike; Raine, Rosalind			Strengthening clinical and research ethics in Nigeria- an agenda for change	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; INFORMED-CONSENT; BIOMEDICAL-RESEARCH; MEDICAL-RESEARCH; TRIALS; ATTITUDES; STUDENTS; AFRICA; HIV		[Anya, Ike; Raine, Rosalind] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Anya, I (corresponding author), NHS Hammersmith & Fulham, 1A Hammersmith Broadway, London W6 9DL, England.	ikeanya@doctors.org.uk		Raine, Rosalind/0000-0003-0904-749X				*AFR LEAD FOR, 1993, ETH PROF MED PRACT P; Ajuwon Ademola J, 2008, BMC Med Ethics, V9, P1, DOI 10.1186/1472-6939-9-1; Alubo O, 2001, HEALTH POLICY PLANN, V16, P313, DOI 10.1093/heapol/16.3.313; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Benatar SR, 2005, PLOS MED, V2, P717, DOI 10.1371/journal.pmed.0020260; Chima SC, 2006, BMJ-BRIT MED J, V332, P848, DOI 10.1136/bmj.332.7545.848; Dowdy DW, 2006, J MED ETHICS, V32, P357, DOI 10.1136/jme.2005.012955; Ezeome ER, 2009, DEV WORLD BIOETH, V9, P138, DOI 10.1111/j.1471-8847.2008.00234.x; FALEYIMU BL, 2004, INT C AIDS BANGK THA; Geary CW, 2007, AIDS EDUC PREV, V19, P51, DOI 10.1521/aeap.2007.19.1.51; GLEASON G, 1990, DEV COMMUN REP, V71, P6; Ibrahim M, 2007, MED TEACH, V29, P901, DOI 10.1080/01421590701832130; Kilama W. L., 2003, EQUIPPING AFRICAS RE; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Lenzer J, 2007, BRIT MED J, V334, P1181, DOI 10.1136/bmj.39237.658171.DB; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Manafa Ogenna, 2007, Indian J Med Ethics, V4, P26; Mills EJ, 2005, BRIT MED J, V331, P1403, DOI 10.1136/bmj.331.7529.1403; Molyneux CS, 2005, SOC SCI MED, V61, P443, DOI 10.1016/j.socscimed.2004.12.003; Moodley K, 2007, J MED ETHICS, V33, P673, DOI 10.1136/jme.2006.018432; *NURS MIDW COUNC N, BAS CURR; Nwabueze RN, 2003, INDIANA INT COMP LAW, V14, P88, DOI [10.18060/17787, DOI 10.18060/17787]; Ogundiran Temidayo O, 2004, BMC Med Educ, V4, P21, DOI 10.1186/1472-6920-4-21; OGUNDIRAN TO, 2007, ANN HUM RES PROT PRO; OLUKOYA AA, 1983, MED EDUC, V17, P83, DOI 10.1111/j.1365-2923.1983.tb01104.x; Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Strauss RP, 2001, AM J PUBLIC HEALTH, V91, P1938, DOI 10.2105/AJPH.91.12.1938; Tettey WJ, 2001, MEDIA CULT SOC, V23, P5, DOI 10.1177/016344301023001001; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; Watson R, 2007, BRIT MED J, V334, P1076, DOI 10.1136/bmj.39220.615127.DB; Wendler D, 2004, AM J PUBLIC HEALTH, V94, P923, DOI 10.2105/AJPH.94.6.923; Wolinsky H, 2006, EMBO REP, V7, P670, DOI 10.1038/sj.embor.7400743; 2006, FINAL REPORT NETWORK	34	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1594	1597		10.1016/S0140-6736(08)61661-X	http://dx.doi.org/10.1016/S0140-6736(08)61661-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984194				2022-12-28	WOS:000260590500033
J	Ceesay, SJ; Casals-Pascual, C; Erskine, J; Anya, SE; Duah, NO; Fulford, AJC; Sesay, SSS; Abubakar, I; Dunyo, S; Sey, O; Palmer, A; Fofana, M; Corrah, T; Bojang, KA; Whittle, HC; Greenwood, BM; Conway, DJ				Ceesay, Serign J.; Casals-Pascual, Climent; Erskine, Jamie; Anya, Samuel E.; Duah, Nancy O.; Fulford, Anthony J. C.; Sesay, Sanie S. S.; Abubakar, Ismaela; Dunyo, Samuel; Sey, Omar; Palmer, Ayo; Fofana, Malang; Corrah, Tumani; Bojang, Kalifa A.; Whittle, Hilton C.; Greenwood, Brian M.; Conway, David J.			Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis	LANCET			English	Article							TREATED BED NETS; MOSQUITO NETS; RURAL AREA; FOLLOW-UP; MORTALITY; CHILDREN; MORBIDITY; AFRICA; TRIAL; RISK	Background Malaria is a major cause of morbidity and mortality in Africa. International effort and funding for control has been stepped up, with substantial increases from 2003 in the delivery of malaria interventions to pregnant women and children younger than 5 years in The Gambia. We investigated the changes in malaria indices in this country, and the causes and public-health significance of these changes. Methods We undertook a retrospective analysis of original records to establish numbers and proportions of malaria inpatients, deaths, and blood-slide examinations at one hospital over 9 years (January, 1999-December, 2007), and at four health facilities in three different administrative regions over 7 years (January, 2001-December, 2007). We obtained additional data from single sites for haernoglobin concentrations in paediatric admissions and for age distribution of malaria admissions. Findings From 2003 to 2007, at four sites with complete slide examination records, the proportions of malaria-positive slides decreased by 82% (3397/10861 in 2003 to 337/6142 in 2007), 85% (137/1259 to 6/368), 73% (3664/16932 to 666/11333), and 50% (1206/3304 to 336/1853). At three sites with complete admission records, the proportions of malaria admissions fell by 74% (435/2530 to 69/1531), 69% (797/2824 to 89/1032), and 27% (2204/4056 to 496/1251.). Proportions of deaths attributed to malaria in two hospitals decreased by 100% (seven of 115 in 2003 to none of 117 in 2007) and 90% (22/122 in 2003 to one of 58 in 2007). Since 2004, mean haemoglobin concentrations for all-cause admissions increased by 12 g/L (85 g/L in 2000-04 to 97 g/L in 2005-07), and mean age of paediatric malaria admissions increased from 3.9 years (95% CI 3.7-4 . 0) to 5.6 years (5.0-6.2). Interpretation A large proportion of the malaria burden has been alleviated in The Gambia. Our results encourage consideration of a policy to eliminate malaria as a public-health problem, while emphasising the importance of accurate and continuous surveillance. Funding UK Medical Research Council,	[Ceesay, Serign J.; Casals-Pascual, Climent; Duah, Nancy O.; Fulford, Anthony J. C.; Sesay, Sanie S. S.; Abubakar, Ismaela; Dunyo, Samuel; Corrah, Tumani; Bojang, Kalifa A.; Whittle, Hilton C.; Conway, David J.] MRC Labs, Banjul, Gambia; [Erskine, Jamie] WEC Mission Hosp, Sibanor, Western Region, Gambia; [Anya, Samuel E.] Univ Gambia, Sch Med & Allied Hlth Sci, Kanifing, Gambia; [Anya, Samuel E.; Palmer, Ayo] CIAM Publ Hlth Res & Dev Ctr, Kanifing, Gambia; [Fulford, Anthony J. C.; Greenwood, Brian M.; Conway, David J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Sey, Omar] AFPRC Farafenni Hosp, N Bank Region, Gambia; [Fofana, Malang] NMCP, Banjul, Gambia	MRC Laboratory Molecular Biology; University of the Gambia; University of London; London School of Hygiene & Tropical Medicine	Conway, DJ (corresponding author), MRC Labs, POB 273, Banjul, Gambia.	dconway@mrc.gm	Casals-Pascual, Climent/N-7692-2018; Sesay, Sanie Samuel Sogoyan/M-2982-2014	Casals-Pascual, Climent/0000-0002-0867-8954; Sesay, Sanie Samuel Sogoyan/0000-0001-6233-7854; Bojang, Kalifa/0000-0001-7506-0938; Conway, David/0000-0002-8711-3037; Duah-Quashie, Nancy/0000-0001-8819-1793	UK Medical Research Council; Medical Research Council [MC_U190074193] Funding Source: researchfish; MRC [MC_U190074193] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support for the research was provided by the UK Medical Research Council (MRC). We thank Jula Jaiteh. and Lamin Sanyang (Senior Nursing Officers at Government health facilities) for providing hospital records and helping to extract data; Gibril Bah, Lamin Manneh, Bernard Ndaye, Lamin Gibba. Fabakary Sanyang, Hawa Manneh. Demba B T Sainbou, and Yorro Bah (MRC staff) for data extraction of the haematology laboratory) and ward records: Aja Abbie Khan (Head of Regional Health Team for Western Division) for support in implementing the project at the Government health facilities: Andrew Prentice (Head of MRC Nutrition Research Programme) for supporting the Keneba laboratory record database management: Pamela Collier Njie and Muminatou Jallow for help with the provision of clinical data front the MRC ward in Fajara; and many other colleagues and partner organisations who have encouraged this work.	ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; [Anonymous], 2007, LANCET, V370, P1459; Anya SE, 2004, AM J TROP MED HYG, V70, P510, DOI 10.4269/ajtmh.2004.70.510; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Butler D, 2007, NATURE, V450, P144, DOI 10.1038/450144b; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Chambers RG, 2008, LANCET, V371, P1399, DOI 10.1016/S0140-6736(08)60609-1; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; GREENWOOD BM, 1988, LANCET, V1, P1121; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; MARSDEN P. D., 1964, TRANS ROY SOC TROP MED HYG, V58, P455, DOI 10.1016/0035-9203(64)90101-4; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L; MENON A, 1990, T ROY SOC TROP MED H, V84, P638, DOI 10.1016/0035-9203(90)90130-7; *MICS, 2002, GAMB MULT IND CLUST, P1; *MICS, 2007, GAMB MULT IND CLUST, P1; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Shanks GD, 2008, LANCET INFECT DIS, V8, P564, DOI 10.1016/S1473-3099(08)70130-0; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P838, DOI 10.1016/0035-9203(88)90011-9; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; *UNICEF, 2007, MAL CHILDR PROGR INT, P1; *WHO, 2008, IMP LONG LAST INS NE; Williams Christopher J, 2007, Travel Med Infect Dis, V5, P295, DOI 10.1016/j.tmaid.2007.05.001	41	307	311	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1545	1554		10.1016/S0140-6736(08)61654-2	http://dx.doi.org/10.1016/S0140-6736(08)61654-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984187	Green Published, Green Accepted			2022-12-28	WOS:000260590500026
J	Cui, YJ; Costa, RM; Murphy, GG; Elgersma, Y; Zhu, Y; Gutmann, DH; Parada, LF; Mody, I; Silva, AJ				Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Zhu, Yuan; Gutmann, David H.; Parada, Luis F.; Mody, Istvan; Silva, Alcino J.			Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning	CELL			English	Article							LONG-TERM POTENTIATION; MORRIS WATER MAZE; ACTIVATED PROTEIN-KINASE; MOUSE MODEL; SYNAPTIC PLASTICITY; DOWN-SYNDROME; MEMORY; TYPE-1; DEFICITS; RATS	We uncovered a role for ERK signaling in GABA release, long-term potentiation (LTP), and learning, and show that disruption of this mechanism accounts for the learning deficits in a mouse model for learning disabilities in neurofibromatosis type I (NF1). Our results demonstrate that neurofibromin modulates ERK/synapsin I-dependent GABA release, which in turn modulates hippocampal LTP and learning. An Nf1 heterozygous null mutation, which results in enhanced ERK and synapsin I phosphorylation, increased GABA release in the hippocampus, and this was reversed by pharmacological downregulation of ERK signaling. Importantly, the learning deficits associated with the Nf1 mutation were rescued by a subthreshold dose of a GABAA antagonist. Accordingly, Cre deletions of Nf1 showed that only those deletions involving inhibitory neurons caused hippocampal inhibition, LTP, and learning abnormalities. Importantly, our results also revealed lasting increases in GABA release triggered by learning, indicating that the mechanisms uncovered here are of general importance for learning.	[Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; [Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90095 USA; [Cui, Yijun; Costa, Rui M.; Murphy, Geoffrey G.; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA; [Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20852 USA; [Murphy, Geoffrey G.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Elgersma, Ype] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Zhu, Yuan] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhu, Yuan] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75235 USA; [Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Elgersma, Ype/F-5164-2013; Zhu, Yuan/ABF-8405-2020; Parada, luis F/B-9400-2014; Silva, Alcino/ABD-7684-2021	Elgersma, Ype/0000-0002-3758-1297; Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Gutmann, David/0000-0002-3127-5045; Costa, Rui M./0000-0003-0495-8374	NIH [R01 NS38480]; Neurofibromatosis Inc.; Children's Tumor Foundation; United States Army [W81XWH-06-1-0174]; Coelho Endowment [NS30549]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549, R01NS038480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurofibromatosis Inc.; Children's Tumor Foundation; United States Army(United States Department of DefenseUnited States Army); Coelho Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the NIH (R01 NS38480), Neurofibromatosis Inc., the Children's Tumor Foundation, and United States Army (W81XWH-06-1-0174) to A.J.S. and NS30549 and the Coelho Endowment to I. M. This work was also supported by a generous donation from C. M. Spivak to A. J.S.Y.C. was supported by a fellowship from the Children's Tumor Foundation. We thank P. Greengard and J.N. Jovanovic for the generous gift of the phospho-Syn I antibodies. We are grateful to Steven Kushner, Brandon M. Stell, and Weizheng Wei for fruitful discussions.	Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dilts CV, 1996, J DEV BEHAV PEDIATR, V17, P229; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Guilding C, 2007, EUR J NEUROSCI, V25, P99, DOI 10.1111/j.1460-9568.2006.05238.x; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; INTROINICOLLISON IB, 1994, BEHAV NEURAL BIOL, V61, P150, DOI 10.1016/S0163-1047(05)80068-8; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782; Lynch TM, 2002, NEUROL CLIN, V20, P841, DOI 10.1016/S0733-8619(01)00019-6; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; McElroy MW, 2005, LEARN MEMORY, V12, P150, DOI 10.1101/lm.86205; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Stenman J, 2003, J NEUROSCI, V23, P167; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Wiltgen BJ, 2005, LEARN MEMORY, V12, P327, DOI 10.1101/lm.89705; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	43	295	303	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					549	560		10.1016/j.cell.2008.09.060	http://dx.doi.org/10.1016/j.cell.2008.09.060			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984165	Green Accepted, Bronze			2022-12-28	WOS:000260536300024
J	Keizer, K; Lindenberg, S; Steg, L				Keizer, Kees; Lindenberg, Siegwart; Steg, Linda			The Spreading of Disorder	SCIENCE			English	Article							NORMS; LITTER; FIELD	Imagine that the neighborhood you are living in is covered with graffiti, litter, and unreturned shopping carts. Would this reality cause you to litter more, trespass, or even steal? A thesis known as the broken windows theory suggests that signs of disorderly and petty criminal behavior trigger more disorderly and petty criminal behavior, thus causing the behavior to spread. This may cause neighborhoods to decay and the quality of life of its inhabitants to deteriorate. For a city government, this may be a vital policy issue. But does disorder really spread in neighborhoods? So far there has not been strong empirical support, and it is not clear what constitutes disorder and what may make it spread. We generated hypotheses about the spread of disorder and tested them in six field experiments. We found that, when people observe that others violated a certain social norm or legitimate rule, they are more likely to violate other norms or rules, which causes disorder to spread.	[Keizer, Kees; Lindenberg, Siegwart; Steg, Linda] Univ Groningen, Fac Behav & Social Sci, NL-9712 TS Groningen, Netherlands	University of Groningen	Keizer, K (corresponding author), Univ Groningen, Fac Behav & Social Sci, NL-9712 TS Groningen, Netherlands.	K.E.Keizer@rug.nl	Steg, Linda/H-6878-2014; Lindenberg, Siegwart/E-2932-2013	Steg, Linda/0000-0002-8375-9607; Lindenberg, Siegwart/0000-0003-0053-3651				Berkowitz L., 1972, ADV EXP SOC PSYCHOL, V6, P63, DOI [DOI 10.1016/S0065-2601(08)60025-8, 10.1016/S0065-2601(08)60025-8]; BICKMAN L, 1972, J SOC PSYCHOL, V87, P323, DOI 10.1080/00224545.1972.9922533; Chaiken S., 1996, PSYCHOL ACTION LINKI, P553; Cialdini R., 1993, PSYCHOL INFLUENCE; Cialdini R.B., 2006, SOC INFLUENCE, V1, p3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL, P151; Cialdini RB, 2003, CURR DIR PSYCHOL SCI, V12, P105, DOI 10.1111/1467-8721.01242; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; CODOL JP, 1975, EUR J SOC PSYCHOL, V5, P457, DOI 10.1002/ejsp.2420050404; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Eck JohnE., 2000, CRIME DROP AM, P207; FINNIE WC, 1973, ENVIRON BEHAV, V5, P123, DOI 10.1177/001391657300500201; Fleishman J.A., 1978, US SOC PSYCHOL, V41, P306; Gladwell M., 2006, TIPPING POINT LITTLE; Harcourt BE, 1998, MICH LAW REV, V97, P291, DOI 10.2307/1290289; HAROURT BE, 2006, U CHICAGO LAW REV, V73, P271; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Kelling G.L., 2001, 22 MANH I CTR CIV IN; Kelling GL., 1996, FIXING BROKEN WINDOW; KRAUSS RM, 1978, J EXP SOC PSYCHOL, V14, P109, DOI 10.1016/0022-1031(78)90064-1; Lindenberg S, 2007, J SOC ISSUES, V63, P117, DOI 10.1111/j.1540-4560.2007.00499.x; Marques JM, 1998, J PERS SOC PSYCHOL, V75, P976, DOI 10.1037/0022-3514.75.4.976; REITER SM, 1980, J APPL SOC PSYCHOL, V10, P45, DOI 10.1111/j.1559-1816.1980.tb00692.x; RENO RR, 1993, J PERS SOC PSYCHOL, V64, P104, DOI 10.1037/0022-3514.64.1.104; Rimal RN, 2005, J HEALTH COMMUN, V10, P433, DOI 10.1080/10810730591009880; Sampson RJ, 1999, AM J SOCIOL, V105, P603, DOI 10.1086/210356; Schultz PW, 2008, SOC INFLUENCE, V3, P4, DOI 10.1080/15534510701755614; SHAFFER LS, 1983, J MIND BEHAV, V4, P275; Skogan W., 2004, FAIRNESS EFFECTIVENE; Skogan W.G., 1990, DISORDER DECLINE CRI; Winter PL, 2000, ENVIRON MANAGE, V26, P589, DOI 10.1007/s002670010117	33	576	592	4	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2008	322	5908					1681	1685		10.1126/science.1161405	http://dx.doi.org/10.1126/science.1161405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	382LU	19023045	Green Published			2022-12-28	WOS:000261608300042
J	Greenberg, JI; Shields, DJ; Barillas, SG; Acevedo, LM; Murphy, E; Huang, JH; Scheppke, L; Stockmann, C; Johnson, RS; Angle, N; Cheresh, DA				Greenberg, Joshua I.; Shields, David J.; Barillas, Samuel G.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Stockmann, Christian; Johnson, Randall S.; Angle, Niren; Cheresh, David A.			A role for VEGF as a negative regulator of pericyte function and vessel maturation	NATURE			English	Article							GROWTH-FACTOR PDGF; INDUCED ANGIOGENESIS; ENDOTHELIAL-CELLS; IN-SITU; BETA; BB; DIFFERENTIATION; RECRUITMENT; INHIBITION; PROMOTES	Angiogenesis does not only depend on endothelial cell invasion and proliferation: it alsorequires pericyte coverage of vascular sprouts for vessel stabilization(1,2). These processes are coordinated by vascular endothelial growth factor ( VEGF) and platelet- derived growth factor ( PDGF) through their cognate receptors on endothelial cells and vascular smooth muscle cells ( VSMCs), respectively(3,4). PDGF induces neovascularization by priming VSMCs/pericytes to release proangiogenic mediators(5-7). Although VEGF directly stimulates endothelial cell proliferation and migration, its role in pericyte biology is less clear. Here we define a role for VEGF as an inhibitor of neovascularization on the basis of its capacity to disrupt VSMC function. Specifically, under conditions of PDGF- mediated angiogenesis, VEGF ablates pericyte coverage of nascent vascular sprouts, leading to vessel destabilization. At the molecular level, VEGF- mediated activation of VEGF- R2 suppresses PDGF- R beta signalling in VSMCs through the assembly of a previously undescribed receptor complex consisting of PDGF- Rb and VEGF- R2. Inhibition of VEGF- R2 not only prevents assembly of this receptor complex but also restores angiogenesis in tissues exposed to both VEGF and PDGF. Finally, genetic deletion of tumour cell VEGF disrupts PDGF-R beta/VEGF-R2 complex formation and increases tumour vessel maturation. These findings underscore the importance of VSMCs/ pericytes in neovascularization(8,9) and reveal a dichotomous role forVEGF and VEGF-R2 signalling as both a promoter of endothelial cell function and a negative regulator of VSMCs and vessel maturation.	[Shields, David J.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Greenberg, Joshua I.; Barillas, Samuel G.; Angle, Niren] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Shields, David J.; Acevedo, Lisette M.; Murphy, Eric; Huang, Jianhua; Scheppke, Lea; Cheresh, David A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Stockmann, Christian; Johnson, Randall S.] Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	Johnson, Randall/AAM-1189-2021; Stockmann, Christian/L-6956-2017; Stockmann, Christian/Q-1615-2017	Johnson, Randall/0000-0002-4084-6639; Stockmann, Christian/0000-0002-9726-6838	National Institutes of Health [R37-CA50286, CA082515, GM 68524]; University of California Academic Senate Grant; Deutsche Forschungsgemeinschaft [DFG STO 787/1-1]; Institutional Research and Academic Career Development Award; NATIONAL CANCER INSTITUTE [R01CA118165, R37CA050286, R01CA095262, P01CA078045, R01CA082515, R21CA129660] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Academic Senate Grant(University of California System); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institutional Research and Academic Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Stupack and D. Schlaepfer for advice and review of the manuscript. We also thank A. Tomar for assistance with the PLA imaging; C. Heldin for the PDGF-Rb complementary DNA; and J. Desgrosellier for processing pancreatic tumour samples. This work was supported by National Institutes of Health grants R37-CA50286 (D.A.C.) and CA082515 (R.S.J.), and by a University of California Academic Senate Grant (N.A.). C.S. was funded by the Deutsche Forschungsgemeinschaft (DFG STO 787/1-1), and L.M.A. received an Institutional Research and Academic Career Development Award postdoctoral fellowship (National Institutes of Health grant GM 68524).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Alavi AS, 2007, CANCER RES, V67, P2766, DOI 10.1158/0008-5472.CAN-06-3648; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fong TAT, 1999, CANCER RES, V59, P99; GRUNSTEIN J, 2004, CANCER RES, V23, P2800; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; INUI H, 1994, J BIOL CHEM, V269, P30546; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LUO J, 2007, NATURE PROTOC, V2, P1536; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Sennino B, 2007, CANCER RES, V67, P7358, DOI 10.1158/0008-5472.CAN-07-0293; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Vincent L, 2004, CANCER CELL, V6, P307, DOI 10.1016/j.ccr.2004.09.024; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	27	472	502	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					809	U101		10.1038/nature07424	http://dx.doi.org/10.1038/nature07424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18997771	Green Submitted, Green Accepted			2022-12-28	WOS:000261559900053
J	Craythorne, EE; du Vivier, AWP				Craythorne, E. E.; du Vivier, A. W. P.			Non-healing ulcer on the toe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MELANOMA		[Craythorne, E. E.; du Vivier, A. W. P.] Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Craythorne, EE (corresponding author), Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England.	emma_craythorne@hotmail.com						Baran R, 1996, J AM ACAD DERMATOL, V34, P87, DOI 10.1016/S0190-9622(96)90839-7; Helfand M., 2001, AHRQ PUBLICATION; Kaskel P, 2000, BRIT J DERMATOL, V143, P749, DOI 10.1046/j.1365-2133.2000.03770.x; Kato T, 1999, INT J DERMATOL, V38, P515, DOI 10.1046/j.1365-4362.1999.00736.x; MCGOVERN VJ, 1986, PATHOLOGY, V18, P12, DOI 10.3109/00313028609090822; Metzger S, 1998, MELANOMA RES, V8, P181, DOI 10.1097/00008390-199804000-00014; National Institute for Health and Clinical Excellence, 2006, IMPR OUTC PEOPL SKIN; Roberts DLL, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.2001.04614.x; Soon SL, 2003, J AM ACAD DERMATOL, V48, P183, DOI 10.1067/mjd.2003.63	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2008	337								a2460	10.1136/bmj.a2460	http://dx.doi.org/10.1136/bmj.a2460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385QB	19036769				2022-12-28	WOS:000261827600005
J	Whooley, MA; de Jonge, P; Vittinghoff, E; Otte, C; Moos, R; Carney, RM; Ali, S; Dowray, S; Na, B; Feldman, MD; Schiller, NB; Browner, WS				Whooley, Mary A.; de Jonge, Peter; Vittinghoff, Eric; Otte, Christian; Moos, Rudolf; Carney, Robert M.; Ali, Sadia; Dowray, Sunaina; Na, Beeya; Feldman, Mitchell D.; Schiller, Nelson B.; Browner, Warren S.			Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPORTED PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; MEDICATION ADHERENCE; ENHANCING RECOVERY; CONSTRUCT-VALIDITY; EXERCISE TREATMENT; RATE-VARIABILITY; NATIONAL-HEART; OLDER PERSONS	Context Depressive symptoms predict adverse cardiovascular outcomes in patients with coronary heart disease, but the mechanisms responsible for this association are unknown. Objective To determine why depressive symptoms are associated with an increased risk of cardiovascular events. Design and Participants The Heart and Soul Study is a prospective cohort study of 1017 outpatients with stable coronary heart disease followed up for a mean ( SD) of 4.8 ( 1.4) years. Setting Participants were recruited between September 11, 2000, and December 20, 2002, from 12 outpatient clinics in the San Francisco Bay Area and were followed up to January 12, 2008. Main Outcome Measures Baseline depressive symptoms were assessed using the Patient Health Questionnaire ( PHQ). We used proportional hazards models to evaluate the extent to which the association of depressive symptoms with subsequent cardiovascular events ( heart failure, myocardial infarction, stroke, transient ischemic attack, or death) was explained by baseline disease severity and potential biological or behavioral mediators. Results A total of 341 cardiovascular events occurred during 4876 person- years of follow-up. The age- adjusted annual rate of cardiovascular events was 10.0% among the 199 participants with depressive symptoms ( PHQ score >= 10) and 6.7% among the 818 participants without depressive symptoms ( hazard ratio [ HR], 1.50; 95% confidence interval, [ CI], 1.16- 1.95; P=. 002). After adjustment for comorbid conditions and disease severity, depressive symptoms were associated with a 31% higher rate of cardiovascular events ( HR, 1.31; 95% CI, 1.00- 1.71; P=. 04). Additional adjustment for potential biological mediators attenuated this association ( HR, 1.24; 95% CI, 0.94- 1.63; P=. 12). After further adjustment for potential behavioral mediators, including physical inactivity, there was no significant association ( HR, 1.05; 95% CI, 0.79- 1.40; P=. 75). Conclusion In this sample of outpatients with coronary heart disease, the association between depressive symptoms and adverse cardiovascular events was largely explained by behavioral factors, particularly physical inactivity.	[Whooley, Mary A.; Ali, Sadia; Dowray, Sunaina; Na, Beeya; Schiller, Nelson B.] VA Med Ctr, San Francisco, CA USA; [Whooley, Mary A.; Vittinghoff, Eric; Feldman, Mitchell D.; Schiller, Nelson B.; Browner, Warren S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [de Jonge, Peter] Univ Groningen, Groningen, Netherlands; [de Jonge, Peter] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Otte, Christian] Univ Hosp Hamburg Eppendorf, Hamburg, Germany; [Moos, Rudolf] Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Moos, Rudolf] Stanford Univ, Palo Alto, CA 94304 USA; [Carney, Robert M.] Washington Univ, St Louis, MO USA; [Browner, Warren S.] Calif Pacific Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of Groningen; Tilburg University; University of Hamburg; University Medical Center Hamburg-Eppendorf; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Washington University (WUSTL); California Pacific Medical Center	Whooley, MA (corresponding author), 4150 Clement St 111A1, San Francisco, CA 94121 USA.	mary.whooley@ucsf.edu	de Jonge, peter/L-6395-2013	de Jonge, peter/0000-0002-0866-6929; Otte, Christian/0000-0002-4051-997X	VA Epidemiology (Merit Review) Program; VA Health Research and Development Service Career Development Program; National Heart, Lung, and Blood Institute [R01 HL079235]; American Federation for Aging Research (Paul Beeson Scholars Program); Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program); Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	VA Epidemiology (Merit Review) Program(US Department of Veterans Affairs); VA Health Research and Development Service Career Development Program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Federation for Aging Research (Paul Beeson Scholars Program); Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program)(Robert Wood Johnson Foundation (RWJF)); Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the VA Epidemiology (Merit Review) Program; the VA Health Research and Development Service Career Development Program; the National Heart, Lung, and Blood Institute (R01 HL079235); the American Federation for Aging Research (Paul Beeson Scholars Program); the Robert Wood Johnson Foundation ( Generalist Physician Faculty Scholars Program); the Ischemia Research and Education Foundation; and the Nancy Kirwan Heart Research Fund.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P422, DOI 10.1097/HJR.0b013e3280128d00; Abramson J, 2001, ARCH INTERN MED, V161, P1725, DOI 10.1001/archinte.161.14.1725; Ades PA, 2002, AM HEART J, V143, P151, DOI 10.1067/mhj.2002.119379; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALI S, IN PRESS PSYCHOTHER; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; BLOUIN AG, 1988, PSYCHIAT RES, V23, P335, DOI 10.1016/0165-1781(88)90024-8; Blumberg EJ, 2005, J CLIN EPIDEMIOL, V58, P645, DOI 10.1016/j.jclinepi.2004.11.022; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Blumenthal JA, 2007, CLIN TRIALS, V4, P548, DOI 10.1177/1740774507083388; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Borowicz L, 2002, PSYCHOSOMATICS, V43, P464, DOI 10.1176/appi.psy.43.6.464; Bowles HR, 2004, AM J EPIDEMIOL, V160, P279, DOI 10.1093/aje/kwh209; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Carney RM, 2004, PSYCHOSOM MED, V66, P466, DOI 10.1097/01.psy.0000133362.75075.a6; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Craft LL, 1998, J SPORT EXERCISE PSY, V20, P339, DOI 10.1123/jsep.20.4.339; de Jonge P, 2007, AM J PSYCHIAT, V164, P1371, DOI 10.1176/appi.ajp.2007.06091492; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Frasure-Smith N, 2007, BIOL PSYCHIAT, V62, P302, DOI 10.1016/j.biopsych.2006.09.029; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; GREIST JH, 1987, HOSP COMMUNITY PSYCH, V38, P1304; Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Jackson AW, 2007, RES Q EXERCISE SPORT, V78, P24; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Kaleta Dorota, 2004, Int J Occup Med Environ Health, V17, P457; KNAPIK J, 1993, AM J PREV MED, V9, P203, DOI 10.1016/S0749-3797(18)30716-5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lett H, 2008, PSYCHOSOM MED, V70, P444, DOI 10.1097/PSY.0b013e31816c3c5c; Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MATSUI D, 1994, J CLIN PHARMACOL, V34, P944, DOI 10.1002/j.1552-4604.1994.tb04009.x; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Otte C, 2005, AM J PSYCHIAT, V162, P2139, DOI 10.1176/appi.ajp.162.11.2139; Otte C, 2004, BIOL PSYCHIAT, V56, P241, DOI 10.1016/j.biopsych.2004.06.003; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Ren XS, 2007, AM J CARDIOL, V99, P1643, DOI 10.1016/j.amjcard.2007.01.041; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Ruo B, 2004, AM J CARDIOL, V94, P96, DOI 10.1016/j.amjcard.2004.03.035; Schins A, 2004, LIFE SCI, V76, P637, DOI 10.1016/j.lfs.2004.04.060; Schmoor C, 2000, STAT MED, V19, P441, DOI 10.1002/(SICI)1097-0258(20000229)19:4<441::AID-SIM349>3.0.CO;2-N; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Vaccarino V, 2001, J AM COLL CARDIOL, V38, P199, DOI 10.1016/S0735-1097(01)01334-1; Vaccarino V, 2007, J AM COLL CARDIOL, V50, P2044, DOI 10.1016/j.jacc.2007.07.069; Van Melle JP, 2007, BRIT J PSYCHIAT, V190, P460, DOI 10.1192/bjp.bp.106.028647; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wellenius GA, 2008, CIRCULATION, V117, P2313, DOI 10.1161/CIRCULATIONAHA.107.741058; WHO, 2007, WORLD HLTH STAT; Whooley MA, 2007, BIOL PSYCHIAT, V62, P314, DOI 10.1016/j.biopsych.2006.10.016; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	80	569	584	5	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2008	300	20					2379	2388		10.1001/jama.2008.711	http://dx.doi.org/10.1001/jama.2008.711			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375YX	19033588	Green Accepted			2022-12-28	WOS:000261150800020
J	Bignami, GF				Bignami, Giovanni F.			ASTRONOMY Gamma Rays and Neutron Stars	SCIENCE			English	Editorial Material							TELESCOPE; PULSAR; NEBULA		[Bignami, Giovanni F.] IUSS, I-27100 Pavia, Italy	IUSS PAVIA	Bignami, GF (corresponding author), IUSS, Viale Lungo Ticino Sforza 56, I-27100 Pavia, Italy.	giovanni.bignami@gmail.com		Bignami, Giovanni/0000-0001-9582-2450				Abdo AA, 2008, SCIENCE, V322, P1218, DOI 10.1126/science.1165572; Aliu E, 2008, SCIENCE, V322, P1221, DOI 10.1126/science.1164718; Bignami GF, 1996, ANNU REV ASTRON ASTR, V34, P331, DOI 10.1146/annurev.astro.34.1.331; Bulgarelli A, 2008, ASTRON ASTROPHYS, V489, pL17, DOI 10.1051/0004-6361:200810711; HALPERN J, ASTROPHYS J IN PRESS; KNIFFEN DA, 1974, NATURE, V251, P397, DOI 10.1038/251397a0; NOLAN PL, 1993, ASTROPHYS J, V409, P697, DOI 10.1086/172699; THOMPSON DJ, 1975, ASTROPHYS J, V200, pL79, DOI 10.1086/181902; WILLS RD, 1982, NATURE, V296, P723, DOI 10.1038/296723a0	9	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1193	1194		10.1126/science.1166967	http://dx.doi.org/10.1126/science.1166967			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023068				2022-12-28	WOS:000261033400023
J	Durr, S; Fodor, Z; Frison, J; Hoelbling, C; Hoffmann, R; Katz, SD; Krieg, S; Kurth, T; Lellouch, L; Lippert, T; Szabo, KK; Vulvert, G				Duerr, S.; Fodor, Z.; Frison, J.; Hoelbling, C.; Hoffmann, R.; Katz, S. D.; Krieg, S.; Kurth, T.; Lellouch, L.; Lippert, T.; Szabo, K. K.; Vulvert, G.			Ab Initio Determination of Light Hadron Masses	SCIENCE			English	Article							QUANTUM-FIELD THEORIES; VOLUME DEPENDENCE; ENERGY-SPECTRUM	More than 99% of the mass of the visible universe is made up of protons and neutrons. Both particles are much heavier than their quark and gluon constituents, and the Standard Model of particle physics should explain this difference. We present a full ab initio calculation of the masses of protons, neutrons, and other light hadrons, using lattice quantum chromodynamics. Pion masses down to 190 mega- electron volts are used to extrapolate to the physical point, with lattice sizes of approximately four times the inverse pion mass. Three lattice spacings are used for a continuum extrapolation. Our results completely agree with experimental observations and represent a quantitative confirmation of this aspect of the Standard Model with fully controlled uncertainties.	[Duerr, S.; Fodor, Z.] Deutsch Elekt Synchrotron Zeuthen, John von Neumann Inst Comp, D-15738 Zeuthen, Germany; [Duerr, S.; Fodor, Z.; Lippert, T.] Forschungszentrum Julich, Julich Supercomp Ctr, D-52425 Julich, Germany; [Fodor, Z.; Hoelbling, C.; Hoffmann, R.; Katz, S. D.; Krieg, S.; Kurth, T.; Lippert, T.; Szabo, K. K.] Berg Univ Wuppertal, D-42119 Wuppertal, Germany; [Fodor, Z.; Hoelbling, C.; Katz, S. D.] Eotvos Lorand Univ, Inst Theoret Phys, H-1117 Budapest, Hungary; [Frison, J.; Hoelbling, C.; Lellouch, L.; Vulvert, G.] Univ Aix Marseille 1, Ctr Phys Theor, UMR 6207, CNRS, F-13288 Marseille 9, France	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz Association; Research Center Julich; University of Wuppertal; Eotvos Lorand University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Durr, S (corresponding author), Deutsch Elekt Synchrotron Zeuthen, John von Neumann Inst Comp, D-15738 Zeuthen, Germany.		Kurth, Thorsten/Z-2117-2018; Katz, Sandor D/A-4154-2011; Frison, Julien/AAB-2264-2020	Kurth, Thorsten/0000-0003-0832-6198; Frison, Julien/0000-0002-1125-5928; Katz, Sandor/0000-0001-6524-2965; Krieg, Stefan/0000-0002-8417-9823; Hoelbling, Christian/0000-0001-5715-1086	European Union (EU) [I3HP]; Orszagos Tudomanyos Kutatasi Alapprogramok [AT049652]; Deutsche Forshungsgemeinschaft [FO 502/1-2, SFB-TR 55]; EU; RTN [MRTN-CT-2006-035482 (FLAVIAnet), (FP7/2007-2013)/ERC no. 208740]; CNRS's GDR [2921]	European Union (EU)(CGIAREuropean Commission); Orszagos Tudomanyos Kutatasi Alapprogramok(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Deutsche Forshungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); RTN; CNRS's GDR	Computations were performed on the Blue Gene supercomputers at FZ Julich and at IDRIS and on clusters at Wuppertal and CPT. This work is supported in part by European Union (EU) grant I3HP; Orszagos Tudomanyos Kutatasi Alapprogramok grant AT049652; Deutsche Forshungsgemeinschaft grants FO 502/1-2 and SFB-TR 55; EU grants RTN contract MRTN-CT-2006-035482 (FLAVIAnet) and (FP7/2007-2013)/ERC no. 208740; and the CNRS's GDR grant 2921. Useful discussions with J. Charles and M. Knecht are acknowledged.	Antonio DJ, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.114501; Aoki S, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.034503; Aoki S, 2000, PHYS REV LETT, V84, P238, DOI 10.1103/PhysRevLett.84.238; Aubin C, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.094505; Bernard C, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.054506; Clark M. A, 2006, POS LAT2006, VLAT2006; Colangelo G, 2004, EUR PHYS J C, V33, P543, DOI 10.1140/epjc/s2004-01593-y; Davies CTH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.022001; Del Debbio L, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/02/056; Gockeler M., 2007, P SCI LAT2007, VLAT2007, P129; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; Khan A. Ali, 2004, NUCL PHYS B, VB689, P175; LUSCHER M, 1986, COMMUN MATH PHYS, V105, P153, DOI 10.1007/BF01211097; LUSCHER M, 1991, NUCL PHYS B, V364, P237, DOI 10.1016/0550-3213(91)90584-K; LUSCHER M, 1991, NUCL PHYS B, V354, P531, DOI 10.1016/0550-3213(91)90366-6; LUSCHER M, 1986, COMMUN MATH PHYS, V104, P177, DOI 10.1007/BF01211589; MICHAEL C, 1995, PHYS REV D, V51, P3745, DOI 10.1103/PhysRevD.51.3745; NAOKI J, 2007, P SCI LAT2007, P126; Orth B, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.014503; POLITZER HD, 1973, PHYS REV LETT, V30, P1346, DOI 10.1103/PhysRevLett.30.1346; Ukita N., 2007, P SCI LAT2007, VLAT2007, P138; WILCOX WM, 2007, P SCI LAT2007; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445; Yao WM, 2006, J PHYS G NUCL PARTIC, V33, P1, DOI 10.1088/0954-3899/33/1/001	24	391	394	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1224	1227		10.1126/science.1163233	http://dx.doi.org/10.1126/science.1163233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023076	Green Submitted, Green Accepted			2022-12-28	WOS:000261033400035
J	Liberman, N; Trope, Y				Liberman, Nira; Trope, Yaacov			The Psychology of Transcending the Here and Now	SCIENCE			English	Review							TEMPORAL DISTANCE; PREFRONTAL CORTEX; SPATIAL DISTANCE; FUTURE; TIME; EVENTS; LEVEL; GRATIFICATION; PROBABILITY; PERSPECTIVE	People directly experience only themselves here and now but often consider, evaluate, and plan situations that are removed in time or space, that pertain to others' experiences, and that are hypothetical rather than real. People thus transcend the present and mentally traverse temporal distance, spatial distance, social distance, and hypotheticality. We argue that this is made possible by the human capacity for abstract processing of information. We review research showing that there is considerable similarity in the way people mentally traverse different distances, that the process of abstraction underlies traversing different distances, and that this process guides the way people predict, evaluate, and plan near and distant situations.	[Liberman, Nira] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel; [Trope, Yaacov] NYU, Dept Psychol, New York, NY 10003 USA	Tel Aviv University; New York University	Liberman, N (corresponding author), Tel Aviv Univ, Dept Psychol, POB 39040, IL-69978 Tel Aviv, Israel.	niralib@post.tau.ac.il; yaacov.trope@nyu.edu	Liberman, Nira/D-7994-2011	Liberman, Nira/0000-0002-7496-9434	Israeli Science Foundation [1346-2004]; Binational Science Foundation [2001-057]; National Institute of Mental Health; NIH [R01 MH059030]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059030] Funding Source: NIH RePORTER	Israeli Science Foundation(Israel Science Foundation); Binational Science Foundation(US-Israel Binational Science Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by an Israeli Science Foundation grant 1346-2004 to N.L., a Binational Science Foundation grant 2001-057 to N.L. and Y.T., and a National Institute of Mental Health, NIH, grant R01 MH059030 to Y.T.	Addis DR, 2008, HIPPOCAMPUS, V18, P227, DOI 10.1002/hipo.20405; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Bar-Anan Y, 2007, J EXP PSYCHOL GEN, V136, P610, DOI 10.1037/0096-3445.136.4.610; Bar-Anan Y, 2006, J EXP PSYCHOL GEN, V135, P609, DOI 10.1037/0096-3445.135.4.609; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; FIEDLER K, 1995, PERS SOC PSYCHOL B, V21, P525, DOI 10.1177/0146167295215010; Flinn MV, 2005, EVOL HUM BEHAV, V26, P10, DOI 10.1016/j.evolhumbehav.2004.08.005; Forster J, 2004, J PERS SOC PSYCHOL, V87, P177, DOI 10.1037/0022-3514.87.2.177; FRANK MG, 1989, J PERS SOC PSYCHOL, V57, P399, DOI 10.1037/0022-3514.57.3.399; Freitas AL, 2001, J PERS SOC PSYCHOL, V80, P410, DOI 10.1037//0022-3514.80.3.410; Fujita K, 2006, J PERS SOC PSYCHOL, V90, P351, DOI 10.1037/0022-3514.90.3.351; Fujita K, 2006, PSYCHOL SCI, V17, P278, DOI 10.1111/j.1467-9280.2006.01698.x; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gilbert DT, 1998, J PERS SOC PSYCHOL, V75, P617, DOI 10.1037/0022-3514.75.3.617; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Henderson MD, 2006, J PERS SOC PSYCHOL, V91, P845, DOI 10.1037/0022-3514.91.5.845; Henderson MD, 2006, J PERS SOC PSYCHOL, V91, P712, DOI 10.1037/0022-3514.91.4.712; Jones E. E., 1972, ATTRIBUTION PERCEIV; Kahneman D, 2006, SCIENCE, V312, P1908, DOI 10.1126/science.1129688; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Liberman N, 1998, J PERS SOC PSYCHOL, V75, P5, DOI 10.1037/0022-3514.75.1.5; Liberman N, 2002, J EXP SOC PSYCHOL, V38, P523, DOI 10.1016/S0022-1031(02)00535-8; Liberman N., 2007, SOCIAL PSYCHOL HDB B, P353; Liberman N, 2007, J EXP SOC PSYCHOL, V43, P143, DOI 10.1016/j.jesp.2005.12.009; LIEBERMAN MD, 2002, ADV EXPT SOCIAL PSYC, V34, P200; Linville PW, 1996, J PERS SOC PSYCHOL, V70, P421, DOI 10.1037/0022-3514.70.3.421; Liviatan I, 2008, J EXP SOC PSYCHOL, V44, P1256, DOI 10.1016/j.jesp.2008.04.007; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Nussbaum S, 2003, J PERS SOC PSYCHOL, V84, P485, DOI 10.1037/0022-3514.84.3.485; Nussbaum S, 2006, J EXP PSYCHOL GEN, V135, P152, DOI 10.1037/0096-3445.135.2.152; O'Donoghue T, 2000, J BEHAV DECIS MAKING, V13, P233, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<233::AID-BDM325>3.0.CO;2-U; PARK B, 1990, J PERS SOC PSYCHOL, V59, P173, DOI 10.1037/0022-3514.59.2.173; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; READ D, 2003, TIME DECISION; Sagristano MD, 2002, J EXP PSYCHOL GEN, V131, P364, DOI 10.1037//0096-3445.131.3.364; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; SCHELLING TC, 1984, AM ECON REV, V74, P1; Smith PK, 2006, J PERS SOC PSYCHOL, V90, P578, DOI 10.1037/0022-3514.90.4.578; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P335, DOI 10.1017/S0140525X0700221X; Todorov A, 2007, J EXP SOC PSYCHOL, V43, P473, DOI 10.1016/j.jesp.2006.04.002; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2000, J PERS SOC PSYCHOL, V79, P876, DOI 10.1037//0022-3514.79.6.876; Wakslak CJ, 2006, J EXP PSYCHOL GEN, V135, P641, DOI 10.1037/0096-3445.135.4.641; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2	50	622	649	10	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1201	1205		10.1126/science.1161958	http://dx.doi.org/10.1126/science.1161958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	374HC	19023074	Green Accepted			2022-12-28	WOS:000261033400029
J	Prager, LM				Prager, Laura M.			Raising Doctors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lmprager@partners.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2225	2226		10.1001/jama.2008.676	http://dx.doi.org/10.1001/jama.2008.676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017899				2022-12-28	WOS:000260965500001
J	Etangs, AL; Vidal-Madjar, A; Desert, JM				des Etangs, A. Lecavelier; Vidal-Madjar, A.; Desert, J. -M.			The origin of hydrogen around HD 209458b	NATURE			English	Letter							HD209458B; PLANET		[des Etangs, A. Lecavelier; Vidal-Madjar, A.; Desert, J. -M.] UPMC Univ Paris 6, CNRS, UMR 7095, Inst Astrophys, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Etangs, AL (corresponding author), UPMC Univ Paris 6, CNRS, UMR 7095, Inst Astrophys, 98 Bis Blvd Arago, F-75014 Paris, France.	lecaveli@iap.fr	Lecavelier des Etangs, Alain/GLU-6503-2022	Lecavelier des Etangs, Alain/0000-0002-5637-5253				Holmstrom M, 2008, NATURE, V451, P970, DOI 10.1038/nature06600; Vidal-Madjar A, 2008, ASTROPHYS J LETT, V676, pL57, DOI 10.1086/587036; Vidal-Madjar A, 2004, ASTR SOC P, V321, P152; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448	4	18	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					E1	E1		10.1038/nature07402	http://dx.doi.org/10.1038/nature07402			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005500	Green Submitted, Bronze			2022-12-28	WOS:000261039300028
J	Sekhri, N; Feder, GS; Junghans, C; Eldridge, S; Umaipalan, A; Madhu, R; Hemingway, H; Timmis, AD				Sekhri, Neha; Feder, Gene S.; Junghans, Cornelia; Eldridge, Sandra; Umaipalan, Athavan; Madhu, Rashmi; Hemingway, Harry; Timmis, Adam D.			Incremental prognostic value of the exercise electrocardiogram in the initial assessment of patients with suspected angina: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY-DISEASE; EURO HEART SURVEY; STABLE ANGINA; RISK SCORE; PREDICTING PROGNOSIS; TREADMILL SCORE; CHEST-PAIN; PECTORIS; TRIAL; VALIDATION	Objective To determine whether resting and exercise electrocardiograms (ECGs) provide prognostic value that is incremental to that obtained from the clinical history in ambulatory patients with suspected angina attending chest pain clinics. Design Multicentre cohort study. Setting Rapid access chest pain clinics of six hospitals in England. Participants 8176 consecutive patients with suspected angina and no previous diagnosis of coronary artery disease, all of whom had a resting ECG recorded. 4848 patients with a summary exercise ECG result recorded (positive, negative, equivocal for ischaemia) comprised the summary ECG subset of whom 1422 with more detailed exercise ECG data recorded comprised the detailed ECG subset. Main outcome measure Composite of death due to coronary heart disease or non- fatal acute coronary syndrome during median follow- up of 2.46 years. Results Receiver operating characteristics curves for the basic clinical assessment model alone and with the results of resting ECGs were superimposed with little difference in the C statistic. With the exercise ECGs the C statistic in the summary ECG subset increased from 0.70 (95% confidence interval 0.68 to 0.73) to 0.74 (0.71 to 0.76) and in the detailed ECG subset from 0.74 (0.70 to 0.79) to 0.78 (0.74 to 0.82). However, risk stratified cumulative probabilities of the primary end point at one year and six years for all three prognostic indices (clinical assessment only; clinical assessment plus resting ECG; clinical assessment plus resting ECG plus exercise ECG) showed only small differences at all time points and at all levels of risk. Conclusion In ambulatory patients with suspected angina, basic clinical assessment encompasses nearly all the prognostic value of resting ECGs and most of the prognostic value of exercise ECGs. The limited incremental value of these widely applied tests emphasises the need for more effective methods of risk stratification in this group of patients.	[Sekhri, Neha] Newham Univ Hosp, London, England; [Eldridge, Sandra; Umaipalan, Athavan; Madhu, Rashmi; Timmis, Adam D.] Barts & London Queen Marys Sch Med & Dent, London, England; [Junghans, Cornelia; Hemingway, Harry] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; [Feder, Gene S.] Univ Bristol, Unit Acad Primary Hlth Care, Bristol, Avon, England	University of London; Queen Mary University London; University of London; University College London; UCL Medical School; University of Bristol	Timmis, AD (corresponding author), London Chest Hosp, Barts & London NHS Trust, London E2 9JX, England.	adamtimmis@mac.com	Junghans, Cornelia/ABG-4494-2020; Hemingway, Harry/C-1219-2009	Junghans, Cornelia/0000-0002-0663-3090; Hemingway, Harry/0000-0003-2279-0624; Feder, Gene/0000-0002-7890-3926	National Health Service's Service Delivery and Organisation research and development programme	National Health Service's Service Delivery and Organisation research and development programme	The study was funded by the National Health Service's Service Delivery and Organisation research and development programme, to which interim progress reports were submitted. The funding body was not involved in the study design or analysis. Competing interests: None declared.	Balady GJ, 2004, CIRCULATION, V110, P1920, DOI 10.1161/01.CIR.0000143226.40607.71; Bogaty P, 1997, J AM COLL CARDIOL, V29, P1497, DOI 10.1016/S0735-1097(97)00091-0; BOGATY P, 1995, AM HEART J, V129, P666, DOI 10.1016/0002-8703(95)90313-5; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Clayton TC, 2005, BMJ-BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63; CONSTANT J, 1983, CLIN CARDIOL, V6, P11; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; Daly CA, 2005, EUR HEART J, V26, P996, DOI 10.1093/eurheartj/ehi171; DIAMOND GA, 1982, CIRCULATION, V65, P641, DOI 10.1161/01.CIR.65.3.641; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P474; *DOH, 2000, NAT SERV FRAM COR HE; Forslund L, 2000, EUR HEART J, V21, P901, DOI 10.1053/euhj.1999.1936; Fox KM, 2003, LANCET, V362, P782; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gulati M, 2005, AM J CARDIOL, V96, P369, DOI 10.1016/j.amjcard.2005.03.078; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; Hlatky MA, 1999, J GEN INTERN MED, V14, P63, DOI 10.1046/j.1525-1497.1999.00283.x; Jones RC, 2004, AM J MED, V117, P380, DOI 10.1016/j.amjmed.2004.06.004; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; Marwick TH, 1997, J AM COLL CARDIOL, V30, P83, DOI 10.1016/S0735-1097(97)00148-4; Newson R, 2006, STATA J, V6, P497, DOI 10.1177/1536867X0600600404; POLLOCK SG, 1992, CIRCULATION, V85, P237, DOI 10.1161/01.CIR.85.1.237; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Ray S, 1998, J ROY COLL PHYS LOND, V32, P420; Rywik TM, 2002, CIRCULATION, V106, P2787, DOI 10.1161/01.CIR.0000039329.47437.3B; Sekhri N, 2007, HEART, V93, P458, DOI 10.1136/hrt.2006.090894; Shaw LJ, 1999, J GEN INTERN MED, V14, P1, DOI 10.1046/j.1525-1497.1999.00273.x; TIMMIS A, 2007, EVALUATION RAPID ACC; Timmis AD, 2007, HEART, V93, P786, DOI 10.1136/hrt.2006.103119; 2005, ICD 10 MORTALITY	35	34	34	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2008	337								a2240	10.1136/bmj.a2240	http://dx.doi.org/10.1136/bmj.a2240			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008264	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000261784500004
J	Galy, V; Beyssac, O; France-Lanord, C; Eglinton, T				Galy, Valier; Beyssac, Olivier; France-Lanord, Christian; Eglinton, Timothy			Recycling of Graphite During Himalayan Erosion: A Geological Stabilization of Carbon in the Crust	SCIENCE			English	Article							PARTICULATE ORGANIC-CARBON; BLACK CARBON; BURIAL; RIVERINE; SEDIMENTS; BENGAL; CYCLE; FATE	At geological time scales, the role of continental erosion in the organic carbon (OC) cycle is determined by the balance between recent OC burial and petrogenic OC oxidation. Evaluating its net effect on the concentration of carbon dioxide and dioxygen in the atmosphere requires the fate of petrogenic OC to be assessed. Here, we report a multiscale ( nanometer to micrometer) structural characterization of petrogenic OC in the Himalayan system. We show that graphitic carbon is preserved and buried in marine sediments, while the less graphitized forms are oxidized during fluvial transport. Radiocarbon dating indicates that 30 to 50% of the carbon initially present in the Himalayan rocks is conserved during the erosion cycle. Graphitization during metamorphism thus stabilizes carbon in the crust over geological time scales.	[Galy, Valier; Eglinton, Timothy] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Galy, Valier; France-Lanord, Christian] Univ Nancy 1, Ctr Rech Petrog & Geochim, CNRS, INSU, F-54501 Vandoeuvre Les Nancy, France; [Beyssac, Olivier] Ecole Normale Super, CNRS, Geol Lab, UMR 8538, F-75005 Paris 5, France	Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Galy, V (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	vgaly@whoi.edu	Galy, valier/AAD-2248-2021; IMPMC, ROCKS @/U-8478-2017; France-Lanord, Christian/F-8848-2010; galy, valier/I-6185-2012; Beyssac, Olivier/F-6811-2012	Galy, valier/0000-0003-0385-8443; France-Lanord, Christian/0000-0002-4873-5546; galy, valier/0000-0003-0385-8443; Eglinton, Timothy/0000-0001-5060-2155	French INSU program "Reliefs de la Terre"; Woods Hole Oceanographic Institution	French INSU program "Reliefs de la Terre"; Woods Hole Oceanographic Institution	We thank H. Kudrass, who provided Bengal Fan samples collected during the RV Sonne cruise; M. Rahman from Dhaka University; A. Gajurel from Tribhuvan University ( Kathmandu) for their help during field work in Bangladesh and Nepal; and A. Galy for insightful comments, as well as J. Hayes and an anonymous referee for constructive reviews. This study was supported by the French INSU program "Reliefs de la Terre" and a scholarship from Woods Hole Oceanographic Institution to V. G.	Aucour AM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002324; BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382; Beyssac O, 2004, EARTH PLANET SC LETT, V225, P233, DOI 10.1016/j.epsl.2004.05.023; Blair NE, 2004, MAR CHEM, V92, P141, DOI 10.1016/j.marchem.2004.06.023; Blair NE, 2003, GEOCHIM COSMOCHIM AC, V67, P63, DOI 10.1016/S0016-7037(02)01043-8; Burdige DJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002368; Dickens AF, 2004, NATURE, V427, P336, DOI 10.1038/nature02299; FranceLanord C, 1997, NATURE, V390, P65, DOI 10.1038/36324; Galy A, 1999, CHEM GEOL, V159, P31, DOI 10.1016/S0009-2541(99)00033-9; Galy A, 2001, GEOLOGY, V29, P23, DOI 10.1130/0091-7613(2001)029<0023:HERITH>2.0.CO;2; Galy V, 2008, GEOCHIM COSMOCHIM AC, V72, P1767, DOI 10.1016/j.gca.2008.01.027; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; GARRELS RM, 1976, AM SCI, V64, P306; Gelinas Y, 2001, ENVIRON SCI TECHNOL, V35, P3519, DOI 10.1021/es010504c; Haberstroh PR, 2006, GEOCHIM COSMOCHIM AC, V70, P1483, DOI 10.1016/j.gca.2005.12.001; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Ittekkot V, 2003, DEEP-SEA RES PT II, V50, P853, DOI 10.1016/S0967-0645(02)00608-2; Lasaga A.C., 1985, AM GEOPHYS UNION GEO, V32, P397, DOI DOI 10.1029/GM032P0397; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; SACKETT WM, 1974, SCIENCE, V185, P1045, DOI 10.1126/science.185.4156.1045; Schlunz B, 2000, INT J EARTH SCI, V88, P599, DOI 10.1007/s005310050290	22	162	170	8	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					943	945		10.1126/science.1161408	http://dx.doi.org/10.1126/science.1161408			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988852				2022-12-28	WOS:000260674100047
J	Goodarzi, MO; Psaty, BM				Goodarzi, Mark O.; Psaty, Bruce M.			Glucose Lowering to Control Macrovascular Disease in Type 2 Diabetes Treating the Wrong Surrogate End Point?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; BLOOD-GLUCOSE; INSULIN; HYPERINSULINEMIA; EVENTS; TRIAL; RISK		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Inst Med Genet, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu	Goodarzi, Mark/AAH-7106-2021	Goodarzi, Mark/0000-0001-6364-5103	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, R01HL085251, R01HL080295, U01HL080295, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL085251, HL080295, HL74745, HL087652] Funding Source: Medline; NIDDK NIH HHS [DK079888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Dandona P, 2004, METAB SYNDR RELAT D, V2, P137, DOI 10.1089/met.2004.2.137; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goalstone ML, 1998, ENDOCRINOLOGY, V139, P4067, DOI 10.1210/en.139.10.4067; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; HOLMAN RR, 10 YEAR FOLLOW UP IN; Kronmal RA, 2004, J CLIN ENDOCR METAB, V89, P2852, DOI 10.1210/jc.2003-031822; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Port SC, 2006, AM J EPIDEMIOL, V163, P342, DOI 10.1093/aje/kwj027; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; Schwartz TB, 2004, PERSPECT BIOL MED, V47, P564, DOI 10.1353/pbm.2004.0071; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	15	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2051	2053		10.1001/jama.2008.510	http://dx.doi.org/10.1001/jama.2008.510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984894				2022-12-28	WOS:000260605400028
J	Zhang, SMM; Cook, NR; Albert, CM; Gaziano, JM; Buring, JE; Manson, JE				Zhang, Shumin M.; Cook, Nancy R.; Albert, Christine M.; Gaziano, J. Michael; Buring, Julie E.; Manson, Joann E.			Effect of Combined Folic Acid, Vitamin B-6, and Vitamin B-12 on Cancer Risk in Women A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR EVENTS; BREAST-CANCER; PLASMA FOLATE; DIETARY-FOLATE; B-VITAMINS; HOMOCYSTEINE; PREVENTION; SUPPLEMENTATION; DEFICIENCY	Context Folate, vitamin B-6, and vitamin B-12 are thought to play an important role in cancer prevention. Objective To evaluate the effect of combined folic acid, vitamin B-6, and vitamin B-12 treatment on cancer risk in women at high risk for cardiovascular disease. Design, Setting, and Participants In the Women's Antioxidant and Folic Acid Cardiovascular Study, 5442 US female health professionals aged 42 years or older, with preexisting cardiovascular disease or 3 or more coronary risk factors, were randomly assigned to receive either a daily combination of folic acid, vitamin B-6, and vitamin B-12 or a matching placebo. They were treated for 7.3 years from April 1998 through July 31, 2005. Intervention Daily supplementation of a combination of 2.5 mg of folic acid, 50 mg of vitamin B-6, and 1 mg of vitamin B-12 ( n= 2721) or placebo ( n= 2721). Main Outcome Measures Confirmed newly diagnosed total invasive cancer or breast cancer. Results A total of 379 women developed invasive cancer ( 187 in the active treatment group and 192 in the placebo group). Compared with placebo, women receiving the active treatment had similar risk of developing total invasive cancer ( 101.1/ 10 000 person- years for the active treatment group vs 104.3/ 10 000 person- years for placebo group; hazard ratio [ HR], 0.97; 95% confidence interval [ CI], 0.79- 1.18; P=. 75), breast cancer ( 37.8/ 10 000 person- years vs 45.6/ 10 000 person- years, respectively; HR, 0.83; 95% CI, 0.60- 1.14; P=. 24), or any cancer death ( 24.6/ 10 000 personyears vs 30.1/10 000 person- years, respectively; HR, 0.82; 95% CI, 0.56- 1.21; P=. 32). Conclusion Combined folic acid, vitamin B-6, and vitamin B-12 treatment had no significant effect on overall risk of total invasive cancer or breast cancer among women during the folic acid fortification era. Trial Registration clinicaltrials. gov Identifier: NCT00000541.	[Zhang, Shumin M.; Cook, Nancy R.; Albert, Christine M.; Gaziano, J. Michael; Buring, Julie E.; Manson, Joann E.] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA; [Gaziano, J. Michael; Buring, Julie E.] Brigham & Womens Hosp, Div Aging, Dept Med, Boston, MA 02215 USA; [Zhang, Shumin M.; Cook, Nancy R.; Albert, Christine M.; Gaziano, J. Michael; Buring, Julie E.; Manson, Joann E.] Harvard Univ, Sch Med, Boston, MA USA; [Cook, Nancy R.; Buring, Julie E.; Manson, Joann E.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School	Zhang, SMM (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	szhang@rics.bwh.harvard.edu		Albert, Christine/0000-0002-2081-1121	NHLBI NIH HHS [R01 HL046959, R01 HL046959-13, R01 HL046959-13S1, R01 HL046959-12, R01 HL046959-08, HL47959, R01 HL046959-10, R01 HL046959-07, R01 HL046959-11, R01 HL046959-09] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046959, R43HL047959] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; BAGGOTT JE, 1992, JNCI-J NATL CANCER I, V84, P1740, DOI 10.1093/jnci/84.22.1740; Bassuk SS, 2004, J WOMENS HEALTH, V13, P99, DOI 10.1089/154099904322836519; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Charles D, 2004, BMJ-BRIT MED J, V329, P1375, DOI 10.1136/bmj.329.7479.1375; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; *DIET REF INT THIA, 2000, RIB NIAC VIT B6 FOL; Giovannucci E, 2002, J NUTR, V132, p2350S, DOI 10.1093/jn/132.8.2350S; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Kotsopoulos J, 2005, CARCINOGENESIS, V26, P1603, DOI 10.1093/carcin/bgi117; Kotsopoulos J, 2003, CARCINOGENESIS, V24, P937, DOI 10.1093/carcin/bgg036; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Manson Joann E., 1995, Annals of Epidemiology, V5, P261, DOI 10.1016/1047-2797(94)00091-7; Mason J B, 1996, Oncology (Williston Park), V10, P1727; *NCI, 2003, PUBL US DAT 1973 200; PASPATIS GA, 1994, DIS COLON RECTUM, V37, P1340, DOI 10.1007/BF02257810; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Ulrich CM, 2007, AM J CLIN NUTR, V86, P271, DOI 10.1093/ajcn/86.2.271; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373	29	134	138	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2012	2021		10.1001/jama.2008.555	http://dx.doi.org/10.1001/jama.2008.555			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984888	Green Accepted, Bronze			2022-12-28	WOS:000260605400021
J	Kelleher, RJ; Bear, MF				Kelleher, Raymond J., III; Bear, Mark F.			The Autistic Neuron: Troubled Translation?	CELL			English	Article							LONG-TERM DEPRESSION; FRAGILE-X-SYNDROME; OCULAR DOMINANCE PLASTICITY; DENDRITIC PROTEIN-SYNTHESIS; MAMMALIAN-CELL SIZE; SYNAPTIC PLASTICITY; MOUSE MODEL; TUBEROUS-SCLEROSIS; MENTAL-RETARDATION; SPECTRUM DISORDERS	Autism is a complex genetic disorder, but single-gene disorders with a high prevalence of autism offer insight into its pathogenesis. Recent evidence suggests that some molecular defects in autism may interfere with the mechanisms of synaptic protein synthesis. We propose that aberrant synaptic protein synthesis may represent one possible pathway leading to autistic phenotypes, including cognitive impairment and savant abilities.	[Kelleher, Raymond J., III] Harvard Univ, Sch Med, Harvard Partners Ctr, Ctr Human Genet Res, Boston, MA 02115 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Program Neurosci,Autism Consortium, Boston, MA 02115 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Bear, Mark F.] Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Bear, Mark F.] MIT, Autism Consortium, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Northwell Health; Massachusetts Institute of Technology (MIT)	Kelleher, RJ (corresponding author), Harvard Univ, Sch Med, Harvard Partners Ctr, Ctr Human Genet Res, Boston, MA 02115 USA.	kelleher@helix.mgh.harvard.edu; mbear@mit.edu		Bear, Mark/0000-0002-9903-2541				Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dasgupta B, 2003, CURR OPIN GENET DEV, V13, P20, DOI 10.1016/S0959-437X(02)00015-1; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Hanson JE, 2007, J NEUROSCI, V27, P4014, DOI 10.1523/JNEUROSCI.4717-06.2007; Heaton P, 2004, J CHILD PSYCHOL PSYC, V45, P899, DOI 10.1111/j.1469-7610.2004.t01-1-00284.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kanner L, 1943, NERV CHILD, V2, P217; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Maffei L, 2002, NEURON, V34, P328, DOI 10.1016/S0896-6273(02)00688-8; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zho WM, 2002, J NEUROSCI, V22, P8838; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	60	419	433	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					401	406		10.1016/j.cell.2008.10.017	http://dx.doi.org/10.1016/j.cell.2008.10.017			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984149	Bronze			2022-12-28	WOS:000260536300008
J	Petrovic, M; Hummel, T				Petrovic, Milan; Hummel, Thomas			Temporal identity in axonal target layer recognition	NATURE			English	Article							ZINC-FINGER PROTEIN; LAMINA-SPECIFIC CONNECTIVITY; N-CADHERIN; TRANSCRIPTION FACTORS; GENE-FUNCTION; DROSOPHILA; RECEPTOR; EXPRESSION; SYSTEM; REGULATOR	The segregation of axon and dendrite projections into distinct synaptic layers is a fundamental principle of nervous system organization and the structural basis for information processing in the brain(1). Layer- specific recognition molecules that allow projecting neurons to stabilize transient contacts and initiate synaptogenesis(2,3) have been identified. However, most of the neuronal cell- surface molecules critical for layer organization are expressed broadly in the developing nervous system(4,5), raising the question of how these so- called permissive adhesion molecules support synaptic specificity. Here we show that the temporal expression dynamics of the zinc- finger protein sequoia is the major determinant of Drosophila photoreceptor connectivity into distinct synaptic layers. Neighbouring R8 and R7 photoreceptors show consecutive peaks of elevated sequoia expression, which correspond to their sequential target- layer innervation. Loss of sequoia in R7 leads to a projection switch into the R8 recipient layer, whereas a prolonged expression in R8 induces a redirection of their axons into the R7 layer. The sequoia- induced axon targeting is mediated through the ubiquitously expressed Cadherin- N cell adhesion molecule. Our data support a model in which recognition specificity during synaptic layer formation is generated through a temporally restricted axonal competence to respond to broadly expressed adhesion molecules. Because developing neurons innervating the same target area often project in a distinct, birth- order- dependent sequence, temporal identity seems to contain crucial information in generating not only cell type diversity during neuronal division(6) but also connection diversity of projecting neurons.	[Petrovic, Milan; Hummel, Thomas] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Hummel, T (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	hummel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SFB629]; EMBO Young Investigator Programme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO))	We thank H. Bellen, J. Brenman, I. Salecker and R. Schuh for fly stocks and antibodies; D. Hawellek for the identification and analysis of seq<SUP>6</SUP>; and H. Aberle, S. Bogdan, C. Klambt, A. Puschel and members of the Hummel laboratory for critical comments on the manuscript. T. H. is supported by the Deutsche Forschungsgemeinschaft (SFB629) and the EMBO Young Investigator Programme.	BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; DESAI CJ, 1994, J NEUROSCI, V14, P7272; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Gil OD, 2002, J COMP NEUROL, V453, P372, DOI 10.1002/cne.10424; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MCGUIRE SE, 2004, SCI STKE, pPL6; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Sun Q, 2000, DEVELOPMENT, V127, P801; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	42	60	60	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					800	U87		10.1038/nature07407	http://dx.doi.org/10.1038/nature07407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18978776				2022-12-28	WOS:000261559900051
J	Cullen, M; Thatcher, N				Cullen, Michael; Thatcher, Nicholas			Gefitinib or docetaxel in advanced non-small-cell lung cancer	LANCET			English	Editorial Material							SUPPORTIVE CARE; CHEMOTHERAPY; ERLOTINIB; EGFR		[Cullen, Michael] Univ Hosp Birmingham, Ctr Canc, Birmingham B15 2TH, W Midlands, England; [Thatcher, Nicholas] Christie Hosp & Holt Radium Inst, Dept Med Oncol, Manchester M20 9BX, Lancs, England	University of Birmingham; Christie NHS Foundation Trust; Christie Hospital	Cullen, M (corresponding author), Univ Hosp Birmingham, Ctr Canc, Birmingham B15 2TH, W Midlands, England.	michael.cullen@uhb.nhs.uk						Crino L, 2008, J CLIN ONCOL, V26, P4253, DOI 10.1200/JCO.2007.15.0672; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Shepherd FA, 2008, J CLIN ONCOL, V26, P2426, DOI 10.1200/JCO.2007.15.4286; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	9	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1785	1786		10.1016/S0140-6736(08)61741-9	http://dx.doi.org/10.1016/S0140-6736(08)61741-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027472				2022-12-28	WOS:000261112000004
J	Menzies, D; Long, R; Trajman, A; Dion, MJ; Yang, J; Al Jahdali, H; Memish, Z; Khan, K; Gardam, M; Hoeppner, V; Benedetti, A; Schwartzman, K				Menzies, Dick; Long, Richard; Trajman, Anete; Dion, Marie-Josee; Yang, Jae; Al Jahdali, Hamdan; Memish, Ziad; Khan, Kamran; Gardam, Michael; Hoeppner, Vernon; Benedetti, Andrea; Schwartzman, Kevin			Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection	ANNALS OF INTERNAL MEDICINE			English	Article							PREVENTIVE THERAPY; TREATMENT COMPLETION; RANDOMIZED-TRIAL; LOW-RISK; PYRAZINAMIDE; HEPATITIS; ADHERENCE	Background: Treatment of latent tuberculosis infection with isoniazid for 9 months is complicated by poor patient adherence and the need for close follow-up of side effects, especially hepatotoxicity. Shorter and safer regimens are needed. Objective: To compare the frequency of adverse events and treatment completion in 2 treatment regimens for latent tuberculosis infection. Design: Multicenter, randomized, open-label trial. Setting: Tuberculosis clinics located in university hospitals in Canada, Brazil, and Saudi Arabia. Patients: 847 patients without a contraindication for rifampin and requiring treatment for latent tuberculosis infection. Intervention: Four months of daily rifampin therapy or 9 months of daily isoniazid therapy. Measurements: Grade 3 to 4 drug-related adverse events resulting in drug discontinuation (primary outcome), and on-time treatment completion, grade 1 to 2 drug-related adverse events, and changes in liver enzymes and hematologic variables (secondary outcomes). Results: Seventeen of 422 participants who started isoniazid therapy developed grade 3 to 4 adverse events compared with 7 of 418 who started rifampin therapy (risk difference [rifampin minus isoniazid], -2.3% [95% CI, -5% to -0.1%]; P = 0.040). Grade 3 or 4 hepatitis occurred in 16 of 422 isoniazid recipients compared with 3 of 418 rifampin recipients (risk difference, -3.1% [CI, -5% to -1%]; P = 0.003). Grade 1 or 2 adverse events attributed to study drugs occurred with similar frequency. Asymptomatic reduction in platelet and leukocyte counts were more frequent in rifampin recipients. More patients completed rifampin treatment (78%) than isoniazid treatment (60%) (difference, 18% [CI, 12% to 24%]; P < 0.001]). Limitation: The study did not measure efficacy, and the open-label design may increase the chance of bias in ascertainment of adverse events. Conclusion: Treatment of latent tuberculosis with 4 months of rifampin leads to fewer serious adverse events and better adherence than 9 months of isoniazid. These findings justify a large-scale trial to compare the efficacy of rifampin with that of isoniazid.	[Menzies, Dick] McGill Univ, Montreal Chest Inst, Montreal, PQ H2X 2P4, Canada; Univ Alberta, Edmonton, AB, Canada; Univ Toronto, Toronto, ON, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Univ Saskatchewan, Saskatoon, SK, Canada; Univ Gama Filho, Rio De Janeiro, Brazil; King Abdulaziz Bin Saud Univ, King Abdulaziz Med City, Riyadh, Saudi Arabia	McGill University; University of Alberta; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Saskatchewan; Universidade Gama Filho; King Abdulaziz University	Menzies, D (corresponding author), McGill Univ, Montreal Chest Inst, 3650 St Urbain,Room K1-24, Montreal, PQ H2X 2P4, Canada.	dick.menzies@mcgill.ca	Trajman, Anete/C-7679-2016; Memish, Ziad Ahmed/AEJ-9424-2022	Trajman, Anete/0000-0002-4000-4984; Memish, Ziad Ahmed/0000-0002-5099-0714	FOGARTY INTERNATIONAL CENTER [U2RTW006883] Funding Source: NIH RePORTER; FIC NIH HHS [5U2R TW006883-03] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 1975, LANCET, V2, P1105; *ATS HEP ANT THER, 2006, AM J RESP CRIT CARE, V174, P935; *CAN LUNG ASS PUBL, 2007, CAN TUB STAND; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; DASH LA, 1980, AM REV RESPIR DIS, V121, P1039; DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; FEREBEE SH, 1970, ADV TUBERC RES, V17, P28; Gao XF, 2006, INT J TUBERC LUNG D, V10, P1080; GARIBALDI RA, 1972, AM REV RESPIR DIS, V106, P357, DOI 10.1164/arrd.1972.106.3.357; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; HOLDINESS MR, 1987, TUBERCLE, V68, P301, DOI 10.1016/0041-3879(87)90072-9; Jasmer RM, 2003, AM J RESP CRIT CARE, V167, P809, DOI 10.1164/rccm.2301002; JORDAN TJ, 1991, JAMA-J AM MED ASSOC, V265, P2987, DOI 10.1001/jama.265.22.2987; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Kunimoto D, 2003, CLIN INFECT DIS, V36, pE158, DOI 10.1086/375072; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; Long R., 2007, CANADIAN TUBERCULOSI, V6th; MASON BJ, 1995, DIABETES EDUCATOR, V21, P52, DOI 10.1177/014572179502100109; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; National Cancer Institute (NCI), COMM TERM CRIT ADV E; NOLAN CM, 1986, AM REV RESPIR DIS, V133, P431; Ormerod LP, 1998, ARCH DIS CHILD, V78, P169, DOI 10.1136/adc.78.2.169; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Pocock SJ, 2003, FUND CLIN PHARMACOL, V17, P483, DOI 10.1046/j.1472-8206.2003.00162.x; Polesky A, 1996, AM J RESP CRIT CARE, V154, P1473, DOI 10.1164/ajrccm.154.5.8912767; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; Schwed A, 1999, J CLIN PHARMACOL, V39, P402, DOI 10.1177/00912709922007976; *SHORT COURS RIF P, 2002, ANN INTERN MED, V137, P640; SNIDER DE, 1992, AM REV RESPIR DIS, V145, P494, DOI 10.1164/ajrccm/145.2_Pt_1.494; STEELE MA, 1991, CHEST, V99, P465, DOI 10.1378/chest.99.2.465; Villarino ME, 1997, AM J RESP CRIT CARE, V155, P1735, DOI 10.1164/ajrccm.155.5.9154885; 2001, MMWR MORB MORTAL WKL, V50, P289; 1971, AM REV RESP DIS, V104, P460	41	165	172	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2008	149	10					689	U4		10.7326/0003-4819-149-10-200811180-00003	http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373FL	19017587				2022-12-28	WOS:000260956300001
J	Doyle, JP; Dougherty, JD; Heiman, M; Schmidt, EF; Stevens, TR; Ma, G; Bupp, S; Shrestha, P; Shah, RD; Doughty, ML; Gong, S; Greengard, P; Heintz, N				Doyle, Joseph P.; Dougherty, Joseph D.; Heiman, Myriam; Schmidt, Eric F.; Stevens, Tanya R.; Ma, Guojun; Bupp, Sujata; Shrestha, Prerana; Shah, Rajiv D.; Doughty, Martin L.; Gong, Shiaoching; Greengard, Paul; Heintz, Nathaniel			Application of a Translational Profiling Approach for the Comparative Analysis of CNS Cell Types	CELL			English	Article							BACTERIAL ARTIFICIAL CHROMOSOMES; GENE-EXPRESSION; NERVOUS-SYSTEM; MOUSE-BRAIN; DIFFERENTIAL EXPRESSION; RECEPTOR SUBUNIT; SPINAL-CORD; TRANSCRIPTION; NETWORKS; FAMILY	Comparative analysis can provide important insights into complex biological systems. As demonstrated in the accompanying paper, translating ribosome affinity purification (TRAP) permits comprehensive studies of translated mRNAs in genetically defined cell populations after physiological perturbations. To establish the generality of this approach, we present translational profiles for 24 CNS cell populations and identify known cell-specific and enriched transcripts for each population. We report thousands of cell-specific mRNAs that were not detected in whole-tissue microarray studies and provide examples that demonstrate the benefits deriving from comparative analysis. To provide a foundation for further biological and in silico studies, we provide a resource of 16 transgenic mouse lines, their corresponding anatomic characterization, and translational profiles for cell types from a variety of central nervous system structures. This resource will enable a wide spectrum of molecular and mechanistic studies of both well-known and previously uncharacterized neural cell populations.	[Doyle, Joseph P.; Dougherty, Joseph D.; Schmidt, Eric F.; Stevens, Tanya R.; Ma, Guojun; Bupp, Sujata; Shrestha, Prerana; Shah, Rajiv D.; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Heiman, Myriam; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Doughty, Martin L.; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Schmidt, Eric F./AAE-8723-2019	Schmidt, Eric F./0000-0002-7869-0270; Dougherty, Joseph/0000-0002-6385-3997; Greengard, Paul/0000-0002-4437-0893	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [P01 AG009464-16A1, P01 AG009464-17, P01 AG009464, AG09464] Funding Source: Medline; NIDA NIH HHS [F32 DA021487, P01 DA010044-11, P01 DA010044-10, F32 DA021487-01, 5F32DA021487, P01 DA010044, F32 DA021487-02, DA10044, P01 DA010044-09] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-010005, P50 MH074866-020005, P50 MH074866-017204, P50 MH074866-030005, P50 MH074866-010002, P50 MH074866-040005, P50 MH074866-02, P50 MH074866-019001, P50 MH074866, P50 MH074866-030002, P50 MH074866-029001, P50 MH074866-019002, P50 MH074866-020002, P50 MH074866-049001, P50 MH074866-03, P50 MH074866-040002, P50 MH074866-039002, P50 MH074866-010001, P50 MH074866-020001, MH074866, P50 MH074866-039001, P50 MH074866-04, P50 MH074866-049002, P50 MH074866-030001, P50 MH074866-029002, P50 MH074866-040001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021487, P01DA010044] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Berthele A, 1999, DEV BRAIN RES, V112, P39, DOI 10.1016/S0165-3806(98)00156-4; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; DENOLORENTE R, 1934, PHYSL NERVOUS SYSTEM, P291; Fuhrman S, 2000, BIOSYSTEMS, V55, P5, DOI 10.1016/S0303-2647(99)00077-5; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Kaelin-Lang A, 1999, NEUROSCI LETT, V261, P189, DOI 10.1016/S0304-3940(99)00022-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Malgaretti N, 1997, J BIOL CHEM, V272, P17632, DOI 10.1074/jbc.272.28.17632; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Nishiyori A, 2004, J COMP NEUROL, V469, P214, DOI 10.1002/cne.11015; Nunzi MG, 2002, J COMP NEUROL, V451, P189, DOI 10.1002/cne.10344; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ramon y Cajal S., 1899, TEXTURE NERVOUS SYST; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Schneider T. D., 2007, INFORM THEORY PRIMER; SHANNON CE, 1969, MATH THEORY COMMUNIC; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Wang SS, 1997, J NEUROSCI, V17, P4149; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Ziambaras K, 1997, WESTERN J MED, V167, P435; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	33	612	618	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					749	762		10.1016/j.cell.2008.10.029	http://dx.doi.org/10.1016/j.cell.2008.10.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013282	Green Accepted, Bronze			2022-12-28	WOS:000260886900024
J	Liu, SX; Abbondanzieri, EA; Rausch, JW; Le Grice, SFJ; Zhuang, XW				Liu, Shixin; Abbondanzieri, Elio A.; Rausch, Jason W.; Le Grice, Stuart F. J.; Zhuang, Xiaowei			Slide into Action: Dynamic Shuttling of HIV Reverse Transcriptase on Nucleic Acid Substrates	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRAND DISPLACEMENT SYNTHESIS; DEPENDENT DNA-POLYMERASE; RNASE-H; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SINGLE MOLECULES; ENERGY-TRANSFER	The reverse transcriptase ( RT) of human immunodeficiency virus ( HIV) catalyzes a series of reactions to convert single- stranded viral RNA into double- stranded DNA for host cell integration. This process requires a variety of enzymatic activities, including DNA polymerization, RNA cleavage, strand transfer, and strand displacement synthesis. We used single- molecule fluorescence resonance energy transfer to probe the interactions between RT and nucleic acid substrates in real time. RT was observed to slide on nucleic acid duplexes, rapidly shuttling between opposite termini of the duplex. Upon reaching the DNA 3' terminus, RT can spontaneously flip into a polymerization orientation. Sliding kinetics were regulated by cognate nucleotides and anti- HIV drugs, which stabilized and destabilized the polymerization mode, respectively. These long- range translocation activities facilitate multiple stages of the reverse transcription pathway, including normal DNA polymerization and strand displacement synthesis.	[Liu, Shixin; Abbondanzieri, Elio A.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Rausch, Jason W.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Liu, Shixin/A-4560-2012		NIH [GM 068518]; Intramural Research Program of the Center for Cancer Research; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by NIH (GM 068518 to X. Z.) and the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (to S.F.J.L.G.). X.Z. is a Howard Hughes Medical Institute investigator. E.A.A. is a Jane Coffin Childs postdoctoral fellow. Nevirapine was provided through the AIDS Research and Reference Reagent Program of NIH.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; Fuentes GM, 1996, NUCLEIC ACIDS RES, V24, P1719, DOI 10.1093/nar/24.9.1719; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HOSTOMSKY Z, 1992, J VIROL, V66, P3179, DOI 10.1128/JVI.66.5.3179-3182.1992; HOTTIGER M, 1994, J BIOL CHEM, V269, P986; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1989, J BIOL CHEM, V264, P4669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kelleher CD, 1998, J BIOL CHEM, V273, P9976, DOI 10.1074/jbc.273.16.9976; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lanciault C, 2004, J BIOL CHEM, V279, P32252, DOI 10.1074/jbc.M404117200; LEIS JP, 1973, P NATL ACAD SCI USA, V70, P466, DOI 10.1073/pnas.70.2.466; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; OMER CA, 1984, J VIROL, V50, P465, DOI 10.1128/JVI.50.2.465-470.1984; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SMITH JK, 1984, J VIROL, V49, P200, DOI 10.1128/JVI.49.1.200-204.1984; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Telesnitsky A., 1997, P121; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WHITING SH, 1994, J VIROL, V68, P4747, DOI 10.1128/JVI.68.8.4747-4758.1994; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P18682; Winshell J, 2004, J BIOL CHEM, V279, P52924, DOI 10.1074/jbc.M409134200; Wisniewski M, 2000, J BIOL CHEM, V275, P37664, DOI 10.1074/jbc.M007381200	44	128	130	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1092	1097		10.1126/science.1163108	http://dx.doi.org/10.1126/science.1163108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008444	Green Accepted			2022-12-28	WOS:000260867700035
J	Xu, CQ; Gagnon, E; Call, ME; Schnell, JR; Schwieters, CD; Carman, CV; Chou, JJ; Wucherpfennig, KW				Xu, Chenqi; Gagnon, Etienne; Call, Matthew E.; Schnell, Jason R.; Schwieters, Charles D.; Carman, Christopher V.; Chou, James J.; Wucherpfennig, Kai W.			Regulation of T Cell Receptor Activation by Dynamic Membrane Binding of the CD3 epsilon Cytoplasmic Tyrosine-Based Motif	CELL			English	Article							EFFECTOR DOMAIN; PROTEIN; PHOSPHORYLATION; BICELLES; BILAYER; COMPLEX; ZAP-70; ZETA	Many immune system receptors signal through cytoplasmic tyrosine-based motifs (ITAMs), but how receptor ligation results in ITAM phosphorylation remains unknown. Live-cell imaging studies showed a close interaction of the CD3 epsilon cytoplasmic domain of the T cell receptor (TCR) with the plasma membrane through fluorescence resonance energy transfer between a C-terminal fluorescent protein and a membrane fluorophore. Electrostatic interactions between basic CD3 epsilon residues and acidic phospholipids enriched in the inner leaflet of the plasma membrane were required for binding. The nuclear magnetic resonance structure of the lipid-bound state of this cytoplasmic domain revealed deep insertion of the two key tyrosines into the hydrophobic core of the lipid bilayer. Receptor ligation thus needs to result in unbinding of the CD3 epsilon ITAM from the membrane to render these tyrosines accessible to Src kinases. Sequestration of key tyrosines into the lipid bilayer represents a previously unrecognized mechanism for control of receptor activation.	[Call, Matthew E.; Schnell, Jason R.; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Xu, Chenqi; Gagnon, Etienne; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Carman, Christopher V.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Schwieters, Charles D.] Natl Inst Hlth, Imaging Sci Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	james_chou@hms.harvard.edu; kai_wucherpfennig@dfci.harvard.edu	Carman, Christopher/L-8108-2016; Chou, James J/N-9840-2013; Chou, James/AAD-6230-2022; Carman, Christopher V./AAX-8995-2020	Carman, Christopher/0000-0001-7358-2548; Chou, James J/0000-0002-4442-0344; Chou, James/0000-0002-4442-0344; Carman, Christopher V./0000-0001-7358-2548; Call, Matthew/0000-0001-5846-6469; Xu, Chenqi/0000-0002-4968-6782	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [R01 AI054520, R01 AI054520-05, AI054520] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054520] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Prosser RS, 2006, BIOCHEMISTRY-US, V45, P8453, DOI 10.1021/bi060615u; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Ross SR, 2006, J VIROL, V80, P9000, DOI 10.1128/JVI.00788-06; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	33	313	323	5	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					702	713		10.1016/j.cell.2008.09.044	http://dx.doi.org/10.1016/j.cell.2008.09.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013279	Bronze, Green Accepted			2022-12-28	WOS:000260886900020
J	O'Connell, RL; Riaz, AA; Morgan, B; Smock, E; Hubbard, JG				O'Connell, Rachel L.; Riaz, Amjid A.; Morgan, Barry; Smock, Elliott; Hubbard, Johnathan G.			Not only coughs and sneezes	LANCET			English	Editorial Material							AMEBIC-COLITIS; PERFORATION; BOWEL		[O'Connell, Rachel L.; Riaz, Amjid A.; Smock, Elliott; Hubbard, Johnathan G.] St Thomas Hosp, Dept Gen Surg, London SE1 7EH, England; [Morgan, Barry] St Thomas Hosp, Dept Histopathol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Hubbard, JG (corresponding author), St Thomas Hosp, Dept Gen Surg, 1st Floor North Wing,Westminster Bridge Rd, London SE1 7EH, England.	johnathan.hubbard@gstt.nhs.uk	O'Connell, R./AAP-2467-2020					Abbas MA, 2000, DIGEST DIS SCI, V45, P1836, DOI 10.1023/A:1005561607130; EGGLESTON FC, 1978, BRIT J SURG, V65, P748, DOI 10.1002/bjs.1800651021; Huston CD, 1999, EXPERT REV MOL MED, V1, P1; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; TUCKER PC, 1975, ARCH INTERN MED, V135, P681, DOI 10.1001/archinte.135.5.681	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1706	1706		10.1016/S0140-6736(08)61696-7	http://dx.doi.org/10.1016/S0140-6736(08)61696-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18994670				2022-12-28	WOS:000260899900035
J	Kausrud, KL; Mysterud, A; Steen, H; Vik, JO; Ostbye, E; Cazelles, B; Framstad, E; Eikeset, AM; Mysterud, I; Solhoy, T; Stenseth, NC				Kausrud, Kyrre L.; Mysterud, Atle; Steen, Harald; Vik, Jon Olav; Ostbye, Eivind; Cazelles, Bernard; Framstad, Erik; Eikeset, Anne Maria; Mysterud, Ivar; Solhoy, Torstein; Stenseth, Nils Chr.			Linking climate change to lemming cycles	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; POPULATION-CYCLES; LONG-TERM; NORWEGIAN LEMMINGS; PHASE-DEPENDENCE; VOLES; DYNAMICS; DENSITY; TIME; NORWAY	The population cycles of rodents at northern latitudes have puzzled people for centuries(1,2), and their impact is manifest throughout the alpine ecosystem(2,3). Climate change is known to be able to drive animal population dynamics between stable and cyclic phases(4,5), and has been suggested to cause the recent changes in cyclic dynamics of rodents and their predators(3,6-9). But although predator - rodent interactions are commonly argued to be the cause of the Fennoscandian rodent cycles(1,10-13), the role of the environment in the modulation of such dynamics is often poorly understood in natural systems(8,9,14). Hence, quantitative links between climate-driven processes and rodent dynamics have so far been lacking. Here we show that winter weather and snow conditions, together with density dependence in the net population growth rate, account for the observed population dynamics of the rodent community dominated by lemmings ( Lemmus lemmus) in an alpine Norwegian core habitat between 1970 and 1997, and predict the observed absence of rodent peak years after 1994. These local rodent dynamics are coherent with alpine bird dynamics both locally and over all of southern Norway, consistent with the influence of large- scale fluctuations in winter conditions. The relationship between commonly available meteorological data and snow conditions indicates that changes in temperature and humidity, and thus conditions in the subnivean space, seem to markedly affect the dynamics of alpine rodents and their linked groups. The pattern of less regular rodent peaks, and corresponding changes in the overall dynamics of the alpine ecosystem, thus seems likely to prevail over a growing area under projected climate change.	[Kausrud, Kyrre L.; Mysterud, Atle; Vik, Jon Olav; Eikeset, Anne Maria; Stenseth, Nils Chr.] Univ Oslo, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Steen, Harald; Ostbye, Eivind; Mysterud, Ivar] Univ Oslo, Dept Biol, N-0316 Oslo, Norway; [Cazelles, Bernard] Ecole Normale Super, CNRS, UMR 7625, F-75230 Paris, France; [Cazelles, Bernard] IRD GEODES, F-93142 Bondy, France; [Framstad, Erik] Norwegian Inst Nat Res, N-0349 Oslo, Norway; [Solhoy, Torstein] Univ Bergen, Dept Biol, N-5007 Bergen, Norway	University of Oslo; University of Oslo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Norwegian Institute Nature Research; University of Bergen	Stenseth, NC (corresponding author), Univ Oslo, Ctr Ecol & Evolutionary Synth, POB 1066 Blindern, N-0316 Oslo, Norway.	n.c.stenseth@bio.uio.no	Mysterud, Atle/AAQ-2864-2020; Vik, Jon Olav/B-9350-2008; Cazelles, Bernard/B-1572-2013; Stenseth, Nils Chr./G-5212-2016	Mysterud, Atle/0000-0001-8993-7382; Vik, Jon Olav/0000-0002-7778-4515; Cazelles, Bernard/0000-0002-7972-361X; Stenseth, Nils Chr./0000-0002-1591-5399; Kausrud, Kyrre/0000-0002-2738-7351	Norwegian Institute for Nature Research; University of Oslo; Nansen Fund; Research Council of Norway; Centre for Ecological and Evolutionary Synthesis, Oslo.	Norwegian Institute for Nature Research(Bioforsk); University of Oslo; Nansen Fund; Research Council of Norway(Research Council of Norway); Centre for Ecological and Evolutionary Synthesis, Oslo.	E. Leslie, D. Svalastog and a number of other field workers helped gather the data used in this paper, T. Rouyer provided advice on performing wavelet analyses in R, and R.A. Ims provided valuable input on an earlier version of the paper. Funding has been provided by the Norwegian Institute for Nature Research, the University of Oslo, the Nansen Fund, the Research Council of Norway and the Centre for Ecological and Evolutionary Synthesis, Oslo.	Aars J, 2002, ECOLOGY, V83, P3449, DOI 10.2307/3072093; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Dennis B, 2003, OIKOS, V102, P329, DOI 10.1034/j.1600-0706.2003.12387.x; Framstad E, 1997, P ROY SOC B-BIOL SCI, V264, P31, DOI 10.1098/rspb.1997.0005; Geritz SAH, 2004, J THEOR BIOL, V228, P261, DOI 10.1016/j.jtbi.2004.01.003; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Hanssen-Bauer I, 2003, CLIMATE RES, V25, P15, DOI 10.3354/cr025015; HENTTONEN H, 1987, OIKOS, V50, P353, DOI 10.2307/3565496; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Hornfeldt B, 2005, P ROY SOC B-BIOL SCI, V272, P2045, DOI 10.1098/rspb.2005.3141; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Klemola T, 2003, ADV ECOL RES, V33, P75, DOI 10.1016/S0065-2504(03)33010-7; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; LINDSTROM ER, 1994, OIKOS, V70, P156, DOI 10.2307/3545711; MACLEAN S F JR, 1974, Arctic and Alpine Research, V6, P1, DOI 10.2307/1550365; Marchand PJ., 1996, LIFE COLD INTRO WINT; MERRITT JF, 1978, J MAMMAL, V59, P576, DOI 10.2307/1380235; Niklasson B, 2006, OECOLOGIA, V150, P1, DOI 10.1007/s00442-006-0493-1; Nordli O, 2007, ANN GLACIOL-SER, V46, P404, DOI 10.3189/172756407782871657; OKSANEN L, 1992, ECOGRAPHY, V15, P226, DOI 10.1111/j.1600-0587.1992.tb00029.x; Ostbye E., 1975, ECOLOGICAL B, P225, DOI DOI 10.1657/1523-0430(07-001)[VISTNES]2.0.CO;2; Ostbye Eivind, 2007, Ornis Norvegica, V30, P4; Ostbye Eivind, 2002, Ornis Norvegica, V25, P19; Rouyer T, 2008, MAR ECOL PROG SER, V359, P11, DOI 10.3354/meps07330; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Steen H, 1997, J ZOOL, V243, P831, DOI 10.1111/j.1469-7998.1997.tb01980.x; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; Stenseth NC, 1998, P ROY SOC B-BIOL SCI, V265, P1957, DOI 10.1098/rspb.1998.0526; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; STENSETH NC, 1995, TRENDS ECOL EVOL, V10, P512, DOI 10.1016/S0169-5347(00)89218-6; Strann KB, 2002, ECOGRAPHY, V25, P81, DOI 10.1034/j.1600-0587.2002.250109.x; Turchin P, 2001, ECOL LETT, V4, P267, DOI 10.1046/j.1461-0248.2001.00204.x	41	311	337	0	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					93	U3		10.1038/nature07442	http://dx.doi.org/10.1038/nature07442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987742				2022-12-28	WOS:000260674000047
J	Aoi, S; Kunugi, T; Fujiwara, H				Aoi, Shin; Kunugi, Takashi; Fujiwara, Hiroyuki			Trampoline Effect in Extreme Ground Motion	SCIENCE			English	Article							EARTHQUAKE; JAPAN	In earthquake hazard assessment studies, the focus is usually on horizontal ground motion. However, records from the 14 June 2008 Iwate- Miyagi earthquake in Japan, a crustal event with a moment magnitude of 6.9, revealed an unprecedented vertical surface acceleration of nearly four times gravity, more than twice its horizontal counterpart. The vertical acceleration was distinctly asymmetric; the waveform envelope was about 1.6 times as large in the upward direction as in the downward direction, which is not explained by existing models of the soil response. We present a simple model of a mass bouncing on a trampoline to account for this asymmetry and the large vertical amplitude. The finding of a hitherto- unknown mode of strong ground motion may prompt major progress in near- source shaking assessments.	[Aoi, Shin; Kunugi, Takashi; Fujiwara, Hiroyuki] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan	National Research Institute for Earth Science & Disaster Resilience	Aoi, S (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	aoi@bosai.go.jp						Aoi S., 2004, J JAPAN ASS EARTHQUA, V4, P65; AOI S, 2000, EOS T AGU, V81; Aoi S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005452; Bonilla LF, 2005, B SEISMOL SOC AM, V95, P2373, DOI 10.1785/0120040128; Bonilla LF, 2002, B SEISMOL SOC AM, V92, P3165, DOI 10.1785/0120010235; Field EH, 1997, NATURE, V390, P599, DOI 10.1038/37586; Frankel AD, 1999, SCIENCE, V283, P2032, DOI 10.1126/science.283.5410.2032; IDRISS IM, 1968, B SEISMOL SOC AM, V58, P2013; Kanamori H, 1997, NATURE, V390, P461, DOI 10.1038/37280; Kinoshita S, 1998, SEISMOL RES LETT, V69, P309, DOI DOI 10.1785/GSSRL.69.4.309; Koketsu K, 2000, SCIENCE, V288, P1237, DOI 10.1126/science.288.5469.1237; Oglesby DD, 1998, SCIENCE, V280, P1055, DOI 10.1126/science.280.5366.1055; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV, DOI 10.1186/BF03353076; Wald DJ., 1999, EARTHQ SPECTRA, V15, P537, DOI [10.1193/1.1586057, DOI 10.1193/1.1586057]	14	88	91	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					727	730		10.1126/science.1163113	http://dx.doi.org/10.1126/science.1163113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974349				2022-12-28	WOS:000260605200044
J	Hawkes, N				Hawkes, Nigel			Continuing medical education What price education?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 31	2008	337								a2333	10.1136/bmj.a2333	http://dx.doi.org/10.1136/bmj.a2333			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375RA	18977794				2022-12-28	WOS:000261129800005
J	Walker, SC; Engelke, DR				Walker, Scott C.; Engelke, David R.			A Protein-Only Rnase P in Human Mitochondria	CELL			English	Editorial Material								In bacteria, archaea, and the eukaryote nucleus, the endonuclease ribonuclease P (RNase P) is composed of a catalytic RNA that is assisted by protein subunits. Holzmann et al. (2008) now provide evidence that the human mitochondrial RNase P is an entirely protein-based enzyme.	[Walker, Scott C.; Engelke, David R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Engelke, DR (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	engelke@umich.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034869] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034869-20, R01 GM034869] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Coughlin DJ, 2008, P NATL ACAD SCI USA, V105, P12218, DOI 10.1073/pnas.0801906105; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rossmanith W, 2001, MOL CELL BIOL, V21, P8236, DOI 10.1128/MCB.21.23.8236-8237.2001; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Seif ER, 2003, RNA, V9, P1073, DOI 10.1261/rna.5880403; Thomas B C, 1995, Nucleic Acids Symp Ser, P95; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634	9	22	22	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					412	414		10.1016/j.cell.2008.10.010	http://dx.doi.org/10.1016/j.cell.2008.10.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984152	Green Accepted, Bronze			2022-12-28	WOS:000260536300011
J	Yusufzai, T; Kadonaga, JT				Yusufzai, Timur; Kadonaga, James T.			HARP Is an ATP-Driven Annealing Helicase	SCIENCE			English	Article							REPLICATION PROTEIN-A; CHROMATIN REMODELING PROTEIN; IMMUNO-OSSEOUS DYSPLASIA; DNA; SUBFAMILIES; REGRESSION; CLONING; FAMILY; ENZYME; REPAIR	DNA- dependent adenosine triphosphatases ( ATPases) participate in a broad range of biological processes including transcription, DNA repair, and chromatin dynamics. Mutations in the HepA- related protein ( HARP) ATPase are responsible for Schimke immuno- osseous dysplasia ( SIOD), but the function of the protein is unknown. We found that HARP is an ATP- dependent annealing helicase that rewinds single- stranded DNA bubbles that are stably bound by replication protein A. Other related ATPases, including the DNA translocase Rad54, did not exhibit annealing helicase activity. Analysis of mutant HARP proteins suggests that SIOD is caused by a deficiency in annealing helicase activity. Moreover, the pleiotropy of HARP mutations is consistent with the function of HARP as an annealing helicase that acts throughout the genome to oppose the action of DNA- unwinding activities in the nucleus.	[Yusufzai, Timur; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jkadonaga@ucsd.edu			NIH [GM058272]; NIH National Research Service Award fellowship [F32 GM76936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076936, R01GM058272] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Rattner, J.-Y. A. Hsu, T. Juven-Gershon, D. Urwin, and J. Theisen for critical reading of the manuscript; M. Coleman for the gift of HARP cDNAs in the early stages of this study; M. Wold for the human RPA expression vector; B. Cairns for the triple- helix plasmid; R. Kingston for the BRG1 expression vector; and M. Gellert for a helpful discussion on this work prior to publication. Supported by NIH grant GM058272 (J.T.K.) and by NIH National Research Service Award fellowship F32 GM76936 (T.Y.).	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Elizondo LI, 2006, AM J MED GENET A, V140A, P340, DOI 10.1002/ajmg.a.31089; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; HOCKENSMITH JW, 1986, BIOCHEMISTRY-US, V25, P7812, DOI 10.1021/bi00372a005; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Muthuswami R, 2000, J BIOL CHEM, V275, P7648, DOI 10.1074/jbc.275.11.7648; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636	19	136	141	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					748	750		10.1126/science.1161233	http://dx.doi.org/10.1126/science.1161233			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974355	Green Accepted			2022-12-28	WOS:000260605200051
J	Kim, JV; Kang, SS; Dustin, ML; McGavern, DB				Kim, Jiyun V.; Kang, Silvia S.; Dustin, Michael L.; McGavern, Dorian B.			Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis	NATURE			English	Article							BLOOD-BRAIN-BARRIER; MURINE LYMPHOCYTIC CHORIOMENINGITIS; CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION; T-CELLS; ANTICONVULSANT PROLONGATION; CHEMOKINE RECEPTOR; HOST-DEFENSE; MICE; PERMEABILITY	Lymphocytic choriomeningitis virus(1) infection of the mouse central nervous system (CNS) elicits fatal immunopathology through blood - brain barrier breakdown(2) and convulsive seizures(3). Although lymphocytic- choriomeningitis- virus- specific cytotoxic T lymphocytes ( CTLs) are essential for disease(4), their mechanism of action is not known. To gain insights into disease pathogenesis, we observed the dynamics of immune cells in the meninges by two-photon microscopy. Here we report visualization of motile CTLs and massive secondary recruitment of pathogenic monocytes and neutrophils that were required for vascular leakage and acute lethality. CTLs expressed multiple chemoattractants capable of recruiting myelomonocytic cells. We conclude that a CD8(+) T- cell- dependent disorder can proceed in the absence of direct T- cell effector mechanisms and rely instead on CTL- recruited myelomonocytic cells.	[Kim, Jiyun V.; Dustin, Michael L.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Program Mol Pathogenesis, New York, NY 10016 USA; [Kang, Silvia S.; McGavern, Dorian B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	New York University; Scripps Research Institute	Dustin, ML (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Program Mol Pathogenesis, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu; mcgad@scripps.edu	Dustin, Michael/AAM-4611-2020; McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X; Dustin, Michael/0000-0003-4983-6389	National Institutes of Health [AI070967-01, AI055037, NS041219-06]; The Burroughs Wellcome Fund; Dana Foundation; National Research Service [NS061447-01]; Multiple Sclerosis Society Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055037, R21AI055037, R01AI070967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003112, T32NS041219, F32NS061447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Burroughs Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; National Research Service; Multiple Sclerosis Society Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants AI070967-01 (D.B.M.), AI055037 (M.L.D.), a grant from The Burroughs Wellcome Fund (D.B.M.) and the Dana Foundation (M.L.D.). S.S.K. was supported by a National Institutes of Health training grant NS041219-06 and is presently supported by a National Research Service Award (NS061447-01), and J.V.K. is supported by a Multiple Sclerosis Society Center Grant. We thank C. Yau for technical support and the Scripps DNA Array core for their assistance with the gene array experiment.	Ancuta P, 2004, IMMUNOBIOLOGY, V209, P11, DOI 10.1016/j.imbio.2004.04.001; ANDERSEN IH, 1991, J NEUROIMMUNOL, V31, P155, DOI 10.1016/0165-5728(91)90021-X; Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Bjork J, 1982, Agents Actions Suppl, V11, P63; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; CAMENGA DL, 1977, J NEUROPATH EXP NEUR, V36, P9, DOI 10.1097/00005072-197701000-00003; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; DOHERTY PC, 1990, IMMUNOL TODAY, V11, P55; Faust N, 2000, BLOOD, V96, P719; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hixenbaugh EA, 1997, AM J PHYSIOL-HEART C, V273, pH981, DOI 10.1152/ajpheart.1997.273.2.H981; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; JOHNSON ED, 1978, CELL IMMUNOL, V36, P143, DOI 10.1016/0008-8749(78)90257-5; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kang SS, 2008, FRONT BIOSCI-LANDMRK, V13, P4529, DOI 10.2741/3021; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lauterbach H, 2006, J EXP MED, V203, P1963, DOI 10.1084/jem.20060039; LEIST TP, 1987, J IMMUNOL, V138, P2278; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; MARKER O, 1984, ACTA NEUROPATHOL, V63, P229, DOI 10.1007/BF00685249; Maus U, 2002, AM J RESP CRIT CARE, V166, P268, DOI 10.1164/rccm.2112012; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; ROSENGREN S, 1989, MICROVASC RES, V38, P243, DOI 10.1016/0026-2862(89)90003-4; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Storm P, 2006, J VIROL, V80, P1222, DOI 10.1128/JVI.80.3.1222-1230.2006; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; WALKER DH, 1977, J NEUROPATH EXP NEUR, V36, P21, DOI 10.1097/00005072-197701000-00004; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	36	248	250	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					191	U85		10.1038/nature07591	http://dx.doi.org/10.1038/nature07591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19011611	Green Accepted			2022-12-28	WOS:000262360200032
J	Noor, AM; Mutheu, JJ; Tatem, AJ; Hay, SI; Snow, RW				Noor, Abdisalan M.; Mutheu, Juliette J.; Tatem, Andrew J.; Hay, Simon I.; Snow, Robert W.			Insecticide-treated net coverage in Africa: mapping progress in 2000-07	LANCET			English	Article							MALARIA CONTROL; PLASMODIUM-FALCIPARUM; TRANSMISSION	Background Insecticide-treated bednets (ITNs) provide a means to improve child survival across Africa. Sales figures of these nets and survey coverage data presented nationally mask inequities in populations at biological and economic risk, and do not allow for precision in the estimation of unmet commodity needs. We gathered subnational ITN coverage sample survey data from 40 malaria-endemic countries in Africa between 2000 and 2007. Methods We computed the projected ITN coverage among children aged less than 5 years for age-adjusted population data that were stratified according to malaria transmission risks, proximate determinants of poverty, and methods of ITN delivery. Findings In 2000, only 1.7 million (1.8%) African children living in stable malaria-endemic conditions were protected by an ITN and the number increased to 20.3 million (18. 5%) by 2007 leaving 89.6 million children unprotected. Of these, 30 million were living in some of the poorest areas of Africa: 54% were living in only seven countries and 25% in Nigeria alone. Overall, 33 (83%) countries were estimated to have ITN coverage of less than 40% in 2007. On average, we noted a greater increase in ITN coverage in areas where free distribution had operated between survey periods. Interpretation By mapping the distribution of populations in relation to malaria risk and intervention coverage, we provide a means to track the future requirements for scaling up essential disease- prevention strategies. The present coverage of ITN in Africa remains inadequate and a focused effort to improve distribution in selected areas would have a substantial effect on the continent's malaria burden. Funding Wellcome Trust.	[Noor, Abdisalan M.; Mutheu, Juliette J.; Tatem, Andrew J.; Hay, Simon I.; Snow, Robert W.] KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford, England; [Tatem, Andrew J.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England	University of Oxford; University of Oxford	Noor, AM (corresponding author), KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, POB 43640-00100, Nairobi, Kenya.	anoor@nairobi.kemri-wellcome.org	Hay, Simon Iain/F-8967-2015; Snow, Robert William/AFR-1436-2022	Hay, Simon Iain/0000-0002-0611-7272; Snow, Robert William/0000-0003-3725-6088; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	AMN (Research Training Fellowship, 081829), SIH (Senior Research Fellowship, 079091), and RWS (Principal Researcli Fellowship, 079081) are supported by the Wellcome Trust. This work forms part of die output of the Malaria Atlas Project, mainly funded by the Wellcome Trust, UK. We thank Priscilla Gikandi and Victor Alegana for their assistance during data abstraction and digitisation ofadministrative boundaries; Alfredo Fort of Opinion Research Corporation-Macro International for his assistance in connecting the authors with national survey teams; Pete Gething and Emelda Okiro for comments on earlier versions of this report. This report is published with the permission of the Director of KEMRI.	[Anonymous], GLOB MAL ACT PLAN; [Anonymous], MAL CHILDR PROGR INT; [Anonymous], DEM HLTH SURV; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2000, GLOB PARTN ROLL BACK; *CIESIN COL U IFPR, 2007, GLOB RUR URB MAPP PR; *DMSP, NIGHTT LIGHTS WORLD; *FED MIN HLTH, 2007, SUD HOUS HLTH SURV; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; HANSON K, 2007, MONITORING EVALUATIO; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; KULKARNI M, 2008, EVALUATION APPROPRAT; Lengeler C, 2007, AM J TROP MED HYG, V77, P222, DOI 10.4269/ajtmh.2007.77.222; *MIN HLTH ANG, 2007, ANG NAT MAL IND SURV; *MIN HLTH ETH, 2008, ETH NAT MAL IND SURV; *MIN HLTH KEN, 2008, KEN NAT MAL IND SURV; *MIN HLTH MOZ, 2007, MOZ NAT MAL IND SURV; *MIN HLTH SOC WELF, 2008, ZANZ NAT MAL IND SUR; *MIN SANT, 2007, ENQ NAT PAL SEN 2006; Ministry of Health [Zambia], 2006, ZAMB NAT MAL IND SUR; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; *POP SERV INT, 2007, DET UT MOUST IMPR BU; RBM, 2005, GLOB STRAT PLAN ROLL; *RBM, 2000, WHOCDSRBM200017 RBM; *RBM MERG, COR HOUS QUEST; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 2004, NATURE, V430, P934, DOI 10.1038/430934a; Teklehaimanot A, 2007, AM J TROP MED HYG, V77, P138, DOI 10.4269/ajtmh.2007.77.138; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; *UNGIWG SALB, 2 ADM LEV BOUND; *UNICEF, BEDN SUPPL UPD; *UNICEF, MULT CLUST IND SURV; United Nation, 2001, ROAD MAP IMPL UN MIL; *UNPD, WORLD POP PROSP 2006; *WHO UN CHILDR FUN, 2008, WORLD MAL REP	39	148	150	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					58	67		10.1016/S0140-6736(08)61596-2	http://dx.doi.org/10.1016/S0140-6736(08)61596-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19019422	Green Accepted, Green Submitted			2022-12-28	WOS:000262183800032
J	Bocquet, N; Nury, H; Baaden, M; Le Poupon, C; Changeux, JP; Delarue, M; Corringer, PJ				Bocquet, Nicolas; Nury, Hugues; Baaden, Marc; Le Poupon, Chantal; Changeux, Jean-Pierre; Delarue, Marc; Corringer, Pierre-Jean			X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP; CRYSTAL-STRUCTURE; GATING MECHANISM; BINDING-SITE; AMINO-ACIDS; DOMAIN; IDENTIFICATION; SELECTIVITY; PERMEATION	Pentameric ligand-gated ion channels from the Cys- loop family mediate fast chemo-electrical transduction(1-3), but the mechanisms of ion permeation and gating of these membrane proteins remain elusive. Here we present the X- ray structure at 2.9 angstrom resolution of the bacterial Gloeobacter violaceus pentameric ligand- gated ion channel homologue(4) ( GLIC) at pH 4.6 in an apparently open conformation. This cationic channel is known to be permanently activated by protons(5). The structure is arranged as a funnel- shaped transmembrane pore widely open on the outer side and lined by hydrophobic residues. On the inner side, a 5 angstrom constriction matches with rings of hydrophilic residues that are likely to contribute to the ionic selectivity(6-9). Structural comparison with ELIC, a bacterial homologue from Erwinia chrysanthemi solved in a presumed closed conformation(10), shows a wider pore where the narrow hydrophobic constriction found in ELIC is removed. Comparative analysis of GLIC and ELIC reveals, in concert, a rotation of each extracellular beta-sandwich domain as a rigid body, interface rearrangements, and a reorganization of the transmembrane domain, involving a tilt of the M2 and M3 alpha-helices away from the pore axis. These data are consistent with a model of pore opening based on both quaternary twist and tertiary deformation.	[Nury, Hugues; Delarue, Marc] Inst Pasteur, Unit Struct Dynam & Macromol, CNRS, URA 2185, F-75015 Paris, France; [Bocquet, Nicolas; Nury, Hugues; Le Poupon, Chantal; Changeux, Jean-Pierre; Corringer, Pierre-Jean] Inst Pasteur, Grp Channel Receptor G5, CNRS, URA 2182, F-75015 Paris, France; [Baaden, Marc] CNRS, Inst Biol Physicochim, UPR 9080, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Delarue, M (corresponding author), Inst Pasteur, Unit Struct Dynam & Macromol, CNRS, URA 2185, F-75015 Paris, France.	marc.delarue@pasteur.fr; pjcorrin@pasteur.fr	Baaden, Marc/C-6623-2008	Baaden, Marc/0000-0001-6472-0486; Nury, Hugues/0000-0002-3433-256X	Region Ile-de-France; Association Francaise contre les Myopathies; College de France; Commission of the European Communities; Network of European Neuroscience Institutes	Region Ile-de-France(Region Ile-de-France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); College de France; Commission of the European Communities(European Commission); Network of European Neuroscience Institutes	We thank P. Koehl for his program Aquasol and help with electrostatic calculations; P. Delepelaire and S. Edelstein for discussions; the staff of ESRF (Grenoble) ID14 and ID23 beamlines for data collection; facilities of the Pasteur Institute (A. Haouz for crystallogenesis, P. England for ultracentrifugation experiments, J. d'Alayer for mass spectroscopy controls and J. Bellalou for help in protein expression); and B. De Foresta (CEA, Orsay) for a gift of the two brominated DDM analogues. The latter diffraction data sets were collected at SLS and PSI (Villingen, Switzerland). We thank M. Fuchs for assistance during data collection; and the IDRIS supercomputer centre and its support staff for allocating CPU time at very short notice (project 082292). This work was supported by the Region Ile-de-France (N.B.), the Association Francaise contre les Myopathies, the College de France (C.L.P.), the Commission of the European Communities (Neurocypres project; H.N.) and the Network of European Neuroscience Institutes (ENI-NET).	Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer P.-J., 2008, SCHOLARPEDIA, V3, P3468; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1	30	580	585	7	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					111	114		10.1038/nature07462	http://dx.doi.org/10.1038/nature07462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	18987633				2022-12-28	WOS:000262104900041
J	Licatalosi, DD; Mele, A; Fak, JJ; Ule, J; Kayikci, M; Chi, SW; Clark, TA; Schweitzer, AC; Blume, JE; Wang, XN; Darnell, JC; Darnell, RB				Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Ule, Jernej; Kayikci, Melis; Chi, Sung Wook; Clark, Tyson A.; Schweitzer, Anthony C.; Blume, John E.; Wang, Xuning; Darnell, Jennifer C.; Darnell, Robert B.			HITS-CLIP yields genome-wide insights into brain alternative RNA processing	NATURE			English	Article							PRE-MESSENGER-RNA; BINDING PROTEIN; NOVA; POLYADENYLATION; GENE; IDENTIFICATION; NETWORK; DISEASE; ANTIGEN; TARGET	Protein - RNA interactions have critical roles in all aspects of gene expression. However, applying biochemical methods to understand such interactions in living tissues has been challenging. Here we develop a genome- wide means of mapping protein - RNA binding sites in vivo, by high- throughput sequencing of RNA isolated by crosslinking immunoprecipitation ( HITS- CLIP). HITS- CLIP analysis of the neuron- specific splicing factor Nova revealed extremely reproducible RNA- binding maps in multiple mouse brains. These maps provide genome- wide in vivo biochemical footprints confirming the previous prediction that the position of Nova binding determines the outcome of alternative splicing; moreover, they are sufficiently powerful to predict Nova action de novo. HITS- CLIP revealed a large number of Nova - RNA interactions in 39 untranslated regions, leading to the discovery that Nova regulates alternative polyadenylation in the brain. HITS- CLIP, therefore, provides a robust, unbiased means to identify functional protein - RNA interactions in vivo.	[Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Chi, Sung Wook; Wang, Xuning; Darnell, Jennifer C.; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Licatalosi, Donny D.; Mele, Aldo; Fak, John J.; Chi, Sung Wook; Darnell, Jennifer C.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Ule, Jernej; Kayikci, Melis] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Clark, Tyson A.; Schweitzer, Anthony C.; Blume, John E.] Affymetrix Inc, Express Res, Santa Clara, CA 95051 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; MRC Laboratory Molecular Biology; Affymetrix	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Ule, Jernej/C-6315-2013	Darnell, Robert B/0000-0002-5134-8088; Ule, Jernej/0000-0002-2452-4277; Blume, John/0000-0003-3026-953X; Clark, Tyson/0000-0002-7779-3227	NIH [R01 NS34389]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040955, R01NS034389] Funding Source: NIH RePORTER; MRC [MC_U105185858] Funding Source: UKRI; Medical Research Council [MC_U105185858] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to members of the Darnell and Ule laboratories and J. Richter for critical discussions and review of the manuscript, B. Friedman for suggesting the use of exon arrays, F. Allain for communicating unpublished results, and M. Suarez- Farinas for help with statistics. This work was supported by NIH R01 NS34389 ( R. B. D.) and the Howard Hughes Medical Institute. R. B. D. is an HHMI Investigator.	Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell RB, 2006, COLD SPRING HARB SYM, V71, P321, DOI 10.1101/sqb.2006.71.002; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; DEDUVE C, 1993, GENE, V135, P29, DOI 10.1016/0378-1119(93)90045-5; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; MAIZELS N, 1987, NATURE, V330, P616, DOI 10.1038/330616a0; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	48	962	981	2	114	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					464	U22		10.1038/nature07488	http://dx.doi.org/10.1038/nature07488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18978773	Green Accepted			2022-12-28	WOS:000261170500030
J	Greene, M				Greene, Michael			POLICY A Force for Peace in the Middle East	SCIENCE			English	Editorial Material									[Greene, Michael] Natl Acad, Policy & Global Affairs Div, Washington, DC 20418 USA	National Academies of Sciences, Engineering & Medicine	Greene, M (corresponding author), Natl Acad, Policy & Global Affairs Div, Washington, DC 20418 USA.	mgreene@nas.edu						Bohannon J, 2006, SCIENCE, V312, P352; JEANLOZ R, 2005, APS NEWS, V14, P6; *USAID, MIDDL E REG COOP MER; 2002, M INT COOP LON UNPUB	4	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1192	1192		10.1126/science.1166978	http://dx.doi.org/10.1126/science.1166978			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	374HC	19023067				2022-12-28	WOS:000261033400022
J	Lazzarini, Z				Lazzarini, Zita			South Dakota's Abortion Script - Threatening the Physician-Patient Relationship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lazzarini, Zita] Univ Connecticut, Ctr Hlth, Div Med Humanities Hlth Law & Eth, Farmington, CT 06032 USA	University of Connecticut	Lazzarini, Z (corresponding author), Univ Connecticut, Ctr Hlth, Div Med Humanities Hlth Law & Eth, Farmington, CT 06032 USA.							Post R, 2007, U ILLINOIS LAW REV, P939	1	23	23	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2189	2191		10.1056/NEJMp0806742	http://dx.doi.org/10.1056/NEJMp0806742			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	373SW	19020321				2022-12-28	WOS:000260994000001
J	Miller, W; Drautz, DI; Ratan, A; Pusey, B; Qi, J; Lesk, AM; Tomsho, LP; Packard, MD; Zhao, FQ; Sher, A; Tikhonov, A; Raney, B; Patterson, N; Lindblad-Toh, K; Lander, ES; Knight, JR; Irzyk, GP; Fredrikson, KM; Harkins, TT; Sheridan, S; Pringle, T; Schuster, SC				Miller, Webb; Drautz, Daniela I.; Ratan, Aakrosh; Pusey, Barbara; Qi, Ji; Lesk, Arthur M.; Tomsho, Lynn P.; Packard, Michael D.; Zhao, Fangqing; Sher, Andrei; Tikhonov, Alexei; Raney, Brian; Patterson, Nick; Lindblad-Toh, Kerstin; Lander, Eric S.; Knight, James R.; Irzyk, Gerard P.; Fredrikson, Karin M.; Harkins, Timothy T.; Sheridan, Sharon; Pringle, Tom; Schuster, Stephan C.			Sequencing the nuclear genome of the extinct woolly mammoth	NATURE			English	Article							DNA; HUMANS; SIZE	In 1994, two independent groups extracted DNA from several Pleistocene epoch mammoths and noted differences among individual specimens(1,2). Subsequently, DNA sequences have been published for a number of extinct species. However, such ancient DNA is often fragmented and damaged(3), and studies to date have typically focused on short mitochondrial sequences, never yielding more than a fraction of a per cent of any nuclear genome. Here we describe 4.17 billion bases ( Gb) of sequence from several mammoth specimens, 3.3 billion ( 80%) of which are from the woolly mammoth ( Mammuthus primigenius) genome and thus comprise an extensive set of genome- wide sequence from an extinct species. Our data support earlier reports(4) that elephantid genomes exceed 4 Gb. The estimated divergence rate between mammoth and African elephant is half of that between human and chimpanzee. The observed number of nucleotide differences between two particular mammoths was approximately one- eighth of that between one of them and the African elephant, corresponding to a separation between the mammoths of 1.5 - 2.0 Myr. The estimated probability that orthologous elephant and mammoth amino acids differ is 0.002, corresponding to about one residue per protein. Differences were discovered between mammoth and African elephant in amino- acid positions that are otherwise invariant over several billion years of combined mammalian evolution. This study shows that nuclear genome sequencing of extinct species can reveal population differences not evident from the fossil record, and perhaps even discover genetic factors that affect extinction.	[Miller, Webb; Drautz, Daniela I.; Ratan, Aakrosh; Pusey, Barbara; Qi, Ji; Lesk, Arthur M.; Tomsho, Lynn P.; Packard, Michael D.; Zhao, Fangqing; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Sher, Andrei] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; [Tikhonov, Alexei] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Raney, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Patterson, Nick; Lindblad-Toh, Kerstin; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Fredrikson, Karin M.; Harkins, Timothy T.; Sheridan, Sharon] Roche Diagnost Corp, Indianapolis, IN 46250 USA; [Pringle, Tom] Sperling Fdn, Eugene, OR 97405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; University of California System; University of California Santa Cruz; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Roche Holding	Miller, W (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, 310 Wartik Bldg, University Pk, PA 16802 USA.	webb@bx.psu.edu; scs@bx.psu.edu	QI, JI/E-2797-2016; Raney, Brian/ABE-6267-2020; Tikhonov, Alexei/G-7478-2016; Zhao, Fangqing/A-9992-2009; Zhao, Fangqing/P-6309-2019	Tikhonov, Alexei/0000-0002-7227-5797; Lesk, Arthur/0000-0002-2596-0601; Fredrikson, Karin/0000-0001-7360-4276; Zhao, Fangqing/0000-0002-6216-1235	National Human Genome Research Institute [HG002238]; Gordon and Betty Moore Foundation; Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This sequencing-by-synthesis study was made possible through generous funding from Penn State University and Roche Applied Sciences. W. M. was supported by grant HG002238 from the National Human Genome Research Institute and S. C. S. is supported in part by the Gordon and Betty Moore Foundation. This project is funded in part under a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds appropriated by the US legislature. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. We thank T. Gilbert for introducing us to the use of hair shafts as a source of ancient DNA, C. Grondahl for providing Asian elephant hair samples, and M. Wilson for suggestions. This paper is dedicated to the memory of Andrei Sher.	Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; HAGELBERG E, 1994, NATURE, V370, P333, DOI 10.1038/370333b0; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LANDER E S, 1988, Genomics, V2, P231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Redi CA, 2007, J MOL EVOL, V64, P484, DOI 10.1007/s00239-006-0237-1; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TABERLET P, 1995, CONSERV BIOL, V9, P1255, DOI 10.1046/j.1523-1739.1995.951255.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	38	216	227	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					387	U51		10.1038/nature07446	http://dx.doi.org/10.1038/nature07446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020620	Bronze			2022-12-28	WOS:000261039600043
J	Daxinger, L; Kanno, T; Matzke, M				Daxinger, Lucia; Kanno, Tatsuo; Matzke, Marjori			Pol V Transcribes to Silence	CELL			English	Editorial Material							DIRECTED DNA-METHYLATION; RNA-POLYMERASE-IV	In most cases, the functions of long noncoding RNAs remain uncertain. Working in the model plant Arabidopsis, Wierzbicki et al. (2008) provide evidence that transcription of intergenic noncoding regions by RNA polymerase V promotes heterochromatin formation and silencing of nearby genes.	[Daxinger, Lucia; Kanno, Tatsuo; Matzke, Marjori] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Matzke, M (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Daxinger, Lucia/A-6840-2013	Daxinger, Lucia/0000-0001-6557-6201; KANNO, Tatsuo/0000-0001-5958-4686				Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	9	5	5	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					592	594		10.1016/j.cell.2008.10.027	http://dx.doi.org/10.1016/j.cell.2008.10.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013268	Bronze			2022-12-28	WOS:000260886900008
J	Fragoso, G; Spencer, T				Fragoso, Gerardo; Spencer, Tom			Physiographic Control on the Development of Spartina Marshes	SCIENCE			English	Article							SALT-MARSH; ALTERNIFLORA		[Fragoso, Gerardo] UNEP WCMC, Cambridge CB3 0DL, England; [Spencer, Tom] Univ Cambridge, Dept Geog, Cambridge Coastal Res Unit, Cambridge CB2 3EN, England	United Nations Environment Programme; University of Cambridge	Fragoso, G (corresponding author), UNEP WCMC, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	gerardo.fragoso@unep-wcmc.org						GOODMAN PJ, 1961, J ECOL, V49, P391, DOI 10.2307/2257271; GRAY AJ, 1991, ADV ECOL RES, V21, P1, DOI 10.1016/S0065-2504(08)60096-3; MCKEE KL, 1988, ESTUARIES, V11, P143, DOI 10.2307/1351966; Mendelssohn IA, 2003, ECOL ENG, V21, P115, DOI 10.1016/j.ecoleng.2003.09.006; Morris JT, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P87; MORRIS JT, 1984, AM J BOT, V71, P979, DOI 10.2307/2443668; REDFIELD AC, 1965, SCIENCE, V147, P50, DOI 10.1126/science.147.3653.50; Tukey J. W., 1977, EXPLORATORY DATA ANA	8	13	14	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1064	1064		10.1126/science.1159973	http://dx.doi.org/10.1126/science.1159973			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008437				2022-12-28	WOS:000260867700027
J	Hawkridge, A; Hatherill, M; Little, F; Goetz, MA; Barker, L; Mahomed, H; Sadoff, J; Hanekom, W; Geiter, L; Hussey, G				Hawkridge, Anthony; Hatherill, Mark; Little, Francesca; Goetz, Margaret Ann; Barker, Lew; Mahomed, Hassan; Sadoff, Jerald; Hanekom, Willem; Geiter, Larry; Hussey, Greg		S African BCG Trial Team	Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial	BRITISH MEDICAL JOURNAL			English	Article							BACILLE CALMETTE-GUERIN; MULTIPUNCTURE METHOD; IMMUNE-RESPONSES; WESTERN CAPE; VACCINATION; IMMUNIZATION; METAANALYSIS; POPULATION; MENINGITIS	Objective To compare the incidence of tuberculosis over two years in infants vaccinated at birth with intradermal BCG or with percutaneous BCG. Design Randomised trial. Setting South Africa. Participants 11 680 newborn infants. Interventions Infants were randomised by week of birth to receive Tokyo 172 BCG vaccine through the percutaneous route (n=5775) or intradermal route (n=5905) within 24 hours of birth and followed up for two years. Main outcome measures The primary outcome measure was documented Mycobacterium tuberculosis infection or radiological and clinical evidence of tuberculosis disease. Secondary outcome measures were rates of adverse events, all cause and tuberculosis specific admissions to hospital, and mortality. Results The difference in the cumulative incidence of definite, probable, and possible tuberculosis between the intradermal group and the percutaneous group, as defined using study definitions based on microbiological, radiological, and clinical findings was -0.36% (95.5% confidence interval - 1.27% to 0.54%). No significant differences were found between the routes in the cumulative incidence of tuberculosis using a range of equivalence of "within 25%." Additionally, no significant differences were found between the routes in the cumulative incidence of adverse events (risk ratio 0.98, 95% confidence interval 0.91 to 1.06), including deaths (1.19, 0.89 to 1.58). Conclusion Equivalence was found between intradermal BCG vaccine and percutaneous BCG in the incidence of tuberculosis in South African infants vaccinated at birth and followed up for two years. The World Health Organization should consider revising its policy of preferential intradermal vaccination to allow national immunisation programmes to choose percutaneous vaccination if that is more practical. Trial registration ClinicalTrials. gov NCT00242047.	[Hawkridge, Anthony; Hatherill, Mark; Mahomed, Hassan; Hanekom, Willem; Hussey, Greg] Univ Cape Town, S African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Little, Francesca] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Goetz, Margaret Ann; Barker, Lew; Sadoff, Jerald; Geiter, Larry] Aeras Global TB Vaccine Fdn, Rockville, MD USA	University of Cape Town; University of Cape Town	Hawkridge, A (corresponding author), Aeras Global TB Vaccine Fdn, Africa Off, Belmont Sq, ZA-7700 Rondebosch, South Africa.	thawkridge@aeras.org	Tameris, Michele/AAR-6663-2021	Tameris, Michele/0000-0002-7983-7203; Hanekom, Willem/0000-0003-3070-6154; Schaaf, Hendrik Simon/0000-0001-5755-4133; Zar, Heather/0000-0002-9046-759X; Little, Francesca/0000-0002-5917-9928	Aeras Global TB Vaccine Foundation	Aeras Global TB Vaccine Foundation	The study was supported by the Aeras Global TB Vaccine Foundation, a non-profit organisation that aims to develop tuberculosis vaccines. LG (co- principal investigator) and LB, JS, and MAG (coinvestigators) were full time employees of the sponsor at the time of the trial.	Al Jared N, 1999, THORAX, V54, P762, DOI 10.1136/thx.54.9.762; [Anonymous], S AFR DEM HLTH SURV; BERMAN S, 1992, TUBERCLE LUNG DIS, V73, P349, DOI 10.1016/0962-8479(92)90039-M; Bricks Lucia F., 2004, J. Pediatr. (Rio J.), V80, P93, DOI 10.1590/S0021-75572004000200004; *BTTA RES COMM, 1971, TUBERCLE, V52, P19; Canner E W, 1991, Public Health, V105, P405, DOI 10.1016/S0033-3506(05)80601-8; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Davids V, 2007, CLIN VACCINE IMMUNOL, V14, P198, DOI 10.1128/CVI.00309-06; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; GROENEWALD P, 2002, BOLAND OVERBERG REGI; HART PD, 1967, BRIT MED J, V1, P587, DOI 10.1136/bmj.1.5540.587; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; Kemp EB, 1996, J INFECT DIS, V174, P113, DOI 10.1093/infdis/174.1.113; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Mori T, 1996, TUBERCLE LUNG DIS, V77, P269, DOI 10.1016/S0962-8479(96)90012-X; Moyo S, 2007, J PAEDIATR CHILD H, V43, P178, DOI 10.1111/j.1440-1754.2007.01039.x; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; ORMEROD LP, 1993, ARCH DIS CHILD, V69, P155, DOI 10.1136/adc.69.1.155; Pater C, 2004, CURR CONTR TRIALS C, V5, DOI 10.1186/1468-6708-5-8; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; STARKE JR, 1989, PEDIATRICS, V84, P28; VAUGHAN JP, 1973, J TROP MED HYG, V76, P143; *WHO, WHOEPIGEN93, V5, P4; World Health Organization, 2004, Weekly Epidemiological Record, V79, P27; YAMAGATA S, 1966, IMPLEMENTATION PERCU	27	75	75	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 13	2008	337								a2052	10.1136/bmj.a2052	http://dx.doi.org/10.1136/bmj.a2052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008268	Green Published, hybrid			2022-12-28	WOS:000261784500001
J	Marmot, M; Friel, S; Bell, R; Houweling, TAJ; Taylor, S				Marmot, Michael; Friel, Sharon; Bell, Ruth; Houweling, Tanja A. J.; Taylor, Sebastian		Commission Social Determinants Hlt	Closing the gap in a generation: health equity through action on the social determinants of health	LANCET			English	Article							MENTAL-HEALTH; INEQUALITIES; EMPLOYMENT; CHILDREN; IMPACT; POPULATION; MORTALITY; RISK	The Commission on Social Determinants of Health, created to marshal the evidence on what can be done to promote health equity and to foster a global movement to achieve it, is a global collaboration of policy makers, researchers, and civil society, led by commissioners with a unique blend of political, academic, and advocacy experience. The focus of attention is on countries at all levels of income and development. The commission launched its final report on August 28, 2008. This paper summarises the key findings and recommendations; the full list is in the final report.	[Marmot, Michael; Friel, Sharon; Bell, Ruth; Houweling, Tanja A. J.; Taylor, Sebastian; Commission Social Determinants Hlt] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Marmot, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 119 Torrington Pl, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019; Houweling, Tanja/GRF-6127-2022	Marmot, M G/0000-0002-2431-6419; Houweling, Tanja AJ/0000-0001-6090-4376; Friel, Sharon/0000-0002-8345-5435	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G8802774, G0100222, G19/35] Funding Source: Medline; NIMHD NIH HHS [U54 MD008173] Funding Source: Medline; ESRC [ES/F02679X/1] Funding Source: UKRI; National Institute on Minority Health and Health Disparities [U54MD008173] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		[Anonymous], 1999, DEV FREEDOM; Artazcoz L, 2005, J EPIDEMIOL COMMUN H, V59, P761, DOI 10.1136/jech.2004.028704; Benach J, 2007, J EPIDEMIOL COMMUN H, V61, P276, DOI 10.1136/jech.2005.045237; Campbell T, 2007, J URBAN HEALTH, V84, pI54, DOI 10.1007/s11524-007-9181-7; Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA; *EARL CHILD DEV KN, 2007, DET HLTH EARL CHILD; Eastwood R, 2000, RURAL URBAN DIMENSIO; Elinder LS, 2005, BMJ-BRIT MED J, V331, P1333, DOI 10.1136/bmj.331.7528.1333; Farmer P, 1999, AM J PUBLIC HEALTH, V89, P1486, DOI 10.2105/AJPH.89.10.1486; Globalisation Knowledge Network of the Commission on Social Determinants of Health, 2007, HLTH EQ GLOB RIGHTS; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Gwatkin D. R., 2005, REACHING POOR HLTH N; *IND HLTH GROUP, SOC DET IND HLTH INT; *INT LAB ORG, ILO LAUNCH GLOB CAMP; International Labor Organization, 2008, GLOB EMPL TRENDS; Kickbusch I, 2007, HLTH PROMOTION CANAD; Kim IH, 2006, SOC SCI MED, V63, P566, DOI 10.1016/j.socscimed.2006.02.004; Kivimaki M, 2003, AM J EPIDEMIOL, V158, P663, DOI 10.1093/aje/kwg185; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Mackenbach JP, 2003, LANCET, V362, P1409, DOI 10.1016/S0140-6736(03)14639-9; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; MARMOT M, 2004, STAT SYNDROME; Marmot MG., 2006, SOCIAL DETERMINANTS; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202; National Heart Forum, 2007, BUILD HLTH CREAT ENH; Ooi GL, 2007, J URBAN HEALTH, V84, pI27, DOI 10.1007/s11524-007-9167-5; *PUBL HLTH AG CAN, 2007, CROSS SECT EXP INT A; RANDEL J, 2004, REALITY AID 2004 IND; Shaw M, 2004, ANNU REV PUBL HEALTH, V25, P397, DOI 10.1146/annurev.publhealth.25.101802.123036; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Stern N. H., 2006, STERN REV EC CLIMATE; UNESCO, 2006, 2 UNESCO; *UNICEF, STAT WORLDS CHILDR 2; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; World Health Organization, 2005, WORLD HLTH REP 2005; *WORLDWATCH I, 2007, STAT WORLD 2007 OUR; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; [No title captured]; [No title captured]	41	2585	2612	14	371	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 8	2008	372	9650					1661	1669		10.1016/S0140-6736(08)61690-6	http://dx.doi.org/10.1016/S0140-6736(08)61690-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994664	Green Published			2022-12-28	WOS:000260899900028
J	Formisano, E; De Martino, F; Bonte, M; Goebel, R				Formisano, Elia; De Martino, Federico; Bonte, Milene; Goebel, Rainer			"Who" Is Saying "What"? Brain-Based Decoding of Human Voice and Speech	SCIENCE			English	Article							AUDITORY-CORTEX; TEMPORAL CORTEX; PERCEPTION; CLASSIFICATION; STIMULI; FMRI; REPRESENTATIONS; ORGANIZATION; EXTRACTION; RESPONSES	Can we decipher speech content ("what" is being said) and speaker identity ("who" is saying it) from observations of brain activity of a listener? Here, we combine functional magnetic resonance imaging with a data- mining algorithm and retrieve what and whom a person is listening to from the neural fingerprints that speech and voice signals elicit in the listener's auditory cortex. These cortical fingerprints are spatially distributed and insensitive to acoustic variations of the input so as to permit the brain- based recognition of learned speech from unknown speakers and of learned voices from previously unheard utterances. Our findings unravel the detailed cortical layout and computational properties of the neural populations at the basis of human speech recognition and speaker identification.	[Formisano, Elia; De Martino, Federico; Bonte, Milene; Goebel, Rainer] Univ Maastricht, Dept Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands	Maastricht University	Formisano, E (corresponding author), Univ Maastricht, Dept Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands.	e.formisano@psychology.unimaas.nl	De Martino, Federico/ABF-9850-2021; De Martino, Federico/I-1817-2012	De Martino, Federico/0000-0002-0352-0648; De Martino, Federico/0000-0002-0352-0648; Formisano, Elia/0000-0001-5008-2460; Bonte, Milene/0000-0002-0203-8913; Goebel, Rainer/0000-0003-1780-2467	Maastricht University; Netherlands Organization for Scientific Research; Innovational Research Incentives Scheme Vidi [452-04-337]; Veni [451-07-002]	Maastricht University; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Innovational Research Incentives Scheme Vidi(Netherlands Organization for Scientific Research (NWO)); Veni(Netherlands Organization for Scientific Research (NWO))	Work supported by Maastricht University and the Netherlands Organization for Scientific Research (NWO), Innovational Research Incentives Scheme Vidi grant 452-04-337(E.F.) and Veni grant 451-07-002 (M.B.). We thank J. Obleser, U. Hasson, J.-D. Haynes, N. Kriegeskorte, J. Ashburner, and G. Valente for comments and discussions.	Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Davis MH, 2003, J NEUROSCI, V23, P3423; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Desai R, 2008, J COGNITIVE NEUROSCI, V20, P1174, DOI 10.1162/jocn.2008.20081; EGINEER CT, 2008, NAT NEUROSCI, V11, P603; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Obleser J, 2004, J COGNITIVE NEUROSCI, V16, P31, DOI 10.1162/089892904322755539; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034	28	375	385	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					970	973		10.1126/science.1164318	http://dx.doi.org/10.1126/science.1164318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988858	Green Submitted			2022-12-28	WOS:000260674100055
J	Takehara-Nishiuchi, K; McNaughton, BL				Takehara-Nishiuchi, Kaori; McNaughton, Bruce L.			Spontaneous Changes of Neocortical Code for Associative Memory During Consolidation	SCIENCE			English	Article							TIME-DEPENDENT REORGANIZATION; MEDIAL PREFRONTAL CORTEX; HIPPOCAMPAL; TRACE; AMNESIA; LESIONS; SLEEP; JUDGMENTS; MONKEYS; SYSTEMS	After learning, the medial prefrontal cortex (mPFC) gradually comes to modulate the expression of memories that initially depended on the hippocampus. We show that during this consolidation period, neural firing in the mPFC becomes selective for the acquired memories. After acquisition of memory associations, neuron populations in the mPFC of rats developed sustained activity during the interval between two paired stimuli, but reduced activity during the corresponding interval between two unpaired stimuli. These new patterns developed over a period of several weeks after learning, with and without continued conditioning trials. Thus, in agreement with a central tenet of consolidation theory, acquired associations initiate subsequent, gradual processes that result in lasting changes of the mPFC's code, without continued training.	[Takehara-Nishiuchi, Kaori; McNaughton, Bruce L.] Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	University of Arizona	McNaughton, BL (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA.	bruce@nsma.arizona.edu	Takehara-Nishiuchi, Kaori/Q-9053-2019; Takehara, Kaori/ABD-2977-2020	Takehara-Nishiuchi, Kaori/0000-0002-7282-7838; Takehara, Kaori/0000-0002-7282-7838	NIH [NS020331, MH046823]; Human Frontier Science Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046823, R37MH046823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020331, R37NS020331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS020331 and MH046823 (B.L.M.) and the Human Frontier Science Program (K.T.-N.). We thank M. Tatsuno and S. Cowen for helping with construction of the experimental apparatus and programming of the code for data analysis; J. Meltzer, J. Wang, H. DeFour, and A. Mosley for help with data collection and analysis; K. Bohne for constructing hyperdrives; and N. Insel for critical reading of the manuscript.	Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freeman JH, 1999, NEUROBIOL LEARN MEM, V72, P259, DOI 10.1006/nlme.1998.3896; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McEchron MD, 1999, HIPPOCAMPUS, V9, P385, DOI 10.1002/(SICI)1098-1063(1999)9:4<385::AID-HIPO5>3.0.CO;2-K; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; MOSS M, 1981, J NEUROSCI, V1, P227; Paller KA, 1997, MEMORY, V5, P73, DOI 10.1080/741941150; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	27	166	166	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					960	963		10.1126/science.1161299	http://dx.doi.org/10.1126/science.1161299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988855				2022-12-28	WOS:000260674100052
J	Prainsack, B; Reardon, J; Hindmarsh, R; Gottweis, H; Naue, U; Lunshof, JE				Prainsack, Barbara; Reardon, Jenny; Hindmarsh, Richard; Gottweis, Herbert; Naue, Ursula; Lunshof, Jeantine E.			Personal genomes: Misdirected precaution	NATURE			English	Editorial Material							CONSUMER		[Prainsack, Barbara] Kings Coll London, Ctr Biomed & Soc, London WC2R 2LS, England; [Prainsack, Barbara] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Reardon, Jenny] Univ Calif Santa Cruz, Dept Sociol, Santa Cruz, CA 95064 USA; [Hindmarsh, Richard] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Hindmarsh, Richard] Griffith Univ, Ctr Governance & Publ Policy, Nathan, Qld 4111, Australia; [Gottweis, Herbert; Naue, Ursula] Univ Vienna, Dept Polit Sci, Life Sci Governance Res Platform, A-1010 Vienna, Austria; [Lunshof, Jeantine E.] Maastricht Univ, Dept Social Med, NL-6211 LK Maastricht, Netherlands; [Lunshof, Jeantine E.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, Amsterdam, Netherlands	University of London; King's College London; University of London; King's College London; University of California System; University of California Santa Cruz; Griffith University; Griffith University; University of Vienna; Maastricht University; Vrije Universiteit Amsterdam	Prainsack, B (corresponding author), Kings Coll London, Ctr Biomed & Soc, London WC2R 2LS, England.	barbara.prainsack@kcl.ac.uk	Prainsack, Barbara/AAF-5739-2021	Prainsack, Barbara/0000-0002-6335-1532; Naue, Ursula/0000-0003-2678-9962; Hindmarsh, Richard/0000-0001-5560-2904				Borry P, 2008, NAT BIOTECHNOL, V26, P736, DOI 10.1038/nbt0708-736; Gniady J, 2008, FORDHAM LAW REV, V76, P2429; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Reardon Jenny, 2007, BIOSOCIETIES, V2, P239, DOI DOI 10.1017/S174585520700573X; Rose Nikolas, 2007, POLITICS LIFE ITSELF; van Ommen GB, 2008, EUR J HUM GENET, V16, P403, DOI 10.1038/ejhg.2008.32; 2008, NATURE BIOTECHNOL, V26, P716	8	83	87	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					34	35		10.1038/456034a	http://dx.doi.org/10.1038/456034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987720				2022-12-28	WOS:000260674000025
J	Yang, HB; Rameau, JD; Johnson, PD; Valla, T; Tsvelik, A; Gu, GD				Yang, H. -B.; Rameau, J. D.; Johnson, P. D.; Valla, T.; Tsvelik, A.; Gu, G. D.			Emergence of preformed Cooper pairs from the doped Mott insulating state in Bi2Sr2CaCu2O8+delta	NATURE			English	Article							CUPRATE SUPERCONDUCTORS; UNDERDOPED BI2212; ENERGY-GAP; PSEUDOGAP; TRANSITION; SPIN; PHOTOEMISSION; SURFACE; ONSET	Superconductors are characterized by an energy gap that represents the energy needed to break the pairs of electrons (Cooper pairs) apart. At temperatures considerably above those associated with superconductivity, the high- transition- temperature copper oxides have an additional 'pseudogap'. It has been unclear whether this represents preformed pairs of electrons that have not achieved the coherence necessary for superconductivity, or whether it reflects some alternative ground state that competes with superconductivity(1). Paired electrons should display particle - hole symmetry with respect to the Fermi level (the energy of the highest occupied level in the electronic system), but competing states(2-4) need not show such symmetry. Here we report a photoemission study of the underdoped copper oxide Bi2Sr2CaCu2O8+delta that shows the opening of a symmetric gap only in the anti-nodal region, contrary to the expectation that pairing would take place in the nodal region. It is therefore evident that the pseudogap does reflect the formation of preformed pairs of electrons and that the pairing occurs only in well- defined directions of the underlying lattice.	[Yang, H. -B.; Rameau, J. D.; Johnson, P. D.; Valla, T.; Tsvelik, A.; Gu, G. D.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Johnson, PD (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.	pdj@bnl.gov	Valla, Tonica/ABD-7811-2021; Gu, Genda/D-5410-2013	Valla, Tonica/0000-0002-3237-9102; Gu, Genda/0000-0002-9886-3255	US Department of Energy	US Department of Energy(United States Department of Energy (DOE))	We thank S. Chakravarty, A. Chubukov, P. Lee, M. Norman, M. Rice, D. Scalapino and J. Tranquada for discussions. The assistance of J. Wen and Z. Xu with the preparation of underdoped crystals is also acknowledged. This work was supported by the US Department of Energy.	Chakravarty S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.100504; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; Greber T, 1997, PHYS REV LETT, V79, P4465, DOI 10.1103/PhysRevLett.79.4465; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; KISKER E, 1987, PHYS REV LETT, V58, P1784, DOI 10.1103/PhysRevLett.58.1784; Konik RM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086407; Lee WS, 2007, NATURE, V450, P81, DOI 10.1038/nature06219; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Matsui H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.217002; MATSUI H, 2005, PHYS REV LETT, V94; Norman MR, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174501; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Schafer J, 1999, PHYS REV LETT, V83, P2069, DOI 10.1103/PhysRevLett.83.2069; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Tsvelik AM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.237001; Valla T, 2006, SCIENCE, V314, P1914, DOI 10.1126/science.1134742; Wang YY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247002; Wen XG, 1998, PHYS REV LETT, V80, P2193, DOI 10.1103/PhysRevLett.80.2193; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016; Yang KY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174501	25	182	183	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					77	80		10.1038/nature07400	http://dx.doi.org/10.1038/nature07400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987738				2022-12-28	WOS:000260674000043
J	Adabag, AS; Therneau, TM; Gersh, BJ; Weston, SA; Roger, VL				Adabag, A. Selcuk; Therneau, Terry M.; Gersh, Bernard J.; Weston, Susan A.; Roger, Veronique L.			Sudden Death After Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; COMMUNITY-WIDE PERSPECTIVE; CARDIAC DEATH; TEMPORAL TRENDS; OLMSTED COUNTY; RISK-FACTORS; NATIONAL REGISTRY; CLINICAL-TRIALS; TIME-DEPENDENCE	Context Sudden cardiac death after myocardial infarction (MI) has not been assessed recently in the community. Risk stratification for sudden cardiac death after MI commonly relies on baseline characteristics and little is known about the relationship between recurrent ischemia or heart failure and sudden cardiac death. Objective To evaluate the risk of sudden cardiac death after MI and the impact of recurrent ischemia and heart failure on sudden cardiac death. Design, Setting, and Participants Population- based surveillance study of 2997 residents ( mean [ SD] age, 67 [ 14] years; 59% were men) experiencing an MI in Olmsted County, Minnesota, between 1979 and 2005, and followed up through February 29, 2008. Main Outcome Measures Sudden cardiac death defined as out- of- hospital death due to coronary disease; and observed survival free of sudden cardiac death compared with that expected in Olmsted County, Minnesota. Results During a median follow- up of 4.7 years ( 25th- 75th percentile, 1.6- 7.1 years), 1160 deaths occurred, 282 from sudden cardiac death ( 24%). The 30- day cumulative incidence of sudden cardiac death was 1.2% ( 95% confidence interval [ CI], 0.8%1.6%). Thereafter, the rate of sudden cardiac death was constant at 1.2% per year yielding a 5- year cumulative incidence of 6.9% ( 95% CI, 5.9%- 7.9%). The 30- day incidence of sudden cardiac death was 4- fold higher than expected ( standardized mortality ratio, 4.2; 95% CI, 2.9- 5.8). The risk of sudden cardiac death has declined significantly over time ( hazard ratio [ HR], 0.62 [ 95% CI, 0.44- 0.88] for MIs that occurred between 1997 and 2005 compared with between 1979 and 1987; P=. 03). The recurrent events of ischemia ( n= 842), heart failure ( n= 365), or both ( n= 873) occurred in 2080 patients. After adjustment for baseline characteristics, recurrent ischemia was not associated with sudden cardiac death ( HR, 1.26 [ 95% CI, 0.96- 1.65]; P=. 09), while heart failure markedly increased the risk of sudden cardiac death ( HR, 4.20 [ 95% CI, 3.10- 5.69]; P <. 001). Conclusions The risk of sudden cardiac death following MI in community practice has declined significantly over the past 30 years. Sudden cardiac death is independently associated with heart failure but not with recurrent ischemia.	[Therneau, Terry M.; Weston, Susan A.; Roger, Veronique L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Adabag, A. Selcuk] Vet Affairs Med Ctr, Div Cardiol, Minneapolis, MN USA; [Gersh, Bernard J.; Roger, Veronique L.] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Mayo Clinic	Roger, VL (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.	roger.veronique@mayo.edu	Roger, Veronique/AAV-5951-2020	Adabag, Selcuk/0000-0003-2154-8596	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072435, R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL072435-06, R01 HL059205, R01 HL 59205, R01 HL 72435, R01 HL059205-10A1, R01 HL072435] Funding Source: Medline; NIAMS NIH HHS [R01 AR030582, AR30582, R01 AR030582-43] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abildstrom SZ, 2002, HEART, V88, P573, DOI 10.1136/heart.88.6.573; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; BERGER CJ, 1992, JAMA-J AM MED ASSOC, V268, P1545, DOI 10.1001/jama.268.12.1545; Bunch TJ, 2007, CIRCULATION, V115, P2451, DOI 10.1161/CIRCULATIONAHA.106.683235; Bursi F, 2007, AM J MED, V120, P616, DOI 10.1016/j.amjmed.2006.07.039; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Devlin G, 2005, HEART, V91, P1394, DOI 10.1136/hrt.2004.054007; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Gandy A, 2008, STAT MED, V27, P831, DOI 10.1002/sim.2972; Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Goraya TY, 2000, MAYO CLIN PROC, V75, P681; Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057; Guidry UC, 1999, CIRCULATION, V100, P2054, DOI 10.1161/01.CIR.100.20.2054; Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hohnloser SH, 2003, CIRCULATION, V107, P941, DOI 10.1161/01.CIR.0000054211.00668.9B; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Jordaens L, 2001, EUR HEART J, V22, P1214, DOI 10.1053/euhj.2000.2464; KANNEL WB, 1979, AM J CARDIOL, V44, P53, DOI 10.1016/0002-9149(79)90250-9; Lloyd-Jones DM, 2006, ARCH INTERN MED, V166, P1342, DOI 10.1001/archinte.166.13.1342; Makikallio TH, 2006, AM J CARDIOL, V97, P480, DOI 10.1016/j.amjcard.2005.09.077; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Myerburg RJ, 1998, CIRCULATION, V97, P1514; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prineas R., 1982, MINNESOTA CODE MANUA; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Roger VL, 2002, J CLIN EPIDEMIOL, V55, P593, DOI 10.1016/S0895-4356(02)00390-6; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Salukhe TV, 2004, CIRCULATION, V109, P1848, DOI 10.1161/01.CIR.0000125522.10053.29; Singh JP, 2005, J AM COLL CARDIOL, V46, P1712, DOI 10.1016/j.jacc.2005.05.088; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Spencer FA, 1999, J AM COLL CARDIOL, V34, P1378, DOI 10.1016/S0735-1097(99)00390-3; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Watkins S, 2005, AM J CARDIOL, V96, P1349, DOI 10.1016/j.amjcard.2005.07.037; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; Wiviott SD, 2006, J AM COLL CARDIOL, V47, P1553, DOI 10.1016/j.jacc.2005.11.075; Yap YG, 2005, EUR HEART J, V26, P1385, DOI 10.1093/eurheartj/ehi268	52	173	179	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2022	2029		10.1001/jama.2008.553	http://dx.doi.org/10.1001/jama.2008.553			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984889	Green Accepted, Bronze			2022-12-28	WOS:000260605400022
J	Ross, JR; Riley, J				Ross, J. R.; Riley, J.			Commentary: Controversies in SIGN guidance on pain control in patients with cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ross, J. R.] St Josephs Hospice, London E8 4SA, England; [Ross, J. R.] Univ London Imperial Coll Sci Technol & Med, London SW3 6LR, England; [Riley, J.] Royal Marsden Hosp, London SW3 6JJ, England	Imperial College London; Royal Marsden NHS Foundation Trust	Ross, JR (corresponding author), St Josephs Hospice, London E8 4SA, England.	J.Ross@STJH.org.uk						DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Hansson PT, 2005, PAIN, V113, P251, DOI 10.1016/j.pain.2004.10.007; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Markman JD, 2008, PAIN, V136, P227, DOI 10.1016/j.pain.2008.03.011; Ross JR, 2008, CANCER-AM CANCER SOC, V112, P1390, DOI 10.1002/cncr.23292; Scottish Intercollegiate Guidelines Network (SIGN), 2008, 106 SIGN; Skorpen F, 2008, PALLIATIVE MED, V22, P310, DOI 10.1177/0269216308089302; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS5	8	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 5	2008	337								a2234	10.1136/bmj.a2234	http://dx.doi.org/10.1136/bmj.a2234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FB	18987039				2022-12-28	WOS:000261236000001
J	Coll, AP; Yeo, GSH; Farooqi, IS; O'Rahilly, S				Coll, Anthony P.; Yeo, Giles S. H.; Farooqi, I. Sadaf; O'Rahilly, Stephen			SnapShot: The Hormonal Control of Food Intake	CELL			English	Editorial Material							OBESITY; NEURONS		[Coll, Anthony P.; Yeo, Giles S. H.; Farooqi, I. Sadaf; O'Rahilly, Stephen] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England	University of Cambridge	Coll, AP (corresponding author), Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England.		O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Coll, Anthony Patrick/0000-0003-2594-7463; Farooqi, Sadaf/0000-0001-7609-3504; Yeo, Giles See How/0000-0001-8823-3615	MRC [G9824984, G108/617] Funding Source: UKRI; Medical Research Council [G9824984, G108/617] Funding Source: Medline; Wellcome Trust [082390] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007	10	8	9	2	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3							572.e1	10.1016/j.cell.2008.10.014	http://dx.doi.org/10.1016/j.cell.2008.10.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984167	Bronze			2022-12-28	WOS:000260536300026
J	Jacobs, Z; Roberts, RG; Galbraith, RF; Deacon, HJ; Grun, R; Mackay, A; Mitchell, P; Vogelsang, R; Wadley, L				Jacobs, Zenobia; Roberts, Richard G.; Galbraith, Rex F.; Deacon, Hilary J.; Gruen, Rainer; Mackay, Alex; Mitchell, Peter; Vogelsang, Ralf; Wadley, Lyn			Ages for the Middle Stone Age of Southern Africa: Implications for Human Behavior and Dispersal	SCIENCE			English	Article							POST-HOWIESONS POORT; SIBUDU CAVE; SHELL BEADS; BLOMBOS CAVE; ORIGINS; POPULATIONS; ANTARCTICA; SETTLEMENT; GREENLAND; INDUSTRY	The expansion of modern human populations in Africa 80,000 to 60,000 years ago and their initial exodus out of Africa have been tentatively linked to two phases of technological and behavioral innovation within the Middle Stone Age of southern Africa- the Still Bay and Howieson's Poort industries- that are associated with early evidence for symbols and personal ornaments. Establishing the correct sequence of events, however, has been hampered by inadequate chronologies. We report ages for nine sites from varied climatic and ecological zones across southern Africa that show that both industries were short- lived ( 5000 years or less), separated by about 7000 years, and coeval with genetic estimates of population expansion and exit times. Comparison with climatic records shows that these bursts of innovative behavior cannot be explained by environmental factors alone.	[Jacobs, Zenobia; Roberts, Richard G.] Univ Wollongong, GeoQuEST Res Ctr, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Galbraith, Rex F.] UCL, Dept Stat Sci, London WC1E 6BT, England; [Deacon, Hilary J.] Iziko Museums Cape Town, ZA-8000 Cape Town, South Africa; [Gruen, Rainer] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Mackay, Alex] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT 0200, Australia; [Mitchell, Peter] Univ Oxford, Sch Archaeol, Oxford OX1 2PG, England; [Vogelsang, Ralf] Univ Cologne, Inst Prehist Archaeol, African Archaeol Unit, D-50823 Cologne, Germany; [Wadley, Lyn] Univ Witwatersrand, Sch Geog Archaeol & Environm Sci, ZA-2050 Johannesburg, South Africa; [Wadley, Lyn] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Johannesburg, South Africa	University of Wollongong; University of London; University College London; Australian National University; Australian National University; University of Oxford; University of Cologne; University of Witwatersrand; University of Witwatersrand	Jacobs, Z (corresponding author), Univ Wollongong, GeoQuEST Res Ctr, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia.	zenobia@uow.edu.au	Jacobs, Zenobia/B-2721-2012; Wadley, Lyn/AAC-6577-2022; Roberts, Richard Graham/B-8245-2013; Grun, Rainer/A-1437-2012; Mackay, Alex/F-1811-2014	Jacobs, Zenobia/0000-0001-5424-5837; Roberts, Richard Graham/0000-0002-0128-4119; Grun, Rainer/0000-0003-1366-3674; Mackay, Alex/0000-0002-6396-0821	Australian Research Council; Deutsche Forschungsgemeinschaft; National Museum of Namibia; The South African Heritage Resource Agency; Amafa; Namibian Heritage Council of Namibia; Protection and Preservation Commission of Lesotho	Australian Research Council(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Museum of Namibia; The South African Heritage Resource Agency; Amafa; Namibian Heritage Council of Namibia; Protection and Preservation Commission of Lesotho	We acknowledge support from the Australian Research Council (R.G.R., R.G., and Z.J.), Deutsche Forschungsgemeinschaft, and National Museum of Namibia (R.V.). The South African Heritage Resource Agency, Amafa, the Namibian Heritage Council of Namibia, and the Protection and Preservation Commission of Lesotho (N. Khitsane) issued permits.	Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bird MI, 2003, QUATERNARY SCI REV, V22, P943, DOI 10.1016/S0277-3791(03)00005-2; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; d'Errico F, 2008, J ARCHAEOL SCI, V35, P2675, DOI 10.1016/j.jas.2008.04.023; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; JACOBS Z, 2008, S AFR ARCHAEOL SOC G, V10, P8; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1808, DOI 10.1016/j.jas.2007.11.027; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Lian OB, 2006, QUATERNARY SCI REV, V25, P2449, DOI 10.1016/j.quascirev.2005.11.013; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, S AFR ARCHAEOL BULL, V62, P62, DOI 10.2307/20474947; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Rigaud JP, 2006, CR PALEVOL, V5, P839, DOI 10.1016/j.crpv.2006.02.003; Scholz CA, 2007, P NATL ACAD SCI USA, V104, P16416, DOI 10.1073/pnas.0703874104; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wurz S, 1999, S AFR ARCHAEOL BULL, V54, P38, DOI 10.2307/3889138	31	412	423	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					733	735		10.1126/science.1162219	http://dx.doi.org/10.1126/science.1162219			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974351	Green Published, Green Submitted			2022-12-28	WOS:000260605200046
J	Hurtado, A; Holmes, KA; Geistlinger, TR; Hutcheson, IR; Nicholson, RI; Brown, M; Jiang, J; Howat, WJ; Ali, S; Carroll, JS				Hurtado, Antoni; Holmes, Kelly A.; Geistlinger, Timothy R.; Hutcheson, Iain R.; Nicholson, Robert I.; Brown, Myles; Jiang, Jie; Howat, William J.; Ali, Simak; Carroll, Jason S.			Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen	NATURE			English	Article							BREAST-CANCER CELLS; MCF-7 CELLS; RESISTANCE; COACTIVATOR; EXPRESSION; ACTIVATION; AIB1; TRANSCRIPTION; SURVIVAL; THERAPY	Crosstalk between the oestrogen receptor (ER) and ERBB2/HER-2 pathways has long been implicated in breast cancer aetiology and drug eresponse(1), yet no direct connection at a transcriptional level has been shown. Here we show that oestrogen-ER and tamoxifen ER complexes directly repress ERBB2 transcription by means of a cis- regulatory element within the ERBB2 gene in human cell lines. We implicate the paired box 2 gene product ( PAX2), in a previously unrecognized role, as a crucial mediator of ER repression of ERBB2 by the anti- cancer drug tamoxifen. Weshow that PAX2 and the ER co-activator AIB-1/SRC-3 compete for binding and regulation of ERBB2 transcription, the outcome of which determines tamoxifen response in breast cancer cells. The repression of ERBB2 by ER-PAX2 links these two breast cancer subtypes and suggests that aggressive ERBB2- positive tumours can originate from ER- positive luminal tumours by circumventing this repressive mechanism. These data provide mechanistic insight into the molecular basis of endocrine resistance in breast cancer.	[Hurtado, Antoni; Holmes, Kelly A.; Howat, William J.; Carroll, Jason S.] Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Geistlinger, Timothy R.; Brown, Myles] Dana Farber Canc Inst, Boston, MA 02115 USA; [Geistlinger, Timothy R.; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hutcheson, Iain R.; Nicholson, Robert I.] Cardiff Univ, Tenovus Ctr Canc Res, Welsh Sch Pharm, Cardiff CF10 3XF, Wales; [Jiang, Jie; Ali, Simak] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cardiff University; Imperial College London	Carroll, JS (corresponding author), Cambridge Res Inst, Canc Res UK, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	jason.carroll@cancer.org.uk	Ali, Simak/N-4740-2019; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008	Ali, Simak/0000-0002-1320-0816; Brown, Myles/0000-0002-8213-1658; Coombes, Raoul Charles/0000-0002-4811-1100; Hurtado, Antoni/0000-0002-0145-4763; Carroll, Jason/0000-0003-3643-0080	National Institute of Diabetes and Digestive and Kidney Disease [R01DK074967]; National Cancer Institute [P01CA8011105]; DF/HCC Breast Cancer SPORE; University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; NATIONAL CANCER INSTITUTE [P01CA080111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074967] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DF/HCC Breast Cancer SPORE; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Carroll, S.-F. Chin, I. Mills, C. Massie and P. Edwards for discussions; J. Mitchell for histology work; M. Eldridge, S. Vowler and B. Adryan for bioinformatic help; S. Buttiglieri for the p-TARGET-PAX2 construct; J. Eeckhoute for the pcDNA- AIB- 1 construct; and M. Iddawela for the gift of Herceptin. This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Disease (R01DK074967 to M. B.) and the National Cancer Institute (P01CA8011105, and the DF/HCC Breast Cancer SPORE Grant to M. B.). We acknowledge support from the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bates NP, 1997, ONCOGENE, V15, P473, DOI 10.1038/sj.onc.1201368; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Clark J, 2002, GENE CHROMOSOME CANC, V34, P104, DOI 10.1002/gcc.10039; Clarke R, 2001, PHARMACOL REV, V53, P25; Dowsett M, 2001, ENDOCR-RELAT CANCER, V8, P191, DOI 10.1677/erc.0.0080191; Dowsett M, 2001, CANCER RES, V61, P8452; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhou ZC, 2005, J CENT SOUTH UNIV T, V12, P1, DOI 10.1007/s11771-005-0190-y	30	245	254	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					663	U93		10.1038/nature07483	http://dx.doi.org/10.1038/nature07483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	19005469	Bronze, Green Accepted			2022-12-28	WOS:000261340000046
J	Coleman, HR; Chan, CC; Ferris, FL; Chew, EY				Coleman, Hanna R.; Chan, Chi-Chao; Ferris, Frederick L., III; Chew, Emily Y.			Age-related macular degeneration	LANCET			English	Review							COMPLEMENT FACTOR-H; VITAMIN-E SUPPLEMENTATION; 3RD NATIONAL-HEALTH; BODY-MASS INDEX; VISUAL IMPAIRMENT; RISK-FACTORS; GEOGRAPHIC ATROPHY; DIETARY-FAT; CIGARETTE-SMOKING; 5-YEAR INCIDENCE	Age-related macular degeneration is the leading cause of blindness in elderly populations of European descent. The most consistent risk factors associated with this ocular condition are increasing age and cigarette smoking. Genetic investigations have shown that complement factor H, a regulator of the alternative complement pathway, and LOC387715/HtrA1 are the most consistent genetic risk factors for age-related macular degeneration. Although the pathogenesis of this disease is unknown, oxidative stress might have an important role. Treatment with antioxidant vitamins and zinc can reduce the risk of developing advanced age-related macular degeneration by about a quarter in those at least at moderate risk. Intravitreal injections of ranibizumab, a monoclonal antibody that inhibits all forms of vascular endothelial growth factor, have been shown to stabilise loss of vision and, in some cases, improve vision in individuals with neovascular age-related macular degeneration. These findings, combined with assessments of possible environmental and genetic interactions and new approaches to modulate inflammatory pathways, will hopefully further expand our ability to understand and treat age-related macular degeneration.	[Coleman, Hanna R.; Ferris, Frederick L., III; Chew, Emily Y.] NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA; [Chan, Chi-Chao] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chew, EY (corresponding author), NEI, Div Epidemiol & Clin Res, NIH, Bldg 10,CRC,Room 3-2531,10 Ctr Dr,MSC-1204, Bethesda, MD 20892 USA.	echew@nei.nih.gov		Ferris, Frederick/0000-0002-4933-0639	NATIONAL EYE INSTITUTE [ZICEY000461, ZIAEY000418, ZIAEY000222] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 EY000418-04, Z01 EY000222-22, Z99 EY999999] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Albanes D, 2007, JAMA-J AM MED ASSOC, V298, P400, DOI 10.1001/jama.298.4.400-a; Allikmets R, 2008, NAT GENET, V40, P820, DOI 10.1038/ng0708-820; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; [Anonymous], 1993, Arch Ophthalmol, V111, P104; [Anonymous], 2005, ARCH OPHTHALMOL-CHIC, V123, P1570, DOI DOI 10.1001/ARCHOPHT.123.11.1570; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; BRESSLER NM, 1994, RETINA-J RET VIT DIS, V14, P130, DOI 10.1097/00006982-199414020-00006; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; BRESSLER NM, 1989, ARCH OPHTHALMOL-CHIC, V107, P847, DOI 10.1001/archopht.1989.01070010869032; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; Chan Chi-Chao, 2007, Trans Am Ophthalmol Soc, V105, P92; Chen J, 2007, J CLIN INVEST, V117, P2758, DOI 10.1172/JCI33513; Chew EY, 2005, ARCH OPHTHALMOL-CHIC, V123, P395, DOI 10.1001/archopht.123.3.395; Cho E, 2001, AM J CLIN NUTR, V73, P209; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; Chua B, 2006, ARCH OPHTHALMOL-CHIC, V124, P981, DOI 10.1001/archopht.124.7.981; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Cruickshanks KJ, 1997, ARCH OPHTHALMOL-CHIC, V115, P242, DOI 10.1001/archopht.1997.01100150244015; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; DASTGHEIB K, 1994, ARCH OPHTHALMOL-CHIC, V112, P813, DOI 10.1001/archopht.1994.01090180111045; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Delcourt C, 2001, ARCH OPHTHALMOL-CHIC, V119, P1463; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FINE SL, 1982, ARCH OPHTHALMOL-CHIC, V100, P912; Flood V, 2002, OPHTHALMOLOGY, V109, P2272, DOI 10.1016/S0161-6420(02)01263-0; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Friberg TR, 2006, OPHTHALMOLOGY, V113, P612, DOI 10.1016/j.ophtha.2005.10.066; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; GASS JD, 1973, T AM ACAD OPHTHALMOL, V77; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; GOLDBERG J, 1988, AM J EPIDEMIOL, V128, P700, DOI 10.1093/oxfordjournals.aje.a115023; Gottfredsdottir MS, 1999, ACTA OPHTHALMOL SCAN, V77, P422, DOI 10.1034/j.1600-0420.1999.770413.x; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Green W R, 1999, Mol Vis, V5, P27; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HAWKINS BS, 1986, ARCH OPHTHALMOL-CHIC, V104, P694; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heuberger RA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1833, DOI 10.1001/archopht.119.12.1833; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Huang HY, 2007, JAMA-J AM MED ASSOC, V298, P400, DOI 10.1001/jama.298.4.400-b; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P471, DOI 10.1097/00006982-200208000-00012; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P464, DOI 10.1097/00006982-200208000-00011; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; KLEIN ML, 1994, ARCH OPHTHALMOL-CHIC, V112, P932, DOI 10.1001/archopht.1994.01090190080025; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 1998, ARCH OPHTHALMOL-CHIC, V116, P506, DOI 10.1001/archopht.116.4.506; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 1999, OPHTHALMOLOGY, V106, P1056, DOI 10.1016/S0161-6420(99)90255-5; KLEIN R, 1999, AGE RELATED MACULAR, P31; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Lamb LE, 2004, PHOTOCHEM PHOTOBIOL, V79, P127, DOI 10.1562/0031-8655(2004)079<0127:AACOOL>2.0.CO;2; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Lau LI, 2006, INVEST OPHTH VIS SCI, V47, P3242, DOI 10.1167/iovs.05-1532; Gluud LL, 2007, JAMA-J AM MED ASSOC, V298, P402, DOI 10.1001/jama.298.4.402; Lutty G, 1999, MOL VIS, V5; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Mares-Perlman JA, 2001, AM J EPIDEMIOL, V153, P424, DOI 10.1093/aje/153.5.424; MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014; MARESPERLMAN JA, 1995, ARCH OPHTHALMOL-CHIC, V113, P743, DOI 10.1001/archopht.1995.01100060069034; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; MEYERS SM, 1995, AM J OPHTHALMOL, V120, P757, DOI 10.1016/S0002-9394(14)72729-1; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Mukesh BN, 2004, OPHTHALMOLOGY, V111, P1176, DOI 10.1016/j.ophtha.2003.08.042; Mullins RF, 1997, OPHTHALMOLOGY, V104, P288, DOI 10.1016/S0161-6420(97)30322-4; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okamoto H, 2006, MOL VIS, V12, P156; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Owens SL, 2006, AM J OPHTHALMOL, V141, P276, DOI 10.1016/j.ajo.2005.08.019; Park DW, 2006, OPHTHALMOLOGY, V113, P1974, DOI 10.1016/j.ophtha.2006.08.015; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ross RJ, 2007, INVEST OPHTH VIS SCI, V48, P1128, DOI 10.1167/iovs.06-0999; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Sarks JP, 1997, EYE, V11, P515, DOI 10.1038/eye.1997.137; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Sarks S, 2007, INVEST OPHTH VIS SCI, V48, P968, DOI 10.1167/iovs.06-0443; SCHACHAT AP, 1995, ARCH OPHTHALMOL-CHIC, V113, P728, DOI 10.1001/archopht.1995.01100060054032; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schmitz-Valckenberg S, 2006, INVEST OPHTH VIS SCI, V47, P2648, DOI 10.1167/iovs.05-0892; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Smith W, 1998, AUST NZ J OPHTHALMOL, V26, P203, DOI 10.1111/j.1442-9071.1998.tb01311.x; Snellen ELM, 2002, ACTA OPHTHALMOL SCAN, V80, P368, DOI 10.1034/j.1600-0420.2002.800404.x; Souied EH, 2005, MOL VIS, V11, P1135; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Steinbrook R, 2006, NEW ENGL J MED, V355, P1409, DOI 10.1056/NEJMp068185; Tan JSL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1089, DOI 10.1001/archopht.125.8.1089; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5; *VERT ROUNDT 2000, 2002, RETINA, V22, P6; VINDING T, 1992, ACTA OPHTHALMOL, V70, P66; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Vingerling JR, 1996, ARCH OPHTHALMOL-CHIC, V114, P1193, DOI 10.1001/archopht.1996.01100140393005; Vu HTV, 2006, BRIT J OPHTHALMOL, V90, P389, DOI 10.1136/bjo.2005.078055; Wang JJ, 2000, CLIN EXP OPHTHALMOL, V28, P268, DOI 10.1046/j.1442-9071.2000.00315.x; Weih LM, 2000, ARCH OPHTHALMOL-CHIC, V118, P264; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Yates YR, 2007, NEW ENGL J MED, V357, P19; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	163	405	421	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1835	1845		10.1016/S0140-6736(08)61759-6	http://dx.doi.org/10.1016/S0140-6736(08)61759-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	19027484	Green Accepted			2022-12-28	WOS:000261112000026
J	Chambouvet, A; Morin, P; Marie, D; Guillou, L				Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure			Control of Toxic Marine Dinoflagellate Blooms by Serial Parasitic Killers	SCIENCE			English	Article							18S RDNA SEQUENCES; CHESAPEAKE BAY; EUKARYOTIC DIVERSITY; AMOEBOPHRYA-CERATII; PICOPLANKTON; SURVIVAL; PLANKTON; STRAINS; TIME; SITE	The marine dinoflagellates commonly responsible for toxic red tides are parasitized by other dinoflagellate species. Using culture- independent environmental ribosomal RNA sequences and fluorescence markers, we identified host- specific infections among several species. Each parasitoid produces 60 to 400 offspring, leading to extraordinarily rapid control of the host's population. During 3 consecutive years of observation in a natural estuary, all dinoflagellates observed were chronically infected, and a given host species was infected by a single genetically distinct parasite year after year. Our observations in natural ecosystems suggest that although bloom- forming dinoflagellates may escape control by grazing organisms, they eventually succumb to parasite attack.	[Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure] CNRS, Biol Stn, UMR 7144, F-29682 Roscoff, France; [Chambouvet, Aurelie; Morin, Pascal; Marie, Dominique; Guillou, Laure] Univ Paris 06, Lab Adapt & Divers Milieu Marin, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Guillou, L (corresponding author), CNRS, Biol Stn, UMR 7144, Pl Georges Teissier, F-29682 Roscoff, France.	lguillou@sb-roscoff.fr	Morin, Pascal/A-1112-2016	Morin, Pascal/0000-0003-2766-1821; Chambouvet, Aurelie/0000-0003-3932-0098; Guillou, Laure/0000-0003-1032-7958	Groupement d'Interet Scientifique Genomique Marine; French Agence National de la Recherche project Aquaparadox	Groupement d'Interet Scientifique Genomique Marine; French Agence National de la Recherche project Aquaparadox(French National Research Agency (ANR))	We thank A. Carlier, D. Charruaud, A. Groisillier, and S. Maury for their earlier contributions to this work; D. Vaulot, P. von Dassow, and A. Worden for critically reading this manuscript; P. Falkowski for his help with corrections and discussions; W. Coats for cultures of Amoebophrya spp. that greatly helped us to test the oligonucleotide probes and for constructive discussions; D. Jollivet for his help with genetic population analysis; The Service Mer et Observation of the Roscoff Biological Station; and E. Mace for sample collections and nutrient acquisition parameters. This work was financially supported by the Groupement d'Interet Scientifique Genomique Marine and the French Agence National de la Recherche project Aquaparadox. We also thank Zeiss for help in the acquisition of the confocal micrographs. Sequences have been deposited in GenBank under accession numbers FJ356776 to FJ357007. The authors declare no competing financial interests.	Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; [Anonymous], [No title captured]; CHACHON J, 1964, ANN SCI NAT ZOOL, V6, P1; Chatton E., 1920, Archives de Zoologie Experimentale Paris, V59; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; COATS DW, 1994, J EUKARYOT MICROBIOL, V41, P586, DOI 10.1111/j.1550-7408.1994.tb01520.x; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Gunderson JH, 2002, J EUKARYOT MICROBIOL, V49, P469, DOI 10.1111/j.1550-7408.2002.tb00230.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Maguer JF, 2004, LIMNOL OCEANOGR, V49, P1108, DOI 10.4319/lo.2004.49.4.1108; Medlin LK, 2006, MICROB ECOL, V52, P53, DOI 10.1007/s00248-005-0062-x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Nishitani L., 1985, P225; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Salomon PS, 2003, ENVIRON MICROBIOL, V5, P1046, DOI 10.1046/j.1462-2920.2003.00511.x; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; TAYLOR FJR, 1968, J FISH RES BOARD CAN, V25, P2241, DOI 10.1139/f68-197; Zingone A, 2000, OCEAN COAST MANAGE, V43, P725, DOI 10.1016/S0964-5691(00)00056-9	23	209	215	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1254	1257		10.1126/science.1164387	http://dx.doi.org/10.1126/science.1164387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023082				2022-12-28	WOS:000261033400044
J	Holt, JW; Safaeinili, A; Plaut, JJ; Head, JW; Phillips, RJ; Seu, R; Kempf, SD; Choudhary, P; Young, DA; Putzig, NE; Biccari, D; Gim, Y				Holt, John W.; Safaeinili, Ali; Plaut, Jeffrey J.; Head, James W.; Phillips, Roger J.; Seu, Roberto; Kempf, Scott D.; Choudhary, Prateek; Young, Duncan A.; Putzig, Nathaniel E.; Biccari, Daniela; Gim, Yonggyu			Radar Sounding Evidence for Buried Glaciers in the Southern Mid-Latitudes of Mars	SCIENCE			English	Article							POLAR LAYERED DEPOSITS; LOBATE DEBRIS APRONS; CLIMATE-CHANGE; ICE; SUBSURFACE; OBLIQUITY; ACCUMULATION; REGION; FLOW	Lobate features abutting massifs and escarpments in the middle latitudes of Mars have been recognized in images for decades, but their true nature has been controversial, with hypotheses of origin such as ice- lubricated debris flows or glaciers covered by a layer of surface debris. These models imply an ice content ranging from minor and interstitial to massive and relatively pure. Soundings of these deposits in the eastern Hellas region by the Shallow Radar on the Mars Reconnaissance Orbiter reveal radar properties entirely consistent with massive water ice, supporting the debris- covered glacier hypothesis. The results imply that these glaciers formed in a previous climate conducive to glaciation at middle latitudes. Such features may collectively represent the most extensive nonpolar ice yet recognized on Mars.	[Holt, John W.; Kempf, Scott D.; Choudhary, Prateek; Young, Duncan A.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Safaeinili, Ali; Plaut, Jeffrey J.; Gim, Yonggyu] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Phillips, Roger J.; Putzig, Nathaniel E.] SW Res Inst, Boulder, CO 80302 USA; [Seu, Roberto; Biccari, Daniela] Univ Roma La Sapienza, INFOCOM Dept, I-00184 Rome, Italy	University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University; Sapienza University Rome	Holt, JW (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	jack@ig.utexas.edu	Young, Duncan A./G-6256-2010; Holt, John/C-4896-2009	Young, Duncan A./0000-0002-6866-8176; Putzig, Nathaniel/0000-0003-4485-6321	Institute for Geophysics of the Jackson School of Geosciences and NASA [NAG5-12693]	Institute for Geophysics of the Jackson School of Geosciences and NASA	We thank F. Russo, M. Cutigni, O. Fuga, and E. Giacomoni of the SHARAD Operations Center for their role in acquiring the data over these targets; F. Bernardini for his assistance in the U. S. data processing effort; and two anonymous reviewers for their comments and suggestions. Work at the University of Texas was supported by the Institute for Geophysics of the Jackson School of Geosciences and NASA grant NAG5-12693 (J.W.H.). MRO is operated for NASA by Caltech's Jet Propulsion Laboratory. SHARAD was provided to MRO by the Italian Space Agency through a contract with Thales Alenia Space Italia and is operated by the INFOCOM Department, University of Rome. This is UTIG contribution 2006.	Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr M.H, 1996, WATER MARS; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Forget F, 2006, SCIENCE, V311, P368, DOI 10.1126/science.1120335; GUDMANDSEN P, 1971, ELECTROMAGNETIC PROB, P329; Head JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024360; Head JW, 2006, EARTH PLANET SC LETT, V241, P663, DOI 10.1016/j.epsl.2005.11.016; Head JW, 2005, NATURE, V434, P346, DOI 10.1038/nature03359; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Heggy E., 2007, LUNAR PLANET SCI, VXXXVIII; Holt JW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002525; KRESS AM, 2008, LUNAR PLANET SCI C, V39, P1293; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; Li H, 2005, ICARUS, V176, P382, DOI 10.1016/j.icarus.2005.02.011; Lucchitta B. K., 1984, Journal of Geophysical Research, V89, P409, DOI 10.1029/JB089iS02p0B409; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; Marchant DR, 2007, ICARUS, V192, P187, DOI 10.1016/j.icarus.2007.06.018; Mest SC, 2001, ICARUS, V153, P89, DOI 10.1006/icar.2001.6655; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Pierce TL, 2003, ICARUS, V163, P46, DOI 10.1016/S0019-1035(03)00046-0; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; PLAUT JJ, 2008, LUNAR PLANET SCI, V39, P2290; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; SQUYRES SW, 1979, J GEOPHYS RES, V84, P8087, DOI 10.1029/JB084iB14p08087	30	231	236	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1235	1238		10.1126/science.1164246	http://dx.doi.org/10.1126/science.1164246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023078				2022-12-28	WOS:000261033400038
J	Schmittner, A; Galbraith, ED				Schmittner, Andreas; Galbraith, Eric D.			Glacial greenhouse-gas fluctuations controlled by ocean circulation changes	NATURE			English	Article							ATMOSPHERIC CO2; CARBON-CYCLE; ICE CORE; CLIMATE; REORGANIZATIONS; DYNAMICS; SURFACE; SYSTEM; EARTH; PUMP	Earth's climate and the concentrations of the atmospheric greenhouse gases carbon dioxide (CO2) and nitrous oxide (N2O) varied strongly on millennial timescales during past glacial periods. Large and rapid warming events in Greenland and the North Atlantic were followed by more gradual cooling, and are highly correlated with fluctuations of N2O as recorded in ice cores. Antarctic temperature variations, on the other hand, were smaller and more gradual, showed warming during the Greenland cold phase and cooling while the North Atlantic was warm, and were highly correlated with fluctuations in CO2. Abrupt changes in the Atlantic meridional overturning circulation (AMOC) have often been invoked to explain the physical characteristics of these Dansgaard - Oeschger climate oscillations(1-3), but the mechanisms for the greenhouse- gas variations and their linkage to the AMOC have remained unclear(4-8). Here we present simulations with a coupled model of glacial climate and biogeochemical cycles, forced only with changes in the AMOC. The model simultaneously reproduces characteristic features of the Dansgaard - Oeschger temperature, as well as CO2 and N2O fluctuations. Despite significant changes in the land carbon inventory, CO2 variations on millennial timescales are dominated by slow changes in the deep ocean inventory of biologically sequestered carbon and are correlated with Antarctic temperature and Southern Ocean stratification. In contrast, N2O co-varies more rapidly with Greenland temperatures owing to fast adjustments of the thermocline oxygen budget. These results suggest that ocean circulation changes were the primary mechanism that drove glacial CO2 and N2O fluctuations on millennial timescales.	[Schmittner, Andreas] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Galbraith, Eric D.] Princeton Univ, Princeton, NJ 08544 USA	Oregon State University; Princeton University	Schmittner, A (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	aschmitt@coas.oregonstate.edu	Galbraith, Eric D./F-9469-2014; Schmittner, Andreas/O-9647-2015	Galbraith, Eric D./0000-0003-4476-4232; Schmittner, Andreas/0000-0002-8376-0843	NSF Marine Geology and Geophysics [0728315-OCE]; NSF Paleoclimate programme [0602395-ATM]	NSF Marine Geology and Geophysics(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF Paleoclimate programme(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the NSF Marine Geology and Geophysics programme grant 0728315-OCE, and the NSF Paleoclimate programme grant 0602395-ATM. We thank J. Ahn, E. Brook, R. Toggweiler and V. Brovkin for discussions and comments on the manuscript.	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Ahn JH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029551; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Goldstein B, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016418; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; Kohler P, 2005, CLIM DYNAM, V25, P689, DOI 10.1007/s00382-005-0058-8; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Marchal O, 1998, PALEOCEANOGRAPHY, V13, P225, DOI 10.1029/98PA00726; Meissner KJ, 2003, CLIM DYNAM, V21, P515, DOI 10.1007/s00382-003-0352-2; Menviel L, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001445; Nevison C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002068; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Schmittner A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024368; Schmittner A, 2005, NATURE, V434, P628, DOI 10.1038/nature03476; Schmittner A, 2003, QUATERNARY SCI REV, V22, P659, DOI 10.1016/S0277-3791(02)00184-1; Schmittner A., 2007, GEOPHYS MONOGR SER, V173, P209, DOI DOI 10.1029/173GM20; Schmittner A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001384; Schmittner A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002953; Scholze M, 2003, HOLOCENE, V13, P327, DOI 10.1191/0959683603hl625rp; Sigman D. M., 2003, TREATISE GEOCHEMISTR, V6, P491, DOI DOI 10.1016/B978-0-08-095975-7.00618-5; Sowers T, 2003, SCIENCE, V301, P945, DOI 10.1126/science.1085293; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001401	30	141	145	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					373	376		10.1038/nature07531	http://dx.doi.org/10.1038/nature07531			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020618				2022-12-28	WOS:000261039600040
J	Churchill, LR; Schenck, D				Churchill, Larry R.; Schenck, David			Healing Skills for Medical Practice	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE	It is well recognized that physicians' relationships with their patients can have healing effects, but the skills in this area of medical practice are understudied. This article reports on research designed to identify a core set of healing skills. The authors interviewed 50 practitioners, who were identified by their peers as "healers," representing both allopathic and complementary medicine and alternative medicine. Interviews were tape-recorded, transcribed, made anonymous, and analyzed independently, and differences were reconciled by discussion. Eight skills emerged as pivotal from the transcripts of these interviews: do the little things; take time; be open and listen; find something to like, to love; remove barriers; let the patient explain; share authority; and be committed. Mastery of these skills would provide enduring improvements in patient care and reaffirm medicine's calling as a healing profession.	[Churchill, Larry R.] Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, Nashville, TN 37203 USA	Vanderbilt University	Churchill, LR (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, 2525 W End Ave,Suite 400, Nashville, TN 37203 USA.	larry.churchill@vanderbilt.edu						BILLINGS JA, 1999, CLIN ENCOUNTER GUIDE; BRODY H, 1980, PLACEBOS PHILOS MED; CASSELL EJ, 1985, TALKING PATIENTS, V1; CHAPMAN E, 2007, CAREGIVER MEDITATION; Charon R., 2006, NARRATIVE MED HONORI; Charon R., 2002, STORIES MATTER ROLE; COULEHAN JL, 2001, MED INTERVIEW MASTER; Groopman J, 2007, DOCTORS THINK; Hsu C, 2008, ANN FAM MED, V6, P307, DOI 10.1370/afm.838; Kleinman A., 1988, ILLNESS NARRATIVES; Mishler EG, 1984, DISCOURSE MED DIALEC; Moerman Daniel E., 2002, CAMBRIDGE STUDIES ME; PELLEGRINO ED, 1979, HUMANISM PHYS, P117; REMEN R, 2007, SPEAKING FAITH, P213; Scott JG, 2008, ANN FAM MED, V6, P315, DOI 10.1370/afm.860; Tresolini C. P., 1994, HLTH PROFESSIONS ED	16	50	50	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2008	149	10					720	U9		10.7326/0003-4819-149-10-200811180-00006	http://dx.doi.org/10.7326/0003-4819-149-10-200811180-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373FL	19017590				2022-12-28	WOS:000260956300004
J	Alkire, MT; Hudetz, AG; Tononi, G				Alkire, Michael T.; Hudetz, Anthony G.; Tononi, Giulio			Consciousness and Anesthesia	SCIENCE			English	Review							CEREBRAL-BLOOD-FLOW; COGNITIVE NEUROSCIENCE; GENERAL-ANESTHESIA; NEURONAL PATHWAYS; BISPECTRAL INDEX; NITROUS-OXIDE; SLEEP; BRAIN; ISOFLURANE; AWARENESS	When we are anesthetized, we expect consciousness to vanish. But does it always? Although anesthesia undoubtedly induces unresponsiveness and amnesia, the extent to which it causes unconsciousness is harder to establish. For instance, certain anesthetics act on areas of the brain's cortex near the midline and abolish behavioral responsiveness, but not necessarily consciousness. Unconsciousness is likely to ensue when a complex of brain regions in the posterior parietal area is inactivated. Consciousness vanishes when anesthetics produce functional disconnection in this posterior complex, interrupting cortical communication and causing a loss of integration; or when they lead to bistable, stereotypic responses, causing a loss of information capacity. Thus, anesthetics seem to cause unconsciousness when they block the brain's ability to integrate information.	[Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Alkire, Michael T.] Univ Calif Irvine, Dept Anesthesiol, Irvine, CA 92868 USA; [Alkire, Michael T.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92868 USA; [Hudetz, Anthony G.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of California System; University of California Irvine; Medical College of Wisconsin	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu	Tononi, Giulio/B-8387-2009		NIH Director's Pioneer Award; James S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056398] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the NIH Director's Pioneer Award and the James S. McDonnell Foundation (G.T.). G.T. has a patent pending on the use of TMS-EEG in anesthesia.	Alkire MT, 2008, P NATL ACAD SCI USA, V105, P1722, DOI 10.1073/pnas.0711651105; Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; ALKIRE MT, 2007, ANESTHESIOLOGY, V104, pA1219; ANGEL A, 1993, BRIT J ANAESTH, V71, P148, DOI 10.1093/bja/71.1.148; [Anonymous], 2006, ANESTHESIOLOGY, V104, P847; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Blumenfeld H, 2005, PROG BRAIN RES, V150, P271, DOI 10.1016/S0079-6123(05)50020-7; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRENCH JD, 1955, J NEUROPHYSIOL, V18, P74, DOI 10.1152/jn.1955.18.1.74; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Gyulai FE, 1996, ANESTH ANALG, V83, P291, DOI 10.1097/00000539-199608000-00016; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Hudetz AG, 2008, INT ANESTHESIOL CLIN, V46, P25, DOI 10.1097/AIA.0b013e3181755db5; Hudetz AG, 2007, ANESTHESIOLOGY, V107, P983, DOI 10.1097/01.anes.0000291471.80659.55; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; Imas OA, 2006, NEUROSCI LETT, V402, P216, DOI 10.1016/j.neulet.2006.04.003; John ER, 2005, ANESTHESIOLOGY, V102, P447, DOI 10.1097/00000542-200502000-00030; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lydic R, 2005, ANESTHESIOLOGY, V103, P1268; Magnin M, 2004, CEREB CORTEX, V14, P858, DOI 10.1093/cercor/bhh044; Maquet P, 2000, J SLEEP RES, V9, P207; Markowitsch HJ, 2000, EXP BRAIN RES, V133, P94, DOI 10.1007/s002210000404; Mashour GA, 2004, ANESTHESIOLOGY, V100, P428, DOI 10.1097/00000542-200402000-00035; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; MILLER JW, 1990, NEUROPHARMACOLOGY, V29, P649, DOI 10.1016/0028-3908(90)90026-N; MUNGLANI R, 1993, BRIT J ANAESTH, V71, P633, DOI 10.1093/bja/71.5.633; Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9; NAKAKIMURA K, 1988, ANESTHESIOLOGY, V68, P777, DOI 10.1097/00000542-198805000-00017; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; POSNER JB, 2007, CONT NEUROLOGY SER, V71; Ries CR, 1999, J NEUROPHYSIOL, V81, P1795, DOI 10.1152/jn.1999.81.4.1795; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2000, J CLIN NEUROPHYSIOL, V17, P438, DOI 10.1097/00004691-200009000-00002; Schneider G, 2003, BRIT J ANAESTH, V91, P329, DOI 10.1093/bja/aeg188; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Steyn-Ross ML, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011917; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; TOPULOS GP, 1993, J CLIN ANESTH, V5, P369, DOI 10.1016/0952-8180(93)90099-Z; TUCKER MR, 1984, J ORAL MAXIL SURG, V42, P668, DOI 10.1016/0278-2391(84)90210-6; Vahle-Hinz C, 2007, EXP BRAIN RES, V176, P159, DOI 10.1007/s00221-006-0604-6; Velly LJ, 2007, ANESTHESIOLOGY, V107, P202, DOI 10.1097/01.anes.0000270734.99298.b4; Veselis RA, 2004, ANESTH ANALG, V99, P399, DOI 10.1213/01.ANE.0000131971.92180.DF; Veselis RA, 2002, ANESTHESIOLOGY, V97, P329, DOI 10.1097/00000542-200208000-00008; VILLABLANCA J, 1972, ARCH ITAL BIOL, V110, P383; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Voss L, 2007, BEST PRACT RES-CLIN, V21, P313, DOI 10.1016/j.bpa.2007.04.003; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	66	763	780	5	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					876	880		10.1126/science.1149213	http://dx.doi.org/10.1126/science.1149213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988836	Green Accepted			2022-12-28	WOS:000260674100030
J	Jasny, BR; Kelner, KL; Pennisi, E				Jasny, Barbara R.; Kelner, Katrina L.; Pennisi, Elizabeth			From Genes to Social Behavior Introduction	SCIENCE			English	Editorial Material																			0	10	11	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					891	891		10.1126/science.322.5903.891	http://dx.doi.org/10.1126/science.322.5903.891			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369DI	18988838				2022-12-28	WOS:000260674100032
J	Liu, LJ; Spasojevic, S; Gurnis, M				Liu, Lijun; Spasojevic, Sonja; Gurnis, Michael			Reconstructing Farallon Plate Subduction Beneath North America Back to the Late Cretaceous	SCIENCE			English	Article							MANTLE CIRCULATION; MOTION; TOMOGRAPHY; SUBSIDENCE; INTERIOR; MODELS; BASIN	Using an inverse mantle convection model that assimilates seismic structure and plate motions, we reconstruct Farallon plate subduction back to 100 million years ago. Models consistent with stratigraphy constrain the depth dependence of mantle viscosity and buoyancy, requiring that the Farallon slab was flat lying in the Late Cretaceous, consistent with geological reconstructions. The simulation predicts that an extensive zone of shallow- dipping subduction extended beyond the flat-lying slab farther east and north by up to 1000 kilometers. The limited region of flat subduction is consistent with the notion that subduction of an oceanic plateau caused the slab to flatten. The results imply that seismic images of the current mantle provide more constraints on past tectonic events than previously recognized.	[Liu, Lijun; Spasojevic, Sonja; Gurnis, Michael] CALTECH, Seismol Lab, Pasadena, CA 91125 USA	California Institute of Technology	Liu, LJ (corresponding author), CALTECH, Seismol Lab, Pasadena, CA 91125 USA.	lijun@gps.caltech.edu	Liu, Lijun/C-2840-2012		Gordon and Betty Moore Foundation; Tectonics Observatory; NSF [EAR-0609707]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Tectonics Observatory; NSF(National Science Foundation (NSF))	This is contribution no. TO 88 of the Caltech Tectonics Observatory. The work was partially supported by the Gordon and Betty Moore Foundation through the Tectonics Observatory and the NSF through EAR-0609707. We appreciate discussions with J. Saleeby and R. D. Muller. The original CitcomS software was obtained from the Computational Infrastructure for Geodynamics (CIG) (http://geodynamics.	BOND G, 1976, GEOLOGY, V4, P557, DOI 10.1130/0091-7613(1976)4<557:EFCSIN>2.0.CO;2; Bunge HP, 2000, NATURE, V405, P337, DOI 10.1038/35012586; Bunge HP, 2003, GEOPHYS J INT, V152, P280, DOI 10.1046/j.1365-246X.2003.01823.x; Burgess PM, 1997, GEOL SOC AM BULL, V109, P1515, DOI 10.1130/0016-7606(1997)109<1515:FOSITC>2.3.CO;2; Cook T. D., 1975, STRATIGRAPHIC ATLAS; DAVIES GF, 1999, DYNAMIC EARTH PLATES, P262; FLOWERS RM, 2007, EOS, V52; Goes S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000049; Grand SP, 2002, PHILOS T R SOC A, V360, P2475, DOI 10.1098/rsta.2002.1077; Gurnis M, 1998, SCIENCE, V279, P1499, DOI 10.1126/science.279.5356.1499; GURNIS M, 2007, EOS, V52; Gutscher MA, 2000, TECTONICS, V19, P814, DOI 10.1029/1999TC001152; Liu LJ, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005594; Liu SF, 2005, BASIN RES, V17, P487, DOI 10.1111/j.1365-2117.2005.00277.x; LIVACCARI RF, 1981, NATURE, V289, P276, DOI 10.1038/289276a0; Milne GA, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002619; MITROVICA JX, 1989, TECTONICS, V8, P1079, DOI 10.1029/TC008i005p01079; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; PANG M, 1995, GEOLOGY, V23, P173, DOI 10.1130/0091-7613(1995)023<0173:FSABTO>2.3.CO;2; Ren Y, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004154; Saleeby J, 2003, GEOL SOC AM BULL, V115, P655, DOI 10.1130/0016-7606(2003)115<0655:SOTLSF>2.0.CO;2; SCHUBERT G, 2001, MANTLE CONVECTION EA, P417; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Zhong SJ, 2000, J GEOPHYS RES-SOL EA, V105, P11063, DOI 10.1029/2000JB900003; ZHONG SJ, 1995, SCIENCE, V267, P838, DOI 10.1126/science.267.5199.838	26	219	232	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					934	938		10.1126/science.1162921	http://dx.doi.org/10.1126/science.1162921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988850				2022-12-28	WOS:000260674100044
J	Foster, MA; Salem, R; Geraghty, DF; Turner-Foster, AC; Lipson, M; Gaeta, AL				Foster, Mark A.; Salem, Reza; Geraghty, David F.; Turner-Foster, Amy C.; Lipson, Michal; Gaeta, Alexander L.			Silicon-chip-based ultrafast optical oscilloscope	NATURE			English	Article							CONVERSION TIME MICROSCOPE; GROUP-VELOCITY DISPERSION; WAVE-GUIDES; WAVELENGTH CONVERSION; PULSE; INTERFEROMETRY; MAGNIFICATION; GENERATION; SYSTEMS; PHASE	With the realization of faster telecommunication data rates and an expanding interest in ultrafast chemical and physical phenomena, it has become important to develop techniques that enable simple measurements of optical waveforms with subpicosecond resolution(1). State- of- the- art oscilloscopes with high- speed photodetectors provide single- shot waveform measurement with 30- ps resolution. Although multiple- shot sampling techniques can achieve few- picosecond resolution, single- shot measurements are necessary to analyse events that are rapidly varying in time, asynchronous, or may occur only once. Further improvements in single- shot resolution are challenging, owing to microelectronic bandwidth limitations. To overcome these limitations, researchers have looked towards all- optical techniques because of the large processing bandwidths that photonics allow. This has generated an explosion of interest in the integration of photonics on standard electronics platforms, which has spawned the field of silicon photonics(2) and promises to enable the next generation of computer processing units and advances in high- bandwidth communications. For the success of silicon photonics in these areas, on- chip optical signal- processing for optical performance monitoring will prove critical. Beyond next- generation communications, siliconcompatible ultrafast metrology would be of great utility to many fundamental research fields, as evident from the scientific impact that ultrafast measurement techniques continue to make(3-5). Here, using time- to- frequency conversion(6) via the nonlinear process of four- wave mixing on a silicon chip, we demonstrate a waveform measurement technology within a silicon- photonic platform. We measure optical waveforms with 220- fs resolution over lengths greater than 100 ps, which represent the largest record- length- to-resolution ratio (> 450) of any single- shot- capable picosecond waveform measurement technique(6-16). Our implementation allows for single- shot measurements and uses only highly developed electronic and optical materials of complementary metal- oxide-semiconductor (CMOS)- compatible silicon- on- insulator technology and single- mode optical fibre. The mature silicon- on- insulator platform and the ability to integrate electronics with these CMOS-compatible photonics offer great promise to extend this technology into commonplace bench- top and chip- scale instruments.	[Foster, Mark A.; Salem, Reza; Geraghty, David F.; Gaeta, Alexander L.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Turner-Foster, Amy C.; Lipson, Michal] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Gaeta, AL (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	a.gaeta@cornell.edu	Gaeta, Alexander/AAE-2095-2019; Foster, Amy C/E-8009-2010; Foster, Mark/E-8011-2010	Foster, Mark/0000-0002-4524-141X	DARPA; NSF; New York State Office of Science, Technology and Academic Research	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); New York State Office of Science, Technology and Academic Research	This work was supported by DARPA through the optical arbitrary waveform generation programme and by the Center for Nanoscale Systems, supported by the NSF and the New York State Office of Science, Technology and Academic Research.	Akhmanov S. A., 1986, Soviet Physics - Uspekhi, V29, P642, DOI 10.1070/PU1986v029n07ABEH003462; Azana J, 2004, APPL OPTICS, V43, P483, DOI 10.1364/AO.43.000483; BENNETT CV, 1994, APPL PHYS LETT, V65, P2513, DOI 10.1063/1.112620; Bennett CV, 1999, OPT LETT, V24, P783, DOI 10.1364/OL.24.000783; Bennett CV, 2000, IEEE J QUANTUM ELECT, V36, P430, DOI 10.1109/3.831018; BENNETT CV, 2008, OSA SERIES OPTICAL S; Bromage J, 2006, OPT LETT, V31, P3523, DOI 10.1364/OL.31.003523; Cheben P, 2007, OPT EXPRESS, V15, P2299, DOI 10.1364/OE.15.002299; Chou J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799741; Dorrer C, 1999, OPT LETT, V24, P1644, DOI 10.1364/OL.24.001644; Dorrer C, 2006, IEEE J SEL TOP QUANT, V12, P843, DOI 10.1109/JSTQE.2006.876304; Dudley JM, 2007, NAT PHYS, V3, P597, DOI 10.1038/nphys705; Dulkeith E, 2006, OPT EXPRESS, V14, P3853, DOI 10.1364/OE.14.003853; Fernandez-Pousa CR, 2006, OPT LETT, V31, P3049, DOI 10.1364/OL.31.003049; Foster MA, 2007, OPT EXPRESS, V15, P12949, DOI 10.1364/OE.15.012949; Foster MA, 2006, NATURE, V441, P960, DOI 10.1038/nature04932; Goodman J., 2005, MCGRAW HILL PHYS QUA; Jalali B, 2008, PHYS STATUS SOLIDI A, V205, P213, DOI 10.1002/pssa.200723302; Kan'an AM, 1998, J OPT SOC AM B, V15, P1242, DOI 10.1364/JOSAB.15.001242; KANE DJ, 1993, OPT LETT, V18, P823, DOI 10.1364/OL.18.000823; KAUFFMAN MT, 1994, APPL PHYS LETT, V64, P270, DOI 10.1063/1.111177; Koch BR, 2007, OPT EXPRESS, V15, P11225, DOI 10.1364/OE.15.011225; KOLNER BH, 1994, IEEE J QUANTUM ELECT, V30, P1951, DOI 10.1109/3.301659; Lin Q, 2006, OPT EXPRESS, V14, P4786, DOI 10.1364/OE.14.004786; Mouradian LK, 2000, IEEE J QUANTUM ELECT, V36, P795, DOI 10.1109/3.848351; Oba K, 1999, APPL OPTICS, V38, P3810, DOI 10.1364/AO.38.003810; Solli DR, 2008, NAT PHOTONICS, V2, P48, DOI 10.1038/nphoton.2007.253; Solli DR, 2007, NATURE, V450, P1054, DOI 10.1038/nature06402; Turner AC, 2006, OPT EXPRESS, V14, P4357, DOI 10.1364/OE.14.004357; van Howe J, 2007, OPT LETT, V32, P1408, DOI 10.1364/OL.32.001408	30	339	348	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					81	U2		10.1038/nature07430	http://dx.doi.org/10.1038/nature07430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987739				2022-12-28	WOS:000260674000044
J	Springel, V; White, SDM; Frenk, CS; Navarro, JF; Jenkins, A; Vogelsberger, M; Wang, J; Ludlow, A; Helmi, A				Springel, V.; White, S. D. M.; Frenk, C. S.; Navarro, J. F.; Jenkins, A.; Vogelsberger, M.; Wang, J.; Ludlow, A.; Helmi, A.			Prospects for detecting supersymmetric dark matter in the Galactic halo	NATURE			English	Article							GAMMA-RAYS; GALAXIES	Dark matter is the dominant form of matter in the Universe, but its nature is unknown. It is plausibly an elementary particle, perhaps the lightest supersymmetric partner of known particle species(1). In this case, annihilation of dark matter in the halo of the Milky Way should produce gamma-rays at a level that may soon be observable(2,3). Previous work has argued that the annihilation signal will be dominated by emission from very small clumps(4,5) ( perhaps smaller even than the Earth), which would be most easily detected where they cluster together in the dark matter haloes of dwarf satellite galaxies(6). Here we report that such small- scale structure will, in fact, have a negligible impact on dark matter detectability. Rather, the dominant and probably most easily detectable signal will be produced by diffuse dark matter in the main halo of the MilkyWay(7,8). If the main halo is strongly detected, then small dark matter clumps should also be visible, but may well contain no stars, thereby confirming a key prediction of the cold dark matter model.	[Springel, V.; White, S. D. M.; Vogelsberger, M.; Wang, J.] Max Planck Inst Astrophys, D-85740 Garching, Germany; [Frenk, C. S.; Jenkins, A.] Univ Durham, Dept Phys, Inst Computat Cosmol, Durham DH1 3LE, England; [Navarro, J. F.; Ludlow, A.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Navarro, J. F.] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Helmi, A.] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands	Max Planck Society; Durham University; University of Victoria; University of Massachusetts System; University of Massachusetts Amherst; University of Groningen	Springel, V (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85740 Garching, Germany.	vspringel@mpa-garching.mpg.de	Frenk, Carlos/Z-3084-2019; White, Simon/Y-2399-2019	White, Simon/0000-0002-1061-6154; wang, jie/0000-0002-9937-2351; Jenkins, Adrian/0000-0003-4389-2232; Frenk, Carlos/0000-0002-2338-716X; Springel, Volker/0000-0001-5976-4599; Navarro, Julio/0000-0003-3862-5076	STFC Rolling Grant; STFC [ST/F002289/1, ST/F002300/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002289/1, ST/F002300/1] Funding Source: researchfish	STFC Rolling Grant(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the Leibniz Supercomputing Centre of the Bavarian Academy of Sciences and Humanities, and the Computing Centre of the Max-Planck Society in Garching, where the simulations were carried out. C.S.F. acknowledges a Royal Society-Wolfson Research Merit award. This work was supported in part by an STFC Rolling Grant to the ICC.	Aloisio R, 2004, ASTROPHYS J, V601, P47, DOI 10.1086/380425; Berezinsky V, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.103003; BEREZINSKY V, 1994, PHYS LETT B, V325, P136, DOI 10.1016/0370-2693(94)90083-3; Bergstrom L, 1998, ASTROPART PHYS, V9, P137, DOI 10.1016/S0927-6505(98)00015-2; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Calcaneo-Roldan C, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.123005; De Lucia G, 2004, MON NOT R ASTRON SOC, V348, P333, DOI 10.1111/j.1365-2966.2004.07372.x; Diemand J, 2008, NATURE, V454, P735, DOI 10.1038/nature07153; Evans NW, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.123501; Gehrels N, 1999, ASTROPART PHYS, V11, P277, DOI 10.1016/S0927-6505(99)00066-3; Hofmann S, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.083507; Hunter SD, 1997, ASTROPHYS J, V481, P205, DOI 10.1086/304012; Koushiappas SM, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.043501; KUHLEN M, IN PRESS ASTROPHYS J; Michelson PF, 2007, AIP CONF PROC, V921, P8; Mohayaee R, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/05/015; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Peirani S, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043503; Penarrubia J, 2008, ASTROPHYS J, V672, P904, DOI 10.1086/521543; Pieri L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.211301; Prada F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.241301; Springel V, 2001, MON NOT R ASTRON SOC, V328, P726, DOI 10.1046/j.1365-8711.2001.04912.x; Springel V, 2009, HIGH PERFORMANCE COMPUTING IN SCIENCE AND ENGINEERING, GARCH/MUNICH 2007, P93, DOI 10.1007/978-3-540-69182-2_8; Stoehr F, 2003, MON NOT R ASTRON SOC, V345, P1313, DOI 10.1046/j.1365-2966.2003.07052.x; Strigari LE, 2008, ASTROPHYS J, V678, P614, DOI 10.1086/529488; Strigari LE, 2007, ASTROPHYS J, V669, P676, DOI 10.1086/521914; Strigari LE, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.083526; Strong AW, 2004, ASTROPHYS J, V613, P962, DOI 10.1086/423193	30	198	201	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					73	76		10.1038/nature07411	http://dx.doi.org/10.1038/nature07411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987737	Green Submitted			2022-12-28	WOS:000260674000042
J	Bennett, S; Adam, T; Zarowsky, C; Tangcharoensathien, V; Ranson, K; Evans, T; Mills, A				Bennett, Sara; Adam, Taghreed; Zarowsky, Christina; Tangcharoensathien, Viroj; Ranson, Kent; Evans, Tim; Mills, Anne		Alliance STAC	From Mexico to Mali: progress in health policy and systems research	LANCET			English	Article							KNOWLEDGE; THAILAND; COVERAGE; IMPACT	In 2004, the ministerial summit in Mexico drew attention to the historic neglect of health policy and systems research (HPSR) and called for increased funding, investment in national institutional capacity for HPSR, and resources for selected priority research topics. On the basis of meeting discussions, published reports, and available data from research funders and organisations in low-income and middle-income countries, we discuss how HPSR has evolved since the summit in Mexico. Funding for HPSR, particularly in low-income countries, is mainly supported by international and bilateral organisations. Increased interest in health systems has translated into increased support for HPSR. However, small grants and lack of coordination between funders inhibit capacity development, and substantial gaps remain between institutional capacities of high-income and low-income countries. Lack of national capacity is judged to be the key constraint to the development of HPSR. Recommendations from the summit in Mexico remain pertinent, and momentum towards their achievement must be accelerated through the ministerial forum in Mali and beyond.	[Bennett, Sara; Adam, Taghreed; Ranson, Kent; Evans, Tim] WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva 27, Switzerland; [Zarowsky, Christina] Int Dev Res Ctr, Ottawa, ON, Canada; [Tangcharoensathien, Viroj] Int Hlth Policy Programme, Bangkok, Thailand; [Mills, Anne] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Bennett, S (corresponding author), WHO, Alliance Hlth Policy & Syst Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	bennetts@who.int		Zarowsky, Christina/0000-0002-0850-6212; bennett, sara/0000-0001-8094-8798; Mills, Anne/0000-0001-9863-9950	Alliance for Health Policy and Systems Research; WHO; International Development Research Centre (Canada)	Alliance for Health Policy and Systems Research; WHO(World Health Organization); International Development Research Centre (Canada)	We think Hannah Sarah Faich. Portia Taylor Veronique McKinnon, Yunpeng Huang for research assistance and contributions to various parts of this paper: Sam Adjei and John Gyapong for contributions to the Ghana case study; and all the other participants at the Nyon stocktaking meeting for their helpful comments and insights. The stocktaking meeting was financially supported by the Alliance for Health Policy and Systems Research, WHO, and the International Development Research Centre (Canada).	*ALL HLTH POL SYST, 2008, MEX MAL TAK STOCK AC; Alliance for Health Policy and Systems Research, 2007, SOUND CHOIC ENH CAP; Alliance for Health Policy and Systems Research, WHAT IS HLTH POL SYS; [Anonymous], 2001, MACR HLTH INV HLTH E; *BILL MEL GAT FDN, 2008, ANN REP 2007; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; COHRED, 2008, AL HARM HLTH RES AHA; *COMM AUSTR, 2008, AUSAID DEV RES STRAT; Department for International Development (DFID), 2008, DFID RES STRAT 2008; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; *GLOB FUND WHO, GUID OP RES PROGR SU; Gonzalez Block MA, 2006, HEALTH RES POLICY SY, V4, P7, DOI DOI 10.1186/1478-4505-4-7; Gray B., 2003, HLTH AFF MILWOOD W, VW3, P283; Joint Learning Initiative, 2005, HUM RES HLTH OV CRIS; Kasemsup V, 2006, VALUE HEALTH, V9, pA385, DOI 10.1016/S1098-3015(10)63770-9; Lane C, 2007, HEALTH AFFAIR, V26, P935, DOI 10.1377/hlthaff.26.4.935; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; MADON T, SCIENCE, V318, P1728; *MIN SUMM HLTH RES, 2004, MEX STAT HLTH RES ME; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; *NICHSR, INTR HLTH SERV RES B; OECD, 2005, PARIS DECLARATION AI; Paganini JM, 2006, BIBLIOMETRIC ANAL HL; Paraje G, 2005, SCIENCE, V308, P959, DOI 10.1126/science.1108705; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Tangcharoensathien V, 2004, B WORLD HEALTH ORGAN, V82, P750; *TASK FORC HLTH SY, 2004, INF CHOIC ATT MILL D, V364, P997; Task Force on Health Systems Research, 2005, MILL DEV GOALS WILL; Teerawattananon Y, 2007, VALUE HEALTH, V10, P61, DOI 10.1111/j.1524-4733.2006.00145.x; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNAIDS WHO, 2005, PROGR GLOB ACC HIV A; United Nations Development Program (UNDP), 2008, CAP DEV PRACT NOT; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; WHO, 2005, REP MIN SUMM HLTH RE; WORLD HEALTH ORG, 2005, 58 WORLD HLTH ASS RE, P136; World Health Organization, 2005, HLTH MILL DEV GOALS; World Health Organization, 2004, WORLD REP KNOWL BETT; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	38	59	63	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1571	1578		10.1016/S0140-6736(08)61658-X	http://dx.doi.org/10.1016/S0140-6736(08)61658-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984191				2022-12-28	WOS:000260590500030
J	Byass, P				Byass, Peter			Making sense of long-term changes in malaria	LANCET			English	Editorial Material									[Byass, Peter] Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden	Umea University	Byass, P (corresponding author), Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden.	peter.byass@epiph.umu.se		Byass, Peter/0000-0001-5474-4361				Byass Peter, 2007, Popul Health Metr, V5, P12, DOI 10.1186/1478-7954-5-12; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Jezek Z, 1988, HUMAN MONKEYPOX; Nicholls A, 2000, MED HIST, V44, P513, DOI 10.1017/S0025727300067107; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Perdiguero E, 2001, J EPIDEMIOL COMMUN H, V55, P667, DOI 10.1136/jech.55.9.667; Reiter P, 2000, EMERG INFECT DIS, V6, P1; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Silue KD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-111; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; United Nations Development Programme, MILL DEV GOALS GOAL; WALL S, 2008, GLOBAL HLTH ACTION, V1, DOI DOI 10.3402/GHA.V52I0.1822; *WHO, 2006, PROJ MORT BURD DIS; 2008, LANCET, V372, P1193	15	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1523	1525		10.1016/S0140-6736(08)61631-1	http://dx.doi.org/10.1016/S0140-6736(08)61631-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984172				2022-12-28	WOS:000260590500005
J	Ho, TW; Ferrari, MD; Dodick, DW; Galet, V; Kost, J; Fan, XY; Leibensperger, H; Froman, S; Assaid, C; Lines, C; Koppen, H; Winner, PK				Ho, Tony W.; Ferrari, Michel D.; Dodick, David W.; Galet, Vince; Kost, James; Fan, Xiaoyin; Leibensperger, Heather; Froman, Samar; Assaid, Christopher; Lines, Christopher; Koppen, Hille; Winner, Paul K.			Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial	LANCET			English	Article							PHARMACOLOGICAL CHARACTERIZATION; 5-HT1B/1D AGONISTS; CGRP; TRIPTANS; VASCULATURE; SUMATRIPTAN; POTENT; TARGET	Background Calcitonin gene-related peptide (CGRP) probably has a role in migraine pathophysiology, and antagonism of its receptors might provide treatment without the vasoconstrictor effects of triptans. We aimed to assess the clinical profile of MK-0974 (telcagepant), an orally bioavailable antagonist of CGRP receptor. Methods In a randomised, parallel-treatment, placebo-controlled, double-blind, trial at 81 sites in the Europe and the USA, adults with migraine diagnosed by International Headache Society criteria treated moderate or severe attacks with either oral telcagepant 1.50 mg or 300 mg, zolmitriptan 5 mg, or placebo. The five co-primary endpoints were pain freedom, pain relief, or absence of photophobia, phonophobia, or nausea at 2 h after treatment. Analysis was by the full analysis set and multiplicity was controlled for with a step-down closed-testing procedure. This trial is registered with ClinicalTrials.gov, number NCT00442936. Findings 1380 patients were randomly assigned to receive telcagepant 150 mg (n=333) or 300 mg (354), zolmitriptan (345), or placebo (348). Telcagepant 300 mg was more effective than placebo for pain freedom (95 [27%] of 353 patients vs 33 [10%] of 343 [p<0.0001]), pain relief (194 [55%] of 353 vs 95 [28%] of 343 [p<0.0001]), and absences of phonophobia(204[58%] of 353 vs 126 [37% of 342 [p<0.0001.]), photophobia (180 [51%] of 353 vs 99 [29%] of 342 [p<0.0001]), and nausea (229 [65%] of 352 vs 1.89 [55%] of 342 [p=0.0061]). Efficacy of telcagepant 300 mg and zolmitriptan 5 mg were much the same, and both were more effective than telcagepant 150 mg. Adverse events were recorded for 31% taking telcagepant 1.50 mg, 37% taking telcagepant 300 mg, 51% taking zolmitriptan 5 mg, and 32% taking placebo. Interpretation Telcagepant 300 mg is effective as an acute treatment for migraine with efficacy comparable to that of zolmitriptan 5 mg, but with fewer associated adverse effects. Funding Merck Research Laboratories.	[Ho, Tony W.; Galet, Vince; Kost, James; Fan, Xiaoyin; Leibensperger, Heather; Froman, Samar; Assaid, Christopher; Lines, Christopher] Merck Res Labs, N Wales, PA 19454 USA; [Ferrari, Michel D.; Koppen, Hille] Leiden Univ, Ctr Med, Leiden, Netherlands; [Dodick, David W.] Mayo Clin, Scottsdale, AZ USA; [Winner, Paul K.] Palm Beach Headache Ctr, W Palm Beach, FL USA	Merck & Company; Leiden University; Leiden University - Excl LUMC; Mayo Clinic; Mayo Clinic Phoenix	Ho, TW (corresponding author), Merck Res Labs, UG 4C-18,POB 1000, N Wales, PA 19454 USA.	tony_ho@merck.com	Ho, Tony W/F-1019-2011; Ferrari, Michel D./ABE-3758-2021; Domitrz, Izabela/M-8960-2018	Ferrari, Michel D./0000-0001-9691-9449; Domitrz, Izabela/0000-0003-3130-1036; Ho, Tony/0000-0002-3489-3594	Merck Research Laboratories	Merck Research Laboratories(Merck & Company)	This study was funded by Merck Research Laboratories.	*ASTRAZENECA PHARM, 2007, PRESCR INF ZOLM TABL; Cady RK, 2000, CLIN THER, V22, P1035, DOI 10.1016/S0149-2918(00)80083-1; Cady R, 2006, HEADACHE, V46, P914, DOI 10.1111/j.1526-4610.2006.00466.x; Dodick D, 2004, HEADACHE, V44, P414, DOI 10.1111/j.1526-4610.2004.04078.x; Dodick DW, 2005, HEADACHE, V45, P156, DOI 10.1111/j.1526-4610.2005.05031.x; Durham PL, 2006, HEADACHE, V46, pS3, DOI 10.1111/j.1526-4610.2006.00483.x; Edvinsson L, 2004, CEPHALALGIA, V24, P611, DOI 10.1111/j.1468-2982.2003.00719.x; Edvinsson L, 2005, CLIN SCI, V109, P335, DOI 10.1042/CS20050016; Edvinsson L, 2003, EXPERT OPIN THER TAR, V7, P377, DOI 10.1517/eott.7.3.377.22440; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Goadsby PJ, 2005, DRUGS, V65, P2557, DOI 10.2165/00003495-200565180-00002; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Paone DV, 2007, J MED CHEM, V50, P5564, DOI 10.1021/jm070668p; Salvatore CA, 2008, J PHARMACOL EXP THER, V324, P416, DOI 10.1124/jpet.107.130344; SANTANELLO NC, 1995, HEADACHE, V35, P330, DOI 10.1111/j.1526-4610.1995.hed3506330.x; Sheftell FD, 2004, HEADACHE, V44, P661, DOI 10.1111/j.1526-4610.2004.04124.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tfelt-Hansen P, 2000, CEPHALALGIA, V20, P765; UDDMAN R, 1985, NEUROSCI LETT, V62, P131, DOI 10.1016/0304-3940(85)90296-4; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Welch KMA, 2000, CEPHALALGIA, V20, P687, DOI 10.1046/j.1468-2982.2000.00116.x	26	440	487	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2115	2123		10.1016/S0140-6736(08)61626-8	http://dx.doi.org/10.1016/S0140-6736(08)61626-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19036425				2022-12-28	WOS:000261894000034
J	Barwick, B; Park, HS; Kwon, OH; Baskin, JS; Zewail, AH				Barwick, Brett; Park, Hyun Soon; Kwon, Oh-Hoon; Baskin, J. Spencer; Zewail, Ahmed H.			4D Imaging of Transient Structures and Morphologies in Ultrafast Electron Microscopy	SCIENCE			English	Article							CRYSTALLOGRAPHY; DIFFRACTION; GRAPHITE; NANOSCALE; DYNAMICS; ATOMS	With advances in spatial resolution reaching the atomic scale, two- dimensional ( 2D) and 3D imaging in electron microscopy has become an essential methodology in various fields of study. Here, we report 4D imaging, with in situ spatiotemporal resolutions, in ultrafast electron microscopy ( UEM). The ability to capture selected- area- image dynamics with pixel resolution and to control the time separation between pulses for temporal cooling of the specimen made possible studies of fleeting structures and morphologies. We demonstrate the potential for applications with two examples, gold and graphite. For gold, after thermally induced stress, we determined the atomic structural expansion, the nonthermal lattice temperature, and the ultrafast transients of warping/ bulging. In contrast, in graphite, striking coherent transients of the structure were observed in both image and diffraction, directly measuring, on the nanoscale, the longitudinal resonance period governed by Young's elastic modulus. The success of these studies demonstrates the promise of UEM in real- space imaging of dynamics.	[Barwick, Brett; Park, Hyun Soon; Kwon, Oh-Hoon; Baskin, J. Spencer; Zewail, Ahmed H.] CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Arthur Amos Noyes Lab Chem Phys, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Arthur Amos Noyes Lab Chem Phys, Pasadena, CA 91125 USA.	zewail@caltech.edu	Park, Hyun Soon/D-3941-2013; Kwon, Oh-Hoon/B-3324-2015	Park, Hyun Soon/0000-0002-1039-7334; Kwon, Oh-Hoon/0000-0001-7114-8617; gaber, sarah/0000-0002-5995-7291	National Science Foundation; Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at Caltech; National Institutes of Health; Caltech	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at Caltech(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech	We thank F. Carbone for his handling of the graphite film and for helpful discussion. This work was supported by the National Science Foundation and Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at Caltech. Research on biological UEM imaging was supported by the National Institutes of Health. Caltech has filed a provisional patent application for the microscope described here.	Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; BLAKSLEE OL, 1970, J APPL PHYS, V41, P3373, DOI 10.1063/1.1659428; Boyes ED, 1997, ULTRAMICROSCOPY, V67, P219, DOI 10.1016/S0304-3991(96)00099-X; Choudhary SK, 2007, JPN J APPL PHYS 1, V46, P7450, DOI 10.1143/JIAP.46.7450; CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338; DAVIES DG, 1986, PHILOS T R SOC A, V320, P243, DOI 10.1098/rsta.1986.0114; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; Domer H, 2003, REV SCI INSTRUM, V74, P4369, DOI 10.1063/1.1611612; Ertl G, 2000, ADV CATAL, V45, P1; FUJITA FE, 1961, J PHYS SOC JPN, V16, P214, DOI 10.1143/JPSJ.16.214; Fultz B., 2002, TRANSMISSION ELECT M, V2nd ed.; Gahlmann A, 2008, PHYS CHEM CHEM PHYS, V10, P2894, DOI 10.1039/b802136h; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; HAWKES PW, 2006, SCI MICROSCOPY, V1; Henderson R, 2004, Q REV BIOPHYS, V37, P3, DOI 10.1017/S0033583504003920; Hirsch P., 1965, ELECT MICROSCOPY THI; Hohlfeld J, 2000, CHEM PHYS, V251, P237, DOI 10.1016/S0301-0104(99)00330-4; Howie A, 2007, TURNING POINTS IN SOLID-STATE, MATERIALS AND SURFACE SCIENCE: A BOOK IN CELEBRATION OF THE LIFE AND WORK OF SIR JOHN MEURIG THOMAS, P687, DOI 10.1039/9781847558183-00687; Kimoto K, 2007, NATURE, V450, P702, DOI 10.1038/nature06352; Knoll M, 1932, Z PHYS, V78, P318, DOI 10.1007/BF01342199; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kwon OH, 2008, NANO LETT, V8, P3557, DOI 10.1021/nl8029866; Kwon OH, 2008, P NATL ACAD SCI USA, V105, P8519, DOI 10.1073/pnas.0803344105; LaGrange T, 2007, ACTA MATER, V55, P5211, DOI 10.1016/j.actamat.2007.05.043; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; O'Keefe MA, 2008, ULTRAMICROSCOPY, V108, P196, DOI 10.1016/j.ultramic.2007.07.009; Park HS, 2007, NANO LETT, V7, P2545, DOI 10.1021/nl071369q; REYNOLDS WN, 1968, PHYS PROPERTIES GRAP; Shindo D., 1998, HIGH RESOLUTION ELEC; THOMAS JM, 2008, PHYS BIOL ATOM MED; Wang Z.-L, 1995, ELASTIC INELASTIC SC; Zewail A. H., 2006, U. S. patent, Patent No. [7,154,091 B2, 7154091]; ZEWAIL AH, 2008, VISIONS DISCOVERY SH, pCH2; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; Zou X, 2008, ACTA CRYSTALLOGR A, V64, P149, DOI 10.1107/S0108767307060084	37	187	191	5	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1227	1231		10.1126/science.1164000	http://dx.doi.org/10.1126/science.1164000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023077				2022-12-28	WOS:000261033400036
J	Imai, J; Katagiri, H; Yamada, T; Ishigaki, Y; Suzuki, T; Kudo, H; Uno, K; Hasegawa, Y; Gao, JH; Kaneko, K; Ishihara, H; Niijima, A; Nakazato, M; Asano, T; Minokoshi, Y; Oka, Y				Imai, Junta; Katagiri, Hideki; Yamada, Tetsuya; Ishigaki, Yasushi; Suzuki, Toshinobu; Kudo, Hirohito; Uno, Kenji; Hasegawa, Yutaka; Gao, Junhong; Kaneko, Keizo; Ishihara, Hisamitsu; Niijima, Akira; Nakazato, Masamitsu; Asano, Tomoichiro; Minokoshi, Yasuhiko; Oka, Yoshitomo			Regulation of Pancreatic beta Cell Mass by Neuronal Signals from the Liver	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; INSULIN; GENE; PROLIFERATION; SENSITIVITY; DYSFUNCTION; DISRUPTION; OBESITY	Metabolic regulation in mammals requires communication between multiple organs and tissues. The rise in the incidence of obesity and associated metabolic disorders, including type 2 diabetes, has renewed interest in interorgan communication. We used mouse models to explore the mechanism whereby obesity enhances pancreatic beta cell mass, pathophysiological compensation for insulin resistance. We found that hepatic activation of extracellular regulated kinase (ERK) signaling induced pancreatic b cell proliferation through a neuronal- mediated relay of metabolic signals. This metabolic relay from the liver to the pancreas is involved in obesity- induced islet expansion. In mouse models of insulin- deficient diabetes, liver- selective activation of ERK signaling increased b cell mass and normalized serum glucose levels. Thus, interorgan metabolic relay systems may serve as valuable targets in regenerative treatments for diabetes.	[Katagiri, Hideki; Suzuki, Toshinobu; Kudo, Hirohito; Uno, Kenji; Gao, Junhong; Kaneko, Keizo] Tohoku Univ, Grad Sch Med, Div Adv Therapeut Metab Dis, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan; [Imai, Junta; Yamada, Tetsuya; Ishigaki, Yasushi; Suzuki, Toshinobu; Kudo, Hirohito; Hasegawa, Yutaka; Kaneko, Keizo; Ishihara, Hisamitsu; Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 9808575, Japan; [Niijima, Akira] Niigata Univ, Sch Med, Niigata 9518150, Japan; [Nakazato, Masamitsu] Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Hiroshima, Japan; [Minokoshi, Yasuhiko] Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Tohoku University; Tohoku University; Niigata University; University of Miyazaki; Hiroshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Katagiri, H (corresponding author), Tohoku Univ, Grad Sch Med, Div Adv Therapeut Metab Dis, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan.	katagiri@mail.tains.tohoku.ac.jp		Minokoshi, Yasuhiko/0000-0002-7119-4805	21st Center of Excellence (COE); Global-COE; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	21st Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global-COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank M. Yokoyama for the generous gift of recombinant adenoviruses. This work was supported by Grants-in Aid (H.K., Y.O., and J.I.); the 21st Center of Excellence (COE) (H.K.) and Global-COE (Y.O.) programs from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Grant-in Aid (Y.O.) from the Ministry of Health, Labor and Welfare of Japan. Tohoku University, J.I., H.K., and Y.O have applied for patents related to this work in the United States and Japan.	Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Edvell A, 1998, AM J PHYSIOL-ENDOC M, V274, pE1034, DOI 10.1152/ajpendo.1998.274.6.E1034; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kiba T, 1996, GASTROENTEROLOGY, V110, P885, DOI 10.1053/gast.1996.v110.pm8608899; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yang J, 2001, CANCER RES, V61, P4010	24	158	162	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1250	1254		10.1126/science.1163971	http://dx.doi.org/10.1126/science.1163971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023081				2022-12-28	WOS:000261033400043
J	Kronfeld, AS				Kronfeld, Andreas S.			PHYSICS The Weight of the World Is Quantum Chromodynamics	SCIENCE			English	Editorial Material							LATTICE QCD; MASS		[Kronfeld, Andreas S.] Fermilab Natl Accelerator Lab, Theoret Phys Grp, Batavia, IL 60510 USA	United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory	Kronfeld, AS (corresponding author), Fermilab Natl Accelerator Lab, Theoret Phys Grp, POB 500, Batavia, IL 60510 USA.	ask@fnal.gov		Kronfeld, Andreas/0000-0003-2716-1149				ALIKHAN A, 2002, PHYS REV D, V65; Aubin C, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.094505; Bernard C, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.054506; BUTLER F, 1994, NUCL PHYS B, V430, P179, DOI 10.1016/0550-3213(94)90654-8; CABIBBO N, 1963, PHYS REV LETT, V10, P531, DOI 10.1103/PhysRevLett.10.531; CREUTZ M, 1980, PHYS REV LETT, V45, P313, DOI 10.1103/PhysRevLett.45.313; Davies CTH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.022001; Durr S, 2008, SCIENCE, V322, P1224, DOI 10.1126/science.1163233; FRITZSCH H, 1973, PHYS LETT B, VB 47, P365, DOI 10.1016/0370-2693(73)90625-4; GOLDSTONE J, 1961, NUOVO CIMENTO, V19, P154, DOI 10.1007/BF02812722; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; Kronfeld AS, 2006, J PHYS CONF SER, V46, P147, DOI 10.1088/1742-6596/46/1/020; LEINWEBER D, VISUALIZATIONS QUANT; NAMBU Y, 1960, PHYS REV LETT, V4, P380, DOI 10.1103/PhysRevLett.4.380; POLITZER HD, 1973, PHYS REV LETT, V30, P1346, DOI 10.1103/PhysRevLett.30.1346; Wilczek F, 2000, PHYS TODAY, V53, P13, DOI 10.1063/1.882927; Wilczek F, 1999, PHYS TODAY, V52, P11, DOI 10.1063/1.882562; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445	19	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1198	1199		10.1126/science.1166844	http://dx.doi.org/10.1126/science.1166844			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023072				2022-12-28	WOS:000261033400027
J	Lammert, E				Lammert, Eckhard			DEVELOPMENTAL BIOLOGY Brain Wnts for Blood Vessels	SCIENCE			English	Editorial Material							ANGIOGENESIS; BARRIER; DISEASE		[Lammert, Eckhard] Univ Dusseldorf, Inst Anim Physiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Lammert, E (corresponding author), Univ Dusseldorf, Inst Anim Physiol, D-40225 Dusseldorf, Germany.	lammert@uni-duesseldorf.de						Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; DERMIETZEL R, 1992, DEV DYNAM, V193, P152, DOI 10.1002/aja.1001930207; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; LAMMERT E, 2007, ENDOTHELIAL BIOMEDIC, pCH22; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8; Parmalee NL, 2008, CURR DRUG TARGETS, V9, P558, DOI 10.2174/138945008784911822; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; TRACEY KJ, 2007, ENDOTHELIAL BIOMEDIC, pCH124	12	4	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1195	1196		10.1126/science.1167451	http://dx.doi.org/10.1126/science.1167451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	19023070				2022-12-28	WOS:000261033400025
J	Nalluri, SR; Chu, D; Keresztes, R; Zhu, XL; Wu, SH				Nalluri, Shobha Rani; Chu, David; Keresztes, Roger; Zhu, Xiaolei; Wu, Shenhong			Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							METASTATIC COLORECTAL-CANCER; ENDOTHELIAL GROWTH-FACTOR; CELL LUNG-CANCER; PHASE-II TRIAL; RANDOMIZED-TRIAL; BREAST-CANCER; FLUOROURACIL; LEUCOVORIN; COMBINATION; CHEMOTHERAPY	Context Venous thromboembolism is one of the leading causes of morbidity and mortality in patients with cancer. Concerns have arisen regarding the risk of venous thromboembolism with the novel antiangiogenic agent bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor that is widely used in cancer treatment. Currently, the role of bevacizumab in venous thromboembolism is controversial. Objective To assess the overall risk of venous thromboembolism associated with the use of bevacizumab, a systematic review and meta- analysis of published randomized controlled trials was performed. Data Sources The databases of PubMed and Web of Science were searched for articles published in the English language from January 1966 until January 2008 and abstracts presented at American Society of Clinical Oncology conferences held between January 2000 and January 2008 were searched to identify relevant clinical trials. Study Selection and Data Extraction Eligible studies included prospective randomized controlled trials in which standard antineoplastic therapy was used with and without bevacizumab and data on venous thromboembolism were available. Summary incidence rates, relative risks ( RRs), and 95% confidence intervals ( CIs) were calculated using random- effects or fixed- effects models based on the heterogeneity of included studies. Data Synthesis A total of 7956 patients with a variety of advanced solid tumors from 15 randomized controlled trials were identified and included for analysis. Among those patients receiving bevacizumab, the summary incidences of all- grade and high-grade venous thromboembolism were 11.9% ( 95% CI, 6.8%- 19.9%) and 6.3% ( 95% CI, 4.8%- 8.3%), respectively. Patients treated with bevacizumab had a significantly increased risk of venous thromboembolism with an RR of 1.33 ( 95% CI, 1.13- 1.56; P <. 001) compared with controls. The risk was significantly increased for both all-grade and high- grade venous thromboembolism. In addition, the risk was similarly increased for bevacizumab at 2.5 mg/ kg per week ( low dose; RR, 1.31 [ 95% CI, 1.08-1.60]; P=. 007) and 5 mg/ kg per week ( high dose; RR, 1.31 [ 95% CI, 1.02- 1.68]; P=. 04). Conclusion The use of bevacizumab was significantly associated with an increased risk of developing venous thromboembolism in cancer patients receiving this drug.	[Nalluri, Shobha Rani; Chu, David; Keresztes, Roger; Wu, Shenhong] SUNY Stony Brook, Ctr Canc, Div Med Oncol, Dept Med, Stony Brook, NY 11794 USA; [Zhu, Xiaolei] Kidney Doc PLLC, Port Jefferson Stn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wu, SH (corresponding author), SUNY Stony Brook, Ctr Canc, Div Med Oncol, Dept Med, 9447 SUNY, Stony Brook, NY 11794 USA.	shenhong.wu@stonybrook.edu						Bennett CL, 2006, JAMA-J AM MED ASSOC, V296, P2558, DOI 10.1001/jama.296.21.2558-c; Dahut WL, 2004, J CLIN ONCOL, V22, P2532, DOI 10.1200/JCO.2004.05.074; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; El Accaoui RN, 2007, THROMB HAEMOSTASIS, V97, P1031, DOI 10.1160/TH06-09-0494; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gordon MS, 2005, ONCOLOGY-BASEL, V69, P25, DOI 10.1159/000088481; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; KARRISON T, 2007, 2007 AM SOC CLIN ONC; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Kilickap S, 2003, J CLIN ONCOL, V21, P3542, DOI 10.1200/JCO.2003.99.046; KINDLER HL, 2005, 2005 AM SOC CLIN ONC; Kruse FE, 1998, GRAEF ARCH CLIN EXP, V236, P461, DOI 10.1007/s004170050106; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; LYONS JA, 2006, 2006 AM SOC CLIN ONC; MANEGOLD C, 2007, 2007 AM SOC CLIN ONC; Meade MO, 1997, ANN INTERN MED, V127, P531, DOI 10.7326/0003-4819-127-7-199710010-00005; Midgley R, 2005, ANN ONCOL, V16, P999, DOI 10.1093/annonc/mdi208; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; PRICE TJ, 2008, 2008 GASTR CANC S JA; SALTZ LB, 2007, 2007 AM SOC CLIN ONC; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	38	563	581	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2008	300	19					2277	2285		10.1001/jama.2008.656	http://dx.doi.org/10.1001/jama.2008.656			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373IO	19017914				2022-12-28	WOS:000260965500028
J	Fleming, J; Brayne, C				Fleming, Jane; Brayne, Carol		CC75C Study Grp	Inability to get up after falling, subsequent time on floor, and summoning help: prospective cohort study in people over 90	BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY RESPONSE SYSTEMS; OLDER-ADULTS; RISK-FACTORS; INJURIOUS FALLS; ELDERLY PEOPLE; COMMUNITY; HOME; PREVENTION; DEMENTIA; VIEWS	Objectives To describe the incidence and extent of lying on the floor for a long time after being unable to get up from a fall among people aged over 90; to explore their use of call alarm systems in these circumstances. Design 1 year follow- up of participants in a prospective cohort study of ageing, using fall calendars, phone calls, and visits. Setting Participants' usual place of residence ( own homes or care homes), mostly in Cambridge. Participants 90 women and 20 men aged over 90 ( n= 110), surviving participants of the Cambridge City over-75s Cohort, a population based sample. Main outcome measures Inability to get up without help, lying on floor for a long time after falling, associated factors; availability and use of call alarm systems; participants' views on using call alarms to summon help if needed after falling. Results In one year's intensive follow- up, 54% ( 144/ 265) of fall reports described the participant as being found on the floor and 82% ( 217/ 265) of falls occurred when the person was alone. Of the 60% who fell, 80% ( 53/ 66) were unable to get up after at least one fall and 30% ( 20/ 66) had lain on the floor for an hour or more. Difficulty in getting up was consistently associated with age, reported mobility, and severe cognitive impairment. Cognition was the only characteristic that predicted lyingonthe floor for a long time. Lying on the floor for a long time was strongly associated with serious injuries, admission to hospital, and subsequent moves into long term care. Call alarms were widely available but were not used in most cases of falls that led to lying on the floor for a long time. Comments from older people and carers showed the complexity of issues around the use of call alarms, including perceptions of irrelevance, concerns about independence, and practical difficulties. Conclusions Lying on the floor for a long time after falling is more common among the "oldest old" than previously thought and is associated with serious consequences. Factors indicating higher risk and comments from participants suggest practical implications. People need training in strategies to get up from the floor. Work is needed on access and activation issues for design of call	[Fleming, Jane; Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Fleming, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 0SR, England.	jane.fleming@phpc.cam.ac.uk; carol.brayne@medschl.cam.ac.uk	Fleming, Jane/L-5300-2015; Matthews, Fiona/O-6932-2015; Dening, Tom/E-1335-2013; Brayne, Carol/AAA-4285-2020	Fleming, Jane/0000-0002-8127-2061; Matthews, Fiona/0000-0002-1728-2388; Dening, Tom/0000-0003-3387-4241; Brayne, Carol/0000-0001-5307-663X	Medical Research Council [MC_U105292687] Funding Source: Medline; MRC [MC_U105292687] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander NB, 1997, J AM GERIATR SOC, V45, P564, DOI 10.1111/j.1532-5415.1997.tb03088.x; Asbjornsen G, 2000, Tidsskr Nor Laegeforen, V120, P3119; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Bergland A, 2005, AGING CLIN EXP RES, V17, P181; Bernstein M, 2000, Manag Care Q, V8, P38; Brownsell S, 2004, J TELEMED TELECARE, V10, P262, DOI 10.1258/1357633042026251; CAMERON ID, 1994, ARCH GERONTOL GERIAT, V19, P273, DOI 10.1016/0167-4943(94)00573-7; Demiris G, 2004, MED INFORM INTERNET, V29, P87, DOI 10.1080/14639230410001684387; FLEMING J, 2006, THESIS U CAMBRIDGE C; Fleming J, 2007, INT J EPIDEMIOL, V36, P40, DOI 10.1093/ije/dyl293; Fleming Jane, 2008, BMC Geriatr, V8, P6, DOI 10.1186/1471-2318-8-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; Gooberman-Hill, 2004, REV CLIN GERONTOLOGY, V14, P63, DOI [10.1017/S0959259804001212, DOI 10.1017/S0959259804001212]; Halter M, 2000, FALLS OLDER POPULATI; Hofmeyer MR, 2002, J AM GERIATR SOC, V50, P1702, DOI 10.1046/j.1532-5415.2002.50463.x; HUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529, DOI 10.1111/j.2044-8260.1995.tb01487.x; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; LEVINE DA, 1995, MT SINAI J MED, V62, P293; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; Mann WC, 2005, ASSIST TECHNOL, V17, P82, DOI 10.1080/10400435.2005.10132098; Miskelly FG, 2001, AGE AGEING, V30, P455, DOI 10.1093/ageing/30.6.455; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; REECE A, 1996, PHYSIOTHERAPY, V82, P27; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Shaw FE, 1998, AGE AGEING, V27, P7, DOI 10.1093/ageing/27.1.7; SIMPSON JM, 1993, AGE AGEING, V22, P294, DOI 10.1093/ageing/22.4.294; Skelton D, 2005, AGE AGEING, V34, P636, DOI 10.1093/ageing/afi174; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650	36	165	167	0	21	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2008	337								a2227	10.1136/bmj.a2227	http://dx.doi.org/10.1136/bmj.a2227			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HP	19015185	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000262653800002
J	Hezel, DC; Russell, SS				Hezel, Dominik C.; Russell, Sara S.			Comment on "Ancient Asteroids Enriched in Refractory Inclusions"	SCIENCE			English	Editorial Material							ALUMINUM-RICH INCLUSIONS; CARBONACEOUS CHONDRITES; CONSTRAINTS; AL-26	Sunshine et al. ( Reports, 25 April 2008, p. 514) reported that certain asteroids contain 30 +/- 10 volume percent calcium- and aluminum- rich inclusions ( CAIs). We contend that the amount of CAIs in CV chondrites is two to three times as low as the 10 volume percent assumed by the authors; thus, we question whether the CAI- rich bodies they studied are indeed older than known asteroids or formed before the injection of (26)Al into the solar nebula.	[Hezel, Dominik C.; Russell, Sara S.] Nat Hist Museum, Dept Mineral, IARC, London SW7 5BD, England	Imperial College London; Natural History Museum London	Hezel, DC (corresponding author), Nat Hist Museum, Dept Mineral, IARC, Cromwell Rd, London SW7 5BD, England.	d.hezel@nhm.ac.uk	Hezel, Dominik/O-5287-2015	Hezel, Dominik/0000-0002-5059-2281; Russell, Sara/0000-0001-5531-7847	STFC [PP/D001714/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D001714/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Brearley A.J., 1998, REV MINERALOGY, V36; BURBINE TH, 1992, METEORITICS, V27, P424, DOI 10.1111/j.1945-5100.1992.tb00224.x; Hezel DC, 2008, EARTH PLANET SC LETT, V265, P716, DOI 10.1016/j.epsl.2007.11.003; HEZEL DC, 2008, METEORIT PLANET SCI; Kornacki A. S., 1984, Journal of Geophysical Research, V89, P573, DOI 10.1029/JB089iS02p0B573; Krot AN, 2004, CHEM ERDE-GEOCHEM, V64, P185, DOI 10.1016/j.chemer.2004.05.001; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; May C., 1999, LUN PLANET SCI C, V30, P1688; MCSWEEN HY, 1977, GEOCHIM COSMOCHIM AC, V41, P1777, DOI 10.1016/0016-7037(77)90210-1; MCSWEEN HY, 1977, GEOCHIM COSMOCHIM AC, V41, P477, DOI 10.1016/0016-7037(77)90286-1; MURAKAMI T, 1994, METEORITICS, V29, P397, DOI 10.1111/j.1945-5100.1994.tb00604.x; NORTON MB, 2007, LUN PLANET SCI C, V38, P1807; RUBIN AE, 1985, METEORITICS, V20, P175, DOI 10.1111/j.1945-5100.1985.tb00859.x; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Russell SS, 1998, GEOCHIM COSMOCHIM AC, V62, P689, DOI 10.1016/S0016-7037(97)00374-8; Sunshine JM, 2008, SCIENCE, V320, P514, DOI 10.1126/science.1154340	17	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904								10.1126/science.1161386	http://dx.doi.org/10.1126/science.1161386			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	19008430				2022-12-28	WOS:000260867700016
J	Stallard, T; Miller, S; Lystrup, M; Achilleos, N; Bunce, EJ; Arridge, CS; Dougherty, MK; Cowley, SWH; Badman, SV; Talboys, DL; Brown, RH; Baines, KH; Buratti, BJ; Clark, RN; Sotin, C; Nicholson, PD; Drossart, P				Stallard, Tom; Miller, Steve; Lystrup, Makenzie; Achilleos, Nicholas; Bunce, Emma J.; Arridge, Christopher S.; Dougherty, Michele K.; Cowley, Stan W. H.; Badman, Sarah V.; Talboys, Dean L.; Brown, Robert H.; Baines, Kevin H.; Buratti, Bonnie J.; Clark, Roger N.; Sotin, Christophe; Nicholson, Phil D.; Drossart, Pierre			Complex structure within Saturn's infrared aurora	NATURE			English	Article							JOVIAN IONOSPHERE; EMISSION; DYNAMICS	The majority of planetary aurorae are produced by electrical currents flowing between the ionosphere and the magnetosphere which accelerate energetic charged particles that hit the upper atmosphere. At Saturn, these processes collisionally excite hydrogen, causing ultraviolet emission(1-8), and ionize the hydrogen, leading to H-3(+) infrared emission(9-15). Although the morphology of these aurorae is affected by changes in the solar wind(6,11), the source of the currents which produce them is a matter of debate(16,17). Recent models predict only weak emission away from the main auroral oval(18). Here we report images that show emission both poleward and equatorward of the main oval (separated by a region of low emission). The extensive polar emission is highly variable with time, and disappears when the main oval has a spiral morphology; this suggests that although the polar emission may be associated with minor increases in the dynamic pressure from the solar wind, it is not directly linked to strong magnetospheric compressions. This aurora appears to be unique to Saturn and cannot be explained using our current understanding of Saturn's magnetosphere. The equatorward arc of emission exists only on the nightside of the planet, and arises from internal magnetospheric processes that are currently unknown.	[Stallard, Tom; Bunce, Emma J.; Cowley, Stan W. H.; Badman, Sarah V.; Talboys, Dean L.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Miller, Steve; Lystrup, Makenzie; Achilleos, Nicholas] UCL, Atmospher Phys Lab, Dept Phys & Astron, London WC1E 6BT, England; [Arridge, Christopher S.] Univ Coll London, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; [Dougherty, Michele K.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Space & Atmospher Phys Grp, London SW7 2AZ, England; [Brown, Robert H.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Brown, Robert H.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Baines, Kevin H.; Buratti, Bonnie J.; Sotin, Christophe] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Clark, Roger N.] US Geol Survey, Lakewood, CO 80225 USA; [Nicholson, Phil D.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Drossart, Pierre] Observ Paris, F-92195 Meudon, France	University of Leicester; University of London; University College London; University of London; University College London; Imperial College London; University of Arizona; University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Cornell University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Stallard, T (corresponding author), Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England.	tss@ion.le.ac.uk	Achilleos, Nicholas/C-1647-2008; Drossart, Pierre/H-8670-2013; Stallard, Tom/W-8743-2019; Bunce, Emma J/I-9067-2016; Arridge, Christopher S/A-2894-2009	Stallard, Tom/0000-0003-3990-670X; Bunce, Emma J/0000-0002-9456-0345; Arridge, Christopher S/0000-0002-0431-6526; Cowley, Stanley/0000-0002-4041-0034; Achilleos, Nicholas/0000-0002-5886-3509; Miller, Steven/0000-0002-7159-6871	Research Councils UK Fellowship; UK Science and Technology Facilities Council; European Union's Sixth Framework Programme; Science and Technology Facilities Council [PP/E001076/1, PP/E000983/1, PP/D000912/1, PP/E001173/1] Funding Source: researchfish; STFC [PP/E001076/1, PP/D000912/1, PP/E000983/1, PP/E001173/1] Funding Source: UKRI	Research Councils UK Fellowship(UK Research & Innovation (UKRI)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); European Union's Sixth Framework Programme(European Commission); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by a Research Councils UK Fellowship (T.S.) and by the UK Science and Technology Facilities Council (N.A., S.V.B., D.L.T., C.S.A., E.J.B., M.K.D.). The European authors are part of the Europlanet European Planetology Network, supported by the European Union's Sixth Framework Programme.	Badman SV, 2006, ANN GEOPHYS-GERMANY, V24, P3533, DOI 10.5194/angeo-24-3533-2006; BAKER DN, 1978, J GEOPHYS RES-SPACE, V83, P4863, DOI 10.1029/JA083iA10p04863; Bunce EJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013257; Bunce EJ, 2006, ADV SPACE RES, V38, P806, DOI 10.1016/j.asr.2005.08.005; Clarke JT, 2005, NATURE, V433, P717, DOI 10.1038/nature03331; Cowley SWH, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010796; Cowley SWH, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010375; Cowley SWH, 2003, ANN GEOPHYS-GERMANY, V21, P1691, DOI 10.5194/angeo-21-1691-2003; DROSSART P, 2005, BAAS, V37, P657; Gerard JC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010513; Grodent D, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010983; Grodent D, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA010017; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; Melin H, 2007, ICARUS, V186, P234, DOI 10.1016/j.icarus.2006.08.014; Millward G, 2002, ICARUS, V160, P95, DOI 10.1006/icar.2002.6951; PRYOR WR, 2007, FALL M AM GEOPH UN; SANDEL BR, 1982, SCIENCE, V215, P548, DOI 10.1126/science.215.4532.548; Sittler EC, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011191; Stallard T, 2002, ICARUS, V156, P498, DOI 10.1006/icar.2001.6793; Stallard T, 1999, ASTROPHYS J, V521, pL149, DOI 10.1086/312189; Stallard T, 2008, NATURE, V453, P1083, DOI 10.1038/nature07077; Stallard T, 2007, ICARUS, V191, P678, DOI 10.1016/j.icarus.2007.05.016; Stallard T, 2008, ASTROPHYS J LETT, V675, pL117, DOI 10.1086/533584; Stallard T, 2007, ICARUS, V189, P1, DOI 10.1016/j.icarus.2006.12.027; Stallard TS, 2004, ICARUS, V167, P204, DOI 10.1016/j.icarus.2003.09.006; Trauger JT, 1998, J GEOPHYS RES-PLANET, V103, P20237, DOI 10.1029/98JE01324	26	40	40	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					214	217		10.1038/nature07440	http://dx.doi.org/10.1038/nature07440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005549				2022-12-28	WOS:000261039300034
J	Treadway, K				Treadway, Katharine			The Future of Primary Care: Sustaining Relationships	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Treadway, Katharine] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Treadway, Katharine] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Treadway, K (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2086	+		10.1056/NEJMp0805762	http://dx.doi.org/10.1056/NEJMp0805762			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005191				2022-12-28	WOS:000260823900002
J	Vincent, C; Aylin, P; Franklin, BD; Holmes, A; Iskander, S; Jacklin, A; Moorthy, K				Vincent, Charles; Aylin, Paul; Franklin, Bryony Dean; Holmes, Alison; Iskander, Sandra; Jacklin, Ann; Moorthy, Krishna			Is health care getting safer?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; PATIENT SAFETY; ERRORS		[Vincent, Charles; Iskander, Sandra] St Marys Hosp, Imperial Ctr Patient Safety & Serv Qual, Dept Biosurg & Technol, London W2 1NY, England; [Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol & Publ Hlth, London, England; [Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London, England; [Franklin, Bryony Dean; Holmes, Alison; Jacklin, Ann; Moorthy, Krishna] Imperial Coll Healthcare NHS Trust, Ctr Med Safety & Serv Qual, London, England; [Franklin, Bryony Dean; Jacklin, Ann] Univ London, Sch Pharm, London WC1N 1AX, England; [Moorthy, Krishna] Univ London Imperial Coll Sci Technol & Med, Clin Safety Res Unit, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; University College London; University of London School of Pharmacy; Imperial College London	Vincent, C (corresponding author), St Marys Hosp, Imperial Ctr Patient Safety & Serv Qual, Dept Biosurg & Technol, Praed St, London W2 1NY, England.	c.vincent@imperial.ac.uk	Vincent, Charles A/D-1134-2010; Aylin, Paul/A-1073-2014	Vincent, Charles A/0000-0003-0270-0222; Aylin, Paul/0000-0003-4589-1743; Moorthy, Krishna/0000-0001-8960-465X; Franklin, Bryony/0000-0002-2892-1245				Agency for Healthcare Research and Quality, 2008, QUAL IND; [Anonymous], 2003, 2003 REP NAT CONF EN; Audit Commission, 2004, INF DAT QUAL NHS KEY; Barber N, 2006, SAFER FASTER BETTER; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Bottle A., 2008, HLTH CARE RISK R MAY, P12; BOTTLE A, QUAL SAFETY IN PRESS; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Department of Health National Audit Office, 2005, SAF PLAC PAT LEARN I; Franklin BD, 2005, DRUG SAFETY, V28, P891, DOI 10.2165/00002018-200528100-00005; Hansell A, 2001, J PUBLIC HEALTH MED, V23, P51, DOI 10.1093/pubmed/23.1.51; Health Protection Agency, 2006, MAND SURV HEALTHC AS; Healthcare Commission, 2007, HEALTHC ASS INF WHAT; *HLTH PROT AG, 2008, Q REP RES CLOS DIFF; Holmes AH, 2007, J HOSP INFECT, V65, P191, DOI 10.1016/S0195-6701(07)60042-5; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Neale G, 2001, J ROY SOC MED, V94, P322, DOI 10.1177/014107680109400702; O'Neill, 2008, SAFE BIRTHS EVERYBOD; *OFF NAT STAT, 2008, HLTH STAT Q, V37, P7; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; *SCOTT AUD SURG MO, 2008, PERC CAS ADV EV MAN; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Vincent C., 2006, PATIENT SAFETY	23	116	116	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 13	2008	337								a2426	10.1136/bmj.a2426	http://dx.doi.org/10.1136/bmj.a2426			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AE	19008272	Green Submitted			2022-12-28	WOS:000261784500010
J	Hu, K; Davis, A; O'Sullivan, E				Hu, Kuang; Davis, Alison; O'Sullivan, Eoin			Distinguishing optic disc drusen from papilloedema	BRITISH MEDICAL JOURNAL			English	Article							NERVE HEAD DRUSEN; IDIOPATHIC INTRACRANIAL HYPERTENSION; COMPUTED-TOMOGRAPHY; ANGIOGRAPHY		[Hu, Kuang; Davis, Alison; O'Sullivan, Eoin] Mayday Univ Hosp, Dept Ophthalmol, Croydon CR7 7YE, England	Croydon University Hospital	Hu, K (corresponding author), Mayday Univ Hosp, Dept Ophthalmol, Croydon CR7 7YE, England.	kuanghu@kuanghu.com						Antcliff R, 1999, OPHTHALMOLOGY, V106, P1278, DOI 10.1016/S0161-6420(99)00708-3; Ashwin PT, 2006, POSTGRAD MED J, V82, P580, DOI 10.1136/pgmj.2006.046508; Auw-Haedrich C, 2002, SURV OPHTHALMOL, V47, P515, DOI 10.1016/S0039-6257(02)00357-0; Bhatt UK, 2005, EMERG MED J, V22, P827, DOI 10.1136/emj.2003.012971; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; CARTER JE, 1989, J CLIN NEURO-OPHTHAL, V9, P273; CARTLIDGE NEF, 1977, BRIT J OPHTHALMOL, V61, P385, DOI 10.1136/bjo.61.6.385; Floyd MS, 2005, AM J OPHTHALMOL, V139, P664, DOI 10.1016/j.ajo.2004.11.041; Haynes RJ, 1997, BRIT J OPHTHALMOL, V81, P654, DOI 10.1136/bjo.81.8.654; Hoover D L, 1988, J Pediatr Ophthalmol Strabismus, V25, P191; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Kanski JJ, 2003, CLIN OPHTHALMOLOGY; Kurz-Levin MM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1045; LORENTZEN S, 1961, ACTA OPHTHALMOL, V39, P626; Miller NR., 1998, WALSH HOYTS CLIN NEU, V5; Mishra A, 2007, EUR J PAEDIATR NEURO, V11, P39, DOI 10.1016/j.ejpn.2006.10.001; MULLIE MA, 1985, AM J OPHTHALMOL, V99, P356, DOI 10.1016/0002-9394(85)90369-1; MUSTONEN E, 1982, ACTA OPHTHALMOL, V60, P849; Roh S, 1998, OPHTHALMOLOGY, V105, P878, DOI 10.1016/S0161-6420(98)95031-X; ROSENBERG MA, 1979, ARCH OPHTHALMOL-CHIC, V97, P65, DOI 10.1001/archopht.1979.01020010005001; Rossiter JD, 2005, EYE, V19, P234, DOI 10.1038/sj.eye.6701430; Spencer TS, 2004, J NEURO-OPHTHALMOL, V24, P297, DOI 10.1097/00041327-200412000-00006; STERNBACH G, 1985, Journal of Emergency Medicine, V2, P199, DOI 10.1016/0736-4679(85)90397-X; Taylor D, 1997, PAEDIAT OPHTHALMOLOG, V2	24	10	10	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 10	2008	337								a2360	10.1136/bmj.a2360	http://dx.doi.org/10.1136/bmj.a2360			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384ZZ	19001007				2022-12-28	WOS:000261784000002
J	Lagos, M; Ballhaus, C; Munker, C; Wohlgemuth-Ueberwasser, C; Berndt, J; Kuzmin, DV				Lagos, M.; Ballhaus, C.; Muenker, C.; Wohlgemuth-Ueberwasser, C.; Berndt, J.; Kuzmin, Dmitry V.			The Earth's missing lead may not be in the core	NATURE			English	Article							GEOCHEMICAL CONSTRAINTS; DIFFERENTIATION; MOON; AGE; ACCRETION; PRESSURE; ORIGIN; METAL	Relative to the CI chondrite class of meteorites (widely thought to be the ` building blocks' of the terrestrial planets), the Earth is depleted in volatile elements. For most elements this depletion is thought to be a solar nebular signature, as chondrites show depletions qualitatively similar to that of the Earth(1). Onthe other hand, as lead is a volatile element, some Pb may also have been lost after accretion. The unique Pb-206/Pb-204 and Pb-207/Pb-204 ratios of the Earth's mantle suggest that some lead was lost about 50 to 130 Myr after Solar System formation(2-4). This has commonly been explained by lead lost via the segregation of a sulphide melt to the Earth's core(5-7), which assumes that lead has an affinity towards sulphide. Some models, however, have reconciled the Earth's lead deficit with volatilization(8). Which ever model is preferred, the broad coincidence of U-Pb model ages with the age of the Moon(9-11) suggests that lead loss may be related to the Moon- forming impact. Here we report partitioning experiments in metal - sulphide - silicate systems. We show that lead is neither siderophile nor chalcophile enough to explain the high U/Pb ratio of the Earth'smantle as being a result of lead pumping to the core. The Earth may have accreted from initially volatile- depleted material, some lead may have been lost to degassing following the Moon- forming giant impact, or a hidden reservoir exists in the deep mantle with lead isotope compositions complementary to upper- mantle values; it is unlikely though that the missing lead resides in the core.	[Lagos, M.; Ballhaus, C.; Muenker, C.; Wohlgemuth-Ueberwasser, C.] Univ Bonn, Steinmann Inst, D-53115 Bonn, Germany; [Lagos, M.; Muenker, C.; Wohlgemuth-Ueberwasser, C.; Berndt, J.] Univ Munster, Inst Mineral, D-48149 Munster, Germany; [Kuzmin, Dmitry V.] Max Planck Inst Chem, Abt Geochem, D-55128 Mainz, Germany; [Kuzmin, Dmitry V.] Russian Acad Sci, SB, Inst Geol & Mineral, Novosibirsk 630090, Russia	University of Bonn; University of Munster; Max Planck Society; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences	Lagos, M (corresponding author), Univ Bonn, Steinmann Inst, Poppelsdorfer Schloss, D-53115 Bonn, Germany.	lagos@uni-bonn.de	Munker, Carsten/O-7606-2015; Wohlgemuth-Ueberwasser, Cora/L-8759-2016; Kuzmin, Dmitry/A-3809-2014; Berndt, Jasper/L-4781-2014	Wohlgemuth-Ueberwasser, Cora/0000-0003-2263-3899; Berndt, Jasper/0000-0002-6766-3066; Munker, Carsten/0000-0001-6406-559X	German Research Council	German Research Council(German Research Foundation (DFG))	The paper benefited from our discussions with F. Tomaschek, E.E. Scherer, A. Rohrbach, R. Fonseca and K. Mezger, as well as from a review by S.B. Jacobsen. Financial support from the German Research Council through the Priority Programme 'Mars and the Terrestrial Planets' to C.B. and C.M. is acknowledged.	ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; Allegre CJ, 2008, EARTH PLANET SC LETT, V267, P386, DOI 10.1016/j.epsl.2007.11.056; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Galer S.J.G., 1996, EARTH PROCESSES READ, P75; Hart SR, 2006, CONTRIB MINERAL PETR, V152, P295, DOI 10.1007/s00410-006-0108-1; HOFMANN AW, 2003, TREATISE GEOCHEMISTR, V2, P6101; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; JONES JH, 1986, NATURE, V322, P221, DOI 10.1038/322221a0; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Malavergne V, 2007, GEOCHIM COSMOCHIM AC, V71, P2637, DOI 10.1016/j.gca.2007.03.011; Ohtani E, 1997, PHYS EARTH PLANET IN, V100, P97, DOI 10.1016/S0031-9201(96)03234-7; ONEILL HSC, 1993, AM MINERAL, V78, P456; OVERSBY VM, 1971, NATURE, V234, P463, DOI 10.1038/234463a0; Ozima M, 1999, J GEOPHYS RES-SOL EA, V104, P25493, DOI 10.1029/1999JB900257; Palme H, 2005, TREATISE GEOCHEM, V1, P41; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; PETITET JP, 1987, CHEM GEOL, V62, P31, DOI 10.1016/0009-2541(87)90054-4; Porcelli D, 2001, EARTH PLANET SC LETT, V193, P237, DOI 10.1016/S0012-821X(01)00493-9; Rohrbach A, 2007, NATURE, V449, P456, DOI 10.1038/nature06183; Schuth S, 2004, CONTRIB MINERAL PETR, V148, P288, DOI 10.1007/s00410-004-0604-0; Solomatov V.S., 2000, ORIGIN EARTH MOON, P323; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763; Wood BJ, 2005, NATURE, V437, P1345, DOI 10.1038/nature04129; Yin QZ, 2006, NATURE, V444, DOI 10.1038/nature05358	29	41	42	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					89	92		10.1038/nature07375	http://dx.doi.org/10.1038/nature07375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987741				2022-12-28	WOS:000260674000046
J	Denny, CC; Emanuel, EJ				Denny, Colleen C.; Emanuel, Ezekiel J.			US Health Aid Beyond PEPFAR The Mother & Child Campaign	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVENESS ANALYSIS; DEVELOPING-COUNTRIES; INTERVENTIONS; STRATEGIES; HIV/AIDS		[Denny, Colleen C.; Emanuel, Ezekiel J.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov		Denny, Colleen/0000-0001-5671-6540				Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; JAMISON DT, 2006, DIS CONTROL PRIORITI, pCH10; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; *OFF US GLOB AIDS, US PRES EM PLAN AIDS; SINGER P, 1972, PHILOS PUBLIC AFF, V1, P229; *UN AIDS, GLOB SUMM AIDS EP; *UNICEF, MILL DEV GOALS RED C; Varley RCG, 1998, B WORLD HEALTH ORGAN, V76, P617; WHO, WHY DO SO MAN WOM ST; *WHO, 2007, 310 WHO; *WHO, 2007, 104 WHO; WHO, WAT REL DIS; World Health Organization, CHOOS INT AR COST EF	15	36	37	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2048	2051		10.1001/jama.2008.556	http://dx.doi.org/10.1001/jama.2008.556			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984893				2022-12-28	WOS:000260605400027
J	Farag, N; Delbanco, T; Strewler, GJ				Farag, Nadine; Delbanco, Tom; Strewler, Gordon J.			Update: A 64-Year-Old Woman With Primary Hyperparathyroidism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ORAL ALENDRONATE; OSTEOPOROSIS											Chow CC, 2003, J CLIN ENDOCR METAB, V88, P581, DOI 10.1210/jc.2002-020890; Grey A, 2005, J CLIN ENDOCR METAB, V90, P2122, DOI 10.1210/jc.2004-1772; Khan AA, 2004, J CLIN ENDOCR METAB, V89, P3319, DOI 10.1210/jc.2003-030908; Parker CR, 2002, J CLIN ENDOCR METAB, V87, P4482, DOI 10.1210/jc.2001-010385; Rossini M, 2001, J BONE MINER RES, V16, P113, DOI 10.1359/jbmr.2001.16.1.113; SCHOLZ DA, 1981, MAYO CLIN PROC, V56, P473; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Strewler GJ, 2005, JAMA-J AM MED ASSOC, V293, P1772, DOI 10.1001/jama.293.14.1772	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2044	2045		10.1001/jama.2008.561	http://dx.doi.org/10.1001/jama.2008.561			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18984891				2022-12-28	WOS:000260605400025
J	Hodgkinson, R; Urquhart, DS; Thia, L; Padley, S; Bush, A; Gupta, A				Hodgkinson, R.; Urquhart, D. S.; Thia, L.; Padley, S.; Bush, A.; Gupta, Atul			An 11 month old girl with bilateral wrist swelling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-D-DEFICIENCY; RICKETS		[Hodgkinson, R.; Urquhart, D. S.; Thia, L.; Bush, A.; Gupta, Atul] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England; [Padley, S.] Royal Brompton Hosp, Dept Radiol, London SW3 6NP, England	Royal Brompton Hospital; Royal Brompton Hospital	Gupta, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	atulgupta@doctors.org.uk						Department of Health, 1998, NUTR BON HLTH PART R; Ford L, 2006, ANN CLIN BIOCHEM, V43, P468, DOI 10.1258/000456306778904614; Ladhani S, 2004, ARCH DIS CHILD, V89, P781, DOI 10.1136/adc.2003.031385; Maiya S, 2008, HEART, V94, P581, DOI 10.1136/hrt.2007.119792; Najada AS, 2004, J TROP PEDIATRICS, V50, P364, DOI 10.1093/tropej/50.6.364; National Institute for Health and Clinical Excellence, 2008, IMPR NUTR PREGN BREA; Seerat I, 2007, EMERG MED J, V24, P778, DOI 10.1136/emj.2007.050237; Ward LM, 2007, CAN MED ASSOC J, V177, P161, DOI 10.1503/cmaj.061377	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2008	337								a2149	10.1136/bmj.a2149	http://dx.doi.org/10.1136/bmj.a2149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377FB	18987032				2022-12-28	WOS:000261236000012
J	Jeger, RV; Radovanovic, D; Hunziker, PR; Pfisterer, ME; Stauffer, JC; Erne, P; Urban, P				Jeger, Raban V.; Radovanovic, Dragana; Hunziker, Patrick R.; Pfisterer, Matthias E.; Stauffer, Jean-Christophe; Erne, Paul; Urban, Philip		AMIS Plus Registry Investigators	Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; EARLY REVASCULARIZATION; REPERFUSION THERAPY; TASK-FORCE; TRIAL; MANAGEMENT; OUTCOMES; ADMISSION; SURVIVAL	Background: Few studies describe recent changes in the incidence, treatment, and outcomes of cardiogenic shock. Objective: To examine temporal trends in the incidence, therapeutic management, and mortality rates of patients with the acute coronary syndrome (ACS) and cardiogenic shock, and to assess associations of therapeutic management with death and cardiogenic shock developing during hospitalization. Design: Analysis of registry data collected among patients admitted to hospitals between 1997 and 2006. Setting: 70 of the 106 acute cardiac care hospitals in Switzerland. Patients: 23 696 adults with ACS enrolled in the AMIS (Acute Myocardial Infarction in Switzerland) Plus Registry. Measurements: Cardiogenic shock incidence; treatment, including rates of percutaneous coronary intervention; and in-hospital mortality rates. Results: Rates of overall cardiogenic shock (8.3% of patients with ACS) and cardiogenic shock developing during hospitalization (6.0% of patients with ACS and 71.5% of patients with cardiogenic shock) decreased during the past decade (P < 0.001 for temporal trend), whereas rates of cardiogenic shock on admission remained constant (2.3% of patients with ACS and 28.5% of patients with cardiogenic shock). Rates of percutaneous coronary intervention increased among patients with cardiogenic shock (7.6% to 65.9%; P = 0.010), whereas in-hospital mortality decreased (62.8% to 47.7%; P = 0.010). Percutaneous coronary intervention was independently associated with lower risk for both in-hospital mortality in all patients with ACS (odds ratio, 0.47 [95% CI, 0.30 to 0.73]; P = 0.001) and cardiogenic shock development during hospitalization in patients with ACS but without cardiogenic shock on admission (odds ratio, 0.59 [CI, 0.39 to 0.89]; P = 0.012). Limitations: There was no central review of cardiogenic shock diagnoses, and follow-up duration was confined to the hospital stay. Unmeasured or inaccurately measured characteristics may have confounded observed associations of treatment with outcomes. Conclusion: Over the past decade, rates of cardiogenic shock developing during hospitalization and in-hospital mortality decreased among patients with ACS. Increased percutaneous coronary intervention rates were associated with decreased mortality among patients with cardiogenic shock and with decreased development of cardiogenic shock during hospitalization.	Univ Basel Hosp, CH-4031 Basel, Switzerland; Univ Zurich, Zurich, Switzerland; Univ Lausanne Hosp, Lausanne, Switzerland; Cantonal Hosp Lucerne, Luzern, Switzerland; Tour Hosp, Geneva, Switzerland	University of Basel; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Lucerne Cantonal Hospital	Urban, P (corresponding author), Tour Hosp, Cardiovasc Dept, Ave Maillard 1, CH-1217 Meyrin, Switzerland.	philip.urban@latour.ch	Radovanovic, Dragana I/F-7908-2013; Jeger, Raban/ABG-1678-2021	Radovanovic, Dragana I/0000-0002-9507-6272; Jeger, Raban/0000-0003-1290-5491	Swiss Heart Foundation and Novartis Pharma Schweiz, Bern; Bayer (Schweiz); Pfizer; SPSS (Schweiz); St. Jude Medical, Zurich; AstraZeneca, Zug; Biotronik Schweiz; Bristol-Myers Squibb; Schering, Baar; Boehringer Ingelheim (Schweiz), Basel; Boston Scientific, Solothurn; Cordis, Johnson & Johnson, Spreitenbach; GlaxoSmithKline, Munchenbuchsee; Invatec, Schaffhausen; Medtronic Schweiz, Tolochenaz; MCM medsys, Kirchberg; Merck Sharp & Dohme Chibret, Opfikon-Glattbrugg; Nycomed Pharma, Dubendorf; Sanofi-Aventis; Servier, Meyrin; Takeda Pharma, Lachen, Switzerland	Swiss Heart Foundation and Novartis Pharma Schweiz, Bern; Bayer (Schweiz)(Bayer AG); Pfizer(Pfizer); SPSS (Schweiz); St. Jude Medical, Zurich(St. Jude Medical); AstraZeneca, Zug(AstraZeneca); Biotronik Schweiz; Bristol-Myers Squibb(Bristol-Myers Squibb); Schering, Baar; Boehringer Ingelheim (Schweiz), Basel(Boehringer Ingelheim); Boston Scientific, Solothurn(Boston Scientific); Cordis, Johnson & Johnson, Spreitenbach(Johnson & JohnsonJohnson & Johnson USA); GlaxoSmithKline, Munchenbuchsee(GlaxoSmithKline); Invatec, Schaffhausen; Medtronic Schweiz, Tolochenaz; MCM medsys, Kirchberg; Merck Sharp & Dohme Chibret, Opfikon-Glattbrugg; Nycomed Pharma, Dubendorf; Sanofi-Aventis(Sanofi-Aventis); Servier, Meyrin(Servier); Takeda Pharma, Lachen, Switzerland	The AMIS Plus Registry project was supported by the following sources (all in Switzerland; grouped by city rather than by grant size or any other preferential factor): Swiss Heart Foundation and Novartis Pharma Schweiz, Bern; A. Menarini, Bayer (Schweiz), Pfizer, SPSS (Schweiz), and St. Jude Medical, Zurich; AstraZeneca, Zug; Biotronik Schweiz, Bristol-Myers Squibb, and Schering, Baar; Boehringer Ingelheim (Schweiz), Basel; Boston Scientific, Solothurn; Cordis, Johnson & Johnson, Spreitenbach; GlaxoSmithKline, Munchenbuchsee; Invatec, Schaffhausen; Medtronic Schweiz, Tolochenaz; MCM medsys, Kirchberg; Merck Sharp & Dohme Chibret, Opfikon-Glattbrugg; Nycomed Pharma, Dubendorf; Sanofi-Aventis (Suisse) and Servier (Suisse), Meyrin; and Takeda Pharma, Lachen, Switzerland.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; CALIFF RM, 1994, NEW ENGL J MED, V330, P1724, DOI 10.1056/NEJM199406163302406; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Conde-Vela C, 2007, INT J CARDIOL, V123, P29, DOI 10.1016/j.ijcard.2006.11.102; Dauerman HL, 2002, AM J CARDIOL, V90, P838, DOI 10.1016/S0002-9149(02)02704-2; Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8; Fang J, 2006, AM HEART J, V152, P1035, DOI 10.1016/j.ahj.2006.07.013; Fassa AA, 2005, HEART, V91, P882, DOI 10.1136/hrt.2004.037689; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504; Hasdai D, 1999, EUR HEART J, V20, P128, DOI 10.1053/euhj.1999.1282; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2; Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511; HOLMES DR, 1995, J AM COLL CARDIOL, V26, P668, DOI 10.1016/0735-1097(95)00215-P; Holmes DR, 1999, CIRCULATION, V100, P2067, DOI 10.1161/01.CIR.100.20.2067; Jacobs AK, 2000, J AM COLL CARDIOL, V36, P1091, DOI 10.1016/S0735-1097(00)00888-3; Jeger RV, 2006, EUR HEART J, V27, P664, DOI 10.1093/eurheartj/ehi729; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Schoenenberger AW, 2008, J AM GERIATR SOC, V56, P510, DOI 10.1111/j.1532-5415.2007.01589.x; Singh M, 2007, J AM COLL CARDIOL, V50, P1752, DOI 10.1016/j.jacc.2007.04.101; Urban P, 1999, EUR HEART J, V20, P1030, DOI 10.1053/euhj.1998.1353; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8	27	248	265	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					618	+		10.7326/0003-4819-149-9-200811040-00005	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18981487				2022-12-28	WOS:000260585700003
J	Imtiaz, KE; Zaki, A; Scales, C; Ross, C; Nirodi, GN				Imtiaz, Komal Eram; Zaki, Asyifah; Scales, Chris; Ross, Caroline; Nirodi, Gajanan Niranjan			Trapped in bed (after 32 years of a blocked nose)	LANCET			English	Editorial Material							CHURG-STRAUSS-SYNDROME; PATIENT		[Imtiaz, Komal Eram; Zaki, Asyifah; Scales, Chris] Chorley & S Ribble Hosp, Dept Endocrinol, Cent Lancashire Teaching Hosp, Chorley PR7 1PP, Lancs, England; [Ross, Caroline] Chorley & S Ribble Hosp, Dept Neurophysiol, Cent Lancashire Teaching Hosp, Chorley PR7 1PP, Lancs, England; [Nirodi, Gajanan Niranjan] Market Surg, Bolton, England		Imtiaz, KE (corresponding author), Chorley & S Ribble Hosp, Dept Endocrinol, Cent Lancashire Teaching Hosp, Chorley PR7 1PP, Lancs, England.	komal.imtiaz@lthtr.nhs.uk						Djukic M, 2008, NERVENARZT, V79, P457, DOI 10.1007/s00115-007-2377-y; Gielen C L I, 2008, Ned Tijdschr Geneeskd, V152, P513; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Mukhtyar C, 2008, ANN RHEUM DIS, V67, P1004, DOI 10.1136/ard.2007.071936; Winchester DE, 2008, AM FAM PHYSICIAN, V77, P501	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1606	1606		10.1016/S0140-6736(08)61662-1	http://dx.doi.org/10.1016/S0140-6736(08)61662-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18984195				2022-12-28	WOS:000260590500035
J	McElrath, MJ; De Rosa, SC; Moodie, Z; Dubey, S; Kierstead, L; Janes, H; Defawe, OD; Carter, DK; Hural, J; Akondy, R; Buchbinder, SP; Robertson, MN; Mehrotra, DV; Self, SG; Corey, L; Shiver, JW; Casimiro, DR				McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Dubey, Sheri; Kierstead, Lisa; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Akondy, Rama; Buchbinder, Susan P.; Robertson, Michael N.; Mehrotra, Devan V.; Self, Steven G.; Corey, Lawrence; Shiver, John W.; Casimiro, Danilo R.		Step Study Protocol Team	HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis	LANCET			English	Article; Proceedings Paper	15th Conference on Retroviruses and Opportunistic Infections	FEB 03-06, 2008	Boston, MA				T-CELL RESPONSES; VIRAL LOAD; INFECTION; REPLICATION; DIVERSITY; SELECTION; TRIAL; IMMUNOGENICITY; PROLIFERATION; PROTECTION	Background In the Step Study, the MRKAd5 HIV-1 gag/pol/nef vaccine did not reduce plasma viraemia after infection, and HIV-1 incidence was higher in vaccine-treated than in placebo-treated men with pre-existing adenovirus serotype 5 (ALIS) immunity. We assessed vaccine-induced immunity and its potential contributions to infection risk. Methods To assess immunogenicity, we characterised HIV-specific T cells ex vivo with validated interferon-Y ELISPOT and intracelluilar cytokine staining assays, using a case-cohort design. To establish effects of vaccine and pre-existing Ad5 immunity on infection risk, we undertook flow cytometric studies to measure Ad5-specific T cells and circulating activated (Ki-67+/BcL-2(lo)) CD4+ T cells expressing CCR5. Findings We detected interferon-V-secreting HIV-specific T cells (range 1.63/106 to 686/106 peripheral blood mononuclear cells) ex vivo by ELISPOT in 77% (258/354) of people receiving vaccine; 218 of 354 (62%) recognised two to three HIV proteins. We identified HIV-specific CD4+ T cells by intracellular cytokine staining in 58 of 142 (41%) people. In those with reactive CD4+ T cells, the median percentage of CD4+ T cells expressing interleukin 2 was 88%, and the median co-expression of interferon y or tumor necrosis factor a (TNFa), or both, was 72%. We noted HIV-specific CD8+ T cells (range 0.4-1.0%) in 117 of 160 (73%) participants, expressing predominantly either interferon V alone or with TNFa. Vaccine-induced HIV-specific immunity, including response rate, magnitude, and cytokine profile, did not differ between vaccinated male cases (before infection) and non-cases. Ad5-specific T cells were lower in cases than in non-cases in several subgroup analyses. The percentage of circ it la ti jig Ki-67+BcL-2(lo)/CCR5+ CD4+ T cells did not differ between cases and non-cases. Interpretation Consistent with previous trials, the MRKAd5 HIV-1 gag/pol/nef vaccine was highly immunogenic for inducing HIV-specific CD8+ T cells. Our findings suggest that future candidate vaccines have to elicit responses that either exceed in magnitude or differ in breadth or function from those recorded in this trial. Funding National Institute of Allergy and Infectious Diseases, US National Institutes of Health; and Merck Research Laboratories.	[McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Self, Steven G.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [McElrath, M. Juliana; De Rosa, Stephen C.; Moodie, Zoe; Janes, Holly; Defawe, Olivier D.; Carter, Donald K.; Hural, John; Self, Steven G.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98109 USA; [McElrath, M. Juliana; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [McElrath, M. Juliana; De Rosa, Stephen C.; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Self, Steven G.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Akondy, Rama] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA USA; [Dubey, Sheri; Kierstead, Lisa; Robertson, Michael N.; Mehrotra, Devan V.; Shiver, John W.; Casimiro, Danilo R.] Merck Res Labs, West Point, PA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; San Francisco Department of Public Health; Merck & Company	McElrath, MJ (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, 1100 Fairview Ave N,D3-100, Seattle, WA 98109 USA.	jmcelrat@fhcrc.org	Emery, Sean/J-3825-2017; Frew, Paula M./B-4774-2012; Akondy, Rama/AAC-4656-2020; Corey, Lawrence/AAE-1796-2020; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Frew, Paula M./0000-0002-3078-9124; Corey, Lawrence/0000-0002-2179-2436; Emery, Sean/0000-0001-6072-8309; Akondy, Rama/0000-0003-4737-5240	NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NIAID NIH HHS [U01 AI068618, U01 AI068614, U01 AI068618-02, U01 AI068614-03, U01 AI068618-01, U01 AI068618-03, P30 AI027757, U01 AI068614-01, U01 AI068614-02] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068614, U01AI068618, P30AI027757] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BUCHBINDER SP, 2008, LANCET          1113, DOI DOI 10.1016/S0140-6736(08)61591-3; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Li FS, 2007, CURR HIV RES, V5, P97, DOI 10.2174/157016207779316260; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; ROSENBLUM MG, 1989, CRIT REV IMMUNOL, V9, P21; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Shulman N, 2008, CYTOM PART A, V73A, P847, DOI 10.1002/cyto.a.20600; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Trinvuthipong C, 2004, SCIENCE, V303, P954; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	40	572	598	2	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1894	1905		10.1016/S0140-6736(08)61592-5	http://dx.doi.org/10.1016/S0140-6736(08)61592-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	379IA	19012957	Green Accepted			2022-12-28	WOS:000261388700024
J	Mills, A; Gilson, L; Hanson, K; Palmer, N; Lagarde, M				Mills, Anne; Gilson, Lucy; Hanson, Kara; Palmer, Notasha; Lagarde, Mylene			What do we mean by rigorous health-systems research?	LANCET			English	Editorial Material							POLICY ANALYSIS; IMPACT; ACCESS		[Mills, Anne; Gilson, Lucy; Hanson, Kara; Palmer, Notasha; Lagarde, Mylene] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Mills, A (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	anne.mills@lshtm.ac.uk	Lagarde, Mylene/GVS-9289-2022; Gilson, Lucy/R-8846-2019	Gilson, Lucy/0000-0002-2775-7703; Mills, Anne/0000-0001-9863-9950				Alliance for Health Policy and Systems Research, 2004, STRENGTH HLTH SYST R; DIOP F, 1995, HEALTH POLICY PLANN, V10, P223, DOI 10.1093/heapol/10.3.223; George A. L., 2005, CASE STUDIES THEORY; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Kelly MP, 2007, SOCIAL DETERMINANTS; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; LITVACK JI, 1993, SOC SCI MED, V37, P369, DOI 10.1016/0277-9536(93)90267-8; Mays N., 2001, STUDYING ORG DELIVER; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Ravallion M, 2001, WORLD BANK ECON REV, V15, P115, DOI 10.1093/wber/15.1.115; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; Walt G, 2008, HEALTH POLICY PLANN, V23, P308, DOI 10.1093/heapol/czn024	13	42	43	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 1	2008	372	9649					1527	1529		10.1016/S0140-6736(08)61633-5	http://dx.doi.org/10.1016/S0140-6736(08)61633-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367ZG	18984174				2022-12-28	WOS:000260590500007
J	Goff, SP				Goff, Stephen P.			Knockdown Screens to Knockout HIV-1	CELL			English	Review							SACCHAROMYCES-CEREVISIAE; HOST GENES; INTEGRASE; REPLICATION; INFECTION; LEDGF/P75; PROTEINS; NUCLEAR	Three recent screens use siRNAs to identify host genes that are critical for HIV-1 replication. These screens have uncovered hundreds of human genes not previously known to be commandeered by the virus during infection. Although some caveats remain, this screening approach opens up a new landscape of viral-host interactions for future exploration.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, HHSC 1310C, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	PHS [R37 CA 30488]; National Cancer Institute; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by PHS grant R37 CA 30488 from the National Cancer Institute. S. P. G. is an Investigator of the Howard Hughes Medical Institute.	Aye M, 2004, GENETICS, V168, P1159, DOI 10.1534/genetics.104.028126; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Griffith JL, 2003, GENETICS, V164, P867; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Irwin B, 2005, GENOME RES, V15, P641, DOI 10.1101/gr.3739005; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KRISHNAN MN, 2008, NATURE, V454, P1; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Luban J, 2008, CURR BIOL, V18, pR710, DOI 10.1016/j.cub.2008.07.037; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Scholes DT, 2001, GENETICS, V159, P1449; Zaitseva L, 2006, PLOS BIOL, V4, P1689, DOI 10.1371/journal.pbio.0040332; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	14	92	92	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					417	420		10.1016/j.cell.2008.10.007	http://dx.doi.org/10.1016/j.cell.2008.10.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984154	Bronze, Green Accepted			2022-12-28	WOS:000260536300013
J	Mekhail, K; Seebacher, J; Gygi, SP; Moazed, D				Mekhail, Karim; Seebacher, Jan; Gygi, Steven P.; Moazed, Danesh			Role for perinuclear chromosome tethering in maintenance of genome stability	NATURE			English	Article							RIBOSOMAL-RNA GENES; SACCHAROMYCES-CEREVISIAE; RENT COMPLEX; YEAST RDNA; PROTEIN; DNA; RECOMBINATION; REPLICATION; SIR2; TRANSCRIPTION	Repetitive DNA sequences, which constitute half the genome in some organisms, often undergo homologous recombination. This can instigate genomic instability resulting from a gain or loss of DNA(1). Assembly of DNA into silent chromatin is generally thought to serve as a mechanism ensuring repeat stability by limiting access to the recombination machinery(2). Consistent with this notion is the observation, in the budding yeast Saccharomyces cerevisiae, that stability of the highly repetitive ribosomal DNA( rDNA) sequences requires a Sir2- containing chromatin silencing complex that also inhibits transcription from foreign promoters and transposons inserted within the repeats by a process called rDNA silencing(2-5). Here we describe a protein network that stabilizes rDNA repeats of budding yeast by means of interactions between rDNA- associated silencing proteins and two proteins of the inner nuclear membrane (INM). Deletion of either the INM or silencing proteins reduces perinuclear rDNA positioning, disrupts the nucleolus nucleoplasm boundary, induces the formation of recombination foci, and destabilizes the repeats. In addition, artificial targeting of rDNA repeats to the INM suppresses the instability observed in cells lacking an rDNA- associated silencing protein that is typically required for peripheral tethering of the repeats. Moreover, in contrast to Sir2 and its associated nucleolar factors, the INM proteins are not required for rDNA silencing, indicating that Sir2-dependent silencing is not sufficient to inhibit recombination within the rDNA locus. These findings demonstrate a role for INM proteins in the perinuclear localization of chromosomes and show that tethering to the nuclear periphery is required for the stability of rDNA repeats. The INM proteins studied here are conserved and have been implicated in chromosome organization in metazoans(6,7). Our results therefore reveal an ancient mechanism in which interactions between INM proteins and chromosomal proteins ensure genome stability.	[Mekhail, Karim; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mekhail, Karim; Seebacher, Jan; Gygi, Steven P.; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	danesh@hms.harvard.edu		Mekhail, Karim/0000-0002-6084-020X	National Institutes of Health; Howard Hughes Medical Institute; Canadian Institutes of Health Research Institute of Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research Institute of Aging(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Yip, T. Walz, J. Huang, M. Buhler, D. Koshland, A. Palazzo, D. E. Libuda, F. Winston, L. Vasiljeva, S. Buratowski, J. E. Warner, C. Anderson, G. A. Beltz, M. Lisby, T. Daniel, L. Ding and the Harvard NeuroDiscovery Optical Imaging Center for technical assistance or materials, and T. Rapoport, T. Iida, M. Motamedi, A. Johnson, M. Onishi, E. Gerace, S. Buker, M. Halic and members of the Moazed laboratory for helpful discussions and comments. This work was supported by the National Institutes of Health and the Howard Hughes Medical Institute (D.M.), and the Canadian Institutes of Health Research Institute of Aging (K.M.). D.M. is a scholar of the Leukemia and Lymphoma Society.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KEIL RL, 1984, CELL, V39, P377, DOI 10.1016/0092-8674(84)90016-3; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; SZOSTAK JW, 1980, NATURE, V284, P426, DOI 10.1038/284426a0; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775	36	179	183	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					667	U98		10.1038/nature07460	http://dx.doi.org/10.1038/nature07460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18997772	Green Accepted			2022-12-28	WOS:000261340000047
J	Algra, RE; Verheijen, MA; Borgstrom, MT; Feiner, LF; Immink, G; van Enckevort, WJP; Vlieg, E; Bakkers, EPAM				Algra, Rienk E.; Verheijen, Marcel A.; Borgstrom, Magnus T.; Feiner, Lou-Fe; Immink, George; van Enckevort, Willem J. P.; Vlieg, Elias; Bakkers, Erik P. A. M.			Twinning superlattices in indium phosphide nanowires	NATURE			English	Article							ZINCBLENDE-TYPE SEMICONDUCTORS; OPTICAL-PROPERTIES; DIAMOND-TYPE; GROWTH; INP; LAYERS; GAAS	Semiconducting nanowires offer the possibility of nearly unlimited complex bottom- up design(1,2), which allows for new device concepts(3,4). However, essential parameters that determine the electronic quality of the wires, and which have not been controlled yet for the III-V compound semiconductors, are the wire crystal structure and the stacking fault density(5). In addition, a significant feature would be to have a constant spacing between rotational twins in the wires such that a twinning superlattice is formed, as this is predicted to induce a direct bandgap in normally indirect bandgap semiconductors(6,7), such as silicon and gallium phosphide. Optically active versions of these technologically relevant semiconductors could have a significant impact on the electronics(8) and optics(9) industry. Here we show first that we can control the crystal structure of indium phosphide (InP) nanowires by using impurity dopants. We have found that zinc decreases the activation barrier for two- dimensional nucleation growth of zinc- blende InP and therefore promotes crystallization of the InP nanowires in the zinc- blende, instead of the commonly found wurtzite, crystal structure(10). More importantly, we then demonstrate that we can, once we have enforced the zinc- blende crystal structure, induce twinning superlattices with long-range order in InP nanowires. We can tune the spacing of the superlattices by changing the wire diameter and the zinc concentration, and we present a model based on the distortion of the catalyst droplet in response to the evolution of the cross- sectional shape of the nanowires to quantitatively explain the formation of the periodic twinning.	[Algra, Rienk E.; Verheijen, Marcel A.; Borgstrom, Magnus T.; Feiner, Lou-Fe; Immink, George] Philips Res Labs, NL-5656 AE Eindhoven, Netherlands; [Algra, Rienk E.] Mat Innovat Inst M2i, NL-2628 CD Delft, Netherlands; [Algra, Rienk E.; van Enckevort, Willem J. P.; Vlieg, Elias] Radboud Univ Nijmegen, IMM, NL-6525 AJ Nijmegen, Netherlands	Philips; Philips Research; Radboud University Nijmegen	Bakkers, EPAM (corresponding author), Philips Res Labs, High Tech Campus 11, NL-5656 AE Eindhoven, Netherlands.	erik.bakkers@philips.com	Verheijen, Marcel/AAT-3889-2021; Borgström, Magnus T/B-2237-2008; Vlieg, Elias/G-3386-2012; van Enckevort, Willem J. P./D-5226-2012	Borgström, Magnus T/0000-0001-8061-0746; Vlieg, Elias/0000-0002-1343-4102; Verheijen, Marcel/0000-0002-8749-7755				Akiyama T, 2006, JPN J APPL PHYS 2, V45, pL275, DOI 10.1143/JJAP.45.L275; Bao JM, 2008, NANO LETT, V8, P836, DOI 10.1021/nl072921e; Brakke K.A., 1992, EXP MATH, V1, P141, DOI [DOI 10.1080/10586458.1992.10504253, 10.1080/10586458.1992.10504253]; BRAKKE KA, 2008, SURFACE EVOLVER VERS; Dick KA, 2004, NAT MATER, V3, P380, DOI 10.1038/nmat1133; Fissel A, 2006, J CRYST GROWTH, V290, P392, DOI 10.1016/j.jcrysgro.2006.02.009; Glas F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146101; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; Hao YF, 2006, NANO LETT, V6, P1650, DOI 10.1021/nl060695n; Hibino H, 1998, J VAC SCI TECHNOL A, V16, P1934, DOI 10.1116/1.581199; HIRUMA K, 1995, J APPL PHYS, V77, P447, DOI 10.1063/1.359026; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; HURLE DTJ, 1995, J CRYST GROWTH, V147, P239, DOI 10.1016/0022-0248(94)00666-0; IKONIC Z, 1993, PHYS REV B, V48, P17181, DOI 10.1103/PhysRevB.48.17181; IKONIC Z, 1995, PHYS REV B, V52, P14078, DOI 10.1103/PhysRevB.52.14078; Johansson J, 2006, NAT MATER, V5, P574, DOI 10.1038/nmat1677; Krames MR, 2007, J DISP TECHNOL, V3, P160, DOI 10.1109/JDT.2007.895339; Liu QKK, 1999, PHYS REV B, V60, P17008, DOI 10.1103/PhysRevB.60.17008; Lui A.S, 2006, PHYSICA E, V35, P223; MALINA V, 1994, SEMICOND SCI TECH, V9, P1523, DOI 10.1088/0268-1242/9/8/014; Mattila M, 2006, NANOTECHNOLOGY, V17, P1580, DOI 10.1088/0957-4484/17/6/008; Minot ED, 2007, NANO LETT, V7, P367, DOI 10.1021/nl062483w; Ross FM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146104; Van Dam JA, 2006, NATURE, V442, P667, DOI 10.1038/nature05018; Verheijen MA, 2007, NANO LETT, V7, P3051, DOI 10.1021/nl071541q; WEIZER GW, 1994, 106590 NASA; Xiong QH, 2006, NANO LETT, V6, P2736, DOI 10.1021/nl0616983	27	572	578	3	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					369	372		10.1038/nature07570	http://dx.doi.org/10.1038/nature07570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020617	Green Submitted			2022-12-28	WOS:000261039600039
J	Biver, S; Belge, H; Bourgeois, S; Van Vooren, P; Nowik, M; Scohy, S; Houillier, P; Szpirer, J; Szpirer, C; Wagner, CA; Devuyst, O; Marini, AM				Biver, Sophie; Belge, Hendrica; Bourgeois, Soline; Van Vooren, Pascale; Nowik, Marta; Scohy, Sophie; Houillier, Pascal; Szpirer, Josiane; Szpirer, Claude; Wagner, Carsten A.; Devuyst, Olivier; Marini, Anna Maria			A role for Rhesus factor Rhcg in renal ammonium excretion and male fertility	NATURE			English	Article							TUBULAR-ACIDOSIS; RHAG PROTEIN; TRANSPORT; GLYCOPROTEIN; KIDNEY; RHBG; EXPRESSION; MECHANISMS; MOUSE; IDENTIFICATION	The kidney has an important role in the regulation of acid - base homeostasis. Renal ammonium production and excretion are essential for net acid excretion under basal conditions and during metabolic acidosis. Ammonium is secreted into the urine by the collecting duct, a distal nephron segment where ammonium transport is believed to occur by non- ionic NH3 diffusion coupled to H+ secretion. Here we show that this process is largely dependent on the Rhesus factor Rhcg. Mice lacking Rhcg have abnormal urinary acidification due to impaired ammonium excretion on acid loading - a feature of distal renal tubular acidosis. In vitro microperfused collecting ducts of Rhcg(-/-) acid- loaded mice show reduced apical permeability to NH3 and impaired transepithelial NH3 transport. Furthermore, Rhcg is localized in epididymal epithelial cells and is required for normal fertility and epididymal fluid pH. We anticipate a critical role for Rhcg in ammonium handling and pH homeostasis both in the kidney and the male reproductive tract.	[Biver, Sophie; Van Vooren, Pascale; Scohy, Sophie; Szpirer, Josiane; Szpirer, Claude; Marini, Anna Maria] Univ Libre Bruxelles, Inst Biol & Med Mol, Labs Biol Dev & Physiol Mol Cellule, B-6041 Gosselies, Belgium; [Belge, Hendrica; Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, B-1200 Brussels, Belgium; [Bourgeois, Soline; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Houillier, Pascal] INSERM, UMS 872, F-75006 Paris, France; [Bourgeois, Soline; Houillier, Pascal] Univ Paris 06, F-75006 Paris, France; [Bourgeois, Soline; Houillier, Pascal] Univ Paris 05, F-75006 Paris, France	Universite Libre de Bruxelles; Universite Catholique Louvain; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Marini, AM (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Labs Biol Dev & Physiol Mol Cellule, Rue Prof Jeener & Brachet 12, B-6041 Gosselies, Belgium.	ammarini@dbm.ulb.ac.be	Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917; Biver, Sophie/0000-0002-7903-2413; Devuyst, Olivier/0000-0003-3744-4767	Belgian agencies FNRS; FRSM [3.4.546.04. F, 3.4.635.05. F, 3.4592.06. F]; Fonds Brachet-recherche; Fonds Van Buuren; Fondation Alphonse Jean Forton; Concerted Research Action [05/10-328]; Inter-university Attraction Pole [IUAP P6/05]; Swiss National Science Foundation [31-109677]; INSERM; EuReGene; EUNEFRON [GA#201590]; European Community [FP6, FP7]; FRIA fellowship	Belgian agencies FNRS(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); Fonds Brachet-recherche; Fonds Van Buuren; Fondation Alphonse Jean Forton; Concerted Research Action; Inter-university Attraction Pole(Belgian Federal Science Policy Office); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EuReGene; EUNEFRON; European Community(European Commission); FRIA fellowship(Fonds de la Recherche Scientifique - FNRS)	We are grateful to P. Dreze, B. Andre and P. Gabant for their contribution to the initial step of this study. We thank H. Mezdour, L. Pouilly and P. Persoons for microinjection experiments, B. Pajak for help in broad- spectrum histological assessment, V. Beaujean, Y. Cnops, H. Debaix and T. Nishino for excellent technical assistance, and A. Tamah and M.-F. Vincent for amino acid chromatography. These studies were supported by the Belgian agencies FNRS and FRSM (3.4.546.04. F, 3.4.635.05. F, 3.4592.06. F), the 'Fonds Brachet-recherche', the 'Fonds Van Buuren', the 'Fondation Alphonse & Jean Forton', a Concerted Research Action (05/10-328), an Inter-university Attraction Pole (IUAP P6/05), the Swiss National Science Foundation (31-109677), an INSERM grant, and the EuReGene and EUNEFRON (GA#201590) projects of the European Community (FP6 and FP7). S. Bi. was the recipient of a FRIA fellowship; H.B., A.M.M. and C.S. are Research fellow, Research associate and Research director of the FNRS, respectively.	Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; BEVENSEE MO, 2008, CONTROL INTRACELLULA, P1429; Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P240; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; CHERIFZAHAR B, 1994, GENOMICS, V19, P68, DOI 10.1006/geno.1994.1014; DUBOSE TD, 1991, J AM SOC NEPHROL, V1, P1193; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; HAMM LL, 1987, AM J PHYSIOL, V253, pF595, DOI 10.1152/ajprenal.1987.253.4.F595; Ji QM, 2006, P NATL ACAD SCI USA, V103, P5881, DOI 10.1073/pnas.0600901103; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Kim SC, 1998, INT J ANDROL, V21, P29; KNEPPER MA, 1991, KIDNEY INT, V40, pS95; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; LEVANKIM C, 1992, P NATL ACAD SCI USA, V89, P10925, DOI 10.1073/pnas.89.22.10925; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Philip L., 1939, JAMA-J AM MED ASSOC, V113, P126; PITTS RF, 1948, FED PROC, V7, P418; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; RIDGWELL K, 1992, BIOCHEM J, V287, P223, DOI 10.1042/bj2870223; SARTORIUS OW, 1949, J CLIN INVEST, V28, P423, DOI 10.1172/JCI102087; Soriano JR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023430.92674.E5; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weiner ID, 2007, ANNU REV PHYSIOL, V69, P317, DOI 10.1146/annurev.physiol.69.040705.142215; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	40	129	131	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					339	343		10.1038/nature07518	http://dx.doi.org/10.1038/nature07518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020613				2022-12-28	WOS:000261039600033
J	Hanna, RA; Campbell, RL; Davies, PL				Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.			Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin	NATURE			English	Article							CRYSTAL-STRUCTURES; ACTIVE-SITE; MU-CALPAIN; ACTIVATION; PEPTIDE; BINDING; MODEL; COMPLEXES	Calpains are non-lysosomal calcium-dependent cysteine proteinases that selectively cleave proteins in response to calcium signals(1) and thereby control cellular functions such as cytoskeletal remodelling, cell cycle progression, gene expression and apoptotic cell death(2-4). In mammals, the two best-characterized members of the calpain family, calpain 1 and calpain 2 ( mu-calpain and m-calpain, respectively), are ubiquitously expressed. The activity of calpains is tightly controlled by the endogenous inhibitor calpastatin, which is an intrinsically unstructured protein capable of reversibly binding and inhibiting four molecules of calpain, but only in the presence of calcium(5,6). To date, the mechanism of inhibition by calpastatin and the basis for its absolute specificity have remained speculative(7-9). It was not clear how this unstructured protein inhibits calpains without being cleaved itself, nor was it known how calcium induced changes that facilitated the binding of calpastatin to calpain. Here we report the 2.4-angstrom-resolution crystal structure of the calcium-bound calpain 2 heterodimer bound by one of the four inhibitory domains of calpastatin. Calpastatin is seen to inhibit calpain by occupying both sides of the active site cleft. Although the inhibitor passes through the active site cleft it escapes cleavage in a novel manner by looping out and around the active site cysteine. The inhibitory domain of calpastatin recognizes multiple lower affinity sites present only in the calcium-bound form of the enzyme, resulting in an interaction that is tight, specific and calcium dependent. This crystal structure, and that of a related complex(10), also reveal the conformational changes that calpain undergoes on binding calcium, which include opening of the active site cleft and movement of the domains relative to each other to produce a more compact enzyme.	[Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca		Campbell, Robert/0000-0002-5473-5876	Canadian Institutes for Health Research; Bauman Fellowship; R. J. Wilson Fellowship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Bauman Fellowship; R. J. Wilson Fellowship	This work was funded by the Canadian Institutes for Health Research. R. A. H. is the recipient of a Bauman Fellowship and an R. J. Wilson Fellowship. P. L. D. holds a Canada Research Chair in Protein Engineering. We are grateful to S. Gauthier for technical assistance, to M. Kuiper for the simulation of the conformational change in calpain on binding Ca<SUP>2+</SUP>, to the Queen's University Protein Function Discovery (PFD) Facility and D. McLeod for mass spectrometry, Z. Jia for access to data collection on a home source and to M. Allaire at Brookhaven National Laboratory for assistance with data collection on beam line X6A.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; CROALL DE, 1994, BIOCHEMISTRY-US, V33, P13223, DOI 10.1021/bi00249a008; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; ISHIMA R, 1991, FEBS LETT, V294, P64, DOI 10.1016/0014-5793(91)81344-8; Li M, 2000, NAT STRUCT BIOL, V7, P113, DOI 10.1038/72378; Maekawa A, 2003, J MOL CELL CARDIOL, V35, P1277, DOI 10.1016/S0022-2828(03)00238-4; MAKI M, 1989, J BIOL CHEM, V264, P18866; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2004, J BIOL CHEM, V279, P6106, DOI 10.1074/jbc.M310460200; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Neffe AT, 2005, CURR OPIN DRUG DISC, V8, P684; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Pfizer J, 2008, BIOL CHEM, V389, P83, DOI 10.1515/BC.2008.004; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	32	221	240	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					409	U78		10.1038/nature07451	http://dx.doi.org/10.1038/nature07451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	19020623				2022-12-28	WOS:000261039600048
J	Gunnell, D; Hawton, K; Ho, D; Evans, J; O'Connor, S; Potokar, J; Donovan, J; Kapur, N				Gunnell, David; Hawton, Keith; Ho, Davidson; Evans, Jonathan; O'Connor, Susan; Potokar, John; Donovan, Jenny; Kapur, Nav			Hospital admissions for self harm after discharge from psychiatric inpatient care: cohort study	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE-PREVENTION; RISK; ADOLESCENTS; MANAGEMENT	Objective To determine the risk of non- fatal self harm in the 12 months after discharge from psychiatric inpatient care. Design Cohort study based on national hospital episode statistics. Setting England. Population Patients aged 16- 64 years discharged from psychiatric inpatient care between 1 April 2004 and 31 March 2005 and followed up for one year. Results 75 401 people were discharged from psychiatric inpatient care over the study period, 4935 ( 6.5%) of whom were admitted at least once for self harm in the following 12 months. Risk of self harm was greatest in the four weeks after discharge; one third ( 32%, n= 1578) of admissions for self harm occurred in this period. The strongest risk factor for self harm after discharge was admission for self harm in the previous 12 months ( hazard ratio 4.9, 95% confidence interval 4.6 to 5.2). The risk of self harm was also higher in females, younger people, those with diagnoses of depression, personality disorders, and substance misuse, and those with short lengths of stay. Conclusion More than 6% of patients discharged from psychiatric inpatient care are readmitted for an episode of self harm within 12 months, with one third of these episodes occurring in the month after discharge. Self harm after discharge from hospital shares many of the features of suicide after discharge. Interventions should be developed to reduce risk in this period.	[Gunnell, David; Ho, Davidson; Donovan, Jenny] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Hawton, Keith] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford, England; [Ho, Davidson] SW Publ Hlth Observ, Bristol, Avon, England; [Evans, Jonathan; Potokar, John] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England; [O'Connor, Susan] Avon & Wiltshire Partnership NHS Trust, Chippenham, Wilts, England; [Kapur, Nav] Univ Manchester, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England	University of Bristol; University of Oxford; University of Bristol; University of Manchester	Gunnell, D (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	d.j.gunnell@bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Evans, Jonathan/0000-0003-3171-640X; Kapur, Nav/0000-0002-3100-3234	National Institute of Health Research	National Institute of Health Research(National Institute for Health Research (NIHR))	This work was funded by a National Institute of Health Research programme grant for applied research.	Department of Health, 2002, NAT SUIC PREV STRAT; GEDDES JR, 1995, BRIT MED J, V311, P357, DOI 10.1136/bmj.311.7001.357; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; Goldston DB, 1999, J AM ACAD CHILD PSY, V38, P660, DOI 10.1097/00004583-199906000-00012; Gunnell D, 2005, J PUBLIC HEALTH-UK, V27, P67, DOI 10.1093/pubmed/fdh192; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; King EA, 2001, BRIT J PSYCHIAT, V178, P531, DOI 10.1192/bjp.178.6.531; Meehan J, 2006, BRIT J PSYCHIAT, V188, P129, DOI 10.1192/bjp.188.2.129; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; MOTTO JA, 1976, SUICIDE LIFE-THREAT, V6, P223; National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH). Manchester: University of Manchester, 2006, MAKING MENTAL HLTH C; Prinstein MJ, 2008, J CONSULT CLIN PSYCH, V76, P92, DOI 10.1037/0022-006X.76.1.92; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; SELLAR C, 1990, J EPIDEMIOL COMMUN H, V44, P313, DOI 10.1136/jech.44.4.313; Skeem JL, 2006, BEHAV SCI LAW, V24, P731, DOI 10.1002/bsl.726; Taylor SJ, 1997, ACTA PSYCHIAT SCAND, V95, P457, DOI 10.1111/j.1600-0447.1997.tb10132.x	16	62	62	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2278	10.1136/bmj.a2278	http://dx.doi.org/10.1136/bmj.a2278			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19018041	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000262653900003
J	Hawkes, N				Hawkes, Nigel			National obesity strategy: what's the big idea?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2548	10.1136/bmj.a2548	http://dx.doi.org/10.1136/bmj.a2548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19017715				2022-12-28	WOS:000262653900006
J	McColl, K				McColl, Karen			The fattening truth about restaurant food	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFORMATION					karen@karenmccoll.co.uk						BARRON J, 2008, NY TIMES        0422; Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020; Berman M, 2008, JAMA-J AM MED ASSOC, V300, P433, DOI 10.1001/jama.300.4.433; BRUNI F, 2008, NY TIMES        0422; Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; *CTR SCI PUBL INT, 2003, AN GUESS NEED NUTR L; DIGREGORIA A, VILLAGE VOICE; *FOOD COMM, 2008, FOOD MAGAZINE    AUG, P82; Food Standards Agency, 2008, CONS GIV THEIR VIEWS; *NEW YORK CIT DEP, 2008, CAL POST LEG TIM; US Centers for Disease control and Prevention, 2008, OV OB	11	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2008	337								a2229	10.1136/bmj.a2229	http://dx.doi.org/10.1136/bmj.a2229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HQ	19017714				2022-12-28	WOS:000262653900002
J	Greenhalgh, T				Greenhalgh, Trisha			Role of routines in collaborative work in healthcare organisations	BRITISH MEDICAL JOURNAL			English	Editorial Material							TECHNOLOGY; STRUCTURATION; COORDINATION; RECORD		[Greenhalgh, Trisha] UCL, UCL Res Dept Primary Care & Populat Hlth, London N19 5LW, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, UCL Res Dept Primary Care & Populat Hlth, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Argyris C., 1985, STRATEGY CHANGE DEFE; BARLEY SR, 1986, ADMIN SCI QUART, V31, P78, DOI 10.2307/2392767; BATE SP, 2006, ACHIEVING SUSTAINING; Becker MC, 2004, IND CORP CHANGE, V13, P643, DOI 10.1093/icc/dth026; Ben-Tovim DI, 2008, MED J AUSTRALIA, V188, pS14; Berg M, 1997, SCI TECHNOL HUM VAL, V22, P403, DOI 10.1177/016224399702200401; Berg M, 1999, INT J MED INFORM, V55, P87, DOI 10.1016/S1386-5056(99)00011-8; Beringer AJ, 2006, J ADV NURS, V56, P325, DOI 10.1111/j.1365-2648.2006.04023.x; Braithwaite Jeffrey, 2004, J Health Organ Manag, V18, P240, DOI 10.1108/14777260410554269; Braithwaite Jeffrey, 2007, J Health Organ Manag, V21, P353, DOI 10.1108/14777260710778899; Davidson E, 2005, ORG VISIONS IT HEALT; Edmondson AC, 2001, ADMIN SCI QUART, V46, P685, DOI 10.2307/3094828; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; FELDMAN M, 2002, ADM SCI Q, V48, P94; Feldman MS, 2003, IND CORP CHANGE, V12, P727, DOI 10.1093/icc/12.4.727; Feldman MS, 2000, ORGAN SCI, V11, P611, DOI 10.1287/orsc.11.6.611.12529; Fraser SW, 2001, BRIT MED J, V323, P799, DOI 10.1136/bmj.323.7316.799; Garvin DA, 2008, HARVARD BUS REV, V86, P109; Giddens A, 1984, CONSTITUTION SOC OUT; Gittell JH, 2004, J MANAGE STUD, V41, P127, DOI 10.1111/j.1467-6486.2004.00424.x; Goffman E., 1969, PRESENTATION SELF EV, DOI DOI 10.1073/PNAS.75.2.580; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Greenhalgh T, 2007, SOCIOL HEALTH ILL, V29, P931, DOI 10.1111/j.1467-9566.2007.01047.x; Hoffmarcher MM, 2007, IMPROVED HLTH SYSTEM; Howard-Grenville JA, 2005, ORGAN SCI, V16, P618, DOI 10.1287/orsc.1050.0150; Institute of Medicine, 2003, CROSS QUAL CHASM NEW; Obstfelder A, 2006, STUD HEALTH TECHNOL, V122, P626; Orlikowski WJ, 2000, ORGAN SCI, V11, P404, DOI 10.1287/orsc.11.4.404.14600; OSTERLUND C, 2004, J CTR INFORM STUDIES, V5, P35; OSTERLUND C, 2006, HAW INT C SYST SCI, pA50; OSTERLUND C, 2004, 2 ANN M DOC AC SCH I; PENTLAND BT, 1995, ORGAN SCI, V6, P541, DOI 10.1287/orsc.6.5.541; Perlow LA, 2004, ORGAN SCI, V15, P520, DOI 10.1287/orsc.1040.0097; Pinder R, 2005, SOCIOL HEALTH ILL, V27, P759, DOI 10.1111/j.1467-9566.2005.00473.x; Pratt MG, 2006, ACAD MANAGE J, V49, P235, DOI 10.5465/AMJ.2006.20786060; Renholm M, 2002, J NURS ADMIN, V32, P196, DOI 10.1097/00005110-200204000-00008; Scott W.R, 1995, CINEMA J; Taylor AJ, 2007, INT J PALLIAT NURS, V13, P163, DOI 10.12968/ijpn.2007.13.4.23489; Weick K.E., 1995, SENSEMAKING ORG; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85	40	56	57	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2008	337								a2448	10.1136/bmj.a2448	http://dx.doi.org/10.1136/bmj.a2448			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397HP	19015186				2022-12-28	WOS:000262653800003
J	Chadwick, DW; Baker, GA; Jacoby, A; Marson, AG; Smith, PE				Chadwick, David W.; Baker, Gus A.; Jacoby, Ann; Marson, Anthony G.; Smith, Phil E.			What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DRUG; LAMOTRIGINE; TOPIRAMATE; SEIZURES; OUTCOMES; SANAD		[Chadwick, David W.; Baker, Gus A.; Jacoby, Ann; Marson, Anthony G.] Univ Liverpool, Walton Ctr, Liverpool L9 7LJ, Merseyside, England; [Smith, Phil E.] Univ Wales Hosp, Cardiff CF14 4XW, Wales	University of Liverpool; Walton Centre; Cardiff University	Chadwick, DW (corresponding author), Univ Liverpool, Walton Ctr, Liverpool L9 7LJ, Merseyside, England.	d.w.chadwick@liverpool.ac.uk	Marson, Anthony/AAW-9776-2020	Marson, Anthony/0000-0002-6861-8806				ANNEGERS JF, 1979, EPILEPSIA, V20, P729, DOI 10.1111/j.1528-1157.1979.tb04857.x; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Deckers CLP, 2000, EPILEPSIA, V41, P1364, DOI 10.1111/j.1528-1157.2000.tb00111.x; Gilliam Frank, 2003, Curr Neurol Neurosci Rep, V3, P357, DOI 10.1007/s11910-003-0014-0; Jacoby A, 2007, NEUROLOGY, V68, P1188, DOI 10.1212/01.wnl.0000259411.78423.50; JACOBY A, 1992, EPILEPSIA, V33, P1123, DOI 10.1111/j.1528-1157.1992.tb01769.x; Jacoby A, 1996, EPILEPSIA, V37, P148, DOI 10.1111/j.1528-1157.1996.tb00006.x; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; McCorry D, 2004, LANCET NEUROL, V3, P729, DOI 10.1016/S1474-4422(04)00935-4; *NAT I HLTH CLIN E, 2004, EP AD NEW DRUGS GUID; *NAT I HLTH CLIN E, 2004, EP AD CHILDR NICE GU	12	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 14	2008	337								a2199	10.1136/bmj.a2199	http://dx.doi.org/10.1136/bmj.a2199			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385AF	19010969				2022-12-28	WOS:000261784600001
J	Kohanski, MA; Dwyer, DJ; Wierzbowski, J; Cottarel, G; Collins, JJ				Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.			Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death	CELL			English	Article							COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; GENE ONTOLOGY; FTSH HFLB; PERIPLASMIC PROTEASE; BACTERICIDAL ACTION; GYRASE INHIBITORS; AMINOGLYCOSIDES; ENVELOPE	Aminoglycoside antibiotics, such as gentamicin and kanamycin, directly target the ribosome, yet the mechanisms by which these bactericidal drugs induce cell death are not fully understood. Recently, oxidative stress has been implicated as one of the mechanisms whereby bactericidal antibiotics kill bacteria. Here, we use systems-level approaches and phenotypic analyses to provide insight into the pathway whereby aminoglycosides ultimately trigger hydroxyl radical formation. We show, by disabling systems that facilitate membrane protein traffic, that mistranslation and misfolding of membrane proteins are central to aminoglycoside-induced oxidative stress and cell death. Signaling through the envelope stress-response two-component system is found to be a key player in this process, and the redox-responsive two-component system is shown to have an associated role. Additionally, we show that these two-component systems play a general role in bactericidal antibiotic-mediated oxidative stress and cell death, expanding our understanding of the common mechanism of killing induced by bactericidal antibiotics.	[Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Kohanski, Michael A.; Dwyer, Daniel J.; Wierzbowski, Jamey; Cottarel, Guillaume; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Kohanski, Michael A.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Dwyer, Daniel J.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, 44 Cummington St, Boston, MA 02215 USA.	jcollins@bu.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644-02, DP1 OD003644] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; DOUGHERTY TJ, 1985, ANTIMICROB AGENTS CH, V28, P200, DOI 10.1128/AAC.28.2.200; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P429, DOI 10.1093/jac/8.6.429; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; IUCHI S, 1989, J BACTERIOL, V171, P2889, DOI 10.1128/jb.171.5.2889-2893.1989; Jepras RI, 1997, ANTIMICROB AGENTS CH, V41, P2001, DOI 10.1128/AAC.41.9.2001; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; MARTIN JP, 1987, J BACTERIOL, V169, P2516, DOI 10.1128/jb.169.6.2516-2522.1987; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; RAHAL JJ, 1979, ANTIMICROB AGENTS CH, V16, P13, DOI 10.1128/AAC.16.1.13; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Umezawa N, 1997, ARCH BIOCHEM BIOPHYS, V342, P275, DOI 10.1006/abbi.1997.0124; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; WEISBLUM B, 1968, BACTERIOL REV, V32, P493, DOI 10.1128/MMBR.32.4_Pt_2.493-528.1968; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wu WJ, 2002, AUDIOL NEURO-OTOL, V7, P171, DOI 10.1159/000058305; ZASKE DE, 1982, ANTIMICROB AGENTS CH, V21, P407, DOI 10.1128/AAC.21.3.407	59	380	392	10	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					679	690		10.1016/j.cell.2008.09.038	http://dx.doi.org/10.1016/j.cell.2008.09.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013277	Bronze, Green Accepted			2022-12-28	WOS:000260886900018
J	Schenck, S				Schenck, Sarah			A Lesson Learned by Accident	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sschenck@christianacare.org							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2008	300	18					2101	2101		10.1001/jama.2008.630	http://dx.doi.org/10.1001/jama.2008.630			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370WM	19001611				2022-12-28	WOS:000260793800001
J	Altshuler, D; Daly, MJ; Lander, ES				Altshuler, David; Daly, Mark J.; Lander, Eric S.			Genetic Mapping in Human Disease	SCIENCE			English	Review							GENOME-WIDE ASSOCIATION; COMPLEMENT FACTOR-H; SINGLE-NUCLEOTIDE POLYMORPHISMS; DENSITY-LIPOPROTEIN CHOLESTEROL; FRAGMENT LENGTH POLYMORPHISMS; CORONARY-ARTERY-DISEASE; PROSTATE-CANCER RISK; C-REACTIVE PROTEIN; BETA-CELL FUNCTION; LINKAGE DISEQUILIBRIUM	Genetic mapping provides a powerful approach to identify genes and biological processes underlying any trait influenced by inheritance, including human diseases. We discuss the intellectual foundations of genetic mapping of Mendelian and complex traits in humans, examine lessons emerging from linkage analysis of Mendelian diseases and genome- wide association studies of common diseases, and discuss questions and challenges that lie ahead.	[Altshuler, David; Daly, Mark J.; Lander, Eric S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Altshuler, David; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Altshuler, David; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Altshuler, David; Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Altshuler, D (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	altshuler@molbio.mgh.harvard.edu; mjdaly@chgr.mgh.harvard.edu; lander@broad.mit.edu	Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752	NHGRI NIH HHS [U54 HG003067-03, U54 HG003067] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AIRD I, 1954, BRIT MED J, V1, P153, DOI 10.1136/bmj.1.4854.153; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altenburg E, 1920, GENETICS, V5, P1; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; CLARKE L, 1980, P NATL ACAD SCI-BIOL, V77, P2173, DOI 10.1073/pnas.77.4.2173; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; East EM, 1910, AM NAT, V44, P65, DOI 10.1086/279117; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Hazra A, 2008, CANCER CAUSE CONTROL, V19, P975, DOI 10.1007/s10552-008-9164-3; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIMURA M, 1973, GENETICS, V75, P199; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lewontin R., 1972, EVOL BIOL, V6, P391; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; LI WH, 1991, GENETICS, V129, P513; Lifton Richard P, 2004, Harvey Lect, V100, P71; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	134	956	1005	2	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					881	888		10.1126/science.1156409	http://dx.doi.org/10.1126/science.1156409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18988837	Green Accepted			2022-12-28	WOS:000260674100031
J	Djukanovic, R; Gadola, SD				Djukanovic, Ratko; Gadola, Stephan D.			Virus Infection, Asthma, and Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							KILLER T-CELLS		[Djukanovic, Ratko; Gadola, Stephan D.] Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO9 4XY, Hants, England	University of Southampton	Djukanovic, R (corresponding author), Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO9 4XY, Hants, England.			Djukanovic, Ratko/0000-0001-6039-5612	GlaxoSmithKline; Synairgen; Boehringer Ingelheim; Cellestis; Medigene	GlaxoSmithKline(GlaxoSmithKline); Synairgen; Boehringer Ingelheim(Boehringer Ingelheim); Cellestis; Medigene	Dr. Djukanovic reports receiving consulting and lecture fees and grant support from GlaxoSmithKline, receiving consulting fees and having an equity interest in Synairgen, and receiving consulting fees from Boehringer Ingelheim; and Dr. Gadola, receiving lecture fees from Cellestis and Medigene. No other potential conflict of interest relevant to this article was reported.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691	5	10	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2062	2064		10.1056/NEJMcibr0806978	http://dx.doi.org/10.1056/NEJMcibr0806978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987374				2022-12-28	WOS:000260632700015
J	Ley, TJ; Mardis, ER; Ding, L; Fulton, B; McLellan, MD; Chen, K; Dooling, D; Dunford-Shore, BH; McGrath, S; Hickenbotham, M; Cook, L; Abbott, R; Larson, DE; Koboldt, DC; Pohl, C; Smith, S; Hawkins, A; Abbott, S; Locke, D; Hillier, LW; Miner, T; Fulton, L; Magrini, V; Wylie, T; Glasscock, J; Conyers, J; Sander, N; Shi, XQ; Osborne, JR; Minx, P; Gordon, D; Chinwalla, A; Zhao, Y; Ries, RE; Payton, JE; Westervelt, P; Tomasson, MH; Watson, M; Baty, J; Ivanovich, J; Heath, S; Shannon, WD; Nagarajan, R; Walter, MJ; Link, DC; Graubert, TA; DiPersio, JF; Wilson, RK				Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Fulton, Bob; McLellan, Michael D.; Chen, Ken; Dooling, David; Dunford-Shore, Brian H.; McGrath, Sean; Hickenbotham, Matthew; Cook, Lisa; Abbott, Rachel; Larson, David E.; Koboldt, Dan C.; Pohl, Craig; Smith, Scott; Hawkins, Amy; Abbott, Scott; Locke, Devin; Hillier, LaDeana W.; Miner, Tracie; Fulton, Lucinda; Magrini, Vincent; Wylie, Todd; Glasscock, Jarret; Conyers, Joshua; Sander, Nathan; Shi, Xiaoqi; Osborne, John R.; Minx, Patrick; Gordon, David; Chinwalla, Asif; Zhao, Yu; Ries, Rhonda E.; Payton, Jacqueline E.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark; Baty, Jack; Ivanovich, Jennifer; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.			DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome	NATURE			English	Article							ADULT PATIENTS; MUTATIONS; AML; NUCLEOPHOSMIN; CANCER; GENES; FLT3	Acute myeloid leukaemia is a highly malignant haematopoietic tumour that affects about 13,000 adults in the United States each year. The treatment of this disease has changed little in the past two decades, because most of the genetic events that initiate the disease remain undiscovered. Whole- genome sequencing is now possible at a reasonable cost and timeframe to use this approach for the unbiased discovery of tumour- specific somatic mutations that alter the protein- coding genes. Here we present the results obtained from sequencing a typical acute myeloid leukaemia genome, and its matched normal counterpart obtained from the same patient's skin. We discovered ten genes with acquired mutations; two were previously described mutations that are thought to contribute to tumour progression, and eight were new mutations present in virtually all tumour cells at presentation and relapse, the function of which is not yet known. Our study establishes whole- genome sequencing as an unbiased method for discovering cancer- initiating mutations in previously unidentified genes that may respond to targeted therapies.	[Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Magrini, Vincent; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Ley, Timothy J.; Zhao, Yu; Ries, Rhonda E.; Westervelt, Peter; Tomasson, Michael H.; Heath, Sharon; Shannon, William D.; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA; [Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Fulton, Bob; McLellan, Michael D.; Chen, Ken; Dooling, David; Dunford-Shore, Brian H.; McGrath, Sean; Hickenbotham, Matthew; Cook, Lisa; Abbott, Rachel; Larson, David E.; Koboldt, Dan C.; Pohl, Craig; Smith, Scott; Hawkins, Amy; Abbott, Scott; Locke, Devin; Hillier, LaDeana W.; Miner, Tracie; Fulton, Lucinda; Magrini, Vincent; Wylie, Todd; Glasscock, Jarret; Conyers, Joshua; Sander, Nathan; Shi, Xiaoqi; Osborne, John R.; Minx, Patrick; Chinwalla, Asif; Watson, Mark; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Ley, Timothy J.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark; Ivanovich, Jennifer; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Walter, Matthew J.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Payton, Jacqueline E.; Watson, Mark; Nagarajan, Rakesh] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Baty, Jack] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63108 USA; [Ivanovich, Jennifer] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63108 USA; [Hillier, LaDeana W.; Gordon, David] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Mardis, ER (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA.	emardis@wustl.edu	McGrath, Sean David/AAT-3540-2020; Magrini, Vincent/AAT-5830-2020; Mardis, Elaine/W-2202-2019; Chen, Ken/AAU-1432-2021; Walter, Matthew J/S-7758-2018; Wilson, Richard K./AAF-4139-2019; Chen, Ken/A-1074-2009	McGrath, Sean David/0000-0001-9064-8449; Magrini, Vincent/0000-0002-2019-4872; Chen, Ken/0000-0003-4013-5279; Wilson, Richard K./0000-0002-1992-1358; Tomasson, Michael/0000-0003-4518-7123; Graubert, Timothy/0000-0002-7710-1171; Ries, Rhonda/0000-0002-3702-7923; Chinwalla, Asif/0000-0001-7831-3996; MCLELLAN, MICHAEL/0000-0002-2703-8784; Larson, David/0000-0001-7934-5906; Locke, Devin/0000-0002-2527-0475	National Cancer Institute; National Human Genome Research Institute; Barnes-Jewish Hospital Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002042] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Barnes-Jewish Hospital Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to our AML patients and their families, and to A.J. Siteman, whose generous and visionary gift provided the main funding source for this study. We thank G. Flance, D. Kipnis and K. Polonsky for their support, and C. Bloomfield, M. Caligiuri and J. Vardiman from the Cancer and Leukemia Group B for providing important AML samples for validation studies. We also thank the staff of The Genome Center at Washington University for their support of and their many contributions to this project, and H. Li of the Sanger Institute for assistance with the use of Maq. Further funding was provided by the National Cancer Institute (T.J.L.), the National Human Genome Research Institute (R.K.W.), and the Barnes-Jewish Hospital Foundation (T.J.L.).	Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; den Besten W, 2005, CELL CYCLE, V4, P1593; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Paulsson K, 2006, LEUKEMIA, V20, P840, DOI 10.1038/sj.leu.2404145; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN, P302; Raghavan M, 2005, CANCER RES, V65, P375; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Wendl MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-239; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	29	895	997	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					66	72		10.1038/nature07485	http://dx.doi.org/10.1038/nature07485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18987736	Green Accepted, hybrid			2022-12-28	WOS:000260674000041
J	Holzmann, J; Frank, P; Loffler, E; Bennett, KL; Gerner, C; Rossmanith, W				Holzmann, Johann; Frank, Peter; Loeffler, Esther; Bennett, Keiryn L.; Gerner, Christopher; Rossmanith, Walter			RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing Enzyme	CELL			English	Article							RIBONUCLEASE-P; AQUIFEX-AEOLICUS; PROTEIN; MATURATION; EVOLUTION; SEQUENCES; GENE; DEHYDROGENASE; MUTATIONS; MECHANISM	tRNAs are synthesized as immature precursors, and on their way to functional maturity, extra nucleotides at their 50 ends are removed by an endonuclease called RNase P. All RNase P enzymes characterized so far are composed of an RNA plus one or more proteins, and tRNA 50 end maturation is considered a universal ribozyme-catalyzed process. Using a combinatorial purification/proteomics approach, we identified the components of human mitochondrial RNase P and reconstitutedthe enzymatic activity from three recombinant proteins. We thereby demonstrate that human mitochondrial RNase P is a protein enzyme that does not require a trans-acting RNA component for catalysis. Moreover, the mitochondrial enzyme turns out to be an unexpected type of patchwork enzyme, composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase-family member, and a protein of hitherto unknown functional and evolutionary origin, possibly representing the enzyme's metallonuclease moiety. Apparently, animal mitochondria lost the seemingly ubiquitous RNA world remnant after reinventing RNase P from preexisting components.	[Holzmann, Johann; Loeffler, Esther; Rossmanith, Walter] Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria; [Frank, Peter; Gerner, Christopher] Med Univ Vienna, Dept Med 1, Inst Canc Res, A-1090 Vienna, Austria; [Bennett, Keiryn L.] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Austrian Academy of Sciences	Rossmanith, W (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria.	walter.rossmanith@meduniwien.ac.at	Rossmanith, Walter/F-3662-2010	Rossmanith, Walter/0000-0003-2337-2248; Gerner, Christopher/0000-0003-4964-0642; Bennett, Keiryn L./0000-0001-9356-7708	Austrian Science Fund [P17453]	Austrian Science Fund(Austrian Science Fund (FWF))	We thank Maria Selmer for comments on the manuscript and Philippe Giege for pointing out a third Arabidopsis homolog of MRPP3. This work was supported by Austrian Science Fund grant P17453 to W. R.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Chen JX, 2007, J ALZHEIMERS DIS, V12, P177; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DANG YL, 1993, J BIOL CHEM, V268, P19791; Dupureur CM, 2008, CURR OPIN CHEM BIOL, V12, P250, DOI 10.1016/j.cbpa.2008.01.012; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Gegenheimer P, 1996, MOL BIOL REP, V22, P147, DOI 10.1007/BF00988720; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; HENTZE MW, 1994, TRENDS BIOCHEM SCI, V19, P101, DOI 10.1016/0968-0004(94)90198-8; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Marszalkowski M, 2008, BIOL CHEM, V389, P395, DOI 10.1515/BC.2008.042; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Prokisch Holger, 2007, Methods Mol Biol, V372, P573, DOI 10.1007/978-1-59745-365-3_39; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; ROBERTSON HD, 1972, J BIOL CHEM, V247, P5243; Rossmanith W, 2001, MOL CELL BIOL, V21, P8236, DOI 10.1128/MCB.21.23.8236-8237.2001; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Rossmanith W, 1997, J MOL BIOL, V265, P365, DOI 10.1006/jmbi.1996.0750; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; Salavati R, 2001, MOL BIOCHEM PARASIT, V115, P109, DOI 10.1016/S0166-6851(01)00273-0; Schafer B, 2005, GENE, V354, P80, DOI 10.1016/j.gene.2005.03.032; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; STARK BC, 1978, P NATL ACAD SCI USA, V75, P3717, DOI 10.1073/pnas.75.8.3717; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUSSMAN JL, 1976, SCIENCE, V192, P853, DOI 10.1126/science.775636; Swanson RV, 2001, METHOD ENZYMOL, V330, P158; Thomas B C, 1995, Nucleic Acids Symp Ser, P95; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; Willkomm DK, 2007, TRENDS BIOCHEM SCI, V32, P247, DOI 10.1016/j.tibs.2007.04.005; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006	48	412	422	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 31	2008	135	3					462	474		10.1016/j.cell.2008.09.013	http://dx.doi.org/10.1016/j.cell.2008.09.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984158	Bronze			2022-12-28	WOS:000260536300017
J	Martin, AC; Kaschube, M; Wieschaus, EF				Martin, Adam C.; Kaschube, Matthias; Wieschaus, Eric F.			Pulsed contractions of an actin-myosin network drive apical constriction	NATURE			English	Article							CELL-SHAPE CHANGES; DROSOPHILA GASTRULATION; FOLDED-GASTRULATION; ADHERENS JUNCTIONS; MORPHOGENESIS; MICROFILAMENTS; LOCALIZATION; MICROTUBULES; NEURULATION; MECHANISM	Apical constriction facilitates epithelial sheet bending and invagination during morphogenesis(1,2). Apical constriction is conventionally thought to be driven by the continuous purse- string- like contraction of a circumferential actin and non- muscle myosin- II ( myosin) belt underlying adherens junctions(3-7). However, it is unclear whether other force- generating mechanisms can drive this process. Here we show, with the use of real- time imaging and quantitative image analysis of Drosophila gastrulation, that the apical constriction of ventral furrow cells is pulsed. Repeated constrictions, which are asynchronous between neighbouring cells, are interrupted by pauses in which the constricted state of the cell apex is maintained. In contrast to the purse- string model, constriction pulses are powered by actin - myosin network contractions that occur at the medial apical cortex and pull discrete adherens junction sites inwards. The transcription factors Twist and Snail differentially regulate pulsed constriction. Expression of snail initiates actin - myosin network contractions, whereas expression of twist stabilizes the constricted state of the cell apex. Our results suggest a new model for apical constriction in which a cortical actin - myosin cytoskeleton functions as a developmentally controlled subcellular ratchet to reduce apical area incrementally.	[Martin, Adam C.; Wieschaus, Eric F.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Martin, Adam C.; Wieschaus, Eric F.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kaschube, Matthias] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kaschube, Matthias] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University; Princeton University	Wieschaus, EF (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	efw@princeton.edu			American Cancer Society [PF-06-143-01-DDC]; National Institutes of Health/National Institute of General Medical Sciences [P50 GM071508]; National Institute of Child Health and Human Development [5R37HD15587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kiehart and R. Karess for providing flies; J. Goodhouse for assisting with microscopy; and S. De Renzis, X. Lu, T. Schupbach, A. Sokac, F. Ulrich and Y.-C. Wang for helpful comments on the manuscript. This work is supported by grant PF-06-143-01-DDC from the American Cancer Society to A. C. M., National Institutes of Health/National Institute of General Medical Sciences grant P50 GM071508 to M. K., and by National Institute of Child Health and Human Development grant 5R37HD15587 to E.F. W.E.F.W. is an investigator of the Howard Hughes Medical Institute.	Alberts B, 2008, MOL BIOL CELL; Arziman Z, 2005, NUCLEIC ACIDS RES, V33, pW582, DOI 10.1093/nar/gki468; BAKER PC, 1967, DEV BIOL, V15, P432, DOI 10.1016/0012-1606(67)90036-X; BURNSIDE B, 1971, DEV BIOL, V26, P416, DOI 10.1016/0012-1606(71)90073-X; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; KARFUNKEL P, 1972, J EXP ZOOL, V181, P289, DOI 10.1002/jez.1401810302; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Oda H, 2001, J CELL SCI, V114, P493; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; SWEETON D, 1991, DEVELOPMENT, V112, P775; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; YOUNG PE, 1991, DEVELOPMENT, V111, P1	29	782	791	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					495	U11		10.1038/nature07522	http://dx.doi.org/10.1038/nature07522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19029882	Green Accepted			2022-12-28	WOS:000262519200050
J	Bonetta, L				Bonetta, Laura			Tough Challenges for the Next NIH Director	CELL			English	Editorial Material								The new US President will be selecting the next director of the National Institutes of Health (NIH) at a time when the agency faces many challenges. Priorities for the new director include boosting the NIH coffers in troubled economic times, balancing funding for basic and translational research, and helping young scientists.											0	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					583	585		10.1016/j.cell.2008.10.038	http://dx.doi.org/10.1016/j.cell.2008.10.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013266	Bronze			2022-12-28	WOS:000260886900006
J	Brown, SP; Buckling, A				Brown, Sam P.; Buckling, Angus			A Social Life for Discerning Microbes	CELL			English	Review							BACTERIA; COOPERATION; EVOLUTION; BEHAVIOUR; VIRULENCE; SELFISH; ECOLOGY; BEARD	Microbes are not only extremely social but also extremely discerning about whom they socialize with. Recent research has uncovered some of the evolutionary explanations behind these feats of social sophistication in bacteria (Ackermann et al., 2008; Diggle et al., 2007) and, most recently, has provided insights into the molecular mechanisms of discrimination in yeast (Smukalla et al., 2008).	[Brown, Sam P.; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Brown, SP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sam.brown@zoo.ox.ac.uk	Brown, Sam/B-5234-2009	Brown, Sam/0000-0003-1892-9275; Buckling, Angus/0000-0003-1170-4604	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; Brown SP, 2006, CURR BIOL, V16, P2048, DOI 10.1016/j.cub.2006.08.089; Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; Dawkins Richard, 1976, SELFISH GENE; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Joo J, 2006, P ROY SOC B-BIOL SCI, V273, P1843, DOI 10.1098/rspb.2006.3512; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104	19	33	34	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 14	2008	135	4					600	603		10.1016/j.cell.2008.10.030	http://dx.doi.org/10.1016/j.cell.2008.10.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013271	Bronze			2022-12-28	WOS:000260886900011
J	Simpson, SW; Quade, J; Levin, NE; Butler, R; Dupont-Nivet, G; Everett, M; Semaw, S				Simpson, Scott W.; Quade, Jay; Levin, Naomi E.; Butler, Robert; Dupont-Nivet, Guillaume; Everett, Melanie; Semaw, Sileshi			A Female Homo erectus Pelvis from Gona, Ethiopia	SCIENCE			English	Article							MIDDLE PLEISTOCENE; BRAIN GROWTH; BODY-SIZE; DMANISI; GEORGIA; MALES; GAIT; EAST	Analyses of the KNM- WT 15000 Homo erectus juvenile male partial skeleton from Kenya concluded that this species had a tall thin body shape due to specialized locomotor and climatic adaptations. Moreover, it was concluded that H. erectus pelves were obstetrically restricted to birthing a small- brained altricial neonate. Here we describe a nearly complete early Pleistocene adult female H. erectus pelvis from the Busidima Formation of Gona, Afar, Ethiopia. This obstetrically capacious pelvis demonstrates that pelvic shape in H. erectus was evolving in response to increasing fetal brain size. This pelvis indicates that neither adaptations to tropical environments nor endurance running were primary selective factors in determining pelvis morphology in H. erectus during the early Pleistocene.	[Everett, Melanie; Semaw, Sileshi] Stone Age Inst, Gosport, IN 47433 USA; [Everett, Melanie; Semaw, Sileshi] Indiana Univ, CRAFT, Bloomington, IN 47405 USA; [Simpson, Scott W.] Case Western Reserve Univ, Dept Anat, Cleveland, OH 44106 USA; [Simpson, Scott W.] Cleveland Museum Nat Hist, Lab Phys Anthropol, Cleveland, OH 44106 USA; [Quade, Jay] Univ Arizona, Dept Geosci, Desert Lab, Tucson, AZ 85721 USA; [Levin, Naomi E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Levin, Naomi E.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Butler, Robert] Univ Portland, Dept Phys, Portland, OR 97203 USA; [Dupont-Nivet, Guillaume] Univ Utrecht, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [Everett, Melanie] Indiana Univ, Dept Geol Sci, Bloomington, IN 47407 USA	Indiana University System; Indiana University Bloomington; Case Western Reserve University; Cleveland Museum of Natural History; University of Arizona; Utah System of Higher Education; University of Utah; California Institute of Technology; University of Portland; Utrecht University; Indiana University System; Indiana University Bloomington	Semaw, S (corresponding author), Stone Age Inst, 1392 W Dittemore Rd, Gosport, IN 47433 USA.	ssemaw@indiana.edu	DUPONT-NIVET, Guillaume/HII-9066-2022; Levin, Naomi E/B-4124-2010; Simpson, Scott/GRS-0081-2022; Semaw, Sileshi/M-7021-2018	Levin, Naomi E/0000-0001-5703-3717; Dupont-Nivet, Guillaume/0000-0001-9905-9739; Semaw, Sileshi/0000-0001-8377-8288	L. S. B. Leakey Foundation; National Geographic Society; Wenner-Gren Foundation; NSF	L. S. B. Leakey Foundation; National Geographic Society(National Geographic Society); Wenner-Gren Foundation; NSF(National Science Foundation (NSF))	The Gona Project thanks the Authority for Research and Conservation of Cultural Heritage of the Ministry of Culture and Tourism, and the National Museum of Ethiopia, for research permits and support. Support for this research was provided by the L. S. B. Leakey Foundation, National Geographic Society, Wenner-Gren Foundation, and NSF.	Arsuaga JL, 1999, NATURE, V399, P255, DOI 10.1038/20430; Bondioli L, 2006, J HUM EVOL, V50, P479, DOI 10.1016/j.jhevol.2006.01.001; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Coqueugniot H, 2004, NATURE, V431, P299, DOI 10.1038/nature02852; Correia H, 2005, HOMO, V56, P153, DOI 10.1016/j.jchb.2005.05.003; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; DeSilva J, 2006, J HUM EVOL, V51, P207, DOI 10.1016/j.jhevol.2006.05.006; Holloway RL, 2004, BRAIN ENDOCASTS PALE, V3; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; RAK Y, 1987, AM J PHYS ANTHROPOL, V73, P227, DOI 10.1002/ajpa.1330730209; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Rosenberg KR, 2006, P NATL ACAD SCI USA, V103, P3552, DOI 10.1073/pnas.0508681103; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff C, 2007, AM J PHYS ANTHROPOL, V133, P698, DOI 10.1002/ajpa.20568; Ruff Christopher B., 1993, P234; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Tague RG, 1998, J HUM EVOL, V35, P75, DOI 10.1006/jhev.1998.0223; Tague RG, 2005, AM J PHYS ANTHROPOL, V127, P392, DOI 10.1002/ajpa.20226; TAGUE RG, 1989, AM J PHYS ANTHROPOL, V80, P59, DOI 10.1002/ajpa.1330800108; Walker Alan, 1993, P221; WALRATH D, 1997, THESIS U PENNSYLVANI	25	185	189	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1089	1092		10.1126/science.1163592	http://dx.doi.org/10.1126/science.1163592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	371YD	19008443				2022-12-28	WOS:000260867700034
J	Suganuma, T; Workman, JL				Suganuma, Tamaki; Workman, Jerry L.			Crosstalk among Histone Modifications	CELL			English	Review							METHYLATION; H3; HETEROCHROMATIN; COMPLEX; UBIQUITYLATION; TRANSCRIPTION; TETRAHYMENA; CHROMATIN	Histone modifications play a complex role in the regulation of transcription. Recent studies (Duncan et al., 2008; Lee et al., 2007; Li et al., 2008) reveal that regulation of histone modifications can be functionally linked to reinforce the activation or repression of gene expression.	[Suganuma, Tamaki; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Workman, JL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlw@stowers-institute.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLIS CD, 1980, CELL, V20, P55; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; KIM DH, 2008, P NATL ACAD SCI USA, V105; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035	21	253	268	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					604	607		10.1016/j.cell.2008.10.036	http://dx.doi.org/10.1016/j.cell.2008.10.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013272	Bronze			2022-12-28	WOS:000260886900012
J	Wierzbicki, AT; Haag, JR; Pikaard, CS				Wierzbicki, Andrzej T.; Haag, Jeremy R.; Pikaard, Craig S.			Noncoding Transcription by RNA Polymerase Pol IVb/Pol V Mediates Transcriptional Silencing of Overlapping and Adjacent Genes	CELL			English	Article							DIRECTED DNA-METHYLATION; IV; HETEROCHROMATIN; ELEMENTS; SIRNA; ORGANIZATION; THALIANA; REQUIRES; PATHWAY; CORE	Nuclear transcription is not restricted to genes but occurs throughout the intergenic and noncoding space of eukaryotic genomes. The functional significance of this widespread noncoding transcription is mostly unknown. We show that Arabidopsis RNA polymerase IVb/Pol V, a multisubunit nuclear enzyme required for siRNA-mediated gene silencing of transposons and other repeats, transcribes intergenic and noncoding sequences, thereby facilitating heterochromatin formation and silencing of overlapping and adjacent genes. Pol IVb/Pol V transcription requires the chromatin-remodeling protein DRD1 but is independent of siRNA biogenesis. However, Pol IVb/Pol V transcription and siRNA production are both required to silence transposons, suggesting that Pol IVb/Pol V generates RNAs or chromatin structures that serve as scaffolds for siRNA-mediated heterochromatin-forming complexes. Pol IVb/Pol V function provides a solution to a paradox of epigenetic control: the need for transcription in order to transcriptionally silence the same region.	[Wierzbicki, Andrzej T.; Haag, Jeremy R.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077590, GM077590, R01 GM077590-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Baulcombe DC, 2006, COLD SPRING HARB SYM, V71, P13, DOI 10.1101/sqb.2006.71.052; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Gilbert C., 2006, CURRENT PROTOCOLS MO; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2005, NAT METHODS, V2, P219, DOI 10.1038/nmeth0305-219; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke SM, 2006, COLD SPRING HARB SYM, V71, P497, DOI 10.1101/sqb.2006.71.062; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Myouga F, 2001, GENES GENET SYST, V76, P169, DOI 10.1266/ggs.76.169; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; Willingham AT, 2006, COLD SPRING HARB SYM, V71, P101, DOI 10.1101/sqb.2006.71.068; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zecherle GN, 1996, MOL CELL BIOL, V16, P5801; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	52	494	524	3	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 14	2008	135	4					635	648		10.1016/j.cell.2008.09.035	http://dx.doi.org/10.1016/j.cell.2008.09.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	372FG	19013275	Green Accepted, Bronze			2022-12-28	WOS:000260886900015
J	Goncharov, AF; Haugen, BD; Struzhkin, VV; Beck, P; Jacobsen, SD				Goncharov, Alexander F.; Haugen, Benjamin D.; Struzhkin, Viktor V.; Beck, Pierre; Jacobsen, Steven D.			Radiative conductivity in the Earth's lower mantle	NATURE			English	Article							OPTICAL-ABSORPTION SPECTRA; THERMAL-CONDUCTIVITY; ELECTRONIC-STRUCTURE; HEAT-TRANSPORT; IRON; PEROVSKITE; OLIVINE; TRANSITIONS; VISCOSITY; (MG	Iron in crustal and mantle minerals adopts several possible oxidation states: this has implications for biogeochemical processes(1), oxygenation of the atmosphere(2) and the oxidation state of the mantle(3,4). In the deep Earth, iron in silicate perovskite, (Mg0.9Fe0.1)SiO3, and ferropericlase, (Mg0.85Fe0.15)O, influences the thermal conductivity of the lower mantle and therefore heat flux from the core. Little is known, however, about the effect of iron oxidation states on transport properties. Here we show that the radiative component of thermal conductivity in the dominant silicate perovskite material of Earth's lower mantle is controlled by the amount of ferric iron, Fe3+. We obtained the optical absorption spectra of silicate perovskite and ferropericlase at pressures up to 133 GPa, corresponding to pressures at the core - mantle boundary. Absorption spectra of ferropericlase up to 800 K and 60 GPa exhibit minimal temperature dependence. The results on silicate perovskite show that optical absorption in the visible and near- infrared spectral range is dominated by O-Fe3+ charge transfer and Fe3+-Fe2+ intervalence transitions, whereas a contribution from the Fe2+ crystal- field transitions is substantially smaller. The estimated pressure- dependent radiative conductivity, k(rad), from these data is 2-5 times lower than previously inferred from model extrapolations, with implications for the evolution of the mantle, such as generation and stability of thermo- chemical plumes in the lower mantle.	[Goncharov, Alexander F.; Haugen, Benjamin D.; Struzhkin, Viktor V.; Beck, Pierre] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Haugen, Benjamin D.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Jacobsen, Steven D.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA	Carnegie Institution for Science; University of Colorado System; University of Colorado Boulder; Northwestern University	Goncharov, AF (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	goncharov@gl.ciw.edu	Beck, Pierre/F-3149-2011; Struzhkin, Viktor V/J-9847-2013; Goncharov, Alexander F./AAX-9943-2020; Jacobsen, Steven/F-3443-2013	Struzhkin, Viktor V/0000-0002-3468-0548; Goncharov, Alexander F./0000-0002-6422-8819; Jacobsen, Steven/0000-0002-9746-958X	NSF/EAR; DOE/BES; DOE/NNSA (CDAC); W. M. Keck Foundation; NSF Research Experience for Undergraduates (REU) Program at the Carnegie Institution of Washington; Balzan Foundation	NSF/EAR(National Science Foundation (NSF)); DOE/BES(United States Department of Energy (DOE)); DOE/NNSA (CDAC)(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); W. M. Keck Foundation(W.M. Keck Foundation); NSF Research Experience for Undergraduates (REU) Program at the Carnegie Institution of Washington(National Science Foundation (NSF)); Balzan Foundation	We acknowledge support from NSF/EAR, DOE/BES, DOE/NNSA (CDAC) and the W. M. Keck Foundation. S.D.J. thanks D.J. Frost, S.J. Mackwell and D. P. Dobson for help with sample synthesis, C.A. McCammon for Mossbauer spectroscopy, J.R. Smyth for single- crystal X- ray diffraction, H. Watson for electron microprobe analysis of the silicate perovskite material and the NSF and Bayerishes Geoinstitut Visitor's Program for support. B.D.H. was supported by the NSF Research Experience for Undergraduates (REU) Program at the Carnegie Institution of Washington. P.B. was partially supported by the Balzan Foundation.	Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; Bocquet AE, 1996, PHYS REV B, V53, P1161, DOI 10.1103/PhysRevB.53.1161; Burns R. G, 1993, MINERALOGICAL APPL C; CLARK SP, 1957, T AM GEOPHYS UNION, V38, P931; Dubuffet F, 2002, NONLINEAR PROC GEOPH, V9, P311, DOI 10.5194/npg-9-311-2002; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Goncharov AF, 2006, SCIENCE, V312, P1205, DOI 10.1126/science.1125622; Hofmeister AM, 1999, SCIENCE, V283, P1699, DOI 10.1126/science.283.5408.1699; Hofmeister AM, 2007, J GEODYN, V44, P186, DOI 10.1016/j.jog.2007.03.002; Johnson CM, 2005, SCIENCE, V309, P1025, DOI 10.1126/science.1112552; Keppler H, 2005, AM MINERAL, V90, P1209, DOI 10.2138/am.2005.1908; KEPPLER H, 1994, AM MINERAL, V79, P1215; Keppler H, 2007, AM MINERAL, V92, P433, DOI 10.2138/am.2007.2454; Li J, 2006, PHYS CHEM MINER, V33, P575, DOI 10.1007/s00269-006-0105-y; MAO HK, 1972, SCIENCE, V176, P403, DOI 10.1126/science.176.4033.403; MATTSON SM, 1987, PHYS CHEM MINER, V14, P94, DOI 10.1007/BF00311152; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; Montague NL, 1998, GEOPHYS RES LETT, V25, P2345, DOI 10.1029/98GL51872; Naliboff JB, 2007, PHYS EARTH PLANET IN, V161, P86, DOI 10.1016/j.pepi.2007.01.009; Pertermann M, 2006, AM MINERAL, V91, P1747, DOI 10.2138/am.2006.2105; ROSS RG, 1984, REP PROG PHYS, V47, P1347, DOI 10.1088/0034-4885/47/10/002; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; SHANKLAND TJ, 1979, J GEOPHYS RES, V84, P1603, DOI 10.1029/JB084iB04p01603; SHEN GY, 1994, PHYS CHEM MINER, V20, P478; SHERMAN DM, 1991, J GEOPHYS RES-SOLID, V96, P14299, DOI 10.1029/91JB01202; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; van den Berg AP, 2005, PHYS EARTH PLANET IN, V149, P259, DOI 10.1016/j.pepi.2004.10.008; Yanagawa TKB, 2005, EARTH PLANETS SPACE, V57, P15, DOI 10.1186/BF03351802; Zhong SJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003972	30	76	81	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					231	234		10.1038/nature07412	http://dx.doi.org/10.1038/nature07412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005553				2022-12-28	WOS:000261039300038
J	Long, MA; Fee, MS				Long, Michael A.; Fee, Michale S.			Using temperature to analyse temporal dynamics in the songbird motor pathway	NATURE			English	Article							ZEBRA FINCH SONG; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; CENTRAL PATTERN GENERATOR; VOCAL CONTROL; BRAIN-STEM; SEQUENCE GENERATION; MEMBRANE-PROPERTIES; FOREBRAIN; BIRDSONG; SYSTEM	Many complex behaviours, like speech or music, have a hierarchical organization with structure on many timescales, but it is not known how the brain controls the timing of behavioural sequences, or whether different circuits control different timescales of the behaviour. Here we address these issues by using temperature to manipulate the biophysical dynamics in different regions of the songbird forebrain involved in song production. We find that cooling the premotor nucleus HVC ( formerly known as the high vocal centre) slows song speed across all timescales by up to 45 per cent but only slightly alters the acoustic structure, whereas cooling the downstream motor nucleus RA ( robust nucleus of the arcopallium) has no observable effect on song timing. Our observations suggest that dynamics within HVC are involved in the control of song timing, perhaps through a chain- like organization. Local manipulation of brain temperature should be broadly applicable to the identification of neural circuitry that controls the timing of behavioural sequences and, more generally, to the study of the origin and role of oscillatory and other forms of brain dynamics in neural systems.	[Long, Michael A.; Fee, Michale S.] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fee@mit.edu		Fee, Michale/0000-0001-7539-1745	US National Institutes of Health [MH067105, DC009280]; Human Frontiers Science Project; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC009280, K99DC009280] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Project; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Aronov, T. Gardner, J. Goldberg, L. Las, B. Olveczky, S. Seung and M. Wilson for their comments on earlier versions of this manuscript. This work is supported by funding from the US National Institutes of Health to M. S. F. (MH067105) and to M. A. L. (DC009280) as well as funding from the Human Frontiers Science Project.	ABELES M, 1991, CORTICONICS NEURAL C, P208; ARBAS EA, 1984, J COMP PHYSIOL, V155, P783, DOI 10.1007/BF00611595; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROSCI, V28, P2613, DOI 10.1523/JNEUROSCI.4547-07.2008; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; HERRMANN K, 1991, J NEUROSCI, V11, P2063; JAMES W, 2001, PSYCHOL BRIEFER COUR, P1; Janata P, 1999, J NEUROSCI, V19, P5108; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Katz PS, 2004, J NEUROPHYSIOL, V92, P1904, DOI 10.1152/jn.00864.2003; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Laje R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288102; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; MOONEY R, 1992, J NEUROSCI, V12, P2464; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; THOMPSON SM, 1985, J NEUROSCI, V5, P817; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Volgushev M, 2000, NEUROSCIENCE, V98, P9, DOI 10.1016/S0306-4522(00)00109-3; VU ET, 1994, J NEUROSCI, V14, P6924; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; [No title captured]	45	309	312	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					189	194		10.1038/nature07448	http://dx.doi.org/10.1038/nature07448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	19005546	Green Accepted			2022-12-28	WOS:000261039300030
J	Roland, M				Roland, Martin			The Future of Primary Care: Lessons from the UK	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERFORMANCE; QUALITY; ENGLAND; PAY		[Roland, Martin] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England	University of Manchester	Roland, M (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England.			Roland, Martin/0000-0002-8533-3060				Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	5	9	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2008	359	20					2087	+		10.1056/NEJMp0805633	http://dx.doi.org/10.1056/NEJMp0805633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	371IB	19005192				2022-12-28	WOS:000260823900006
J	Kivimaki, M; Shipley, MJ; Ferrie, JE; Singh-Manoux, A; Batty, GD; Chandola, T; Marmot, MG; Smith, GD				Kivimaki, Mika; Shipley, Martin J.; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Chandola, Tarani; Marmot, Michael G.; Smith, George Davey			Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study	LANCET			English	Article							RISK-FACTORS; CARDIOVASCULAR-DISEASE; SOCIAL INEQUALITIES; YANOMAMO INDIANS; CIVIL-SERVANTS; ABSOLUTE; HEALTH; METAANALYSIS; HYPERTENSION; EFFICACY	Background How much the successful implementation of the most effective (ie, best-practice) interventions could reduce socioeconomic inequalities of coronary heart disease mortality is not known. We assessed this issue in an occupational cohort study comparing low with high socioeconomic groups. Methods We undertook a prospective cohort study on 17 186 male civil servants aged 40-69 years between 1967 and 1970 in the UK (the Whitehall study). Socioeconomic position was based on employment grade. We compared the potential reduction in excess coronary heart disease mortality in men of low with those of high socioeconomic position with either best-practice interventions (reduction of systolic blood pressure by 10 mm Hg, of total cholesterol by 2 mmol/L, and of blood glucose by 1 mmol/L in pre-diabetic people; halving the prevalence of non-insulin-dependent diabetes; and complete cessation of cigarette smoking) or primordial prevention. Findings 15-year absolute risk of death due to coronary heart disease per 100 men, standardised to age 55 years, was 11.0 for men in the low employment grade group and 7.5 for those in the high grade group. Population-wide best-practice interventions would reduce coronary heart disease mortality by 57%, and the difference in mortality between socioeconomic groups by 69%. For primordial prevention, the corresponding reductions would be 73% and 86%, respectively. Interpretation Our results suggest that current best-practice interventions to reduce classic coronary risk factors, if successfully implemented in both high and low socioeconomic groups, could eliminate most of the differences in coronary heart disease mortality. Modest further benefits would result if the classic coronary risk factors could be reduced to primordial levels for the whole population.	[Kivimaki, Mika; Shipley, Martin J.; Ferrie, Jane E.; Singh-Manoux, Archana; Chandola, Tarani; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Singh-Manoux, Archana] Hop Paul Brousse, INSERM, Villejuif, France; [Batty, G. David] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Smith, George Davey] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Bristol	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018; Singh-Manoux, Archana/F-6804-2013; Ferrie, Jane/AAZ-2009-2020; Marmot, M G/Y-3920-2019; Davey Smith, George/A-7407-2013; Chandola, Tarani/I-3192-2013	Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; Singh-Manoux, Archana/0000-0002-1244-5037; Marmot, M G/0000-0002-2431-6419; Davey Smith, George/0000-0002-1407-8314; Chandola, Tarani/0000-0002-1864-3413; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Department of Health and Social Security (UK); Tobacco Research Council (UK); British Heart Foundation (UK); Medical Research Council (UK); European Science Foundation (EU); Wellcome Trust (UK); Academy of Finland (Finland); British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_U130059821, G8802774, G0700704B, G19/35, G0100222] Funding Source: researchfish; MRC [MC_U130059821] Funding Source: UKRI	Department of Health and Social Security (UK); Tobacco Research Council (UK); British Heart Foundation (UK)(British Heart Foundation); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Science Foundation (EU)(European Science Foundation (ESF)European Commission); Wellcome Trust (UK)(Wellcome Trust); Academy of Finland (Finland)(Academy of Finland); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding Department of Health and Social Security (UK), Tobacco Research Council (UK), British Heart Foundation (UK), Medical Research Council (UK), European Science Foundation (EU), Wellcome Trust (UK), and Academy of Finland (Finland). The original screening of the Whitehall study was funded by the Department of Health and Social Security, and the Tobacco Research Council (UK). MK was supported by the Academy of Finland (Finland); MJS by the British Heart Foundation (UK); JEF by the Medical Research Council (UK); and ASM by the European Science Foundation (EU). GDB is a Wellcome Trust fellow. MGM is a Medical Research Council professor and, at the time of this work, was supported by the WHO Commission on Determinants of Socioeconomic inequalities in Health, which he chaired.	Acheson D., 1998, INDEPENDENT INQUIRY; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Black D, 1980, INEQUALITIES HLTH RE; Brunner EJ, 2006, DIABETES CARE, V29, P26; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; CSDH, 2008, CLOS GAP GEN HLTH EQ; *DEP HLTH, 2003, NAT STAT RISK FACT C; Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Edwards Jayne E, 2003, BMC Fam Pract, V4, P18, DOI 10.1186/1471-2296-4-18; EYER J, 1975, INT J HEALTH SERV, V5, P539, DOI 10.2190/UT72-3RTX-V0KN-64AF; FAHEY T, 2006, COCHRANE DB SYST REV, V4, P5182; Fuchs FD, 2004, LANCET, V363, P332, DOI 10.1016/S0140-6736(03)15405-0; Getz L, 2005, BMJ-BRIT MED J, V331, P551, DOI 10.1136/bmj.38555.648623.8F; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Khang YH, 2008, HEART, V94, P75, DOI 10.1136/hrt.2007.117747; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; Lynch J, 2006, J EPIDEMIOL COMMUN H, V60, P436, DOI 10.1136/jech.2005.041350; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; MANCILHACARVALHO JJ, 1989, J HUM HYPERTENS, V3, P309; MANCILHACARVALHO JJ, 1990, PREV MED, V19, P66, DOI 10.1016/0091-7435(90)90009-9; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; ODEA K, 1992, J INTERN MED, V232, P103, DOI 10.1111/j.1365-2796.1992.tb00559.x; REID DD, 1974, LANCET, V1, P469; ROSE G, 1990, LANCET, V335, P275, DOI 10.1016/0140-6736(90)90082-G; ROSE GA, 1964, LANCET, V1, P296; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P599, DOI 10.1097/EDE.0b013e3181761cdc; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZIMMET P, 1978, AUST NZ J MED, V8, P141, DOI 10.1111/j.1445-5994.1978.tb04500.x	41	90	90	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1648	1654		10.1016/S0140-6736(08)61688-8	http://dx.doi.org/10.1016/S0140-6736(08)61688-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18994662	Bronze, Green Submitted			2022-12-28	WOS:000260899900026
J	Melhuish, E; Belsky, J; Leyland, AH; Barnes, J				Melhuish, Edward; Belsky, Jay; Leyland, Alastair H.; Barnes, Jacqueline		Natl Evaluation Sure Start Res Tea	Effects of fully-established Sure Start Local Programmes on 3-year-old children and their families living in England: a quasi-experimental observational study	LANCET			English	Article							INTERVENTION	Background Sure Start Local Programmes (SSLPs) are area-based interventions to improve services for young children and their families in deprived communities, promote health and development, and reduce inequalities. We therefore investigated whether SSLPs affect the wellbeing of 3-year-old children and their families. Methods In a quasi-experimental observational study, we compared 5883 3-year-old children and their families from 93 disadvantaged SSLP areas with 1879 3-year-old children and their families from 72 similarly deprived areas in England who took part in the Millennium Cohort Study. We studied 14 outcomes--children's immunisations, accidents, language development, positive and negative social behaviours, and independence; parenting risk; home-learning environment; father's involvement; maternal smoking, body-mass index,and life satisfaction; family's service use; and mother's rating of area. Findings After we controlled for background factors, we noted beneficial effects associated with the programmes for five of 14 outcomes. Children in the SSLP areas showed better social development than those in the non-SSLP areas, with more positive social behaviour (mean difference 0.45, 95% CI 0.09 to 0.80, p=0.01) and greater independence (0.32, 0.18 to 0.47, p<0.0001). Families in SSLP areas showed less negative parenting (-0.90, -1.11 to -0.69, p<0.0001) and provided a better home-learning environment (1.30, 0.75 to 1. 86, p<0.0001). These families used more services for supporting child and family development than those not living in SSLP areas (0.98, 0.86 to 1.09, p<0.0001). Effects of SSLPs seemed to apply to all subpopulations and SSLP areas. Interpretation Children and their families benefited from living in SSLP areas. The contrast between these and previous findings on the effect of SSLPs might indicate increased exposure to programmes that have become more effective. Early interventions can improve the life chances of young children living in deprived areas.	[Melhuish, Edward; Belsky, Jay; Barnes, Jacqueline] Univ London Birkbeck Coll, Inst Study Children Families & Social Issues, London WC1B 3RA, England; [Leyland, Alastair H.] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of London; Birkbeck University London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT	Melhuish, E (corresponding author), Univ London Birkbeck Coll, Inst Study Children Families & Social Issues, 7 Bedford Sq, London WC1B 3RA, England.	e.melhuish@bbk.ac.uk	Leyland, Alastair/C-6069-2011	Belsky, Jay/0000-0003-2191-2503; Ram, Bina/0000-0003-0023-1573; Leyland, Alastair/0000-0003-3741-7099	Department for Children, Schools and Families (DCSF); Medical Research Council; Chief Scientist Office of the Scottish Government Health Directorates [wbs U.1300.00.001]; Medical Research Council [MC_U130059823] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059823] Funding Source: UKRI	Department for Children, Schools and Families (DCSF); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Department for Children, Schools and Families (DCSF) after competitive tender. The Medical Research Council Social and Public Health Sciences Unit is jointly funded by the Medical Research Council and the Chief Scientist Office of the Scottish Government Health Directorates (wbs U.1300.00.001).	[Anonymous], 2006, SAS MIXED MODELS; Belsky J., 2007, NATL EVALUATION SURE; Belsky J, 2006, BMJ-BRIT MED J, V332, P1476, DOI 10.1136/bmj.38853.451748.2F; Caldwell B., 1984, HOME OBSERVATION MEA; Elliot C. D., 1996, BRIT ABILITY SCALES; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; HANSEN K, 2006, MILLENNIUM COHORT ST; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; Love JM, 2005, DEV PSYCHOL, V41, P885, DOI 10.1037/0012-1649.41.6.885; MATHENY AP, 1995, J APPL DEV PSYCHOL, V16, P429, DOI 10.1016/0193-3973(95)90028-4; MEADOWS P, 2007, NATL EVALUATION SURE; MELHUISH E, 2007, NATL EVALUATION SURE; Melhuish EC, 2008, J SOC ISSUES, V64, P95, DOI 10.1111/j.1540-4560.2008.00550.x; *ODPM, 2004, ENGL IND DEPR REV; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; Pianta, 2001, STUDENT TEACHER RELA; Raghunathan TE., 2007, IVEWARE IMPUTATION V; RAMEY CT, 2000, APPL DEV SCI, V0004; Roberts C, 2006, J CLIN CHILD ADOLESC, V35, P180, DOI 10.1207/s15374424jccp3502_2; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; SAMMONS P, 2003, 8B DFES; Schafer J., 1999, ANAL INCOMPLETE MULT; STPIERRE RG, 1997, NATL IMPACT EVALUATI; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9	26	134	135	2	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1641	1647		10.1016/S0140-6736(08)61687-6	http://dx.doi.org/10.1016/S0140-6736(08)61687-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994661	Bronze, Green Submitted			2022-12-28	WOS:000260899900025
J	Schrecker, T; Labonte, R; De Vogli, R				Schrecker, Ted; Labonte, Ronald; De Vogli, Roberto			Globalisation and health: the need for a global vision	LANCET			English	Article							LABOR STANDARDS; GOVERNANCE; PATTERNS; POLICY; TRADE	The reduction of health inequities is an ethical imperative, according to the WHO Commission on Social Determinants of Health (CSDH). Drawing on detailed multidisciplinary evidence assembled by the Globalization Knowledge Network that supported the CSDH, we define globalisation in mainly economic terms. We consider and reject the presumption that globalisation will yield health benefits as a result of its contribution to rapid economic growth and associated reductions in poverty. Expanding on this point, we describe four disequalising dynamics by which contemporary globalisation causes divergence: the global reorganisation of production and emergence of a global labour-market; the increasing importance of binding trade agreements and processes to resolve disputes; the rapidly increasing mobility of financial capital; and the persistence of debt crises in developing countries. Generic policies designed to reduce health inequities are described with reference to the three Rs of redistribution, regulation, and rights. We conclude with an examination of the interconnected intellectual and institutional challenges to reduction of health inequities that are created by contemporary globalisation.	[Schrecker, Ted; Labonte, Ronald] Univ Ottawa, Dept Epidemiol & Community Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; [De Vogli, Roberto] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Ottawa; University of London; University College London	Schrecker, T (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Inst Populat Hlth, 1 Stewart St, Ottawa, ON K1N 6N5, Canada.	tschrecker@gmail.com	Labonte, Ronald/G-4229-2011	Schrecker, Ted/0000-0002-4447-5281	International Affairs Directorate of Health Canada	International Affairs Directorate of Health Canada	The thoughtful comments of three external reviewers substantially improved this article. The operations of the Globalization Knowledge Network were supported by a grant from the International Affairs Directorate of Health Canada. This paper is informed by the work of the Globalization Knowledge Network, but all views are those of the article authors, or cited authors, and are not those of Health Canada, other members of the Globalization Knowledge Network, the CSDH, or WHO. The funding agency played no role in the design or execution of the research.	*AS DEV BANK DEV I, 2007, KEY IND 2007 IN AS; Babb S, 2005, ANNU REV SOCIOL, V31, P199, DOI 10.1146/annurev.soc.31.041304.122258; Bair J, 2005, COMPET CHANG, V9, P153, DOI 10.1179/102452905X45382; Barry C, 2006, CORNELL INT LAW J, V39, P545; Baunsgaard Thomas, 2005, WP05112 IMF; Birdsall N, 1998, FOREIGN POLICY, P76, DOI 10.2307/1149380; Birdsall Nancy, 2006, WIDER ANN LECT 2005; BLOUIN C, 2008, TRADE HLTH SEEKING C; BLOUIN C, 2008, TRADE LIBERALIZATION; BROCK K, 2004, 225 IDS; BRUNNER E, 2005, SOCIAL DETERMINANTS, P6; Center for Global Development, 2007, WORK GROUP IMF PROGR; Chen S., 2008, 4703 WORLD BANK; Chowla Peter, 2007, BRIDGING DEMOCRATIC; Collier P., 2007, BOTTOM BILLION WHY P; Collier P, 2006, WORLD ECON, V29, P1423, DOI 10.1111/j.1467-9701.2006.00844.x; *COMM SECR, 2008, COMM HEADS GOV M REF; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Cornia GA, 2001, B WORLD HEALTH ORGAN, V79, P834; CORNIA GA, 2008, GLOBALISATION HLTH P; Correa CM, 2007, TRADE AND HEALTH: SEEKING COMMON GROUND, P11; *COUNTD WORK GROUP, 2008, TRACK PROGR MAT NEWB; DEACON B, 2005, 6 GASPP STAKES; Dicken P., 2007, GLOBAL SHIFT RESHAPI; Diderichsen F, 2001, CHALLENGING INEQUITI; Dollar D, 2004, ECON J, V114, pF22, DOI 10.1111/j.0013-0133.2004.00186.x; Edison HJ, 2002, J INT MONEY FINANC, V21, P749, DOI 10.1016/S0261-5606(02)00021-9; Feachem RGA, 2001, BRIT MED J, V323, P504, DOI 10.1136/bmj.323.7311.504; FREEMAN R, 2007, GLOBAL CAPITALISM UN, P23; Frobel F., 1980, NEW INT DIVISION LAB; Garcia F.J., 2004, BOSTON COLL INT COMP, V27, P291; GEORGE S, 1988, FATE WORSE DEBT; Gereffi Gary, 1994, COMMODITY CHAINS GLO; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Glenday G., 2006, FISCALLY FEASIBLE EF; Gore C., 2004, GLOBAL SOCIAL POLICY, V4, P277, DOI DOI 10.1177/146801810400400302; Gourinchas PO, 2006, REV ECON STUD, V73, P715, DOI 10.1111/j.1467-937X.2006.00393.x; Hammonds R., 2004, Health and Human Rights, V8, P27, DOI 10.2307/4065375; Helleiner E., 2001, CHALLENGE, V44, P19; Hopkins S, 2006, HEALTH POLICY, V75, P347, DOI 10.1016/j.healthpol.2005.04.002; Hunt P., 2004, EC SOCIAL CULTURAL R; *IND EV OFF INT MO, 2007, IMF AID SUBS AFR; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jenkins R., 2004, Journal of International Development, V16, P1, DOI 10.1002/jid.1059; Kabeer N, 2004, FEM ECON, V10, P3, DOI 10.1080/1354570042000198227; KAWACHI I, 2007, GLOBALISATION HLTH, P122; KICKBUSCH I, 2004, CONSTRUCTING GLOBAL; King J, 2003, ADV ODIOUS DEBT DOCT; KLINGEBIEL D., 2004, 3377 WORLD BANK; Labonte R, 2007, HLTH EQUITABLE GLOBA; LEE K, 2008, GLOBALIZATION GLOBAL; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Mandel S., 2006, DEBT RELIEF PEOPLE M; Mandel S., 2006, ODIOUS LENDING DEBT; Marchak P., 1991, INTEGRATED CIRCUS NE; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; MOSLEY L, 2006, GLOBALIZATION EGALIT, P87; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Ndikumana L, 1998, DEV CHANGE, V29, P195, DOI 10.1111/1467-7660.00076; NICKELL S, 1995, OXFORD REV ECON POL, V11, P40, DOI 10.1093/oxrep/11.1.40; Nissanke M, 2006, WORLD DEV, V34, P1338, DOI 10.1016/j.worlddev.2005.10.008; NYGRENKRUG H, 2002, HLTH HUMAN RIGHTS PU, V1; Plamenatz J, 2002, GLOBAL JUSTICE TRANS, P151; POGGE T, 2005, LEIDEN J INT LAW, V18, P717, DOI DOI 10.1017/S0922156505002980; POGGE T, 2007, FREEDOM POVERTY HUMA; Pogge T. W., 2007, FREEDOM POVERTY HUMA; PRASAD E, 2008, 3475 IZA I STUD LAB; RAMPHAL S, 1999, UNICEF PROGR NATIONS, P26; Rodriguez F.M.A., 1987, CAPITAL FLIGHT 3 WOR, P129; Rodrik D., 2007, SAVE GLOBALIZATION I; Ruger JP, 2006, J EPIDEMIOL COMMUN H, V60, P998, DOI 10.1136/jech.2005.041947; SACHS JD, 2007, HOR PROJ POL COH AV, P7; Schrecker T., 2007, GLOBALIZATION HLTH, V3, P1, DOI DOI 10.1186/1744-8603-3-5; Sepehri A, 2005, HEALTH POLICY PLANN, V20, P90, DOI 10.1093/heapol/czi011; Shaw M, 2005, BMJ-BRIT MED J, V330, P1016, DOI 10.1136/bmj.330.7498.1016; Solar O, 2007, CONCEPTUAL FRAMEWORK; Stephany Griffith-Jones, 2003, PROVIDING GLOBAL PUB, P435; Stiglitz J, 2004, WORLD TRADE REV, V3, P495, DOI DOI 10.1017/S1474745604001971; SUTCLIFFE B, 2005, 2 DESA; Teichman J, 2008, WORLD DEV, V36, P446, DOI 10.1016/j.worlddev.2007.04.010; *UN COUNTR TEAM VI, 2003, 2 UN COUNTR TEAM VET; UN Millennium Project, 2005, INV DEV PRACT PLAN A; United Nations Economic Commission for Latin America and the Caribbean, 2000, SOC PAN LAT AM 1999; VANDERHOEVEN R, 2005, FINANCIAL OPENNESS E; WILLIAMSON J, 1993, WORLD DEV, V21, P1329, DOI 10.1016/0305-750X(93)90046-C; Wood A, 1998, ECON J, V108, P1463, DOI 10.1111/1468-0297.00354; Woods N, 2006, REV INT POLIT ECON, V13, P480, DOI 10.1080/09692290600769351; Woodward David, 2006, GROWTH ISNT WORKING; World Bank, 2007, GLOB EC PROSP 2007 M; *WORLD BANK, 1995, WORLD DEV REP 1995 W	90	36	37	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1670	1676		10.1016/S0140-6736(08)61691-8	http://dx.doi.org/10.1016/S0140-6736(08)61691-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372KG	18994665				2022-12-28	WOS:000260899900029
J	Marik, PE; Plante, LA				Marik, Paul E.; Plante, Lauren A.			Current Concepts: Venous Thromboembolic Disease and Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MOLECULAR-WEIGHT HEPARIN; MASSIVE PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; RISK-FACTORS; D-DIMER; THROMBOLYTIC THERAPY; COST-EFFECTIVENESS; WOMEN; THROMBOPHILIA; POSTPARTUM		[Marik, Paul E.] Thomas Jefferson Univ, Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA; [Plante, Lauren A.] Thomas Jefferson Univ, Dept Obstet & Gynecol, Philadelphia, PA 19107 USA; [Plante, Lauren A.] Thomas Jefferson Univ, Dept Anesthesiol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Marik, PE (corresponding author), Thomas Jefferson Univ, Div Pulm & Crit Care Med, 834 Walnut St,Suite 650, Philadelphia, PA 19107 USA.	paul.marik@jefferson.edu	Plante, Lauren A./AAO-2920-2020; Marik, Paul E/U-9733-2019					[Anonymous], SAV MOTH LIV REV MAT; Baglin TP, 2006, BRIT J HAEMATOL, V134, P590, DOI 10.1111/j.1365-2141.2006.06226.x; Bank I, 2003, J THROMB HAEMOST, V1, P859, DOI 10.1046/j.1538-7836.2003.t01-7-00115.x; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bonnar J, 1999, AM J OBSTET GYNECOL, V180, P784, DOI 10.1016/S0002-9378(99)70648-4; BRANCAZIO LR, 1995, AM J OBSTET GYNECOL, V173, P1240, DOI 10.1016/0002-9378(95)91362-9; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Brill-Edwards P, 2000, NEW ENGL J MED, V343, P1439, DOI 10.1056/NEJM200011163432002; Casele HL, 1999, AM J OBSTET GYNECOL, V181, P1113, DOI 10.1016/S0002-9378(99)70091-8; Chan WS, 2007, ANN INTERN MED, V147, P165, DOI 10.7326/0003-4819-147-3-200708070-00005; Clark P, 2002, LANCET, V359, P1919, DOI 10.1016/S0140-6736(02)08740-8; De Stefano V, 2006, BRIT J HAEMATOL, V135, P386, DOI 10.1111/j.1365-2141.2006.06317.x; Dempfle CEH, 2004, NEW ENGL J MED, V350, P1914, DOI 10.1056/NEJM200404293501825; Duhl AJ, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.022; Eichinger S, 1999, THROMB HAEMOSTASIS, V82, P1232; Eskandari MK, 2000, ANGIOLOGY, V51, P705; Fagher B, 1990, ACTA OBSTET GYN SCAN, V69, P659, DOI 10.3109/00016349009028716; FORESTIER F, 1984, THROMB RES, V34, P557, DOI 10.1016/0049-3848(84)90260-3; Fraser DGW, 2002, ANN INTERN MED, V136, P89, DOI 10.7326/0003-4819-136-2-200201150-00006; FREDE TE, 1988, J ULTRAS MED, V7, P33, DOI 10.7863/jum.1988.7.1.33; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gerhardt A, 2007, THROMB HAEMOSTASIS, V97, P496, DOI 10.1160/TH06-10-0577; GINSBERG JS, 1992, THROMB HAEMOSTASIS, V67, P519; Greer IA, 2006, J THROMB THROMBOLYS, V21, P57, DOI 10.1007/s11239-006-5578-5; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9; Greer IA, 1997, BAILLIERE CLIN OB GY, V11, P403, DOI 10.1016/S0950-3552(97)80019-3; Groves AM, 2006, RADIOLOGY, V240, P765, DOI 10.1148/radiol.2403050910; HALL RJC, 1972, BMJ-BRIT MED J, V4, P647, DOI 10.1136/bmj.4.5841.647; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Horlocker TT, 2003, REGION ANESTH PAIN M, V28, P172, DOI 10.1053/rapm.2003.50046; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2005, AM J OBSTET GYNECOL, V193, P216, DOI 10.1016/j.ajog.2004.11.037; Kearon C, 1998, ANN INTERN MED, V129, P425, DOI 10.7326/0003-4819-128-8-199804150-00011; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Kopp Sandra L, 2008, Anesthesiol Clin, V26, P1, DOI 10.1016/j.anclin.2007.12.002; Lagrange F, 2002, THROMB HAEMOSTASIS, V87, P831; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Lee HC, 2003, J KOREAN MED SCI, V18, P764, DOI 10.3346/jkms.2003.18.5.764; Leonhardt G, 2006, J THROMB THROMBOLYS, V21, P271, DOI 10.1007/s11239-006-5709-z; Lindqvist P, 1999, OBSTET GYNECOL, V94, P595, DOI 10.1016/S0029-7844(99)00308-7; Macklon NS, 1996, SCOT MED J, V41, P83, DOI 10.1177/003693309604100305; Macklon NS, 1997, BRIT J OBSTET GYNAEC, V104, P191, DOI 10.1111/j.1471-0528.1997.tb11043.x; Macklon NS, 1997, BRIT J OBSTET GYNAEC, V104, P198, DOI 10.1111/j.1471-0528.1997.tb11044.x; McColl MD, 2000, BRIT J HAEMATOL, V108, P272; Meignan M, 2000, ARCH INTERN MED, V160, P159, DOI 10.1001/archinte.160.2.159; Merhi Z, 2006, OBSTET GYNECOL, V107, P468, DOI 10.1097/01.AOG.0000167390.40616.ca; Morris TA, 2005, THROMB RES, V115, P45, DOI 10.1016/j.thromres.2004.07.010; *NAT I CLIN EXC, 2003, WHY MOTH DIE 2000 20; Nelson SM, 2006, OBSTET GYN CLIN N AM, V33, P413, DOI 10.1016/j.ogc.2006.05.009; Nijkeuter M, 2006, CRIT CARE MED, V34, P2701, DOI 10.1097/01.CCM.0000240786.73945.9F; Pabinger I, 2005, J THROMB HAEMOST, V3, P949, DOI 10.1111/j.1538-7836.2005.01307.x; PATI S, 1994, REPROD TOXICOL, V8, P115, DOI 10.1016/0890-6238(94)90018-3; Pettila V, 2002, THROMB HAEMOSTASIS, V87, P182; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; Rodger MA, 2006, AM J OBSTET GYNECOL, V194, P436, DOI 10.1016/j.ajog.2005.07.044; Rodie VA, 2002, BJOG-INT J OBSTET GY, V109, P1020, DOI 10.1016/S1470-0328(02)01525-2; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; *ROYAL COLL OBSTET, 1995, REP RCOG WORK PART P; Royal College of Obstetrics and Gynaecologists, 2007, THROMB DIS PREGN PUE; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Sephton V, 2003, OBSTET GYNECOL, V101, P1307, DOI 10.1016/S0029-7844(03)00340-5; Simioni P, 2001, THROMB HAEMOSTASIS, V86, P929, DOI 10.1055/s-0037-1616153; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Stefanovic BS, 2006, AM J EMERG MED, V24, P502, DOI 10.1016/j.ajem.2005.12.003; The Royal College of Obstetricians and Gynecologists, 2004, THROMB PREGN LAB VAG; To MS, 2008, J OBSTET GYNAECOL, V28, P222, DOI 10.1080/01443610801915975; Trujillo-Santos J, 2005, CHEST, V127, P1631, DOI 10.1378/chest.127.5.1631; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; Verdonkschot A. E. M., 2005, Archives of Gynecology and Obstetrics, V271, P163, DOI 10.1007/s00404-004-0615-0; Walker ID, 2001, BRIT J HAEMATOL, V114, P512, DOI 10.1046/j.1365-2141.2001.02981.x; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wesseling J, 2001, THROMB HAEMOSTASIS, V85, P609, DOI 10.1055/s-0037-1615641; Winer-Muram HT, 2002, RADIOLOGY, V224, P487, DOI 10.1148/radiol.2242011581; Wu O, 2005, BRIT J HAEMATOL, V131, P80, DOI 10.1111/j.1365-2141.2005.05715.x; ZERHOUNI EA, 1980, AM J ROENTGENOL, V134, P753, DOI 10.2214/ajr.134.4.753	81	261	280	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					2025	2033		10.1056/NEJMra0707993	http://dx.doi.org/10.1056/NEJMra0707993			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18987370				2022-12-28	WOS:000260632700007
J	Hou, C; Zuo, WY; Moses, ME; Woodruff, WH; Brown, JH; West, GB				Hou, Chen; Zuo, Wenyun; Moses, Melanie E.; Woodruff, William H.; Brown, James H.; West, Geoffrey B.			Energy Uptake and Allocation During Ontogeny	SCIENCE			English	Article							DYNAMIC ACTION; GROWTH; MODEL; SDA	All organisms face the problem of how to fuel ontogenetic growth. We present a model, empirically grounded in data from birds and mammals, that correctly predicts how growing animals allocate food energy between synthesis of new biomass and maintenance of existing biomass. Previous energy budget models have typically had their bases in rates of either food consumption or metabolic energy expenditure. Our model provides a framework that reconciles these two approaches and highlights the fundamental principles that determine rates of food assimilation and rates of energy allocation to maintenance, biosynthesis, activity, and storage. The model predicts that growth and assimilation rates for all animals should cluster closely around two universal curves. Data for mammals and birds of diverse body sizes and taxa support these predictions.	[Hou, Chen; Woodruff, William H.; Brown, James H.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Zuo, Wenyun; Brown, James H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Woodruff, William H.; West, Geoffrey B.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	The Santa Fe Institute; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory	Hou, C (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	houc@santafe.edu	Woodruff, William/AAH-6890-2021	Hou, Chen/0000-0002-3665-225X; ZUO, WENYUN/0000-0002-7623-0481	NIH [P20 RR-018754, DK36263]; NSF [DEB-0083422, CCF0621900, PHY 0706174, PHY 0202180]; Thaw Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Thaw Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants P20 RR-018754 (for M.E.M.) and DK36263 (for W.H.W.) and by NSF grants DEB-0083422 and CCF0621900 (for J.H.B.) and PHY 0706174 and PHY 0202180 (for G.B.W.) G.B.W. also acknowledges the Thaw Charitable Trust for its support.	ASHWORTH A, 1969, NATURE, V223, P407, DOI 10.1038/223407a0; BLAXTER KL, 1989, ENERGY METABOLISM AN; Brody S, 1964, BIOENERGETICS GROWTH; Cummins K. W, 1971, Mitt int Verein theor angew Limnol, VNo. 18, P1; EVANS E, 1968, P NUTR SOC, V27, P121, DOI 10.1079/PNS19680036; JOBLING M, 1983, J FISH BIOL, V23, P549, DOI 10.1111/j.1095-8649.1983.tb02934.x; KIRKWOOD JK, 1991, J NUTR S, V121, P29; Kleiber M., 1961, FIRE LIFE INTRO ANIM; KRIEGER I, 1978, AM J CLIN NUTR, V31, P764, DOI 10.1093/ajcn/31.5.764; Makarieva AM, 2004, ECOL MODEL, V176, P15, DOI 10.1016/j.ecolmodel.2003.09.037; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; Moses ME, 2008, AM NAT, V171, P632, DOI 10.1086/587073; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; RICKLEFS R. E., 1974, NUTTALL ORNITHOLOGIC, p[152, 15]; Ricklefs RE, 2003, FUNCT ECOL, V17, P384, DOI 10.1046/j.1365-2435.2003.00745.x; Robbins C.T., 1983, WILDLIFE FEEDING NUT; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; WITHERS PC, 1992, COMP ANIMAL PHYSL	19	128	134	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					736	739		10.1126/science.1162302	http://dx.doi.org/10.1126/science.1162302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18974352	Green Accepted			2022-12-28	WOS:000260605200047
J	Turrigiano, GG				Turrigiano, Gina G.			The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses	CELL			English	Review							ACTIVITY-DEPENDENT REGULATION; AMPA RECEPTOR TRAFFICKING; HOMEOSTATIC PLASTICITY; QUANTAL AMPLITUDE; RELEASE PROBABILITY; VESICULAR GLUTAMATE; EXPRESSION; BDNF; ARC/ARG3.1; SUBUNIT	Homeostatic synaptic scaling is a form of synaptic plasticity that adjusts the strength of all of a neuron's excitatory synapses up or down to stabilize firing. Current evidence suggests that neurons detect changes in their own firing rates through a set of calcium-dependent sensors that then regulate receptor trafficking to increase or decrease the accumulation of glutamate receptors at synaptic sites. Additional mechanisms may allow local or network-wide changes in activity to be sensed through parallel pathways, generating a nested set of homeostatic mechanisms that operate over different temporal and spatial scales.	[Turrigiano, Gina G.] Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA; [Turrigiano, Gina G.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA.	turrigiano@brandeis.edu			NS [36853, EY14439]; National Institutes of Health Director's Pioneer Award; NATIONAL EYE INSTITUTE [R01EY014439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS036853, R01NS036853] Funding Source: NIH RePORTER	NS; National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I thank all current and former members of my lab and many collaborators and colleagues for their important contributions to these ideas. G. G. T. is supported by NS 36853, EY14439, and a National Institutes of Health Director's Pioneer Award.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cannon W.B., 1932, WISDOM BODY; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Copi A, 2005, J NEUROPHYSIOL, V94, P4538, DOI 10.1152/jn.00155.2005; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Desai NS, 2003, J PHYSIOL-PARIS, V97, P391, DOI 10.1016/j.jphysparis.2004.01.005; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Li BS, 2000, J NEUROSCI, V20, P6055, DOI 10.1523/JNEUROSCI.20-16-06055.2000; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu Z, 1998, J NEUROSCI, V18, P2309; Lobo FM, 1999, J IMMUNOL, V162, P2057; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marder E, 2003, NEURON, V37, P2, DOI 10.1016/S0896-6273(02)01173-X; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MCLEAN BM, 2000, J NEUROSCI, V20, P3221; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rabinowitch I, 2008, TRENDS NEUROSCI, V31, P377, DOI 10.1016/j.tins.2008.05.005; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sjostrom PJ, 2007, NEUROPHARMACOLOGY, V52, P176, DOI 10.1016/j.neuropharm.2006.07.021; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Sullivan TJ, 2006, NEURAL NETWORKS, V19, P734, DOI 10.1016/j.neunet.2006.05.006; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	99	968	974	3	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 31	2008	135	3					422	435		10.1016/j.cell.2008.10.008	http://dx.doi.org/10.1016/j.cell.2008.10.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	367EW	18984155	Bronze, Green Accepted			2022-12-28	WOS:000260536300014
J	Ridker, PM; Danielson, E; Fonseca, FAH; Genest, J; Gotto, AM; Kastelein, JJP; Koenig, W; Libby, P; Lorenzatti, AJ; MacFadyen, JG; Nordestgaard, BG; Shepherd, J; Willerson, JT; Glynn, RJ				Ridker, Paul M.; Danielson, Eleanor; Fonseca, Francisco A. H.; Genest, Jacques; Gotto, Antonio M., Jr.; Kastelein, John J. P.; Koenig, Wolfgang; Libby, Peter; Lorenzatti, Alberto J.; MacFadyen, Jean G.; Nordestgaard, Borge G.; Shepherd, James; Willerson, James T.; Glynn, Robert J.		JUPITER Study Grp	Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; STATIN THERAPY; PRAVASTATIN; RISK; INFLAMMATION; TRIALS; PREDICTION; ATHEROSCLEROSIS	Background: Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as well as cholesterol, we hypothesized that people with elevated high-sensitivity C-reactive protein levels but without hyperlipidemia might benefit from statin treatment. Methods: We randomly assigned 17,802 apparently healthy men and women with low-density lipoprotein (LDL) cholesterol levels of less than 130 mg per deciliter (3.4 mmol per liter) and high-sensitivity C-reactive protein levels of 2.0 mg per liter or higher to rosuvastatin, 20 mg daily, or placebo and followed them for the occurrence of the combined primary end point of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from cardiovascular causes. Results: The trial was stopped after a median follow-up of 1.9 years (maximum, 5.0). Rosuvastatin reduced LDL cholesterol levels by 50% and high-sensitivity C-reactive protein levels by 37%. The rates of the primary end point were 0.77 and 1.36 per 100 person-years of follow-up in the rosuvastatin and placebo groups, respectively (hazard ratio for rosuvastatin, 0.56; 95% confidence interval [CI], 0.46 to 0.69; P<0.00001), with corresponding rates of 0.17 and 0.37 for myocardial infarction (hazard ratio, 0.46; 95% CI, 0.30 to 0.70; P=0.0002), 0.18 and 0.34 for stroke (hazard ratio, 0.52; 95% CI, 0.34 to 0.79; P=0.002), 0.41 and 0.77 for revascularization or unstable angina (hazard ratio, 0.53; 95% CI, 0.40 to 0.70; P<0.00001), 0.45 and 0.85 for the combined end point of myocardial infarction, stroke, or death from cardiovascular causes (hazard ratio, 0.53; 95% CI, 0.40 to 0.69; P<0.00001), and 1.00 and 1.25 for death from any cause (hazard ratio, 0.80; 95% CI, 0.67 to 0.97; P=0.02). Consistent effects were observed in all subgroups evaluated. The rosuvastatin group did not have a significant increase in myopathy or cancer but did have a higher incidence of physician-reported diabetes. Conclusions: In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence of major cardiovascular events. (ClinicalTrials.gov number, NCT00239681.).	[Ridker, Paul M.; Danielson, Eleanor; MacFadyen, Jean G.; Glynn, Robert J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Ridker, Paul M.; Libby, Peter] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02215 USA; [Fonseca, Francisco A. H.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Genest, Jacques] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Gotto, Antonio M., Jr.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Ulm, Germany; [Lorenzatti, Alberto J.] Hosp Cordoba, Cordoba, Argentina; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Herlev, Denmark; [Shepherd, James] Univ Glasgow, Glasgow, Lanark, Scotland; [Willerson, James T.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); McGill University; Cornell University; University of Amsterdam; Academic Medical Center Amsterdam; Ulm University; University of Copenhagen; Herlev & Gentofte Hospital; University of Glasgow; Saint Lukes Episcopal Hospital; Texas Heart Institute	Ridker, PM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA.	pridker@partners.org	Complexos, INCT Fluidos/H-9172-2013; Karpov, Rostislav S./F-5406-2014; Buczkowski, Krzysztof/H-7696-2014; Fonseca, Francisco Antonio Helfenstein/A-6480-2010; Baguet, Jean-Philippe/M-5536-2014; Urina-Triana, Miguel A/H-2605-2016; Marchev, Sotir/AAH-6529-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Yarokhno, Natalya/R-4854-2017; Buczkowski, Krzysztof/O-5443-2019; Libby, Peter/AAY-6404-2021; Kastelein, John/AAF-7950-2020; JARDIM, PAULO CESAR/C-4574-2015	Karpov, Rostislav S./0000-0002-7011-4316; Buczkowski, Krzysztof/0000-0002-7700-0952; Fonseca, Francisco Antonio Helfenstein/0000-0002-9911-4598; Urina-Triana, Miguel A/0000-0001-6003-4622; Marchev, Sotir/0000-0001-9250-510X; Yarokhno, Natalya/0000-0003-2055-648X; Buczkowski, Krzysztof/0000-0002-7700-0952; Libby, Peter/0000-0002-1502-502X; Lawlor, Debbie A/0000-0002-6793-2262; Ruiz, Alvaro J/0000-0001-6528-4268; Koenig, Wolfgang/0000-0002-2064-9603; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Bhorat, Qasim Ebrahim/0000-0002-4102-8750; JARDIM, PAULO CESAR/0000-0002-5333-013X; Mora, Samia/0000-0001-6283-0980; BOBESCU, ELENA/0000-0002-0945-9067; da Silva Franco, Roberto Jorge/0000-0001-9787-4393; Costa Duarte Barbosa, Eduardo/0000-0002-4361-936X	AstraZeneca; Novartis; Merck; Abbott; Roche; Sanofi-Aventis; Merck-Schering-Plough; Isis; Dade Behring; Vascular Biogenics; Pfizer; Merck Frosst; Resverlogix; Dupont; Aegerion; Arisaph; Kowa; Genentech; Martek; Reliant; Genzyme; GlaxoSmithKline; Boehringer Ingelheim; DiaDexus; Medlogix; Anthera; Bristol-Myers Squibb; VIA Pharmaceuticals; Interleukin Genetics; Kowa Research Institute; Takeda; BG Medicine; Oxford Biosciences	AstraZeneca(AstraZeneca); Novartis(Novartis); Merck(Merck & Company); Abbott(Abbott Laboratories); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Merck-Schering-Plough(Merck & CompanySchering Plough Corporation); Isis; Dade Behring; Vascular Biogenics; Pfizer(Pfizer); Merck Frosst; Resverlogix; Dupont; Aegerion; Arisaph; Kowa; Genentech(Roche HoldingGenentech); Martek; Reliant; Genzyme(Sanofi-AventisGenzyme Corporation); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); DiaDexus; Medlogix; Anthera; Bristol-Myers Squibb(Bristol-Myers Squibb); VIA Pharmaceuticals; Interleukin Genetics; Kowa Research Institute; Takeda(Takeda Pharmaceutical Company Ltd); BG Medicine; Oxford Biosciences	Supported by AstraZeneca.; Dr. Ridker reports receiving grant support from AstraZeneca, Novartis, Merck, Abbott, Roche, and Sanofi-Aventis; consulting fees or lecture fees or both from AstraZeneca, Novartis, Merck, Merck-Schering-Plough, Sanofi-Aventis, Isis, Dade Behring, and Vascular Biogenics; and is listed as a coinventor on patents held by Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease, including the use of high-sensitivity C-reactive protein in the evaluation of patients' risk of cardiovascular disease. These patents have been licensed to Dade Behring and AstraZeneca. Dr. Fonseca reports receiving research grants, lecture fees, and consulting fees from AstraZeneca, Pfizer, Schering-Plough, Sanofi-Aventis, and Merck; and Dr. Genest, lecture fees from AstraZeneca, Schering-Plough, Merck-Schering-Plough, Pfizer, Novartis, and Sanofi-Aventis and consulting fees from AstraZeneca, Merck, Merck Frosst, Schering-Plough, Pfizer, Novartis, Resverlogix, and Sanofi-Aventis. Dr. Gotto reports receiving consulting fees from Dupont, Novartis, Aegerion, Arisaph, Kowa, Merck, Merck-Schering-Plough, Pfizer, Genentech, Martek, and Reliant; serving as an expert witness; and receiving publication royalties. Dr. Kastelein reports receiving grant support from AstraZeneca, Pfizer, Roche, Novartis, Merck, Merck-Schering-Plough, Isis, Genzyme, and Sanofi-Aventis; lecture fees from AstraZeneca, GlaxoSmithKline, Pfizer, Novartis, Merck-Schering-Plough, Roche, Isis, and Boehringer Ingelheim; and consulting fees from AstraZeneca, Abbott, Pfizer, Isis, Genzyme, Roche, Novartis, Merck, Merck-Schering-Plough, and Sanofi-Aventis. Dr. Koenig reports receiving grant support from AstraZeneca, Roche, Anthera, Dade Behring and GlaxoSmithKline; lecture fees from AstraZeneca, Pfizer, Novartis, GlaxoSmithKline, DiaDexus, Roche, and Boehringer Ingelheim; and consulting fees from GlaxoSmithKline, Medlogix, Anthera, and Roche. Dr. Libby reports receiving lecture fees from Pfizer and lecture or consulting fees from AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Pfizer, Sanofi- Aventis, VIA Pharmaceuticals, Interleukin Genetics, Kowa Research Institute, Novartis, and Merck-Schering-Plough. Dr. Lorenzatti reports receiving grant support, lecture fees, and consulting fees from AstraZeneca, Takeda, and Novartis; Dr. Nordestgaard, lecture fees from AstraZeneca, Sanofi- Aventis, Pfizer, Boehringer Ingelheim, and Merck and consulting fees from AstraZeneca and BG Medicine; Dr. Shepherd, lecture fees from AstraZeneca, Pfizer, and Merck and consulting fees from AstraZeneca, Merck, Roche, GlaxoSmithKline, Pfizer, Nicox, and Oxford Biosciences; and Dr. Glynn, grant support from AstraZeneca and Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.; We thank the 17,802 study participants, their individual physicians, and the medical and clinical teams at AstraZeneca for their personal time and commitment to this project.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Grundy, 2004, CIRCULATION, V110, P763, DOI 10.1161/01.CIR.0000140446.06098.6B; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Morrow DA, 2006, CIRCULATION, V114, P281, DOI 10.1161/CIRCULATIONAHA.106.628909; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Ridker PM, 2008, ARTERIOSCL THROM VAS, V28, P1222, DOI 10.1161/ATVBAHA.108.168989; Ridker PM, 2007, AM J CARDIOL, V100, P1659, DOI 10.1016/j.amjcard.2007.09.072; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 2005, J AM COLL CARDIOL, V45, P1644, DOI 10.1016/j.jacc.2005.02.080; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sabatine MS, 2004, CIRCULATION, V110, P834; Sasaki J, 2006, J ATHEROSCLER THROMB, V13, P123, DOI 10.5551/jat.13.123; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001	31	4721	5037	13	451	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2008	359	21					2195	2207		10.1056/NEJMoa0807646	http://dx.doi.org/10.1056/NEJMoa0807646			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	373SW	18997196	Bronze			2022-12-28	WOS:000260994000003
